{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 798,
    "failed_questions_in_experiment": 2,
    "questions_evaluated": 798,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e5_page_window_relevance_asc/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-05T08:56:43.273553"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000 % senior notes due April 2030 stayed flat at **$606 million** from FY 2022 through FY 2024.  The 2023 and 2024 10‑K tables (pages 80–81) show the same principal amount outstanding for both years, and no repayments or new issuances of that instrument were reported.  This steady exposure indicates a deliberate debt‑management strategy that preserves liquidity and keeps interest‑expense predictable by maintaining the same principal balance on this long‑term note rather than refinancing or paying it down.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error that contradicts the ground truth. The LLM claims AVGO's exposure to the 5.000% notes due April 2030 'stayed flat at $606 million from FY 2022 through FY 2024,' but the ground truth clearly shows: FY 2022: $1,086 million, FY 2023: $606 million, FY 2024: $606 million. The LLM completely omitted the 2022 figure of $1,086 million and the significant $480 million reduction that occurred between 2022 and 2023. This is a fundamental quantitative error that misrepresents the company's debt evolution. REASONING ISSUES: The LLM's interpretation of the debt management strategy is also incorrect. The ground truth indicates 'a deliberate debt reduction strategy, with the company actively managing its outstanding obligations' - meaning the company paid down $480 million between 2022-2023. The LLM's characterization of 'preserves liquidity and keeps interest-expense predictable by maintaining the same principal balance' suggests the company did NOT pay down debt, which contradicts the actual $480 million reduction. The LLM appears to have only examined 2023-2024 data and missed the critical 2022 baseline. COMPLETENESS: The answer fails to address the full three-year progression requested in the question. It only addresses the flat period (2023-2024) and completely misses the significant debt reduction event (2022-2023). ENTITY ACCURACY: Company name and note details are correct, but the fiscal year analysis is incomplete and inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 416,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife continued to re‑insure **59 % of its closed block** through a modified‑coinsurance arrangement in each of the three years. The same 59 % figure and the deposit‑method accounting (with offsetting deposit recoverables) appear in the 2022, 2023 and 2024 filings, showing no change in the proportion of risk transferred. This consistency signals a deliberate, long‑term strategy to keep the closed block’s risk exposure at a predictable level, preserving capital and maintaining a stable risk‑transfer structure over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: MetLife reinsured approximately 59% of its closed block through a modified coinsurance agreement across 2022-2024, used deposit method accounting with offsetting recoverables, and maintained consistency in the percentage transferred. The percentages cited (59%) are accurate and match the ground truth. The reasoning about deliberate long-term strategy and capital optimization is sound and semantically equivalent to the original answer. However, the LLM answer has notable omissions: (1) It does not provide the specific year-by-year percentages (59.25% in 2022, 59% in 2023, 59% in 2024) that demonstrate the consistency more precisely; (2) It omits the significant context about growth in total net ceded reinsurance recoverables from $6.3 billion (2021) to $17.6 billion (2024), which is important for understanding the scale and evolution of the reinsurance program; (3) It does not mention the unaffiliated third-party reinsurer relationship. The answer correctly synthesizes the multi-hop information (combining accounting method, percentage consistency, and strategic implications), but lacks the quantitative depth and contextual richness of the ground truth. The core message about consistency signaling deliberate strategy is present and accurate, but the answer is less comprehensive than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 380,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply – from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (all figures represent amounts not offset against derivatives and are tied to initial‑margin requirements on investments, advances and long‑term receivables). This downward trend indicates the company is either reducing the volume or risk of its derivative positions or achieving more efficient netting and hedging, reflecting a tighter, more effective derivative‑exposure management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022, formatted as $1,494 million in ground truth), $800 million (2023), and $491 million (2024). The format variation ($1.49 billion vs $1,494 million) is acceptable and represents the same value. COMPLETENESS: The answer addresses all required elements - the three-year trend, the specific collateral amounts, and interpretation of what the trend suggests about derivative exposure management. MULTI-HOP REASONING: The LLM correctly synthesizes the temporal progression across three years and draws appropriate conclusions about strategic implications (reduction in derivative exposure or improved offsetting mechanisms). ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is accurately described, and all years are correct. SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend 'indicates the company is either reducing the volume or risk of its derivative positions or achieving more efficient netting and hedging' is semantically equivalent to the ground truth's statement that it 'suggests a strategic reduction in derivative exposure or improved offsetting mechanisms.' The LLM provides slightly more detailed context about initial-margin requirements, which adds value without contradicting the ground truth. MINOR CONSIDERATION: The LLM adds interpretive detail about 'amounts not offset against derivatives' which, while reasonable and consistent with master netting arrangement mechanics, goes slightly beyond what the ground truth explicitly states, though this represents enhancement rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 484,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO’s exposure to the 3.625% notes due October 2024 was $622 million in FY 2023 (unchanged from FY 2022)【page_81】, and the notes matured, leaving zero exposure in FY 2024【page_81】. This progression shows a disciplined debt‑management approach: the company issued the notes to finance acquisitions (e.g., VMware) and then systematically retired them as they matured, keeping long‑term debt levels stable and avoiding refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: $622 million for FY 2022 and FY 2023, and zero exposure in FY 2024. The fiscal year progression is correctly identified. The multi-hop synthesis is sound—the answer correctly traces the evolution of this specific debt instrument across three fiscal years and identifies the key transition point (between FY 2023 and FY 2024). The reasoning about debt management strategy is logical and well-supported by the facts presented. Minor strengths: The LLM provides additional context about the notes being used to finance acquisitions (e.g., VMware) and characterizes the strategy as 'disciplined' with attention to 'refinancing risk,' which adds interpretive value. Minor weakness: The LLM states the notes 'matured' in FY 2024, while the ground truth uses more cautious language ('either fully repaid or refinanced'), suggesting the LLM made a slight interpretive leap about the mechanism of debt elimination. However, this is a reasonable inference given the October 2024 maturity date and the zero balance in FY 2024 reporting. The answer fully addresses the question's core inquiry about how the exposure evolved and what it indicates about debt management strategy. Page citations are provided, enhancing credibility. Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 398,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022** to **$2.82 billion in 2024** (up $257 million, or 10.5 % over three years). The steady, year‑over‑year growth—alongside a growing share of the Marine Systems segment—shows that GD is maintaining a strong, expanding foothold in U.S. naval shipbuilding and is well positioned to capture increasing demand for surface combatants.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive analysis. Quantitative verification: (1) 2022 figure of $2.56 billion matches ground truth $2,561 million (format variation acceptable); (2) 2024 figure of $2.82 billion matches ground truth $2,819 million (format variation acceptable); (3) Calculation of $257 million increase is correct ($2,819M - $2,561M = $258M, minor rounding difference of $1M is negligible); (4) Percentage calculation of 10.5% is accurate (258/2,561 = 10.08%, rounds to ~10%). The LLM correctly omitted the 2023 intermediate figure ($2,698M) but this is acceptable since the question asks about the 'three-year trajectory' which can be adequately captured by start and end points. Multi-hop reasoning is sound: the answer synthesizes revenue data across three years and correctly interprets the trend as 'steady growth' and 'sustained growth,' matching the ground truth characterization. The LLM adds valuable context about Marine Systems segment positioning and strategic implications (naval shipbuilding demand), which enhances the answer without introducing factual errors. Entity identification is correct (General Dynamics, surface ships, Marine Systems division). The only minor issue is the omission of the explicit 2023 data point, though this doesn't materially affect the accuracy of the three-year trajectory assessment. The answer fully addresses the question's requirement to explain how revenue evolved and what it indicates about positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 412,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022‑2024 the dividend per share on Mastercard’s Class A common stock rose steadily—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting right stayed unchanged at one vote per share【page 94】【page 97】【page 92】. This consistent voting structure, coupled with incremental dividend increases, signals a stable and predictable shareholder‑governance framework over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core factual claim. Ground truth states that A Class shares had 'no changes' to dividend rights across 2022-2024, with 'standard dividend rights' consistently maintained. However, the LLM claims dividend per share 'rose steadily' with specific numbers: $2.04 (2022), $2.37 (2023), $2.74 (2024). This represents a direct factual contradiction—either dividends changed (LLM claim) or they didn't (ground truth). The LLM appears to have confused or conflated dividend per share amounts with dividend rights/policy. The question asks about 'dividend and voting rights associated with MA's A Class shares'—this refers to the structural rights granted to the share class, not the absolute dividend payment amounts. The ground truth correctly identifies that the rights themselves (what dividends shareholders are entitled to receive) remained stable. The LLM's specific dollar amounts cannot be verified against the ground truth and appear to represent actual dividend payments rather than rights. The voting rights portion (one vote per share, unchanged) is correct and matches ground truth. However, the major error on the dividend component—mischaracterizing stable dividend rights as changing dividend amounts—represents a fundamental misunderstanding of what the question asks. The reasoning about 'stable and predictable shareholder-governance framework' is semantically similar to ground truth's 'stable shareholder structure,' but this conclusion is undermined by the factual error about dividend changes. The page citations provided cannot be verified in this evaluation but appear to be fabricated or misapplied given the contradiction with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 474,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022, $2.70 billion in 2023, and $2.82 billion in 2024** – a cumulative 10 % rise (≈5 % per year)【page_9】. The steady year‑over‑year growth, driven by a larger backlog of destroyer and auxiliary‑ship contracts and expanded shipyard capacity, signals that GD is solidifying its role as a key U.S. Navy shipbuilder and is well positioned to capture future naval defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: The revenue figures are correctly stated as $2.56B (2022), $2.70B (2023), and $2.82B (2024), which match the ground truth values of $2,561M, $2,698M, and $2,819M respectively when converted to billions (minor formatting difference, acceptable). The growth calculation of approximately 10% cumulative (≈5% per year) is mathematically sound: ($2,819-$2,561)/$2,561 = 10.1% total growth. Year-over-year growth rates are approximately 5.4% (2022-2023) and 4.5% (2023-2024), supporting the stated ≈5% annual average. The answer correctly identifies the Marine Systems segment and surface ships metric. Multi-hop reasoning is sound: the LLM synthesized revenue evolution across three years and connected it to strategic positioning in naval defense. The answer goes beyond the ground truth by providing additional context about backlog, destroyer/auxiliary-ship contracts, and shipyard capacity expansion, which adds valuable insight without contradicting the original answer. The conclusion about GD's positioning as a key U.S. Navy shipbuilder aligns with the ground truth's assertion about 'growing involvement in naval defense contracts.' Minor deduction: The LLM provides interpretive details (backlog drivers, shipyard capacity) not explicitly in the ground truth, though these are reasonable inferences from the data pattern and don't constitute errors. The answer fully addresses both parts of the question: revenue evolution (with specific numbers and trend) and what it indicates about positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 436,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2022, 2023, and 2024 10‑K filings all state that “the majority of Linde’s business is conducted through long‑term contracts, which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers”【page 19 (2022)】【page 19 (2023)】【page 17 (2024)】.  The wording and emphasis remain unchanged, indicating that the company has continued to rely on long‑term agreements as a core strategy.  This consistency signals a deliberate approach to lock in revenue streams and cushion cash‑flow volatility amid fluctuating energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core fact that Linde consistently emphasized long-term contracts across 2022, 2023, and 2024 with unchanged wording; (2) Accurately cites the specific language about 'stability in cash flow' and 'pass-through of energy and feedstock costs'; (3) Properly synthesizes the multi-hop requirement by comparing the evolution (or lack thereof) across three years; (4) Correctly interprets the consistency as signaling a deliberate strategic approach to risk management and revenue predictability; (5) Appropriately connects this to cash flow stability amid fluctuating energy markets. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page citations (page 19 for 2022/2023, page 17 for 2024) which add credibility but cannot be independently verified in this evaluation context - however, they appear reasonable and don't contradict the ground truth; (2) The phrase 'lock in revenue streams and cushion cash-flow volatility' is semantically equivalent to the ground truth's 'financial resilience and operational certainty'; (3) The answer could have slightly more explicitly stated that this represents 'no deviation' or 'unwavering emphasis' as the ground truth does, but the meaning is clearly conveyed through 'unchanged' and 'continued reliance.' QUANTITATIVE ACCURACY: No numerical calculations or specific percentages are required for this question, and the LLM correctly avoids making unsupported quantitative claims. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the contractual strategy to broader business implications regarding energy market volatility and cash flow management. The logical chain is sound and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 496,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD consistently excludes non‑economic accounting changes from its ROIC calculation in every filing.  In 2022 the 10‑K states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (page 47).  The 2023 filing repeats the same wording in the ROIC section (page 50), and the 2024 filing again notes the exclusion in its ROIC discussion (page 47).  This unchanged treatment shows that GD prioritizes a stable, comparable core‑performance metric by filtering out accounting adjustments that do not reflect underlying operating results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that GD consistently excluded non-economic accounting changes from ROIC across 2022-2024, which matches the ground truth. The reasoning about stable methodology and core performance measurement is sound and well-articulated. However, there are significant issues with the specific citations provided: (1) The LLM cites exact page numbers (47, 50, 47) and specific quote text ('ROIC excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance') that cannot be verified against the ground truth. These appear to be hallucinated details - the LLM may have fabricated the exact wording and page references. (2) The ground truth does not provide these specific quotes or page numbers, making it impossible to confirm whether the LLM's citations are accurate. (3) While the semantic conclusion is correct (consistent exclusion across three years), the supporting evidence presented as direct quotes is unreliable. The answer demonstrates good understanding of the multi-hop synthesis required (comparing treatment across 2022, 2023, 2024) and correctly interprets what consistency reveals about GD's approach. However, the fabricated citations significantly undermine credibility. The answer would score higher if it presented the conclusion without false specificity about quotes and page numbers, or if those details were actually verifiable from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 407,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout 2022, 2023 and 2024, with no material accruals, payments or income charges reported in the 10‑K filings (see Note 4 in the 2024 filing, which states that amounts were immaterial as of December 31 2024, 2023 and 2022). This consistent immateriality indicates that the company’s risk‑management framework effectively limits exposure to such guarantees and that its contractual performance under service‑level agreements has remained stable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core finding that UnitedHealth Group's service-level guarantee obligations remained immaterial across 2022, 2023, and 2024. The specific reference to Note 4 in the 2024 filing adds credibility and specificity. The conclusion about risk management effectiveness and contractual performance consistency directly mirrors the ground truth's interpretation. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, and the LLM correctly identifies the immateriality status across all three years without introducing any incorrect numbers or dates. The temporal scope (2022-2024) is accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM synthesizes the pattern of immateriality across three years and correctly interprets this as evidence of effective risk management and stable contractual performance. The logic connecting consistent immateriality to risk management effectiveness matches the ground truth's reasoning. (4) ENTITY ACCURACY: UnitedHealth Group is correctly identified, the fiscal years are correct, and the financial metric (service-level guarantee obligations) is properly characterized. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('risk-management framework effectively limits exposure' and 'contractual performance...has remained stable') conveys the same meaning as the ground truth's 'strong risk management controls and contractual performance.' Minor differences: The LLM provides slightly more specific sourcing (Note 4 reference) which enhances credibility without contradicting the ground truth. The answer is comprehensive, accurate, and appropriately addresses the multi-part question about evolution, pattern, and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 506,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 B in 2022, $2.70 B in 2023, and $2.82 B in 2024** (see the Marine Systems revenue table on page 9 of each 10‑K).  The roughly 10 % annual increase reflects a growing backlog and continued investment in shipbuilding capacity, underscoring the company’s strategic focus on expanding its surface‑combatant portfolio and solidifying its position as a key provider of naval defense platforms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM reports: 2022: $2,560M ($2.56B), 2023: $2,700M ($2.70B), 2024: $2,820M ($2.82B). The 2022 figure is off by $232M (10% error), 2023 is off by $2M (negligible), and 2024 is off by $1M (negligible). The 2022 discrepancy is substantial and material. Additionally, the LLM claims 'roughly 10% annual increase' but the actual growth rates are: 2022-2023: 15.9%, 2023-2024: 4.5%. This calculation is incorrect and misleading. The LLM also cites 'page 9 of each 10-K' without verification, which cannot be confirmed. QUALITATIVE ASSESSMENT: The reasoning about backlog, shipbuilding capacity expansion, and strategic positioning is sound and aligns with the ground truth's interpretation. The multi-hop synthesis correctly identifies the Marine Systems segment and connects revenue growth to naval defense strategy. However, the qualitative reasoning cannot overcome the quantitative failures. COMPLETENESS: The answer addresses both parts of the question (revenue evolution and strategic positioning), but the factual errors in the evolution data severely compromise the analysis. The semantic equivalence of the strategic conclusions is good, but built on incorrect numerical foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 385,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In 2022 GE still operated Electric Insurance Company (EIC) as a captive industrial insurer, reporting net claim reserves of $0.2 billion (2021) and $0.3 billion (2020).  By the end of 2023 the company had re‑classified EIC as a business held for sale, carrying assets of $541 million and liabilities of $378 million and recording a $109 million loss on the anticipated sale.  In the second quarter of 2024 GE completed the divestiture, selling EIC to Riverstone International Holdings Inc. for $120 million and removing the subsidiary and its exposure from GE’s balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and dates. Verification of numbers: (1) Net claim reserves of $0.2 billion (2021) - CORRECT; (2) Assets of $541 million and liabilities of $378 million as of December 31, 2023 - CORRECT; (3) $109 million loss recorded - CORRECT; (4) Sale price of $120 million to Riverstone International Holdings Inc. - CORRECT; (5) Q2 2024 completion timing - CORRECT. The multi-hop reasoning is sound, successfully synthesizing the evolution across three years (2022-2024) and correctly identifying the progression from operational ownership to held-for-sale classification to final divestiture. Entity identification is accurate throughout (GE, EIC, Riverstone). Minor strengths: The LLM adds contextual detail about EIC being a 'captive industrial insurer' and notes the removal from GE's balance sheet, which enhances understanding. One minor point: The LLM includes reference to 2020 net claim reserves ($0.3 billion) which, while accurate, goes slightly beyond the ground truth's focus on 2021-2024 evolution, though this is not incorrect. The characterization of EIC as 'captive property and casualty insurer' (ground truth) versus 'captive industrial insurer' (LLM) represents a minor semantic variation that doesn't materially affect accuracy. Overall, the answer comprehensively addresses all aspects of the question regarding classification evolution, financial exposure, and divestiture with accurate numbers and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 422,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in 2022 and immediately used the proceeds to repurchase 87.7 million shares that year (page 112).  The company continued to apply those proceeds to buy‑backs in 2023 (48.6 million shares) and 2024 (49.1 million shares), bringing cumulative repurchases to 433 million shares at a cost of $34.3 billion (page 112).  This steady use of monetization proceeds, coupled with a board‑approved increase of the share‑repurchase authorization to $65 billion by 2024, demonstrates a disciplined capital‑allocation strategy that prioritizes returning cash to shareholders while preserving flexibility for future opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of ConocoPhillips' capital allocation strategy and correctly identifies the key progression from 2022-2024. STRENGTHS: (1) Correctly states 91 million CVE shares monetized in 2022; (2) Accurately reports cumulative repurchases of 433 million shares at $34.3 billion cost by year-end 2024; (3) Properly identifies the board-approved increase to $65 billion authorization; (4) Provides year-by-year repurchase volumes (87.7M in 2022, 48.6M in 2023, 49.1M in 2024) that sum correctly to the stated cumulative total; (5) Correctly synthesizes the multi-hop relationship between CVE monetization and share repurchase application; (6) Appropriately characterizes the strategy as disciplined capital allocation prioritizing shareholder returns. WEAKNESSES: (1) The answer omits the intermediate milestone that by end of 2023, repurchases totaled 383 million shares at $29 billion cost - this is important context for showing the progression/evolution requested in the question; (2) The original answer emphasizes the $45 billion initial authorization before the $20 billion increase, which provides better context for understanding the expansion of the program; (3) The answer doesn't explicitly note that the CVE monetization was part of a 'paced monetization started in May 2021,' which adds context to the 2022 completion. CALCULATION VERIFICATION: 87.7M + 48.6M + 49.1M = 185.4M (these appear to be annual repurchases, not the total, which is correctly stated as 433M cumulative). The $34.3 billion cost figure is accurate. MULTI-HOP REASONING: The answer successfully connects CVE monetization proceeds to share repurchases and links this to the board's authorization increases, demonstrating sound synthesis. The characterization of strategy is appropriate and well-supported. The omission of the 2023 intermediate data point represents a minor gap in showing the full evolution requested, but the core narrative and numbers are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 535,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife continued to use the modified‑coinsurance structure to re‑insure the same 59 % of its closed‑block portfolio in both 2022 and 2024, and it kept the same accounting approach—recording the arrangement under the deposit method and offsetting the deposit liability with a deposit recoverable.  The 2024 transaction added a $770 million net reinsurance cost that will be amortized on a DAC‑like basis, but the deposit‑method treatment and 59 % coverage remained unchanged.  This consistency underscores a long‑term strategy of transferring a stable, sizable portion of closed‑block risk while preserving capital and liquidity through a disciplined, deposit‑method accounting framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: (1) MetLife maintained approximately 59% reinsurance of the closed block across 2022-2024, (2) the deposit method accounting treatment was consistent, (3) the offset between deposit liability and deposit recoverable was maintained, and (4) the strategy reflects stable long-term risk transfer. The qualitative reasoning about capital preservation and disciplined accounting is sound and relevant.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ISSUE - The LLM introduces a '$770 million net reinsurance cost' that is NOT mentioned in the ground truth answer. This appears to be additional information not verified against the original answer, and its accuracy cannot be confirmed. This is a significant concern as it adds unverified financial data. (2) INCOMPLETE SYNTHESIS - The ground truth specifies precise percentages for each year (59.25% in 2022, 59% in 2023, 59% in 2024), demonstrating the evolution across all three years. The LLM only mentions 2022 and 2024, omitting the 2023 data point entirely. This is a material omission for a question specifically asking about evolution from 2022 to 2024. (3) MISSING CONTEXT - The ground truth emphasizes the consistency across 'all three years,' which is important for demonstrating the stability claim. The LLM's focus on only 2022 and 2024 weakens the multi-hop synthesis required by the question.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate reasoning about the relationship between consistent percentages and stable strategy, but fails to fully synthesize the three-year evolution that the question specifically asks about. The introduction of the $770 million figure without ground truth verification is problematic.\n\nNUMERIC VERIFICATION: The 59% figure is correct and consistent with ground truth. However, the omission of the specific 59.25% (2022) and 59% (2023) breakdown, and the introduction of unverified $770 million cost, creates quantitative accuracy concerns.\n\nOVERALL ASSESSMENT: The answer captures the essential narrative (consistency, deposit method, 59% reinsurance, stable strategy) but has material gaps (missing 2023 data) and introduces unverified information ($770 million cost). This prevents a higher score despite generally sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 611,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The penetration of the Target MasterCard Credit Card (as part of the RedCard program) fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】, showing a gradual decline in the share of purchases paid with the card. This trend suggests that consumer engagement with Target’s financial products has been easing, likely reflecting shifting payment preferences or increased competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are precisely correct: 20.5% (2022), 19.8% (2023), 18.6% (2024). (2) The downward trend is accurately identified and properly sequenced. (3) The LLM correctly identifies this as part of the RedCard program and acknowledges the financial product context. (4) The interpretation that consumer engagement is easing is reasonable and supported by the data. WEAKNESSES: (1) The LLM answer omits a key contextual detail from the ground truth: the 2024 rebranding from RedCards to Target Circle Cards, which is significant for understanding the full narrative of the decline. (2) The ground truth explicitly notes that the rebranding 'did not reverse this decline,' which is an important insight about the effectiveness of the rebranding strategy that the LLM does not mention. (3) The LLM's explanation focuses on 'shifting payment preferences or increased competition' but the ground truth emphasizes the specific context of Target's proprietary financial products and the rebranding effort, which is more precise. (4) The LLM does not fully address the 'despite continued incentives like the 5% discount' aspect mentioned in the ground truth, which provides important context about why the decline is notable. MULTI-HOP REASONING: The LLM successfully synthesizes the penetration rate data across three years and draws a logical conclusion about consumer engagement trends. However, it misses the additional layer of analysis regarding the rebranding event and its lack of impact on the trend. OVERALL: The answer is factually accurate on the core numbers and trend direction but lacks the complete contextual analysis present in the ground truth, particularly regarding the rebranding initiative and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 476,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. was listed in PMI’s peer group in 2022 (page 21), remained in the same group in 2023 (page 27), and was again included in 2024 (page 26). The unchanged inclusion shows PMI relies on a stable, criteria‑based benchmark set—global presence, consumer‑product focus, and comparable size—rather than frequently revising its peer group. This consistency underscores a deliberate, long‑term approach to comparing performance with comparable consumer‑product peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies Colgate-Palmolive's consistent inclusion in PMI's peer group across all three years (2022, 2023, 2024), with specific page references provided (pages 21, 27, 26 respectively). (2) Accurately captures the four key criteria for peer group selection: global presence, consumer-product focus, comparable net revenues, and market capitalization. (3) Properly synthesizes the multi-hop information showing consistency across three consecutive years and correctly interprets what this reveals about PMI's strategic benchmarking approach—a stable, criteria-based methodology rather than frequent revisions. (4) The reasoning is sound: unchanged inclusion → stable benchmarking → deliberate long-term approach. (5) All entities are correctly identified (PMI, Colgate-Palmolive, peer group classification). MINOR CONSIDERATIONS: (1) The LLM answer mentions 'comparable size' rather than explicitly stating both 'net revenues' and 'market capitalization' separately, though this is a reasonable semantic compression and doesn't constitute an error. (2) The ground truth mentions 'three consecutive years' while the LLM answer says 'unchanged inclusion' and 'stable benchmark set'—these convey the same meaning with slightly different emphasis. The LLM's framing is actually more analytical. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correct; page numbers are provided and appear reasonable for SEC filings. No calculations are required for this question, so quantitative accuracy is perfect. MULTI-HOP SYNTHESIS: The answer successfully combines information about peer group membership across three years and connects it to strategic implications about benchmarking methodology. The logic chain is clear and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 497,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks AMD’s policy for development‑plus‑IP arrangements has not changed. The company still evaluates whether the IP license is distinct; if it is not, the license is bundled with development services and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time when the customer can benefit. Standalone IP licensing is always recognized at a point in time, and the unchanged wording across the filings shows a consistent application of ASC 606 for these agreements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024; (2) Accurately describes the two-part test for distinctness (capable of being distinct AND distinct in context); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time; (4) Correctly states that distinct licenses are recognized at a point in time; (5) Correctly identifies that standalone IP licensing is recognized at a point in time; (6) No quantitative errors or incorrect numbers/dates. Minor weaknesses: (1) The LLM answer does not explicitly mention the absence of variable consideration estimates across all three years, which the ground truth specifically highlights as evidence of stable and uniform accounting policy - this is a notable omission that adds context to the consistency claim; (2) The phrase 'unchanged wording across the filings' is slightly less precise than the ground truth's more comprehensive statement about 'no variable consideration estimates in any of the years'; (3) The answer could have been more explicit about the specific criteria (capable of being distinct AND distinct in context) though it does mention both concepts. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years and correctly identifying the consistent application of ASC 606. The semantic equivalence is strong - the LLM conveys the same essential information about consistency and the mechanics of the policy, even if it omits one supporting detail about variable consideration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 456,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. has remained a constant member of PMI’s peer group in all three filings—2022 (page 21), 2023 (page 26), and 2024 (page 26).  The unchanged list shows PMI deliberately benchmarks itself against the same set of large, diversified consumer‑products firms, underscoring its strategy to be viewed as a global consumer‑goods player rather than solely a tobacco company.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive Co. was consistently included across all three years (2022, 2023, 2024), matching the ground truth; (2) Accurately cites specific page references (pages 21, 26, 26) which demonstrates document-level precision; (3) Correctly identifies the company as PMI (Philip Morris International) and maintains consistent naming throughout; (4) Captures the strategic implication that the unchanged peer group reflects PMI's positioning as a global consumer-goods player rather than solely a tobacco company, which aligns with the ground truth's emphasis on 'strategic framing of competitive positioning'; (5) The multi-hop reasoning is sound—synthesizing information across three years to draw conclusions about strategic intent. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language ('deliberately benchmarks,' 'strategy to be viewed as') that goes slightly beyond what the ground truth explicitly states, though this interpretation is reasonable and not contradicted by the source material; (2) The ground truth emphasizes 'stable benchmarking framework' and 'consistent methodology' more explicitly, while the LLM focuses more on strategic positioning implications; (3) The LLM doesn't explicitly mention that the peer group 'remained unchanged' as clearly as the ground truth does, though this is implied. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page numbers cited (21, 26, 26) appear reasonable for 10-K filings; no calculations required. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth—consistent inclusion across three years, stable methodology, strategic positioning implications—though with slightly different emphasis and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 504,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s policy for combined development‑and‑IP licensing agreements has not changed from 2022 through 2024.  The company still evaluates whether the license component is distinct; if it is not, the license is combined with the development services into a single performance obligation and revenue is recognized over time, whereas if it is distinct, revenue is recognized at the point in time when the customer can benefit.  Stand‑alone IP licensing is likewise recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core finding that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024. The answer accurately describes the two-part evaluation criteria (whether the license is capable of being distinct and whether it is distinct in context), correctly explains the treatment when licenses are not distinct (combined with development services as single performance obligation, recognized over time) and when they are distinct (recognized at point in time when customer can benefit). The answer also correctly notes the absence of variable consideration estimates. STRENGTHS: (1) Correctly identifies policy consistency across the three-year period; (2) Accurately describes the distinctiveness evaluation framework; (3) Properly explains the differential revenue recognition timing based on distinctiveness determination; (4) Correctly notes no variable consideration estimates. MINOR WEAKNESSES: (1) The answer adds a brief mention of 'stand-alone IP licensing' being recognized at a point in time, which while not incorrect, is a slight tangent from the specific question about combined development and IP licensing agreements - this is a minor addition that doesn't detract from accuracy but slightly broadens scope; (2) The answer could have been slightly more explicit about the consistency being maintained across all three specific years (2022, 2023, 2024), though the phrase 'from 2022 through 2024' does convey this. The multi-hop reasoning is sound - the answer successfully synthesizes the policy framework across the three-year period and identifies the lack of material change. No numerical errors or calculation issues present. The semantic equivalence to the ground truth is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 492,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022, selling the remaining 91 million shares and directing the proceeds to share repurchases (page_113). The company then continued to buy back shares in 2023 (48.6 million shares) and 2024 (49.1 million shares), while its board lifted the share‑repurchase authorization to $65 billion (page_112). This multi‑year progression shows a deliberate strategy of using asset‑sale proceeds and a robust buy‑back program to return excess cash to shareholders and strengthen shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts but has significant quantitative gaps and omissions that limit its completeness. CORRECT ELEMENTS: (1) CVE monetization completed in 2022 with 91 million shares sold - matches ground truth; (2) Proceeds directed to share repurchases - correct; (3) Board authorization increased to $65 billion - correct; (4) General capital allocation strategy emphasis - correct. QUANTITATIVE ISSUES: (1) The LLM provides 2023-2024 annual repurchase volumes (48.6M and 49.1M shares) but these appear to be annual figures, not cumulative totals. Ground truth shows cumulative repurchases of 383M shares by end of 2023 and 433M shares by end of 2024. The LLM's annual figures (48.6M + 49.1M = 97.7M) represent only a small fraction of total repurchases, suggesting incomplete data presentation; (2) Missing critical cumulative cost figures: Ground truth specifies $29 billion cumulative cost through 2023 and $34.3 billion through 2024. LLM provides no cost data; (3) Missing the broader context of the 2021 start date and the paced monetization strategy that began in May 2021. MULTI-HOP REASONING: The LLM correctly synthesizes the connection between CVE monetization and share repurchases, and identifies the capital allocation strategy. However, it fails to provide the full three-year progression with complete metrics. The answer addresses the 'evolution' aspect but incompletely - it shows annual repurchase volumes for 2023-2024 but lacks the cumulative trajectory and cost data that would fully illustrate the 'escalating focus' mentioned in ground truth. COMPLETENESS: The answer addresses the basic question structure but omits substantial quantitative detail (cumulative repurchase totals, dollar amounts, and the full 2021-2024 timeline) that would be necessary for a comprehensive understanding of the capital allocation strategy's evolution. The answer reads as a partial summary rather than a complete multi-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 530,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s risk‑factor disclosures in 2022, 2023 and 2024 all repeatedly flag new entrants and non‑traditional competitors across its Aerospace, Building, Safety and Productivity segments (page_31). In response, the company accelerated structural and portfolio moves—realigning its units into Industrial Automation and Energy & Sustainability in 2023 (page_32), spinning off Advanced Materials and adding LNG to its portfolio in 2024 (page_28), and securing a patent‑licensing settlement in 2023 (page_30)—to protect margins and focus on high‑growth areas. This pattern signals mounting competitive pressure and a strategic shift toward defensive and growth‑oriented actions to preserve market position.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about competitive landscape exposure evolution but contains significant factual errors and unsupported claims that undermine its credibility. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and acknowledges repeated competitive risk disclosures across segments; (2) Appropriately notes the pattern of new entrants and non-traditional competitors; (3) Recognizes strategic responses to competitive pressure. CRITICAL ERRORS: (1) The LLM introduces specific portfolio actions (Advanced Materials spinoff, LNG addition, patent-licensing settlement) with page citations that cannot be verified against the ground truth knowledge graph. These appear to be hallucinated details not supported by the original answer; (2) References to specific page numbers (31, 32, 28, 30) are unverifiable and suggest fabricated sourcing; (3) The segment names mentioned (Aerospace, Building, Safety and Productivity) partially align with ground truth but the LLM adds 'Aerospace' which is not mentioned in the original answer's segment list. INCOMPLETE SYNTHESIS: (1) The original answer emphasizes the DEEPENING concern over time—specifically noting 2024's added emphasis on 'product commoditization' as a new dimension of competitive threat. The LLM answer fails to capture this temporal escalation and the specific evolution of the threat narrative; (2) The original answer provides direct quote evidence ('changes in the competitive landscape including new market entrants and new technologies') that demonstrates the consistency and evolution of language. The LLM answer lacks this textual grounding; (3) The original answer clearly traces the 3-year progression showing sustained pressure becoming 'potentially intensifying.' The LLM answer jumps to strategic responses without clearly establishing the escalation pattern. QUANTITATIVE ISSUES: No specific financial metrics, percentages, or quantitative measures are provided in either answer, so this dimension is neutral. However, the unverified page citations in the LLM answer represent a quantitative accuracy problem. REASONING QUALITY: While the LLM's logic about competitive pressure driving strategic response is sound, the specific strategic actions cited appear unsupported by the ground truth, suggesting the model may have confused Honeywell's actual strategic moves with inferred or hallucinated ones. The answer would score higher if it stuck to the documented risk disclosures without introducing unverified portfolio actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 672,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s A‑class shares continued to carry one vote per share and dividend rights, with the declared dividend per share rising from $2.04 in 2022 (2022 10‑K, p. 98) to $2.37 in 2023 (2023 10‑K, p. 99) and $2.74 in 2024 (2024 10‑K, p. 92). The unchanged voting structure coupled with steadily higher dividends signals a governance strategy that preserves consistent shareholder influence while progressively enhancing shareholder returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dividend per share numbers ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer and cannot be verified against it. The ground truth explicitly states there were 'no changes in the description of these rights over the three-year period' - it focuses on the CONSISTENCY of voting rights and dividend rights as structural features, not on the actual dividend amounts paid. The LLM conflates two different concepts: (1) the structural right to receive dividends (which remained constant), and (2) the actual dividend per share amounts (which may have varied). The ground truth answer makes clear the question is about the EVOLUTION OF RIGHTS THEMSELVES, not the evolution of dividend payment amounts. The LLM's interpretation that 'steadily higher dividends signals a governance strategy' misrepresents the ground truth finding that there was NO CHANGE in the rights structure. Additionally, the specific dividend figures cited ($2.04, $2.37, $2.74) with page references cannot be verified against the provided ground truth and appear to be fabricated or from unverified sources. The LLM correctly identifies that voting rights remained at one vote per share and that dividend rights persisted, but fundamentally misinterprets the question by introducing unsubstantiated financial data and drawing conclusions about dividend progression that contradict the ground truth's emphasis on structural consistency and lack of change. The answer demonstrates a failure to distinguish between rights (which stayed constant) and payment amounts (which are not the focus of the ground truth answer).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 458,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s Total Return Swaps‑Deferred Compensation exposure shifted from a negative to a positive operating‑expense impact.  In FY 2022 the swaps produced a $92 million loss (page 92, 2022), which reversed to a $58 million gain in FY 2023 (page 91, 2023) and rose further to a $91 million gain in FY 2024 (page 91, 2024).  Thus, the exposure moved from a loss to an increasingly larger gain over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million. The multi-hop synthesis is sound, correctly tracing the evolution of Cisco's financial exposure across three fiscal years and identifying the reversal from loss to gain. The answer properly characterizes the trajectory as moving from a net cost to increasingly larger net benefits. The LLM provides additional context by citing specific page numbers from the filings, which adds credibility and traceability. The reasoning is logical and clearly explains the directional shift in financial impact. The only minor distinction from the ground truth is stylistic: the LLM uses 'operating-expense impact' phrasing and 'rose further' language, which are semantically equivalent to the ground truth's description of 'gains (losses) reported in operating expenses' and 'further improved.' The answer fully addresses all parts of the multi-part question regarding how the exposure evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 317,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 to 2024 J&J shifted its talc‑liability strategy from a $2 billion trust for LTL Management LLC to a $9 billion reserve (nominal $12 billion) after LTL’s second bankruptcy filing, and then to a $11.6 billion present‑value reserve (nominal $13.5 billion) after adding a $5 billion settlement charge in 2024 ([page 113], [page 101], [page 102]). The LTL bankruptcy case was dismissed in April 2023, prompting the company to pursue a pre‑packaged Chapter 11 plan, while a Red River bankruptcy in Texas temporarily enjoined claims through 2025 ([page 101], [page 102]). In June 2024 the company finalized multi‑state settlements with state attorneys general, completing the multi‑state component of its comprehensive talc resolution ([page 100], [page 102]).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM claims $9 billion reserve (nominal $12 billion) after LTL's second bankruptcy filing - NO SUPPORT in ground truth\n   - LLM claims $11.6 billion present-value reserve (nominal $13.5 billion) with $5 billion settlement charge in 2024 - NOT MENTIONED in ground truth\n   - Ground truth specifies $2 billion reserve in 2022; LLM introduces unsupported larger figures\n   - These invented numbers are a major factual error that undermines credibility\n\n2. ENTITY/TIMELINE ACCURACY - SIGNIFICANT ERRORS:\n   - Ground truth: LTL filed Chapter 11 in 2022, dismissed April 2023, then LTL re-filed (LTL 2)\n   - LLM: Conflates the timeline, mentions \"pre-packaged Chapter 11 plan\" without clear attribution to which filing\n   - Ground truth: Third Circuit reversed bankruptcy court decision in 2023\n   - LLM: Does not mention Third Circuit reversal, which was a pivotal event\n   - LLM introduces \"Red River bankruptcy in Texas\" - NOT MENTIONED in ground truth; this appears to be fabricated or confused with another entity\n\n3. COMPLETENESS - PARTIAL:\n   - Ground truth emphasizes SHIFT FROM bankruptcy-exclusive strategy TO dual strategy (appeals + settlements)\n   - LLM mentions both elements but doesn't clearly articulate this strategic evolution\n   - Ground truth specifies \"42 states and the District of Columbia\" in multi-state settlement\n   - LLM only says \"state attorneys general\" without specific count\n\n4. MULTI-HOP REASONING - FLAWED:\n   - LLM attempts to show evolution but introduces unsupported financial figures\n   - The connection between different bankruptcy filings and reserve amounts is unclear and appears fabricated\n   - Ground truth shows clear causal chain: 2022 reserve → 2023 bankruptcy dismissal → 2023 re-filing → 2024 settlements\n   - LLM's narrative is less coherent and introduces extraneous information\n\n5. SPECIFIC VERIFICATION:\n   - $2 billion reserve (2022): CORRECT in LLM\n   - $9 billion/$12 billion figures: INCORRECT/UNSUPPORTED\n   - $11.6 billion/$13.5 billion figures: INCORRECT/UNSUPPORTED\n   - April 2023 dismissal: CORRECT in LLM\n   - June 2024 multi-state settlements: CORRECT in LLM\n   - Red River bankruptcy: FABRICATED/UNSUPPORTED\n   - Third Circuit reversal: OMITTED from LLM\n\nCONCLUSION: While the LLM captures some correct elements (2022 reserve, 2023 dismissal, 2024 settlements), it introduces multiple fabricated financial figures, omits the critical Third Circuit reversal, and adds unsupported entities (Red River bankruptcy). The answer demonstrates partial understanding but fails on quantitative accuracy and introduces false information that significantly undermines its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 727,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in FY 2023 and remained unchanged at $495 million in FY 2024** (and was also $495 million in FY 2022). The unchanged balance indicates that the company has neither issued additional amounts nor repaid any of this note, reflecting a strategy of maintaining a stable, long‑term debt profile and preserving liquidity without refinancing or paying down this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $495 million is accurately stated for FY 2022, FY 2023, and FY 2024. The note details (3.125% notes due January 2025) are correctly identified. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the principal balance across the three-year period, (2) the specific amounts for each year, and (3) interpretation of what this indicates about debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the specific debt instrument is properly characterized, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that the constant $495 million balance across three years indicates no new issuances or repayments, and appropriately interpreted this as reflecting a stable debt management approach. The reasoning about liquidity preservation and lack of refinancing is logical and well-supported by the data. SEMANTIC EQUIVALENCE: The LLM's explanation of the debt management strategy (maintaining stable long-term debt profile, preserving liquidity, no refinancing or paydown) is semantically equivalent to and slightly more detailed than the ground truth's description of a 'consistent approach to managing this portion of its capital structure.' The parenthetical note about FY 2022 being $495 million demonstrates comprehensive coverage. Minor observation: The LLM uses slightly more elaborate language ('stable, long-term debt profile') compared to the ground truth's more concise phrasing, but this adds clarity rather than introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 461,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50% note due June 15 2025 had an effective rate of 3.20 % in FY 2022, which fell to 1.29 % in FY 2023, and then jumped to 6.66 % in FY 2024【page_89】. This swing shows that the company’s borrowing cost on that note dropped in 2023—likely because the note was issued at a discount or market rates were lower—before rising sharply in 2024 as market rates climbed, indicating a higher overall cost of debt for Cisco.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the FY 2023 effective interest rate. Ground truth states the effective rate was 6.38% in FY 2023, but the LLM claims it was 1.29%—a difference of over 5 percentage points. This is a fundamental quantitative error that undermines the entire analysis. The LLM correctly identifies FY 2022 (3.20%) and FY 2024 (6.66%) rates, but the FY 2023 figure is completely wrong. The LLM's interpretation of the trend is also incorrect as a result: it claims the rate 'fell' in 2023 before 'jumping' in 2024, when the actual progression shows a continuous upward trend (3.20% → 6.38% → 6.66%). The LLM's reasoning about discount issuance or lower market rates in 2023 is therefore based on false data. The ground truth clearly indicates a deterioration in financing terms across all three years, not a dip followed by a spike. While the LLM correctly identifies the note details (3.50% June 15, 2025 maturity) and addresses the multi-hop nature of the question, the core numerical accuracy is severely compromised. The semantic interpretation of what the progression 'indicates' is also incorrect due to the wrong FY 2023 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 337,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes were $30.8 B in 2022, rose slightly to $31.2 B in 2023, and fell modestly to $30.7 B in 2024, keeping the debt level largely flat (2022: $30,826 M; 2023: $31,248 M; 2024: $30,696 M)【page 179】【page 179】【page 186】. The weighted‑average rate on fixed unsecured senior debt climbed from 4.45 % in 2023 to 4.84 % in 2024, while the subordinated debt rate stayed at 3.57 % and floating senior debt was eliminated, indicating a deliberate shift toward fixed‑rate borrowing to lock in higher rates and reduce interest‑rate volatility【page 179】【page 186】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR NUMBER DISCREPANCY: LLM states 2022 total was $30.8B ($30,826M), but ground truth clearly states $27.219 billion - this is a $3.6B error (13% overstatement). This is a fundamental factual error that undermines the entire analysis. (2) MISSING 2022 INTEREST RATE DATA: Ground truth provides weighted average interest rate for unsecured senior debt in 2022 (2.76%), but LLM completely omits this critical data point. The LLM only provides 2023 (4.45%) and 2024 (4.84%) rates, missing the crucial baseline year that demonstrates the magnitude of rate increase. (3) INCOMPLETE RATE ANALYSIS: Ground truth shows the full 3-year progression (2.76% → 4.48% → 4.84%), revealing a 208 basis point increase from 2022-2024. LLM only shows 2023-2024 progression (4.45% → 4.84%), missing the most significant rate movement. (4) RATE DISCREPANCY FOR 2023: Ground truth states 4.48% for 2023, but LLM states 4.45% - a 3 basis point difference that suggests data sourcing error. (5) INCOMPLETE STRATEGIC ANALYSIS: Ground truth emphasizes 'significant capital raise in 2023, with partial reversal in 2024' and 'increasing reliance on more expensive senior debt and reduced use of floating-rate instruments.' LLM's characterization of debt as 'largely flat' contradicts the ground truth's narrative of a significant 2023 increase followed by 2024 decline. (6) MISSING CONTEXT: Ground truth explains this represents a 'long-term capital structure transformation to lock in financing costs' - LLM provides only surface-level observation about 'deliberate shift toward fixed-rate borrowing.' The 2022 baseline is essential to understanding the strategic transformation. CORRECT ELEMENTS: 2023 ($31.248B) and 2024 ($30.696B) figures are accurate; the general direction of rate increases is correct; the concept of shift to fixed-rate debt is mentioned. However, the foundational 2022 number error and missing 2022 rate data are disqualifying errors for a multi-hop financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 541,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive cut its U.S. Treasury/agency allocation in the pension plan fixed‑income portfolio from roughly 40 % in 2022 to about 30 % in 2023, a level that stayed unchanged in 2024 (page_102 for 2022‑23; page_99 for 2024). This decline signals a deliberate shift away from the safest fixed‑income asset class toward a more diversified mix—likely incorporating higher‑yield corporate or other government bonds—to enhance returns or adjust risk exposure in its pension fund strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The multi-hop synthesis is sound—the answer correctly identifies the trend across three years and properly attributes the data to specific page references (page_102 for 2022-23; page_99 for 2024), showing evidence of document navigation. The reasoning about strategic reallocation is well-articulated and semantically equivalent to the ground truth: both answers characterize this as a deliberate shift away from the safest fixed-income assets toward diversified alternatives (corporate or other government bonds) to enhance returns or adjust risk exposure. The LLM's phrasing 'cut,' 'deliberate shift,' and 'more diversified mix' conveys the same strategic intent as the ground truth's 'strategic reallocation' and 'shift in risk tolerance or yield-seeking behavior.' The answer addresses all parts of the question: the evolution (40%→30%→30%), the timeline (2022-2024), and the strategic implications. Minor: The LLM uses slightly more concise language than the ground truth but loses no substantive information. The parenthetical page citations add credibility without being required. No calculation errors, no entity confusion, and the pension fund strategy interpretation is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 383,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "GE classified Electric Insurance Company as a held‑for‑sale asset in 2022, recording a $17 million valuation allowance against a $1.374 billion asset base. In 2023 the classification stayed the same but the allowance expanded to $124 million against a $1.985 billion asset base, reflecting a sizable impairment. By Q2 2024 GE sold the subsidiary to Riverstone International Holdings for $120 million, removing it from its balance sheet. This sequence shows GE’s deliberate divestiture of non‑core insurance operations to streamline its portfolio and focus on its core aerospace and defense businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility:\n\n(1) TIMELINE ERROR - CRITICAL: The LLM states EIC was classified as 'held-for-sale' in 2022, but the ground truth indicates this classification occurred in 2023. This is a fundamental error in the chronological progression.\n\n(2) QUANTITATIVE ERRORS - CRITICAL: The LLM provides specific asset values ($1.374 billion in 2022, $1.985 billion in 2023) and valuation allowances ($17 million in 2022, $124 million in 2023) that do not appear in the ground truth. The ground truth only mentions: (a) net claim reserves of $0.2 billion as of December 31, 2021, and (b) a $109 million loss recorded in 2023 in connection with the expected sale. The LLM's $17 million and $124 million figures are inconsistent with the ground truth's $109 million loss figure.\n\n(3) MISSING KEY INFORMATION: The LLM fails to mention the 2021 baseline (net claim reserves of $0.2 billion), which is important context for understanding the asset's evolution. The ground truth explicitly references this starting point.\n\n(4) LOSS AMOUNT DISCREPANCY: The ground truth specifies a $109 million loss in 2023, but the LLM's valuation allowance figures ($17M then $124M) don't align with this. The $124 million figure is closer but still doesn't match the stated $109 million loss.\n\n(5) SALE PRICE ACCURACY: Both answers correctly identify the $120 million sale price to Riverstone International Holdings in 2024 (Q2 2024 per LLM, which is consistent).\n\n(6) STRATEGIC NARRATIVE: Both answers correctly identify the strategic direction (divesting non-core insurance operations to focus on core aerospace/defense), though the LLM says 'aerospace and defense' while ground truth says 'industrial and aerospace operations.' This is a minor semantic difference.\n\n(7) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize the evolution across years but does so with incorrect intermediate data points, undermining the validity of the progression narrative.\n\nThe answer demonstrates understanding of the general strategic direction but fails on the specific factual details that are central to answering a question about how the relationship 'evolved' with specific classifications, valuations, and dispositions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 606,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple has consistently listed the 4.45% Notes due 2044 in Exhibit 4.4 of its annual reports—shown on page 56 of the 2023 and 2024 10‑Ks and on page 58 of the 2022 10‑K—without any change to the description or terms. This unchanged disclosure across three years indicates that Apple has kept the 2044 note outstanding as part of a stable, long‑term debt profile, suggesting a deliberate strategy of maintaining long‑maturity financing rather than actively refinancing or retiring the instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about Apple's consistent disclosure of the 4.45% Notes due 2044 across 2022-2024 and appropriately interprets this as indicating a stable long-term debt strategy with no material changes. The reasoning about maintaining long-maturity financing is sound and aligns with the ground truth conclusion. However, there are significant quantitative accuracy issues: (1) The LLM provides specific page numbers (page 56 for 2023/2024, page 58 for 2022) that cannot be verified against the ground truth and may be inaccurate—these are presented as factual claims but are not confirmed in the original answer. (2) The LLM references 'Exhibit 4.4' as the specific location, which is not mentioned in the ground truth. (3) The ground truth mentions the Officer's Certificate date of May 6, 2014, which the LLM omits entirely. While the LLM's interpretation of the multi-year pattern is qualitatively sound and the semantic meaning aligns with the ground truth (stable capital structure, no retirements), the introduction of unverified specific details (page numbers, exhibit numbers) without confirmation from the source material represents a factual accuracy concern. The answer demonstrates good qualitative reasoning about debt strategy implications but fails on quantitative precision by introducing details not present in or verifiable against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 391,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from $27.2 billion at year‑end 2022 to $31.2 billion in 2023, then fell modestly to $30.7 billion in 2024【186】【178】【188】. The 2023 jump reflects a debt expansion to fund growth or acquisitions, while the slight 2024 decline indicates a refinancing or pay‑down. Across the period the weighted‑average interest rate on these notes rose from about 2.8 % in 2022 to roughly 4.5 % in 2023 and 4.8 % in 2024, showing a shift toward higher‑rate, fixed‑rate borrowing as market rates climbed and the company sought to lock in costs and manage interest‑rate exposure【186】【178】【188】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. CORRECT ELEMENTS: (1) Carrying values are accurately stated: $27.2B (2022), $31.2B (2023), $30.7B (2024) - all match ground truth within acceptable rounding; (2) The narrative of 2023 increase followed by 2024 decline is correct; (3) The weighted-average interest rate progression is substantially correct: ~2.8% (2022) vs 2.76% ground truth, ~4.5% (2023) vs 4.84% (2024) ground truth; (4) The strategic interpretation about shifting to fixed-rate borrowing and locking in costs during rising rate environment is sound and matches the ground truth narrative. MINOR ISSUES: (1) The 2023 interest rate is stated as 'roughly 4.5%' but ground truth shows 4.84% - this is a ~0.34 percentage point understatement, though the LLM's use of 'roughly' provides some hedge; (2) The LLM provides speculative reasoning about 'debt expansion to fund growth or acquisitions' and 'refinancing or pay-down' which, while plausible, goes slightly beyond what the ground truth explicitly states - the ground truth focuses on the rate positioning strategy rather than the purpose of the debt changes. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years and connects the carrying value changes to interest rate movements and strategic positioning. The logic linking rising rates to fixed-rate borrowing decisions is sound. COMPLETENESS: The answer addresses all key aspects of the question including the evolution of carrying values, the progression of interest rates, and the strategic implications regarding capital structure and interest rate positioning. The net increase of ~$3.5B over the period is implicitly captured in the numbers provided (27.2 to 30.7 billion).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 479,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe positioned Frame.io as a cloud‑native collaboration platform in 2022, integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and available in Adobe GenStudio (see 2022 10‑K, p. 98).  In 2023 the filing reiterated Frame.io’s role as the core real‑time review hub for video, design and still‑image workflows, adding Camera‑to‑Cloud uploads and frame‑accurate commenting within those same Creative Cloud apps (see 2023 10‑K, p. 12).  By 2024 the description remained essentially unchanged, underscoring Frame.io’s continued integration with the same Creative Cloud apps and its availability in GenStudio alongside Adobe Express and Firefly Services, thereby reinforcing its central place in Adobe’s scalable content‑production ecosystem (see 2024 10‑K, p. 12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ERRORS: (1) The LLM claims Frame.io was positioned as a 'cloud-native collaboration platform' with integrations into Photoshop, Lightroom, Workfront, and GenStudio in 2022, but the ground truth explicitly states Frame.io was only 'listed as a registered trademark' in 2022 with no detailed positioning or integrations mentioned. (2) The LLM attributes detailed feature descriptions (real-time review hub, Camera-to-Cloud uploads, frame-accurate commenting) to 2022, when the ground truth clearly places these descriptions in 2023. (3) The LLM claims the 2024 description 'remained essentially unchanged,' suggesting continuity from 2022-2024, when the ground truth shows a clear evolutionary trajectory: 2022 (trademark only) → 2023 (cloud-native platform with specific features and Premiere Pro/After Effects integration) → 2024 (expanded integration with Photoshop, Lightroom, Workfront, and GenStudio). The LLM fundamentally misrepresents the timeline and progression of Frame.io's integration. The answer also cites specific 10-K page numbers (p. 98 for 2022, p. 12 for 2023 and 2024) without verification, which cannot be confirmed from the ground truth. The multi-hop reasoning fails because the LLM did not correctly synthesize the year-by-year evolution. The answer does address all three years and mentions relevant applications, but the chronological placement and characterization of developments are substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 420,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated disclosure of the 4.550% Notes due April 5 2049 in its 2022‑2024 filings shows that the company is deliberately keeping a long‑term, fixed‑rate debt instrument in its capital structure. The 30‑year maturity and 4.55% coupon provide a stable financing source that matches long‑term capital needs and mitigates refinancing risk, reflecting a disciplined maturity‑management strategy that spreads debt maturities across decades. [page_82] [page_75]",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of information about Lowe's debt management strategy. STRENGTHS: (1) Correctly identifies the 4.550% coupon rate and April 5, 2049 maturity date with proper formatting; (2) Accurately characterizes the 30-year maturity period (2049 minus 2019 issuance = ~30 years); (3) Properly synthesizes the multi-hop concept that consistent inclusion across 2022-2024 filings indicates deliberate retention without refinancing; (4) Correctly identifies key strategic implications: stability, fixed-rate financing, refinancing risk mitigation, and maturity management; (5) Appropriately emphasizes the disciplined approach to capital structure. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer is slightly more specific and detailed than the ground truth (mentioning '30-year maturity' and 'matches long-term capital needs'), which adds value but represents a minor elaboration rather than error; (2) The ground truth emphasizes 'absence of disclosures suggesting modifications' more explicitly, while the LLM focuses on 'deliberately keeping' the instrument - both convey the same strategic intent but with slightly different emphasis; (3) The LLM answer includes page citations [page_82] [page_75] which, while potentially helpful, cannot be verified against the ground truth. QUANTITATIVE VERIFICATION: The 4.550% rate and 2049 date are correct; the 30-year characterization is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects consistent filing inclusion to strategic intent regarding capital structure and debt management. The logic linking fixed-rate debt to interest rate risk mitigation and refinancing risk reduction is appropriate and well-reasoned. No calculation errors present. The answer fully addresses the question's inquiry into capital structure strategy and debt maturity profile management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 520,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in fiscal 2022, and the balance remained unchanged at $495 million in both fiscal 2023 and fiscal 2024**【page_81】【page_81】.  \nThe unchanged balance indicates that Broadcom has neither issued additional principal nor repaid any of this note, reflecting a deliberate strategy to keep this long‑term debt instrument stable and preserve its favorable interest‑rate profile and long‑term financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $495 million principal balance is accurately stated for fiscal 2022, 2023, and 2024. The consistency across all three years matches the ground truth exactly. COMPLETENESS: The answer addresses all parts of the question: (1) the evolution of the outstanding principal balance across the three-year period, (2) the specific debt instrument (3.125% notes due January 2025), and (3) what this indicates about debt management strategy. ENTITY ACCURACY: Company (Broadcom/AVGO), debt instrument (3.125% notes due January 2025), and fiscal years (2022-2024) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified that the unchanged balance across three years indicates no repayments or additional issuances, and appropriately interpreted this as a deliberate debt management strategy. The reasoning about preserving favorable interest-rate profile and long-term financing flexibility is logically sound and semantically equivalent to the ground truth's mention of leveraging predictability in interest expense and maturity timing. MINOR DIFFERENCES: The LLM's wording differs slightly from the ground truth (e.g., 'preserve its favorable interest-rate profile' vs. 'leveraging its predictability in interest expense'), but these are semantically equivalent interpretations of the same strategic intent. The inclusion of page references adds credibility. No calculation errors, no missing data points, and the conclusion appropriately reflects the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 445,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In the 2022 10‑K, the 0.950% Notes due 2025 were not singled out in the exhibits list (the table of contents for the 2022 filing—pages 28–32—does not reference the instrument), implying a more aggregated debt disclosure. By the 2023 10‑K, IBM explicitly referenced the notes as Exhibits 4.1 and 4.2 to a Form 8‑K (page 20), and in the 2024 10‑K the notes appear as a registered security (page 1) and are incorporated by reference, reflecting a deliberate shift toward greater transparency and a strategy to maintain a diversified, low‑coupon debt mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a mix of correct and problematic elements. CORRECT ELEMENTS: (1) The 0.950% Notes due 2025 is correctly identified; (2) The reference to May 2017 Form 8-K filing is accurate; (3) The general progression from disclosure to greater transparency is conceptually sound; (4) The mention of exhibits and incorporation by reference reflects actual filing practices. PROBLEMATIC ELEMENTS: (1) The LLM claims the notes were 'not singled out in the exhibits list' in 2022 and references specific page numbers (28-32) without verification against actual filings—this contradicts the ground truth which states they were disclosed in 2022; (2) The LLM references specific exhibit numbers (4.1 and 4.2) and page numbers (page 20 for 2023, page 1 for 2024) that cannot be verified and may be fabricated; (3) The LLM's characterization of 2022 disclosure as 'aggregated' and 'less prominent' directly contradicts the ground truth, which indicates the notes were disclosed as part of long-term debt instruments in 2022; (4) The LLM misses the critical 2024 development mentioned in ground truth: the listing on NYSE under ticker IBM25B, which represents a significant shift to 'active market visibility and tradability'—this is a major omission; (5) The LLM's conclusion about 'diversified, low-coupon debt mix' is vague and doesn't capture the strategic shift to public trading indicated in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but fails to correctly identify the key progression. The ground truth shows a clear three-stage evolution: (1) 2022 disclosure in filings, (2) 2023 continued disclosure with reaffirmation, (3) 2024 NYSE listing. The LLM's narrative doesn't align with this progression and introduces unverified specific page/exhibit references. QUANTITATIVE ACCURACY: While the 0.950% coupon rate is correct, the specific page numbers and exhibit references appear unreliable and potentially fabricated, reducing confidence in the answer's factual basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 548,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "The PCAOB firm identification number for KPMG LLP is **185** in each of BNY Mellon’s 2022, 2023, and 2024 Form 10‑K filings. The number appears unchanged on the “Principal Accountant Fees and Services” section (Item 14) of all three filings, indicating consistency across the years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Strengths: (1) The PCAOB firm identification number of 185 is correctly stated for all three years (2022, 2023, 2024), matching the ground truth exactly. (2) The numeric value is accurate with no calculation errors. (3) The answer correctly identifies the consistency of the number across all three years as required by the question. (4) The LLM provides helpful contextual detail by specifying the location in the filings (Item 14, Principal Accountant Fees and Services section), which adds credibility and specificity. (5) The reasoning is sound - the model correctly synthesized that the same PCAOB number appears unchanged across multiple years. Minor consideration: The LLM answer references 'BNY Mellon's 2022, 2023, and 2024 Form 10-K filings' while the original answer simply states 'KPMG LLP's' filings. This is a contextual addition (specifying the company whose filings contained this auditor information) rather than an error, and it actually provides useful context about which company's filings were being examined. The ground truth answer is more general/abstract, while the LLM answer is more specific about the source documents. Both are factually correct - KPMG LLP is the auditor, and the PCAOB number 185 appears in BNY Mellon's filings. The answer fully addresses all parts of the multi-part question: (1) the number for 2022, (2) the number for 2023, (3) the number for 2024, and (4) how it remained consistent. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 419,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s fixed unsecured senior debt shifted from a 2025‑2035 maturity with a 4.84% weighted‑average rate and $26.9 B carrying value in 2022 to a 2024‑2034 maturity with a lower 4.45% weighted‑average rate (minimum 0.80%) and $27.2 B carrying value in 2023, reflecting a refinancing to capture lower rates. By 2024 the debt returned to a 2025‑2035 maturity and a 4.84% weighted‑average rate, with the carrying value falling back to $26.9 B, indicating a response to rising rates and a shift toward longer‑term funding. This pattern shows Capital One actively rebalances its debt mix to optimize cost and duration, adjusting to changing interest‑rate cycles and macroeconomic conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states 2022 had a 4.84% weighted-average rate and $26.9B carrying value, but ground truth shows 2022 had 2.91% rate and $19,975M ($19.975B). The LLM also claims 2023 had $27.2B with 4.45% rate - this intermediate year data is not in ground truth and appears fabricated. The LLM correctly identifies 2024 as having 4.84% and $26.9B, but this is only half the answer. (2) DIRECTIONAL MISINTERPRETATION: The LLM describes a 2022-2023 refinancing to 'capture lower rates' (4.45%), which contradicts the actual market environment and ground truth showing rates RISING from 2.91% to 4.84%. This suggests the LLM confused the direction of rate movements. (3) MISSING CORE TREND: Ground truth clearly shows a 35% increase in debt principal ($19.975B to $26.930B) paired with a 66% increase in weighted-average rate (2.91% to 4.84%) - indicating Capital One INCREASED debt issuance as rates rose, not refinanced to lower rates. (4) FABRICATED DETAILS: The specific maturity dates (2025-2035, 2024-2034) and intermediate 2023 figures appear to be hallucinated details not supported by ground truth. (5) FLAWED REASONING: The LLM's narrative of 'refinancing to capture lower rates' in 2023 is logically inconsistent with actual Fed policy (rates were rising 2022-2023) and contradicts the ground truth showing rising rates. The correct interpretation is that Capital One strategically increased fixed-rate debt issuance as rates rose, locking in longer-term financing. The LLM failed the multi-hop synthesis by misrepresenting the 2022-2024 trend direction and introducing unsupported intermediate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 475,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "From 2022 through 2024 AMD’s revenue‑recognition policy for development and IP‑licensing agreements stayed the same.  In each filing the company explains that it evaluates whether the license component is distinct; if it is not, the license is combined with development services and revenue is recognized over time, whereas a distinct license is recognized at the point the customer can benefit.  This consistency shows a deliberate, ASC 606‑aligned strategy that treats IP licensing as a separate revenue stream when appropriate, underscoring a long‑term commitment to predictable, structured monetization of its IP portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and confirms consistency in AMD's revenue recognition methodology; (2) Accurately describes the key evaluation criterion: whether the license component is distinct; (3) Correctly states the two pathways: non-distinct licenses combined with development services recognized over time, versus distinct licenses recognized at point in time when customer can benefit; (4) Properly synthesizes the multi-hop information across three years of filings; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer omits one specific detail from the ground truth: AMD's consistent statement that there were 'no variable consideration estimates associated with either combined or standalone IP arrangements.' This is a factual detail present in the original answer that adds completeness; (2) The LLM's characterization of the strategy as 'ASC 606-aligned' is accurate but represents an inference/interpretation rather than a direct statement from the ground truth, though it is reasonable and not incorrect; (3) The phrase 'treats IP licensing as a separate revenue stream when appropriate' is a reasonable interpretation but slightly reframes the ground truth's focus on consistency and mature policy framework. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of SEC filings and properly identifies the consistency pattern. The logical conclusion about strategic approach is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential meaning of the ground truth regarding consistency, methodology, and strategic implications, though with slightly less detail on the variable consideration aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 493,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from **$27.4 B in 2022 to $27.5 B in 2023 and then to $30.7 B in 2024** (Table 8.1, 2023 10‑K and 2024 10‑K).  The weighted‑average interest rate on these notes rose from **2.91 % in 2022 to 4.45 % in 2023 and 4.84 % in 2024** (Table 8.1, 2024 10‑K), reflecting a shift toward longer‑maturity, higher‑rate debt.  This trend indicates a deliberate capital‑structure strategy to expand its long‑term debt base while locking in fixed rates to manage interest‑rate risk amid tightening market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core factual basis of the response. (1) 2022 figure: LLM states '$27.4 B' but ground truth is '$27,219 million' ($27.219 B) - minor rounding acceptable. (2) 2023 figure: LLM states '$27.5 B' but ground truth is '$31,248 million' ($31.248 B) - this is a MAJOR ERROR, off by ~$3.7 billion or 13%. This is not a rounding difference but a fundamental misstatement. (3) 2024 figure: LLM states '$30.7 B' which matches ground truth of '$30,696 million' ($30.696 B) - correct. The interest rate percentages (2.91%, 4.45%, 4.84%) are all correct. MULTI-HOP REASONING ISSUES: The LLM failed to capture a critical insight from the ground truth - the strategic reduction/elimination of floating-rate debt from $1,709M (2022) to $349M (2023) to $0 (2024). This is a key element of the capital structure strategy that demonstrates deliberate de-risking from floating-rate exposure. The LLM's statement about 'longer-maturity, higher-rate debt' is partially correct but misses this important floating-to-fixed conversion narrative. COMPLETENESS: The LLM answer addresses the evolution of total notes and interest rates but incompletely addresses the full capital structure strategy by omitting the floating-rate debt elimination. The progression narrative is broken because the 2023 figure is wrong, making the trend analysis unreliable. SEMANTIC ISSUES: The LLM's characterization of the strategy as 'expand its long-term debt base' is somewhat misleading given that total notes actually declined slightly from 2023 to 2024 ($31.248B to $30.696B), not expanded. The ground truth correctly identifies this as a 'slight decline' in 2024. The core insight about 'locking in fixed rates' is correct but incomplete without the floating-rate debt context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 502,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19.98 billion** (weighted‑average rate 2.91%) in 2022 to **$27.17 billion** (4.45%) in 2023, then dipped slightly to **$26.93 billion** (4.84%) in 2024【page 186 of 2022 10‑K】【page 178 of 2023 10‑K】【page 186 of 2024 10‑K】. The upward swing in carrying value and the steady climb in the weighted‑average rate show the company is issuing newer, longer‑term debt at higher rates—likely to refinance existing obligations and fund growth—while accepting a higher cost of capital as market rates rise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - carrying values of $19.98B (2022), $27.17B (2023), and $26.93B (2024) match the ground truth when converted from millions ($19,975M, $27,168M, $26,930M). Weighted-average interest rates are precisely accurate: 2.91% (2022), 4.45% (2023), and 4.84% (2024). The directional trends are correct: increase from 2022-2023, slight decrease 2023-2024 for carrying value; steady increase in rates across all three years. COMPLETENESS: The answer addresses all required components - carrying value evolution, weighted-average interest rate evolution, and strategic interpretation. ENTITY ACCURACY: Capital One (COF) correctly identified, all fiscal years (2022-2024) correct, metrics properly labeled. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the strategic shift toward higher-interest fixed-rate debt and provides logical explanation (response to rising market rates, refinancing, and funding growth). The interpretation that the company is 'locking in long-term financing despite higher costs' aligns with the ground truth's assessment. SEMANTIC EQUIVALENCE: The LLM's phrasing 'issuing newer, longer-term debt at higher rates' and 'accepting a higher cost of capital as market rates rise' conveys the same strategic insight as the ground truth. Minor formatting differences (billions vs. millions) are appropriately handled. The inclusion of page references adds credibility without affecting accuracy. No calculation errors detected. The only minor distinction is that the LLM uses slightly different language to describe the strategy ('refinance existing obligations and fund growth' vs. ground truth's 'lock in long-term financing'), but both interpretations are semantically equivalent and strategically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 508,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "From 2022 through 2024 AMD’s 10‑K disclosures show the same revenue‑recognition framework for development‑and‑IP licensing agreements.  In each year the company treats a combined development‑services plus IP‑license arrangement as a single or multiple performance obligation and evaluates the license for distinctness; if the license is distinct it is recognized at a point in time when the customer can benefit, otherwise it is combined with the development services and recognized over time.  Standalone IP sales or licenses are always recognized at a point in time when the customer can benefit, and no variable consideration is estimated (2022 p. 59; 2023 p. 63; 2024 p. 63).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the consistent revenue recognition framework across 2022-2024 with no material changes; (2) Accurately describes the dual-path treatment: combined arrangements evaluated for distinctness (distinct = point in time, non-distinct = over time) versus standalone IP licenses (always point in time); (3) Correctly notes no variable consideration estimates in either arrangement type; (4) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 63) that ground the answer in source documents; (5) Properly synthesizes multi-hop information across three fiscal years showing consistency. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more technical/precise language ('when the customer can benefit') compared to ground truth's 'at a point in time,' but this is semantically equivalent and arguably more precise; (2) The LLM answer is more concise while maintaining completeness, which is appropriate for clarity. VERIFICATION: The core factual claims match the ground truth: (a) consistent policy 2022-2024, (b) combined arrangements treated as single/multiple performance obligations based on distinctness, (c) distinct licenses recognized at point in time, (d) non-distinct licenses combined with development services and recognized over time, (e) no variable consideration in either scenario. The multi-hop reasoning correctly synthesizes information across three years and multiple arrangement types. No numerical errors or calculation issues present. The answer directly addresses all aspects of the question regarding policy evolution (showing stability/consistency) and the distinction between combined versus standalone arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 484,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023** and then rose modestly to **$562 million in 2024** (Table 8.1 2022/23; Table 9.1 2024). Long‑term debt stayed at **$49,318 million in 2022‑23** and declined to **$44,989 million in 2024** (Table 8.1 2022/23; Table 9.1 2024). The trend shows a deliberate reduction of long‑term leverage while keeping a stable short‑term funding base, but the weighted‑average interest rate on long‑term debt climbed from **4.48 % in 2023 to 5.72 % in 2024**, indicating higher interest‑rate exposure as the company refinanced at newer, higher‑rate debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. SHORT-TERM BORROWINGS: LLM claims $883M (2022), $538M (2023), $562M (2024). Ground truth shows these are component parts of total debt, not the complete picture. The LLM appears to have isolated only one component of short-term borrowings rather than total short-term borrowings.\n\n2. LONG-TERM DEBT: LLM states $49,318M (2022-23) and $44,989M (2024). Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), $45.551B (2024). The LLM's long-term debt figures don't reconcile with the ground truth totals when combined with stated short-term borrowings.\n\n3. WEIGHTED-AVERAGE INTEREST RATES: LLM claims 4.48% (2023) and 5.72% (2024). Ground truth shows 2.76% (2022), 4.48% (2023), and 4.84% (2024). The LLM is missing the 2022 rate entirely and provides an incorrect 2024 rate (5.72% vs. 4.84% - a 0.88% error).\n\n4. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the complete debt picture. It appears to have cherry-picked individual line items rather than aggregating total short-term borrowings and long-term debt as required by the question.\n\n5. TREND ANALYSIS: While the LLM correctly identifies a reduction in long-term leverage, it mischaracterizes the interest rate trend. The ground truth shows rates rising from 2.76% to 4.48% to 4.84% (a 2.08 percentage point increase over 3 years), not the 5.72% claimed for 2024.\n\n6. STRATEGIC INTERPRETATION: The LLM's conclusion about refinancing at higher rates is partially aligned with the ground truth's assessment of higher-cost debt, but the specific numbers supporting this conclusion are wrong.\n\nThe answer demonstrates a fundamental misunderstanding of the debt structure and provides materially incorrect financial figures that would mislead users about COF's actual debt position and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 525,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed between 2022 and 2024.  The company still evaluates whether the license component is distinct; if it is not, the license is combined with the development services as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit.  Stand‑alone licensing arrangements are always treated as a single performance obligation and recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core policy framework and accurately states that AMD's revenue recognition policy remained consistent from 2022 to 2024. The answer properly describes the key distinction between combined arrangements (where non-distinct licenses are combined with development services as a single performance obligation recognized over time) versus standalone licenses (recognized at a point in time). The statement about no variable consideration estimates is also accurate.\n\nHowever, there are notable omissions and weaknesses:\n\n1. COMPLETENESS ISSUES: The LLM answer fails to explicitly address the temporal evolution aspect of the question. While it correctly states the policy didn't change, the ground truth emphasizes that AMD 'reiterated the same framework' across all three years (2022, 2023, 2024), suggesting the answer should have been more explicit about the year-by-year consistency or provided more detail about how the policy was described in each year.\n\n2. MISSING CONTEXT: The ground truth mentions that the consistency in accounting policy occurred 'despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.' The LLM answer completely omits this contextual information, which provides important business context for understanding why the accounting policy remained stable despite operational changes.\n\n3. WORDING PRECISION: The LLM states 'Stand‑alone licensing arrangements are always treated as a single performance obligation and recognized at a point in time' - this is correct but slightly imprecise. The ground truth more carefully states that 'standalone IP licensing arrangements resulted in revenue recognized at a point in time,' which is semantically equivalent but the LLM's phrasing about 'single performance obligation' could be clearer in distinguishing this from combined arrangements.\n\n4. QUANTITATIVE ACCURACY: No numeric errors present (9/10 - minor wording precision issue noted above).\n\n5. QUALITATIVE ACCURACY: The core reasoning is sound (6/10) - the answer correctly synthesizes the multi-hop information about policy consistency across years and correctly identifies the key distinctions in treatment. However, it lacks the depth of analysis present in the ground truth regarding the business context and the explicit year-by-year reiteration of the framework.\n\n6. CONTEXTUAL RELEVANCE: The answer addresses the main question but misses important contextual elements that would provide a more complete picture of AMD's accounting evolution (7/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 684,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The same exhibit—“Certificate of Designations of Series B Convertible Participating Preferred Stock”—appears in Visa’s 2022, 2023, and 2024 10‑K filings (page 114, 2022; page 109, 2023; page 109, 2024). This repetition indicates that the Series B preferred shares have not been retired or cancelled and remain an active part of Visa’s capital structure, underscoring the instrument’s stability and ongoing relevance as a potential convertible financing tool.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures the core insight about the Series B instrument's stability and ongoing relevance, but contains significant factual errors that undermine its credibility. CORRECT ELEMENTS: (1) The instrument appears consistently across 2022, 2023, and 2024 filings; (2) The repetition indicates the instrument remains active and unmodified; (3) The reasoning about stability and ongoing relevance is sound. CRITICAL ERRORS: (1) The LLM provides specific page numbers (114 for 2022, 109 for 2023 and 2024) that cannot be verified against the ground truth and appear to be hallucinated; (2) The ground truth specifies exhibit numbers (4.5 for 2022, 4.4 for 2023 and 2024) and the consistent filing date of June 21, 2016, which the LLM completely omits; (3) The LLM fails to mention the exhibit number consistency across years, which is a key indicator of the instrument's static nature. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and draws appropriate conclusions about capital structure stability, but the reasoning lacks the specific documentary evidence (exhibit numbers and filing dates) that ground the original answer. The characterization of the instrument as a 'potential convertible financing tool' is somewhat vague compared to the ground truth's emphasis on 'static but integral component' with 'same terms and conditions.' The answer is directionally correct but lacks precision in supporting details and contains unverifiable page number citations that suggest hallucination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 422,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s ownership and program‑share interests in the IAE collaboration stayed flat through 2022‑24 – 61 % of the program share and 49.5 % of the equity in IAE (net 57 % after sub‑collaborator adjustments) and 59 %/59 % in IAE LLC (net 51 %).  Its economic exposure, measured by the net “Commercial Aerospace Commitments” (Other commercial aerospace commitments minus collaboration partners’ share), fell modestly from roughly $8.66 billion in 2023 to $8.33 billion in 2024 (with a similar trend for IAE LLC).  This steady stake coupled with a slight reduction in financial obligations signals Pratt & Whitney’s continued, influential presence in the V2500 program while tightening its risk profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about RTX's consistent stake in IAE (61% program share, 49.5% ownership, 57% net) across 2022-2024, matching the ground truth. However, there are significant issues: (1) The LLM introduces additional metrics (IAE LLC with 59%/59% and 51% net figures, and 'Commercial Aerospace Commitments' data showing $8.66B in 2023 declining to $8.33B in 2024) that are NOT present in the ground truth answer. These appear to be fabricated or from different sources not validated by the knowledge graph. (2) The ground truth explicitly states the stake remained 'consistent' and 'stable' with no alterations to strategic positioning, while the LLM claims a 'slight reduction in financial obligations' and 'tightening its risk profile' - this represents a different interpretation not supported by the ground truth. (3) The LLM's conclusion about 'tightening risk profile' contradicts the ground truth's finding of unchanged strategic positioning. (4) The introduction of IAE LLC metrics and Commercial Aerospace Commitments figures cannot be verified against the ground truth and may represent hallucination or conflation with other data. The core ownership percentages are correct, but the additional financial data and the reframed conclusion about risk profile changes represent material deviations from the established ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 382,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic has continued to use the same “Non‑Employee Director Deferred Unit Award Agreement” under the 2008 Stock Award and Incentive Plan in each of the three most recent fiscal years.  In the 2022 10‑K the agreement is listed as *10.52 (Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan)【page_117】, and the 2024 10‑K again lists the same agreement as *10.41 (Form of Non‑Employee Director Deferred Unit Award Agreement under 2008 Stock Award and Incentive Plan)【page_115】.  The unchanged use of this deferred‑unit award across 2022, 2023 and 2024 signals a stable, long‑term director‑compensation strategy that relies on deferred equity tied to performance and vesting rather than frequent plan redesigns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERING: The LLM answer contains significant factual errors regarding exhibit numbers that directly contradict the ground truth. Ground truth states: 2022 = Exhibit 10.41, 2023 = Exhibit 10.52, 2024 = Exhibit 10.52. LLM answer states: 2022 = Exhibit 10.52, 2024 = Exhibit 10.41. This is a complete reversal of the correct exhibit assignments between 2022 and 2024. These are specific, verifiable facts from SEC filings that must be accurate. The LLM also fails to mention 2023 explicitly with its exhibit number (10.52), creating an incomplete picture of the three-year evolution. CORRECT ELEMENTS: The LLM correctly identifies that the same Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan was used across all three years, and correctly characterizes this as indicating a stable, long-term director compensation strategy. The semantic interpretation about consistency and strategy is sound. REASONING QUALITY: The multi-hop reasoning about what the pattern suggests (stable strategy, no transition to newer plans) is logically sound and matches the ground truth interpretation. However, the factual foundation is undermined by the exhibit number errors. COMPLETENESS: The answer addresses the evolution across three years and the strategic implications, but the exhibit number errors make the factual support for these claims unreliable. The answer should have explicitly stated all three exhibit numbers in chronological order to fully demonstrate the pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 424,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin continued to use variable‑interest‑rate swaps to hedge its fixed‑rate debt through 2022‑2024. The aggregate notional amount of outstanding interest‑rate swaps stayed at $1.3 billion in each year (2022, 2023, and 2024)【page_66】【page_52】. This steady notional level indicates a deliberate, stable hedging policy that maintains a consistent exposure to interest‑rate risk rather than expanding or contracting the swap program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that LMT's notional amount of interest rate swaps was $500 million in 2022, then increased to $1.3 billion in 2023 and remained at $1.3 billion in 2024. The LLM answer incorrectly claims the notional amount was $1.3 billion in 2022, 2023, and 2024 - stating it 'stayed at $1.3 billion in each year (2022, 2023, and 2024).' This is a major quantitative error that misrepresents the evolution of LMT's hedging strategy. The LLM answer completely misses the significant tripling of exposure from 2022 to 2023 ($500M to $1.3B), which is the core finding that reveals the strategic shift in interest rate risk management. The LLM's interpretation that the company maintained a 'steady notional level' and 'consistent exposure' is factually incorrect and contradicts the actual progression. While the LLM correctly identifies that the company used variable interest rate swaps to hedge fixed-rate debt and that the amount stabilized from 2023-2024, the failure to accurately report the 2022 baseline figure ($500M, not $1.3B) is a critical error that undermines the entire analysis. The answer does address the general topic of interest rate risk management but fails on the specific multi-hop synthesis required to show the evolution over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 389,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 2022 Form 10‑K (page 46) already listed a provision that “stockholders may only remove directors for cause.” The same wording appears unchanged in the 2023 Form 10‑K (page 27) and the 2024 Form 10‑K (page 27). Over three consecutive years the company has maintained this clause, underscoring a deliberate, consistent strategy to preserve board independence and strengthen its defensive posture against hostile takeover attempts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AbbVie maintained consistent director removal provisions across 2022-2024, with the exact wording 'stockholders may only remove directors for cause' appearing unchanged. The answer appropriately cites specific page numbers (46 for 2022, 27 for 2023 and 2024) and correctly characterizes this as a deliberate governance strategy. However, there are notable gaps: (1) The LLM answer mentions 'board independence' as a rationale, which is somewhat imprecise—the ground truth emphasizes 'insulating the board from activist pressures' and maintaining 'strong control over corporate governance,' which are distinct concepts. Board independence typically refers to director conflicts of interest, not takeover defense. (2) The LLM answer omits mention of other consistent anti-takeover provisions referenced in the ground truth (staggered board terms, supermajority voting requirements), which would have strengthened the multi-hop synthesis by showing the broader defensive architecture. (3) The phrase 'preserve board independence' is semantically misaligned with the actual purpose of these provisions, which is to entrench management/board control rather than ensure independence. The answer correctly synthesizes the three-year consistency and appropriately concludes this reflects a deliberate defensive strategy, but the reasoning about 'board independence' introduces a subtle conceptual error that partially undermines the accuracy of the governance analysis. The quantitative elements (years, page numbers, exact wording) are accurate, but the qualitative interpretation of governance purpose is imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 455,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s balance sheet shows money‑market funds and time deposits falling from **$21 million in 2022 to $10 million in 2023 and remaining at $10 million in 2024** (page 79 for 2022‑23, page 84 for 2024). This modest, stable allocation indicates the company is keeping a small, highly liquid buffer while relying more on cash balances and other liquid assets to meet short‑term liquidity needs amid the year‑to‑year swings in its cash position.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states money market funds and time deposits were '$21 million in 2022' when ground truth shows $12 million in 2022. The LLM then claims they fell to $10 million in 2023, but ground truth shows they increased to $21 million in 2023. The LLM correctly identifies $10 million in 2024, but the trajectory is completely reversed. (2) SEQUENCE ERROR: Ground truth shows an increase from 2022 to 2023 ($12M → $21M), then a decrease to 2024 ($21M → $10M). The LLM incorrectly describes a decrease from 2022 to 2023 ($21M → $10M), which is factually wrong. (3) MULTI-HOP SYNTHESIS FAILURE: While the LLM attempts to contextualize the trend within broader cash balance fluctuations, the foundational numbers are incorrect, making the entire analysis unreliable. The LLM correctly identifies the overall cash positions ($8,449M in 2022, $9,201M in 2023, $5,524M in 2024 are not contradicted), but fails on the primary metric being analyzed. (4) REASONING QUALITY: The qualitative interpretation about 'modest, stable allocation' and 'small, highly liquid buffer' may be reasonable conclusions, but they are based on incorrect data sequences. The claim that allocations 'fell' from 2022 to 2023 is demonstrably false. (5) ENTITY AND METRIC ACCURACY: Company (AbbVie) and metrics (money market funds, time deposits, cash balances) are correctly identified, but the numerical values are wrong. This is a case where the LLM appears to have confused or inverted the year-to-year progression, leading to a fundamentally incorrect answer despite addressing the right question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 472,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 10‑K filings show that the provision limiting stockholder removal of directors to “for cause” was in place in 2022 (page 46), remained unchanged in 2023 (page 27), and is still present in 2024 (page 27). The unchanged language indicates a deliberate, long‑term strategy to preserve board independence and create a robust defense against hostile takeovers by restricting stockholder power to replace directors.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AbbVie maintained a consistent 'for cause' director removal provision across 2022, 2023, and 2024. The answer accurately captures the key governance mechanism and its anti-takeover purpose. However, there are some notable differences from the ground truth: (1) The LLM provides specific page numbers (46, 27, 27) which adds detail but cannot be verified against the ground truth provided; (2) The LLM uses slightly different framing - it emphasizes 'board independence' and 'restricting stockholder power' rather than the ground truth's emphasis on 'board stability' and 'discouraging activist interventions,' though these are semantically related concepts; (3) The LLM answer is more concise and omits some of the ground truth's contextual language about 'deliberate and sustained effort to insulate the board' and 'strategic continuity,' though it does capture the 'deliberate, long-term strategy' concept; (4) The ground truth explicitly mentions this is 'part of a broader set of governance mechanisms' while the LLM focuses narrowly on this single provision. The multi-hop reasoning is sound - the answer correctly synthesizes information across three years and draws the appropriate conclusion about consistency indicating strategic intent. The factual core (unchanged provision across three years, anti-takeover purpose) is correct. The answer would have been stronger with more explicit reference to the broader governance context and the specific anti-takeover mechanisms mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 430,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In 2022, Intel’s 10‑K did not reference PowerVia, indicating the technology was not yet part of its roadmap (page 6). By the 2023 filing, PowerVia was introduced as a breakthrough backside‑power technology for the upcoming Intel 20A node, promising up to 15 % performance‑per‑watt gains (page 14). In the 2024 filing, Intel positioned PowerVia as the first high‑volume commercial implementation in its next‑generation Intel 18A process, underscoring a strategic shift toward backside power delivery to enhance power efficiency and reduce front‑side routing complexity in advanced nodes (page 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate positioning at each stage; (2) Accurately captures the strategic shift from Intel 20A (2023) to Intel 18A (2024); (3) Correctly notes that PowerVia was not mentioned in 2022 10-K; (4) Properly synthesizes the multi-hop information about backside power delivery benefits and front-side routing elimination; (5) Appropriately contextualizes the shift as a strategic pivot toward practical implementation and foundry offerings. MINOR ISSUES: (1) The LLM includes a specific performance metric ('up to 15% performance-per-watt gains') that is not mentioned in the ground truth answer. While this detail may be factually correct from the 2023 filing, it represents information beyond what the ground truth explicitly validates, creating a slight discrepancy in scope; (2) The LLM cites specific page numbers (page 6, 14, 10) which cannot be verified against the ground truth but appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two process nodes (20A and 18A), correctly identifying the evolution and strategic implications. The reasoning about the shift from initial introduction to refined roadmap implementation is sound and matches the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's description of the strategic pivot and the emphasis on practical implementation aligns well with the ground truth's interpretation. The answer appropriately emphasizes both the technical benefits (backside power delivery, reduced front-side complexity) and strategic positioning (foundry offerings). Overall, this is a high-quality response with only minor additions beyond the ground truth scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 503,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption rose from 23.04 % in FY 2022 to 24.05 % in FY 2023 and 24.29 % in FY 2024 (see the option‑valuation tables on pages 83 and 84). This gradual upward trend indicates the company is updating its volatility estimate to reflect higher market swings, thereby increasing the fair value—and expense—of its non‑qualified stock options and adopting a more conservative, market‑responsive valuation approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the question and provides incorrect information. CRITICAL ISSUES: (1) The question asks about the METHODOLOGY EVOLUTION (historical vs. implied volatility approach), not the numerical volatility percentages themselves. The ground truth explicitly states the key insight: MDT evolved from using ONLY historical volatility in 2022 to a BLENDED approach (historical + implied) in 2023-2024. The LLM completely ignores this methodological shift. (2) The LLM provides specific volatility percentages (23.04%, 24.05%, 24.29%) that cannot be verified against the ground truth and appear to be fabricated or misread. The ground truth makes no mention of these specific numbers. (3) The LLM's interpretation that 'gradual upward trend indicates the company is updating its volatility estimate to reflect higher market swings' is a superficial observation that misses the actual strategic shift in methodology. (4) The LLM fails to address the multi-hop synthesis required: understanding HOW the company changed its approach (methodology), not just WHAT the numbers were. (5) The reference to 'pages 83 and 84' cannot be verified and may be hallucinated. The ground truth emphasizes the transition from historical-only to hybrid (historical + implied from market-traded options), which is the substantive answer to the question about the company's 'approach to valuing non-qualified stock options.' The LLM's answer, while discussing volatility trends, completely misses this methodological evolution that is central to understanding the company's strategic shift in valuation philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 445,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022, PowerVia was not mentioned in Intel’s 10‑K (pages 5‑9), indicating it had not yet entered the public roadmap【page_6】. By 2023, Intel announced PowerVia as a breakthrough backside‑power technology for the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt improvement【page_14】. In 2024, the technology was moved to the Intel 18A node and slated for high‑volume production of Panther Lake in 2025, underscoring its role as a core enabler of performance‑per‑watt and density scaling in Intel’s advanced process roadmap【page_10】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PowerVia's evolution but contains one significant factual discrepancy and an incomplete characterization. STRENGTHS: (1) Correctly identifies the 15% performance-per-watt improvement metric for Intel 20A in 2023; (2) Accurately captures the transition from Intel 20A to Intel 18A in 2024; (3) Correctly notes Panther Lake as the first processor on Intel 18A with 2025 high-volume manufacturing plans; (4) Properly synthesizes the multi-hop progression across three years; (5) Appropriately emphasizes PowerVia's central role in the advanced process roadmap. WEAKNESSES: (1) CRITICAL ERROR: States PowerVia was 'not mentioned in Intel's 10-K' in 2022, contradicting the ground truth which explicitly states Intel 'first introduced PowerVia in 2022.' The LLM's claim that it 'had not yet entered the public roadmap' in 2022 is factually incorrect; (2) INCOMPLETE: Fails to mention RibbonFET, which the ground truth identifies as a key integration partner with PowerVia for achieving the performance gains; (3) Missing the characterization of PowerVia as an 'industry-first backside power delivery solution' and its role in 'optimizing signal transmission.' QUANTITATIVE ACCURACY: The 15% figure is correct and properly attributed to Intel 20A. The 2023, 2024, and 2025 dates are all accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the technology evolution to strategic implications, though the 2022 characterization undermines the completeness of the progression narrative. The reasoning about PowerVia's persistence as a core innovation despite the node name change is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 466,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 Medtronic’s Black‑Scholes assumptions moved to higher risk‑free rates (0.90 % → 4.16 %), higher volatility (23.04 % → 24.29 %) and higher dividend yields (1.95 % → 3.18 %), with a slight increase in expected life from 6.0 to 6.1 years. This trend shows a more conservative, market‑condition‑driven valuation that anticipates greater stock price swings and a longer, more spread‑out exercise pattern among employees, reflecting a cautious approach to estimating volatility and employee exercise behavior.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical data (risk-free rates, volatility percentages, dividend yields, expected life) that cannot be verified against the ground truth, which contains no such quantitative details. The ground truth focuses on the methodological evolution—specifically the incorporation of implied volatility from market-traded options in 2023-2024 alongside historical volatility—as the key insight about MDT's approach. The LLM answer completely misses this critical methodological shift and instead provides different metrics (risk-free rates, dividend yields, expected life changes) that are not mentioned in the ground truth. While the LLM's interpretation that the changes reflect 'market-condition-driven valuation' and 'cautious approach' is somewhat aligned with the ground truth's conclusion about market-informed approaches, the specific numbers and focus are fundamentally different. The LLM fails to address the core finding: the transition from historical volatility alone to a hybrid approach using both implied and historical volatility. Without access to the actual 10-K filings, the specific percentages cited (0.90% → 4.16%, 23.04% → 24.29%, 1.95% → 3.18%) cannot be verified, but their absence from the ground truth and the complete omission of the implied volatility methodology shift suggests the LLM may have hallucinated these numbers or confused them with different metrics. The answer demonstrates partial understanding of the question's intent but fails on the most critical dimension: identifying the actual evolution in Black-Scholes assumptions that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 445,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "The collateral under master‑netting arrangements that is included in the “Other assets, including intangibles – net” line fell from **$1.494 billion in 2022 to $491 million in 2024** – a drop of roughly $1.0 billion. This sharp decline indicates that ExxonMobil has reduced its collateral requirements, likely through a smaller derivative exposure or more efficient netting, reflecting a more disciplined derivative‑exposure management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the starting value ($1.494 billion in 2022) and ending value ($491 million in 2024). (2) The calculation of the decline (~$1.0 billion) is accurate. (3) The qualitative interpretation about reduced derivative exposure and more disciplined management is reasonable and aligns with the ground truth's assessment. (4) The answer appropriately addresses the question about the trend and what it suggests about derivative exposure management.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM failed to include the intermediate 2023 data point ($800 million), which is essential for a complete multi-hop analysis of the three-year trend. The ground truth explicitly shows the progression: $1,494M (2022) → $800M (2023) → $491M (2024). (2) The LLM's characterization of the decline as 'sharp' is somewhat accurate, but without the 2023 data, it misses the nuanced trend showing a more gradual decline in the first year ($694M decrease) followed by a steeper decline in the second year ($309M decrease). (3) The answer doesn't fully capture the complete temporal pattern that would strengthen the analysis of derivative exposure management strategy.\n\nQUANTITATIVE VERIFICATION: 2022 value: $1,494M ✓ (correctly stated as $1.494 billion); 2024 value: $491M ✓; Calculation: $1,494M - $491M = $1,003M ≈ $1.0B ✓. However, the missing 2023 intermediate value ($800M) represents incomplete data presentation for a multi-year trend analysis.\n\nMULTI-HOP REASONING: The answer demonstrates sound reasoning about what the trend suggests (reduced exposure, efficient netting, disciplined management), but the reasoning is based on incomplete data. A complete multi-hop analysis would incorporate all three years to show the acceleration of the decline pattern.\n\nSCORE JUSTIFICATION: The answer is partially correct with accurate endpoint numbers and reasonable interpretation, but the omission of the critical 2023 intermediate data point significantly undermines the completeness of a multi-hop trend analysis. This is a 6/10 because core numbers are right and reasoning is sound, but a key data point required for full trend analysis is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 582,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra’s Options – primarily gas fair value stayed essentially flat at about $100 million (assets) and $102 million (liabilities) in both 2023 and 2024 (see the 2024 table on page 86 and the 2023 table on page 85).  In 2022 the fair value of these options was lower (the net‑derivative fair value at December 31 of the prior year was $170 million【page_87】) and the valuation model used a higher implied‑volatility assumption of 17 % (vs. 15 % in 2023‑24) and a lower implied‑correlation assumption of 32 % (vs. 56 % in 2023‑24)【page_86】.  The decline in implied volatility and rise in implied correlation, coupled with a stable fair‑value level, indicate a shift toward a more conservative, hedging‑oriented risk posture in gas derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) FAIR VALUE NUMBERS: Ground truth shows 2022 fair value of $356M (assets) and $347M (liabilities), declining to $100M/$97M in 2023 and $100M/$102M in 2024. The LLM incorrectly states 2022 fair value was 'lower' at $170M net-derivative value, which is a mischaracterization and wrong number. The LLM also fails to report the actual 2022 asset/liability values of $356M/$347M. (2) IMPLIED VOLATILITY: Ground truth clearly states volatility was 36% in 2022, 50% in 2023, and 52% in 2024 - showing an INCREASE in volatility, not a decrease. The LLM incorrectly reports 17% in 2022 vs 15% in 2023-24, which is completely wrong and contradicts the ground truth direction. This is a critical error as volatility trends are central to the question. (3) IMPLIED CORRELATION: The LLM introduces implied correlation data (32% vs 56%) that is not mentioned in the ground truth answer, suggesting potential confusion or misreading of source documents. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year evolution. Ground truth shows a clear pattern: significant decline from 2022 to 2023 in fair values, then stabilization 2023-2024, with volatility increasing over time. The LLM's narrative about 'stable fair-value level' and 'decline in implied volatility' is factually incorrect. (5) RISK POSITIONING INTERPRETATION: The LLM's conclusion about 'conservative, hedging-oriented risk posture' may be reasonable, but it's based on incorrect volatility data (claiming volatility declined when it actually increased). The ground truth interpretation about 'reduction in perceived market volatility' is also questionable given the actual volatility increase, but the LLM's numbers are definitively wrong. VERDICT: Multiple critical numerical errors, incorrect volatility direction, missing key 2022 data points, and flawed multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 539,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, the Unsecured Notes – 35A remained a $750,000 obligation with an annual debt service of $19,875 (interest rate 2.65% and maturity 07/15/30) – the same figures reported in the 2022 10‑K (page 50), the 2023 10‑K (page 50), and the 2024 10‑K (page 51).  The unchanged face amount, debt‑service cost, and long‑term maturity demonstrate SPG’s strategy of keeping this debt stable and low‑cost, thereby preserving predictable cash flows and minimizing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: face amount of $750,000, annual debt service of $19,875, interest rate of 2.65%, and maturity date of 07/15/30 are all accurate. The answer correctly identifies that these figures remained unchanged from 2022 through 2024, matching the ground truth. The LLM provides additional valuable context by citing specific page numbers from the 10-K filings (pages 50 for 2022-2023, page 51 for 2024) and including the interest rate and maturity date, which enhances the answer's credibility and informativeness. The multi-hop reasoning is sound—the answer synthesizes information across three years of filings and correctly concludes that the stability indicates SPG's strategy of maintaining consistent debt structure. The interpretation about preserving predictable cash flows and minimizing refinancing risk is logically sound and semantically equivalent to the ground truth's statement about 'prioritizing predictability in its debt servicing obligations.' The only minor distinction is that the LLM provides more specific strategic insights (low-cost characterization, refinancing risk minimization) compared to the ground truth's more general statement about consistency. This additional detail is appropriate and accurate, not contradictory. The answer fully addresses all parts of the question regarding how obligations evolved and what this reveals about long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 406,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments’ MD&A in 2022, 2023 and 2024 (pages 21, 19 and 19 respectively) all reiterate a core focus on analog and embedded‑processing products, with a particular emphasis on industrial and automotive markets.  Yet the embedded‑processing segment’s performance has shifted: revenue grew only modestly from $3.26 bn in 2022 to $3.37 bn in 2023 (page 20, 2023) before falling to $2.53 bn in 2024 (page 20, 2024), while operating profit dropped from $1.25 bn to $0.35 bn (page 20, 2024).  This steady strategic emphasis, coupled with a sharp decline in embedded‑processing profitability, signals that TI remains committed to the segment but must sharpen cost efficiencies and innovation to sustain its long‑term competitive position in the semiconductor industry.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant quantitative issues. STRENGTHS: (1) Correctly identifies the core strategic emphasis on embedded processing across 2022-2024; (2) Appropriately cites MD&A page references; (3) Correctly identifies industrial and automotive markets as key focus areas; (4) Sound reasoning that declining profitability despite maintained strategic emphasis indicates need for cost efficiencies and innovation. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The embedded processing revenue figures appear problematic. The LLM states revenue grew from $3.26bn (2022) to $3.37bn (2023) then fell to $2.53bn (2024). This represents a 24.5% decline from 2023 to 2024, which is a dramatic drop that requires verification against actual filings. Without access to verify these specific numbers, the magnitude of decline seems questionable; (2) Operating profit figures ($1.25bn to $0.35bn) represent a 72% decline, which is extremely severe and should be verified for accuracy; (3) The LLM introduces specific financial metrics (revenue and operating profit by segment) that are NOT present in the ground truth answer, suggesting either additional research or potential fabrication of data points. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects strategic emphasis to financial performance, which is sound reasoning. However, the introduction of unverified segment-level financial data undermines confidence in the analysis. SEMANTIC ALIGNMENT: The LLM answer goes beyond the ground truth by adding financial performance analysis, which wasn't requested but provides additional context. However, this additional detail introduces quantitative risk if the numbers are inaccurate. The core conclusion about stable strategic emphasis with performance challenges is reasonable but depends on verification of the cited financial figures. The answer would score higher (8-9) if the quantitative data could be verified as accurate, but the specific revenue and profit figures require validation against actual 10-K filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 565,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 through 2024 CMCSA continued to offer shared data plans only as part of bundled service packages for residential broadband customers, giving them unlimited, shared‑data, or per‑gigabyte options (page_5 2022, page_5 2023). In 2024 the company broadened its payment mix by adding prepaid unlimited data plans marketed under the NOW brand, expanding the range of plan types while keeping the bundled‑service positioning unchanged (page_5 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key evolution of CMCSA's shared data plan strategy from 2022-2024. Strengths: (1) Correctly identifies that shared data plans were offered consistently across all three years as part of bundled offerings; (2) Accurately notes the three plan options available (unlimited, shared-data, per-gigabyte) in 2022-2023; (3) Correctly identifies the 2024 expansion with prepaid unlimited plans under the NOW brand; (4) Properly synthesizes the multi-hop information showing continuity with strategic expansion. Minor weaknesses: (1) The LLM answer omits mention of device financing options (24 months) that were available in 2022-2023, which the ground truth explicitly includes as part of the payment/plan options available to customers; (2) The phrasing 'only as part of bundled service packages' is slightly more restrictive than the ground truth's 'as part of its wireless service bundles,' though semantically similar; (3) The answer could have been more explicit about the device financing terms being part of the 'range of payment or plan options' mentioned in the question. The core narrative is accurate: shared data plans remained consistent, multiple plan types were offered, and 2024 saw expansion with NOW brand prepaid options. The omission of device financing details represents a minor gap in addressing the 'range of payment or plan options' aspect of the question, but does not fundamentally undermine the correctness of the strategic evolution described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 419,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock grew steadily, rising from $51.354 billion at December 31, 2022 to $60.429 billion at December 31, 2023 and $71.431 billion at December 31, 2024 (page 72, 73, 70).  Correspondingly, purchases of treasury stock increased from $8.773 billion in 2022 to $9.088 billion in 2023 and $11.025 billion in 2024 (same pages).  This upward trend reflects a deliberate buy‑back program, indicating the company’s capital‑allocation strategy prioritizes returning cash to shareholders by reducing shares outstanding and potentially boosting earnings per share.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental misinterpretations of the financial data. The ground truth shows treasury stock investments as negative values: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. These negative values represent cash outflows for stock repurchases. The LLM incorrectly reports these as positive billions ($51.354B, $60.429B, $71.431B), fundamentally misrepresenting the nature of the transactions. Additionally, the LLM introduces entirely new figures ($8.773B, $9.088B, $11.025B for annual purchases) that are not present in the ground truth answer and cannot be verified. The LLM appears to have confused treasury stock balance sheet values with annual purchase amounts, creating a false narrative. While the LLM correctly identifies the upward trend and accurately characterizes the capital allocation strategy (stock buybacks returning value to shareholders), the core quantitative foundation is severely compromised. The reasoning about buyback programs and EPS impact is sound in principle, but is built on incorrect numerical data. The answer demonstrates partial understanding of the strategic implications but fails critically on the primary requirement of accurate financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 360,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported repair‑and‑other‑services revenue of **$1,169 million in 2022** and **$1,132 million in 2024**—a decline of **$37 million (≈3 %)**. The flat $1.132 billion figure in 2023 and 2024, after a 2022 dip, shows the service business has plateaued rather than expanded, indicating a modest contraction in maintenance and support activity amid a broader focus on new construction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the 2022 figure ($1,169 million) and 2024 figure ($1,132 million), and accurately calculated the decline as $37 million and approximately 3%. The qualitative assessment about plateauing and stagnation aligns with the ground truth interpretation. The reasoning about the service business trajectory is sound and contextually appropriate.\n\nWEAKNESSES: (1) CRITICAL ERROR - The LLM states '2022 dip' when 2022 was actually the HIGHEST year at $1,169M. The decline occurred FROM 2022 TO 2023, not the other way around. (2) INCOMPLETE DATA - The LLM fails to explicitly state the 2023 figure ($1,132 million), only referencing it indirectly as 'flat $1.132 billion figure in 2023 and 2024.' The ground truth clearly shows 2023 was $1,132M. (3) MISLEADING PHRASING - Saying 'after a 2022 dip' is factually incorrect; 2022 was the peak, not a dip. (4) SEGMENT ATTRIBUTION - While the LLM correctly identifies this as Marine Systems segment data, the original question asks about 'General Dynamics' Repair and other services' without specifying segment, which could be interpreted as company-wide. However, the numbers match Marine Systems specifically, so this is acceptable.\n\nCALCULATION VERIFICATION: $1,169M - $1,132M = $37M ✓; $37M/$1,169M = 3.16% ≈ 3% ✓\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesized the three-year trend and drew appropriate conclusions about business trajectory, though the characterization of 2022 as a 'dip' undermines the analysis.\n\nOVERALL: The answer contains the correct key numbers and reaches the correct conclusion about stagnation, but the mischaracterization of 2022 as a 'dip' and incomplete explicit statement of the 2023 figure represent meaningful errors in accuracy and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 482,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "From 2022 to 2023, CVS’s residential mortgage‑backed securities (RMBS) fair value in its investment portfolio fell from $721 million to $614 million, while unrealized losses dropped from $89 million to $60 million (page 149). In 2024, the company’s separate‑account RMBS fair value rose to $71 million (up from $51 million in 2023) and no unrealized losses were reported (page 160), indicating a shift toward lower‑risk, more liquid RMBS holdings and an overall improvement in risk positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS - 2022 fair value stated as $721M vs. ground truth $629M (discrepancy of $92M or 14.6%); 2022 unrealized losses stated as $89M vs. ground truth $10M (800% error); 2023 fair value correctly stated as $614M; 2023 unrealized losses correctly stated as $60M; 2024 fair value stated as $71M (correct) but claimed to be 'up from $51M in 2023' when 2023 RMBS holdings were $614M, not $51M - this represents a fundamental misunderstanding of the data structure; 2024 unrealized losses stated as 'no unrealized losses' vs. ground truth which doesn't explicitly state zero losses. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM incorrectly identifies separate account RMBS in 2024 as distinct from the main portfolio, creating a false narrative of improvement when the actual trajectory shows a dramatic reduction from $614M to $71M. (3) REASONING ERRORS - The conclusion that 2024 represents 'an overall improvement in risk positioning' contradicts the ground truth's assessment of 'deliberate de-risking strategy' in response to deteriorating conditions. The LLM misinterprets a sharp reduction in holdings as a positive shift rather than recognizing it as risk mitigation. (4) ENTITY CONFUSION - The LLM conflates or misidentifies portfolio segments, treating 2024 RMBS as a separate account category rather than the main investment portfolio. The 2022 and 2023 numbers are presented as if from different portfolio segments than 2024, when they should be comparable. The answer demonstrates significant factual inaccuracy on the primary quantitative metrics (2022 figures are substantially wrong) and fails to correctly synthesize the three-year trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 482,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s 2022‑2024 10‑Ks show no material change in the structure of its atmospheric‑gas contracts.  On‑site agreements remain long‑term total‑requirement contracts (10–20 years) with minimum purchase requirements and price‑escalation clauses tied to price indices, and the variable pricing components in those contracts are still considered constrained and non‑material (page 97, 2022; page 101, 2023; page 87, 2024).  Merchant and packaged‑gas contracts likewise continue to use fixed‑price or limited‑variable terms, with any variable components likewise constrained.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how Linde's contractual structure EVOLVED from 2022 to 2024. Key problems: (1) The LLM states 'no material change' in structure across the 3-year period, which directly contradicts the ground truth that explicitly identifies a meaningful evolution—specifically that 2023 introduced NEW explicit documentation of variable pricing components and price index fluctuations that were NOT detailed in 2022. (2) The LLM correctly identifies the 10-20 year contract terms, minimum purchase requirements, and price escalation provisions, which matches ground truth. (3) However, the LLM misses the critical temporal distinction: the ground truth emphasizes that 2023 marked a clarification/evolution in transparency around variable pricing mechanisms and ASC 606 revenue recognition practices, whereas the LLM treats all three years as static. (4) The LLM's claim that variable components are 'non-material' is not supported by the ground truth, which states they are 'present but constrained'—a different characterization. (5) Page citations (97, 101, 87) cannot be verified against ground truth but appear plausible. (6) The LLM's inclusion of merchant and packaged-gas contracts, while potentially accurate, represents scope creep beyond the question's specific focus on atmospheric gases and on-site agreements. (7) The fundamental failure is in the multi-hop reasoning: the question explicitly asks about EVOLUTION, and the LLM's answer of 'no material change' represents a failure to synthesize the temporal progression that the ground truth identifies. The answer is partially correct on static contract features but fundamentally misses the dynamic evolution narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 484,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net notional exposure to natural‑gas forward contracts fell from a net short of 1,307 MMBtu in 2022 to a larger net short of 1,452 MMBtu in 2023, then eased to a net short of 1,131 MMBtu in 2024【page_83】【page_87】.  The net fair value of these contracts improved from a net liability of $854 million in 2022 to a net asset of $300 million in 2023 and $250 million in 2024【page_85】【page_86】, indicating a shift toward a more balanced or less aggressive hedging stance in natural‑gas markets and a reduction in price‑risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the primary metric requested. The question asks about NET EXPOSURE (fair value basis), and the ground truth clearly states: 2022: $160M net exposure, 2023: $300M net exposure, 2024: $250M net exposure. However, the LLM provides completely different numbers: it claims 2022 was a 'net liability of $854 million' (contradicting the ground truth's $160M), then correctly identifies 2023 as $300M and 2024 as $250M. The LLM also introduces notional exposure data (MMBtu quantities: 1,307, 1,452, 1,131) that is NOT part of the ground truth answer and appears to conflate two different metrics. The 2022 figure of $854M net liability is factually wrong - the ground truth explicitly states net exposure was $160M (calculated as $191M assets - $31M liabilities). This is a major quantitative error on a core data point. The LLM's interpretation of the trend is also problematic: it characterizes the pattern as 'net short' positions and discusses 'hedging stance,' which differs from the ground truth's characterization of 'strategic shift toward greater gas market exposure.' While the LLM correctly identifies the 2023-2024 values, the inclusion of incorrect 2022 data and the introduction of notional exposure figures that weren't requested demonstrates a failure to accurately synthesize the multi-hop financial information. The reasoning about 'more balanced hedging' is speculative and not supported by the ground truth analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 411,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across 2022, 2023, and 2024, AVGO consistently listed industrial fiber optics as a core offering within its industrial portfolio, grouping it with optocouplers, motion encoders, and Ethernet ICs under the “Industrial” segment (2022: page 10; 2023: pages 4, 5, 7; 2024: pages 4, 5, 7). The product remained tied to the same application markets—factory automation, renewable energy, automotive electronics, and medical systems—without a notable shift in emphasis or repositioning. Thus, AVGO’s positioning of industrial fiber optics stayed stable, integrated with its broader industrial product mix across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Industrial Fiber Optics remained stable across 2022-2024 within AVGO's industrial portfolio, which matches the ground truth conclusion. The answer appropriately synthesizes information across three years and identifies the key product groupings (optocouplers, motion encoders/control, Ethernet ICs) and application markets (factory automation, renewable energy, automotive). However, there are notable issues: (1) The LLM cites specific page numbers (2022: page 10; 2023: pages 4, 5, 7; 2024: pages 4, 5, 7) without verification against actual filings—these citations cannot be confirmed and may be hallucinated. (2) The LLM omits several application markets mentioned in the ground truth, specifically 'power generation,' 'defense,' 'aerospace,' and 'medical systems' (though medical systems is mentioned in the LLM answer). The ground truth explicitly notes medical systems in 2022 and the LLM only mentions it once without year-specific attribution. (3) The LLM groups 'motion encoders' with other products but the ground truth shows this product was listed in 2023 but replaced by 'motion control subsystems' in 2024—the LLM doesn't capture this subtle evolution. (4) The LLM mentions 'LED devices' from the ground truth's 2023 description is completely absent from the LLM answer. The core conclusion about stability is sound and the multi-hop reasoning across years is present, but the incompleteness of product and market coverage, combined with unverifiable page citations, prevents a higher score. The answer is directionally correct but lacks precision in capturing the full portfolio evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 454,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B has carried a 3.25 % interest rate, a face amount of $750,000 and an annual debt‑service obligation of $24,375, all unchanged across the three years, with a maturity of November 30 , 2026. This stability shows that SPG’s long‑term debt strategy is to keep a predictable, low‑cost debt load and to avoid adding new leverage, focusing instead on maintaining a consistent maturity profile and cash‑flow certainty.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the face amount. Ground truth states $750,000,000 (750 million), but the LLM lists $750,000 (750 thousand) - a 1,000x understatement. Similarly, annual debt service is stated as $24,375 instead of $24,375,000 - again off by 1,000x. These are not formatting variations but fundamental decimal/magnitude errors that severely misrepresent the company's debt obligations. The interest rate (3.25%) and stability narrative are correct. The LLM correctly identifies the three-year period (2022-2024) and notes the consistency across years, which aligns with ground truth. The maturity date of November 30, 2026 is additional information not contradicted by ground truth. However, the reasoning about 'low-cost debt load' and 'avoiding new leverage' is somewhat speculative interpretation beyond what the ground truth explicitly states - the ground truth simply notes 'stable long-term debt strategy' and 'no refinancing or restructuring.' The LLM does address the evolution question by confirming no changes across the three years, which is correct. The multi-hop synthesis is sound in concept (comparing 2022, 2023, 2024 data), but the execution is severely compromised by the magnitude errors in the primary financial figures. These quantitative errors are unacceptable in financial analysis and would lead to material misunderstandings of SPG's debt position.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 399,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Industries’ aggregate expense for U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024** (see TXN 10‑K 2023 and 2024). This modest upward trend—an increase of $5 million followed by a $1 million bump—indicates a steady, slightly expanding investment in employee retirement benefits, reflecting either higher participation, modestly higher contribution rates, or inflationary adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - WRONG COMPANY: The LLM answer references 'Texas Industries' instead of 'Texas Instruments.' While the ticker 'TXN' correctly identifies Texas Instruments, the company name is explicitly wrong in the opening sentence. This is a fundamental entity identification error. QUANTITATIVE ACCURACY: The financial numbers ($70M in 2022, $75M in 2023, $76M in 2024) are correct and match the ground truth exactly. The incremental changes ($5M, then $1M) are accurately calculated. However, the LLM FAILED to calculate or mention the 3-year percentage increase (8.6% from 2022 to 2024), which was explicitly stated in the ground truth answer. This is a significant omission of a key analytical metric. QUALITATIVE REASONING: The LLM provides reasonable interpretation of the trend (steady, slightly expanding investment) and offers plausible explanations (higher participation, contribution rates, inflation). However, the reasoning is somewhat speculative without the quantitative percentage context. COMPLETENESS: The answer addresses the evolution of expenses and provides trend interpretation, but omits the specific percentage calculation that was part of the ground truth. The multi-hop synthesis across years is correct, but incomplete. SEMANTIC ISSUES: While 'Texas Industries' vs 'Texas Instruments' might be a typo, it represents a factual error in entity identification that cannot be overlooked in financial analysis. The core financial data is accurate, but the missing percentage metric and company name error significantly diminish the answer quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 432,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has consistently excluded goodwill impairments and non‑economic accounting changes from its ROIC calculations in 2022, 2023, and 2024 (see 2022 p. 47; 2023 p. 50; 2024 p. 50). This unchanged policy shows that the company’s performance‑evaluation methodology prioritizes core operating profitability and capital efficiency, deliberately omitting accounting adjustments that do not reflect underlying economic performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024 - matching the ground truth's core finding. (2) Accurately cites specific page references (2022 p. 47; 2023 p. 50; 2024 p. 50) that support the claim, demonstrating proper multi-hop synthesis across three years of filings. (3) Correctly characterizes the methodology as 'unchanged' and 'consistent,' which aligns with ground truth language about 'stable methodology.' (4) Provides sound reasoning about why this matters: the company prioritizes 'core operating profitability and capital efficiency' by excluding non-economic items. (5) The semantic meaning matches ground truth - both convey that GD maintains disciplined performance evaluation by removing non-operational accounting adjustments. MINOR CONSIDERATIONS: (1) The LLM adds 'goodwill impairments' as a specific example alongside 'non-economic accounting changes.' While this is a reasonable specification and likely accurate based on typical ROIC adjustments, the ground truth answer is more general and doesn't explicitly mention goodwill impairments. This is a minor enhancement rather than an error, but represents a slight expansion beyond the ground truth scope. (2) The LLM's interpretation that this reveals 'performance-evaluation methodology' priorities is slightly more detailed than the ground truth's simpler statement about 'disciplined approach,' but both convey equivalent meaning. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The years (2022, 2023, 2024) and page numbers are correctly cited. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to demonstrate consistency, which is the core requirement of the multi-hop question. The logic is sound: consistent exclusion across years → stable methodology → reveals disciplined approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 552,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate Accounts Assets grew modestly from **$3,250 million at December 31, 2022 to $3,311 million at December 31, 2023** (page 157) and then held steady at **$3,311 million at December 31, 2024** (page 108). This slight uptick followed by a flat level over the three‑year period indicates that CVS is maintaining a stable, rather than aggressively expanding, investment base in its large‑case pension (long‑term insurance) products, reflecting a consistent long‑term positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states Separate Accounts Assets were '$3,250 million at December 31, 2022' but the ground truth clearly shows $5,087 million in 2022. This is a massive discrepancy ($1,837 million error). The LLM then claims growth to $3,311 million in 2023, but ground truth shows a DECREASE from $5,087M (2022) to $3,250M (2023). The LLM has the 2022 and 2023 figures reversed or confused. (2) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year trend. Ground truth shows: 2022: $5,087M → 2023: $3,250M (36% decline) → 2024: $3,311M (marginal recovery). The LLM incorrectly characterizes this as 'modest growth' and 'slight uptick' when the dominant feature is a significant 2023 decline. (3) INTERPRETATION ERROR: The LLM concludes CVS is 'maintaining a stable' position with 'consistent long-term positioning,' which misses the critical insight that there was a strategic reduction or market-driven devaluation in 2023 followed by stabilization. The ground truth explicitly notes 'significant decline in 2023 followed by marginal recovery in 2024.' (4) ENTITY/METRIC ACCURACY: While the metric name (Separate Accounts Assets) and company (CVS) are correct, the numerical values are fundamentally wrong, making the entire answer unreliable. The LLM appears to have started with 2023 data as the baseline for 2022, creating a cascading error throughout the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 423,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. was originally signed on October 22 2012 and amended twice—once on February 24 2015 and again on November 19 2019 (2022 10‑K Exhibits EE, FF, GG). In 2022 Target executed a third amendment (dated November 1 2022) filed as Exhibit (10)JJ to the October 29 2022 10‑Q, and in 2023 entered a letter agreement dated March 8 2023 filed as Exhibit 10.21.4 to the April 29 2023 10‑Q. The 2024 Form 10‑K lists these two documents as the most recent contractual milestones, indicating no further amendments through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. CRITICAL ISSUES: (1) The LLM claims a third amendment dated November 1, 2022, and a letter agreement dated March 8, 2023, which are NOT mentioned in the ground truth answer. The ground truth explicitly states only two amendments: February 24, 2015 and November 19, 2019. (2) The LLM references specific 10-Q and 10-K exhibits (EE, FF, GG, 10JJ, 10.21.4) that cannot be verified against the ground truth and appear to be fabricated details. (3) The LLM's claim that 'no further amendments through 2024' contradicts its own assertion of amendments in 2022 and 2023. (4) The ground truth indicates the November 19, 2019 amendment was 'explicitly listed' in 2024, but the LLM suggests this was already known in 2022. WHAT WAS CORRECT: The original agreement date (October 22, 2012) and the first amendment date (February 24, 2015) are accurate. The company names and general structure of the answer are appropriate. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across 2022-2024 as described in ground truth. Instead of showing a clear progression of how the agreement was referenced/maintained across years, it introduced unverified amendments and documents. The answer demonstrates hallucination of specific filing references and dates not supported by the ground truth, which is a fundamental failure in financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 401,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In 2022 Linde’s rare gases were produced simply as co‑products of its air‑separation plants, with no explicit emphasis on advanced technology or cross‑segment integration [page_94]. By 2023 the company highlighted its leadership in non‑cryogenic air‑separation and the use of proprietary VPSA and membrane technologies to produce rare gases, while tying them to its engineering and digital‑service offerings [page_100]. In 2024 Linde reiterated this differentiated technology base and further positioned rare gases within its broader engineering, clean‑energy, and digital‑solution portfolio, underpinned by a robust patent portfolio that supports integration across product lines [page_4][page_5][page_6].",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY AND MULTI-HOP SYNTHESIS:\n\n1. CHRONOLOGICAL REVERSAL ERROR (Critical): The LLM answer fundamentally reverses the timeline of technological emphasis. The ground truth states that in 2022, rare gases were listed as primary products with no explicit emphasis on advanced technology, and only by 2023-2024 did Linde emphasize proprietary technologies (VPSA, membrane separation). However, the LLM claims that by 2023 the company 'highlighted its leadership in non-cryogenic air-separation and the use of proprietary VPSA and membrane technologies' - this is backwards. The ground truth explicitly states that 2023 maintained focus on rare gases 'but began to emphasize' these technologies, implying this was a new development in 2023, not something already established.\n\n2. MISCHARACTERIZATION OF 2022 POSITIONING: The LLM states rare gases were 'produced simply as co-products...with no explicit emphasis on advanced technology' which aligns with ground truth. However, the LLM then claims 2023 introduced VPSA and membrane technologies as if this was a major shift, when the ground truth indicates these were innovations highlighted starting in 2023 and continuing into 2024.\n\n3. INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a clear progression: (2022) basic product listing → (2023) emphasis on proprietary technologies and long-term contracts → (2024) elevated strategic positioning with explicit leadership claims and technological innovations. The LLM's answer conflates 2023 and 2024 positioning, failing to capture the distinct evolution across all three years.\n\n4. MISSING KEY DETAILS: The ground truth specifically mentions 'price escalation clauses and variable pricing' in 2023 contracts, and explicitly names rare gases (krypton, neon, xenon) in 2024. The LLM answer omits these specific details.\n\n5. UNSUPPORTED CLAIMS: The LLM references 'a robust patent portfolio that supports integration across product lines' in 2024, but this specific claim is not substantiated in the ground truth answer provided.\n\n6. PAGE REFERENCES: The LLM provides page citations (page_94, page_100, page_4, page_5, page_6) that cannot be verified against the ground truth, raising questions about source accuracy.\n\n7. MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, the fundamental chronological error undermines the validity of the multi-hop analysis. The answer fails to correctly identify and sequence the evolution of strategic positioning.\n\nThe answer demonstrates partial understanding of the general trend (from product-centric to technology-driven) but fails in the critical execution of accurately mapping this evolution across the 2022-2024 timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 726,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: $1.49 billion in 2022, $800 million in 2023, and $491 million in 2024 (all figures are “primarily related to initial‑margin requirements” on derivatives tied to advances to equity companies). The downward trend indicates that the company is holding less collateral to cover these derivative positions, suggesting a reduced exposure to derivative liabilities linked to equity‑company relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022, formatted as $1,494 million in ground truth), $800 million (2023), and $491 million (2024). The format variation ($1.49 billion vs $1,494 million) is acceptable and demonstrates flexibility in presentation. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the evolution of collateral amounts across the three-year period, and (b) what the trend suggests about derivative liability exposure. (3) ENTITY ACCURACY: Correctly identifies ExxonMobil, the specific metric (collateral under master netting arrangements), the relationship type (equity company advances), and all relevant years (2022-2024). (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to reduced derivative exposure and de-risking implications. The addition of context about 'initial-margin requirements' on derivatives adds helpful specificity beyond the ground truth, demonstrating deeper understanding without contradicting the original answer. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that 'holding less collateral to cover these derivative positions' is semantically equivalent to the ground truth's 'strategic reduction in exposure to derivative liabilities.' The conclusion about de-risking/portfolio optimization is well-supported by the data trend. Minor note: The LLM provides slightly more technical detail (initial-margin requirements) which enhances rather than detracts from the answer's quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 447,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s long‑term contract coverage of its net generating capacity rose from roughly 92 % in 2022 to about 94 % in 2023 and stayed at that level in 2024 (NEE 2022 10‑K, p. 19; NEE 2023 10‑K, p. 19; NEE 2024 10‑K, p. 19). This upward trend and subsequent plateau demonstrate a deliberate strategy to lock in revenue and hedge against price volatility, underscoring NEER’s focus on risk mitigation through contractual certainty in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct (92% in 2022, 94% in 2023 and 2024), matching the ground truth exactly. The numerical progression is accurately captured. ENTITY ACCURACY: NEER (NextEra Energy Resources) is correctly identified, fiscal years 2022-2024 are correct, and the metric (long-term bilateral contracts as percentage of net generating capacity) is properly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the trend (steady increase from 92% to 94%, then plateau). The reasoning about risk mitigation strategy is sound and well-supported. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how reliance has evolved (with specific percentages and timeline), and (2) what this suggests about risk mitigation strategy. SEMANTIC EQUIVALENCE: The LLM's phrasing ('upward trend and subsequent plateau,' 'lock in revenue and hedge against price volatility,' 'contractual certainty in competitive wholesale markets') conveys the same strategic insights as the ground truth ('steady increase,' 'revenue stability and risk mitigation,' 'managing price risk'). The inclusion of source citations (NEE 10-K filings with page numbers) adds credibility. MINOR OBSERVATIONS: The ground truth mentions 'shorter-term bilateral contracts as a hedge' which the LLM answer does not explicitly address, but this is a minor omission that doesn't significantly detract from the core answer's accuracy. The LLM's characterization of the strategy is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 452,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal of **$495 million at the end of fiscal 2022**, and this balance remained unchanged at **$495 million at the end of fiscal 2023 and fiscal 2024**. The lack of any repayment or refinancing over this period indicates a conservative debt‑management approach that preserves the maturity schedule and liquidity rather than aggressively reducing long‑term debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024). (2) The quantitative facts are precisely presented with proper formatting and clear year-by-year breakdown. (3) The multi-hop synthesis correctly identifies that the balance remained unchanged across the three-year period. (4) Entity identification is accurate (AVGO, 3.125% notes, January 2025 maturity date). WEAKNESSES: (1) The LLM's interpretation of debt management strategy differs from the ground truth. The LLM characterizes it as a 'conservative debt-management approach that preserves the maturity schedule and liquidity,' while the ground truth suggests AVGO 'may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.' These are subtly different interpretations - the ground truth implies proactive planning for imminent maturity (approaching January 2025), while the LLM's characterization is more passive/defensive. (2) The LLM does not explicitly acknowledge the significance of 'approaching maturity' as emphasized in the ground truth, which is a key contextual element for understanding the debt management strategy. (3) The phrase 'lack of any repayment or refinancing' in the LLM answer is somewhat speculative since the ground truth only states what was reported, not what refinancing may or may not have occurred. MULTI-HOP REASONING: The LLM correctly synthesized the three-year trend and identified the unchanged balance, but the strategic interpretation is less nuanced than the ground truth. The ground truth's mention of refinancing/cash reserves as settlement methods is more forward-looking and specific to the imminent maturity situation. OVERALL: The answer is factually accurate on all numbers and dates, but the qualitative interpretation of the debt management strategy is less insightful than the ground truth, resulting in a solid but not excellent score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 534,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 37B consistently carried a 2.25 % interest rate, a face amount of $700,000, and a maturity date of January 15 , 2032 (SPG_10k_2022 p. 50; SPG_10k_2023 p. 50; SPG_10k_2024 p. 51). The unchanged terms over this period show that the company is maintaining a stable, low‑rate, long‑term debt profile rather than issuing new debt or refinancing, underscoring a conservative long‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - FACE AMOUNT INCORRECT: The LLM states the face amount is $700,000 (seven hundred thousand dollars), but the ground truth clearly indicates $700,000,000 (seven hundred million dollars). This is a massive factual error - off by a factor of 1,000. This is not a formatting variation but a fundamental misreading of the financial data. All other quantitative elements are correct: (1) Interest rate of 2.25% - CORRECT, (2) Maturity date of January 15, 2032 - CORRECT, (3) Consistency across 2022-2024 - CORRECT. However, the face amount error is severe and undermines the entire answer's credibility. The qualitative reasoning about the company's debt strategy is sound and well-articulated, showing understanding of the multi-hop synthesis required (comparing terms across three years and drawing conclusions about strategy). The answer appropriately cites page numbers from the 10-K filings, demonstrating proper sourcing. However, the single but critical quantitative error (face amount) in a financial analysis context is disqualifying for a high score. In financial analysis, precision of dollar amounts is paramount - a $700M vs $700K error represents a fundamental misunderstanding or transcription error that would lead to completely incorrect financial analysis and decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 365,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "From 2022 through 2024, TI’s Melaka, Malaysia site remained an **analog‑only** facility—listed with an “X” under the analog column and no “X” under embedded processing in each year’s property table【page_18】【page_16】【page_16】.  The unchanged classification over three years shows that TI has not expanded embedded‑processing operations in Melaka, underscoring a sustained, analog‑centric focus at that location.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly matches the ground truth. Strengths: (1) Correctly identifies the three-year period (2022-2024) and the consistent analog-only operational status in Melaka, Malaysia. (2) Accurately represents the marking system ('X' under analog, no 'X' under embedded processing) for all three years. (3) Properly synthesizes the multi-hop information showing no change across the time period. (4) Correctly interprets the significance of this consistency as indicating a 'sustained, analog-centric focus' and lack of embedded processing expansion. (5) Provides appropriate page references to support the claims. (6) Uses semantically equivalent language to the ground truth ('analog-only facility' vs 'analog product lines without expanding into embedded processing'). Minor observation: The LLM answer is slightly more concise than the ground truth but loses no material information. The reasoning is sound—the unchanged classification across three years logically supports the conclusion about TI's strategic focus. All entities (Texas Instruments/TI, Melaka Malaysia, analog vs embedded processing) are correctly identified and synthesized. No numerical errors or calculation issues present. The answer fully addresses both parts of the multi-part question: (1) how the operational footprint evolved (answer: it remained stable), and (2) what this reveals about focus (answer: sustained analog-centric strategy with no embedded processing expansion).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 411,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s multi‑layered security program has steadily deepened as its real‑time payment network expanded. In 2022 the program combined a robust information‑security framework, third‑party assessments and EMV technical standards, supporting real‑time payments in 12 of the top 50 GDP markets【MA_10k_2022.pdf: page 11】. By 2023 it added an enterprise resilience component, insurance coverage and regular system testing while extending real‑time infrastructure to 13 markets【MA_10k_2023.pdf: page 11】, and in 2024 the strategy further emphasized resilience, testing, monitoring and the integration of tokenization, fraud‑scoring and virtual‑card controls as the real‑time network remained in 13 markets【MA_10k_2024.pdf: page 11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core numeric facts: 12 markets in 2022, 13 markets in 2023, and maintains 13 markets in 2024. (2) The timeline progression (2022→2023→2024) is accurate. (3) Key security components are mentioned (EMV, tokenization, fraud-scoring, third-party assessments). (4) The answer demonstrates multi-hop synthesis across three years of filings. WEAKNESSES: (1) The LLM states real-time infrastructure 'remained in 13 markets' in 2024, which is technically accurate but misses the significant evolution mentioned in ground truth: the China joint venture expansion and ability to process domestic transactions there represents a major market expansion that should be highlighted as a key 2024 development. (2) The ground truth emphasizes that the security framework 'had to scale further to accommodate this new market' in China - this critical evolution is absent from the LLM answer. (3) The LLM mentions 'enterprise resilience component, insurance coverage' for 2023 which are not explicitly mentioned in the ground truth, suggesting possible hallucination or over-specification. (4) The ground truth emphasizes 'public-private partnerships to address emerging threats' which the LLM does not mention. (5) The LLM's characterization of 2024 as maintaining 13 markets without noting the China expansion represents incomplete synthesis of the multi-hop information. CALCULATION/NUMERIC VERIFICATION: All market counts (12, 13, 13) are correct. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three years but fails to fully integrate the China expansion narrative that represents a key evolution in the security approach's scope and scale. The answer is partially correct on the evolution but incomplete on the most significant 2024 development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 499,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics produced 449 LAVs for the Canadian Army in 2022 (page_11 2022), which fell to 360 in 2023 (page_11 2023) before rising to 399 in 2024 (page_11 2024). The dip in 2023 followed by a rebound in 2024 shows GD is actively adjusting production to meet Canadian demand while maintaining a strategic focus on the LAV platform, including ongoing modernization and upgrades.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect data with numbers in completely wrong order. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units (upward trajectory). LLM answer states: 2022=449 units, 2023=360 units, 2024=399 units (inverted/scrambled sequence). This is a complete reversal of the actual progression. The LLM incorrectly claims a 'dip in 2023 followed by a rebound in 2024' when the ground truth shows consistent growth across all three years. The LLM also misinterprets the data pattern - it suggests production volatility and reactive adjustment to demand, when the ground truth indicates 'consistent and growing strategic emphasis' with an 'upward trajectory.' The reasoning about 'actively adjusting production' contradicts the actual steady increase. While the LLM correctly identifies General Dynamics and the Canadian Army LAV program, and attempts to address the multi-hop question about production evolution and strategic focus, the quantitative foundation is entirely wrong. The numbers are not merely formatted differently - they are factually incorrect and in the wrong chronological order, making all subsequent analysis invalid. This represents a fundamental failure in data accuracy that cannot be overlooked regardless of reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 365,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s target allocation to hedge‑fund limited‑partnership investments grew from 3 % of pension‑plan assets in 2022 (the same level as in 2021 and 2023) to 4 % in 2024. This modest, step‑wise increase over the three‑year period signals a deliberate shift toward a slightly more aggressive, diversified pension strategy that adds greater exposure to hedge funds for potential higher returns. (Target allocations: 3 % in 2022/2023【page_175】, 4 % in 2024【page_169】; 3 % in 2021【page_167】)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a different metric than the ground truth. CRITICAL ERRORS: (1) The LLM reports TARGET ALLOCATIONS (percentages: 3% in 2022/2023, 4% in 2024) while the ground truth provides ACTUAL DOLLAR AMOUNTS ($214M in 2022, $225M in 2023, $252M in 2024). These are two completely different metrics. (2) The LLM claims 2022 and 2023 were 'the same level' at 3%, but the ground truth shows $214M vs $225M - a $11M increase (5.1% growth). (3) The LLM states the allocation was '3% in 2021 and 2023' but provides no 2021 data in the ground truth for comparison. (4) The LLM's characterization of the trend as 'step-wise increase' from 3% to 4% is misleading - the actual dollar amounts show a gradual, continuous increase of 17.8% over three years ($214M to $252M), not a discrete jump. (5) The LLM's interpretation about 'more aggressive, diversified pension strategy' is speculative and not supported by the actual data trajectory. The ground truth explicitly states the trend suggests 'consistent, and potentially more confident' approach - not necessarily 'more aggressive.' MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the actual investment amounts across the three-year period. The question specifically asks about 'allocation' which in the context of pension fund assets typically refers to dollar amounts, not percentage targets. The LLM appears to have confused or conflated two different data points from the filings. The answer demonstrates a fundamental misunderstanding of what metric was being tracked and reported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 434,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "According to the 2024 10‑K (page 27), the penetration rate of the Target MasterCard Credit Card fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024. This downward trend indicates a gradual decline in consumer adoption and engagement with Target’s financial products, suggesting that customers may be shifting to alternative payment options or that the card’s value proposition is becoming less compelling.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN 2024 PENETRATION RATE: The LLM states the 2024 penetration rate was 18.6%, but the ground truth shows it was 17.8%. This is a factual error of 0.8 percentage points on a key metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY ASSESSMENT: The LLM correctly identified two of three years' data but provided an incorrect figure for 2024, which is the most recent and arguably most important data point. This represents a 4.5% error relative to the correct 2024 figure (0.8/17.8). QUALITATIVE REASONING: The LLM's interpretation of the trend is reasonable and aligns with the ground truth's assessment - both identify a consistent decline suggesting weakening consumer adoption. The LLM correctly notes the downward trajectory and provides plausible explanations (shifting to alternative payment options, reduced value proposition). However, the LLM's answer is less comprehensive than the ground truth, which provides additional context about RedCard sales increasing in dollar terms while total sales grew faster, explaining the dilution effect. COMPLETENESS: The LLM addresses the main question about penetration rate evolution and provides interpretation about consumer adoption trends. However, it misses the nuanced explanation about the relationship between RedCard sales growth and overall sales growth that provides deeper insight into the trend. ENTITY ACCURACY: Correctly identifies Target MasterCard Credit Card and the relevant time period (2022-2024). The reference to page 27 of the 2024 10-K adds credibility but cannot verify the exact page number. OVERALL ASSESSMENT: The answer is partially correct with a significant quantitative error in the 2024 figure that undermines confidence in the analysis. The reasoning is sound but less detailed than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 496,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 to 2024, the net fair‑value exposure from FPL Cost Recovery Clauses grew from **$2 million** in 2022 to **$12 million** in 2023 and to **$38 million** in 2024.  \nIn 2022 and 2023 the “significant other observable inputs” were negative (–$5 million and –$12 million) while the “significant unobservable inputs” were positive ($7 million and $24 million). By 2024 the observable inputs turned positive ($4 million) and the unobservable inputs increased to $34 million, reflecting a shift toward more observable‑input‑driven fair‑value estimates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Multiple significant number errors: The LLM states 2022 total fair value was $2 million, but ground truth shows $1 million (100% error on this key figure). More critically, the LLM claims 2022 significant unobservable inputs were $7 million, but ground truth clearly states +$6 million (16.7% error). The 2023 and 2024 total fair values ($12M and $38M) are correct, as are the 2023 unobservable inputs ($24M) and 2024 observable inputs ($4M) and unobservable inputs ($34M). However, the foundational 2022 numbers are wrong. (2) CALCULATION/COMPONENT VERIFICATION - The LLM's statement that 2022 components sum to $2M is mathematically inconsistent with ground truth: -$5M (observable) + $6M (unobservable) = $1M total, not $2M. This suggests the LLM either misread or miscalculated the 2022 baseline. (3) REASONING QUALITY - The LLM's conclusion about 'shift toward more observable-input-driven fair-value estimates' is CONTRADICTED by the data. The ground truth shows unobservable inputs grew from $6M (2022) to $24M (2023) to $34M (2024), while observable inputs went from -$5M to -$12M to +$4M. The trend actually shows GROWING reliance on unobservable inputs, not a shift toward observable inputs. The LLM's interpretation is backwards. (4) MULTI-HOP SYNTHESIS - The answer fails to properly synthesize the three-year evolution. While it identifies the correct 2023 and 2024 totals, the 2022 baseline error cascades through the analysis, and the directional conclusion about the shift is fundamentally incorrect. (5) COMPLETENESS - The answer addresses the main components but with significant factual errors that undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 465,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s 10‑K filings for 2022, 2023 and 2024 all name Anta as a key competitor and repeatedly list the same three competitive pillars—product attributes, innovation and consumer connection (see the “Competition” sections).  In each year the product‑research section continues to spotlight Nike’s technology pipeline (Air, Zoom, Flyknit, React, etc.), underscoring a sustained emphasis on innovation, while the brand‑engagement narrative remains centered on athlete endorsements, digital commerce and social‑media interaction.  Consequently, Nike’s competitive positioning relative to Anta has stayed essentially unchanged, with no shift in the balance of product‑innovation or brand‑engagement focus across the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly documents a clear strategic evolution from 2022-2024: (1) 2022: NKE emphasized quality, performance, reliability, and product style/design innovation; (2) 2023: NKE elevated 'innovation and development' ahead of performance and reliability, signaling a strategic shift; (3) 2024: NKE further solidified innovation focus and reiterated digital experiences, social media, and athlete endorsements. The LLM claims 'Nike's competitive positioning relative to Anta has stayed essentially unchanged, with no shift in the balance of product‑innovation or brand‑engagement focus across the three years.' This is directly contradicted by the ground truth, which documents a multi-year strategic shift toward innovation emphasis and digital engagement. The LLM correctly identifies that Anta is named as a competitor across all three years and correctly notes Nike's technology pipeline (Air, Zoom, Flyknit, React) and brand engagement elements (athlete endorsements, digital commerce, social media). However, the LLM fails to recognize the temporal evolution and strategic prioritization changes documented in the filings. The quantitative accuracy is reasonable (no specific numbers were required), but the qualitative reasoning is severely flawed—the LLM missed the core finding that Nike's competitive strategy evolved significantly from 2022 to 2024, particularly in elevating innovation and digital engagement as primary differentiators. This represents a failure in multi-hop synthesis and temporal analysis of strategic positioning changes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 461,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The equity‑compensation tables for 2022, 2023 and 2024 show no shares remaining for future issuance under the Texas Instruments 2003 Director Compensation Plan – the “remaining‑available” column lists only the 2009 LTIP, 2014 ESPP, 2018 Director Plan, and in 2024 the 2024 LTIP (see footnote (c) on pages 61, 59 and 63). This steady absence indicates that TI has effectively retired the 2003 plan for new director awards, relying instead on newer plans such as the 2018 Director Plan and the 2024 LTIP.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, the 2003 Director Compensation Plan was 'still referenced as active, with shares being issued under it,' but the LLM claims there were 'no shares remaining for future issuance' across all three years (2022, 2023, 2024) with a 'steady absence.' This is a critical quantitative/factual error. The LLM's statement that the plan shows 'steady absence' from 2022-2024 contradicts the ground truth's narrative of evolution/change from 2022 to 2024. The ground truth indicates a progression: (1) 2022 - plan active with shares available, (2) 2023 - no longer listed with remaining shares but still referenced for outstanding grants, (3) 2024 - no longer mentioned. The LLM incorrectly collapses this evolution into a 'steady absence' across all years. While the LLM correctly identifies that TI shifted to newer plans (2018 Director Plan, 2024 LTIP) and that the 2003 plan was phased out, it fundamentally mischaracterizes the timeline and availability of shares in 2022. The answer also lacks the nuance about 2023 being a transition year where the plan was still referenced for outstanding grants. The reasoning about retirement of the plan for new awards is sound, but the factual foundation regarding share availability in 2022 is incorrect, which undermines the entire analysis of the 'trend' the question asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 401,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA’s 2022‑24 filings show a steady integration of data‑driven services into its advertising business, with the company offering technology, tools, data‑driven services and marketplace solutions to media‑industry customers (CMCSA_10k_2022.pdf page 6; CMCSA_10k_2023.pdf page 4; CMCSA_10k_2024.pdf page 4).  Over this period the firm broadened its reach by adding representation agreements and digital platforms—such as Sky‑branded networks and the NOW brand DTC streaming service (CMCSA_10k_2023.pdf page 4; CMCSA_10k_2023.pdf page 6)—and continued to upgrade its technology stack, deploying DOCSIS 4.0, virtualizing core network functions, and enhancing X1, Sky Q, NOW and Xumo platforms (CMCSA_10k_2024.pdf page 7).  No additional tool or marketplace upgrades were specifically disclosed beyond these ongoing initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in alignment with the ground truth:\n\n1. MAJOR FACTUAL DIVERGENCE: The LLM answer introduces information about DOCSIS 4.0, X1, Sky Q, NOW, and Xumo platforms that are NOT mentioned in the ground truth answer. While these may be legitimate from the filings, they represent a different focus than what the ground truth emphasizes. The ground truth specifically highlights: (a) cloud-based platforms and integrated search functionality (2023), (b) enhanced digital advertising tools and representation agreements (2024). The LLM answer conflates general platform/technology upgrades with advertising-specific enhancements.\n\n2. INCOMPLETE SYNTHESIS OF KEY EVOLUTION: The ground truth emphasizes a strategic evolution in DATA-DRIVEN SERVICES specifically within advertising from 2022-2024, including cloud-based platforms and integrated search functionality. The LLM answer mentions these offerings exist but fails to clearly articulate the specific evolution of data-driven advertising services across the three years. Instead, it pivots to discussing streaming platforms and network virtualization, which are tangential to the core question about advertising services evolution.\n\n3. MISSING CRITICAL DETAILS: The ground truth explicitly mentions:\n   - 2023: \"cloud-based platforms and integrated search functionality across content sources\"\n   - 2024: \"enhancing its digital advertising tools and strengthening its representation agreements\"\n   The LLM answer mentions representation agreements but omits the cloud-based platforms and integrated search functionality details that are central to the 2023 evolution.\n\n4. SCOPE CREEP: The LLM answer discusses DOCSIS 4.0 and network virtualization, which are infrastructure/connectivity improvements, not advertising service enhancements. This represents a misunderstanding of the question's focus on advertising offerings specifically.\n\n5. QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral. However, the LLM's statement \"No additional tool or marketplace upgrades were specifically disclosed\" contradicts the ground truth's assertion of specific enhancements in 2023 and 2024.\n\n6. MULTI-HOP REASONING: The LLM correctly identifies the three-year period and attempts to synthesize across documents, but the synthesis is incomplete and misdirected toward general platform improvements rather than advertising-specific evolution.\n\nThe answer is partially correct in acknowledging the general trend of integration and expansion, but significantly misses the specific advertising-focused enhancements that form the core of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 720,
        "total_tokens": 2184
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed security (CMBS) holdings fell sharply from 2022 to 2024.  In 2022 the fair value of CMBS in unrealized‑loss positions was $992 million with $155 million in unrealized losses (page 149); by 2023 the fair value had dropped to $675 million and unrealized losses to $100 million (page 149).  In 2024 the fair value of CMBS in Separate Accounts fell to only $3 million (page 160) and the company reported no unrealized losses for CMBS, indicating that the exposure has been largely divested or written down.  This trend shows CVS is actively trimming its CMBS portfolio and moving toward a more conservative risk stance in this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) 2022 CMBS Fair Value: LLM states $992 million vs. ground truth of $574 million - a 73% overstatement. (2) 2022 Unrealized Losses: LLM states $155 million vs. ground truth of $12 million - a 1,192% overstatement. (3) 2023 Fair Value: LLM correctly states $675 million (matches ground truth). (4) 2023 Unrealized Losses: LLM correctly states $100 million (matches ground truth). (5) 2024 Fair Value: LLM states $3 million vs. ground truth of $6 million - close but incorrect. (6) 2024 Unrealized Losses: Both correctly state no significant losses. The LLM appears to have confused or conflated different CMBS metrics (possibly mixing in data from securities in unrealized-loss positions vs. total CMBS holdings). The 2022 baseline numbers are critically wrong, which undermines the entire trend analysis. While the LLM correctly identifies the general trend of declining CMBS exposure and the de-risking strategy, the foundational data is substantially incorrect. The reasoning about CVS's risk positioning is sound in principle, but is built on faulty numbers. The reference to 'Separate Accounts' in 2024 may indicate a different categorization, but the ground truth figure of $6 million should be the correct total CMBS exposure for that year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 380,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023, and 2024 all describe the employee benefit as “merchandise and other discounts” within the broader compensation package (see 2022 page 6, 2023 page 6, 2024 page 6).  None of the disclosures specify a discount rate or change the wording, indicating that the scope and value of the benefit have remained essentially unchanged over the three years.  This consistency suggests that Target treats the merchandise discount as a stable, tangible perk aimed at supporting employee satisfaction and retention rather than a variable or frequently adjusted benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core findings of the ground truth and provides an incomplete analysis of Target's employee benefits evolution. Key issues: (1) FACTUAL ERRORS: The LLM claims 'None of the disclosures specify a discount rate or change the wording, indicating that the scope and value of the benefit have remained essentially unchanged.' This directly contradicts the ground truth, which documents significant evolution in how benefits were framed and what was emphasized alongside merchandise discounts. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth demonstrates a clear three-year progression showing: 2022 (basic benefits with $15/hour minimum), 2023 (expanded wage range $15-$24/hour with enhanced financial wellness components), and 2024 (further expansion with mental health and virtual healthcare). The LLM completely fails to capture this evolution and instead claims static consistency. (3) MISSING CONTEXTUAL ANALYSIS: The ground truth identifies a strategic shift toward 'holistic employee well-being' with layering of modern benefits while maintaining traditional perks. The LLM reduces this to a simple statement that merchandise discounts are 'stable' and 'unchanged,' missing the broader benefits ecosystem evolution entirely. (4) REASONING FAILURE: The LLM's conclusion that consistency 'suggests Target treats the merchandise discount as a stable, tangible perk' is not wrong per se, but it completely ignores the actual strategic evolution documented in the filings—the shift from basic compensation to comprehensive wellness benefits. (5) CITATION ISSUES: While the LLM cites page numbers, it provides no evidence of the actual content changes documented in the ground truth regarding wage ranges, 401(k) matching, tuition reimbursement, mental health services, and virtual healthcare additions. The answer demonstrates a surface-level reading that missed the substantive multi-year progression that was the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 533,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In 2022 and 2023, Linde’s risk disclosures listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several integration risks (2022, p.12; 2023, p.12). By 2024, the disclosure expanded this to explicitly mention “integration of operations across different cultures and languages” and the unique risks of foreign acquisitions (2024, p.12), underscoring a heightened focus on cross‑border cultural dynamics. This evolution signals a strategic shift toward more proactive, culturally aware integration planning and risk mitigation in global acquisitions.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues that prevent it from being considered substantially correct: (1) CITATION PROBLEMS: The LLM provides specific page references (2022 p.12, 2023 p.12, 2024 p.12) that cannot be verified and appear to be fabricated. This is a critical error in a financial document evaluation task. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a three-year progression showing how Linde's framing evolved from listing cultural challenges as operational risks (2022) → expanding to regulatory/compliance context (2023) → focusing on financial outcomes and synergy/retention risks (2024). The LLM answer only captures a partial evolution, suggesting the shift went from 2022-2023 (listing challenges) to 2024 (mentioning cross-border dynamics), missing the nuanced 2023 expansion regarding regulatory/compliance integration. (3) MISSING KEY INSIGHT: The ground truth emphasizes that Linde increasingly framed cultural challenges in terms of 'strategic risk management and financial outcomes' rather than just operational hurdles. The LLM answer mentions 'proactive, culturally aware integration planning' but doesn't capture the shift toward financial impact framing (synergies, key personnel retention). (4) SEMANTIC DIFFERENCES: The LLM's conclusion about 'heightened focus on cross-border cultural dynamics' is somewhat aligned with the ground truth but misses the deeper strategic reframing toward financial risk management. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize across three years, it doesn't fully capture the progression in how Linde conceptualized these risks strategically. The answer is partially correct in identifying evolution but incomplete in explaining the nature and significance of that evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 483,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply from **$1.494 billion in 2022 to $491 million in 2024** (a decline of about $1.003 billion, roughly 67 %). This steep reduction indicates that the company has either scaled back its derivative exposure or improved the efficiency of its collateral usage, reflecting stronger derivative‑exposure management.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and trend direction, but has a significant completeness issue. CORRECT ELEMENTS: (1) Starting value of $1.494 billion in 2022 is accurate; (2) Ending value of $491 million in 2024 is accurate; (3) The decline calculation of approximately $1.003 billion is mathematically correct ($1,494M - $491M = $1,003M); (4) The percentage decline of roughly 67% is accurate (1,003/1,494 = 67.1%); (5) The interpretation about derivative exposure reduction and improved collateral efficiency is sound and matches the ground truth's assessment. CRITICAL OMISSION: The LLM answer skips the intermediate 2023 data point ($800 million), which is explicitly provided in the ground truth. The original answer emphasizes the 'consistent decline' across all three years (2022→2023→2024), showing a progressive trend. The LLM's direct comparison from 2022 to 2024 misses this important intermediate data that demonstrates the trend is sustained rather than a single-year anomaly. QUANTITATIVE ACCURACY: 8/10 - All numbers and calculations are correct, but the omission of 2023 data represents incomplete quantitative reporting. QUALITATIVE ACCURACY: 7/10 - The reasoning about derivative exposure management is sound, but the analysis would be stronger with the intermediate year showing the consistent nature of the decline. CONTEXTUAL RELEVANCE: 8/10 - The answer appropriately addresses the question about trend and implications, though the incomplete temporal analysis weakens the contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 424,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "In 2022, the Security Insights Platform (page 11) was positioned as a tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with its data “available for use with in‑house tools for security information and event management.” The 2024 filing (also page 11) repeats the same wording, still emphasizing risk identification, remediation, and SIEM integration, but adds no new reference to external‑tool integration or a broader cybersecurity‑strategy alignment. Thus, the platform’s core positioning and described capabilities remained essentially unchanged between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IN MULTI-HOP SYNTHESIS AND COMPLETENESS:\n\n1. FACTUAL CONTRADICTION WITH GROUND TRUTH:\nThe LLM claims the platform's positioning \"remained essentially unchanged between 2022 and 2024,\" directly contradicting the ground truth which documents a clear evolution:\n- 2022: Standalone risk assessment tool\n- 2023: More explicitly tied to broader cybersecurity portfolio with emphasis on proactive risk response\n- 2024: Contextualized within expanded mainframe software suite (Cybersecurity, AIOps, DevOps) with strategic role in enterprise-wide security planning\n\nThe LLM completely missed the 2023 intermediate step and the 2024 strategic repositioning within the broader suite.\n\n2. INCOMPLETE MULTI-HOP SYNTHESIS:\nThe question explicitly asks about evolution \"from 2022 to 2024\" with three specific dimensions:\n- Integration with external tools: LLM only mentions SIEM integration, missing the broader strategic integration context\n- Remediation processes: LLM correctly identifies this but doesn't show evolution\n- Alignment with broader cybersecurity strategies: LLM explicitly states \"adds no new reference\" to this, which contradicts ground truth showing explicit 2024 alignment with expanded suite\n\n3. MISSING CRITICAL CONTEXT:\nThe LLM failed to identify that by 2024, the platform was repositioned as part of an integrated suite including Cybersecurity, AIOps, and DevOps - a fundamental strategic shift from standalone to integrated offering.\n\n4. QUANTITATIVE ACCURACY:\nPage references (page 11) appear correct, and the 2022 wording quote is accurate. However, the LLM's conclusion that 2024 \"repeats the same wording\" misses the contextual repositioning documented in ground truth.\n\n5. REASONING FAILURE:\nThe LLM's logic is flawed: it equates identical product description wording with unchanged positioning, missing that the CONTEXT of where/how the product is positioned within AVGO's portfolio fundamentally changed.\n\nThe answer demonstrates surface-level accuracy on quoted text but fails at the core task of synthesizing multi-year evolution across strategic positioning dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 573,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "SPG’s Unsecured Notes – 32B remained unchanged from 2022 through 2024, with a face value of **$750,000** and an interest rate of **3.38 %** (maturity 06/15/27) in each year’s debt schedule (2022 10‑K p. 50; 2023 10‑K p. 50; 2024 10‑K p. 51). This stability shows the company has not increased or re‑priced this debt, reflecting a long‑term strategy that prioritizes predictable cash flows and low refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - MAJOR QUANTITATIVE INACCURACY: The LLM states the face value as $750,000 (seven hundred fifty thousand dollars), when the ground truth clearly indicates $750,000,000 (seven hundred fifty million dollars). This is a 1,000x error in magnitude - a fundamental and unacceptable mistake for financial data. The interest rate of 3.38% is correct, the maturity date of 06/15/27 is correct, and the consistency across 2022-2024 is correctly identified. However, the face value error is so severe that it undermines the entire answer's credibility. The reasoning about stable debt strategy and predictable cash flows is sound and semantically equivalent to the ground truth, but this cannot compensate for the massive numerical error. The LLM correctly identifies that the debt remained unchanged across all three years and provides appropriate page references, but the $750M vs $750K discrepancy is a critical failure in quantitative accuracy that would lead to completely incorrect financial analysis and decision-making. This type of error (off by three orders of magnitude) is precisely the kind of mistake that evaluation criteria emphasize as unacceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 331,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024, CMCSA’s filings consistently note that Lumen has been expanding its fiber network across the U.S., adding fiber‑to‑the‑premises infrastructure that enables higher‑speed broadband services (2022, page_9; 2023, page_9; 2024, page_9). The company also highlights that Lumen, along with other carriers, is offering bundled services—combining broadband with wireless or other offerings—which intensifies competition for CMCSA’s residential broadband (2024, page_9). As Lumen’s fiber coverage grows and its bundling strategies become more integrated, the competitive threat to CMCSA’s broadband has increased, especially in markets where CMCSA’s HFC network faces direct fiber competition (2024, page_9).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core competitive threat from Lumen to CMCSA across the 2022-2024 period, accurately capturing the key elements: fiber network expansion, higher-speed services, and bundled service offerings. The semantic content aligns well with the ground truth.\n\nSTRENGTHS:\n- Correctly identifies Lumen as a persistent competitive threat across all three years\n- Accurately describes fiber-to-the-premises expansion as the primary competitive strategy\n- Correctly notes bundled service offerings (broadband + wireless) as a competitive tactic\n- Properly synthesizes the multi-hop information (Lumen's actions → competitive impact on CMCSA)\n- Appropriately characterizes the threat as intensifying over the period\n- Correctly identifies HFC network competition as a key battleground\n\nWEAKNESSES:\n- The citation format (\"2022, page_9; 2023, page_9; 2024, page_9\") appears fabricated or overly specific without verification. While the answer references consistent pages, this level of specificity cannot be verified and may be hallucinated.\n- The answer lacks the nuanced language from the ground truth about Lumen being \"explicitly called out\" in 2023 or the characterization of \"top-tier wireline competitors\" in 2024\n- Missing some contextual depth about the evolution of competitive pressure (ground truth notes \"escalation\" and \"possibly intensifying\")\n- The answer doesn't explicitly mention that Lumen was part of a \"group of wireline telecom companies\" in 2022, which provides important context\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and connects Lumen's strategic actions (fiber expansion, bundling) to competitive impact on CMCSA. The reasoning is sound and logical.\n\nQUANTITATIVE ACCURACY:\nNo specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so quantitative accuracy is not directly testable. However, the citation references appear potentially unreliable, which affects confidence in the sourcing.\n\nOVERALL ASSESSMENT:\nThe answer is substantially correct in its core factual content and reasoning. The main concern is the specificity of page citations which cannot be independently verified and may represent hallucination. The semantic content and multi-hop synthesis are sound, making this a good but not excellent response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 639,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card penetration fell from 20.5 % in 2022 to 18.6 % in 2024 for RedCards (page 27) and from 19.8 % in 2023 to 18.6 % in 2024 for Circle Cards (page 29). The modest decline indicates that the loyalty‑driven payment strategy remains broadly effective but its growth momentum has slowed, suggesting Target may need to refresh incentives or marketing to sustain or boost card usage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims the 2024 penetration rate was 18.6% for both RedCards and Circle Cards, but the ground truth clearly states it was 17.8% in 2024. This is a material error of 0.8 percentage points. Additionally, the LLM introduces 'Circle Cards' as a separate metric with a 19.8% rate in 2023, which appears to be a misinterpretation or fabrication - the ground truth shows a single penetration rate of 19.8% in 2023, not two separate card products. (2) ENTITY CONFUSION - The LLM incorrectly references 'RedCards' and 'Circle Cards' as distinct products with separate penetration rates, citing different page numbers. The ground truth presents a single penetration rate metric across the period (20.5% → 19.8% → 17.8%), not multiple card products with different rates. This suggests the LLM either hallucinated product names or misread the source material. (3) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year trend. The correct trend shows consistent decline: 20.5% (2022) → 19.8% (2023) → 17.8% (2024), totaling a 2.7 percentage point decline. The LLM's version (20.5% → 18.6%) misses the 2023 data point and arrives at the wrong 2024 figure. (4) INTERPRETATION ERROR - While the LLM's qualitative assessment that 'the decline indicates slowing momentum' is reasonable, it contradicts the ground truth's interpretation that the trend 'suggests a weakening in the effectiveness' of the strategy. The ground truth emphasizes weakness; the LLM emphasizes that the strategy 'remains broadly effective.' (5) MISSING CRITICAL DATA - The LLM omits the 2023 penetration rate (19.8%) from its main narrative, breaking the continuity of the three-year trend analysis. The answer demonstrates fundamental factual inaccuracy on the core numeric data required to answer this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 527,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s presence in the Republic of Congo was still part of its global portfolio in 2022, as the company listed the country among its operating regions (page 33).  By 2024, Chevron had begun to divest its non‑operated interests there, selling its 31.5 % working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi project (pages 41, 45).  The divestitures cut Chevron’s asset ownership and capital commitment in the region, reflecting a strategic shift away from non‑operated assets in Congo.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key divestiture transactions (31.5% Haute Mer interest and 15.75% Lianzi interest) with accurate percentages. The 2022 and 2024 timeframe references are correct. The characterization of the shift from active presence to divestiture is accurate. WEAKNESSES: (1) SIGNIFICANT OMISSION - The LLM completely fails to mention the 2023 investment of approximately $0.7 billion in offshore development and natural gas projects across Africa including the Republic of Congo. This is a critical data point that represents the middle phase of the evolution and demonstrates the 'continued capital commitment' mentioned in the ground truth. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution 'from 2022 through 2024' with three key dimensions: asset ownership, investment levels, and strategic positioning. The LLM addresses asset ownership (divestiture) and strategic positioning (shift away from non-operated assets) but completely misses the investment levels dimension for 2023. (3) NARRATIVE INCOMPLETENESS - The ground truth describes a three-phase evolution: 2022 (active presence), 2023 (continued investment), 2024 (divestiture). The LLM only captures phases 1 and 3, missing the critical middle transition point. (4) CONTEXT LOSS - The ground truth's characterization of the 2023 investment as 'signaling continued capital commitment' provides important context about the trajectory that the LLM fails to capture. QUANTITATIVE ACCURACY: The percentages (31.5%, 15.75%) are correct. However, the missing $0.7 billion investment figure represents a significant quantitative omission. QUALITATIVE ACCURACY: While the reasoning about divestiture is sound, the failure to synthesize the complete three-year evolution significantly weakens the qualitative assessment. The answer reads as incomplete rather than comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 509,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s gas‑option exposure fell sharply: the fair value of gas‑option positions dropped from $356 m (assets) and $347 m (liabilities) in 2022 to $100 m and $102 m in 2023 and 2024, while the net notional volume rose from 1,307 MMBtu in 2022 to 1,452 MMBtu in 2023 and then fell to 1,131 MMBtu in 2024【page_83】【page_85】【page_87】. Despite the lower exposure, the weighted‑average implied volatility used to value those options increased from 36 % in 2022 to 52 % in 2023 and 2024【page_83】【page_85】【page_86】, indicating that the company is pricing its remaining gas‑options at higher market uncertainty and adopting a more cautious risk stance in gas markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the sharp decline in fair value from 2022 to 2023 ($356M/$347M to $100M/$102M), accurately reports the implied volatility increase from 36% to 52%, and provides sound reasoning about de-risking and cautious positioning. The multi-hop synthesis across years is logically structured. The answer appropriately addresses the evolution question and risk positioning interpretation.\n\nCRITICAL ERRORS: (1) The LLM states liabilities were $102M in both 2023 and 2024, but ground truth shows $97M in 2023 and $102M in 2024 - this is a factual error in the 2023 liability figure. (2) The LLM introduces net notional volume data (1,307/1,452/1,131 MMBtu) that is NOT present in the ground truth answer. While this additional data may be accurate from the source documents, it was not part of the original answer and represents information beyond the scope of the ground truth comparison.\n\nMINOR ISSUES: (1) The LLM states implied volatility was 52% in both 2023 and 2024, but ground truth indicates 50% in 2023 and 52% in 2024 - another factual discrepancy. (2) The phrasing \"$100 m and $102 m in 2023 and 2024\" is ambiguous and could be misread as applying both figures to both years, though context suggests the LLM meant them separately.\n\nNUMBER VERIFICATION:\n- 2022: Assets $356M ✓, Liabilities $347M ✓, IV 36% ✓\n- 2023: Assets $100M ✓, Liabilities $97M ✗ (LLM says $102M), IV 50% ✗ (LLM says 52%)\n- 2024: Assets $100M ✓, Liabilities $102M ✓, IV 52% ✓\n\nThe quantitative accuracy score reflects the two significant number errors (2023 liabilities and volatility), while the qualitative accuracy remains relatively high because the overall reasoning and interpretation are sound. The contextual relevance is strong as the answer directly addresses the evolution question and risk positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 498,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 10‑K filings for 2022, 2023 and 2024 all list FlyEase in the product research, design and development section as part of the company’s suite of innovative technologies.  The language and placement of the mention remain unchanged across the three years, indicating that FlyEase has been treated as a core, ongoing innovation rather than a one‑off or experimental feature.  This consistency signals that Nike views FlyEase as a foundational element of its strategy to deliver inclusive, performance‑enhancing footwear and apparel.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly describes an EVOLUTION of FlyEase's treatment from 2022 to 2024: (1) 2022 - introduced as part of broader portfolio alongside other technologies, (2) 2023 - expanded presence with emphasis on integration into various categories, (3) 2024 - fully embedded as core technology. The LLM answer claims 'language and placement of the mention remain unchanged across the three years,' which directly contradicts the documented progression showing increasing prominence and integration. This is a critical error in multi-hop reasoning - the question specifically asks about evolution/progression, and the LLM failed to identify or describe the documented changes. The LLM correctly identifies that FlyEase appears in product R&D sections across all three years and correctly characterizes it as a foundational element, but misses the key insight that its role EVOLVED rather than remained static. The answer demonstrates incomplete synthesis of the multi-year progression and misses the strategic significance of the escalating emphasis on FlyEase. While the LLM's conclusion about FlyEase being foundational is correct, the reasoning path is flawed because it denies the evolution that the ground truth documents. The quantitative accuracy is high (correct years, correct filing sections mentioned) but the qualitative accuracy is low because the core analytical claim about consistency contradicts the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 422,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 35A stayed the same: a $750,000 face amount, 2.65 % interest, $19,875 annual debt service, and a 2030 maturity (see the 2023 table on page 50 and the 2024 table on page 51).  The unchanged terms show that Simon has kept this small, long‑term, low‑cost debt instrument on its balance sheet rather than refinancing or issuing new debt, underscoring a conservative, predictable long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: $750,000 face amount, 2.65% interest rate, $19,875 annual debt service, and 07/15/30 maturity date are all accurately stated and consistent with the ground truth across 2022-2024. The answer correctly identifies that these terms remained unchanged throughout the period, which is the core factual finding. The multi-hop synthesis is sound - the model correctly synthesized information across three years of filings to identify the consistency pattern. The reasoning about SPG's (Simon Property Group) debt strategy is logically sound and semantically equivalent to the ground truth: both conclude that the unchanged terms reflect a conservative, stable approach without refinancing or restructuring. Minor strengths: the LLM provides specific page references (pages 50-51) which adds credibility, and uses 'Simon' as an acceptable alternative to 'SPG' in the explanation. The only minor difference is that the ground truth uses 'SPG' consistently while the LLM switches between 'Simon' and 'SPG,' but this is a stylistic variation that doesn't affect accuracy. The characterization of the debt as 'small, long-term, low-cost' is appropriate and supported by the data. No calculation errors, no missing key information, and the answer directly addresses how the obligations 'evolved' (by remaining stable) and what this reveals about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 398,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Texas Instruments’ MD&A consistently frames analog and embedded‑processing as the core of its business model in 2022, 2023 and 2024 (pages 18‑20 of each filing).  The embedded‑processing segment grew modestly in revenue from $3.261 B in 2022 to $3.368 B in 2023 but fell 25 % to $2.533 B in 2024, while operating‑profit margins slid from 38.4 % to 29.9 % to 13.9 % (page 20).  This steady emphasis on embedded products—despite margin pressure—underscores TI’s long‑term strategy to generate and grow free‑cash‑flow per share by leveraging its manufacturing strength, portfolio breadth and market reach.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic emphasis on embedded processing products across 2022-2024 and appropriately connects this to TI's long-term free cash flow per share objective. The qualitative reasoning about TI's consistent positioning and strategic intent is sound and well-articulated.\n\nHowever, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE CONCERNS:\n- The LLM provides specific revenue figures ($3.261B in 2022, $3.368B in 2023, $2.533B in 2024) and operating margin percentages (38.4%, 29.9%, 13.9%) that cannot be verified against the ground truth provided. The ground truth does not include these specific financial metrics.\n- The 25% decline calculation (from $3.368B to $2.533B) is mathematically correct IF those numbers are accurate, but without verification from the original filings, this introduces uncertainty.\n- The ground truth makes no mention of specific revenue figures or margin percentages for the embedded processing segment.\n\n2. COMPLETENESS:\n- The LLM answer goes beyond the ground truth by providing granular financial data, which could be either a strength (more detailed) or a weakness (potentially introducing unverified information).\n- Both answers address the three-year evolution and connection to free cash flow per share strategy.\n\n3. ENTITY AND REASONING ACCURACY:\n- Company identification (Texas Instruments) is correct\n- Years (2022, 2023, 2024) are correct\n- The connection between embedded processing emphasis and free cash flow per share strategy is correctly identified\n- The reasoning that margin pressure despite continued emphasis reveals strategic commitment is sound\n\n4. SEMANTIC EQUIVALENCE:\n- The LLM answer conveys similar strategic insights to the ground truth regarding consistent emphasis on embedded processing\n- Both identify this as foundational to TI's long-term strategy\n- The LLM adds the observation about margin compression, which provides additional context but isn't contradicted by the ground truth\n\nThe primary concern is that specific financial metrics provided by the LLM cannot be independently verified against the ground truth, creating uncertainty about their accuracy. The qualitative analysis and strategic reasoning are strong, but the quantitative claims require validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 625,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "By 2023 Disney had moved the Marvel brand to a top‑level tile on Disney+, making the franchise a primary driver of subscriber acquisition (page 7). In 2024 Marvel’s trademarks were listed among the company’s indefinite‑lived intangible assets, underscoring its sustained value and reflecting Disney’s strategy of monetizing high‑profile IP to accelerate Disney+ growth—illustrated by the platform’s 123 million paid subscribers that year (page 7, page 114).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies Marvel as a top-level tile on Disney+ by 2023. (2) Accurately cites the 123 million Disney+ paid subscribers figure as of September 28, 2024. (3) Correctly identifies Marvel trademarks as indefinite-lived intangible assets in 2024. (4) Numbers and dates are factually accurate with proper formatting.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM answer fails to address the 2022 baseline, which is critical for showing the 3-year evolution requested in the question. The ground truth explicitly mentions Marvel was listed as an indefinite-lived intangible asset in 2022 alongside ESPN and Pixar—this comparison is missing from the LLM answer. (2) MISSING STRATEGIC CONTEXT: The LLM answer does not mention Disney's plan to launch ESPN+ as a tile in early fiscal 2025, which the ground truth identifies as evidence of a broader strategic pattern of leveraging branded content. (3) INCOMPLETE CHARACTERIZATION OF EVOLUTION: The ground truth describes a progression from 'passive asset recognition to active brand utilization'—the LLM answer mentions the tile transition but doesn't explicitly frame this as an evolution from passive to active strategy. (4) VAGUE CAUSALITY: The LLM answer states Marvel 'likely contributed to subscriber retention and growth' but doesn't establish the clear progression showing how the strategic shift from 2022 to 2024 indicates financial strategy evolution. (5) MISSING COMPETITIVE CONTEXT: The ground truth mentions Marvel's role as 'a key differentiator in the competitive DTC market'—this strategic positioning is absent from the LLM answer.\n\nQUANTITATIVE VERIFICATION: The 123 million subscriber figure is correct. The years (2023, 2024) are correct. No calculation errors detected.\n\nMULTI-HOP REASONING: The question requires synthesizing information across 2022, 2023, and 2024 to show evolution. The LLM answer only addresses 2023-2024, missing the critical 2022 baseline needed to demonstrate the full 3-year progression. This is a significant gap in multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE: While the LLM answer uses different wording ('monetizing high-profile IP' vs. 'active brand utilization'), the core concepts are similar. However, the missing 2022 context and ESPN+ strategic parallel significantly reduce the completeness of the answer relative to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 632,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance agreement continued to cover roughly the same portion of its closed block each year—59.25 % in 2022, 59 % in 2023, and 59 % in 2024—while the net ceded reinsurance recoverables tied to the agreement rose from $16.7 billion at December 31 2023 to $17.6 billion at December 31 2024, with 84 % of those balances held with the five largest ceded reinsurers and unsecured recoverables falling slightly from $2.5 billion to $2.4 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) PERCENTAGE ACCURACY: The percentages for 2022-2024 (59.25%, 59%, 59%) are correctly stated in the LLM answer, matching the ground truth. However, this is the only correct element. (2) REINSURANCE RECOVERABLE BALANCES - CRITICAL ERRORS: The LLM provides completely different numbers than the ground truth. Ground truth states unsecured reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). The LLM instead discusses net ceded reinsurance recoverables of $16.7B (2023) and $17.6B (2024), which are entirely different metrics and magnitudes. The LLM also mentions unsecured recoverables of $2.5B declining to $2.4B, which contradicts the ground truth figures of $4.4B to $4.2B. (3) MULTI-HOP SYNTHESIS FAILURE: The question specifically asks about 'unsecured reinsurance recoverable balances' evolution from 2022-2024. The LLM failed to properly synthesize this information across the three-year period. Instead, it introduced different metrics (net ceded reinsurance recoverables) that were not requested and appear to be from a different section of the filings. (4) MISSING 2022 DATA: The LLM provides no unsecured balance figure for 2022, while the ground truth clearly states $3.6 billion. (5) SEMANTIC ISSUES: While the LLM correctly identifies the modified coinsurance agreement and its stability, it fundamentally misidentifies the key financial metrics being tracked. The introduction of the 84% concentration with five largest ceded reinsurers, while potentially accurate, is not part of the ground truth answer and appears to be extraneous information that doesn't address the core question about unsecured balances evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 480,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) rose modestly from **$757 million in 2022 to $810 million in 2023** (fair value, 2022 and 2023)【page 148】, then dropped sharply to **$71 million in separate accounts in 2024**【page 160】.  The RMBS were agency‑guaranteed, AA‑rated with a 5.9‑year duration in 2023【page 148】, so the decline indicates a deliberate shift away from low‑credit‑risk, moderate‑duration mortgage assets toward other fixed‑income holdings, thereby reducing interest‑rate exposure while maintaining a diversified debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: (1) QUANTITATIVE FAILURES: The LLM provides completely incorrect numbers for 2022 and 2023. Ground truth shows $629M (2022) and $614M (2023), but LLM claims $757M (2022) and $810M (2023). These are off by ~$128M and ~$196M respectively - substantial errors of 20%+ magnitude. The 2024 figure of $71M is correct. (2) MISSING CRITICAL DATA: The LLM completely omits the unrealized losses trend ($10M in 2022 → $60M in 2023), which is a key component of the ground truth answer and directly addresses the 'risk exposure' aspect of the question. (3) INCOMPLETE TREND ANALYSIS: The ground truth describes the pattern as 'increased significantly from $629M to $614M' (actually a slight decrease, but relatively stable at high levels), then 'sharp decline to $71M.' The LLM's narrative of 'rose modestly from $757M to $810M' is factually wrong and mischaracterizes the actual trend. (4) REASONING QUALITY: While the LLM's interpretation about 'deliberate shift away from low-credit-risk assets' and 'reducing interest-rate exposure' is reasonable, it is built on incorrect foundational numbers, making the analysis unreliable. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the multi-year trend because the base numbers are wrong. The question asks about evolution from 2022-2024 and what it suggests about risk exposure - the unrealized losses data is essential to this analysis and is completely absent. The LLM provides page citations but the underlying data is incorrect, suggesting either misreading of source documents or hallucination of numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 440,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "From 2022 to 2024, MetLife’s modified‑coinsurance agreement has covered essentially the same portion of the closed block—59.25 % in 2022 and 59 % in both 2023 and 2024. The company continues to account for the arrangement under the deposit method, offsetting the deposit liability with a deposit recoverable, and the accounting treatment has remained unchanged across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. Quantitative verification: All percentages are correct (59.25% in 2022, 59% in 2023 and 2024), matching the ground truth exactly. The temporal progression is accurately captured. Entity accuracy is sound: MetLife is correctly identified, the modified coinsurance agreement is properly named, and the closed block is correctly referenced. The accounting treatment is accurately described as the deposit method with offsetting of deposit liability and deposit recoverable. Multi-hop reasoning is sound: the answer correctly synthesizes information about the reinsurance percentage evolution across three years while maintaining the accounting treatment consistency. The answer demonstrates proper understanding that this represents a stable strategic approach. Minor observation: The ground truth explicitly mentions 'an unaffiliated third-party reinsurer' while the LLM answer omits this detail. This is a minor contextual omission that doesn't affect the core factual accuracy but represents a slight loss of completeness. The LLM answer is more concise while retaining all essential information about the percentage changes and accounting consistency. The semantic equivalence is strong—both answers convey the same fundamental message about stability and consistency in MetLife's approach to the closed block reinsurance arrangement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 392,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net notional exposure to forward gas contracts grew from a net short of 1,307 MMBtu in 2022 to 1,452 MMBtu in 2023, then fell to 1,131 MMBtu in 2024. The peak in 2023 reflects a more aggressive hedging or speculative stance, while the subsequent reduction in 2024 indicates a trimming of that exposure, suggesting a shift toward a more balanced or less aggressive risk position in natural‑gas markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and uses entirely different metrics than the ground truth. CRITICAL ERRORS: (1) METRIC MISMATCH: The ground truth provides net exposure in DOLLAR AMOUNTS ($160M in 2022, $300M in 2023, $250M in 2024), while the LLM answer provides NOTIONAL VOLUMES in MMBtu (1,307 MMBtu in 2022, 1,452 MMBtu in 2023, 1,131 MMBtu in 2024). These are completely different measurement units and data points. (2) DIRECTIONAL ERROR: The ground truth shows net exposure INCREASING from 2022 to 2023 ($160M to $300M), then DECREASING in 2024 ($300M to $250M). The LLM answer shows a similar pattern in MMBtu but this is irrelevant since it's measuring a different metric entirely. (3) COMPONENT BREAKDOWN: The ground truth provides detailed asset/liability breakdowns (2022: $191M assets, $31M liabilities; 2023: $377M assets, $77M liabilities; 2024: $296M assets, $46M liabilities), which the LLM completely omits. (4) INTERPRETATION: While the LLM's qualitative interpretation about 'more aggressive stance in 2023 followed by rebalancing in 2024' aligns directionally with the ground truth's narrative, this cannot compensate for using entirely wrong quantitative data. The LLM appears to have accessed a different data source (notional volumes) rather than the actual financial exposure values required to answer the question. This is a fundamental failure to provide the correct financial metrics requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 396,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In 2022, Broadcom positioned industrial fiber optics as a core part of its industrial portfolio, used across automation, power‑generation/distribution, medical, defense/aerospace and vehicle subsystems, and paired with motion encoders and generic Ethernet ICs. By 2023 the description shifted to highlight factory automation, renewable‑energy and automotive electronics, and the integration moved to motion‑control encoders and more specific Ethernet PHYs, switch ICs and camera microcontrollers. The 2024 filing repeats this expanded focus, underscoring the same diverse application mix while emphasizing tighter coupling with Ethernet PHYs, switch ICs and camera microcontrollers.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant issues: (1) CORRECT ELEMENTS: The answer accurately identifies the core positioning of Industrial Fiber Optics across 2022-2024, correctly names AVGO/Broadcom, accurately lists the application domains (automation, power generation, medical, defense, automotive), and correctly identifies the evolution toward integrated solutions with Ethernet PHYs, switch ICs, and camera microcontrollers. The timeline progression is factually sound. (2) FACTUAL ERRORS: The LLM conflates the 2023 and 2024 positioning by stating '2024 filing repeats this expanded focus' when the ground truth indicates 2024 represents a distinct evolution with 'explicit linking' to Ethernet PHYs and camera microcontrollers that differs from 2023's emphasis. The ground truth shows 2023 grouped fiber optics with 'sensors, encoders, and microcontrollers' while 2024 shows 'Ethernet PHYs, switch ICs, and camera microcontrollers' - these are different technology groupings that the LLM fails to distinguish clearly. (3) MULTI-HOP REASONING: The answer partially synthesizes the evolution but misses the nuanced progression. It correctly identifies the shift from 'standalone components to interconnected systems' but doesn't adequately capture that 2024 represents a MORE SPECIFIC integration pattern (networked and vision-based systems) compared to 2023's broader factory automation focus. (4) COMPLETENESS: The answer addresses application diversity and integration with adjacent technologies but undersells the strategic significance of the 2024 shift toward vision-based and networked systems. The phrase 'repeats this expanded focus' suggests stasis when the ground truth indicates continued evolution. (5) SEMANTIC ISSUES: While the LLM uses 'motion-control encoders' vs ground truth's 'motion encoders,' this is acceptable variation. However, the failure to distinguish 2023 from 2024 positioning is a material error in a question specifically asking about evolution 'from 2022 to 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 547,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock has been a static element of its capital structure from FY 2022 through FY 2024.  The cumulative dividend obligation remains a fixed $0.10 per share payable annually on May 31, and no common‑stock dividends can be declared until that preferred dividend is fully paid.  The stock is fully issued to Sojitz America at a par value of $0.3 million, is redeemable at that par, and no additional preferred shares have been issued or altered in any of the three fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and numbers. All quantitative elements are accurate: the $0.10 per share annual dividend obligation, the $0.3 million par value, the three-year period (FY 2022-2024), and the fact that no structural changes occurred. The statement about dividend priority (preferred dividends must be paid before common stock dividends) is correctly conveyed. However, the answer has a notable omission: it does not explicitly address the stability aspect or the fact that Sojitz America has not sought redemption despite having the option. The ground truth emphasizes that 'This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.' The LLM answer mentions the stock is 'redeemable at that par' but does not highlight the significance that redemption has not occurred or that this reflects relationship stability. The LLM answer also uses slightly different phrasing ('cumulative dividend obligation remains a fixed $0.10 per share') which could be interpreted as potentially ambiguous—'cumulative' might suggest accumulation over time rather than the annual recurring nature, though the context clarifies it means the ongoing obligation. The multi-hop synthesis is sound (combining information about the stock structure, dividend terms, and ownership across three years), but the answer is less complete in addressing the 'evolution' and 'stability' aspects of the question. The answer is factually accurate but somewhat narrower in scope than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 446,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 31B has not changed: it remains a $750,000 note with a 3.25 % coupon and a maturity of November 30, 2026. This stability shows SPG’s long‑term financing strategy of keeping fixed‑rate, long‑term unsecured debt in place to lock in low borrowing costs and preserve a predictable debt‑service profile, rather than restructuring or refinancing the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. QUANTITATIVE VERIFICATION: All numeric values are correct - $750,000 principal amount, 3.25% coupon rate, and November 30, 2026 maturity date match exactly. The three-year period (2022-2024) is correctly identified. COMPLETENESS: The answer addresses the core question about how the debt evolved (remained unchanged) and provides strategic interpretation. However, it omits one contextual detail from the ground truth: the mention of broader portfolio changes (retirement of certain notes, issuance of Unsecured Notes - 41A in 2024) that provide fuller context for understanding why this particular instrument's stability is noteworthy. ENTITY ACCURACY: Company (SPG/Simon Property Group), instrument name (Unsecured Notes - 31B), and all financial metrics are correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly identifies the stability across three years and draws a logical conclusion about SPG's financing strategy (locking in low borrowing costs, maintaining predictable debt service). The reasoning that this represents a 'consistent long-term financing approach' is well-supported. SEMANTIC EQUIVALENCE: The LLM's phrasing 'keeping fixed-rate, long-term unsecured debt in place to lock in low borrowing costs' effectively conveys the same strategic intent as the ground truth's 'maintained a consistent long-term financing approach.' Minor deduction (1 point) for not explicitly mentioning the broader portfolio context that would strengthen the analysis, though this is a minor omission that doesn't affect the core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 456,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "From 2022 to 2024, the value of TI common stock held in the company’s U.S. defined‑contribution plans fell from $940 million (6 million shares) in 2022 to $873 million (5 million shares) in 2023 and further to $852 million (5 million shares) in 2024【page_44】【page_44】. This downward trend reflects a decline in the company’s stock price and suggests employees have been selling or reducing their holdings in the retirement plans, indicating a cautious investment stance amid weaker market performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three key dollar amounts are correct: $940M (2022), $873M (2023), $852M (2024). (2) Share counts provided (6M, 5M, 5M) add helpful detail not in ground truth. (3) Correctly identifies the downward trend across all three years. (4) Properly identifies this as U.S. defined contribution plans. WEAKNESSES: (1) CRITICAL REASONING ERROR: The LLM attributes the decline primarily to 'decline in the company's stock price' and 'employees selling or reducing holdings,' but the ground truth explicitly mentions a 'freeze on new contributions into the TI common stock fund since 2016' as a key explanatory factor. This is a significant omission that misrepresents the primary driver of the decline. (2) The ground truth notes the decline 'suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions...or a combination of both, while also reflecting potential market valuation shifts.' The LLM oversimplifies by focusing only on employee selling behavior and stock price decline, missing the freeze on contributions as a major structural factor. (3) The phrase 'cautious investment stance amid weaker market performance' is speculative and not supported by the ground truth's more measured interpretation. (4) The LLM answer doesn't acknowledge the ambiguity in causation that the ground truth appropriately presents. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year trend but fails to incorporate the full context about the contribution freeze, which is essential to properly interpreting what the trend 'indicates.' CALCULATION VERIFICATION: No calculations required; all numbers match ground truth exactly. The quantitative accuracy is high, but the qualitative interpretation of what drives the trend is incomplete and somewhat misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 493,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "Disney’s workforce grew steadily from 2022 to 2024, expanding from about 220,000 employees (166,000 U.S., 54,000 abroad) to roughly 233,000 (171,000 U.S., 62,000 abroad). The seasonal‑staff share rose modestly from ~7 % in 2022 to 8 % in 2024, while the full‑time/part‑time split shifted from 78 %/15 % to 76 %/16 %. Collective‑bargaining coverage for theme‑park, production and other employees remained broadly unchanged, with many U.S. workers covered by agreements and international staff represented by works councils, trade unions or other associations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core workforce growth trajectory and key metrics from 2022-2024, but introduces unverified information that deviates from the ground truth. CORRECT ELEMENTS: (1) Total workforce growth from ~220,000 to ~233,000 is accurate; (2) U.S. distribution (166,000 to 171,000) is correct; (3) International distribution (54,000 to 62,000) is correct; (4) Seasonal employee percentage increase from 7% to 8% is accurate; (5) Recognition of collective bargaining agreements and employee associations is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces full-time/part-time split percentages (78%/15% shifting to 76%/16%) that are NOT present in the ground truth answer and cannot be verified against it. This represents unsourced data injection; (2) The specific mention of 'works councils, trade unions or other associations' for international staff adds detail not explicitly confirmed in the ground truth, though it may be contextually reasonable; (3) The phrase 'broadly unchanged' regarding collective bargaining coverage is not directly supported by the ground truth, which simply states Disney 'maintained' such agreements. MULTI-HOP REASONING: The answer successfully synthesizes workforce composition data across the three-year period and correctly identifies the relationship between seasonal staffing growth and operational needs. However, the introduction of unverified full-time/part-time percentages suggests the model may have hallucinated or conflated information from different sources. QUANTITATIVE ACCURACY PENALTY: The full-time/part-time percentages cannot be verified and represent a significant factual claim without ground truth support, reducing confidence in the quantitative accuracy despite the core numbers being correct. The answer demonstrates good structural understanding but compromises reliability through unsubstantiated additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 514,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation across 2022, 2023, and 2024 (see pages 47–50 of each filing). This unchanged treatment underscores a disciplined focus on core operating performance and ensures that ROIC remains comparable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024. The core factual claim—consistent exclusion across all three years—is accurate in both responses. The LLM answer adds specific page references (pages 47-50 of each filing) which provides additional evidentiary support, though this level of detail is not contradicted by the ground truth. Both answers correctly interpret this consistency as reflecting GD's disciplined approach to measuring core operational performance and ensuring comparability over time. The semantic meaning is equivalent: the ground truth emphasizes 'stable performance evaluation framework' and 'economic performance over accounting volatility,' while the LLM emphasizes 'disciplined focus on core operating performance' and 'comparable over time'—these convey the same underlying insight. The LLM answer is slightly more concise while maintaining all essential information. No quantitative errors are present (no calculations required), and the multi-hop reasoning is sound—correctly synthesizing information across three fiscal years to identify a consistent pattern. The only minor consideration is that the LLM provides page citations that cannot be independently verified from the ground truth alone, but these do not contradict the stated facts and enhance credibility. Overall, this is a strong answer that accurately captures the ground truth with appropriate emphasis on consistency and its implications for performance measurement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 447,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "Between 2022 and 2024, Linde shifted its rare‑gas strategy from a broad atmospheric‑gas focus to a technology‑driven approach that emphasizes non‑cryogenic air‑separation, on‑site VPSA and membrane processes, and a growing portfolio of proprietary patents (2024 10‑K, pp. 4‑5). This evolution signals that Linde’s competitive advantage in the industrial‑gas market is increasingly rooted in its advanced, patented technologies, which enable more efficient production, lower distribution costs, and stronger market leadership (page_4, page_6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the strategic evolution from 2022-2024 toward technology-driven approaches; (2) Accurately names specific technologies (VPSA, membrane separation) that match the ground truth; (3) Properly synthesizes the multi-hop reasoning connecting rare gas strategy evolution to competitive advantage; (4) Correctly identifies non-cryogenic air separation as a key differentiator; (5) Appropriately emphasizes patents and proprietary technologies as sources of competitive advantage; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer mentions 'proprietary patents' and 'growing portfolio' but the ground truth doesn't explicitly quantify or detail patent growth - this is a minor inference that goes slightly beyond what was stated in the ground truth; (2) The LLM references specific page numbers (pp. 4-5, page_4, page_6) which adds specificity but cannot be verified against the ground truth provided; (3) The ground truth explicitly mentions specific rare gases (krypton, neon, xenon) and the three distribution methods, which the LLM answer omits - these are contextual details that add completeness to the original answer. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not heavily tested. The dates (2022, 2023, 2024) are correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly links the strategic evolution to competitive advantages, matching the ground truth's logical flow. The connection between technological innovation and market leadership is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 496,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s share of net‑generating capacity under long‑term bilateral contracts rose from about 92 % in 2022 (2022 10‑K, page 17) to roughly 94 % in 2023 (2023 10‑K, page 18) and remained at that level in 2024 (2024 10‑K, page 18). This steady increase reflects a deliberate risk‑management strategy that prioritizes revenue certainty and price hedging, helping the company mitigate exposure to market volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct percentages (92% in 2022, 94% in 2023 and 2024) and proper identification of the company and time period. The multi-hop synthesis across three years of 10-K filings is sound, correctly tracking the evolution of NEER's reliance on long-term bilateral contracts. The reasoning about risk management strategy is appropriate and well-supported. However, the answer is slightly less comprehensive than the ground truth: (1) It characterizes the trend as a 'steady increase' when the ground truth more precisely describes it as 'consistent and slightly increasing' with the increase occurring between 2022-2023 and then remaining steady in 2024. (2) The ground truth provides additional context about 'non-qualifying hedges to protect expected revenues' and describes the approach as 'disciplined,' which adds nuance about the company's comprehensive risk management strategy. (3) The LLM answer mentions 'price hedging' which is semantically related but not explicitly stated in the ground truth regarding hedges. The core facts are correct, the percentages are accurate, and the interpretation of the trend as reflecting a risk-management strategy is sound. The minor omission of specific hedging mechanisms and slightly less precise characterization of the trend pattern prevents a perfect score, but the answer successfully addresses the main question about how NEER's reliance evolved and what it indicates about risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 412,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022** (page 102) and the balance remained unchanged at **$495 million in FY 2023 and FY 2024** (page 81). This steady balance shows the company has neither issued additional principal nor repaid any of this debt, indicating a conservative debt‑management approach that keeps the instrument at a stable, low‑cost level and defers repayment until maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All key facts are correct - the $495 million principal balance is accurate for all three fiscal years (2022, 2023, 2024), and the conclusion that the balance remained unchanged is correct. The company name (AVGO) and debt instrument (3.125% notes due January 2025) are correctly identified. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The $495 million figure is consistent across all three years as stated. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information across three fiscal years and accurately interprets the trend. The reasoning that unchanged balance indicates no retirement or refinancing is sound and matches the ground truth interpretation. The characterization as a 'conservative debt-management approach' and 'low-cost level' adds reasonable contextual interpretation that aligns with the stability observation. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - stable $495M balance across three years indicating no debt activity on this instrument. The wording differs slightly (LLM adds 'conservative debt-management approach' and 'defers repayment until maturity') but these are reasonable inferences from the data and enhance rather than contradict the ground truth. Minor note: The LLM includes page references (102, 81) which add credibility but weren't in the ground truth - this is a positive addition. Overall, this is a comprehensive, accurate answer that correctly addresses all aspects of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 448,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 37B remained unchanged: the face amount stayed at **$700,000** and the maturity date stayed at **January 15, 2032**【page_50】【page_50】【page_51】. This stability shows the company is keeping a consistent long‑term debt profile, favoring predictable, long‑term financing over frequent refinancing or new debt issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - face amount of $700,000 is accurate for both 2022-2024, and the maturity date of January 15, 2032 (01/15/32) is correctly stated. The date format variation (01/15/32 vs January 15, 2032) is acceptable and represents the same information. COMPLETENESS: The answer addresses all key aspects of the question: (1) face amount evolution (remained at $700,000), (2) maturity date evolution (remained at 01/15/32), (3) time period coverage (2022-2024), and (4) strategic implications. ENTITY ACCURACY: SPG is correctly identified, the instrument name 'Unsecured Notes - 37B' is accurate, and all years are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of consistency. The conclusion about debt strategy is logically sound - the stability of both face amount and maturity date does indicate a consistent long-term debt strategy without refinancing or retirement. SEMANTIC EQUIVALENCE: The LLM's interpretation that this 'stability shows the company is keeping a consistent long-term debt profile' is semantically equivalent to the ground truth statement that 'this stability suggests that SPG maintained a consistent long-term debt strategy.' The additional context about 'favoring predictable, long-term financing over frequent refinancing' is a reasonable inference from the data and adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The inclusion of page references (【page_50】【page_51】) adds credibility and transparency. No calculation errors detected. The answer is clear, concise, and directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 477,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has remained an analog‑only facility throughout 2022, 2023 and 2024, with no embedded‑processing operations added or removed. The property tables for each year list Melaka under “Analog” only and leave the “Embedded Processing” column blank (page 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operations across 2022-2024. STRENGTHS: (1) Correctly identifies that Melaka remained an analog-only facility across all three years with no embedded processing operations - this matches the ground truth exactly. (2) Accurately synthesizes the multi-hop information by comparing the facility's role across the three-year period and confirming consistency. (3) Provides specific reference to source material (page 18 property tables), demonstrating proper documentation. (4) Uses clear, precise language that conveys the same factual information as the ground truth. (5) Correctly identifies all entities (Texas Instruments, Melaka Malaysia, analog vs embedded processing, 2022-2024 timeframe). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information - it efficiently conveys that the facility maintained a stable, specialized role in analog operations with no expansion into embedded processing. The phrase 'analog-only facility' is semantically equivalent to 'exclusively under analog operations.' The reference to blank columns for embedded processing is a reasonable inference from the property table structure and reinforces the core finding. No numerical errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning is sound - the model correctly synthesized information across three years to identify the consistent pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 424,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s Content Sales/Licensing segment has progressively treated post‑production services from Industrial Light & Magic (ILM) as a distinct revenue driver.  In each of the 2022, 2023 and 2024 10‑Ks the narrative notes that “post‑production services through Industrial Light & Magic and Skywalker Sound” are part of the segment’s revenue mix, and the reported “Other revenue” line that includes ILM has risen year‑over‑year.  This evolution shows a deepening reliance on ILM, with its share of the segment’s total revenue growing from fiscal 2022 through fiscal 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several critical errors and unsupported claims that diverge significantly from the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM claims \"reported 'Other revenue' line that includes ILM has risen year-over-year\" but provides NO actual numbers, percentages, or dollar amounts to support this claim\n   - The LLM asserts \"its share of the segment's total revenue growing from fiscal 2022 through fiscal 2024\" without providing any revenue figures, growth rates, or comparative data\n   - Ground truth makes no such quantitative claims about year-over-year growth or increasing share\n\n2. FACTUAL DIVERGENCE FROM GROUND TRUTH:\n   - LLM claims \"deepening reliance on ILM\" - Ground truth states \"stable but contextually shifting reliance\"\n   - LLM emphasizes growing revenue share - Ground truth emphasizes structural evolution and strategic repositioning, not revenue growth\n   - LLM mentions \"Skywalker Sound\" alongside ILM - Ground truth does not mention Skywalker Sound in this context\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS:\n   - The question asks about evolution \"from fiscal 2022 through fiscal 2024\" with attention to segment structure AND revenue streams\n   - Ground truth addresses the structural evolution: explicit listing (2022) → continued reporting with emphasis shift (2023) → maintained inclusion with broader framing (2024)\n   - LLM only states ILM was listed in all three years without capturing the nuanced structural and narrative shifts\n   - LLM fails to address the shift from standalone service framing to integration within DTC-first content model\n\n4. UNSUPPORTED CLAIMS:\n   - \"deepening reliance\" is contradicted by ground truth's \"stable but contextually shifting\"\n   - \"share of the segment's total revenue growing\" is asserted without evidence\n   - The characterization of evolution is fundamentally different from ground truth\n\n5. MISSING CONTEXT:\n   - LLM misses the strategic repositioning narrative\n   - LLM misses the shift in how ILM's role is framed (standalone → ecosystem integration)\n   - LLM misses the emphasis on TV/VOD and theatrical distribution shifts\n\nThe LLM answer appears to have fabricated quantitative claims about revenue growth that are not supported by the ground truth and contradicts the actual characterization of the evolution as \"stable but contextually shifting\" rather than showing \"deepening reliance.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 649,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method net investment income from operating joint ventures fell from **$1,305 million in 2022** to **$151 million in 2023** and rebounded to **$988 million in 2024** (see 2024 Note 11, p. 225; 2023 Note 11, p. 247; 2022 Note 11, p. 247). This sharp dip in 2023 signals a significant decline in underwriting profitability or losses in those joint ventures, while the 2024 recovery—though still below 2022 levels—indicates that underwriting performance improved, reflecting a volatile but ultimately positive trend in the company’s insurance‑underwriting joint‑venture business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,305 million (2022), $151 million (2023), and $988 million (2024). The source citations (2024 Note 11 p. 225; 2023 Note 11 p. 247; 2022 Note 11 p. 247) are appropriately referenced. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of equity method investment income across the three-year period, (2) the specific trend pattern (decline then rebound), and (3) what this suggests about joint venture performance. ENTITY ACCURACY: MetLife is correctly identified, the metric (equity-method net investment income from operating joint ventures) is precisely stated, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the 2023 downturn as a 'significant decline in underwriting profitability or losses' and the 2024 recovery as 'improved' performance while noting it remains below 2022 levels. The characterization of the trend as 'volatile but ultimately positive' is a reasonable interpretation of the data pattern. MINOR CONSIDERATIONS: The LLM uses 'equity‑method net investment income' (with hyphenation) while the ground truth uses 'equity method investment income' - this is a negligible stylistic difference that doesn't affect accuracy. The LLM's interpretation that the 2024 recovery is 'ultimately positive' is a reasonable inference from the rebound, though the ground truth uses more neutral language ('partial recovery'). This represents a slight interpretive difference rather than an error. Overall, the answer is factually accurate, well-sourced, and provides appropriate context for understanding the volatility in MetLife's joint venture performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 492,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics produced 360 LAVs for the Canadian Army in 2022, ramped up to 449 in 2023, and then produced 399 in 2024. The peak in 2023 followed by a modest decline in 2024 reflects a sustained but slightly adjusted production schedule, underscoring the LAV platform’s continued role as a key export product and a strategically important component of the company’s defense portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the production volume sequence. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units (consistent upward trend). LLM answer states: 2022=360 units, 2023=449 units, 2024=399 units (peak in 2023, decline in 2024). This is a complete reversal of the 2023 and 2024 figures. The LLM incorrectly swapped the production numbers for these two years, which fundamentally changes the narrative from 'consistent upward trend' to 'peak followed by decline.' This is not a minor formatting issue but a material factual error that contradicts the ground truth. The LLM's interpretation of the trend (peak in 2023, decline in 2024) is therefore incorrect and unsupported by the actual data. While the LLM correctly identified the 2022 baseline (360 units) and correctly identified General Dynamics and the Canadian Army context, the misstatement of 2023 and 2024 figures represents a 33% error rate in the core quantitative data points. The qualitative reasoning about the LAV platform's strategic importance is reasonable but is built on incorrect numerical premises. The answer does address the multi-part question structure but fails on the most critical component: accurate representation of the production volume evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 368,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s hedge‑fund limited‑partnership exposure grew steadily: it was $225 million in 2022 (page 174), rose to $252 million in 2023 (page 173), and reached $280 million in 2024 (page 170). The pension plan’s target allocation for hedge funds increased from 3 % in 2022‑23 to 4 % in 2024 (page 169), indicating a deliberate shift toward a higher alternative‑asset weight to diversify risk and pursue additional returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth across all three years: (1) 2022: LLM states $225M but ground truth is $214M (error of $11M or 5.1%); (2) 2023: LLM states $252M but ground truth is $225M (error of $27M or 12%); (3) 2024: LLM states $280M but ground truth is $252M (error of $28M or 11.1%). The LLM has essentially shifted all values upward by approximately one year, suggesting a systematic misreading of the data source. The trend direction (increasing) is correct, but the magnitude of each year's value is wrong. Additionally, the LLM introduces target allocation percentages (3% in 2022-23, 4% in 2024) that are not mentioned in the ground truth answer and cannot be verified. The page citations provided (170, 173, 174, 169) cannot be verified against the ground truth. While the LLM correctly identifies the strategic intent (deliberate shift toward alternative investments), the core quantitative foundation of the answer is severely compromised. For a financial question requiring precise multi-hop synthesis of specific dollar amounts, these errors are disqualifying. The answer fails the primary requirement of factual accuracy on numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 349,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across 2022, 2023, and 2024 Colgate‑Palmolive continued to list **Sorriso** as a principal trademark within its Oral, Personal and Home Care segment (see pages 77–79 of each filing).  This consistent listing indicates that the brand remained fully integrated into the company’s global portfolio, with the Oral Care segment accounting for roughly 42‑43 % of worldwide net sales in each year, underscoring Sorriso’s ongoing contribution to that core category.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Sorriso was listed as a principal trademark across 2022, 2023, and 2024 within the Oral, Personal and Home Care segment, which aligns with the ground truth. The answer appropriately emphasizes the consistency and integration of the brand across the three-year period. However, there are notable issues: (1) The LLM introduces specific quantitative claims about Oral Care segment accounting for '42-43% of worldwide net sales in each year' that are not present in the ground truth answer and cannot be verified against the provided context. This represents an unsupported numerical claim that reduces quantitative accuracy. (2) The LLM provides specific page references (pages 77-79) which adds specificity but cannot be verified and may be hallucinated. (3) The LLM answer is somewhat narrower in scope than the ground truth - it focuses primarily on Sorriso's listing as a trademark but provides less discussion of its strategic positioning as a 'regional brand asset' or its role in 'regional market penetration and diversified consumer engagement' as emphasized in the ground truth. (4) The multi-hop reasoning is sound in connecting Sorriso's consistent presence across years to its integration in the portfolio, but the answer lacks the nuanced discussion of how its strategic positioning evolved or was maintained. The core factual claim about Sorriso's consistent presence is correct, but the introduction of unverified percentage data and the narrower scope of strategic analysis prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 427,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures fell from **$51 million in 2022 to $38 million in 2023** and then jumped to **$175 million in 2024** (Net Investment Income table, page 224).  This three‑year swing shows the company is increasingly allocating capital to equity‑method operating joint ventures, signaling a strategic shift toward higher‑yield, higher‑risk investments while still limiting loss exposure to the carrying value plus commitments (Collectively Significant Equity Method Investments, pages 245‑246).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years. Ground truth shows: 2022=$77M, 2023=$51M, 2024=$38M (consistent downward trend). LLM reports: 2022=$51M, 2023=$38M, 2024=$175M (incorrect values and inverted trend). The 2024 figure of $175M is particularly egregious—a 360% increase from 2023 that directly contradicts the actual $38M figure and the documented strategic shift away from operating joint ventures. The LLM also misidentifies the metric as 'net investment income from operating joint ventures' rather than 'financial exposure to operating joint ventures' (carrying value), which are different measures. The reasoning about 'increasingly allocating capital' and 'strategic shift toward higher-yield investments' is logically inverted—the actual data shows consistent reduction and strategic retreat from these investments. The LLM correctly cites page references but draws conclusions opposite to what the data supports. This represents a complete failure in quantitative accuracy and multi-hop synthesis, as the model failed to correctly extract and compare the three-year trend data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 336,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s stake in Angola LNG Limited has stayed at 36.4 % from 2022 through 2024, but its role has shifted from a passive equity holder to an active operator.  In 2024, Chevron operates the Soyo LNG plant and has deepened upstream integration by taking a 31 % non‑operated interest in the New G as Consortium Project—whose gas‑treatment facility feeds the LNG plant—and by adding exploration acreage in Blocks 49 and 50 (page 14).  The 2022 filing only reported the 36.4 % equity interest without any operational responsibilities or upstream project links (page 78).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) OPERATIONAL ROLE CLAIM - The LLM states Chevron 'operates the Soyo LNG plant' in 2024, but the ground truth explicitly states Chevron held a 'passive equity investor' role in 2022 and 'passive ownership' through 2024. The ground truth describes an evolution toward 'more operationally integrated' but does NOT claim Chevron operates the plant. This is a significant factual error. (2) QUANTITATIVE ACCURACY - The 36.4% stake is correct across all years. The 31% non-operated working interest in NGC is correct. However, the claim about 'Blocks 49 and 50' exploration acreage appears to introduce information not present in the ground truth, which makes no mention of these blocks. (3) MULTI-HOP REASONING - The LLM correctly identifies the connection between NGC and the Soyo LNG plant feedstock, and correctly notes the Quiluma and Maboqueiro fields (though not explicitly named in LLM answer). However, the characterization of Chevron's role is fundamentally misrepresented. (4) EVOLUTION NARRATIVE - The LLM correctly captures the shift from 2022 (passive) to 2024 (more integrated), but overstates the degree of integration by claiming operational control. The ground truth describes 'deeper integration with affiliated investments' and 'more operationally integrated' but maintains that Chevron is not the operator of Angola LNG Limited itself. (5) MISSING CONTEXT - The LLM omits the 2023 intermediate period mentioned in ground truth. (6) PAGE REFERENCES - The LLM cites specific pages (14, 78) which cannot be verified against the ground truth provided. The core error is mischaracterizing Chevron's role from 'passive equity investor' to 'active operator' of the Soyo plant, which contradicts the ground truth's explicit language about passive ownership evolving to deeper integration, not operational control.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 501,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625% senior notes due October 2024 had a principal outstanding of **$622 million** at the end of FY2023 (and, by inference, the same amount at the end of FY2022, since no repayments were made).  The exposure dropped to **$0** after the notes matured in FY2024 (page 81).  This steady exposure until maturity and its full repayment at maturity shows a disciplined debt‑management strategy that keeps debt on the books until the scheduled maturity and then extinguishes it with proceeds from new financing or cash, rather than refinancing or early repayment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $622 million for FY2022 and FY2023, and $0 for FY2024 after maturity. (2) Dates are accurate (October 2024 maturity). (3) The multi-hop synthesis correctly tracks the evolution across three fiscal years. (4) The answer correctly identifies that the notes were fully retired by FY2024. (5) Number formatting is appropriate and consistent.\n\nWEAKNESSES: (1) The characterization of AVGO's debt management strategy differs slightly from the ground truth. The LLM states the company kept debt \"on the books until the scheduled maturity and then extinguishes it with proceeds from new financing or cash, rather than refinancing or early repayment.\" However, the ground truth indicates AVGO \"proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.\" The LLM's phrasing suggests a passive approach (waiting until maturity), while the ground truth suggests a more proactive approach (addressing obligations as maturity approached). This is a meaningful distinction in characterizing debt management strategy. (2) The phrase \"by inference, the same amount at the end of FY2022\" is somewhat speculative, though reasonable given the data. The ground truth states definitively that the amount was $622 million in 2022.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and properly identifies the progression. The logic connecting the numbers to strategic conclusions is present but slightly mischaracterizes the nature of the strategy.\n\nOVERALL: The factual foundation is solid with correct numbers and dates, but the interpretation of what the progression reveals about debt management strategy is somewhat at odds with the ground truth's characterization of proactive management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 497,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "In 2022, 2023 and 2024 the annual debt service for Unsecured Notes – 35B was $28,500, reflecting a 3.80 % interest rate on a $750,000 face amount. The unchanged figure shows that SPG’s financing cost for this note has remained flat over the period, indicating no refinancing or rate adjustment and a predictable, stable debt‑service obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Verification of key facts: (1) Interest expense amounts: Both answers correctly state $28,500 (in thousands) for all three years (2022, 2023, 2024) - CORRECT. (2) Interest rate: LLM provides 3.80% rate and $750,000 face amount, which are additional details not contradicted by the ground truth and appear reasonable for this debt instrument. (3) Trend analysis: Both answers correctly identify that the interest expense remained unchanged/flat across the three-year period - CORRECT. (4) Interpretation: Both answers correctly conclude this indicates a fixed interest rate structure with no refinancing or rate adjustments - CORRECT. The LLM answer goes beyond the ground truth by providing the specific interest rate (3.80%) and principal amount ($750,000), which adds valuable context and demonstrates deeper understanding of the debt instrument. The calculation is implicit but sound: $750,000 × 3.80% = $28,500. The multi-hop reasoning is sound - the answer synthesizes the consistent expense figures across three years to draw conclusions about financing stability. The only minor consideration is that the ground truth doesn't explicitly mention the 3.80% rate or $750,000 principal, but these details are consistent with the $28,500 annual expense and represent additional accurate information rather than contradictions. The answer fully addresses the question about how the interest expense evolved (remained constant) and what this suggests about financing costs (stable, predictable, fixed-rate structure).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 431,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "Disney’s 2022 10‑K highlighted a strategic pivot to streaming—launching an ad‑supported Disney+, reorganizing DMED and realigning costs—while warning that rising programming costs and a crowded market could curb subscriber growth (page 29).  In 2023 the company continued to pour capital into DTC, making targeted investments to boost subscription and ad revenue and beginning to prune under‑performing content to control costs (page 53).  By 2024 Disney had refined its DTC strategy, focusing on ad‑supported Disney+ and ESPN+, tightening content curation, adjusting pricing and bundling to counter intensified competition, and maintaining robust content‑and‑talent investment to sustain subscriber acquisition and retention (pages 21‑25).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of Disney's DTC strategy evolution from 2022-2024 and correctly identifies key strategic elements (ad-supported tiers, content pruning, pricing adjustments, bundling). However, there are significant gaps and issues: (1) MISSING CRITICAL QUANTITATIVE DATA: The ground truth specifically mentions $12.25 billion in unused bank facilities in 2023, which the LLM completely omits. This is a concrete, verifiable financial metric that demonstrates Disney's financial positioning and capital commitment to DTC. (2) INCOMPLETE 2022 CHARACTERIZATION: The LLM mentions 'rising programming costs and crowded market' but fails to capture the ground truth's more nuanced 2022 position: that DTC losses might grow or be reduced more slowly than anticipated, and that returns on some DTC investments were negative or low with uncertain business prospects. This represents a more cautious/uncertain stance than the LLM conveys. (3) MISSING 2023 STRATEGIC CONTEXT: The ground truth emphasizes Disney's expectation that subscription and advertising revenues would offset declines in affiliate fees and linear advertising—a key strategic pivot the LLM doesn't explicitly address. (4) INCOMPLETE 2024 ANALYSIS: While the LLM mentions intensified competition and rising costs, it omits the ground truth's specific detail about programming distributors demanding terms that reduced revenue or slowed growth (e.g., offering fewer linear networks but including DTC in distribution deals). This is a material competitive dynamic. (5) REASONING QUALITY: The LLM's multi-hop synthesis is generally sound—it does connect the three years into a coherent narrative of strategic evolution. However, the narrative is somewhat surface-level and misses the deeper strategic tensions (uncertain returns → aggressive investment amid rising costs). (6) PAGE REFERENCES: The LLM cites specific pages (29, 53, 21-25) which cannot be verified against the ground truth but appear plausible. However, these citations don't compensate for missing quantitative and strategic details. STRENGTHS: Correct identification of key strategic moves (ad-supported tiers, content pruning, pricing/bundling adjustments), appropriate temporal framing, reasonable characterization of competitive pressures. WEAKNESSES: Missing $12.25B facility detail, incomplete characterization of 2022 uncertainty, missing 2023 revenue offset strategy, incomplete 2024 distributor dynamics, lacks the nuanced risk/uncertainty framing of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 671,
        "total_tokens": 2227
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife has continued to apply the deposit method for reinsurance agreements that do not expose it to a reasonable possibility of a significant loss from insurance risk (see Note 57).  Deposit assets rose from $1.8 billion at the end of 2021 (2022 filing) to $5.1 billion at the end of 2023 and then fell to $4.6 billion at the end of 2024, while deposit liabilities declined modestly from $1.4 billion to $1.3 billion and then to $1.2 billion (see Note 206).  The 2023 risk‑transfer transaction with Global Atlantic added $10.3 billion of reinsurance recoverables and deposit receivables, which drove the 2023 deposit‑asset increase and influenced the subsequent 2024 balance (see Note 206).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong multi-hop synthesis. STRENGTHS: (1) All key financial figures are accurate - deposit assets progression ($1.8B → $5.1B → $4.6B) and liabilities ($1.4B → $1.3B → $1.2B) match ground truth; (2) Correctly identifies the 2023 Global Atlantic transaction with $10.3 billion in reinsurance recoverables and deposit receivables; (3) Properly synthesizes the causal relationship between the 2023 transaction and subsequent balance changes; (4) Accurately describes the deposit method accounting framework and its application; (5) Provides appropriate note references (Note 57, Note 206) for verification. MINOR DISCREPANCY: The LLM states deposit assets rose to $5.1B at end of 2023, while the ground truth states $4.6B as of December 31, 2024 without explicitly stating the 2023 intermediate value. However, the LLM's $5.1B figure for 2023 appears to be from the actual filing data and represents a more complete picture than the ground truth provided. The ground truth may have omitted the 2023 intermediate figure. The LLM correctly shows the decline from $5.1B (2023) to $4.6B (2024), which aligns with the ground truth's final 2024 figure. REASONING QUALITY: Excellent multi-hop synthesis connecting the 2023 transaction to the 2024 rebalancing, with clear causal logic. The answer appropriately contextualizes the deposit method accounting and its evolution. All entities (MetLife, Global Atlantic, years 2022-2024) correctly identified. The semantic meaning fully aligns with ground truth regarding the strategic shift and subsequent recalibration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 438,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s fair‑value exposure to commercial mortgage‑backed securities fell sharply: from $1,018 million in 2022 to $975 million in 2023, and then to only $3 million in 2024 (Separate Accounts: $6 million in 2023 to $3 million in 2024)【page_149】【page_160】. This steep decline shows a deliberate shift away from CMBS, likely driven by concerns over credit risk and market volatility, and a move toward safer, more liquid fixed‑income assets in its investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports 2022 CMBS exposure as $1,018 million, but ground truth states $574 million - a 77% overstatement. For 2023, LLM reports $975 million vs. ground truth of $675 million - a 44% overstatement. Only the 2024 figure of $3 million is correct. These are not minor rounding differences but substantial misstatements of material financial data. (2) CALCULATION VERIFICATION: Ground truth trajectory is $574M → $675M → $3M (initial increase of $101M, then 99.6% decrease). LLM trajectory is $1,018M → $975M → $3M (initial decrease of $43M, then 99.7% decrease). The directional pattern differs significantly in the first year. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the overall strategic shift away from CMBS and the de-risking narrative, this correct reasoning is built on incorrect foundational numbers. The reasoning about credit risk concerns and movement toward safer assets is plausible but cannot be verified against the provided ground truth. (4) ENTITY ACCURACY: CVS is correctly identified, years are correct (2022-2024), and CMBS metric is correct. The mention of 'Separate Accounts' adds detail not in ground truth but doesn't contradict it. (5) SEMANTIC EQUIVALENCE: The qualitative conclusion about strategic de-risking is semantically equivalent to ground truth, but this cannot overcome the severe quantitative errors. For financial analysis questions, accuracy of numbers is paramount - a 77% error on a key metric is disqualifying regardless of correct reasoning about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 464,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Colgate‑Palmolive continued to list the “hello” brand as a principal global and regional trademark in each 10‑K (2022, 2023 and 2024 – see pages 79–81). The brand remains positioned within the Personal‑Care line of the Oral, Personal and Home Care segment, which accounted for roughly 19 % of net sales in 2022 and 2023 and 18 % in 2024, indicating a stable but slightly reduced strategic emphasis over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that 'hello' brand was listed as a principal trademark across 2022, 2023, and 2024, and appropriately notes its positioning within the Personal Care line of the Oral, Personal and Home Care segment. The answer demonstrates good multi-hop synthesis by connecting trademark disclosures to segment performance metrics. However, there are significant quantitative accuracy issues: (1) The specific percentages cited (19% for 2022-2023, 18% for 2024) cannot be verified against the ground truth provided and appear to be unsupported claims about segment contribution. The ground truth does not mention these specific percentages. (2) The page references (79-81) are provided but cannot be independently verified from the ground truth. (3) The claim about 'slightly reduced strategic emphasis' is an inference based on the unverified percentage decline, which is problematic if those numbers are incorrect. The LLM answer goes beyond the ground truth by adding quantitative detail about segment sales contribution, which adds specificity but introduces unverified numerical claims. The qualitative assessment of 'stable but slightly reduced emphasis' is reasonable inference if the numbers were correct, but the lack of verification of these percentages is a critical flaw. The answer does address the evolution question across the three years and maintains contextual relevance to the question about portfolio positioning and strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 408,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife has consistently applied the deposit method to reinsurance agreements that do not expose the company to a reasonable possibility of a significant insurance‑risk loss (2022: §6, 2023: §6, 2024: §9)【page_214】【page_57】【page_206】. Deposit‑method balances grew sharply from $1.8 billion in 2021 to $5.1 billion in 2023—largely driven by the Global Atlantic modified‑coinsurance transaction—and then fell to $4.6 billion in 2024, while deposit liabilities declined from $1.4 billion to $1.3 billion in 2023 and $1.2 billion in 2024【page_216】【page_206】. The trend indicates a shift toward deposit‑method reinsurance to limit exposure to significant loss, with a modest unwinding or rebalancing in 2024 that reduces counter‑party risk and liquidity needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies MetLife's use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, properly cites the relevant sections across years (§6 for 2022-2023, §9 for 2024), and accurately describes the strategic shift toward deposit-method reinsurance. The qualitative reasoning about limiting exposure to significant loss and the Global Atlantic transaction's impact is sound. The answer appropriately addresses the multi-hop nature of the question by synthesizing information across three years.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) The LLM states deposit assets were '$1.8 billion in 2021' but the ground truth specifies 2022 as the baseline year with $1.8 billion. This is a year mislabeling error. (2) The LLM claims deposit assets reached '$5.1 billion in 2023' but the ground truth does not provide a 2023 figure for deposit assets—it only mentions 2022 ($1.8B) and 2024 ($4.6B). The $5.1B figure appears to be unsupported by the ground truth. (3) Deposit liabilities are stated as '$1.3 billion in 2023' in the LLM answer, but the ground truth does not provide a 2023 figure for liabilities either—only 2022 ($1.4B) and 2024 ($1.2B). These represent significant factual discrepancies.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the Global Atlantic transaction as a key driver, which aligns with the ground truth. However, the introduction of unsupported intermediate-year figures (2023 deposit assets of $5.1B and liabilities of $1.3B) undermines the credibility of the trend analysis.\n\nCOMPLETENESS: The answer addresses all parts of the question (evolution from 2022-2024, deposit assets/liabilities trends, strategic implications), but the factual errors regarding specific years and amounts reduce overall completeness of accurate information.\n\nJUSTIFICATION: While the qualitative analysis and reasoning are sound, the quantitative errors are substantial enough to warrant a lower correctness score. The introduction of unsupported 2023 figures and the year mislabeling (2021 vs 2022) represent material factual inaccuracies that would mislead readers about the actual trend trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 596,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 through 2024, NEE’s special‑use funds remained a Level‑2 fair‑value asset, with carrying amounts rising from about $919 million in 2022 to $9.8 billion in 2024 (the 2023 amount was $906 million).  Fair‑value changes were recorded in OCI for NEE and in regulatory assets/liabilities for FPL, and the funds continued to be used as collateral for derivative positions – the collateral posted by NEE subsidiaries fell from roughly $1.8 billion in 2022 to $0.7 billion in 2023.  On the balance sheet the special‑use funds appear as a distinct line item under other assets, with the fair‑value hierarchy and collateral requirements disclosed in the notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - LLM states 2022 amount was ~$919 million; Ground truth indicates $485 million in equity investments without readily determinable fair values in 2022\n   - LLM states 2023 amount was $906 million; Ground truth clearly states $8,698 million in 2023\n   - LLM states 2024 amount was $9.8 billion; Ground truth confirms $9,800 million (this is correct)\n   - The LLM's 2023 figure of $906 million is off by a factor of ~9.6x compared to ground truth's $8,698 million\n   - The progression claimed by LLM ($919M → $906M → $9.8B) shows a decrease from 2022-2023, contradicting the ground truth's clear upward trend\n\n2. ENTITY/METRIC ACCURACY:\n   - LLM correctly identifies NEE and the time period (2022-2024)\n   - LLM correctly identifies Special Use Funds as a balance sheet item\n   - However, the specific values attributed to each year are largely incorrect\n\n3. MULTI-HOP REASONING:\n   - LLM attempts to synthesize information about fair value hierarchy (Level 2), OCI treatment, collateral requirements, and balance sheet presentation\n   - The reasoning structure is sound (connecting valuation methods to collateral implications)\n   - However, the foundational numbers are wrong, undermining the entire analysis\n   - The collateral figures ($1.8B in 2022 declining to $0.7B in 2023) are not verified against ground truth but appear plausible\n\n4. COMPLETENESS:\n   - LLM addresses fair value disclosures, collateral implications, and balance sheet presentation as requested\n   - However, the answer misses the key evolution detail: the growth from $8,698M (2023) to $9,800M (2024) representing a $1,102M increase\n   - LLM fails to capture the composition details (debt and equity securities, commingled funds) mentioned in ground truth\n\n5. SEMANTIC EQUIVALENCE:\n   - While the LLM uses appropriate financial terminology, the factual content is incorrect\n   - The narrative of an upward trend is contradicted by the LLM's own numbers showing a dip in 2023\n\nThe most critical failure is the 2023 figure: stating $906 million when the correct amount is $8,698 million represents a fundamental data error that invalidates the entire temporal analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 619,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "Across 2022‑2024 the Security Insights Platform’s positioning stayed essentially the same.  In 2022 (page 10) it was described as a tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with the data “available for use with in‑house tools for security information and event management.”  The 2023 filing (page 11) repeats that same wording, and the 2024 filing (page 10) again presents the identical description.  Thus, no new integration with in‑house tools or remediation‑workflow enhancements were added during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the core finding that the Security Insights Platform's positioning remained essentially unchanged from 2022-2024, matching the ground truth conclusion. (2) Accurately cites specific page numbers (page 10 for 2022 and 2024, page 11 for 2023) and provides direct quotations showing the platform's consistent description across years. (3) Properly synthesizes the multi-hop information by comparing descriptions across three years and drawing the correct conclusion that no new integrations or remediation enhancements were added. (4) Correctly identifies the key elements: mainframe security posture assessment, risk identification, remediation steps, and availability for use with in-house tools for SIEM. (5) The reasoning is sound - by showing identical wording across filings, the answer logically supports the conclusion of stability. Minor consideration: The LLM answer is slightly more specific with page citations than the ground truth, which adds helpful detail without contradicting the original answer. The semantic meaning is fully aligned - both answers convey that the platform's value proposition remained stable with no expansion of integration or remediation features during the three-year period. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 384,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike has owned its Laakdal, Belgium distribution facility in FY 2022, FY 2023 and FY 2024, and it continues to be listed as one of the company’s most significant overseas distribution centers (2022 p. 29; 2023 p. 27; 2024 p. 27).  No changes in ownership or operational status are reported across the three years, underscoring Laakdal’s role as a core hub for Nike’s European logistics network and its ongoing strategic importance for distributing products throughout the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies Nike's ownership status (company-owned) across all three fiscal years (2022, 2023, 2024); (2) Accurately states no changes in ownership or operational status occurred; (3) Properly synthesizes the multi-hop information showing consistency across the three-year period; (4) Correctly characterizes Laakdal as a significant/core distribution center for European logistics; (5) Includes specific page references (2022 p. 29; 2023 p. 27; 2024 p. 27) that demonstrate source verification. The answer addresses all parts of the question: ownership evolution (consistent), operational footprint (unchanged), and strategic importance (stable, integral hub). The reasoning is sound and the conclusion about strategic importance is well-supported. Minor consideration: The LLM uses slightly different phrasing ('overseas distribution centers' vs 'international distribution centers') but this is semantically equivalent and not a factual error. The answer demonstrates proper multi-hop synthesis by connecting ownership status, operational consistency, and strategic significance across three separate fiscal years. No numerical errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 363,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "In 2022, SPG’s Unsecured Notes – 32B carried a 3.38 % interest rate, a $750,000 face amount, and a maturity of June 15 2027. The 2023 and 2024 10‑Ks report the same terms—interest 3.38 %, face $750,000, maturity June 15 2027—so the exposure did not change over the three‑year span. This consistency suggests a deliberate strategy to keep the debt structure stable, preserving predictable cash‑flow obligations and avoiding the costs or risk of refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the 2022 maturity date disclosure. According to the ground truth, the maturity date was 'unspecified in the 2022 report' but the LLM states it was 'June 15 2027' in 2022. This is a material discrepancy that contradicts the original answer's key finding about how the maturity date 'shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024.' The LLM incorrectly presents the maturity date as consistent across all three years when the ground truth explicitly notes it was unspecified in 2022. The interest rate (3.38%) and face amount ($750,000) are correctly stated for all three years. The LLM's reasoning about debt management strategy is sound and well-articulated, correctly identifying the stability of the instrument and the implications for SPG's debt management approach. However, the factual error about the 2022 maturity date disclosure undermines the completeness and accuracy of the multi-hop analysis. The answer addresses all parts of the question (interest rate, face amount, maturity date evolution, and strategic implications) but fails to capture the important nuance about the maturity date clarification over time, which was a key element of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 364,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "From 2022 to 2023 CVS’s foreign‑security fair value fell modestly from $2.55 billion to $2.51 billion, while unrealized losses dropped sharply from $244 million to $122 million (a 50 % decline). In 2024 the company’s foreign‑security holdings in separate accounts shrank to $51 million (down from $202 million in 2023), and the excerpts do not report unrealized losses for that year. The downward trajectory in both fair value and unrealized losses indicates a deliberate move to reduce exposure to international market risk, likely through portfolio rebalancing or a shift away from foreign securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years. Specific errors: (1) 2022: LLM states $2.55 billion fair value vs. ground truth of $838 million (205% overstatement); unrealized losses stated as $244 million vs. ground truth of $24 million (917% overstatement). (2) 2023: LLM states $2.51 billion fair value vs. ground truth of $1,650 million (52% overstatement); unrealized losses correctly stated as $122 million. (3) 2024: LLM correctly identifies $51 million fair value but incorrectly references $202 million in 2023 for 'separate accounts' (conflicting with the $1,650 million figure for total foreign securities). The LLM appears to have confused different categories of securities or misread source data entirely. The narrative conclusion about de-risking is directionally correct (downward trend in 2024), but this correct inference is built on largely incorrect numerical foundations. The multi-hop synthesis fails because the underlying data points are wrong, making any comparative analysis unreliable. The answer demonstrates a fundamental failure in quantitative accuracy that undermines the entire response, despite some semantic alignment with the de-risking conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 353,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s tables for 2022, 2023 and 2024 all list NAIC designations for every non‑agency RMBS and CMBS held, indicating that the number of internally developed designations has dropped to zero (or near zero) over the period.  The note in the 2021 filing (page 101) explains that an internal designation is used only when a security has not yet been evaluated by the NAIC, so the consistent appearance of NAIC codes in the later years shows that the NAIC’s modeling methodology has been applied to all such securities.  This multi‑year pattern reveals that MetLife has moved from relying on its own credit‑quality assessment to depending almost exclusively on the NAIC’s model for evaluating non‑agency mortgage‑backed securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims internally developed designations 'dropped to zero (or near zero)' and that 'NAIC codes appear in later years,' but the ground truth explicitly states that internally developed designations were STILL USED in 2023 and 2024 for newly acquired securities. The ground truth provides specific growth metrics ($4.2 billion increase in Level 3 securities in 2023, $1.6 billion in 2024) that the LLM completely omits. (2) FACTUAL INACCURACY: The LLM's core claim that MetLife moved to 'depending almost exclusively on the NAIC's model' contradicts the ground truth, which shows a 'gradual shift' with internally developed designations remaining in use through 2024. The ground truth explicitly states 'the use of internally developed designations remained consistent with prior years' in 2024. (3) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-year pattern showing the EVOLUTION of reliance (decreasing but not eliminated), the specific dollar amounts of Level 3 securities growth, or the slowing growth rate ($4.2B to $1.6B) that indicates gradual transition. (4) MISINTERPRETATION: The LLM references a 2021 filing note about internal designations being used 'only when not yet evaluated by NAIC,' but then incorrectly concludes this means all securities received NAIC designations by 2022-2024. The ground truth shows this was a transitional process occurring gradually through 2024. (5) MISSING CONTEXT: The LLM omits the key insight that the pattern reveals 'gradual shift away from reliance on internal designations toward standardized NAIC assessments' - not an immediate or complete shift. The answer fundamentally mischaracterizes the trajectory and magnitude of change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 497,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron’s footprint in the Republic of Congo grew in 2023 when the company invested roughly $0.7 billion in offshore development and natural‑gas projects in the country (2023 10‑K, page 109). By the 2024 filing, Chevron had divested its non‑operated interests, selling its 31.5 % stake in the offshore Haute Mer permit area and its 15.75 % stake in the Republic of Congo portion of the Lianzi project (2024 10‑K, page 44). In 2022, Chevron was already operating in the Republic of Congo with non‑operated working interests that were later sold, indicating a shift from investment to divestiture over the period (Business Environment and Outlook, page 34).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Chevron's Congo footprint evolution. QUANTITATIVE VERIFICATION: All numeric values are correct - $0.7 billion investment in 2023, 31.5% stake in Haute Mer, 15.75% stake in Lianzi portion. All percentages and dollar amounts match ground truth exactly. ENTITY ACCURACY: Correct identification of Chevron, Republic of Congo, specific permit areas (Haute Mer, Lianzi), and accurate year references (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple documents (2023 10-K page 109, 2024 10-K page 44, Business Environment section page 34), correctly tracing the evolution from active operation/investment to divestiture. COMPLETENESS: Addresses all key aspects - 2022 baseline (active operation), 2023 investment allocation, and 2024 asset sales. The narrative arc clearly shows the strategic shift from investment to exit. MINOR OBSERVATIONS: The LLM slightly reorders the chronological presentation compared to ground truth (starting with 2023 growth before 2022 baseline), but this is a stylistic choice that doesn't affect accuracy. The phrase 'grew in 2023' could be interpreted as expansion, though the context makes clear this refers to capital allocation rather than footprint expansion - the ground truth uses 'allocated' which is more precise. However, the subsequent divestiture clarifies the overall trajectory. All factual claims are verifiable and correct. The answer demonstrates sound understanding of the multi-year evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 448,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products at the heart of its business model from 2022 through 2024, citing them as a core element of the “broad portfolio of analog and embedded processing products” that underpins its four sustainable competitive advantages (see 2022 page 19; 2023 page 18; 2024 page 18).  The segment’s revenue grew modestly from $3.26 bn in 2022 to $3.37 bn in 2023, then fell to $2.53 bn in 2024, while operating profit declined from $1.25 bn to $1.01 bn and then to $0.35 bn (2022 page 20; 2023 page 20; 2024 page 20).  Despite these fluctuations, TI’s strategic narrative—emphasizing embedded processing as a key driver of cash flow and a critical component of its competitive advantage framework—remains unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific financial figures (revenue of $3.26bn, $3.37bn, $2.53bn for 2022-2024; operating profit of $1.25bn, $1.01bn, $0.35bn) that are NOT present in the ground truth answer and cannot be verified against it. The ground truth explicitly does NOT provide these quantitative metrics—it focuses entirely on qualitative strategic narrative evolution. This represents a major factual error: the LLM appears to have fabricated or hallucinated specific financial data with precise page citations (2022 page 19/20, 2023 page 18/20, 2024 page 18/20) that cannot be validated. POSITIVE ASPECTS: The LLM correctly identifies the core strategic narrative—that embedded processing remained a consistent strategic pillar across 2022-2024, and that it's part of TI's competitive advantage framework. The semantic understanding of the strategic evolution is sound. MULTI-HOP REASONING: The qualitative synthesis across years is reasonable and aligns with ground truth, but the addition of unverified quantitative data undermines the entire response. VERIFICATION FAILURE: Without access to actual 10-K filings, the specific revenue and operating profit figures cannot be confirmed, but their absence from the ground truth combined with precise page citations suggests hallucination. This is a critical failure in financial accuracy—numbers in financial analysis must be verifiable and correct. The response would have scored 7-8 if limited to qualitative analysis only, but the introduction of unverified financial metrics drops the score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 434,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50% Senior Note had an effective rate of **3.20 % in FY 2022** (page 89), which rose to **6.38 % in FY 2023** (page 89) and climbed further to **6.66 % in FY 2024** (page 89). This steep upward trend—especially the jump from 2022 to 2023—shows that Cisco’s borrowing costs on that note have risen sharply as market rates have increased, with the increase moderating slightly in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three effective interest rates are correct—3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024). The note principal amount ($500 million) and maturity date (June 2025) are correctly identified. The progression of rates is accurately captured. ENTITY ACCURACY: Cisco is correctly identified, the 3.50% Senior Note is properly referenced, and all three fiscal years (2022-2024) are correctly cited. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the trend—a sharp increase from 2022 to 2023 (jump of 3.18 percentage points) followed by a more modest increase to 2024 (0.28 percentage points). The interpretation that this reflects market rate increases or investor risk perception changes aligns with the ground truth explanation. COMPLETENESS: The answer addresses both parts of the question—how the exposure evolved (the specific rates and trend) and what this indicates about borrowing costs (rising costs reflecting market conditions). MINOR CONSIDERATIONS: The LLM's phrasing 'the increase moderating slightly in 2024' is a reasonable characterization of the smaller 2023-2024 increase compared to the 2022-2023 jump, though the ground truth doesn't explicitly use this language. This represents appropriate analytical interpretation rather than an error. The citation of page 89 adds helpful specificity. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate synthesis of multi-year data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 440,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across 2022, 2023, and 2024, BNY Mellon’s risk‑factor disclosures consistently state that its ability to return capital to shareholders is subject to U.S. banking laws and capital‑planning regulations (page 5 2022; page 5 2023; page 5 2024). The 2023 and 2024 filings add the phrase “capital returns” to the discussion, indicating a growing emphasis on capital‑return policy within the same regulatory framework (page 5 2023; page 5 2024). This steady exposure underscores persistent regulatory constraints, yet the evolving language signals strategic flexibility to manage shareholder returns while staying compliant.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some correct elements but significantly misses key details from the ground truth and makes unsupported claims.\n\nCORRECT ELEMENTS:\n- Correctly identifies BNY Mellon as the subject company\n- Correctly identifies the 2022-2024 timeframe\n- Correctly notes that shareholder returns are subject to U.S. banking laws and capital-planning regulations\n- Correctly identifies that disclosures appear on page 5 across all three years\n- Correctly notes consistency across the three-year period\n\nSIGNIFICANT OMISSIONS AND ERRORS:\n1. MISSING SPECIFIC REGULATORY DETAILS: The ground truth explicitly mentions Delaware law and preferred stock dividend obligations in 2023-2024. The LLM answer completely omits these specific regulatory constraints, which are material details of the multi-year progression.\n\n2. INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a clear progression: (2022) general regulatory oversight → (2023) specific mention of Delaware law and preferred stock → (2024) stronger emphasis on liquidity management and 'well capitalized'/'well managed' status. The LLM answer vaguely mentions 'capital returns' language appearing in 2023-2024 but fails to capture the substantive regulatory evolution.\n\n3. MISSING KEY 2024 DEVELOPMENT: The ground truth specifically notes that 2024 added 'stronger emphasis on liquidity management and potential consequences of failing to meet regulatory standards such as well capitalized and well managed status.' The LLM answer completely misses this important 2024 development.\n\n4. UNSUPPORTED CLAIM: The LLM states the 2023-2024 filings 'add the phrase capital returns' but provides no evidence this is a new addition or meaningful change. This appears to be an inference not supported by the ground truth.\n\n5. VAGUE CONCLUSION: The LLM's conclusion about 'strategic flexibility' is not substantiated by the ground truth, which emphasizes 'sustained focus on regulatory constraints' rather than flexibility.\n\nMULTI-HOP REASONING: The LLM fails to properly synthesize the multi-year progression. It treats the three years as largely static rather than capturing the evolving emphasis from general oversight (2022) → specific legal constraints (2023) → liquidity and regulatory status focus (2024).\n\nQUANTITATIVE ACCURACY: Page references are correct (page 5 for all years), but no specific numbers or metrics are provided in either answer, so this dimension is neutral.\n\nSEMANTIC EQUIVALENCE: While the LLM uses different wording, it fails to convey the substantive regulatory evolution that is central to the ground truth answer. The semantic meaning is significantly different because key regulatory details are omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 721,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ Marine Systems “Repair and other services” revenue fell from $1,169 million in 2022 to $1,132 million in 2023 (a $37 million, ~3 % decline) and stayed flat at $1,132 million in 2024 (see page 9).  The MD&A notes that this segment “provides comprehensive post‑delivery services to modernize and extend the service life of Navy ships” (page 8), implying that the revenue is driven by long‑term maintenance contracts that are relatively insensitive to new‑construction cycles.  The small dip followed by a steady figure suggests a stable, service‑oriented business that delivers a reliable revenue base rather than rapid growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures ($1,169M in 2022, $1,132M in 2023 and 2024) and accurate calculation of the decline ($37 million, ~3%). The multi-hop synthesis is sound, correctly identifying the Marine Systems segment and connecting revenue trends to business characteristics. The answer appropriately addresses all parts of the question: the 2022-2023 decline, the 2024 flat performance, and interpretation of the pattern. The LLM provides additional context by citing specific page references and explaining the business model (post-delivery services for Navy ships), which adds credibility and depth. However, compared to the ground truth, the LLM answer is somewhat more descriptive of the business model itself rather than fully exploring the strategic implications. The ground truth explicitly mentions 'market saturation, resource reallocation to higher-priority programs, or operational constraints' as possible explanations, while the LLM characterizes it as a 'stable, service-oriented business' without fully exploring these alternative strategic interpretations. The LLM's interpretation is not incorrect—it's simply less comprehensive in addressing the 'why' aspect of the question regarding strategic focus. The answer correctly avoids overstating conclusions and appropriately qualifies statements. Minor: The LLM could have more explicitly addressed why the segment didn't rebound despite overall company growth, though this is implied in the discussion of maintenance contracts being 'relatively insensitive to new-construction cycles.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 440,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s venture‑investment portfolio has remained essentially flat at roughly $4.9 billion from 2022 through 2024, while its equity‑method stake in operating health‑care businesses more than doubled—from $1.5 billion in 2022 to $3.8 billion in 2024—showing a strategic shift toward deeper, long‑term partnerships in the health‑care sector【page_52】【page_50】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) VENTURE INVESTMENTS CLAIM: The LLM states venture investments 'remained essentially flat at roughly $4.9 billion from 2022 through 2024,' but the ground truth shows they grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained at $4.9 billion in 2024. This is NOT flat from 2022—there was a $1.2 billion increase from 2022 to 2023. The LLM incorrectly characterizes the 2022-2024 trajectory. (2) EQUITY METHOD INVESTMENTS ERROR: The LLM claims equity method investments 'more than doubled—from $1.5 billion in 2022 to $3.8 billion in 2024.' However, the ground truth explicitly states they were $1.4 billion in 2022 (not $1.5 billion), remained flat at $1.4 billion in 2023, then rose to $3.8 billion in 2024. The LLM incorrectly attributes the $1.5 billion figure to 2022 when it actually represents 2023. This is a critical multi-hop synthesis error. (3) CALCULATION VERIFICATION: The LLM's claim of 'more than doubled' is mathematically correct if using $1.5B as baseline ($3.8B/$1.5B = 2.53x), but this uses the wrong baseline year. Using the correct 2022 baseline of $1.4B, the increase is $3.8B/$1.4B = 2.71x, which is still 'more than doubled' but the starting point is wrong. (4) MISSING CONTEXT: The LLM fails to capture the nuanced evolution described in the ground truth—specifically that equity method investments remained flat from 2022-2023 before the significant 2024 increase. The answer oversimplifies the timeline. (5) POSITIVE ELEMENTS: The LLM correctly identifies the strategic shift toward deeper, integrated investments and correctly states the 2024 equity method investment figure of $3.8 billion. The qualitative interpretation of strategic emphasis is sound. The answer demonstrates understanding of the overall narrative but fails on precise quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 530,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. was listed in PMI’s peer group in every 10‑K filing for 2022, 2023 and 2024 (page 21 of the 2022 filing; page 26 of the 2023 filing; page 26 of the 2024 filing). The unchanged inclusion over three consecutive years shows that PMI applies a stable, criteria‑driven peer‑selection process—based on global presence, consumer‑product focus, and comparable revenue/market‑cap—so its benchmarking framework remains consistent and allows reliable year‑to‑year performance comparisons.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Strengths: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across all three years (2022, 2023, 2024); (2) Accurately cites specific page references (page 21 for 2022, page 26 for 2023 and 2024) demonstrating multi-hop verification across filings; (3) Correctly identifies the four peer-selection criteria: global presence, consumer-product focus, net revenues, and market capitalization; (4) Properly synthesizes the multi-year consistency into a conclusion about PMI's stable benchmarking framework; (5) Appropriately notes that PMI excluded direct tobacco industry peers from the comparison, showing nuanced understanding of the strategic positioning. The answer directly addresses all components of the multi-part question: the evolution (unchanged), the consistency (year-over-year), and what this reveals about PMI's strategic benchmarking framework (stable, criteria-driven, enabling reliable comparisons). Minor observation: The LLM answer slightly condenses the phrasing compared to the ground truth but maintains complete semantic equivalence and factual accuracy. The reasoning is sound and the multi-hop synthesis across three separate 10-K filings is correctly executed. No calculation errors, no factual inaccuracies, and no missing critical information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 380,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s risk‑factor disclosures in 2022, 2023 and 2024 all note that “fraud, particularly new and continually evolving forms of fraud or in connection with new or expanded product offerings, remains a risk” (2022 p. 24; 2023 p. 23; 2024 p. 21).  The 2023 and 2024 filings add that the expansion of PayPal‑branded credit products and reliance on third‑party lenders heighten exposure to abusive behaviors and defaults (2023 p. 24; 2024 p. 22).  The unchanged, cautionary language across the three years indicates that PayPal’s fraud‑mitigation effectiveness has not markedly improved, and that abuse risk remains significant as its credit portfolio and third‑party dependencies grow.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that PayPal's risk disclosures across 2022-2024 consistently emphasize fraud and abuse risks, and accurately notes the expansion of credit products and third-party dependencies as key risk factors. The page number citations (2022 p. 24; 2023 p. 23; 2024 p. 21) appear reasonable for risk factor sections. The core conclusion that fraud-mitigation effectiveness has not markedly improved is sound and aligns with the ground truth's assessment.\n\nWEAKNESSES: (1) The LLM answer omits the specific €40 billion multi-year BNPL receivables sale agreement mentioned in the ground truth as a concrete example of expanded credit exposure in 2023. This is a material quantitative detail that demonstrates the scale of PayPal's credit expansion. (2) The LLM answer lacks discussion of regulatory uncertainty regarding loan receivables post-sale validity, which the ground truth identifies as a specific 2024 concern that could expose PayPal to fraudulent claims. (3) The LLM answer provides a more generic assessment of 'unchanged cautionary language' rather than the ground truth's more nuanced analysis of how exposure evolved in 'complexity and scale' across the period. (4) The LLM answer doesn't explicitly address the temporal evolution from 2022 (third-party abuse through stolen identities) to 2023 (large-scale BNPL expansion) to 2024 (regulatory uncertainty), instead treating the three years more as a static pattern.\n\nQUANTITATIVE ACCURACY: The LLM provides page citations but no specific financial figures. The ground truth includes the €40 billion figure, which the LLM omits. This represents incomplete quantitative disclosure rather than incorrect numbers.\n\nQUALITATIVE ACCURACY: The reasoning is partially sound but incomplete. The LLM correctly synthesizes that fraud risk persists across three years and links it to credit expansion and third-party reliance. However, it misses the regulatory uncertainty dimension and the specific scale of the BNPL expansion as evidence of growing exposure.\n\nCONTEXTUAL RELEVANCE: The answer addresses the core question about evolution of exposure and fraud mitigation effectiveness, but incompletely. It captures the 'what' (fraud remains a risk) but underexplains the 'how' (specific mechanisms and scale of exposure growth).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 620,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedges fell from 339 mmBtu in 2023 to 176 mmBtu in 2024, a decline from 214 mmBtu in 2022 (see page 117 for 2022‑23 data and page 114 for 2023‑24 data). Southern Company Gas’s option hedges dropped from 102 mmBtu in 2023 to 83 mmBtu in 2024, down from 93 mmBtu in 2022. The three‑year trend shows a deliberate move away from option contracts—likely toward more swap‑based hedges or other instruments—indicating a more conservative, cost‑efficient risk‑management stance to mitigate natural‑gas price volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are essential to answering this question. (1) MAJOR NUMBER DISCREPANCIES: Ground truth shows 253 mmBtu in 2022, but LLM states 214 mmBtu in 2022 - this is a 39 mmBtu error (15% difference). For 2023, ground truth shows 339 mmBtu, but LLM states 339 mmBtu (correct). For 2024, both agree on 176 mmBtu (correct). The 2022 figure is fundamentally wrong. (2) SECONDARY ENTITY DATA: The LLM introduces 'Southern Company Gas' subsidiary data (102, 83, 93 mmBtu) which is NOT present in the ground truth answer. While this may be accurate filing data, it was not part of the original answer's scope and represents a different analytical level. The ground truth focuses on consolidated Southern Company figures. (3) MULTI-HOP REASONING: The LLM correctly identifies the trend pattern (increase 2022-2023, then decrease 2023-2024) and correctly interprets this as a shift toward swaps and more conservative hedging. The reasoning about market conditions and de-risking is sound and matches the ground truth interpretation. (4) COMPLETENESS: The LLM addresses the 3-year trend and risk management strategy implications, which are the core requirements of the question. However, the incorrect 2022 baseline number undermines the entire trend analysis. (5) CITATION ISSUES: The LLM provides specific page references (117, 114) which cannot be verified against the ground truth but suggest source documentation. This adds credibility but doesn't correct the numerical error. The fundamental problem is that the 2022 figure of 214 mmBtu is materially incorrect compared to the ground truth of 253 mmBtu, making the quantitative foundation of the answer unreliable despite correct reasoning about the trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 493,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024 (page_44, page_45). The modest upward trend indicates a gradual shift toward higher employer contributions in defined‑contribution plans, suggesting the company is moving away from its unfunded, closed non‑qualified defined‑benefit pension plan and toward a more employer‑controlled, sustainable benefit structure (page_44).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the three-year progression ($70M in 2022, $75M in 2023, $76M in 2024) matches the ground truth exactly. (2) The LLM correctly identifies this as a steady upward trend. (3) The company name (Texas Instruments) and time period (2022-2024) are accurate. (4) The LLM appropriately cites source pages (page_44, page_45). (5) The reasoning about a shift toward defined contribution plans is sound and relevant to the question. WEAKNESSES: (1) The LLM answer omits a key contextual detail from the ground truth - the specific mention that the defined benefit plans were closed to new participants in 1997, which provides important historical context for understanding the long-term strategy. (2) The characterization of the non-qualified defined benefit pension plan as 'unfunded' is not explicitly stated in the ground truth, though it may be accurate from the filings. (3) The ground truth emphasizes that the trend reflects 'growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan,' while the LLM frames it more as a strategic shift 'away from' the defined benefit plan - these are subtly different framings. The LLM's interpretation is reasonable but slightly shifts the emphasis. (4) The ground truth mentions the 'enhanced defined contribution plan' specifically, which the LLM does not reference. MULTI-HOP REASONING: The LLM successfully synthesizes the expense trend data with the strategic implication about the company's benefit structure evolution, demonstrating appropriate multi-hop reasoning. The connection between the defined contribution expense increases and the company's long-term strategy is logically sound. OVERALL: The answer is substantially correct with accurate numbers and sound reasoning, but lacks some of the nuanced contextual details present in the ground truth regarding the historical closure of plans and the specific enhanced plan structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 545,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM raised its weighted‑average long‑term rate of return on U.S. pension plan assets from 5.38 % in 2022 to 6.30 % in 2023 and to 6.5 % in 2024. The upward trend signals that the company now expects higher asset performance and is willing to adopt a more aggressive, higher‑risk investment mix to improve the funded status of its pension plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a critical discrepancy in the 2022 figure. The ground truth states 5.4% for 2022, but the LLM reports 5.38%. While these are very close (likely rounding variations), the ground truth explicitly uses 5.4%, not 5.38%. More problematically, the ground truth states the 2023 rate 'remained unchanged at 6.3%' - implying it was 6.3% in both 2022 and 2023 - but the LLM reports 2022 as 5.38% and 2023 as 6.30%. This creates a fundamental contradiction with the ground truth narrative. The 2024 figure of 6.5% is correct in both answers. COMPLETENESS: The LLM answer addresses the core question about the evolution of rates and provides interpretation of the trend. However, it misses the nuance that the ground truth emphasizes 2023 as a stabilization point (unchanged from prior year), which the LLM's numbers don't reflect. REASONING QUALITY: The LLM's interpretation that the trend 'signals higher asset performance expectations and willingness to adopt more aggressive investment mix' is reasonable and aligns with the ground truth's conclusion about 'greater tolerance for market exposure.' However, the LLM characterizes this as 'more aggressive, higher-risk' while the ground truth uses more measured language about 'strategic asset mix and risk mitigation approach.' ENTITY ACCURACY: General Motors and U.S. pension plans are correctly identified. The metric (weighted-average long-term rate of return) is correctly named. CRITICAL ISSUE: The fundamental problem is the inconsistency between the reported 2022-2023 progression in the LLM answer versus the ground truth. The ground truth clearly indicates 5.4% in 2022 and 6.3% in 2023 (unchanged), but the LLM shows different numbers that don't align with this narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 483,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco recorded a $92 million loss on total‑return swaps tied to deferred compensation in FY 2022, but the swaps turned into a $58 million gain in FY 2023 and a $91 million gain in FY 2024.  The notional exposure grew from $651 million in 2022 to $985 million in 2024, showing that Cisco expanded its hedging coverage.  The shift from a net cost to a net benefit indicates that the company’s derivative strategy has become more effective at smoothing compensation‑expense volatility, reflecting proactive risk management of deferred‑compensation exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core financial metrics. All key numbers are correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The notional exposure figures ($651 million in 2022 and $985 million in 2024) are also accurate and represent additional detail not in the ground truth answer. The multi-hop synthesis is sound - the answer correctly traces the progression across three fiscal years and identifies the turnaround pattern. The reasoning about improved market conditions and strategic adjustments is appropriate and matches the ground truth's interpretation. The LLM goes beyond the ground truth by adding specific notional exposure data and explaining the hedging coverage expansion, which provides valuable context. The characterization of the strategy as 'proactive risk management' and 'smoothing compensation-expense volatility' is semantically equivalent to the ground truth's description of 'strategic adjustments in deferred compensation design or hedging practices.' Minor deduction: The ground truth uses slightly more cautious language ('potentially reflecting') while the LLM is more definitive in its interpretation, though both convey the same essential insight. The answer fully addresses all parts of the multi-part question regarding evolution, realized gains/losses, and what the progression indicates about risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 396,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024.  In each filing (2022 Note 2‑Revenue, page 80; 2023 Note 2‑Revenue, page 75; 2024 Note 2‑Revenue, page 76) the company reiterates that it is the principal on payment transactions, controls pricing (including tiered, volume‑based rates), and bears full margin risk, while the fees it pays to third‑party processors are recorded as transaction expense.  Although the proportion of processor‑related costs has shifted with transaction volume, the core exposure—price control, use of external processors, and transaction‑expense recognition—has persisted across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that PayPal's margin risk exposure remained essentially unchanged across 2022-2024, matching the ground truth's assertion of 'consistent exposure to margin risk without structural changes.' (2) Accurately cites specific filing locations (Note 2-Revenue with page numbers: 2022 p.80, 2023 p.75, 2024 p.76), demonstrating proper multi-hop synthesis across three years of filings. (3) Correctly identifies all three key elements: pricing control (including tiered, volume-based rates), use of third-party processors, and transaction expense recognition. (4) Properly characterizes PayPal's principal role and full margin risk bearing across all three years. (5) Appropriately notes that while processor-related costs shifted with transaction volume, the structural exposure remained constant—this nuance aligns with the ground truth's emphasis on consistency despite operational changes. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'the proportion of processor-related costs has shifted with transaction volume' adds helpful context not explicitly stated in the ground truth but is logically consistent with it. No quantitative errors detected—all years, page numbers, and conceptual relationships are accurate. The multi-hop reasoning correctly synthesizes information across three separate annual filings to demonstrate consistency. The answer directly addresses all components of the multi-part question regarding margin risk evolution, pricing control, third-party processor usage, and transaction expense recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 478,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of Angola LNG natural‑gas output was 49 MMCFD in 2022, fell to 48 MMCFD in 2023, and remained at 48 MMCFD in 2024 (2023 10‑K p. 9; 2024 10‑K p. 9). The slight dip followed by a flat trend indicates Chevron is maintaining a steady LNG supply, reinforcing its role as a reliable LNG supplier and supporting its strategic focus on sustaining rather than expanding LNG production.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. Ground truth shows: 2022: 592 MMCFD, 2023: 596 MMCFD, 2024: 609 MMCFD (steady increase). LLM reports: 2022: 49 MMCFD, 2023: 48 MMCFD, 2024: 48 MMCFD (slight decline then flat). These are off by an order of magnitude (approximately 12x smaller than actual values). The LLM's numbers (49, 48, 48 MMCFD) are completely inconsistent with the documented production volumes. Additionally, the LLM's interpretation of the trend is inverted - it claims a 'slight dip followed by flat trend' when the actual data shows a consistent upward trajectory (592→596→609). The strategic conclusion is therefore backwards: the LLM suggests 'sustaining rather than expanding' when the ground truth indicates 'growing operational emphasis' and 'upward trajectory.' The LLM does correctly cite 10-K pages (p. 9 for both years), but the actual data extracted from those pages is dramatically wrong. This represents a complete failure in quantitative accuracy and a fundamental misunderstanding of Chevron's Angola LNG production trend and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 331,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "Southern Power’s 2022 10‑K (page 268) required that scheduled payments under outdoor‑lighting leases be shown in the maturity analysis, indicating they were material. In 2023 the company noted that the undiscounted cash flows from such contracts were immaterial and therefore not separately disclosed (page 240). By 2024 the disclosures again presented those scheduled payments in the maturity analysis (page 232), showing that the contracts had regained materiality and structural importance over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual reversal that contradicts the ground truth across all three years. CRITICAL ERRORS: (1) 2022: LLM claims outdoor lighting contracts were MATERIAL and shown in maturity analysis; ground truth states they were IMMATERIAL. (2) 2023: LLM claims they were IMMATERIAL and not separately disclosed; ground truth states they BEGAN being included in maturity analyses, signaling increased attention. (3) 2024: LLM correctly states they were presented in maturity analysis, but this is only 1 of 3 years correct. The LLM has inverted the materiality progression - claiming immateriality in 2023 when the ground truth shows growing materiality and integration. The page references provided (268, 240, 232) cannot be verified but the substantive claims about materiality status are demonstrably backwards. The LLM's conclusion about 'regained materiality' mischaracterizes the actual trend of GROWING materiality from 2022 (immaterial) → 2023 (increased attention/inclusion) → 2024 (explicit integration). The multi-hop reasoning failed because the model reversed the materiality trajectory. The answer does address the three-year evolution question structurally, but with inverted facts that completely undermine the analysis. This is a case where the model appears to have confused or reversed the actual disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 379,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site was listed as an **analog‑only** manufacturing location in all three years.  \n- 2022: Melaka was marked “†” (part‑leased/owned) and had an X for Analog but none for Embedded Processing【page_18】.  \n- 2023: The facility remained “**” (part‑leased/owned) and still carried an X only for Analog【page_16】.  \n- 2024: The same “**” designation persisted, with the site again showing an X for Analog and no Embedded Processing involvement【page_16】.  \n\nThus, across 2022‑2024 the Melaka footprint did not expand into Embedded Processing; it remained an analog‑focused site, with only a change in leasing status.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies that Melaka, Malaysia operated exclusively for the Analog segment across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately notes that there was NO expansion into Embedded Processing during this period, which is the key finding. (3) Provides specific details about leasing status changes († in 2022, ** in 2023-2024) that add contextual depth without contradicting the ground truth. (4) Properly synthesizes multi-hop information across three fiscal years and two business segments. (5) Uses clear formatting with bullet points and citations to enhance readability. (6) The reasoning is sound: comparing segment involvement year-over-year and concluding consistency. MINOR CONSIDERATIONS: (1) The ground truth answer doesn't explicitly mention the leasing status designations (†, **), though this additional detail is not contradictory and appears to be sourced from the actual filings (page references provided). (2) The LLM provides more granular detail than the ground truth, but this represents added value rather than error. VERIFICATION: The core claim that Melaka remained Analog-only across 2022-2024 with no Embedded Processing involvement is directly supported by the ground truth. All entities (Texas Instruments, Melaka Malaysia, Analog segment, Embedded Processing segment, years 2022-2024) are correctly identified. The multi-hop synthesis across three years and two segments is accurate. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 435,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600% Notes remained a $700 million obligation, with semi‑annual interest payments on April 15 and October 15 and a par‑call date of March 15 2026; the only change was a modest principal adjustment of –$1.5 million in 2024. This consistency shows AMT has kept the notes on a fixed, long‑term schedule rather than refinancing or altering terms, underscoring a conservative debt‑management strategy that prioritizes predictable cash flows and maturity alignment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core facts correctly: $700 million principal amount, semi-annual interest payments on April 15 and October 15, and par call date of March 15, 2026. However, there are significant quantitative accuracy issues: (1) The LLM only mentions the 2024 adjustment of -$1.5 million but completely omits the 2023 adjustment of -$2.6 million, which is a critical data point for demonstrating the multi-year progression requested in the question. (2) The ground truth explicitly states adjustments 'decreased from (2.6) in 2023 to (1.5) in 2024,' which is a key analytical point showing the trend over time. The LLM's failure to include the 2023 figure undermines the multi-hop synthesis across the three-year period. (3) The LLM's characterization of the strategy as 'conservative debt-management' and 'prioritizes predictable cash flows' is reasonable inference but goes slightly beyond what the ground truth states—the ground truth more cautiously notes 'consistency suggests...a stable approach' with 'only minor adjustments in administrative or accounting treatments.' The LLM's interpretation is not incorrect but adds interpretive language not explicitly supported. The answer is partially correct on the main facts but incomplete on the multi-year progression analysis, which was explicitly requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 374,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "From FY 2022 through FY 2024 Cisco kept the 5.90% senior note at a constant $2 billion principal and 6.11 % effective rate (see the long‑term debt tables on page 89 for each year).  During that period total long‑term debt rose from $8.4 billion to $19.6 billion, so the 5.90% note represented only about 10 % of the debt mix.  The unchanged, relatively high rate of the note, coupled with the addition of lower‑rate issues, signals a strategy of maintaining a stable high‑yield component while expanding the debt base with cheaper notes to fund growth and keep overall borrowing costs balanced.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics. Verification of numbers: (1) 5.90% Note principal amount of $2 billion (stated as $2,000 million in ground truth) - CORRECT; (2) effective interest rate of 6.11% - CORRECT; (3) long-term debt increase from $8.4 billion to $19.6 billion (ground truth: $8,416M to $19,621M) - CORRECT with appropriate rounding; (4) short-term debt figures not mentioned in LLM answer but not required by question scope. The LLM correctly calculated that the 5.90% note represented approximately 10% of total debt in 2024 ($2,000M / $19,621M ≈ 10.2%), demonstrating sound multi-hop reasoning. The answer properly synthesizes information across fiscal years 2022-2024 and correctly identifies the composition shift. The interpretation of financing strategy is reasonable and supported by the data presented. Minor weakness: The LLM answer does not explicitly mention the short-term debt component ($499M to $488M) or the full scope of debt composition changes, though this is not strictly necessary to answer the core question. The reasoning about maintaining a 'stable high-yield component while expanding with cheaper notes' is a logical inference from the data, though the ground truth uses slightly different framing ('stabilize financing costs'). Both interpretations are semantically equivalent and supported by the facts. The answer appropriately references source documentation (page 89 long-term debt tables), adding credibility. Overall, the response accurately addresses all major components of the multi-part question with correct calculations and sound synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 454,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics increased its Light Armored Vehicle (LAV) production for the Canadian Army from 360 units in 2022 to 399 units in 2023 and 449 units in 2024 (GD_10k_2022.pdf page 11; GD_10k_2023.pdf page 11; GD_10k_2024.pdf page 11). This steady rise demonstrates a deliberate strategic emphasis on expanding LAV manufacturing, reinforcing the company’s market‑leading position and positioning it to meet growing demand from Canada and other allies.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three production volume numbers (360 units in 2022, 399 units in 2023, and 449 units in 2024), demonstrating accurate quantitative data retrieval. The progression is accurately described as a steady increase. The company name (General Dynamics) and product (LAVs for Canadian Army) are correctly identified. WEAKNESSES: The LLM answer is INCOMPLETE regarding a critical component of the ground truth. The original answer specifically mentions the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program introduced in 2024 with 66 specialized LAVs equipped with advanced surveillance systems. This is a significant strategic development that the LLM completely omitted. This omission represents a failure in multi-hop synthesis - the question asks what the progression indicates about strategic focus, and the LRSS program is explicitly part of that strategic narrative in the ground truth. The LLM's reasoning about 'market-leading position' and 'growing demand from Canada and other allies' is somewhat generic and lacks the specific strategic insight about the LRSS expansion that demonstrates GD's deepening commitment to advanced land systems capabilities. CALCULATION VERIFICATION: The numbers are correct (360→399→449 represents increases of 39 units and 50 units respectively). MULTI-HOP REASONING: The LLM successfully synthesized data across three years but failed to incorporate the additional LRSS program data that provides crucial context for understanding the strategic focus question. The answer addresses the basic production volume evolution but misses the deeper strategic narrative about specialized surveillance systems and program diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 471,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth Group’s 2022, 2023 and 2024 10‑Ks all note that CMS has repeatedly reduced or frozen Medicare Advantage benchmarks and periodically altered the risk‑adjustment payment methodology, leaving the company exposed to ongoing funding volatility. In each year the firm has responded by selectively adjusting member benefits and premiums, dropping plans in certain counties, and intensifying medical and operating cost‑management to offset the pressure. Over the three‑year period these cost‑control and benefit‑design measures were reiterated and expanded to mitigate the persistent risk‑adjustment payment uncertainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the core issue: CMS repeatedly reduced/froze Medicare Advantage benchmarks and altered risk-adjustment payment methodologies; (2) Accurately captures UnitedHealth's consistent strategic responses: selective benefit/premium adjustments, county withdrawals, and intensified cost management; (3) Properly synthesizes the multi-hop information showing evolution across all three years; (4) Correctly notes the persistent and ongoing nature of these pressures; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and omits one specific detail mentioned in the original: the particular focus on 'beneficiary health status data submissions' as a 2024-specific risk area. The ground truth notes this as a particular emphasis in 2024, while the LLM answer generalizes to 'payment mechanisms' without this specificity; (2) The phrase 'expanded to mitigate' in the LLM answer is slightly less precise than the ground truth's emphasis on 'sustained operational agility' - though semantically similar, the ground truth emphasizes the need for continuous adaptation rather than simple expansion. MULTI-HOP REASONING: The LLM correctly synthesizes information across three separate 10-K filings, identifying consistent patterns and evolution. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message is preserved - UnitedHealth faced persistent CMS payment pressures and responded with consistent strategic adjustments. The wording differs but conveys equivalent information. Overall, this is a high-quality answer with only minor omissions of specific details rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 498,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes issued in September 2019 stayed flat at $1.5 billion in each of the three reporting periods (2022, 2023 and 2024)【page_107】【page_104】.  The unchanged balance shows the company is not actively refinancing or paying down this portion of debt, reflecting a conservative long‑term debt strategy that prioritizes a stable mix of fixed‑rate, long‑maturity notes to manage interest‑rate risk and preserve predictable cash‑flow obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of PYPL's debt strategy. QUANTITATIVE ACCURACY: All numbers are correct - the $1.5 billion carrying value is accurate for all three years (2022-2024), and the September 2019 issuance date is correct. The flat balance across all periods is accurately represented. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt strategy (conservative approach, stable mix, interest-rate risk management). ENTITY ACCURACY: Company correctly identified as PayPal (PYPL), years correctly specified (2022, 2023, 2024), and the specific debt instrument (2.850% notes) properly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the constant balance to strategic implications about debt management, interest-rate risk, and cash-flow predictability. The logic that unchanged balances indicate no active refinancing/paydown is valid. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth. Both identify the constant $1.5B balance and interpret it as reflecting strategic intent around debt structure. The LLM provides slightly more detail about the reasoning (interest-rate risk management, cash-flow obligations) which adds value without contradicting the ground truth. MINOR DIFFERENCES: The LLM characterizes the strategy as 'conservative' while the ground truth uses 'consistent' - both are semantically compatible interpretations of the same underlying fact. The LLM adds context about the September 2019 issuance date and provides more explicit reasoning about why the company maintains this position, which enhances rather than detracts from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 497,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron has kept a 36.4 % equity stake in Angola LNG Limited from 2022 through 2024, while adding upstream assets that will feed the Soyo LNG plant—namely a 31 % non‑operated interest in the New G as Consortium Project (first production 2026) and new acreage in Blocks 49 and 50 (2024)【page_14】.  The investment value in Angola LNG Limited has remained relatively flat (≈$1.96 B in 2022 to $1.76 B in 2023)【page_82】【page_78】, and the company’s continued focus on securing gas supply and expanding upstream acreage (e.g., Block 0’s Sanha Lean Gas Connection Project that ties gas from Blocks 0 and 14 to the LNG plant【page_76】) signals a long‑term strategy to monetize Angola’s natural gas by ensuring a steady feedstock for the LNG facility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the consistent 36.4% ownership stake across 2022-2024, matching ground truth exactly. (2) Properly identifies the New Gas Consortium Project with 31% non-operated interest and first production 2026. (3) Correctly mentions Blocks 49 and 50 as new acreage acquired in 2024. (4) Captures the strategic evolution toward integrated gas monetization hub concept. (5) Appropriately synthesizes multi-hop information about upstream assets feeding the LNG facility.\n\nWEAKNESSES: (1) CRITICAL ERROR: References 'Soyo LNG plant' instead of 'Angola LNG Limited/Angola LNG plant' - this is a naming error that could cause confusion, though contextually refers to the same facility. (2) QUANTITATIVE ISSUE: States investment value 'remained relatively flat (≈$1.96 B in 2022 to $1.76 B in 2023)' - this is NOT flat; it represents a $200M decline (~10% decrease). This is a calculation/characterization error. (3) INCOMPLETE: Mentions 'Block 0's Sanha Lean Gas Connection Project' but ground truth specifically references 'Quiluma and Maboqueiro (Q&M) gas fields within the New Gas Consortium Project' - the LLM introduces a different project (Block 0/14) not mentioned in ground truth, which may be accurate but represents divergence from the specified answer. (4) MISSING CONTEXT: Ground truth emphasizes the transition from 'standalone LNG export facility' to 'integrated hub' - LLM captures this concept but less explicitly. (5) The characterization of investment value as 'relatively flat' when it declined $200M is misleading and represents poor quantitative accuracy.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and connects upstream development to downstream LNG facility, demonstrating sound multi-hop reasoning. However, the introduction of Block 0/Sanha project (not in ground truth) and the mischaracterization of the investment value trend weaken the synthesis quality.\n\nNUMBER VERIFICATION: 36.4% ✓ | 31% non-operated interest ✓ | 2026 first production ✓ | $1.96B (2022) and $1.76B (2023) values appear cited but characterization as 'flat' is incorrect - this is a $200M decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 580,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "From 2022 to 2024, Southern Company’s trust holdings in domestic equity rose from $651 million to $849 million, while private‑equity investments grew from $161 million to $181 million (2022: page 312; 2023: page 281; 2024: page 273). The steady increase—especially the $198 million jump in domestic equity—shows a deliberate tilt toward higher‑yield, equity‑centric assets within trusts, underscoring a long‑term capital‑allocation strategy that balances growth and diversification while managing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that do not match the ground truth data. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states domestic equity rose from $651M (2022) to $849M (2024), but ground truth shows $1,016M (2022) to $1,099M (2024) - a difference of $365M in 2022 and $250M in 2024. The LLM claims a '$198 million jump in domestic equity' but this calculation is wrong: $849M - $651M = $198M, yet the actual progression per ground truth is $1,016M → $829M → $1,099M. (2) PRIVATE EQUITY ERRORS: The LLM states private equity was $161M in 2022, but ground truth shows $150M in 2022. The 2024 figure of $181M is correct. (3) MISSING CRITICAL DATA: The LLM completely omits the 2023 data point ($829M domestic equity, $161M private equity), which is essential for understanding the three-year progression and the strategic shift indicated by the dip in 2023. (4) FLAWED REASONING: The LLM's conclusion about 'steady increase' is contradicted by ground truth, which shows a decline in 2023 followed by rebound in 2024 - a more nuanced pattern than 'steady increase.' (5) MULTI-HOP SYNTHESIS FAILURE: The answer fails to properly synthesize the three-year trend that demonstrates strategic rebalancing, not just steady growth. The ground truth narrative about 'growing emphasis on private equity' and 'relatively stable' domestic equity with 'minor fluctuations' is more accurate than the LLM's 'steady increase' characterization. The page citations provided cannot be verified but the numerical data is demonstrably incorrect against the ground truth baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 441,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "Eliminations/Reclassifications cut GM’s total net sales and revenue by **$107 million in 2022, $151 million in 2023, and $296 million in 2024** (see the “Eliminations/Reclassifications” column in the revenue tables on page 69 for 2022‑23 and page 68 for 2024). The steadily larger negative impact each year indicates that GM is making increasingly substantial internal adjustments—likely from cross‑segment eliminations, reclassifications of revenue between Automotive, GM Financial, and Cruise, and changes in accounting policies—reflecting growing complexity in its consolidated reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM reports: 2022=$107M, 2023=$151M, 2024=$296M. This represents a fundamental misreading of the data - the 2022 figure is off by $2M (107 vs 105), the 2023 figure is dramatically wrong by $44M (151 vs 107), and only the 2024 figure of $296M is correct. The LLM swapped or confused the 2022 and 2023 values, and provided an entirely incorrect 2023 value. TREND ANALYSIS COMPROMISED: Because the quantitative foundation is wrong, the trend analysis is also incorrect. The ground truth shows a modest increase from 2022-2023 ($105M to $107M, only $2M increase) followed by a sharp jump to 2024 ($296M). The LLM's incorrect numbers suggest a different trend pattern ($107M to $151M to $296M), which misrepresents the actual evolution of eliminations/reclassifications. QUALITATIVE REASONING: The LLM's reasoning about increasing complexity and cross-segment eliminations is plausible and contextually appropriate, but it's built on incorrect numerical premises. The citation references to pages 69 and 68 cannot be verified but appear to be an attempt at source attribution. COMPLETENESS: The answer does address the multi-part question about how the impact evolved and what it reveals, but the factual errors undermine the entire response. The semantic framing about internal adjustments and segment complexity is reasonable, but the specific numbers that drive the conclusion are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 437,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix amended and restated its Performance Bonus Plan in December 2022 and filed the updated plan as Exhibit 10.5† (8‑K) in the 2023 10‑K and again as the same exhibit in the 2024 10‑K (pages 69 of 2023 and 69 of 2024).  Throughout 2022‑2024 the plan was documented as an exhibit rather than incorporated by reference, and it was integrated with the 2020 Stock Plan and performance‑based restricted‑stock‑unit award agreements (exhibits 10.9†–10.10† on page 69 of 2024) and linked to the executive‑officer severance plan (exhibit 10.11† on page 69 of 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The December 2022 amendment and restatement date is accurate; (2) The identification of Exhibit 10.5† as the amended and restated plan is correct; (3) The integration with the 2020 Stock Plan and performance-based RSU agreements is accurate; (4) The reference to the executive severance plan integration is correct; (5) The documentation as exhibits rather than incorporation by reference is accurate. PROBLEMATIC ELEMENTS: (1) The LLM states the plan was filed as an 8-K in the 2023 10-K, which is contradictory and confusing - the ground truth indicates it was filed with a December 9, 2022 date but appears in the 2023 10-K filing; (2) The LLM omits the critical 2022 status where the plan was listed as a historical exhibit (Exhibit 10.6†) from April 28, 2014, showing no updates that year - this is a significant omission for understanding the evolution; (3) The LLM does not clearly articulate the progression/evolution narrative: that 2022 had no updates, 2023 saw active revision, and 2024 showed stabilization; (4) The specific page references (page 69) are provided but not verified against ground truth; (5) The answer lacks the narrative arc of 'strategic update in 2023 followed by stabilization in 2024' that the ground truth emphasizes. MULTI-HOP REASONING: The LLM successfully synthesizes information about exhibit numbers, dates, and integration with other compensation frameworks across multiple years, but fails to capture the temporal evolution aspect that is central to the question. The answer is more of a static description of 2023-2024 status rather than a true evolution narrative. QUANTITATIVE ACCURACY: The dates (December 2022) and exhibit numbers are correct, though the 8-K reference is confusing. QUALITATIVE ACCURACY: The reasoning about integration is sound, but the failure to address 2022 status and the evolution narrative significantly weakens the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 534,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK’s 10‑K filings for 2022, 2023 and 2024 all reference the same “Business Relationships and Related Party Transactions Policy” in the proxy under Item 13, with identical wording and no added detail (see BK_10k_2022.pdf page 13, BK_10k_2023.pdf page 13, BK_10k_2024.pdf page 13). The consistent reference to this policy, together with unchanged mentions of director independence and the same committee structures (Audit, Corporate Governance, Nominating & Social Responsibility, Human Resources & Compensation), demonstrates that BK has maintained a stable and uniform corporate‑governance disclosure framework across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that BK disclosed the 'Business Relationships and Related Party Transactions Policy' consistently across 2022, 2023, and 2024 filings. It accurately names the policy, correctly identifies Item 13 as the location, and properly lists all four committee structures (Audit, Corporate Governance/Nominating & Social Responsibility, Human Resources & Compensation). The conclusion about stable and uniform corporate governance disclosure framework is sound and matches the ground truth's core finding. The semantic equivalence is strong - both answers convey the same essential message about consistency.\n\nWEAKNESSES: The LLM answer makes specific page number claims ('page 13' for all three years) that cannot be verified against the ground truth and appear potentially inaccurate or overly specific without supporting evidence. The claim of 'identical wording and no added detail' is a quantitative assertion that goes beyond what the ground truth states - the ground truth only confirms consistent placement and linkage, not that the wording was identical across all three years. This represents an unsupported factual claim. The LLM also references 'the proxy' which is imprecise terminology - these are 10-K filings, not proxy statements, though related party transaction policies may be disclosed in both documents.\n\nMULTI-HOP REASONING: The reasoning is sound - the model correctly synthesizes information about policy consistency, director independence linkage, and committee structures across three years. However, the specific page citations and claims about identical wording introduce unverified quantitative details that weaken the answer.\n\nCORRECTIONS NEEDED: Remove or verify the specific page number citations. Soften the claim about 'identical wording' to match the ground truth's more measured statement about 'consistent placement and linkage.' Clarify that these are 10-K filings rather than proxies.\n\nThe core answer is directionally correct and addresses the question well, but the introduction of unverified specific details (page numbers, identical wording claim) prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 579,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s debt securities held‑to‑maturity declined in both fair value and carrying (amortized‑cost) amount over the three‑year period: fair value fell from $643 million in 2022 to $596 million in 2023 and to $508 million in 2024, while carrying value fell from $641 million to $603 million to $512 million. The portfolio has shrunk by roughly 20 % and the fair‑value decline slightly exceeds the carrying‑value decline, indicating modest interest‑rate‑driven downward adjustments on securities that are still valued at amortized cost. This trend reflects a conservative, low‑risk investment strategy that maintains a small, fixed‑income H2M holding and relies on observable market inputs (Level 1/2) for fair‑value reporting, with valuation assumptions remaining consistent over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: fair value declined from $643M (2022) → $596M (2023) → $508M (2024), and carrying value from $641M → $603M → $512M. The 20% portfolio shrinkage calculation is accurate (approximately 21% decline from $643M to $508M). The multi-hop synthesis is sound, correctly identifying the relationship between fair value and carrying value movements and their implications. The answer appropriately addresses the 3-year trend question and investment strategy implications. However, there are minor differences from the ground truth: (1) The LLM provides additional analytical detail about interest-rate-driven adjustments and Level 1/2 reliance that goes beyond the ground truth's mention of 'shift away from Level 3 unobservable inputs,' which is a reasonable inference but represents slight elaboration beyond stated facts. (2) The ground truth explicitly mentions 'shift away from Level 3 unobservable inputs by 2023 and 2024,' while the LLM states reliance on 'Level 1/2' without explicitly confirming the Level 3 shift away. (3) The LLM's characterization of 'modest interest-rate-driven downward adjustments' is a reasonable interpretation but adds analytical layer not explicitly in ground truth. All core numbers, dates, and the fundamental trend analysis are correct. The reasoning about strategic reduction and valuation methodology is sound and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 407,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "From 2022 to 2024 PayPal’s exposure to bad transactions in its BNPL loan receivables shifted from a general credit‑risk concern to a deliberate risk‑transfer strategy. In 2022 the company disclosed the risk of default on its credit products but did not report a BNPL portfolio (2022 10‑K, p. 24). In 2023 it entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables, thereby shifting the credit risk of existing loans while retaining exposure to future originations through a forward‑flow arrangement (2023 10‑K, p. 25). By 2024 the company reiterated this arrangement and noted that the sale of future receivables remains contingent on conditions, underscoring a continued reliance on external risk transfer while still managing residual credit risk through internal underwriting (2024 10‑K, p. 23).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the €40 billion figure for the June 2023 BNPL receivables sale agreement; (2) Accurately captures the evolution from general credit risk disclosure in 2022 to deliberate risk-transfer strategy by 2023-2024; (3) Properly synthesizes the forward-flow arrangement concept and its contingent nature; (4) Correctly notes that 2022 did not report a BNPL portfolio; (5) Appropriately emphasizes the conditional nature of future receivables sales in 2024. MINOR ISSUES: (1) The LLM provides specific page references (p. 24, p. 25, p. 23) that cannot be verified against the ground truth, though this does not contradict the ground truth; (2) The phrase 'did not report a BNPL portfolio (2022 10-K, p. 24)' is a reasonable inference but goes slightly beyond what the ground truth explicitly states - the ground truth simply notes PayPal 'highlighted its exposure to bad transactions through its credit and merchant financing products' without explicitly confirming absence of BNPL reporting; (3) The LLM's characterization of 'retaining exposure to future originations through a forward-flow arrangement' is accurate but represents a slightly more technical interpretation than the ground truth's simpler statement about 'offloading a substantial portion.' MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the strategic shift from risk acknowledgment to active risk mitigation. The logic connecting the 2023 agreement to the 2024 contingency conditions is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - PayPal moved from passive risk disclosure to active risk transfer through asset sales - while using more precise financial terminology. All key facts align with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 520,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell sharply from 15 MBD of oil‑equivalent in 2022 to 4 MBD in 2023 and remained at 4 MBD in 2024, while natural‑gas production dropped from 87 MMCFD to 22 MMCFD over the same period. This decline mirrors Chevron’s strategic decision to exit the country—announced in 2022 and completed by April 2024—shifting the company from active production to a non‑operated, orderly transition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect production volume numbers that contradict the ground truth. Ground truth states Myanmar production was 17 MBD in 2022 and 15 MBD in 2023, but the LLM claims 15 MBD in 2022 and 4 MBD in 2023—a fundamental misrepresentation of the data. The LLM also introduces natural gas production figures (87 MMCFD to 22 MMCFD) that are not mentioned in the ground truth and appear to be fabricated or from incorrect sources. The April 2024 complete withdrawal date is correct, but the LLM's characterization of the transition as 'non-operated, orderly transition' differs from the ground truth's description of a 'full exit.' The LLM does correctly identify the strategic shift toward portfolio optimization and risk management, but this is undermined by the pervasive numerical inaccuracies. The answer fails on quantitative accuracy (the core metric for financial questions) with production volumes off by significant margins (claiming 4 MBD instead of 15 MBD for 2023). Multi-hop reasoning is partially present (connecting production decline to strategic exit), but the foundation is built on incorrect numbers, making the synthesis unreliable. The contextual relevance is moderate—the answer addresses the right question but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 364,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & Notebooks moved from the second‑largest sector within TI’s Personal Electronics segment in 2022 and 2023 to the eighth‑largest in 2024 (page_5 2022, page_5 2023, page_5 2024). This decline, despite the segment’s overall growth from 15 % to 20 % of total revenue (page_5 2022, page_5 2024), signals TI’s strategic shift toward other personal‑electronics and automotive categories rather than the consumer‑computing niche.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Personal Electronics segment grew from 15% to 20% of revenue between 2022 and 2024, but the ground truth states it was 24% in 2022, declined to 15% in 2023, then increased to 20% in 2024. The LLM omitted the 2022 figure (24%) entirely and misrepresented the trajectory by starting from 2023's 15% figure. This is a critical factual error. (2) RANKING CLAIM - The LLM asserts PC & Notebooks moved from 'second-largest sector' in 2022-2023 to 'eighth-largest in 2024' but provides no supporting evidence from the ground truth. The original answer does not specify these rankings, making this claim unverifiable and potentially fabricated. (3) INCOMPLETE SYNTHESIS - The LLM failed to capture the full 3-year evolution: it missed the significant 2022-2023 decline (24% to 15%) and only partially addressed the 2023-2024 recovery (15% to 20%). (4) REASONING FLAW - The LLM states the segment's 'overall growth from 15% to 20%' but this ignores the prior decline from 24%, mischaracterizing the strategic trend. The ground truth emphasizes a 'strategic shift away from PC & Notebooks' with the segment declining overall from 2022 baseline, not growing. (5) CORRECT ELEMENTS - The LLM correctly identified the strategic shift away from consumer computing and toward automotive/industrial markets, and correctly noted the segment's 20% revenue contribution in 2024. However, these correct conclusions are built on incomplete and partially inaccurate data presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 421,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "From 2022 through 2024, GM’s 10‑K filings consistently reported **no material accruals** for its indemnification obligations to Stellantis under the 2017 Opel/Vauxhall sale.  In each year (2022 page 91, 2023 page 93, 2024 page 91) GM stated that the known liabilities—emissions claims, product‑liability and recall costs, including Takata inflator recalls—were immaterial and that any future indemnification exposure was “remote.”  The obligations remained subject to the same time limits, thresholds and caps, and the company did not record a change in the assessment of potential future exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - Claims \"no material accruals\" in all years (2022-2024), but ground truth shows GM disclosed accruals in 2024 related to European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era\n   - States obligations were \"immaterial\" consistently, but ground truth indicates 2023 showed disclosed indemnification obligations (though immaterial in amount paid), and 2024 showed specific accruals for regulatory investigations\n   - Incorrectly characterizes the evolution as static (\"did not record a change\"), when ground truth shows clear progression: 2022 (no disclosure) → 2023 (disclosed obligations) → 2024 (specific accruals for regulatory matters)\n\n2. MISSING KEY INFORMATION:\n   - Fails to mention the 2023 disclosure of indemnification for \"pre-sale representations and warranties, emissions claims, product liabilities, and recalls\"\n   - Omits the specific 2024 regulatory exposure (European Commission and UK CMA investigation into end-of-life vehicle practices)\n   - Does not capture the \"increasing specificity and emerging regulatory risk exposure over time\" that is central to the question's focus on evolution\n   - Misses the distinction between immaterial amounts paid vs. accruals for future regulatory matters\n\n3. QUANTITATIVE ACCURACY ISSUES:\n   - Page references provided (2022 page 91, 2023 page 93, 2024 page 91) cannot be verified but appear to be cited with false confidence\n   - No acknowledgment of the accruals mentioned in ground truth for 2024\n\n4. MULTI-HOP REASONING FAILURE:\n   - The question specifically asks about evolution \"from 2022 through 2024\" - the LLM fails to show meaningful progression\n   - Ground truth demonstrates a clear three-year evolution with increasing disclosure and emerging regulatory risks; LLM presents a static picture\n   - Failed to synthesize the relationship between regulatory investigations and indemnification obligations\n\n5. SEMANTIC ISSUES:\n   - Characterizing all obligations as \"remote\" contradicts ground truth's nuanced assessment (remote for Takata, but specific accruals for regulatory matters)\n   - The phrase \"did not record a change\" directly contradicts the emergence of 2024 accruals for regulatory investigations\n\nThe LLM answer appears to describe only the 2022 situation and incorrectly projects it forward, missing the critical evolution that is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 676,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower’s 1.450% Senior Notes due 2026 were first issued in 2021 and are referenced in the supplemental indenture (No. 10) in each of the 2022, 2023, and 2024 10‑K filings, with no new issuance or amendment in those years【page_71 2022】【page_71 2023】【page_71 2024】. The notes have remained unchanged across the three reporting periods, underscoring a conservative debt‑management approach that prioritizes a stable, low‑cost, long‑term financing base rather than frequent refinancing or higher‑rate issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 1.450% Senior Notes due 2026 as the subject instrument; (2) Accurately states the notes were first issued in 2021 (consistent with ground truth's reference to September 27, 2021 date); (3) Correctly references Supplemental Indenture No. 10; (4) Accurately notes the notes appear in all three years' 10-K filings (2022, 2023, 2024) with no new issuance or amendment; (5) Properly synthesizes the multi-year pattern to conclude a stable debt management strategy; (6) The characterization of the strategy as 'conservative' and 'prioritizing stable, low-cost, long-term financing' is semantically equivalent to the ground truth's 'deliberate and stable debt management strategy.' MINOR WEAKNESSES: (1) The LLM answer does not explicitly reference the specific Exhibit numbers (4.25, 4.22, 4.21) that changed across years, which the ground truth includes as documentation evidence of continuity; (2) The page citations provided (page_71 for all three years) appear generic and lack the specificity of the ground truth's exhibit-level documentation; (3) The phrase 'rather than frequent refinancing or higher-rate issuances' adds interpretive language not explicitly in the ground truth, though it is logically sound. QUANTITATIVE VERIFICATION: All dates and percentages are correct (1.450%, 2026 maturity, 2021 issuance, 2022-2024 reporting years). MULTI-HOP REASONING: The answer successfully synthesizes information across three years to identify a pattern and draw a strategic conclusion, meeting the multi-hop requirement. The reasoning is sound and logically connects the consistent presence of unchanged notes to a stable debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 482,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "From 2022 through 2024, BNY Mellon continued to use the 2019 Long‑Term Incentive Plan to issue new performance‑share‑unit agreements each year—2022 Form of Performance Share Unit Agreement (Exhibit 10.21), 2023 Form of Performance Share Unit Agreement (Exhibit 10.26), and 2024 Form of Performance Share Unit Agreement (Exhibit 10.28)—alongside corresponding restricted‑stock‑unit agreements (Exhibit 10.22, 10.27, 10.29) [page_19, page_20]. No new deferred‑stock‑unit agreements were introduced during this period, as the only deferred‑stock‑unit agreement listed is the 2008 Form of Long‑Term Incentive Plan Deferred Stock Unit Agreement (Exhibit 10.8) [page_18].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims 'No new deferred-stock-unit agreements were introduced during this period' and references only a '2008 Form of Long-Term Incentive Plan Deferred Stock Unit Agreement.' However, the ground truth explicitly states that in 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' which is a new deferred stock unit agreement introduced during the 2022-2024 period. This is a critical factual error that directly contradicts the question's focus on 'introduction of new deferred stock unit agreements.' (2) INCOMPLETE SYNTHESIS - The LLM provides exhibit numbers and page references but fails to capture the evolution narrative that the ground truth emphasizes: the progression from 2022 (initial implementation with PSU and RSU forms), to 2023 (expansion to director-level compensation with new DSU agreement), to 2024 (incorporation of 2022 Form PSU). (3) MISSING CONTEXT - The LLM answer does not address the strategic evolution or the 'multi-year strategic alignment' aspect mentioned in the ground truth. It treats the years as parallel rather than showing progression. (4) PARTIAL ACCURACY - The LLM correctly identifies that PSU and RSU agreements were used across 2022-2024, and correctly notes the 2022, 2023, and 2024 forms of PSU agreements, but this accuracy is overshadowed by the fundamental error regarding deferred stock unit agreements. The answer demonstrates a failure in multi-hop reasoning by not synthesizing information about the 2023 director-level DSU agreement introduction, which is central to understanding the plan's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 473,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics’ Combat Systems segment has kept aerostructures as a core element of its missile‑subsystem offering every year – OTS supplies “critical aerostructures … for both legacy and next‑generation missiles, including cutting‑edge hypersonic rocket cases” in 2022, 2023 and 2024【page_12】.  The revenue from weapons systems, armament and munitions grew from $2.0 billion in 2022 to $2.4 billion in 2023 and $2.9 billion in 2024【page_12】【page_13】, showing a scaling emphasis on advanced aerostructures.  This three‑year trend signals GD’s strategic positioning as a key supplier for next‑generation missile subsystems, especially hypersonic and high‑performance warhead platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies General Dynamics' sustained strategic focus on aerostructures for next-generation missile subsystems across 2022-2024, and appropriately emphasizes hypersonic capabilities. The qualitative reasoning about strategic positioning is sound and well-articulated. The answer demonstrates good multi-hop synthesis by connecting aerostructures to weapons systems revenue growth.\n\nCRITICAL ERRORS: (1) MISSING KEY METRIC - The ground truth explicitly states Combat Systems segment revenue as a percentage of consolidated revenue (20% in 2023, 19% in 2024), which is a core metric for understanding strategic positioning. The LLM completely omits this critical context. (2) UNVERIFIED NUMBERS - The LLM provides specific revenue figures ($2.0B in 2022, $2.4B in 2023, $2.9B in 2024) for 'weapons systems, armament and munitions' but these cannot be verified against the ground truth, which does not provide these specific breakdowns. The ground truth only mentions Combat Systems segment percentages, not absolute dollar amounts for this subcategory. (3) ATTRIBUTION ISSUE - The LLM attributes specific language about 'hypersonic rocket cases' to 'OTS' (Orbital ATK Systems?) but the ground truth does not mention this entity or this specific phrasing, raising questions about source accuracy.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and connect it to strategic positioning, which is appropriate. However, the synthesis is incomplete because it fails to incorporate the segment revenue percentage data that the ground truth emphasizes as important for understanding the 'slight revenue share fluctuations' mentioned in the original answer.\n\nCOMPLETENESS: The answer addresses the evolution question and strategic positioning question, but incompletely. It misses the explicit segment revenue percentages (20% → 19%) that are central to the ground truth's conclusion about 'slight revenue share fluctuations.'\n\nJUSTIFICATION: While the qualitative narrative is strong and the general strategic positioning is correctly identified, the quantitative gaps and missing key metrics (segment percentages) represent significant omissions in a financial analysis question. The unverified revenue figures add uncertainty. The score reflects correct directional analysis but incomplete and potentially inaccurate quantitative support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 640,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Philip Morris International consistently lists Jackpot as a local cigarette brand in the Philippines in its 2022, 2023 and 2024 10‑K filings, with no change in emphasis or positioning (2022 10‑K page_5; 2023 10‑K page_5; 2024 10‑K page_5). This steady treatment shows that while Jackpot remains part of PMI’s local portfolio to support regional market coverage, the company’s broader strategy focuses on premium international brands and its smoke‑free product line, using local brands mainly as supplementary assets rather than core strategic drivers.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES WITH INTERPRETATION AND REASONING: (1) QUANTITATIVE ACCURACY: The LLM correctly identifies that Jackpot appears in 2022, 2023, and 2024 10-K filings and cites page 5 for each year. The numeric/date references are accurate. However, the LLM provides no specific financial metrics, market share data, or quantitative measures that could be verified. (2) MAJOR REASONING ERROR - CONTRADICTS GROUND TRUTH: The LLM's core interpretation fundamentally contradicts the ground truth. Ground truth states: 'This consistent mention of Jackpot across three years shows that...traditional cigarette brands like Jackpot remain strategically relevant in key regional markets.' The LLM states the opposite: Jackpot is 'mainly as supplementary assets rather than core strategic drivers.' This is a semantic and factual contradiction of the ground truth's conclusion. (3) INCOMPLETE SYNTHESIS: The ground truth explicitly mentions the context of Swedish Match integration (2023) and IQOS/ZYN expansion to 95 markets (2024), showing how Jackpot fits within PMI's broader portfolio evolution. The LLM mentions these elements but uses them to argue Jackpot is supplementary, not to show its strategic relevance despite the smoke-free pivot. (4) MISINTERPRETATION OF 'NO CHANGE': The LLM states 'no change in emphasis or positioning' but the ground truth indicates consistent strategic emphasis across years despite broader company transformation - these are different conclusions. The ground truth's point is that despite major strategic shifts (smoke-free focus, Swedish Match integration), Jackpot remained strategically relevant. The LLM interprets consistency as evidence of supplementary status. (5) MISSING KEY INSIGHT: The ground truth emphasizes the tension between PMI's long-term smoke-free vision and the continued strategic relevance of traditional cigarette brands in key markets - this nuance is absent from the LLM answer. The LLM's characterization of Jackpot as 'supplementary' directly contradicts the ground truth's characterization as 'strategically relevant.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 558,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "In 2022 Chevron’s 10‑K listed the Republic of Congo among its operating jurisdictions but did not report any major capital deployment or asset disposition there【page_33】. By 2023 the company had invested roughly $0.7 billion in offshore development and natural‑gas projects in the Republic of Congo as part of its Africa portfolio【page_109】. In 2024 Chevron divested its non‑operated interests in the country—selling its 31.5 % stake in the offshore Haute Mer permit area and its 15.75 % stake in the Lianzi project—signaling a shift from investment to divestiture in the Republic of Congo【page_43】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with mostly correct information and sound multi-hop reasoning. STRENGTHS: (1) All key financial figures are accurate: $0.7 billion investment in 2023, 31.5% stake in Haute Mer, 15.75% stake in Lianzi. (2) Timeline is correct: 2022 operational presence, 2023 active investment, 2024 divestiture. (3) Multi-hop synthesis is sound, correctly connecting capital deployment across years and showing the strategic shift from investment to divestiture. (4) Entity identification is accurate (Chevron, Republic of Congo, specific permit areas). (5) The narrative structure effectively captures the 3-year evolution. MINOR ISSUES: (1) The LLM states the divestiture occurred in 2024, but the ground truth specifies January 2025 as the actual transaction date. This is a temporal accuracy issue—the LLM conflates the 2024 10-K reporting of the planned divestiture with the actual 2025 execution. (2) The LLM omits the explicit characterization that this represents 'a strategic exit from upstream assets,' though the phrase 'shift from investment to divestiture' conveys similar meaning. (3) The ground truth notes 2022 signaled 'ongoing presence and strategic importance,' while the LLM states 'did not report any major capital deployment or asset disposition'—this is semantically equivalent but slightly different framing. CALCULATION VERIFICATION: No calculations required; all cited figures match ground truth. MULTI-HOP REASONING: Correctly synthesizes information across three fiscal years and multiple filing sections to show strategic evolution. The temporal precision issue (2024 vs January 2025) prevents a higher score, as this represents a factual discrepancy in timing, though the overall narrative arc is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 481,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company kept classifying outdoor‑lighting contracts as operating leases in 2024, but the lease‑income reported under that category fell from $208 million in 2022 to $136 million in 2024, showing a lower revenue allocation.  The scheduled lease payments under these contracts declined across the group—Alabama Power’s operating‑lease cash flows dropped from $18 million in 2025 to $6 million, Georgia Power’s from $228 million to $24 million, and Southern Company’s from $239 million to $117 million—while the weighted‑average remaining lease term for Southern Company’s operating leases shortened from 17.3 to 16.4 years and the discount rate rose from 4.51 % to 4.73 %.  Materiality stayed immaterial for Georgia Power, Mississippi Power and Southern Power, but the lease income remained material for Southern Company, albeit at a reduced level.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to fabricate specific numerical data not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($208M in 2022 declining to $136M in 2024, Alabama Power $18M to $6M, Georgia Power $228M to $24M, Southern Company $239M to $117M) that are not mentioned in the ground truth. These appear to be invented numbers without source verification. The discount rate changes (4.51% to 4.73%) and weighted-average lease term changes (17.3 to 16.4 years) are also not present in the ground truth. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes that outdoor lighting contracts were 'immaterial' in 2022 with 'no significant value disclosed,' yet the LLM claims specific materiality values and revenue figures. The ground truth focuses on disclosure improvements and transparency across years, not on declining revenue amounts. (3) MULTI-HOP REASONING FAILURE: The LLM attempts to synthesize data across subsidiaries (Alabama Power, Georgia Power, Southern Power, Mississippi Power) but does so with fabricated numbers rather than actual filing data. The ground truth indicates these contracts remained immaterial for most subsidiaries, contradicting the LLM's specific quantitative claims. (4) SEMANTIC DIVERGENCE: While the LLM correctly identifies that these are operating leases and mentions multiple subsidiaries, it fundamentally misrepresents the nature of the change from 2022-2024. The ground truth describes improved disclosure and standardization; the LLM describes declining revenues and changing financial metrics without evidence. (5) MISSING CORE INSIGHT: The LLM fails to capture the ground truth's main point about growing transparency and standardization in lease valuation across subsidiaries, instead focusing on invented numerical declines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 508,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "In 2022 the 3.50% senior note had a carrying amount of $500 million and an effective rate of 3.20 % (page 89).  In 2023 the carrying amount stayed at $500 million but the effective rate rose to 6.38 % (page 89).  By 2024 the carrying amount was still $500 million while the effective rate increased further to 6.66 % (page 89).  This steady principal with a rising effective rate reflects higher market interest rates over time, indicating a more expensive debt environment and a likely decline in the note’s fair value relative to its carrying amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - carrying amount of $500 million consistently across 2022-2024, effective interest rates of 3.20% (2022), 6.38% (2023), and 6.66% (2024) match the ground truth exactly. COMPLETENESS: The answer addresses all required elements: the evolution of carrying amount, the progression of effective interest rates across all three fiscal years, and interpretation of what this progression indicates about debt valuation and market conditions. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, and all three fiscal years (2022, 2023, 2024). REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the debt instrument across three years and draws appropriate conclusions about market conditions. The interpretation that rising effective rates reflect higher market interest rates and a more expensive debt environment is logically sound and consistent with financial principles. SEMANTIC EQUIVALENCE: The LLM's explanation that 'steady principal with a rising effective rate reflects higher market interest rates over time' is semantically equivalent to the ground truth's statement about 'shift in market conditions or internal risk assessments.' The additional detail about 'likely decline in the note's fair value relative to its carrying amount' is a reasonable inference from the data and adds appropriate context. MINOR CONSIDERATIONS: The LLM provides page references (page 89) which adds credibility but wasn't in the ground truth - this is a positive addition. The wording differs slightly but conveys the same information with equal or greater clarity. No calculation errors detected. All facts are accurate and properly synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 495,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "From 2022 through 2024 Simon Property Group’s Unsecured Notes – 35A stayed unchanged: a $750 000 face amount, 2.65 % interest, $19,875 in annual debt service, and a maturity of July 15 2030 (2022 page 50; 2023 page 50; 2024 page 51). The unchanged terms across three consecutive 10‑Ks show a deliberate, stable long‑term debt strategy—maintaining a low‑cost, predictable liability rather than refinancing or altering the instrument, which reflects SPG’s conservative, disciplined approach to debt management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '$750 000 face amount' which appears to be a formatting error for $750 million, but more problematically, the stated '$19,875 in annual debt service' is mathematically incorrect. With a $750 million face value at 2.65% interest, annual interest would be approximately $19.875 million (or $19,875,000), not $19,875. This is a major calculation error that undermines credibility. (2) COMPLETENESS - The LLM answer is incomplete regarding the broader context. The ground truth specifically mentions that this stability 'contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities.' The LLM fails to address this comparative context, which is essential to understanding the multi-year pattern and debt management strategy. The question explicitly asks what the pattern 'reveals about their long-term debt management strategy,' requiring discussion of how 35A fits within broader portfolio changes. (3) ENTITY/METRIC ACCURACY - The core facts about 35A are correct (consistent $750M, 2.65%, July 15 2030 maturity across 2022-2024), but the annual debt service calculation is fundamentally wrong. (4) REASONING - While the LLM correctly identifies the stability of 35A and characterizes it as reflecting a 'conservative, disciplined approach,' it fails to synthesize the multi-hop information about how this stability contrasts with other portfolio changes. The reasoning is partially sound but incomplete. (5) SEMANTIC EQUIVALENCE - The characterization of strategy is reasonable but lacks the nuance of the ground truth's explanation about 'selective refinancing or adding new debt instruments in response to market conditions.' The answer reads as a partial analysis rather than a comprehensive multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 513,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Industries has kept analog and embedded‑processing products at the core of its business model, explicitly listing embedded processing as part of the broad‑portfolio advantage (b) in its four sustainable competitive advantages (MD&A 2024 page 20; 2023 page 19; 2022 page 21).  From 2022 to 2024, embedded‑processing revenue rose modestly in 2023 (to $3.368 bn) but fell in 2024 (to $2.533 bn), and its operating margin dropped from 38.4 % in 2022 to 13.9 % in 2024, reflecting shifting market dynamics and a rebalancing of the portfolio (segment results 2024 page 20).  Despite these fluctuations, TI continues to view embedded processing as a key lever for its manufacturing foundation, market‑channel reach, and product diversity, reinforcing its competitive‑advantage framework (MD&A 2024 page 20).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) COMPANY NAME ERROR: The LLM refers to 'Texas Industries' instead of 'Texas Instruments' - this is a fundamental factual error that undermines credibility. (2) UNVERIFIABLE FINANCIAL DATA: The LLM provides specific revenue figures ($3.368 bn for 2023, $2.533 bn for 2024) and operating margins (38.4% in 2022, 13.9% in 2024) that cannot be verified against the ground truth. The ground truth makes NO mention of these specific financial metrics or revenue figures for Embedded Processing Products. The LLM appears to have fabricated or hallucinated these numbers. (3) INCOMPLETE ANSWER TO CORE QUESTION: The original question asks about the EVOLUTION of strategic emphasis on Embedded Processing Products within the four sustainable competitive advantages from 2022-2024. The ground truth emphasizes that the strategic framing remained STABLE with IDENTICAL PHRASING across all three years, highlighting consistency rather than evolution. The LLM's answer focuses heavily on financial performance fluctuations rather than addressing the strategic positioning and language consistency that the ground truth emphasizes. (4) MISSING KEY INSIGHT: The ground truth specifically notes that TI used identical language ('more opportunity per customer and more value for our investments') across 2022, 2023, and 2024. The LLM does not mention this consistency or the specific language used. (5) MISALIGNED FOCUS: While the LLM correctly identifies Embedded Processing as part of the four sustainable competitive advantages, it pivots to financial performance metrics rather than addressing the strategic evolution question. The ground truth's point is about strategic consistency, not financial volatility. (6) PAGE REFERENCES: The LLM provides specific page numbers (MD&A 2024 page 20; 2023 page 19; 2022 page 21) which cannot be verified but appear plausible. However, the unverifiable financial data suggests these citations may be fabricated. POSITIVE ASPECTS: The LLM correctly identifies that Embedded Processing is part of the four sustainable competitive advantages framework and maintains this positioning across years. The general structure of acknowledging both strategic importance and market dynamics shows some understanding. However, the company name error, unverifiable financial data, and misalignment with the core question's focus on strategic evolution (not financial performance) are disqualifying errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 651,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2023, CMCSA’s wireless service let customers activate multiple lines and choose between unlimited, shared, or per‑gigabyte data plans, with the same flexibility offered to international customers who could pick gigabyte or unlimited options (page 5, 2022; page 7, 2023). In 2024 the company broadened plan flexibility by launching prepaid unlimited data plans under the NOW brand for domestic customers, while continuing to provide international customers unlimited data plans and financing, and maintaining its MVNO‑based service in the United Kingdom to extend its international reach (page 5, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies the three plan types (unlimited, shared, per-gigabyte) available to customers across the 2022-2024 period; (2) Accurately mentions the NOW brand prepaid unlimited data plans introduced in 2024; (3) Correctly references the UK MVNO-based service for international expansion; (4) Properly identifies CMCSA as the company in question; (5) Correctly sequences the timeline of offerings. WEAKNESSES: (1) The claim that international customers had the same flexibility in 2022-2023 as domestic customers is not supported by the ground truth, which states shared data plans were offered 'exclusively as part of bundled service offerings to residential customers in the U.S.' - this suggests limited international presence in those years; (2) The statement about international customers being able to pick 'gigabyte or unlimited options' in 2022-2023 contradicts the ground truth's emphasis that shared data plans were U.S.-focused bundled offerings; (3) The answer overstates early international flexibility when the ground truth indicates international expansion was primarily a 2024 development; (4) Missing explicit mention that 2022 offerings were bundled with broadband services, which is a key contextual detail about plan structure. MULTI-HOP REASONING: The answer attempts to synthesize information across three years but makes an error in characterizing the international availability timeline. The ground truth clearly indicates international expansion occurred in 2024, not that it was available in 2022-2023. CALCULATION/NUMERIC ACCURACY: No calculations required; dates and years are correctly referenced. The core factual error is about the scope and timing of international offerings rather than numeric precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 494,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s risk disclosures flagged third‑party fraud schemes and the default risk of its consumer and merchant credit products (see pages 24, 26, 28). By 2023 the company reiterated those risks, adding emphasis on its reliance on third‑party lenders and the potential for higher default rates amid economic uncertainty (page 26). In 2024 the disclosures explicitly tie evolving fraud schemes to new product offerings and stress that detecting and mitigating abusive behaviors is increasingly complex, underscoring a growing need for sophisticated risk‑management frameworks in its digital‑payments ecosystem (page 24).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 3-year progression (2022-2024) and captures the general evolution of PayPal's fraud and abuse risk disclosures. It appropriately notes the increasing complexity of risk management and the shift toward more sophisticated fraud tactics. The semantic understanding of the question is sound, and the answer demonstrates awareness of PayPal's credit products and third-party fraud concerns. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies a critical detail - the €40 billion BNPL loan receivables agreement in 2023 - which the LLM answer completely omits. This is a major quantitative fact that demonstrates the scale of PayPal's exposure expansion. (2) INCOMPLETE SPECIFICITY: The ground truth mentions specific fraud types (fictitious account creation, stolen financial instruments, account takeovers, synthetic identity fraud) with clear year-by-year attribution. The LLM answer uses vaguer language like 'evolving fraud schemes' without the same level of detail. (3) MISSING LEGAL/REGULATORY CONTEXT: The ground truth notes 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' in 2024, which is a significant risk factor that the LLM answer does not address. (4) PAGE REFERENCES: The LLM provides page numbers (24, 26, 28) but these cannot be verified against the ground truth and appear to be generic citations without substantiation. QUANTITATIVE ACCURACY ISSUES: The LLM fails to include the €40 billion figure, which is a concrete, verifiable metric that should have been included. This represents a significant omission in quantitative data. REASONING ASSESSMENT: While the LLM demonstrates sound multi-hop reasoning about the progression of risks across three years, it lacks the depth and specificity of the ground truth answer. The synthesis is adequate but incomplete. The answer would benefit from more concrete examples and the specific financial metrics that illustrate the scale of PayPal's evolving exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 551,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "By 2022, El Segundo was listed simply as one of Gilead’s principal manufacturing sites (2022 10‑K, page 32) with no specific cell‑therapy role described.  In the 2023 10‑K, the facility is identified as being used for both clinical and commercial manufacturing and processing of cell‑therapy products (2023 10‑K, page 11), and the 2024 10‑K confirms this expanded role (2024 10‑K, page 10).  This evolution shows a strategic shift from a general manufacturing location to a dedicated hub that now supports the full commercial scale of Gilead’s cell‑therapy portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, GILD identified El Segundo as a principal manufacturing facility 'specifically for clinical and commercial manufacturing and processing of its cell therapy products.' However, the LLM answer claims that in 2022, El Segundo was 'listed simply as one of Gilead's principal manufacturing sites...with no specific cell-therapy role described.' This is a fundamental mischaracterization of the 2022 baseline. The LLM then describes an 'evolution' or 'strategic shift from a general manufacturing location to a dedicated hub' that supposedly occurred between 2022-2023, but this contradicts the ground truth which indicates cell therapy manufacturing was already identified at El Segundo in 2022. The ground truth emphasizes 'continuity' and 'no indication of reduced emphasis or facility changes,' whereas the LLM characterizes this as an 'expansion' and 'strategic shift.' While the LLM correctly identifies that the 2023 and 2024 10-Ks mention cell therapy manufacturing at El Segundo, it misinterprets the 2022 baseline, leading to an incorrect narrative about the facility's evolution. The page references provided (2022 10-K page 32, 2023 10-K page 11, 2024 10-K page 10) cannot be verified but the characterization of 2022 content is demonstrably wrong based on the ground truth. The answer fails on the core multi-hop synthesis task by incorrectly establishing the starting point of the timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 421,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Exhibit 4.6 consistently lists the 2.750% Senior Notes due May 18 2024 (COST_10k_2022 p. 66; COST_10k_2023 p. 66; COST_10k_2024 p. 66). The unchanged maturity date shows that Costco has maintained a stable long‑term debt schedule, using these notes as a predictable financing tool and avoiding frequent refinancing. This consistency reflects a disciplined, risk‑averse debt‑management strategy that prioritizes predictable interest obligations and a balanced maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the maturity date of May 18, 2024 is accurately cited, and the consistent appearance across 2022, 2023, and 2024 filings is properly documented. The page references (p. 66 for all three years) and exhibit citation (Exhibit 4.6) add specificity and verifiability. ENTITY ACCURACY: Costco is correctly identified, the 2.750% Senior Notes are properly specified, and all three fiscal years (2022, 2023, 2024) are accurately referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to demonstrate consistency in the debt instrument's maturity structure. The logical inference that unchanged maturity dates indicate no refinancing or extension is sound and matches the ground truth's conclusion. SEMANTIC EQUIVALENCE: The LLM's characterization of Costco's strategy as 'stable,' 'disciplined,' and 'risk-averse' with emphasis on 'predictable financing' and 'balanced maturity profile' conveys the same strategic insight as the ground truth's description of 'static approach' and 'deliberate capital structure decision.' Both answers reach the same conclusion about debt management philosophy. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about the strategic implications ('risk-averse,' 'balanced maturity profile') compared to the ground truth's more straightforward statement, but this represents appropriate elaboration rather than deviation. The answer fully addresses the multi-part question about how the maturity structure evolved (it didn't) and what this reveals about debt management strategy (disciplined, predictable approach).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 484,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of natural‑gas output from Angola LNG fell slightly from 49 million cubic feet per day (MMCFD) in 2022 to 48 MMCFD in 2023, and then held steady at 48 MMCFD in 2024【page_9】【page_9】. This modest decline followed by a plateau shows that Chevron is maintaining a stable gas‑production base in Africa rather than aggressively expanding it, reflecting a strategy of sustaining existing assets while focusing resources on other growth opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS - The LLM reports Angola LNG production volumes of 49, 48, and 48 MMCFD for 2022-2024, which are off by approximately 145x from the ground truth values of 7,107, 7,148, and 7,569 MMCFD respectively. These are not minor rounding differences but represent a complete misrepresentation of the scale of production. (2) DIRECTIONAL ERROR - The LLM claims production 'fell slightly' and then 'held steady,' directly contradicting the ground truth which shows a steady upward trend across all three years (7,107 → 7,148 → 7,569 MMCFD). The LLM's characterization of 'modest decline followed by plateau' is the opposite of the actual 'steady upward trend.' (3) STRATEGIC INTERPRETATION ERROR - The LLM concludes Chevron is 'maintaining a stable gas-production base' and 'not aggressively expanding,' which contradicts the ground truth interpretation that the steady increase 'indicates a strengthening production output' and 'maintained or expanded its operational focus.' (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year trajectory data to identify the upward trend pattern. (5) METRIC CONFUSION - The LLM appears to have confused Chevron's share or equity stake (possibly 49-48%) with actual production volumes in MMCFD, a fundamental category error. The ground truth clearly states these are 'natural gas production volumes' in MMCFD, not percentage shares. This answer demonstrates critical factual inaccuracy that would mislead any user about Chevron's Angola LNG operations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 440,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps that hedge deferred‑compensation costs grew from **$651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024** (page 92 for FY 2022; page 91 for FY 2023‑24).  Correspondingly, the swaps’ effect on earnings swung from a **$92 million gain in FY 2022** to **$58 million expense in FY 2023 and $91 million expense in FY 2024** (page 91).  This shift shows Cisco has expanded its use of market‑linked hedges to manage deferred‑compensation volatility, but the increasing market swings have turned the hedge from a benefit into a cost, underscoring heightened volatility in the underlying equity or index that drives compensation expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) SIGN ERRORS ON GAINS/LOSSES: The ground truth clearly states FY 2022 was a LOSS of $92 million, but the LLM reports a GAIN of $92 million - this is a complete reversal of the financial impact. Similarly, FY 2023 and FY 2024 are reported as expenses/losses in the LLM answer, but the ground truth indicates these were gains ($58M and $91M respectively). The LLM has inverted the entire financial trajectory. (2) NOTIONAL EXPOSURE NUMBERS: The LLM introduces notional exposure figures ($651M, $792M, $985M) that are not mentioned in the ground truth answer. While these may be from the actual filings, they are not part of the core answer being evaluated and their inclusion alongside the incorrect gain/loss figures creates confusion. (3) INTERPRETATION REVERSAL: The ground truth indicates a transformation 'from a net liability to a net benefit,' showing improvement. The LLM's interpretation states the hedge 'turned from a benefit into a cost,' which is the opposite conclusion and stems directly from the sign errors. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year progression of financial impacts. The core question asks about the evolution of financial exposure and what it indicates about strategy - the LLM's inverted numbers lead to an inverted and incorrect strategic interpretation. The answer demonstrates a fundamental misreading of whether these were gains or losses across the fiscal years, which is the most critical factual element of this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 445,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "Lowe’s began 2022 with a wood‑sourcing policy and a human‑rights, conflict‑minerals and Vendor Code of Conduct that required suppliers to meet basic environmental standards. In 2023 the company updated the wood‑sourcing policy to add country‑specific risk levels, a forestry grievance process and stronger monitoring, and in 2024 it further refined that policy with a more robust risk‑based approach, expanded monitoring of supplier emissions (encouraging CDP reporting and scope‑3 GHG reductions), and broadened third‑party product certifications such as ENERGY STAR, WaterSense and other independently certified items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) All dates and years are correct (2022, 2023, 2024). (2) All major policy elements are accurately captured: wood-sourcing policy, human rights policy, Vendor Code of Conduct, conflict minerals policy, and forestry grievance process. (3) The progression of enhancements is correctly sequenced - 2022 baseline, 2023 updates with country-specific risk levels and enhanced monitoring, 2024 further refinements with risk-based framework. (4) Third-party certifications are correctly identified (ENERGY STAR, WaterSense, independently certified products). (5) The multi-hop synthesis is sound, correctly connecting policy evolution across three years. (6) Additional details about CDP reporting and scope-3 GHG reductions in 2024 provide valuable context not contradicting the ground truth. MINOR CONSIDERATIONS: (1) The LLM answer includes specific details about emissions monitoring and CDP reporting that, while accurate and relevant, go slightly beyond what was explicitly stated in the ground truth summary, though this represents appropriate elaboration rather than error. (2) The phrasing 'conflict-minerals' policy is mentioned in the LLM answer but not in the ground truth summary, though this is a legitimate supplier practice element. (3) The ground truth emphasizes 'transparency, accountability, and sustainability' as overarching themes, while the LLM answer focuses more on specific mechanisms - both approaches are valid and complementary. The answer correctly addresses all three sub-components of the question: policy updates (wood sourcing policy evolution), monitoring enhancements (country-specific risk levels, forestry grievance process, emissions monitoring), and third-party certifications (ENERGY STAR, WaterSense, independently certified products). No numerical errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 522,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022‑24, CMCSA’s 10‑Ks consistently flag the same wireless rivals—AT&T, T‑Mobile and Verizon in the U.S. and BT, Virgin Media in the U.K.—as a growing threat to its broadband and wireless businesses, noting their use of 4G, 5G and 5G‑fixed‑wireless technologies. In 2023 the filing added that competitors are bundling higher‑speed DSL, fiber and fixed‑wireless services with unlimited data and voice, while CMCSA’s own MVNO tie‑up with Verizon and rollout of DOCSIS 4.0/2 Gbps speeds are highlighted; by 2024 the company stresses that rivals are further intensifying competition by bundling DTC streaming services with broadband and wireless plans, leveraging their expanding fiber and fixed‑wireless deployments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three major U.S. wireless competitors (AT&T, T-Mobile, Verizon) and accurately captures the technological evolution from 4G/5G to 5G fixed wireless across the 2022-2024 period. The answer correctly notes the bundling strategy evolution, particularly the 2024 emphasis on DTC streaming bundling. The inclusion of U.K. competitors (BT, Virgin Media) and CMCSA's own strategic responses (MVNO with Verizon, DOCSIS 4.0) adds relevant context not explicitly in the ground truth but consistent with typical competitive analysis. The timeline progression is logically sound.\n\nWEAKNESSES: (1) The LLM introduces specific details (DOCSIS 4.0/2 Gbps speeds, MVNO tie-up with Verizon, U.K. competitors) that are not mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent additions beyond what the ground truth synthesized, creating potential discrepancies in scope. (2) The 2023 description of competitors bundling 'higher-speed DSL, fiber and fixed-wireless services with unlimited data and voice' is more detailed than the ground truth's simpler statement about 5G fixed wireless deployment. This level of specificity cannot be verified against the ground truth. (3) The answer conflates CMCSA's own competitive responses with the threat analysis, which slightly shifts focus from the original question's emphasis on external competitive threats.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple competitive dimensions (technology, bundling, specific competitors), demonstrating sound multi-hop reasoning. The progression from 4G/5G to fixed wireless to DTC streaming bundling is logically coherent.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is not directly testable. The dates (2022-2024) are correct. Company names are accurate for the U.S. market.\n\nSEMANTIC EQUIVALENCE: The core message aligns with the ground truth—intensifying wireless competition through technology and bundling—but the LLM answer provides additional specificity that goes beyond the ground truth's scope, making direct comparison difficult.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 606,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s 2022 and 2023 10‑Ks state that it bears full margin risk because it sets transaction fees independently of the costs of payment processors and accounts for those processor fees as transaction expense, while revenue incentives (discounts, rebates, rewards, coupons) are treated as revenue reductions【page 81】【page 80】. The same language appears in the 2024 10‑K, indicating that the company’s pricing discretion and margin‑risk exposure have not materially changed【page 73】. Across 2022‑2024, the consistent emphasis on full pricing control and independent fee setting shows that PayPal continues to manage cost exposure while the inherent margin risk of its transaction‑based model remains unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about PayPal's margin risk exposure from 2022-2024: (1) PayPal bears full margin risk, (2) it sets fees independently of processor costs, (3) processor fees are transaction expenses, and (4) revenue incentives are revenue reductions. The answer accurately synthesizes information across three years and correctly notes the consistency of PayPal's approach. However, the answer has notable gaps compared to the ground truth: (1) It does not mention the 2023 expansion of discussion on incentives to merchants and consumers, treating this as merely a continuation rather than an evolution; (2) It completely omits the 2024 introduction of new revenue streams from contractual compensation (fraud, counterfeiting violations), which the ground truth identifies as 'introducing new revenue streams potentially affecting margin dynamics'; (3) The answer states margin risk 'has not materially changed' and 'remains unchanged,' which is technically accurate but misses the nuance that the ground truth emphasizes an 'evolution' in complexity through new revenue streams and expanded incentive discussions. The page citations provided (81, 80, 73) appear reasonable for 10-K filings but cannot be independently verified. The multi-hop reasoning is sound in connecting pricing discretion to margin control, but the answer undersells the complexity introduced by evolving incentive structures and new revenue sources. The answer correctly identifies the 'disciplined, centralized approach' concept but doesn't fully articulate how new revenue streams in 2024 represent an evolution in margin dynamics despite stable pricing control.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 457,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s treatment of free‑rent periods did not change from FY 2022 through FY 2024.  The company continues to recognize free‑rent and step‑rent provisions on a straight‑line basis over the original lease term and any reasonably certain extension options, with the lease term defined as the non‑cancelable period plus such options.  Accordingly, the right‑of‑use asset remains measured as the present value of discounted minimum lease payments over that lease term using the incremental borrowing rate, with no material change in disclosure or valuation impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly captures the core substance of Costco's lease accounting treatment across FY 2022-2024. STRENGTHS: (1) Correctly identifies that no material changes occurred in the accounting treatment across the three-year period; (2) Accurately describes the straight-line recognition method for free-rent and step-rent provisions; (3) Properly identifies the lease term definition (non-cancelable period plus reasonably certain extension options); (4) Correctly notes the use of incremental borrowing rate for present value calculations; (5) Accurately states that right-of-use assets are measured as present value of discounted minimum lease payments; (6) Appropriately notes the absence of material residual value guarantees or restrictive covenants. MINOR GAPS: (1) The LLM answer does not explicitly mention the variable lease payments treatment for leases with periodic rent increases based on price indices or sales volume, which was emphasized in the FY 2023 disclosure per the ground truth; (2) The answer could have been more explicit about the 'reiteration' and 'reaffirmation' aspects mentioned in the ground truth, which emphasize the consistency narrative across all three years. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution (or lack thereof) in accounting treatment. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM's statement that the company 'continues to recognize' and maintains 'consistent application' aligns well with the ground truth's characterization of a 'stable and consistent approach.' The omission of the variable lease payments detail is the primary limitation, representing approximately 10-15% of the complete answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 494,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s exposure to margin risk has not materially changed between 2022 and 2024.  The company continues to act as principal on every payment transaction, earning a fixed fee plus a variable component that is a percentage of the transaction amount and is known at the time the transaction is processed【75†L1-L6】.  Because PayPal bears the full cost of completing the transaction, it assumes full margin risk, with any fees paid to payment processors or other financial institutions recorded as transaction expense【75†L11-L15】.  Contracts remain open‑ended, defined at the transaction level, automatically renewing, and include tiered, volume‑based pricing, so the contractual structure that underpins margin exposure has stayed the same【75†L17-L23】.  The 2022 filing contains the identical description of pricing, processor use, and contract terms【78†L1-L6】【78†L11-L15】【78†L17-L23】, indicating no change in PayPal’s margin‑risk exposure over this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that PayPal's core margin risk exposure remained structurally stable from 2022-2024, accurately describing the principal-agent relationship, fee structure (fixed plus variable percentage), and transaction-level contract terms. The numeric/factual details about pricing mechanisms and processor costs are accurate. However, the answer has significant gaps in addressing the full scope of the question: (1) It completely omits the 2023 change regarding incentive recognition and revenue reduction based on performance targets or contractual amortization—a material evolution in margin structure that the ground truth explicitly identifies as introducing 'more variability.' (2) It fails to mention the 2024 adoption of ASU 2023-07 segment reporting changes, which the ground truth notes increased transparency around segment-level expenses and affected margin risk analysis across business units. (3) The answer's conclusion that there was 'no change' is overstated—while the fundamental pricing model remained unchanged, the ground truth characterizes the evolution as 'structurally stable but operationally nuanced,' acknowledging meaningful changes in how margins are recognized and reported. The LLM correctly synthesizes the core transaction mechanics but incompletely addresses the multi-hop evolution across the three-year period, missing two significant operational/accounting changes that represent material developments in margin risk exposure. The answer is partially correct on the structural stability claim but incomplete on the nuanced changes that occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 440,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco kept the 5.90 % senior note at a constant $2,000 million in both FY 2022 and FY 2024, but its share of total long‑term debt fell from about 22 % of the $9,000 million debt in 2022 to roughly 10 % of the $20,253 million debt in 2024 (5.90 % note / total debt). The effective interest rate on the note stayed flat at 6.11 % in both years. This shows Cisco is maintaining a stable cost on its high‑coupon debt while shifting its debt mix toward lower‑rate, longer‑maturity instruments, thereby reducing overall financing costs and improving its debt profile. (Sources: page 89 – 2022 and 2024 tables)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the constant $2,000 million principal balance for the 5.90% Note across the period. (2) The effective interest rate of 6.11% is accurately stated as constant. (3) The debt composition analysis (22% in 2022 vs ~10% in 2024) is mathematically sound and demonstrates multi-hop synthesis. (4) The interpretation about Cisco's debt strategy shift toward lower-rate instruments is reasonable and well-reasoned. (5) The answer addresses the evolution question by showing stability in this specific note while contextualizing it within broader portfolio changes.\n\nWEAKNESSES: (1) The LLM only explicitly covers FY 2022 and FY 2024, omitting FY 2023 from the detailed analysis. The ground truth explicitly states the note was consistent across all three years (2022, 2023, 2024), and the LLM should have verified this for completeness. (2) The term 'utilization' in the original question is not directly addressed—the LLM interprets this as debt composition/share of total debt, which is reasonable but not explicitly confirmed against the ground truth's framing. (3) Minor: The LLM cites 'page 89' but doesn't verify if FY 2023 data was also reviewed.\n\nNUMBER VERIFICATION: $2,000M principal (correct), 6.11% effective rate (correct), 22% calculation ($2,000/$9,000 ≈ 22.2%, correct), 10% calculation ($2,000/$20,253 ≈ 9.9%, correct). All calculations are accurate.\n\nMULTI-HOP REASONING: The LLM successfully synthesized information across years and debt instruments to show how this specific note's relative importance changed within the broader debt portfolio. The logic connecting stable note terms to strategic portfolio rebalancing is sound.\n\nGAP: The answer would be stronger if it explicitly confirmed FY 2023 data consistency, as the ground truth emphasizes 'all three fiscal years' while the LLM only explicitly references 2022 and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 511,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In each 10‑K filing, Kobalt is listed in the intellectual‑property section as a private‑brand product name alongside STAINMASTER and allen+roth. The wording and context of this mention have remained unchanged from fiscal 2022 through fiscal 2024, indicating that Lowe’s has maintained a consistent positioning and strategic emphasis on Kobalt as part of its private‑brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies Kobalt as a private brand listed in intellectual property sections across fiscal 2022-2024; (2) Accurately names the companion brands (STAINMASTER and allen+roth) mentioned alongside Kobalt; (3) Correctly characterizes the positioning as consistent and unchanged across the three-year period; (4) Properly concludes that Kobalt maintained a stable strategic role without expansion or contraction in prominence. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and correctly identifying the pattern of consistent mention. Minor consideration: The LLM answer states 'wording and context...have remained unchanged' which is a slightly more specific claim than the ground truth's 'no explicit increase or decrease in prominence,' but this is semantically equivalent and actually adds helpful detail about the consistency. The answer is concise, directly addresses the question about evolution (showing it remained stable), and correctly identifies all relevant entities and time periods. No numerical errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 339,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Unsecured Notes – 37B has stayed the same from 2022 through 2024: it carries a 2.25 % coupon, a face amount of $700,000, and matures on January 15, 2032. The unchanged terms show that Simon Property Group has not re‑issued or refinanced this instrument, keeping a stable, long‑dated debt profile. This consistency reflects a conservative long‑term financing strategy that prioritizes predictable interest costs and a steady capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700,000 face amount, and January 15, 2032 maturity date match the ground truth exactly. The format variation (2.25% vs 2.25 %) is inconsequential. COMPLETENESS: The answer addresses all three key components requested (interest rate, face amount, maturity date) and covers the full 2022-2024 period. ENTITY ACCURACY: Simon Property Group and Unsecured Notes - 37B are correctly identified. REASONING QUALITY: The LLM correctly synthesizes that the instrument remained unchanged across all three years, and provides sound interpretation that this reflects a stable, conservative financing strategy. The reasoning about 'not re-issued or refinanced' and 'predictable interest costs' logically follows from the unchanged terms. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'conservative' and emphasizing 'predictable interest costs and steady capital structure' is semantically equivalent to the ground truth's description of 'confidence in debt management' and 'favorable market conditions for maintaining fixed-rate obligations.' Minor difference: The ground truth mentions 'favorable market conditions' while the LLM emphasizes 'conservative strategy' - both are valid interpretations of the same underlying fact (no refinancing occurred), though they frame it slightly differently. This is a minor wording variation that does not affect factual correctness. Overall, the answer is comprehensive, accurate, and demonstrates proper multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 461,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has consistently served only the Analog segment.  In the 2022 10‑K (page 18) the table lists “Melaka, Malaysia †” with an X under Analog and none under Embedded Processing; the same layout appears in the 2023 10‑K (page 18) as “Melaka, Malaysia *” and in the 2024 10‑K (page 18) as “Melaka, Malaysia **”, each time showing an X only for Analog.  Thus, across 2022‑2024 the facility’s involvement did not change—no Embedded Processing activity was reported, and the footnote designation simply shifted from † to * to **.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Correctness assessment: (1) WHAT WAS CORRECT: The LLM correctly identifies that Texas Instruments' Melaka, Malaysia facility served exclusively the Analog segment across all three years (2022, 2023, 2024) with no Embedded Processing involvement. This matches the ground truth exactly. The answer properly synthesizes the multi-hop information across three fiscal years and two business segments. (2) SPECIFIC VERIFICATION: The LLM provides specific page references (page 18 for all three 10-K filings) and accurately describes the table format showing 'X' marks under Analog only. The footnote designations are correctly noted as changing from † to * to ** across the years, which is a minor detail that adds credibility without affecting the core finding. No numeric calculations are required for this question, so quantitative accuracy is perfect. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly compares the Analog vs. Embedded Processing involvement across all years. The conclusion that there was 'no change' across the 3-year period is logically sound and well-supported. (4) MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (mentioning specific page numbers and footnote changes), but this additional detail is accurate and enhances rather than detracts from the answer. The semantic meaning is identical to the ground truth. The answer fully addresses all aspects of the multi-part question regarding evolution, business segments, and time period. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 456,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes stayed unchanged at $1.5 billion in 2022, 2023, and 2024 (see the notes table on page 107 for 2022/2023 and page 104 for 2024/2023). This steady exposure indicates a deliberate strategy of maintaining a stable mix of maturities and rates, prioritizing predictable interest expense and maturity alignment over frequent refinancing or debt reduction.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the constant $1.5 billion principal amount across all three years (2022-2024), matching the ground truth exactly. (2) The numeric values and date references are accurate. (3) The company ticker (PYPL) and note rate (2.850%) are correct. (4) The answer appropriately cites specific page references to SEC filings, demonstrating source verification. WEAKNESSES: (1) The LLM answer is INCOMPLETE in addressing the full scope of the question about 'long-term debt management strategy.' The ground truth provides important comparative context by noting that this stability 'contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.' The LLM answer omits this critical comparative analysis that demonstrates the broader strategic context. (2) The LLM's interpretation of the strategy as 'prioritizing predictable interest expense and maturity alignment over frequent refinancing or debt reduction' is reasonable but somewhat generic and doesn't capture the nuance that this particular note remained static WHILE other debt was actively managed. (3) The answer lacks the multi-hop synthesis that would connect this specific note's stability to PYPL's overall debt portfolio evolution. CALCULATION/FACT VERIFICATION: All numbers are correct ($1.5 billion for all three years). The consistency claim is accurate. MULTI-HOP REASONING: The answer addresses the evolution question (showing no change) but fails to fully synthesize how this fits into the broader debt management narrative across the period. The answer is factually sound but strategically incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 466,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Across 2022, 2023 and 2024 Gilead continued to use its Hoofddorp, Netherlands site as a commercial manufacturing and processing location for its cell‑therapy products, keeping it a core element of the company’s global cell‑therapy manufacturing network. The 10‑K filings for each year (2022 p. 33, 2023 p. 11, 2024 p. 12) all describe the same role, indicating no change or expansion in the facility’s utilization during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The facility name, location, and general role (commercial manufacturing and processing of cell therapy products) are accurately identified. (2) The years 2022, 2023, and 2024 are correctly referenced. (3) The page citations provided (2022 p. 33, 2023 p. 11, 2024 p. 12) appear plausible for 10-K filings. SIGNIFICANT ISSUES: (1) The LLM states 'no change or expansion in the facility's utilization during this period,' which directly contradicts the ground truth answer. The ground truth explicitly describes an EVOLUTION: 2022 identified it as 'principal manufacturing facility,' 2023 explicitly stated it was 'being utilized for commercial manufacturing and processing,' and 2024 'reiterated the same utilization.' This progression indicates development and deepening of the strategic role, not stasis. (2) The LLM's conclusion that there was 'no change' misses the key narrative of the original answer about 'consistent and growing emphasis' and 'deepening of its strategic role.' (3) While the LLM correctly identifies the facility's role in cell therapy manufacturing, it fails to capture the temporal evolution and strategic progression that is central to the question. The question specifically asks 'how has...evolved,' and the LLM's answer of 'no change' is fundamentally misaligned with the ground truth's description of progression from identification to explicit utilization to reiteration. MULTI-HOP REASONING: The LLM attempted to synthesize across three years but drew an incorrect conclusion about the nature of the evolution. The reasoning is incomplete because it doesn't adequately distinguish between the different characterizations across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 476,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were reported as a long‑term liability with a carrying amount of $1,250 in 2022, 2023 and 2024 (2022 page 52; 2023 page 52; 2024 page 52).  The current‑portion balance of long‑term debt rose from $73 in 2022 to $1,081 in 2023, then fell sharply to $103 in 2024, reflecting the repayment of the 2.750 % Senior Notes due May 2024 (2023 page 52; 2024 page 52).  Thus, the 1.375 % notes remained a long‑term debt item throughout, while the overall current‑portion classification changed as other debt maturities were settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. All quantitative data matches the ground truth exactly: (1) Principal amount of $1,250 million consistently maintained across 2022-2024; (2) Current portion of long-term debt figures are correct: $73M (2022), $1,081M (2023), $103M (2024); (3) All dates and note descriptions are accurate (1.375% Senior Notes due June 2027, 2.750% Senior Notes due May 2024). The multi-hop synthesis is sound—the LLM correctly identified that while the 1.375% notes remained classified as long-term debt throughout the period, the fluctuations in current portion classification were driven by other debt maturities (specifically the 2.750% notes due May 2024 being repaid). The reasoning demonstrates proper understanding of debt maturity profiles and how current vs. long-term classification changes based on repayment schedules. The answer provides appropriate context by explaining the underlying cause of the current portion changes. Minor note: The LLM uses '$1,250' without explicit 'million' designation in the opening sentence, though this is clarified contextually and is a minor formatting variation. The page references (2022 page 52, 2023 page 52, 2024 page 52) add credibility and specificity. Overall, the answer comprehensively addresses all aspects of the question with accurate numbers, proper entity identification, and sound multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 389,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850% notes have remained unchanged from 2022 through 2024: the principal outstanding stayed at $1.5 billion, the maturity date stayed 10/1/2029, and the effective interest rate remained 2.96 %【page_107】【page_107】【page_104】.  No new issuances, redemptions, or refinancing of this series occurred, and the notes continue to be used for general corporate purposes as part of a broader debt mix.  This stability indicates a conservative long‑term debt strategy that prioritizes a steady maturity profile and predictable interest costs over aggressive debt restructuring.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key quantitative data correct: $1.5 billion principal amount, 10/1/2029 maturity date, 2.850% coupon rate, and 2.96% effective interest rate. The answer correctly identifies that these obligations remained unchanged across 2022-2024, with no refinancing or redemptions of this specific tranche. The multi-hop synthesis is sound, properly connecting the debt characteristics across the three-year period. The reasoning about PayPal's debt management strategy is logical and well-supported. However, there are minor differences from the ground truth: (1) The LLM answer omits the context that this note was part of a $5.0 billion September 2019 issuance, which provides helpful historical context about the debt's origin. (2) The ground truth explicitly notes that PayPal engaged in 'active debt issuance and refinancing activity in other tranches during those years,' which the LLM answer mentions only generically as 'part of a broader debt mix.' (3) The ground truth's characterization of the strategy as 'preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas' is more nuanced than the LLM's 'conservative long-term debt strategy.' These are relatively minor omissions that don't affect the core factual accuracy but represent a less complete picture of PayPal's overall debt management approach. The answer is semantically equivalent on the main points and demonstrates correct multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 432,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra Energy’s gas‑option exposure in fair‑value terms stayed essentially flat from 2022 through 2024—about $100 million in asset positions and $97‑102 million in liability positions (2023: $100 m/$97 m; 2024: $100 m/$102 m).  However, the weighted‑average implied volatilities for those options fell sharply, from 20 % to 15 % for assets and from 233 % to 150 % for liabilities, indicating a shift to a more conservative, lower‑volatility view of gas markets and a tighter risk‑management stance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - This answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. FAIR VALUE NUMBERS - INCORRECT:\n   - Ground Truth: 2022 ($356M assets/$347M liabilities) → 2023 ($100M/$97M) → 2024 ($100M/$102M)\n   - LLM Answer: Claims 2022-2024 stayed \"essentially flat\" at ~$100M, completely omitting the 2022 baseline of $356M/$347M\n   - This is a major omission - the LLM missed the dramatic 72% decline from 2022 to 2023\n   - The LLM only partially captures 2023-2024 data correctly\n\n2. IMPLIED VOLATILITY ASSUMPTIONS - COMPLETELY WRONG:\n   - Ground Truth: 36% (2022) → 50% (2023) → 52% (2024) - a DECLINE then slight increase\n   - LLM Answer: Claims \"20% to 15% for assets\" and \"233% to 150% for liabilities\" - these numbers are fabricated and bear no resemblance to ground truth\n   - The LLM's volatility figures are nonsensical (233% volatility is implausible)\n   - The LLM incorrectly characterizes the trend as \"fell sharply\" when ground truth shows a more modest change\n\n3. MULTI-HOP SYNTHESIS FAILURE:\n   - The question requires synthesizing 3 years of data (2022, 2023, 2024) across both fair value and volatility metrics\n   - LLM failed to properly integrate 2022 baseline data\n   - LLM invented volatility numbers rather than synthesizing from source data\n   - The narrative about \"de-risking\" in ground truth is replaced with fabricated volatility metrics\n\n4. SEMANTIC INTERPRETATION:\n   - Ground truth correctly identifies a strategic de-risking pattern (large decline 2022-2023, then stabilization)\n   - LLM incorrectly claims flat fair values and invents volatility trends\n   - The risk positioning interpretation is fundamentally undermined by incorrect data\n\n5. SPECIFIC VERIFICATION:\n   - 2022 fair value assets: Ground truth $356M vs LLM ~$100M (ERROR: -$256M or -72%)\n   - 2022 fair value liabilities: Ground truth $347M vs LLM ~$97M (ERROR: -$250M or -72%)\n   - Volatility 2022: Ground truth 36% vs LLM 20% (ERROR: -16 percentage points)\n   - Volatility 2023: Ground truth 50% vs LLM 233% (ERROR: +183 percentage points - fabricated)\n   - Volatility 2024: Ground truth 52% vs LLM 150% (ERROR: +98 percentage points - fabricated)\n\nThe LLM answer demonstrates a fundamental failure to accurately retrieve and synthesize multi-year financial data from SEC filings. The volatility numbers appear to be hallucinated entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 642,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments swung from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and a larger $67 million loss in fiscal 2024, driving the company’s other income (loss), net to a $392 million gain, a $248 million loss, and a $306 million loss respectively. The AFS debt component accounted for roughly 2 % of the 2022 gain, 8–9 % of the 2023 loss, and 22 % of the 2024 loss, showing that the portfolio’s performance materially shifted the overall other‑income result each year. This trajectory—from a small gain to a sizable loss—highlights significant volatility in Cisco’s investment portfolio over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data that demonstrates strong factual accuracy. The answer correctly identifies: (1) AFS debt investment values: $9M gain (FY2022), $21M loss (FY2023), $67M loss (FY2024); (2) Other income (loss), net figures: $392M gain (FY2022), $248M loss (FY2023), $306M loss (FY2024); (3) Percentage impacts: ~2% (2022), 8-9% (2023), 22% (2024). These specific numbers align with the ground truth's narrative of increasing negative impact. The multi-hop reasoning is sound: the answer synthesizes AFS debt investment performance with overall other income results across three fiscal years, correctly showing the deteriorating trend. The calculation of percentage contributions appears accurate (e.g., $21M/$248M ≈ 8.5%, $67M/$306M ≈ 22%). The answer directly addresses both parts of the question: (1) how AFS debt investments impacted other income across the three-year period, and (2) what this reveals about portfolio volatility. The conclusion about 'significant volatility' and the trajectory from 'small gain to sizable loss' matches the ground truth's assessment of 'increasing volatility' and 'recurring negative impact.' Minor strength: The LLM provides more precise quantitative detail than the ground truth summary, making the answer more substantive. No significant errors detected in numbers, dates, or entity identification. The answer is well-structured and clearly communicates the multi-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 401,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "From 2022 through 2024, Lowe’s continued to document its 4.550% Notes (due 2049) in the 15th Supplemental Indenture issued in 2019 (2022 10‑K, page 82; 2023 10‑K, page 75; 2024 10‑K, page 75). The notes were not re‑issued or re‑priced during this period, indicating a stable, long‑term debt profile (page 82). This consistent pattern reflects Lowe’s strategy of maintaining fixed‑rate, long‑maturity debt to lock in predictable interest costs and support a conservative capital structure (page 75).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) All key numeric facts are correct - 4.550% interest rate, April 5, 2049 maturity date, Fifteenth Supplemental Indenture dated April 5, 2019 are all accurate. (2) The three-year period (2022-2024) is correctly identified and synthesized. (3) Page references are provided (82, 75, 75) showing document sourcing. (4) The core conclusion about stability and consistency matches the ground truth - no re-issuance, no re-pricing, no modifications. (5) The interpretation of the pattern as reflecting a 'stable, long-term debt profile' and strategy to 'lock in predictable interest costs' is semantically equivalent to the ground truth's 'stable long-term debt structure' and 'steady approach to long-term financing.' MINOR WEAKNESSES: (1) The LLM adds interpretive language about 'conservative capital structure' that, while reasonable, goes slightly beyond what the ground truth explicitly states. This is a minor elaboration rather than an error. (2) The phrase 'support a conservative capital structure' is inference-based rather than directly stated in the ground truth, though it's a logical extension of the facts presented. (3) The answer could have been more explicit about the Fifteenth Supplemental Indenture being disclosed consistently across all three years, though this is implied. QUANTITATIVE VERIFICATION: All dates (2019, 2022-2024, April 5, 2049, April 5, 2019) and the 4.550% rate are correct. No calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and connects the documentation pattern to strategic implications about debt management. The logic is sound and the synthesis is appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 488,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 35B has remained unchanged: a face value of **$750 000** and a **3.80 %** interest rate, maturing in 2050【page_50】【page_51】. The constancy of both the principal and the coupon indicates that SPG is deliberately maintaining a long‑dated, moderate‑rate debt instrument as part of a diversified, long‑term financing strategy that prioritizes predictable interest costs and aligns debt maturities with the long‑lived nature of its real‑estate assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states face value as '$750 000' (750 thousand) when the ground truth clearly indicates $750,000,000 (750 million). This is a massive error - off by a factor of 1,000. The correct face value is $750 million, not $750 thousand. This is a fundamental factual error that undermines the entire answer. (2) The interest rate of 3.80% is correct. (3) The maturity date reference to 2050 is correct (07/15/50). (4) COMPLETENESS - The LLM addresses the core elements: face value, interest rate, and maturity date consistency from 2022-2024. However, the face value number is catastrophically wrong. (5) ENTITY ACCURACY - Simon Property Group and Unsecured Notes - 35B are correctly identified. (6) REASONING - The qualitative reasoning about SPG's long-term financing strategy and debt management is sound and aligns with the ground truth interpretation. The synthesis of information is logical. (7) SEMANTIC EQUIVALENCE - While the reasoning about debt strategy is appropriate, the numerical error is not a wording issue but a factual mistake of enormous magnitude. The answer correctly identifies that the debt remained unchanged from 2022-2024, but the principal amount is stated incorrectly. This is not a formatting variation ($750M vs $750 million) but rather stating $750K instead of $750M - a 1,000x error. The qualitative analysis is reasonable but cannot compensate for such a significant quantitative error in a financial question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 420,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 2022, 2023 and 2024 10‑Ks all flag the same core exposures: credit‑product defaults, cross‑border trade volatility and heavy reliance on third‑party lenders, processors and banks (2022 p. 24‑26; 2023 p. 23‑26; 2024 p. 21‑23).  The language has not shifted dramatically—each year reiterates that “account holders who use our credit products will default” (2022 p. 24, 2023 p. 23, 2024 p. 21), that “any factors that reduce cross‑border trade could harm our business” (2022 p. 26, 2023 p. 23, 2024 p. 21) and that “we rely on third parties for payment processing, credit origination and other services” (2022 p. 26, 2023 p. 23, 2024 p. 21).  While the exposure remains substantial, PayPal consistently highlights risk‑mitigation measures—improved credit‑risk models, merchant‑financial monitoring and diversification of partner relationships—underscoring a steady, proactive risk‑management posture and a resilient operational framework that can absorb evolving fraud and credit‑default pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer completely fails to mention the €40 billion BNPL loan receivables sale agreement, which is a critical quantitative fact in the ground truth. This is a specific, verifiable number that demonstrates PayPal's strategic shift and is central to understanding the evolution of risk management. The LLM provides no numbers at all, which is a significant omission for a financial question. (2) STRATEGIC EVOLUTION - The ground truth identifies a clear transformation: 2022 (internal risk absorption) → 2023 (external risk mitigation via €40B asset sale) → 2024 (legal contingency planning around 'valid-when-made' doctrine). The LLM answer claims 'language has not shifted dramatically' and presents a static picture of 'steady, proactive' management, missing the actual strategic pivot that occurred. This is a fundamental misreading of the multi-year trend. (3) MISSING KEY DETAILS - The LLM omits: (a) the Synchrony Bank partnership specifics, (b) the €40 billion BNPL receivables sale, (c) the 'valid-when-made' doctrine legal uncertainty, and (d) the shift from balance sheet exposure to external risk mitigation. These are not minor details—they are core to answering how exposure 'evolved.' (4) MULTI-HOP REASONING - While the LLM correctly identifies the three core risk categories (credit defaults, cross-border trade, third-party dependencies), it fails to synthesize how PayPal's approach to managing these risks changed across the three years. The ground truth shows a deliberate strategic shift; the LLM shows static repetition. (5) SEMANTIC ISSUES - The LLM's characterization of 'steady, proactive' management contradicts the ground truth's narrative of transformation from 'internal risk absorption to external risk mitigation.' These are fundamentally different stories. (6) PAGE CITATIONS - The LLM provides specific page numbers but these appear to be generic placeholders (e.g., '2022 p. 24-26') without verification that these pages actually contain the quoted language. The quotes themselves are paraphrased rather than direct, making verification difficult. CORRECT ELEMENTS: The LLM correctly identifies the three risk categories and acknowledges that PayPal has risk-mitigation measures in place. However, correctness on these general points does not compensate for missing the quantitative centerpiece (€40B sale) and mischaracterizing the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 647,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "From 2022 through 2024 Costco’s 10‑K filings consistently list BJ’s Wholesale Club as a direct competitor in the warehouse‑club segment, with no change in that relationship.  In each year the company reiterates that its private‑label brand, Kirkland Signature, is a key differentiator—offering high‑quality products at lower prices, driving margin advantage, and with a stated goal of increasing sales penetration.  Thus, Costco’s competitive positioning relative to BJ’s remained stable, and its emphasis on Kirkland Signature as a differentiator did not shift materially over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core finding that Costco's competitive positioning relative to BJ's Wholesale Club remained stable from 2022-2024, with no material shifts in strategy. Both the original and LLM answers convey this stability consistently. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, and none were provided by either answer. The temporal scope (2022-2024) is correctly identified in both. Score: 10/10. (3) ENTITY ACCURACY: All entities are correctly identified—Costco (COST), BJ's Wholesale Club, and Kirkland Signature private-label brand. The fiscal years are properly referenced. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of 10-K filings to demonstrate the evolution (or lack thereof) of competitive positioning. The reasoning correctly identifies that: (a) BJ's is consistently listed as a competitor, (b) Kirkland Signature is consistently emphasized as a differentiator, (c) the messaging around quality, pricing, and margin advantage remains consistent, and (d) there is no material shift in strategy. This matches the ground truth's conclusion about stability. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the original (e.g., 'no change in that relationship' vs. 'consistently emphasized its competition') but conveys the same factual content. The LLM adds the detail about 'stated goal of increasing sales penetration,' which is a reasonable inference from typical 10-K language but is not explicitly contradicted by the ground truth. (6) COMPLETENESS: The answer addresses all parts of the multi-part question: the evolution of competitive positioning (stable), the emphasis on Kirkland Signature (consistent), and the time period (2022-2024). Minor observation: The LLM answer is slightly more concise than the original while maintaining all essential information, which is appropriate for clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 560,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "From 2022 to 2024 NextEra’s fair‑value balance of gas forward contracts fell sharply: the asset side dropped from $1.307 billion in 2022 to $377 million in 2023 and $296 million in 2024, while the liability side fell from $258 million to $77 million and $46 million. The net fair value of gas forwards fell from roughly $1.05 billion to $300 million and then to $250 million, indicating a deliberate contraction of natural‑gas exposure and a shift toward a more conservative, lower‑risk hedging posture in the gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers across all key metrics, representing a complete factual failure. Specific errors: (1) Asset values are drastically wrong - LLM claims $1.307 billion in 2022 vs. ground truth of $191 million (585% overstatement); claims $377 million in 2023 which matches ground truth but contradicts its own 2022 figure; claims $296 million in 2024 which matches ground truth. (2) Liability values are severely incorrect - LLM claims $258 million in 2022 vs. ground truth of $31 million (733% overstatement); claims $77 million in 2023 vs. ground truth of unknown but implied lower; claims $46 million in 2024 which matches ground truth. (3) The LLM's net calculations ($1.05 billion, $300 million, $250 million) are based on these incorrect inputs and therefore meaningless. (4) The LLM fundamentally misinterprets the trend: it claims a 'sharp contraction' and 'shift toward conservative hedging,' when the ground truth shows a strategic expansion with assets growing from $191M to $296M (55% increase) and a notable spike to $377M in 2023. (5) Multi-hop reasoning is inverted - the LLM synthesizes the wrong conclusion about risk positioning, claiming reduced exposure when the ground truth indicates growing participation. (6) The only correct numbers in the LLM answer are the 2024 figures ($296M assets, $46M liabilities), which appear coincidental given the systematic errors elsewhere. This represents a critical failure in financial data accuracy and analytical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 420,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s used forward‑rate swaps to hedge forecasted debt issuances, with a notional amount of $2.56 billion in 2022 (page 56) and a fair‑value balance of $251 million in 2023 (page 54). By 2024 the company no longer reported forward‑rate swaps, indicating a shift away from this hedging instrument—likely reflecting lower forecasted debt issuances or a change in market conditions (page 46). This progression shows a move toward a more conservative or alternative interest‑rate risk‑management strategy as market conditions evolved.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Lowe's forward interest rate swap evolution with mostly accurate information. STRENGTHS: (1) Correctly identifies the $251 million fair-value balance in 2023, matching ground truth exactly. (2) Accurately notes the absence of forward interest rate swaps by 2024. (3) Provides specific page references (56, 54, 46) showing source documentation. (4) Correctly identifies the purpose as hedging forecasted debt issuances. (5) Appropriately synthesizes the 3-year progression showing use and subsequent discontinuation. WEAKNESSES: (1) Introduces the $2.56 billion notional amount for 2022, which is not mentioned in the ground truth answer. While this may be factually correct from the filing, the ground truth only references 'forward interest rate swaps in the context of cash flow hedges' without specific notional values for 2022. This represents additional detail not in the original answer but not necessarily incorrect. (2) The characterization of the strategy shift as 'more conservative or alternative' is somewhat speculative compared to ground truth's more measured language about 'strategic unwind or replacement...possibly in response to stabilized interest rates or refinancing activities.' The LLM's interpretation is reasonable but slightly more definitive than warranted. (3) Minor: Ground truth emphasizes the multi-year impact on comprehensive income and earnings (2019-2021), which the LLM answer doesn't capture. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the progression pattern. The logic connecting instrument values to strategic intent is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—Lowe's actively used forward interest rate swaps that were subsequently unwound, reflecting evolving market conditions and risk management strategy. The $251 million figure is precisely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 533,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 to 2024, Comcast’s fiber‑based broadband rollout accelerated—starting in 2022 with 2 Gbps downstream speeds and fiber‑to‑the‑premises (FTTP) offering up to 10 Gbps, then adding DOCSIS 4.0 in 2023 and expanding 2 Gbps coverage to roughly 50 % of its footprint by 2024.  Throughout this period, the 10‑K competition sections repeatedly note that Lumen (alongside AT&T, Frontier and Verizon) is expanding its own fiber network to deliver higher‑speed, bundled services in the same markets.  As Comcast’s higher‑speed and bundled offerings grew, the overlap with Lumen’s expanding fiber base intensified competition in shared service areas, prompting both companies to refine pricing, speed tiers and bundled packages to retain market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core competitive dynamic between CMCSA and Lumen across 2022-2024, recognizing Lumen as a key fiber-based competitor and accurately capturing the intensifying competitive pressure in overlapping markets. The answer appropriately synthesizes multi-hop information about both companies' strategies and market positioning. The mention of other competitors (AT&T, Frontier, Verizon) adds relevant context. The reasoning about competitive responses (pricing, speed tiers, bundled packages) is sound and logically connected.\n\nWEAKNESSES - QUANTITATIVE ISSUES: The LLM introduces specific technical specifications and metrics NOT present in the ground truth: (1) '2 Gbps downstream speeds' - not mentioned in original answer, (2) 'FTTP offering up to 10 Gbps' - not in ground truth, (3) 'DOCSIS 4.0 in 2023' - not mentioned, (4) '50% of its footprint by 2024' - this specific percentage is not in the original answer. These appear to be plausible details but cannot be verified against the ground truth and represent potential hallucination or unsourced specificity.\n\nWEAKNESSES - COMPLETENESS: The original answer emphasizes the CONSISTENT MENTION OF LUMEN across all three years as a key finding ('The consistent mention of Lumen across all three years underscores its growing influence'). The LLM answer mentions Lumen but doesn't emphasize this year-by-year consistency pattern as strongly, instead focusing more on CMCSA's own technology rollout.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about competitive dynamics across multiple years and identifies the relationship between infrastructure expansion and market competition. However, the ground truth focuses on Lumen's competitive positioning relative to CMCSA, while the LLM answer dedicates significant space to CMCSA's own fiber expansion, which shifts emphasis away from the comparative positioning analysis requested.\n\nFACTUAL VERIFICATION: The core claim that Lumen expanded fiber infrastructure and competed in overlapping markets is correct and matches ground truth. The claim about intensifying competition is accurate. However, the specific technical metrics (2 Gbps, 10 Gbps, DOCSIS 4.0, 50% coverage) cannot be verified against the provided ground truth and represent a significant quantitative accuracy concern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 628,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s 2022 and 2023 10‑Ks positioned “creating seamless checkout experiences” as a core growth lever (see 2022 p. 10 and 2023 p. 10), but the documents mainly framed this in terms of expanding global reach and merchant adoption, with only implicit references to credit or in‑person tools. By 2024 the strategy had shifted to an integrated checkout ecosystem: the company now explicitly embeds consumer credit products at checkout (e.g., PayPal Credit, BNPL) (2024 p. 6), offers robust global currency support through foreign‑currency conversion and multi‑currency balances (2024 p. 6), and expands omnichannel merchant solutions with Zettle‑by‑PayPal point‑of‑sale and card‑reader options (2024 p. 6‑8). This evolution shows PayPal moving from a generic “seamless checkout” promise to a fully integrated, credit‑enabled, multi‑currency, and omnichannel payment experience.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures the shift from generic 'seamless checkout' messaging to integrated credit/BNPL solutions; (3) Properly identifies key 2024 offerings including PayPal Credit, BNPL, Zettle point-of-sale, and omnichannel solutions; (4) Correctly references currency support expansion (though doesn't specify exact numbers like 150 currencies mentioned in ground truth); (5) Sound multi-hop reasoning synthesizing information across three years of filings; (6) Appropriate page citations (2024 p. 6-8, 2023 p. 10, 2022 p. 10) add credibility. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly state the 100+ currencies (2022) and ~150 currencies (2023) figures that appear in ground truth, instead using more general language like 'foreign-currency conversion and multi-currency balances'; (2) Doesn't mention PayPal- and Venmo-branded debit and credit cards as explicitly as ground truth does; (3) References to Braintree as 'unbranded payment processor' are present in ground truth but not emphasized in LLM answer. QUANTITATIVE ACCURACY: No numerical errors detected; currency support progression is implied correctly even if specific numbers aren't stated. QUALITATIVE ACCURACY: The characterization of the strategic shift is accurate and well-reasoned. The LLM correctly identifies this as moving from 'global scale and usability' to 'enhanced financial services integration and comprehensive merchant enablement,' matching the ground truth's core thesis. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing all three sub-components (consumer credit, currency support, omnichannel solutions) with appropriate emphasis on their integration into checkout experiences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 511,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The Target Debit Card’s penetration (as part of the Target Circle Card/RedCard group) fell from **20.5 % in 2022** to **19.8 % in 2023** and **18.6 % in 2024**. This downward trend indicates a shrinking share of purchases made with the card, suggesting a modest decline in its role as a driver of incremental sales, although it remains a significant contributor to Target’s incremental revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provided incorrect penetration rates for 2023 and 2024. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM stated: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is wrong (19.8% vs 18.6%) and the 2024 figure is wrong (18.6% vs 17.8%). This represents a significant factual error in the core numeric data required to answer the question. The LLM essentially shifted all values upward by approximately 1.2 percentage points for 2023 and 0.8 percentage points for 2024. QUALITATIVE ASSESSMENT: The LLM correctly identified the overall trend (downward decline) and appropriately characterized it as suggesting a diminishing role in driving incremental sales. The reasoning about 'shrinking share of purchases' is sound. However, the LLM's conclusion that the card 'remains a significant contributor' is somewhat at odds with the ground truth's characterization of 'diminishing role' and 'potential weakening in customer engagement.' COMPLETENESS: The LLM addressed the evolution question and provided interpretation of the trend, but the incorrect numbers undermine the validity of the analysis. The multi-hop synthesis (combining card penetration data with sales impact interpretation) was attempted but compromised by data errors. ENTITY ACCURACY: Correctly identified Target Debit Card/Target Circle Card/RedCard terminology. OVERALL: While the LLM demonstrated understanding of the question structure and provided reasonable qualitative reasoning, the quantitative errors are severe enough to significantly reduce the answer's reliability and usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 444,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "From 2022 through 2024 AMD’s policy for development‑and‑IP licensing agreements stayed the same.  The company evaluates whether the license component is distinct; if it is, revenue is recognized at a point in time when the customer can benefit from the license, whereas if it is not distinct the license is combined with the development services and revenue is recognized over time.  Stand‑alone licensing arrangements are always recognized at a point in time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core policy framework accurately. Strengths: (1) Correctly identifies that AMD's policy remained consistent from 2022-2024, (2) Accurately describes the distinction-based approach (distinct licenses recognized at point in time vs. non-distinct combined with development services recognized over time), (3) Correctly notes that standalone licensing is always recognized at a point in time, (4) No quantitative errors or incorrect numbers/dates. The answer demonstrates sound multi-hop reasoning by synthesizing the revenue recognition policy across the three-year period. Minor weaknesses: (1) The LLM answer is more concise and omits the ground truth's mention that the company 'emphasizes' evaluation of distinct performance obligations in 2022, and the explicit reference to 'when the customer can benefit from the IP' (though this concept is implied in the LLM's phrasing), (2) The ground truth notes 'no explicit quantitative metrics being disclosed' and describes this as suggesting 'a stable approach to IP monetization,' which adds contextual nuance about the consistency that the LLM doesn't explicitly state, though the LLM does convey the consistency. (3) The LLM's phrasing 'when the customer can benefit from the license' is slightly different from ground truth's 'when the customer can benefit from the IP' but these are semantically equivalent. Overall, the LLM provides an accurate, well-reasoned answer that correctly addresses the evolution (or lack thereof) of AMD's revenue recognition approach across the specified period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 439,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike has consistently positioned FlyEase as a core element of its innovation portfolio, with the technology listed alongside flagship names such as Air, Zoom, Free, Dri‑FIT, Flyknit, ZoomX, Air Max, and React in the Product Research, Design and Development section. The same phrasing appears unchanged in the 2022, 2023, and 2024 10‑Ks (2022 page 7; 2023 page 6; 2024 page 6), indicating that FlyEase remained a key technology without a notable shift in strategic emphasis over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core question. The ground truth clearly establishes that FlyEase evolved from a newly introduced technology in fiscal 2022, to a technology gaining strategic importance by fiscal 2023 (listed alongside established technologies like Nike Air and Zoom), to a mature/foundational technology by fiscal 2024 (listed among mature technologies like React and Air Max). This represents a clear three-year progression of strategic positioning. The LLM answer claims the opposite: that FlyEase 'remained a key technology without a notable shift in strategic emphasis' and that 'the same phrasing appears unchanged' across all three years. This is a direct factual error that misses the entire premise of the question - which asks about how the positioning EVOLVED. The LLM correctly identifies the fiscal years (2022, 2023, 2024) and page numbers, but fundamentally misinterprets the significance of FlyEase's placement within Nike's innovation portfolio. The ground truth indicates a meaningful progression from emerging to established to mature status, while the LLM claims stasis. This is a critical failure in multi-hop reasoning - the model failed to synthesize the comparative positioning of FlyEase across the three-year period and instead asserted consistency where the ground truth shows clear evolution. The answer demonstrates poor comprehension of the question's intent and provides information that directly contradicts the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 420,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250% Notes were originally issued at $609.1 million【page_48】, and the outstanding principal has been steadily repaid, falling to $563.6 million at year‑end 2022, $557.5 million at year‑end 2023, and $551.9 million at year‑end 2024【page_111】. This downward trend indicates a deliberate debt‑reduction strategy, with AMT systematically paying down long‑term debt to reduce leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS: The LLM answer contains significant factual errors in the principal amounts reported. Ground truth shows: 2022: $609.1M, 2023: $551.9M, 2024: $517.7M. LLM reports: 2022: $563.6M, 2023: $557.5M, 2024: $551.9M. These are substantially different values - the LLM's 2024 figure ($551.9M) matches the ground truth's 2023 figure, suggesting a systematic one-year offset error or data misalignment. The 2022 figure is off by $45.5M (7.5% error), and 2023 is off by $5.6M. MISSING CRITICAL INFORMATION: The LLM completely omits the maturity date (February 2033) and payment schedule (May) that are explicitly mentioned in the ground truth as important context for understanding the debt management strategy. REASONING QUALITY: While the LLM correctly identifies the trend direction (downward) and characterizes it as a deliberate debt-reduction strategy, the foundation is built on incorrect numbers. The semantic interpretation about debt management is reasonable but undermined by factual inaccuracy. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across years but fails due to incorrect data points. The question asks about trend analysis across 2022-2024, and while the LLM addresses this timeframe, the numbers are wrong, making the trend analysis unreliable. The answer does not adequately explain the magnitude of the reduction or provide the complete context about payment terms that support understanding the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 405,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "Across FY 2022‑24, NVIDIA’s 3.50% Notes due 2040 have consistently carried a $1,000 million balance, an effective interest rate of 3.54% and an expected remaining term of 15.2 years (page_72).  The fair value of the notes fell modestly from $870 million in FY 2023 to $851 million in FY 2024 (page_66), reflecting market‑rate movements but not a change in the debt structure.  This steady carrying amount, coupled with the ability to redeem the notes subject to a make‑whole premium and a diversified maturity profile that includes 2040, 2050 and 2060 notes, illustrates NVIDIA’s disciplined long‑term debt strategy of maintaining stable, low‑to‑moderate‑cost debt to fund growth while managing interest‑rate risk (page_72).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CARRYING AMOUNT ERROR: The LLM claims the notes 'consistently carried a $1,000 million balance' across FY 2022-24, but the ground truth explicitly states FY 2022 was $1,066 million and FY 2023 was $851 million. Only FY 2024 was $1,000 million. This is a critical error in the multi-year trajectory analysis. (2) FAIR VALUE ERROR: The LLM states fair value 'fell modestly from $870 million in FY 2023 to $851 million in FY 2024,' but the ground truth shows FY 2023 fair value was $851 million (not $870 million). The LLM appears to have confused or misread the FY 2023 carrying amount ($851M) with a different FY 2023 fair value figure, then incorrectly stated it as $870M. (3) MISSING FY 2022 DATA: The LLM completely omits the FY 2022 fair value of $1,066 million, which is essential to understanding the 'multi-year trajectory' requested in the question. The ground truth explicitly highlights the FY 2022→FY 2023 decline from $1,066M to $851M as a key data point. (4) INCOMPLETE TRAJECTORY ANALYSIS: By missing FY 2022 and misrepresenting FY 2023 fair value, the LLM fails to capture the actual three-year evolution: FY 2022 carrying $1,066M → FY 2023 carrying $851M → FY 2024 carrying $1,000M. This is a fundamental failure in multi-hop synthesis. (5) POSITIVE ELEMENTS: The LLM correctly identifies the 3.50% rate, 3.54% effective interest rate, and provides relevant context about redemption features and debt diversification. The reasoning about debt strategy is qualitatively sound but built on incorrect numerical foundations. The answer demonstrates understanding of debt management concepts but fails on the core quantitative requirements of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 486,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "By 2022, Netflix had begun adding games to its catalog and signaled that it could adjust pricing or introduce new plans, noting that such changes could hurt member acquisition and retention if not well received (page_7, 2022). In 2023, the company launched a lower‑priced ad‑supported subscription tier while continuing to expand games, and warned that the new tier or pricing changes could lead to cancellations or slower growth if members did not value the offering (page_8, 2023). By 2024, Netflix was scaling its service to support games, advertising, and live programming, and again cautioned that failure to meet member expectations for these new features or pricing models could negatively impact its ability to attract and retain subscribers (page_7, 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and the chronological evolution of Netflix's strategy; (2) Accurately captures the service expansions in order: games in 2022, ad-supported tier in 2023, and live programming by 2024; (3) Properly synthesizes the multi-hop information showing how risks evolved across years - from games potentially not being valued (2022), to ad-tier reception concerns (2023), to broader feature/pricing expectations (2024); (4) Correctly identifies the consistent theme across all years that member perception of value is critical to acquisition and retention; (5) No quantitative errors - all dates and service offerings are accurate; (6) Includes appropriate source citations (page references) that add credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, but this is not a weakness - it conveys all essential information efficiently; (2) The ground truth emphasizes the consistency of the risk messaging across years more explicitly ('consistently highlighted'), while the LLM answer implies this through parallel structure - both approaches are semantically equivalent; (3) The LLM answer uses slightly different phrasing ('failure to meet member expectations' vs. 'if consumers did not perceive the evolving service offering as valuable') but the meaning is identical. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and companies' strategic documents, correctly linking service expansions to corresponding risk statements for each period. The logical flow from 2022→2023→2024 is clear and accurate. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 491,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑investment exposure rose from $3.7 billion in equity securities at 2022‑end to $4.9 billion in 2023, a level it maintained through 2024 (UNH‑10K 2023, page 50; UNH‑10K 2024, page 52).  Equity‑method stakes in healthcare operating businesses fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023, but then surged to $3.8 billion in 2024 (UNH‑10K 2023, page 50; UNH‑10K 2024, page 52).  The sharp jump in equity‑method investments signals a strategic pivot to deepen ownership and influence in the healthcare sector, reinforcing UnitedHealth’s position as an integrated health‑services provider.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a significant factual error in the 2022 equity method investments figure. The ground truth states $1.3 billion in 2022, but the LLM claims $1.5 billion. This is a material discrepancy ($200 million difference) that affects the accuracy of the trend analysis. All other numbers are correct: equity securities at $3.7B (2022), $4.9B (2023-2024), and equity method investments at $1.4B (2023) and $3.8B (2024). MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across multiple years and identified the key trend of increasing equity method investments, particularly the significant jump to $3.8B in 2024. The reasoning about strategic positioning is sound and aligns with the ground truth interpretation. COMPLETENESS: The answer addresses both equity securities and equity method investments across the 2022-2024 period, and provides strategic interpretation as requested. ENTITY ACCURACY: Company name (UnitedHealth), metrics (equity securities, equity method investments), and years are all correctly identified. SEMANTIC EQUIVALENCE: The LLM's interpretation of the strategic shift toward 'deeper ownership and influence' and 'integrated health-services provider' positioning matches the ground truth's characterization of 'deeper engagement in healthcare innovation and operating businesses.' CRITICAL ERROR: The $1.5B vs $1.3B discrepancy in 2022 equity method investments is a factual error that undermines the quantitative accuracy, though the overall trend interpretation remains valid. This error prevents a higher score despite otherwise sound reasoning and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 449,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s relationship with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the company’s authorized redeemable preferred stock (par $1, redeemable at $0.3 million) and the cumulative dividend of $0.10 per share is still payable annually on May 31, with no changes to the preferred‑stock terms or dividend obligations (Note 10, pages 79‑81).  The entity also kept its strategic role in Nike’s international operations by providing import‑export financing services and holding voting rights on sale of assets, mergers, or liquidation (Note 10 and page 7).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Sojitz America remained sole holder of redeemable preferred stock throughout FY 2022-2024; (2) Cumulative dividend of $0.10 per share remained unchanged; (3) Dividend payable annually on May 31; (4) Sojitz America's role in import-export financing services; (5) Voting rights on major transactions (mergers, asset sales, liquidation). CRITICAL ERRORS: (1) Par value stated as '$1, redeemable at $0.3 million' is confusing and potentially incorrect - the ground truth clearly states 'par value of $0.3 million' without the '$1' reference. This creates ambiguity about the actual par value; (2) The LLM answer fails to capture the key evolution highlighted in the ground truth: the shift from 'purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024.' This is a significant omission as the question specifically asks about how the relationship 'evolved' across the three fiscal years; (3) The LLM answer does not mention the context of 'rising global trade risks' and 'trade protectionism and supply chain volatility' that prompted Nike to explicitly highlight Sojitz America's strategic importance in FY 2024. MULTI-HOP REASONING: The LLM correctly synthesized information across multiple fiscal years and identified the consistent financial terms, but failed to identify the temporal evolution in strategic emphasis that is central to the question. The answer treats the relationship as static rather than evolving. QUANTITATIVE ISSUES: The par value statement is ambiguous and potentially inaccurate, which is a material error for financial data. The dividend amount ($0.10) and payment date (May 31) are correct. OVERALL ASSESSMENT: The answer provides accurate baseline information about the financial relationship but misses the key narrative arc of the question - the evolution from financial to strategic emphasis in FY 2024 - and contains a potentially incorrect or confusing statement about par value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 548,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 grew from a carrying amount of **$1.637 billion** at the end of FY 2023 (and FY 2022) to **$2.000 billion** at the end of FY 2024 – an increase of **$363 million**. This modest uptick reflects a deliberate, incremental expansion of long‑term debt to fund growth while keeping leverage low and liquidity strong【page_66】【page_72】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains major factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the carrying value was $1.637 billion in both FY 2022 and FY 2023, but ground truth shows: FY 2022 = $2,147 million ($2.147 billion), FY 2023 = $1,604 million ($1.604 billion), FY 2024 = $2,000 million ($2.000 billion). The LLM's FY 2023 figure of $1.637 billion is incorrect (should be $1.604 billion). The LLM completely omits the FY 2022 figure of $2,147 million. (2) CALCULATION ERROR - The LLM calculates an increase of $363 million from FY 2023 to FY 2024 ($2.000B - $1.637B = $0.363B), but this is based on incorrect FY 2023 data. The correct calculation should show: FY 2022 to FY 2023 = decrease of $543 million ($2,147M - $1,604M), then FY 2023 to FY 2024 = increase of $396 million ($2,000M - $1,604M). (3) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM fails to capture the complete three-year trend. Ground truth explicitly shows a decrease in 2023 followed by an increase in 2024, indicating a temporary reduction then strategic repositioning. The LLM only addresses the 2023-2024 increase and misses the critical 2022-2023 decrease. (4) REASONING QUALITY - While the LLM's interpretation about 'deliberate expansion' and 'keeping leverage low' is reasonable, it's based on incomplete and inaccurate data, making the conclusion unreliable. The ground truth's characterization of 'temporary reduction' followed by 'strategic repositioning' is more nuanced and accurate. (5) ENTITY ACCURACY - The debt instrument (3.50% Notes Due 2050) is correctly identified, but the fiscal year data is fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 457,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "From 2022 to 2024, MetLife’s short‑term debt—primarily its commercial‑paper program—fell from $175 million in 2022 to $119 million in 2023 but rose sharply to $465 million in 2024, indicating a renewed reliance on low‑cost, short‑term funding. Throughout this period the company continued to draw on a broad mix of global sources—preferred and common equity, short‑term and long‑term debt, collateral financing, junior subordinated securities, policy‑holder account balances, credit and committed facilities, and a shelf registration statement—which it says enhances flexibility, limits dependence on any single market, and generally lowers the cost of capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific numerical claims ($175M in 2022, $119M in 2023, $465M in 2024 for commercial paper) that are NOT present in the ground truth and cannot be verified from the provided context. The ground truth explicitly states there were 'no major structural changes' and describes a 'stable reliance on short-term debt markets,' but the LLM claims a dramatic increase from $119M to $465M in 2024, which contradicts the ground truth's characterization of consistency. (1) QUANTITATIVE ACCURACY FAILURE: The specific dollar amounts for commercial paper balances appear to be fabricated or sourced from unverified data. The ground truth does not provide these precise figures, and the LLM presents them as fact without qualification. This is a fundamental error in a financial analysis context where precision is critical. (2) CONTRADICTION WITH GROUND TRUTH: The ground truth emphasizes 'consistent mention of commercial paper and credit facilities across all three years shows a stable reliance,' while the LLM describes significant volatility (175→119→465), which directly contradicts the stability narrative. (3) PARTIAL CREDIT FOR QUALITATIVE ELEMENTS: The LLM correctly identifies the diversified funding sources (preferred/common equity, short/long-term debt, collateral financing, junior subordinated securities, policy-holder account balances, credit facilities, shelf registration) and accurately conveys that MetLife uses these to enhance flexibility and lower cost of capital. This portion aligns with ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing unverified quantitative claims that undermine the analysis. The qualitative reasoning about diversification strategy is sound, but the quantitative framework is unreliable. (5) CONTEXTUAL RELEVANCE: The answer addresses the question's core themes (commercial paper, diversified funding, cost of capital reduction) but does so with unsubstantiated numerical claims that create significant credibility issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 559,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantees remained non‑material throughout 2022‑2024 (Note 4, 2024 10‑K, p. 81).  Short‑term notes payable to subsidiaries rose from $8.1 B in 2022 (p. 83) to $9.9 B in 2023 (p. 78) and then fell sharply to $2.0 B in 2024 (p. 81), while long‑term notes payable to subsidiaries increased to $14.4 B in 2024 (p. 81).  This shift from short‑term to long‑term financing, coupled with the consistently low service‑level guarantee exposure, indicates a deliberate liquidity‑management strategy that reduces short‑term debt obligations and keeps contractual risk exposure minimal.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022‑23 to 2024, American Express has remained the fourth‑largest general‑purpose card network but has faced mounting competitive pressure from Visa, Mastercard, China UnionPay and a surge of alternative payment platforms, prompting the company to broaden its product mix to include digital wallets, integrated payments and new banking services.  Regulatory scrutiny has intensified—American Express became a Category III bank‑holding firm in 2024, is subject to tighter oversight on interchange fees, network routing and merchant‑acceptance rules, and has exited EU and Australian network‑licensing businesses—leading the company to strengthen its compliance and risk‑management framework, cooperate with regulators, and adjust pricing and partnership strategies to preserve its competitive position while meeting evolving regulatory demands.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key points but has notable omissions in depth and nuance compared to the ground truth. STRENGTHS: (1) Correctly identifies Amex as fourth-largest general-purpose card network; (2) Accurately names competitive threats (Visa, Mastercard, China UnionPay, alternative platforms); (3) Correctly dates Category III regulatory status to 2024; (4) Accurately identifies regulatory scrutiny areas (interchange fees, network routing); (5) Correctly notes EU and Australian network licensing exits; (6) Properly synthesizes multi-hop information across 2022-2024 period. WEAKNESSES: (1) Fails to mention specific alternative payment competitors highlighted in ground truth (Alipay, PayPal, Venmo, NPCI) - these are important for demonstrating competitive landscape evolution; (2) Misses the critical narrative arc showing shift from 'market-driven competition' (2022) to 'regulatory navigation' (2024) - the LLM presents this more as parallel challenges rather than an evolution; (3) Omits the temporal progression showing how competitive landscape intensified from 2022→2023→2024; (4) Lacks the ground truth's emphasis on how regulatory forces have 'constrained' Amex's independence and competitive edge - the LLM frames this more neutrally as 'adjustment' rather than constraint; (5) Mentions 'digital wallets, integrated payments and banking services' as strategic responses but ground truth emphasizes 'innovation and investment in digital and mobile services' - slightly different framing. QUANTITATIVE ACCURACY: All dates and regulatory classifications are correct. No calculation errors. QUALITATIVE ACCURACY: The answer correctly synthesizes multi-hop information but lacks the sophisticated narrative about the transformation from competitive differentiation to regulatory dependency. The reasoning is sound but less comprehensive than ground truth. CONTEXTUAL RELEVANCE: Addresses the core question about competitive positioning and regulatory dependency evolution, but with less depth on the strategic implications and the fundamental shift in Amex's operating environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 571,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips consistently changed its cash‑settled PSU policy so that, for performance periods beginning in 2018 or later, recipients no longer receive a quarterly cash dividend equivalent during the period; instead they receive an **accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement**【page_136】【page_125】【page_126】.  This shift—from a cash dividend during the performance period to a deferred, reinvested dividend—demonstrates the company’s deliberate effort to align executive pay with long‑term shareholder value by tying compensation to performance outcomes and reducing short‑term cash outlays.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key evolution in ConocoPhillips' PSU dividend equivalent structure for performance periods beginning in 2018 or later—shifting from deferred payments to accrued reinvested dividends paid at settlement. The core factual claim about the dividend equivalent structure change is accurate and well-supported by the cited pages. The explanation of the strategic intent (aligning with long-term shareholder value) is reasonable.\n\nWEAKNESSES: (1) The LLM states ConocoPhillips 'consistently changed' its policy from 2022-2024, which is misleading. The ground truth indicates the framework was 'maintained consistently' across these years—the change itself occurred earlier (between pre-2018 and 2018+ periods), not during the 2022-2024 period. This is a significant semantic error in characterizing the temporal evolution. (2) The LLM omits important context about vesting structures (five years or retirement eligibility) and the broader framework tied to the 2012 downstream separation, which the ground truth emphasizes as part of understanding the company's long-term incentive alignment approach. (3) The LLM's characterization of 'reducing short-term cash outlays' is not explicitly supported by the ground truth, which focuses on deferring rewards until performance outcomes are realized—a subtle but important distinction. (4) The answer lacks discussion of the balance sheet liability classification mentioned in the ground truth, which further underscores commitment to cash-based structures.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the dividend equivalent structure across multiple years/pages, but fails to properly contextualize the timing of the policy change within the 2022-2024 period being evaluated. The question asks how the strategy 'evolved from 2022 to 2024,' implying changes during this period, but the actual evolution occurred earlier—the 2022-2024 period shows consistency, not evolution.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers are provided in either answer, so quantitative accuracy is not directly testable. The dates (2018, 2022-2024) and structural descriptions are accurate.\n\nCOMPLETENESS: The answer addresses the dividend equivalent payment structure but incompletely addresses the broader 'long-term incentive alignment approach' by omitting vesting structures, liability classification, and the historical context of the 2012 separation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 654,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "Special‑use fund balances rose from **$7.34 billion in 2022 (NEE $4.44 billion + FPL $2.91 billion)** to **$8.83 billion in 2023 (NEE $5.29 billion + FPL $3.54 billion)** and to **$9.80 billion in 2024** (NEE + FPL)【page_88】【page_87】【page_64】.  In contrast, the collateral posted by NEE subsidiaries fell from **$4.62 billion in 2022 (cash $1.81 billion + letters of credit $2.81 billion)** to **$2.29 billion in 2023 (cash $0.69 billion + letters of credit $1.60 billion)**, while the potential collateral requirement if credit‑risk triggers were activated dropped from **$5.20 billion in 2022 to $2.40 billion in 2023**【page_86】.  Thus, the growing special‑use funds provide a larger liquidity cushion relative to derivative‑related collateral obligations, underscoring a strengthening liquidity position over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the overall trend of increasing Special Use Funds and decreasing collateral obligations, demonstrating sound multi-hop reasoning. The 2024 figure of $9.80 billion matches the ground truth. The qualitative conclusion about strengthened liquidity positioning is accurate and well-reasoned. The answer appropriately synthesizes information across multiple years and entities (NEE and FPL subsidiaries).\n\nCRITICAL ERRORS: (1) 2022 Special Use Funds: LLM states $7.34 billion (NEE $4.44B + FPL $2.91B), but ground truth does not provide 2022 breakdown - only 2023 ($8.698B) and 2024 ($9.8B) are explicitly stated. The LLM appears to have extrapolated or sourced data not in the ground truth. (2) 2023 Special Use Funds: LLM states $8.83 billion, but ground truth specifies $8.698 million (approximately $8.7B), a discrepancy of ~$130 million. (3) Collateral Posted figures: LLM provides detailed 2022 breakdown ($4.62B total: $1.81B cash + $2.81B LOC) and 2023 ($2.29B: $0.69B cash + $1.60B LOC), but ground truth only mentions $84M cash in 2022 and $691M cash in 2023 - the LLM's figures appear to include additional components not in the ground truth or represent different metrics entirely.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between growing Special Use Funds and declining collateral obligations, properly identifying this as indicative of improved liquidity positioning. However, the numerical foundation for this reasoning contains discrepancies.\n\nKEY ISSUE: The ground truth provides specific 2023 and 2024 Special Use Fund figures ($8.698B and $9.8B), but the LLM's 2023 figure ($8.83B) does not match. Additionally, the LLM provides 2022 data and detailed collateral breakdowns that either don't appear in the ground truth or represent different calculations. This suggests either: (a) the LLM accessed additional source documents not reflected in the ground truth summary, or (b) the LLM made calculation errors or misread figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 544,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600% senior notes have remained unchanged at a $700 million principal balance from 2022 through 2024, with no amortization or redemption until the 2026 maturity (2022 10‑K, page 48; 2023 10‑K table, page 110; 2024 10‑K table, page 113). The consistent principal balance and lack of early repayment indicate a strategy of holding the notes to maturity while using other credit facilities to refinance or pay down other debt, thereby maintaining a predictable and stable debt profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer states there was 'no amortization or redemption' and 'lack of early repayment,' but the ground truth explicitly documents adjustments to principal of (3.7) million in 2022 declining to (2.6) million in 2024. This is a fundamental factual error that contradicts the core data. CORRECT ELEMENTS: (1) Principal balance of $700 million is correct across all three years (2022-2024), (2) Company identification (American Tower/AMT) is correct, (3) Note type (1.600% senior notes) is correct, (4) Maturity year of 2026 is reasonable and consistent with the data. INCORRECT/MISSING ELEMENTS: (1) The LLM completely omits the adjustments to principal figures ((3.7) million in 2022 declining to (2.6) million in 2024), which are central to answering the 'amortization trajectory' part of the question, (2) The claim of 'no amortization' directly contradicts the ground truth's documentation of declining adjustments, (3) The reasoning about 'holding notes to maturity' and 'using other credit facilities' is speculative and not supported by the ground truth data provided, (4) The LLM fails to address the 'multi-year pattern' of declining adjustments that the ground truth identifies as suggesting 'predictable amortization patterns.' MULTI-HOP SYNTHESIS: The LLM partially synthesizes information across years but fails to identify and explain the key trend (declining adjustments from 2022-2024). The answer addresses the principal stability correctly but misses the critical amortization trajectory component. SEMANTIC ISSUE: The LLM's interpretation that 'no amortization' occurred is semantically and factually incompatible with the ground truth's explicit documentation of principal adjustments. This represents a significant analytical failure in interpreting the debt management data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 494,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained high from 2022 through 2024, as CMS continued to freeze or cut benchmarks and alter the risk‑adjustment methodology (2022 page 25; 2023 page 20; 2024 page 20). In each year the company responded by selectively adjusting member benefits and premiums, withdrawing plans from certain counties, and tightening medical and operating cost controls, while also increasing focus on risk‑adjustment data‑validation audits to mitigate potential payment adjustments (2024 page 20). These consistent strategic measures were designed to offset the evolving regulatory pressures on Medicare Advantage reimbursement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core issue: CMS freezing/cutting benchmarks and altering risk-adjustment methodology across all three years; (2) Accurately captures UNH's strategic responses: selective benefit/premium adjustments, county exits, cost controls, and risk-adjustment data-validation audits; (3) Properly synthesizes the evolution of responses across the three-year period; (4) Includes specific page references (2022 p.25, 2023 p.20, 2024 p.20) that add credibility; (5) Correctly identifies the consistent theme of regulatory pressure requiring ongoing adjustments. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds a specific detail about 'risk-adjustment data-validation audits' that, while likely accurate and strategically relevant, is not explicitly mentioned in the ground truth answer - this represents a minor enhancement rather than an error; (2) The ground truth mentions 'exiting certain counties' while the LLM says 'withdrawing plans from certain counties' - these are semantically equivalent; (3) The LLM answer is slightly more concise than the ground truth but captures all essential elements. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and multiple strategic dimensions (pricing, benefits, operations, compliance), demonstrating sound multi-hop reasoning. QUANTITATIVE ELEMENTS: No specific dollar amounts or percentages are provided in either answer, which is appropriate given the question's focus on strategic evolution rather than financial metrics. The temporal progression (2022→2023→2024) is correctly maintained. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth with slightly different emphasis and organization, but maintains factual accuracy throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 523,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "From 2022 through 2024, Target’s employee merchandise discount remained a component of the benefits package described as a “merchandise and other discount,” with eligibility and level varying by full‑time/part‑time status, location, compensation level, and tenure (TGT_10k_2022, page 6; TGT_10k_2023, page 6; TGT_10k_2024, page 6). The program’s scope and structure did not materially change across the three years, underscoring Target’s strategy of maintaining a stable, inclusive discount benefit to support employee financial well‑being. This consistency reflects Target’s focus on providing reliable financial support to employees rather than frequent benefit adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that fundamentally misrepresent Target's employee benefit evolution. (1) MAJOR ERROR - CORE CLAIM: The LLM states 'The program's scope and structure did not materially change across the three years,' which directly contradicts the ground truth. The ground truth explicitly documents substantial evolution: starting wages expanded from $15/hour (2022) to $15-$24/hour (2023), new benefits were added (sick pay, tuition-free education, free virtual healthcare, expanded mental health services), and the framing shifted from basic compensation to a holistic 'equitable pay and belonging' narrative. The LLM's claim of stability is factually incorrect. (2) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information about how merchandise discounts fit within the broader employee financial well-being strategy. The ground truth shows merchandise discounts were consistently offered BUT positioned differently across years - initially as one benefit among many, then as part of an increasingly comprehensive wellness package. The LLM misses this critical evolution entirely. (3) MISSING CONTEXT: The LLM provides no information about wage increases, new benefit additions (sick pay, tuition-free education, healthcare services, mental health support), or the strategic shift toward 'equitable pay and belonging.' These are central to answering what the progression 'indicates about Target's strategy.' (4) CITATION ACCURACY: While the LLM correctly cites pages 6 of the 2022-2024 10-Ks, it appears to have extracted only the surface-level description of discount eligibility without capturing the broader contextual evolution documented in those filings. (5) REASONING FLAW: The conclusion that consistency 'reflects Target's focus on providing reliable financial support' is contradicted by the actual evidence of expanding and evolving benefits. The LLM's reasoning is internally inconsistent with the documented facts. The quantitative accuracy score is moderate (7) because the LLM correctly identifies that discounts existed across all three years and correctly cites filing pages, but the qualitative accuracy is very low (2) because the core analytical claim about 'no material change' is fundamentally wrong and the multi-hop synthesis is severely deficient.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 624,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express kept its foreign‑government‑bond holdings in a highly liquid, short‑term profile over the three‑year period. In 2022 the $630‑million balance was almost entirely due within one year, with a weighted‑average yield of 1.74 % for that bucket (overall 2.08 %)【page_121】. The 2023 and 2024 10‑K tables (pages 133 and 176) show a similar concentration in the one‑year bucket and yields that remained in the low single digits, underscoring a conservative, liquidity‑centric risk appetite that prioritizes capital preservation while generating modest returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. CRITICAL ERRORS: (1) The LLM claims 2023 and 2024 yields 'remained in the low single digits' - this directly contradicts the ground truth showing 2023 yields of 6.45% (one year) and 4.48% (1-5 years), which are clearly NOT low single digits. (2) The LLM provides NO specific yield data for 2023 and 2024, only vague assertions about 'low single digits,' whereas the ground truth provides precise yields: 2023 (6.45% and 4.48%), 2024 (5.86% and 2.03%). (3) The LLM characterizes the strategy as 'conservative, liquidity-centric' throughout the period, but the ground truth shows a dramatic shift to 'more aggressive short-term investments in 2023' with yields jumping from 1.74% to 6.45% - this is NOT conservative. (4) The LLM fails to capture the key 3-year pattern: low yields in 2022 → significant yield increase in 2023 → partial retreat in 2024. (5) The LLM provides no maturity distribution analysis beyond vague references to 'one-year bucket concentration,' missing the important detail that bonds due 1-5 years existed and had different yield profiles. WHAT WAS CORRECT: The $630 million 2022 balance and 1.74% yield for one-year bonds are accurate. The company name (American Express) and time period (2022-2024) are correct. MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing yield and maturity data across three years to identify strategic patterns. The LLM failed to extract or synthesize the critical yield progression data, instead providing a blanket characterization that contradicts the actual data. The conclusion about 'dynamic response to market conditions' in the ground truth is completely absent from the LLM answer, which instead offers an incorrect 'conservative' characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 491,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements – which is reported within the “Other assets, including intangibles – net” line – fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (page 102 for 2022‑23; page 99 for 2023‑24). This steady decline indicates a tightening of collateral requirements, suggesting the company is managing its derivative exposure more efficiently through improved netting, reduced net derivative positions, or more effective hedging.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1,494 million (formatted as $1.49 billion, which is an acceptable format variation) in 2022, $800 million in 2023, and $491 million in 2024. The downward trend is accurately captured. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) identifies the specific collateral metric within 'Other assets, including intangibles - net', (2) provides the three-year progression (2022-2024), and (3) interprets what the trend suggests about derivative exposure management. ENTITY ACCURACY: Correctly identifies ExxonMobil (XOM), the correct financial line item, and the correct time periods. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the collateral figures to derivative exposure management and provides a logical interpretation of the downward trend. The explanation that the decline suggests 'more efficient' management through improved netting, reduced net derivative positions, or more effective hedging is semantically equivalent to the ground truth's statement about 'strategic reduction in derivative-related exposure or shift in risk management practices.' MINOR CONSIDERATIONS: The LLM provides additional context (page references) that, while not in the ground truth, adds credibility and doesn't contradict the answer. The interpretation of 'tightening of collateral requirements' is a reasonable inference from the declining collateral amounts, though the ground truth uses slightly different language. No calculation errors detected. The answer fully synthesizes information across the three-year period as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 475,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "The 2.700% Notes were first issued on March 29 2021 for $700 million at a fixed 2.700% coupon with a maturity of April 15 2031 (page 48).  Through 2023 and 2024 the notes remained unchanged – the principal stayed at $700 million, the coupon stayed at 2.700%, and no new issuances or rate adjustments were made (pages 111 and 114).  The company used the proceeds from the 2021 offering to repay existing indebtedness under the 2021 Multicurrency Credit Facility (page 47).  This stability indicates a strategy of locking in a low, fixed‑rate long‑term debt and refinancing older, higher‑cost debt, reflecting favorable market conditions and a strong credit profile over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual errors and omissions that significantly impact accuracy: (1) MATURITY DATE ERROR: The LLM states maturity as 'April 15 2031' but the ground truth clearly indicates the maturity date is 'January 15, 2031' - this is a critical factual error. (2) MISSING KEY INFORMATION: The ground truth mentions a 'par call date of January 15, 2031' which the LLM completely omits. (3) INTEREST RATE SPREAD DISCREPANCY: The ground truth explicitly states 'the interest rate spread had decreased from (5.0) to (4.4)' by 2024, which is a significant finding about the company's financing strategy evolution. The LLM claims 'no new issuances or rate adjustments were made' - this directly contradicts the ground truth's disclosure of a spread reduction. (4) INCOMPLETE EVOLUTION ANALYSIS: The question asks how terms 'evolved from 2022 through 2024,' but the LLM treats the notes as static after 2021 issuance, missing the important spread reduction that occurred by 2024. (5) CORRECT ELEMENTS: The LLM correctly identifies the $700 million principal amount, the 2.700% coupon rate, the March 29, 2021 issuance date, and the use of proceeds to repay existing debt. The reasoning about locking in low fixed-rate debt and refinancing is sound. The multi-hop synthesis regarding debt refinancing strategy is appropriate. However, the failure to capture the spread reduction and the maturity date error are material omissions that undermine the answer's accuracy regarding how the financing terms actually evolved over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 425,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 carried a net amount of **$1.25 billion** at the end of 2024, the same figure reported in the 2025 debt schedule (indicating no change since at least 2022)【page_72】.  The overall net carrying amount of all debt fell only modestly from **$8.463 billion** in 2025 to **$8.459 billion** in 2024, underscoring a strategy of maintaining a stable, low‑interest, long‑dated debt profile rather than frequent refinancing or large issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains significant factual errors. The ground truth shows the 2.00% Notes Due 2031 had a fair value of $1.2 billion in 2022, $1.044 billion at beginning of 2023, and $1.057 billion at end of 2023, then $1.25 billion in 2024. The LLM claims the amount was 'the same figure reported in the 2025 debt schedule (indicating no change since at least 2022)' - this is FALSE. The values clearly changed from $1.2B (2022) to $1.044B-$1.057B (2023) to $1.25B (2024). The LLM also introduces completely unsupported figures ($8.463 billion in 2025 and $8.459 billion in 2024 for total debt) that are not mentioned in the ground truth and appear to be fabricated. (2) COMPLETENESS - The LLM fails to address the evolution of the debt from 2022 through 2024 as requested. It only mentions 2024 and 2025 figures, missing the critical 2022-2023 progression that the ground truth documents. (3) ENTITY ACCURACY - The LLM correctly identifies NVIDIA and the 2.00% Notes Due 2031, but introduces extraneous debt figures not in the ground truth. (4) REASONING - The LLM's conclusion that there was 'no change since at least 2022' directly contradicts the ground truth showing clear variation in fair values across the three-year period. The multi-hop synthesis is fundamentally flawed. (5) SEMANTIC EQUIVALENCE - The LLM's characterization of 'stable approach' and 'strategic consistency' contradicts the actual data showing fluctuations in fair value. The answer demonstrates poor data synthesis and contains fabricated supporting figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 436,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance assets grew sharply from $1.8 billion (the last figure disclosed for 2021) to $5.1 billion in 2023 and then fell modestly to $4.6 billion in 2024, while deposit liabilities rose from $1.4 billion to $1.3 billion and then to $1.2 billion【page_216】【page_206】. This pattern shows a rapid expansion of deposit‑method reinsurance in the early 2020s, followed by a slight contraction in 2024, indicating the company is adjusting its reinsurance mix—likely shifting toward more structured or quota‑share arrangements to balance risk and capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DEPOSIT ASSETS NUMBERS: LLM states deposit assets were '$1.8 billion (the last figure disclosed for 2021)' but ground truth clearly indicates 2022 as the starting year with $1.8 billion. More critically, LLM claims deposit assets reached '$5.1 billion in 2023 and then fell modestly to $4.6 billion in 2024,' but ground truth states deposit assets were $5.1 billion 'by the end of 2024' - not 2023. The LLM has misplaced the $5.1 billion figure to 2023 instead of 2024, and introduced a completely unsupported $4.6 billion figure for 2024 that does not appear in the ground truth. (2) DEPOSIT LIABILITIES: LLM correctly identifies the progression from $1.4 billion to $1.3 billion to $1.2 billion, matching ground truth. (3) MISSING CONTEXT: LLM fails to mention the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables, which is a key strategic detail in the ground truth explaining the 2023 activity. (4) TIMELINE CONFUSION: The LLM conflates 2021 and 2022 as starting points, creating ambiguity about the actual 2022-2024 period requested. (5) REASONING: While the LLM attempts to interpret the trend as a strategic shift, it does so based on incorrect numbers and timeline, undermining the validity of its conclusions. The ground truth indicates a clear upward trend in assets from 2022-2024 ($1.8B → $5.1B), not a peak in 2023 followed by decline. This is a fundamental factual error that distorts the entire narrative about MetLife's reinsurance strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 421,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities declined in both fair value and carrying value over the three‑year period: fair value fell from **$679 million in 2022 to $596 million in 2023 and $508 million in 2024**, while carrying value dropped from **$696 million to $603 million and $512 million**. The consistent downward trend reflects the impact of rising interest rates on bond prices, yet the company’s continued “held‑to‑maturity” policy shows a conservative, low‑risk investment strategy that accepts market‑valuation adjustments without recognizing unrealized gains or losses in earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are precisely correct - fair values of $679M (2022), $596M (2023), and $508M (2024) match ground truth exactly; carrying values of $696M, $603M, and $512M are also accurate. The year-over-year progression is correctly presented. COMPLETENESS: The answer addresses all key aspects of the question: (1) fair value evolution, (2) carrying value evolution, (3) the 3-year progression pattern, and (4) implications for investment strategy. ENTITY ACCURACY: Company (UnitedHealth Group/UNH), metric type (Debt Securities - Held-to-Maturity), and time period (2022-2024) are all correctly identified. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (a) tracking both metrics across all three years, (b) identifying the consistent downward trend, and (c) offering contextual interpretation. The explanation about rising interest rates impacting bond prices and the held-to-maturity accounting treatment demonstrates sophisticated understanding of the underlying financial dynamics. MINOR ENHANCEMENT: The LLM answer goes slightly beyond the ground truth by providing additional context about interest rate impacts and accounting treatment, which adds value without contradicting the original answer. The ground truth focuses on 'strategic reduction or repositioning,' while the LLM emphasizes 'conservative, low-risk investment strategy' - both interpretations are valid and complementary. No calculation errors detected. All numbers are formatted consistently and clearly presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 441,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s credit‑card penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (RedCard penetration)【page_27】.  Because Target tracks penetration as a proxy for the incremental sales that the card generates【page_29】, the downward trend suggests the card’s ability to drive additional sales is weakening or that the incremental‑sales benefit is diminishing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match ground truth exactly. (2) Correct identification of the metric as RedCard/Target Credit Card penetration. (3) Accurate characterization of the downward trend. (4) Correct understanding that Target uses penetration as a proxy for incremental sales. WEAKNESSES: (1) INCOMPLETE ANSWER - The LLM fails to address a critical part of the original question about what the trend 'suggests about the effectiveness of Target's credit card strategy.' The ground truth provides nuanced analysis: while the declining penetration suggests weakening engagement/shifting preferences, Target's internal analysis still indicates meaningful incremental sales contribution. The LLM only presents the negative interpretation (weakening ability/diminishing benefit) without acknowledging the counterbalancing evidence that the card still generates incremental sales. (2) MISSING CONTEXT - The original answer notes 'Target's continued emphasis on card-linked discounts and loyalty benefits' and explicitly states 'Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.' The LLM omits this important nuance entirely. (3) REASONING INCOMPLETENESS - While the LLM correctly identifies the downward trend and its implications for weakening card effectiveness, it doesn't synthesize the full picture that the ground truth presents: the trend is concerning but the card still provides strategic value. The LLM's conclusion is one-sided. MULTI-HOP SYNTHESIS: The LLM successfully connects penetration rates to incremental sales tracking, but fails to complete the full multi-hop reasoning required to answer the effectiveness question comprehensively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 506,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike continued to own its Laakdal, Belgium distribution center from FY 2022 through FY 2024, with no change in ownership or operational footprint reported in the 10‑K filings. The center remains listed as a key distribution facility outside the United States, underscoring Nike’s strategy of owning critical European logistics assets to support its global supply chain and e‑commerce operations. [page_27] [page_29]",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Nike's continued ownership of the Laakdal, Belgium facility across FY 2022-2024 with no changes in ownership or operational footprint - this matches the ground truth. (2) Accurately characterizes the facility as a key distribution center outside the US. (3) Properly synthesizes the multi-hop information about ownership consistency across three fiscal years. (4) Correctly infers the strategic implication about maintaining direct control over European logistics assets. (5) No quantitative errors - dates and entities are accurate. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'supporting global supply chain and e-commerce operations' that, while reasonable and likely accurate, goes slightly beyond what the ground truth explicitly states. The ground truth focuses on 'stable strategic focus on maintaining direct control over key logistics nodes in Europe' without explicitly mentioning e-commerce. (2) The ground truth specifically notes the facility was described as 'one of the most significant international distribution centers' in 2022 with this characterization remaining consistent through 2024 - the LLM answer mentions it as a 'key distribution facility' but doesn't explicitly reference the 'most significant' descriptor or the consistency of this characterization across years. (3) Citation references [page_27] [page_29] are provided but cannot be verified against the ground truth source. Overall, the answer demonstrates sound multi-hop reasoning, correct entity identification, and accurate synthesis of information across the three-year period. The semantic meaning aligns well with the ground truth despite minor omissions of specific descriptive language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 495,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings has appeared in NVIDIA’s “networking products” competitor list in every filing from FY 2022 through FY 2024 (pages 15, 9, 9), indicating no change in its presence in the disclosed landscape.  Across the same period, NVIDIA has reiterated its strategy of expanding supply‑chain redundancy in the Asia‑Pacific region (page 10) and of bolstering IP protection through a growing patent portfolio and licensing agreements, with particular attention to jurisdictions with weaker enforcement (pages 15, 9, 9).  These continued supply‑chain and IP‑protection efforts reinforce NVIDIA’s competitive resilience, but Lumentum remains a listed rival without any shift in its relative positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core facts but has some notable limitations: (1) CORRECT ELEMENTS: The answer accurately identifies that Lumentum Holdings appeared consistently across FY 2022-2024 in NVIDIA's competitor disclosures, specifically in networking products. The characterization of NVIDIA's strategic moves (supply chain redundancy, IP protection expansion) aligns with the ground truth. The answer correctly notes no change in Lumentum's relative positioning despite NVIDIA's strategic initiatives. (2) PAGE REFERENCES: The LLM provides specific page citations (pages 15, 9, 9 and page 10), which adds precision but cannot be verified against the ground truth provided. These citations appear plausible but represent claims beyond the ground truth scope. (3) MISSING CONTEXT: The LLM answer omits some important contextual details from the ground truth: (a) specific mention of NVIDIA's manufacturing partnerships (TSMC, Samsung) as part of supply chain strategy, (b) the patent portfolio expansion with specific date ranges (2022 to 2045), (c) the broader characterization of Lumentum as a 'persistent competitive force' despite NVIDIA's advancements. (4) SEMANTIC ALIGNMENT: The core message aligns well - Lumentum remained consistently positioned as a competitor across three years while NVIDIA strengthened its supply chain and IP protections. The LLM's conclusion that 'Lumentum remains a listed rival without any shift in its relative positioning' matches the ground truth's assertion of 'persistent competitive force' and maintained relevance. (5) MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects Lumentum's positioning to NVIDIA's strategic initiatives, demonstrating appropriate multi-hop reasoning. However, the synthesis is somewhat surface-level compared to the ground truth's more nuanced discussion of how these strategic moves relate to competitive dynamics. (6) QUANTITATIVE ELEMENTS: No calculations or specific financial metrics are involved in this question, so quantitative accuracy primarily concerns date/year accuracy, which is correct (FY 2022-2024). The page references cannot be verified but appear reasonable. Overall, the answer is factually sound on core claims but lacks some contextual depth and specific strategic details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 633,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings from 2022‑24 consistently state that the company’s service depends on licensing rights from studios and other rights holders, and that refusal or withdrawal of those rights can harm the business [page_11]. The 2022 filing warned of rising costs and competition, the 2023 filing reiterated the reliance on licensing rights, and the 2024 filing adds that new regulatory frameworks—content quotas, levies and investment obligations—may further constrain licensing, prompting Netflix to accelerate original‑content production and local partnerships to reduce reliance on external rights [page_4]. This evolution shows a strategy that balances licensed titles with a growing slate of original and locally produced content to navigate competitive pressures and regulatory constraints [page_4].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core risk factor of content licensing reliance across all three years (2022-2024); (2) Accurately captures the evolution of Netflix's narrative from emphasizing rising costs and competition (2022) to incorporating regulatory constraints (2024); (3) Properly synthesizes the multi-hop reasoning showing how regulatory pressures (content quotas, levies, investment obligations) prompted strategic shifts toward original and locally produced content; (4) Correctly identifies the strategic balance between licensed and original content as the company's response to competitive and regulatory pressures; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The answer includes page references ([page_11], [page_4]) that cannot be verified against the ground truth, which is a minor presentation issue but doesn't affect factual accuracy; (2) The ground truth mentions 'variability of license terms' as a 2023 focus, which the LLM answer doesn't explicitly highlight, though this is a minor omission; (3) The LLM answer could have been slightly more explicit about the 2023 'consistency' phase mentioned in the ground truth, though the overall progression is captured. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects content licensing challenges to strategic responses (original content, local partnerships), demonstrating sound multi-hop reasoning. The causal chain from regulatory/competitive pressures to strategic shifts is logically sound and matches the ground truth narrative. SEMANTIC EQUIVALENCE: The LLM's framing of 'accelerate original-content production and local partnerships' is semantically equivalent to the ground truth's 'strategic shift toward securing exclusive and original content.' The overall message about navigating a 'more regulated and competitive global environment' is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 543,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In 2022 Southern Company’s note described outdoor‑lighting contracts as operating leases with initial terms of up to seven years, treated the scheduled lease payments as immaterial, and presented them only in the maturity‑analysis table (page 268, page 240).  In 2023 the note was updated to state the initial terms were up to ten years, but the classification, immateriality, and presentation in the maturity analysis remained unchanged (page 242, page 241).  By 2024 the contracts were still classified as operating leases, the payments were still immaterial, and they continued to appear in the updated maturity‑analysis table (page 231, page 232), while lease income for Alabama Power and Southern Power remained included in wholesale revenues.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Southern Company's treatment of outdoor lighting contracts across 2022-2024, accurately noting: (1) consistent classification as operating leases throughout the period, (2) treatment as immaterial in all three years, (3) inclusion in maturity analyses across all years, (4) the change in initial contract terms from seven years (2022) to ten years (2023), and (5) the inclusion of lease income in wholesale revenues for Alabama Power and Southern Power. The specific page references provided add credibility and detail.\n\nWEAKNESSES: The LLM answer contradicts the ground truth on a critical point regarding the evolution of disclosure. The ground truth explicitly states that 'by 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses' - implying this was a NEW inclusion in 2023. However, the LLM answer claims these contracts were 'presented only in the maturity-analysis table' in 2022 and that 'the classification, immateriality, and presentation in the maturity analysis remained unchanged' from 2022 to 2023. This represents a fundamental misunderstanding of the progression described in the ground truth. The ground truth emphasizes an 'increasing emphasis on formalizing the visibility' and a 'shift toward more structured reporting,' suggesting the 2023 inclusion in maturity analyses was a meaningful change. The LLM answer presents this as static/unchanged, which contradicts the narrative of evolution.\n\nMULTI-HOP REASONING: The LLM answer does synthesize information across three years and multiple disclosure elements (classification, materiality, presentation), but it fails to capture the key insight about the CHANGE in disclosure practices between 2022 and 2023. The answer treats the maturity analysis inclusion as constant rather than as an evolution.\n\nNUMERIC/FACTUAL VERIFICATION: The contract term changes (7 years to 10 years) are correctly identified. The immateriality designation is consistent across years. The revenue classification details are accurate. However, the characterization of what changed versus what remained constant is problematic.\n\nSEMANTIC ISSUE: The LLM answer's statement that presentation 'remained unchanged' from 2022-2023 directly contradicts the ground truth's assertion that 2023 marked a shift toward 'more structured reporting' with the inclusion in maturity analyses. This is not merely a wording difference but a substantive disagreement about the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 681,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2022, and this balance remained unchanged at **$606 million** at the end of FY 2023 and FY 2024【page_80】. The steady balance indicates that the company has neither issued additional principal nor redeemed any of this note, reflecting a strategy of keeping the debt load for this instrument stable while using other notes for refinancing or capital‑structure optimization.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was $606 million at the end of FY 2022, but the ground truth clearly shows it was $1,086 million in FY 2022. This is a $480 million discrepancy - a 44% error in the opening balance. The LLM correctly identifies $606 million for FY 2023 and FY 2024, but misses the critical $480 million reduction that occurred between FY 2022 and FY 2023. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks how the balance 'evolved from fiscal year 2022 through 2024.' The ground truth shows a three-year progression: $1,086M → $606M → $606M, demonstrating a significant debt reduction event in 2023. The LLM only captures the static $606M level for all three years, completely missing the evolution and the major repayment activity. (3) REASONING FAILURE: The LLM's interpretation that 'the company has neither issued additional principal nor redeemed any of this note' is factually incorrect. AVGO clearly redeemed $480 million of these notes between FY 2022 and FY 2023. The LLM's conclusion about 'keeping the debt load stable' mischaracterizes what was actually a deliberate debt reduction strategy. (4) STRATEGIC INTERPRETATION ERROR: The ground truth correctly identifies this as 'a deliberate debt reduction strategy in 2023,' while the LLM incorrectly suggests stability and no redemptions. This represents a fundamental misunderstanding of the company's debt management actions. The LLM answer fails on the primary metric (correctness) by providing incorrect baseline data and missing the key evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 473,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % in 2022 and 2023 and increased to 6.5 % at December 31 2024 (2024 10‑K, p. 88; 2023 10‑K, p. 87; 2023 10‑K table, p. 85). The modest rise reflects a deliberate shift toward higher‑return, higher‑risk asset classes—such as private equity, real estate, and other alternatives—to improve funded status while managing volatility in response to changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 rate of return. Ground truth states the 2022 rate was 5.4%, but the LLM claims it was 6.3% in both 2022 and 2023. This is a major discrepancy that undermines the entire answer. The correct progression is: 2022: 5.4% → 2023: 6.3% → 2024: 6.5%, representing a 1.1 percentage point increase over two years. The LLM incorrectly states 6.3% for 2022, which is actually the 2023 figure. This error cascades through the analysis, as the LLM then describes only a 0.2 percentage point increase from 2022-2024 (6.3% to 6.5%), when the actual increase is 1.1 percentage points (5.4% to 6.5%). MULTI-HOP REASONING: While the LLM correctly identifies the 2024 figure (6.5%) and provides reasonable strategic interpretation about asset mix adjustments toward higher-return alternatives, the foundational data is wrong, making the trend analysis incorrect. The LLM does provide relevant context about strategic shifts toward private equity and real estate, which aligns with the ground truth's mention of 'higher-risk, higher-return investment strategies,' but this cannot compensate for the incorrect baseline numbers. COMPLETENESS: The answer addresses the 3-year trend question but with incorrect data points. The strategic interpretation is present but based on flawed numbers. The citation references appear plausible but the actual data extracted is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 404,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower’s 2.700% Senior Notes due 2031 are listed as part of its long‑term debt in the 2022 and 2023 10‑K filings (see page 72).  In the 2024 filing those notes are no longer disclosed, where a new 4.625% Senior Notes due 2031 is issued (page 73).  This shift shows the company is actively refinancing older, lower‑coupon debt and maintaining a diversified long‑term debt mix to manage interest costs and support growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - The LLM claims the 2.700% Senior Notes due 2031 'are no longer disclosed' in the 2024 filing, but the ground truth explicitly states these notes were 'continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf)'. This is a major factual inaccuracy. (2) The LLM introduces a 4.625% Senior Notes due 2031 as a replacement, but the ground truth makes no mention of this note or any refinancing/replacement activity. The ground truth emphasizes CONSISTENCY and CONTINUITY across all three years (2022-2024), not a shift or refinancing. (3) The LLM's interpretation of the financing strategy is fundamentally wrong - it claims 'active refinancing' and 'shift' when the ground truth indicates 'stable long-term financing strategy' with 'steady approach' and 'without modifications'. (4) The LLM references specific page numbers (72, 73) that cannot be verified against the ground truth, and these appear to be fabricated details. (5) Multi-hop reasoning is flawed: the LLM failed to correctly synthesize information across the three filings and instead invented a narrative about debt replacement that contradicts the actual pattern of consistent treatment. The core insight of the ground truth - that the same Supplemental Indenture No. 8 was referenced across all three years indicating stability - is completely missed. The LLM's answer suggests a dynamic refinancing strategy when the evidence points to a stable, unchanged approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 437,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal’s exposure to abusive behaviors remained a persistent risk from 2022 through 2024, especially around its credit products and cross‑border transactions. In 2022 the company flagged fraud and default risks in its credit offerings (page 24) and the potential for third‑party abuse of its platform (page 28). In 2023 it mitigated credit‑risk exposure by selling a large portion of its U.K. and European BNPL loan receivables (page 25) while still noting cross‑border trade risks (page 23). By 2024 PayPal broadened its mitigation strategy by diversifying payment‑processor reliance (page 21), investing in fraud‑detection measures (page 21), and continuing to monitor cross‑border trade risks (page 21).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core trajectory of PayPal's evolving approach to abusive behaviors from 2022-2024 and correctly identifies key strategic actions. STRENGTHS: (1) Correctly identifies the 2022 risk identification phase regarding fraud in credit products; (2) Accurately references the 2023 sale of U.K. and European BNPL loan receivables as a major mitigation strategy; (3) Properly notes the 2024 focus on fraud detection and third-party processor management; (4) Correctly synthesizes the three-year evolution from risk identification to offloading to reinforcement. WEAKNESSES: (1) The LLM answer lacks the specific quantitative detail from the ground truth—it does not mention the €40 billion figure for the BNPL loan receivables sale, which is a material omission for a financial question; (2) The answer provides page references (pages 24, 28, 25, 23, 21) that cannot be verified against the ground truth and may be fabricated; (3) The 2024 mitigation strategies mentioned (diversifying payment-processor reliance, investing in fraud-detection measures) are somewhat generic and lack the specific emphasis on 'ongoing reliance on third-party lenders and processors' and the 'complexity of detecting and preventing fraud attacks' that the ground truth emphasizes; (4) The answer doesn't fully capture the nuance that the 2023 action represented a strategic 'shift in how the company managed exposure' rather than just a mitigation tactic. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and identifies the progression, though it could be more precise about the strategic rationale. The connection between credit product risks and the BNPL receivables sale is implied but not explicitly stated. QUANTITATIVE ACCURACY: The absence of the €40 billion figure is a notable gap, though the answer doesn't contain any incorrect numbers. The page references are problematic and unverifiable. Overall, the answer demonstrates solid understanding of the trajectory but lacks the financial specificity and precision expected for a multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 565,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan reduced its share of Collective Trust and Other Funds from about **46.5 % of plan assets in 2022 (622 / 1,338 million) to 43.9 % in 2023 (370 / 842 million) and to 39.5 % in 2024 (382 / 966 million)**【page_58】. This downward trend reflects a deliberate shift away from these less liquid, higher‑risk funds toward a more diversified mix of equities and debt, in line with the company’s de‑risking strategy and its target allocation of 20‑30 % equity and 70‑80 % debt by 2025【page_55】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM provides dollar amounts ($622M, $370M, $382M, $1,338M, $842M, $966M) that do NOT match the ground truth values. Ground truth states: 2022=$756M, 2023=$382M, 2024=no updated dollar value provided. The LLM's 2023 figure of $370M is close to but not exactly $382M (ground truth), and the 2022 figure of $622M is significantly different from $756M (ground truth). The LLM also calculates percentages (46.5%, 43.9%, 39.5%) based on these incorrect denominators, making all percentage calculations unreliable. (2) CALCULATION VERIFICATION: LLM claims 622/1,338=46.5% (actually ~46.5%, mathematically correct for those numbers, but the base numbers are wrong). The ground truth does not provide these percentage calculations or total plan asset figures, suggesting the LLM may be fabricating or misinterpreting source data. (3) MISSING CRITICAL INFORMATION: The LLM fails to acknowledge that 2024 has 'no updated dollar value provided' per ground truth. Instead, it presents a specific 2024 figure ($382M) which contradicts the ground truth statement. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about de-risking strategy and target allocations (20-30% equity, 70-80% debt by 2025), these details are not present in the provided ground truth, raising questions about source accuracy. (5) SEMANTIC ISSUES: The LLM's interpretation of the trend as 'shift away from less liquid, higher-risk funds' is reasonable but not explicitly supported by the ground truth, which simply states 'de-risking or rebalancing.' The core factual foundation is compromised by incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 478,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer did not grant or have any Breakthrough Performance Awards (BPAs) in 2022, 2023, or 2024 – each 10‑K states that no BPAs were granted and none were outstanding as of December 31 of that year (2022: page 99; 2023: page 96; 2024: page 96). The valuation method remained the intrinsic‑value method based on the closing price of common stock, and the accounting treatment continued to amortize the fair value on a straight‑line basis over the vesting term into operating expenses, with periodic adjustments for stock‑price changes, expected shares earned, and performance‑criteria probability (2022: page 99; 2023‑24: page 96).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all major factual claims. Specific errors: (1) QUANTITATIVE ERRORS - The LLM claims no BPAs were granted in 2022, but the ground truth explicitly states 1,165 thousand BPAs were issued at $38.73 weighted average intrinsic value. The LLM also claims none were outstanding in 2022, contradicting the ground truth's 859 thousand BPAs outstanding at year-end 2022 valued at $59.05 per share. (2) ENTITY/YEAR ACCURACY - The LLM incorrectly states the same status (no grants, none outstanding) across all three years (2022-2024), when the ground truth shows clear evolution: active issuance in 2022, discontinuation in 2023, and new formalized methodology in 2024. (3) MULTI-HOP REASONING - The LLM failed to synthesize the temporal evolution across the three-year period. The question specifically asks about evolution 'from 2022 through 2024,' and the ground truth shows distinct phases, but the LLM presents a static, incorrect narrative. (4) MISSING CRITICAL INFORMATION - The LLM completely omits the 2024 new valuation methodology details that the ground truth emphasizes as a key evolution point. The LLM's statement about valuation methodology being 'intrinsic-value method' and 'straight-line basis' amortization may be partially correct for some years, but this is overshadowed by the completely false claims about grant activity and outstanding awards. The LLM appears to have either misread the filings or conflated different years' data, resulting in a response that is factually incorrect on the primary quantitative metrics that form the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 450,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements for investments, advances and long‑term receivables fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**. The steep decline indicates a shrinking derivative exposure or a shift to more efficient netting/hedging practices, resulting in lower initial‑margin requirements over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022) matches $1,494 million in ground truth (format variation acceptable), $800 million (2023) is exact, and $491 million (2024) is exact. The directional trend (consistent decline) is accurately captured. COMPLETENESS: The answer addresses all required elements: (1) the three-year period (2022-2024), (2) specific collateral amounts, (3) the trend analysis, and (4) interpretation of what the trend suggests about derivative exposure and margin requirements. ENTITY ACCURACY: Company (ExxonMobil/XOM), metric (collateral under master netting arrangements), and time periods are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the declining collateral amounts to implications about derivative exposure and margin requirements. The interpretation that the decline suggests 'shrinking derivative exposure or shift to more efficient netting/hedging practices' is logically consistent with the data and represents reasonable financial analysis. SEMANTIC EQUIVALENCE: The LLM's phrasing 'steep decline indicates a shrinking derivative exposure or a shift to more efficient netting/hedging practices, resulting in lower initial-margin requirements' conveys the same meaning as the ground truth's 'downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements.' Minor deduction (1 point) only because the LLM adds interpretive detail ('initial-margin requirements') that, while reasonable, goes slightly beyond what the ground truth explicitly states, though this is not factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 473,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K positioned industrial fiber optics as a core part of its industrial portfolio, noting use in automation, power‑generation, medical, defense, aerospace and automotive applications—including EV power‑train, infotainment and ADAS (page_10 2022). The 2023 and 2024 10‑Ks repeat that same description, with no change in product mix or scope (page_10 2023; page_10 2024). This consistency signals a deliberate, sustained focus on high‑performance optical solutions for industrial and automotive markets, aiming to capture growth in these high‑margin segments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the key evolution described in the ground truth. CRITICAL ISSUES: (1) The LLM claims 'no change in product mix or scope' across 2022-2024, directly contradicting the ground truth which explicitly describes an evolution in positioning and presentation. (2) The ground truth identifies a clear structural change: 2022 had a broad application list, 2023 introduced a 'structured table format' emphasizing specific applications (Factory Automation, Renewable Energy, Automotive Electronics), and 2024 showed a 'more streamlined presentation' with integration alongside other semiconductor solutions (optocouplers, sensors, encoders, Ethernet ICs). The LLM completely missed this evolution. (3) The LLM's claim that 2023 and 2024 'repeat that same description' is factually incorrect—the ground truth explicitly documents changes in how the product was presented and contextualized. (4) While the LLM correctly identifies some applications (automation, power, medical, defense, aerospace, automotive/EV), it misses the key insight about the EVOLUTION in how these were organized and presented. (5) The LLM's conclusion about 'sustained focus' is partially correct but undermines the actual strategic insight: the company was refining its communication strategy and product positioning, not simply maintaining status quo. The answer demonstrates poor multi-hop synthesis—it failed to identify and articulate the year-over-year changes that are central to answering the question about how positioning 'evolved.' The answer reads as if the LLM found similar language across years and concluded nothing changed, rather than analyzing the structural and presentational differences documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 482,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s 10‑K disclosures for 2022, 2023 and 2024 all state that the company acts as the principal on payment transactions, retains full discretion over fee pricing, and bears the entire margin risk regardless of whether it uses third‑party processors (PYPL_10k_2022.pdf: p. 78; PYPL_10k_2023.pdf: p. 75; PYPL_10k_2024.pdf: p. 75). The same wording—“We therefore bear full margin risk when completing a payment transaction” and the recognition of processor fees as transaction expense—appears unchanged across the three years, indicating no evolution in PayPal’s control over pricing or its margin‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures PayPal's consistent stance across 2022-2024 regarding margin risk exposure, pricing discretion, and principal status. The core claim that PayPal 'bears full margin risk when completing a payment transaction' and maintains discretion over fee pricing is correctly stated and consistent with the ground truth narrative. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required for this question, but the answer correctly identifies the three fiscal years (2022, 2023, 2024) and appropriately cites page numbers from the 10-K filings (p. 78 for 2022, p. 75 for 2023 and 2024), demonstrating precise document referencing. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes information across three years and multiple documents to demonstrate the evolution (or lack thereof) in PayPal's margin risk profile. The identification that the 'same wording appears unchanged across the three years' directly supports the ground truth conclusion of a 'stable margin risk profile with no material changes.' The answer correctly identifies the key entities (PayPal, third-party processors, transaction expenses) and their relationships. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: (a) how exposure evolved (answer: it didn't materially change), (b) relation to control over transaction pricing (answer: maintained full discretion), and (c) use of third-party payment processors (answer: used but margin risk remained with PayPal). The semantic equivalence is strong—both the ground truth and LLM answer convey that PayPal's margin risk exposure remained consistent and stable across the three-year period. Minor note: The LLM answer is slightly more concise than the ground truth but captures all essential information without omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 533,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold its Meridian subsidiary in 2021 for $51 million cash, recording a $167 million net‑of‑tax loss, and then entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑service agreement (MSA) with the buyer that were still in effect in 2022 and 2023 but had no material financial impact (2022 10‑K, note 2B; 2023 10‑K, note 2B).  By 2024 the 10‑K contains no new disclosures about Meridian, indicating the post‑sale service framework remained unchanged and that Pfizer has fully divested the business while retaining only a limited, non‑core supply‑chain relationship (2024 10‑K, pages 2‑6).  This evolution underscores Pfizer’s long‑term strategy to shed non‑core assets and focus its resources on its core biopharma and vaccine portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All numbers are correct - $51 million sale price (2021), $167 million net loss, three-year MSA with two-year extension option (implied in 'three-year manufacturing-service agreement'). The dates are accurate: 2021 sale completion, 2022-2023 service agreements in effect, 2024 no new disclosures. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) and traces the evolution from discontinued operations status through divestiture to post-sale service arrangements. The progression is logically presented: sale → interim TSAs and MSA → continued service framework with no material impact → full divestiture with limited supply-chain relationship. ENTITY ACCURACY: Meridian Medical Technologies correctly identified, Pfizer correctly positioned as seller, buyer relationship properly characterized as arms-length. STRATEGIC POSITIONING: The answer correctly identifies the shift from direct ownership to contract-based relationship and connects this to Pfizer's broader strategic refocus on core therapeutic areas. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer mentions 'interim transition-service agreements (TSAs)' which adds specificity not explicitly stated in the ground truth, though this is consistent with typical post-acquisition arrangements and represents reasonable inference. The LLM answer notes 'no material financial impact' which is a reasonable characterization of the ground truth's statement about the relationship. The LLM answer is slightly more specific about the 2024 status ('no new disclosures') versus the ground truth's 'listed in glossary as Meridian Medical Technologies, Inc.' - both convey similar information about formalized but reduced relationship. COMPLETENESS: All three sub-questions are addressed: financial impact (sale price, loss, no material ongoing impact), contractual arrangements (TSAs, three-year MSA), and strategic positioning (shift to non-core asset divestiture, focus on core portfolio). The conclusion about long-term strategic focus is well-supported and consistent with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 595,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 through 2024 Philip Morris International (PMI) has consistently warned that regulatory limits on product differentiation and on how it can communicate with adult consumers about reduced‑risk products (RRPs/SFPs) threaten its competitive edge. In the 2022 filing (pp. 13‑16) PMI described how advertising bans, plain‑packaging rules, and restrictions on flavoring and novel‑product marketing could commoditize its portfolio and curb adult‑smoker conversion to RRPs. The 2023 filing (pp. 18‑20) reiterated these concerns, noting that new legal challenges around product classification, advertising restrictions, corporate communications and scientific substantiation for SFPs continue to curtail branding, differentiation and truthful information. The 2024 filing (pp. 18‑20) echoes the same narrative, underscoring that ongoing regulatory constraints on branding, communication and product differentiation remain a material risk to PMI’s ability to promote and sell RRPs, and that the company is intensifying compliance and risk‑mitigation efforts to protect its competitive positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc from 2022-2024 regarding regulatory constraints on PMI's product differentiation and consumer communication for RRPs/SFPs. The semantic understanding is sound - the answer captures that regulatory pressure has persisted and evolved across the three-year period, with terminology shifting from RRPs to SFPs. The multi-hop synthesis across three years is logically sound and addresses the question's core requirement to show evolution of competitive positioning impact. The answer correctly identifies key regulatory concerns (advertising bans, plain packaging, flavoring restrictions, product classification challenges, scientific substantiation requirements). WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE - The LLM provides specific page numbers (pp. 13-16 for 2022, pp. 18-20 for 2023 and 2024) that cannot be verified against the ground truth and appear to be hallucinated. The ground truth does not provide page citations, and these specific page references are a red flag for fabrication. (2) SPECIFICITY MISMATCH - The LLM adds specific regulatory mechanisms (advertising bans, plain-packaging rules, flavoring restrictions, novel-product marketing bans) that are not explicitly mentioned in the ground truth answer. While these may be accurate from actual filings, they go beyond what the ground truth confirms and represent unverified elaboration. (3) TERMINOLOGY PRECISION - The ground truth emphasizes that the company 'replaced RRPs with SFPs' in 2024, suggesting a deliberate terminology shift. The LLM uses 'RRPs/SFPs' throughout, which somewhat obscures this important distinction about how the company's language evolved. (4) MISSING NUANCE - The ground truth notes that 2023 language emphasized regulation 'disproportionately impacted the commercialization of RRPs relative to competitors' - a competitive comparison element that the LLM answer doesn't explicitly capture. VERIFICATION: The core factual claims about regulatory constraints persisting 2022-2024 and the shift from RRPs to SFPs terminology align with ground truth. However, the specific page citations and detailed regulatory mechanisms cannot be confirmed and appear to be LLM elaborations beyond the knowledge graph. The answer is directionally correct but contains unverified specificity that reduces confidence in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 636,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements for Notes and accounts receivable – net fell from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (a net decline of **$1.003 billion**). This downward trend, driven by reduced initial‑margin requirements, indicates that the company has tightened its netting and hedging processes, thereby lowering counterparty exposure and improving overall derivative risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024) match the ground truth exactly. The calculated net decline of $1.003 billion is mathematically accurate ($1,494M - $491M = $1,003M). Number formatting variations ($1.494 billion vs $1,494 million) are acceptable and properly handled. ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, metric properly specified as 'collateral under master netting arrangements related to Notes and accounts receivable - net', and all three fiscal years (2022-2024) correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend data and connects it to derivative risk management implications. The downward trend interpretation is sound and aligns with the ground truth's characterization of 'strategic reduction in derivative exposure or shift in risk management practices.' QUALITATIVE ASSESSMENT: The LLM provides slightly more specific reasoning than ground truth by mentioning 'reduced initial-margin requirements' and 'tightened netting and hedging processes,' which are reasonable inferences from the data pattern and add valuable context. The conclusion about 'lowering counterparty exposure and improving overall derivative risk management' is semantically equivalent to the ground truth's assessment. MINOR CONSIDERATIONS: The LLM's explanation is marginally more detailed and specific than ground truth, which could be viewed as either enhanced analysis or minor speculation, but the core facts remain accurate. No calculation errors, no entity confusion, and complete address of all question components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 473,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "From 2022 to 2024, Duke Energy’s TSR‑based performance award model’s expected volatility relative to its peer group rose from 18.7% in 2022 to 28.6% in 2023, then fell back to 18.7% in 2024 (page_206, page_207, page_213). This pattern indicates the company perceived higher market risk in 2023—likely reflecting a spike in market volatility—and then reassessed risk to a lower, more stable level in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors in the volatility percentages that directly contradict the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM states volatility was 18.7% in 2022, but ground truth shows 26.9% in 2022 - this is a 8.2 percentage point error. The LLM correctly identifies 28.6% for 2023 and 18.7% for 2024, but the 2022 figure is completely wrong. (2) SEQUENCE ERROR: The LLM describes the trend as 'rose from 18.7% in 2022 to 28.6% in 2023, then fell back to 18.7% in 2024' - this is incorrect. The actual trend is: 26.9% (2022) → 28.6% (2023) → 18.7% (2024), showing an initial increase followed by a significant drop. (3) INTERPRETATION ERROR: The LLM's interpretation that volatility 'fell back to 18.7% in 2024' suggests a return to baseline, but the ground truth shows 2024 represents a significant decline from the 2022 baseline of 26.9%, not a return to the same level. (4) REASONING FLAW: While the LLM's reasoning about market risk perception is somewhat logical, it's based on incorrect numbers, making the entire analysis unreliable. The ground truth emphasizes a 'notable decline in perceived market risk over the three-year period' despite the 2023 spike, which the LLM fails to capture accurately. (5) MULTI-HOP SYNTHESIS: The LLM did attempt to synthesize information across multiple years and cite sources, but the fundamental numerical errors undermine the entire response. The answer is contextually relevant to the question asked but factually incorrect in critical ways.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 427,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Across FY 2022–FY 2024, the principal of Broadcom’s 3.125% notes due January 2025 stayed constant at $495 million, while the current portion of that debt was $0 in FY 2022 and FY 2023 and rose to $495 million in FY 2024 as the maturity approached【page_81】. This pattern, combined with the issuance of $10 billion of senior notes in 2024 and the repayment of $16.8 billion of term loans, demonstrates a proactive refinancing strategy that rolls short‑term obligations into longer‑term debt to keep short‑term exposure low and maintain covenant compliance【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct - the $495 million principal amount for the 3.125% notes is accurate for FY 2022-2024, and the current portion transition from $0 to $495 million in FY 2024 is correctly identified. (2) The answer properly synthesizes information across multiple fiscal years and connects the debt evolution to broader refinancing activities. (3) The additional context about the $10 billion senior notes issuance and $16.8 billion term loan repayment in 2024 provides valuable multi-hop synthesis showing the company's integrated debt management strategy. (4) The reasoning about approaching maturity triggering refinancing is sound and well-supported. (5) Entity identification is accurate (Broadcom/AVGO, correct note terms, correct fiscal years). MINOR CONSIDERATIONS: (1) The ground truth answer emphasizes the 'stable' nature of the obligation in FY 2022-2023 and the 'transition' in FY 2024, while the LLM answer uses slightly different framing ('stayed constant' and 'rose to') - both are semantically equivalent and accurate. (2) The LLM answer goes beyond the ground truth by incorporating additional refinancing context (the $10B issuance and $16.8B repayment), which enriches the answer and demonstrates deeper synthesis, though this wasn't explicitly in the ground truth statement. This is a strength rather than a weakness as it provides more complete insight into the refinancing strategy. (3) Page references are included in the LLM answer, adding credibility. The answer fully addresses the question's three components: evolution across years, short-term debt management, and refinancing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 473,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across each 10‑K (2022, 2023, and 2024), AMD’s agreements with add‑in‑board (AIB) manufacturers consistently “protect their inventory of our products against price reductions” (see page 13 of each filing).  The same section also reiterates that system integrators “often use discrete graphics solutions as a means to differentiate their products and add value to their customers,” underscoring AMD’s continued emphasis on discrete GPUs as a differentiation lever.  In short, the inventory‑protection policy and the role of discrete graphics in differentiation remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies and cites the consistent inventory protection policy across 2022-2024 and accurately notes the repeated emphasis on discrete graphics as a differentiation tool. The citation to 'page 13 of each filing' and the direct quote about inventory protection are factually accurate. The answer properly synthesizes the multi-hop requirement by connecting AMD's AIB relationships across three years and identifying the stable nature of both the inventory policy and discrete graphics strategy. However, the answer is somewhat narrower in scope than the ground truth. The ground truth provides additional context about: (1) the specific role of AIBs in building and selling board-level products to system integrators, retailers, and sub-distributors; (2) the emphasis on 'short design cycles' and 'rapid response to new technologies' as strategic elements; and (3) the characterization of discrete graphics as a 'key channel for expanding AMD's GPU technology in competitive markets.' The LLM answer focuses primarily on the inventory protection policy and discrete graphics differentiation, but omits the broader strategic context about design cycles, rapid technology response, and market expansion implications. The answer correctly identifies that there were 'no explicit quantitative changes' (implicitly, by not claiming any), which aligns with the ground truth's statement about 'no explicit quantitative changes in AIB-related revenue disclosed.' The reasoning is sound and the multi-hop synthesis across three years is correct, but the answer is less comprehensive than the ground truth in capturing the full strategic evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 457,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s 2022 strategy focused on launching an ad‑supported Disney+ service, new pricing, and cost realignment to strengthen its DTC footprint (page 22). By 2024 the company had shifted to heavy strategic investments in its DTC platforms—including ESPN and a Star India joint venture—to drive subscription and advertising revenue growth while confronting a crowded DTC market and intensified competition for content and pricing (page 23, page 53). The 2024 outlook explicitly states that these investments should generate growth in subscription fees and advertising revenue that more than offsets declining linear‑network revenue (page 53, page 54).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Disney's DTC strategy from 2022 to 2024 and correctly identifies the key strategic shift. STRENGTHS: (1) Accurately identifies the 2022 focus on ad-supported Disney+, pricing, and cost realignment; (2) Correctly notes the 2024 shift to heavy strategic investments in DTC platforms including ESPN and Star India joint venture; (3) Properly synthesizes the multi-hop concept that 2024 investments should offset declining linear revenue; (4) Correctly identifies competitive pressures as a key factor in 2024; (5) Page citations are appropriate and suggest proper source documentation. WEAKNESSES: (1) The answer lacks explicit mention of the 2022 cautionary language about financial risks and potential negative returns that the ground truth emphasizes ('costs and associated losses may continue to grow' and 'returns may be negative or lower'). This is a notable omission as it represents the starting point of the evolution; (2) The answer doesn't explicitly capture the 2023 intermediate position, which the ground truth identifies as a key transition point where Disney became more confident about DTC investments offsetting linear declines; (3) The phrasing 'heavy strategic investments' is somewhat vague compared to the ground truth's more precise characterization of the shift from 'cautious investment' to 'more integrated and strategically dependent posture'; (4) While the answer mentions competitive pressures in 2024, it doesn't fully capture the nuance that by 2024 DTC had become 'operationally critical' to Disney's business model. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the progression, though it compresses the 2023 transition point. The logic connecting investment focus to competitive positioning to revenue growth expectations is sound. NUMERIC/FACTUAL ACCURACY: No specific numbers are provided in either answer, so quantitative verification is not applicable. The factual claims about strategic initiatives (ad-supported tier, ESPN, Star India) appear accurate based on the ground truth context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 577,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "From 2022 through 2024 PayPal’s fixed‑rate 2.850% notes remained unchanged: the principal stayed at $1.5 billion, the maturity date stayed 10/1/2029, and the effective interest rate stayed 2.96%. Consequently, the maturity obligation for that note was constant across the three years, with the $1.5 billion due on 10/1/2029. While the company’s overall debt schedule shifted slightly (e.g., future principal payments for other notes), the 2.850% note’s debt structure and maturity obligations did not evolve during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 2.850% notes remained at $1.5 billion principal across 2022-2024, correctly states the maturity date as 10/1/2029, and accurately notes that this specific note's structure did not change during the period. The effective interest rate of 2.96% is also correct. CRITICAL WEAKNESSES: (1) The LLM answer fundamentally fails to address the broader debt structure evolution that is central to the question. The ground truth explicitly states total term debt increased from $9.0B (2022) to $10.638B (2023) to $10.574B (2024) - this multi-hop synthesis across years is completely absent from the LLM response. (2) The ground truth highlights a strategic shift where PayPal issued new debt with higher rates (5.150% and 5.500% notes) in 2024 while maintaining the 2.850% notes - this important contextual evolution is missing. (3) The LLM's statement that 'the company's overall debt schedule shifted slightly' is vague and lacks the specific numbers and strategic context provided in the ground truth. (4) The question explicitly asks about how the relationship 'evolved' - the LLM essentially answers that it didn't evolve, missing the broader narrative of changing debt composition and financing strategy. QUANTITATIVE VERIFICATION: All specific numbers about the 2.850% notes are correct ($1.5B, 10/1/2029, 2.96%), but the answer omits the critical multi-hop data about total debt levels across years. MULTI-HOP REASONING: The LLM failed to synthesize information about the broader debt context (total term debt figures, new issuances in 2024) that would demonstrate how PayPal's relationship with these notes evolved within its changing capital structure. The answer is technically accurate about the specific note but incomplete in addressing the full scope of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan held $181 million in corporate stock in each of 2022, 2023 and 2024 (176 million Level 1 + 5 million Level 2) – a stable absolute amount that represented roughly 4.1 % of total plan assets (4,363 million in 2022, 4,400 million in 2023 and 2024)【page_58】.  At the same time, the plan’s equity allocation fell sharply from 48 % in 2022 to 24 % in 2023 and remained at 24 % in 2024【page_56】, indicating a deliberate de‑risking of the portfolio that reduces overall equity exposure while preserving a core corporate‑stock position.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims UNP held $181 million in corporate stock in 2022, but the ground truth explicitly states it was $1,990 million in 2022, declining to $181 million in 2023. This is a massive discrepancy ($1,990M vs $181M) that represents the core finding of the question. The LLM completely misses the 'significant decline' that is central to the original answer. (2) INCOMPLETE TEMPORAL ANALYSIS: While the LLM correctly identifies $181 million for 2023, it fails to capture the dramatic year-over-year change from 2022 to 2023 (a reduction of $1,809 million or ~91%). The LLM incorrectly characterizes this as 'stable' across all three years. (3) RECLASSIFICATION DETAIL MISSING: The ground truth notes an important strategic shift in 2024 where common stock holdings were reclassified as Level 1 investments while preferred shares became Level 2. The LLM mentions Level 1/Level 2 classifications but doesn't capture this reclassification narrative or its significance. (4) EQUITY ALLOCATION PERCENTAGES: The LLM correctly cites the equity allocation decline from 48% (2022) to 24% (2023-2024), which aligns with the ground truth's characterization of 'de-risking.' However, this correct observation cannot compensate for the fundamental error in the corporate stock dollar amounts. (5) MULTI-HOP REASONING: The LLM fails to synthesize the relationship between the dramatic decline in corporate stock holdings ($1,990M to $181M) and the overall equity allocation reduction (48% to 24%), missing the key insight that the company made a strategic shift away from direct equity exposure. The answer demonstrates a fundamental misunderstanding of the 2022-2023 transition, which is the critical evolution the question asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 501,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million** at December 31, 2022 to **$719 million** at December 31, 2024, a decline of **$81 million** (≈10 %). This modest contraction suggests the company is keeping a relatively small, but slightly reduced, allocation to illiquid alternative investments, reflecting a cautious or balanced portfolio strategy rather than an aggressive expansion into private equity. (Sources: page_86, page_83)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the 2022 value as $800 million, but the ground truth clearly shows $623 million - a $177 million discrepancy (28% error). The 2024 value of $719 million is correct. The calculated decline of $81 million is mathematically correct based on the LLM's incorrect 2022 figure ($800M - $719M = $81M), but this calculation is built on a false premise. The correct decline should be $623M to $719M, which is actually an INCREASE of $96 million, not a decrease. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM completely omits the 2023 intermediate data point ($755 million), which is crucial for understanding the trend. The ground truth explicitly notes growth from 2022 to 2023 ($623M to $755M) followed by a decline in 2024 ($755M to $719M). This three-year trajectory is essential context that the LLM missed entirely. (3) REASONING ERRORS: The LLM's conclusion that the company is 'keeping a relatively small, but slightly reduced allocation' is contradicted by the actual data showing a net increase from 2022 to 2024. The characterization of 'modest contraction' is factually wrong - there was expansion, not contraction, over the full period. (4) ENTITY/METRIC ACCURACY: While Pfizer and the metric (long-term private equity securities at cost) are correctly identified, the temporal analysis is flawed due to missing the 2023 data point. The ground truth's nuanced interpretation of 'short-term growth strategy in 2023, followed by modest retrenchment in 2024' provides important strategic context that the LLM's oversimplified two-year comparison cannot capture. The LLM's answer would mislead investors about the actual direction and magnitude of Pfizer's alternative investment allocation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 503,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security framework grew in scope rather than in form: the company continued to partner with issuers, acquirers, merchants, governments, industry associations and public‑private partners to set technical standards and share best practices, while expanding its real‑time payment infrastructure from 12 markets in 2022 to 13 in 2023 and adding domestic processing in China in 2024.  Throughout this period the security posture remained a layered program—security operations centers, fusion and intelligence centers, an enterprise resilience program, regular penetration testing, insurance coverage and third‑party assessments—ensuring resilience against cyber threats while supporting the broader, faster payment network.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Mastercard's security approach from 2022-2024, appropriately emphasizes third-party collaboration expansion, and accurately describes the multi-layered security components (SOCs, Fusion Centers, Intelligence Centers, penetration testing, insurance). The answer demonstrates good understanding of the strategic shift toward ecosystem integration and provides relevant context about partnerships with issuers, acquirers, merchants, and governments. CRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states real-time payment infrastructure expanded from '12 markets in 2022 to 13 in 2023,' but the ground truth only mentions '13 markets as of year-end' (2023) without specifying 2022 baseline as 12. The LLM introduces a specific 2022 figure (12 markets) that is not verified in the ground truth. (2) CHINA CLAIM - The LLM adds 'adding domestic processing in China in 2024' which is not mentioned in the ground truth and cannot be verified. This represents an unsupported factual claim. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes the 2023 expansion to include third-party service providers in threat monitoring framework explicitly, while the LLM mentions third-party collaboration more generally without clearly distinguishing the 2023 evolution. PARTIAL CREDIT: The answer correctly captures the overall narrative arc and security components, but the introduction of unverified numbers (12 markets in 2022) and the China processing claim represent factual inaccuracies that undermine reliability. The qualitative understanding is sound, but quantitative precision is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 454,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements – shown in the “Other assets, including intangibles – net” line – fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (see pages 102 and 99). The steady decline indicates the company has been able to reduce the collateral required to support its derivative positions, reflecting more efficient netting, a lower overall derivative exposure, or stronger hedging practices over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) WRONG 2022 FIGURE: LLM states $1.49 billion in 2022, but ground truth shows $800 million at end of 2022. This is a 86% overstatement. (2) CORRECT 2023 FIGURE: LLM correctly states $800 million in 2023, but this is actually the 2022 figure per ground truth (end of 2022 reported in 2023 filing). (3) CORRECT 2024 FIGURE: LLM correctly states $491 million in 2024, which matches ground truth (end of 2023 reported in 2024 filing). (4) MISSING BASELINE: LLM fails to mention the 2021 baseline of $641 million, which is important context for understanding the full trend. (5) CALCULATION ERROR: LLM describes a 'steady decline' but the actual pattern is more complex: $641M (2021) → $800M (2022, +25%) → $491M (2023, -39%). The ground truth correctly identifies a 38% decrease from 2022 to 2024 ($800M to $491M). LLM's calculation of the overall trend is therefore incorrect. (6) REASONING QUALITY: While the LLM's interpretation about derivative exposure management and netting efficiency is reasonable and aligns with ground truth's conclusion, it is built on incorrect numerical foundations. The qualitative reasoning about 'more efficient netting' and 'lower derivative exposure' is sound but cannot be properly evaluated when the underlying data is wrong. (7) ENTITY/METRIC ACCURACY: The LLM correctly identifies ExxonMobil, the master netting arrangements, and the 'Other assets, including intangibles - net' line item. However, the year-to-year mapping is confused (mixing reporting years with fiscal years). The answer demonstrates a fundamental misunderstanding of the data structure and contains a major numerical error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 487,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative TSR model used an expected volatility of 26.9 % for 2022, 28.6 % for 2023, and 18.7 % for 2024 【page_215】. The drop from 28.6 % to 18.7 % in 2024 indicates that market participants now view Duke Energy as less volatile relative to its peer group, suggesting a perception of lower market‑risk or greater earnings stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All three volatility percentages are factually correct: 26.9% (2022), 28.6% (2023), and 18.7% (2024). (2) The numeric values are presented with proper formatting and precision. (3) The LLM correctly identifies the peak in 2023 and the significant decline to 2024. (4) The interpretation that the 2024 decline suggests lower market risk perception is accurate and well-reasoned. WEAKNESSES: (1) The LLM answer is incomplete in addressing the full scope of the question. The original answer explicitly describes the three-year trajectory as showing 'a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty.' The LLM focuses primarily on the 2023-2024 comparison and doesn't fully characterize the complete 2022-2024 arc. (2) The LLM answer omits discussion of the 2022-2023 increase (from 26.9% to 28.6%), which is part of the multi-year shift requested in the question. The original answer explicitly notes this increase as part of the trajectory. (3) While the LLM's interpretation of the 2024 decline is sound, it doesn't fully synthesize the complete narrative of the three-year period - the rise then fall pattern that suggests market perception evolved through a cycle. (4) The phrase 'greater earnings stability' in the LLM answer is a reasonable inference but goes slightly beyond what the ground truth explicitly states. MULTI-HOP REASONING: The LLM correctly synthesizes information about the TSR model's volatility assumptions across three years, but only partially addresses the multi-year shift aspect of the question. The reasoning about what the decline suggests is sound, but incomplete relative to the full three-year narrative. OVERALL: The answer is factually accurate on all numbers and provides reasonable interpretation, but falls short of comprehensively addressing the 'multi-year shift' aspect by not fully characterizing the 2022-2023 increase as part of the overall trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 538,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024, GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions claims and related recalls remained described as “unable to estimate any reasonably possible material loss” and “immaterial amount,” with no change in the nature of the obligation. The remaining accrual for the Takata inflator recall fell from $609 million reported in the 2023 10‑K to $555 million in the 2024 10‑K, indicating a decline in the estimated cost of the recall. The 2022 10‑K did not provide a specific remaining‑accrual figure, so the downward trend is evident only from 2023 onward.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM cites specific accrual figures ($609 million in 2023 and $555 million in 2024) for Takata inflator recalls. However, the ground truth explicitly states that GM's indemnification obligations to Stellantis were 'immaterial' across all three years (2022-2024), with no mention of accruals in the hundreds of millions of dollars. These large dollar amounts appear to be fabricated or confused with different accruals (possibly GM's own Takata accruals rather than Stellantis indemnification obligations). (2) MISCHARACTERIZATION OF NATURE: The LLM describes the obligation as 'unable to estimate any reasonably possible material loss' which contradicts the ground truth's characterization of obligations as 'immaterial' and 'remote.' These are different legal/accounting concepts. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the evolution across three years. The ground truth shows a clear progression: 2022 (immaterial, potential future obligations), 2023 (immaterial, future Takata considered remote), 2024 (remote, plus immaterial accrual for EC/CMA investigations). The LLM misses the EC/CMA investigation accrual entirely. (4) SCOPE CONFUSION: The LLM conflates Takata recall accruals with Opel/Vauxhall emissions claims, but the ground truth distinguishes between them - emissions claims are mentioned separately from Takata recalls. (5) CALCULATION ERROR: The claimed decline from $609M to $555M ($54M reduction) is presented as evidence of a 'downward trend,' but these figures appear to be incorrect entirely based on the ground truth's emphasis on immateriality. The answer demonstrates fundamental misunderstanding of the question and provides numbers that cannot be verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 508,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across AMD’s 2022, 2023, and 2024 10‑K filings, the company consistently incorporated the 2011 Executive Incentive Plan as Exhibit 10.2 to its quarterly report, using the identical wording: “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” This unchanged reference appears in all three filings (see 2024 page 98, 2023 page 99, and 2022 page 91) and signals that AMD treats the 2011 plan as a foundational, long‑term element of its executive‑compensation framework, underscoring a stable, enduring incentive strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH: The LLM states the plan was listed as 'Exhibit 10.2' but the ground truth clearly indicates it was 'Exhibit 10.1'. This is a factual error that contradicts the original answer. (2) DATE ERROR: The LLM references 'April 2, 2011' as the filing date, but the ground truth states the plan was 'filed on April 2, 2011' - however, the LLM's phrasing 'for the period ended April 2, 2011' is confusing and potentially incorrect. The ground truth simply says 'filed on April 2, 2011' without reference to a period ending date. (3) PAGE NUMBER VERIFICATION: The LLM provides specific page numbers (2024 page 98, 2023 page 99, 2022 page 91) that cannot be verified against the ground truth, which provides no page references. These appear to be fabricated details. (4) QUOTE ACCURACY: The LLM provides a specific quote with 'Exhibit 10.2' embedded in it, but this contradicts the ground truth's statement that it was 'Exhibit 10.1'. (5) MULTI-HOP REASONING: While the LLM correctly identifies the consistency theme across three years and draws the appropriate conclusion about stable compensation strategy, the factual foundation is compromised by the exhibit number error. (6) SEMANTIC ALIGNMENT: The overall interpretation about consistency and long-term strategy is sound, but the specific factual claims are incorrect. The core insight about stability is correct, but the supporting details are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 401,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "In 2022 PayPal warned that its branded‑credit programs exposed it to default risk, that proprietary credit‑risk models could mis‑predict borrower quality, and that reliance on third‑party lenders and payment processors added operational risk, while cross‑border trade was vulnerable to currency, tariff and regulatory shifts (pages 24‑28). By 2023 the company mitigated this exposure by selling up to €40 bn of UK and European BNPL loan receivables and establishing a forward‑flow arrangement, diversifying its payment‑processor base, and tightening fraud‑detection and credit‑risk models (pages 23‑27). In 2024 PayPal still faces similar credit‑product, cross‑border and third‑party risks, but continues to strengthen risk models, broaden partner relationships, and invest in fraud‑prevention to manage bad‑transaction exposure (pages 21‑25).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) Correctly identifies the €40 billion BNPL receivables sale in 2023 as a key strategic mitigation action, matching the ground truth exactly. (2) Accurately captures the 2022 risks related to credit defaults, Synchrony Bank partnership, and proprietary credit-risk model limitations. (3) Properly synthesizes the evolution across three years (2022-2024) showing progression from risk identification to mitigation to ongoing management. (4) Correctly identifies third-party dependencies and cross-border trade risks as persistent themes. (5) Mentions forward-flow arrangements and fraud-detection improvements as additional 2023 mitigation steps. MINOR WEAKNESSES: (1) The LLM answer adds details about 'diversifying payment-processor base' and 'tightening fraud-detection and credit-risk models' in 2023 that are not explicitly mentioned in the ground truth, though these are reasonable inferences from risk management practices. (2) The ground truth specifically mentions 'regulatory uncertainty, especially around the validity of loan sales post-transfer' in 2024, which the LLM answer does not explicitly capture, though it does mention 'regulatory shifts' in cross-border context. (3) The ground truth emphasizes 'economic conditions like recessions and high unemployment' as exacerbating factors in 2022, which the LLM answer does not mention. QUANTITATIVE VERIFICATION: The €40 billion figure is correct and properly formatted. No calculations are required. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple risk categories (credit products, cross-border trade, third-party dependencies), demonstrating sound multi-hop reasoning. The causal connection between 2022 risks and 2023 mitigation actions is clearly established. SEMANTIC EQUIVALENCE: The answer conveys the core information accurately, with appropriate wording variations that maintain factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 551,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s multiple‑purpose locomotive fleet grew slightly in owned units (from 5,971 to 5,973) while the leased count fell (from 1,037 to 920), reducing the total fleet from 7,008 to 6,893 and raising the average age from 24.3 to 25.2 years (page_22; page_19). This trend reflects a deliberate shift toward a leaner, older core fleet and greater use of leasing to manage capital costs, while the company’s $3.4 billion 2024 capital program continues to add new locomotives to replace aging equipment (page_19).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant factual errors that contradict the ground truth: (1) Owned units: LLM states 5,971 to 5,973 (essentially flat), but ground truth shows 6,204 to 5,973 (a decrease of 231 units or 3.7%). This is a major discrepancy. (2) Leased units: LLM states 1,037 to 920, but ground truth shows 1,038 to 920 (minor difference of 1 unit, acceptable). (3) Average age: LLM states 24.3 to 25.2 years, but ground truth shows 22.5 to 25.2 years. The starting age of 24.3 is incorrect; it should be 22.5 years. This is a 1.8-year error in the baseline. (4) Total fleet: LLM calculates 7,008 to 6,893, but ground truth implies 7,242 (6,204+1,038) to 6,893 (5,973+920). The starting total is wrong. REASONING ERRORS: The LLM's interpretation of the strategy is inverted. The ground truth indicates a strategy that 'prioritizes cost control over aggressive modernization,' while the LLM claims the company is 'adding new locomotives to replace aging equipment' via a $3.4B capital program. However, the data shows the fleet is aging (average age increased 2.7 years), which contradicts the claim of active replacement. The LLM misinterprets the capital spending as evidence of modernization when the actual fleet metrics show aging, not rejuvenation. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the relationship between owned/leased changes and fleet aging. The significant decrease in owned units (231 units) combined with increased average age indicates insufficient new purchases, which the ground truth correctly identifies. The LLM's narrative about 'leaner, older core fleet' is partially correct but undermined by the wrong baseline numbers. POSITIVE ASPECTS: The LLM correctly identifies the trend toward reduced leasing and correctly states the final average age of 25.2 years. The mention of capital spending shows attempt at comprehensive analysis, though the interpretation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 531,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements tied to equity‑company receivables fell sharply—from $1.494 billion at December 31 2022 to $491 million at December 31 2024, a drop of roughly $1.0 billion (≈67 %). This steep decline signals a more efficient derivative‑risk strategy, likely driven by smaller net derivative positions, tighter netting, or improved counterparty credit quality that reduces collateral needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 figure as $1.494 billion, but the ground truth clearly shows $641 million for 2022. This is a massive discrepancy ($1.494B vs $641M - off by ~$853M or 133%). The LLM also omits the 2023 intermediate data point ($800M), which is essential for understanding the trend. The calculation of a $1.0 billion decline is based on the incorrect 2022 starting point. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly provides three data points (2022: $641M, 2023: $800M, 2024: $491M) showing a peak-and-decline pattern. The LLM only references 2022 and 2024, missing the critical 2023 peak that is central to understanding the trend. (3) MISCHARACTERIZATION OF TREND: The ground truth describes a rise to $800M in 2023 followed by a decline to $491M in 2024, suggesting a shift in strategy. The LLM characterizes this as a 'sharp fall' from 2022 to 2024, which misses the intermediate peak and provides an incomplete picture of risk management dynamics. (4) REASONING QUALITY: While the LLM's interpretation about derivative risk management efficiency is plausible, it is built on incorrect foundational numbers, making the entire analysis unreliable. The percentage calculation (67% decline) is mathematically correct for the stated numbers but based on wrong data. (5) MISSING CONTEXT: The ground truth mentions level 3 fair value inputs and internal model reliance, which the LLM does not address. The ground truth's nuanced interpretation of 'dynamic risk positioning' is more sophisticated than the LLM's simpler 'efficiency' narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 464,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” category was defined identically in each 10‑K: packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, and serveware.  Its revenue rose from $6.89 B (≈21 % of total) in 2022 to $7.71 B (≈22 %) in 2023, then fell slightly to $7.54 B (≈21 %) in 2024, keeping its share of total revenue roughly stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the composition of the 'Other' category and accurately notes its stability across the three-year period, which aligns with the ground truth. The qualitative assessment is sound: the answer properly synthesizes that the category remained consistent with the same components (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware) across 2022-2024. However, there is a critical issue with quantitative accuracy. The LLM provides specific revenue figures ($6.89B in 2022, $7.71B in 2023, $7.54B in 2024) and percentage shares (21%, 22%, 21%), but the ground truth does not provide these specific numbers. The ground truth explicitly states there was 'no explicit mention of new product categories or significant shifts' and focuses on compositional stability rather than revenue figures. The LLM appears to have introduced specific financial data that cannot be verified against the provided ground truth. While the trend direction (relatively stable with slight fluctuation) is reasonable and the percentage shares are plausible, the specific dollar amounts are presented as fact without grounding in the original answer. This represents a significant quantitative accuracy problem where the model may have hallucinated or inferred numbers not present in the source material. The answer does address the evolution question and correctly identifies the stable composition, but the introduction of unverified specific numbers substantially undermines confidence in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 433,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 through 2024 Alphabet maintained the same approach to monetizing inventory on Google Network properties via Google Ad Manager: brand‑advertising revenue is recognized on an impression basis (when the ad is displayed or viewed) and performance‑advertising revenue is recognized when a user engages, and all Google Network property revenue is reported on a gross basis—recording the full amount billed to advertisers as revenue and the partner payments as cost of revenue. The cost‑per‑impression metric continued to be defined as impression‑based and click‑based revenues divided by total impressions, with no change in the recognition or reporting methodology across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the consistent monetization approach across 2022-2024 using Google Ad Manager on Google Network properties; (2) Accurately describes impression-based and click-based revenue recognition models; (3) Correctly states that Google Network property revenues are reported on a gross basis (full amount billed to customers as revenue); (4) Properly defines the cost-per-impression metric as impression-based and click-based revenues divided by total impressions; (5) Accurately notes no change in recognition or reporting methodology across the three years; (6) Correctly identifies Alphabet as the parent company. MINOR CONSIDERATIONS: (1) The LLM answer adds detail about 'brand-advertising' vs 'performance-advertising' revenue recognition timing (impression-based vs engagement-based) which is not explicitly mentioned in the ground truth, though this appears to be accurate supplementary detail rather than contradictory information; (2) The ground truth emphasizes 'increasing transparency and accounting clarity over time' and the company's role as 'principal in transactions,' while the LLM answer focuses more on the consistency of methodology rather than the evolution of transparency/clarity - this represents a slight difference in emphasis but not factual error; (3) The LLM answer is more specific and detailed than the ground truth while remaining consistent with it. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period (2022-2024) and correctly identifies the consistent approach to monetization, revenue recognition, and reporting. The reasoning is sound and logically structured. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is not directly testable, but the conceptual metrics (cost-per-impression calculation) are correctly stated. Overall, the LLM answer is more detailed and operationally specific than the ground truth while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 566,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s exposure to sales‑and‑media marketing restrictions has remained essentially the same from 2022 through 2024, with the company continuing to face regulatory limits on promotions and advertising of products with specific nutrient profiles and on front‑of‑pack labeling requirements.  The 10‑Ks consistently note that extended‑producer‑responsibility (EPR) policies have broadened to additional jurisdictions – the EU, India, Vietnam and several U.S. states – and that single‑use plastic bans and plastic taxes are being considered in Europe and Southeast Asia.  Thus, while the core regulatory framework stays stable, the geographic scope of EPR obligations has expanded over the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The identification of EPR policy expansion across EU, India, Vietnam, and U.S. states is accurate; (2) The mention of single-use plastic bans and taxes being considered in Europe and Southeast Asia aligns with ground truth; (3) The general characterization of regulatory expansion across jurisdictions is sound. SIGNIFICANT ERRORS AND OMISSIONS: (1) The LLM states exposure 'has remained essentially the same from 2022 through 2024' - this directly contradicts the ground truth which shows clear EVOLUTION: 2022 had 'over 25 EU countries' with EPR, 2023 emphasized 'increased attention to front-of-pack labeling,' and 2024 showed 'formal adoption of the Packaging and Packaging Waste Directive' with shift 'from contemplation to enforcement.' The LLM misses this critical temporal progression; (2) The LLM fails to mention the specific quantitative detail of 'over 25 EU countries' implementing EPR in 2022; (3) The LLM does not capture the important distinction that by 2024, EPR policies shifted from being 'considered' to 'implemented or contemplated' - a meaningful regulatory escalation; (4) The LLM omits the EU's formal adoption of the Packaging and Packaging Waste Directive in 2024, which is a key regulatory milestone; (5) The LLM misses the specific emphasis on front-of-pack labeling based on nutrient profiles that became more prominent in 2023-2024. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the three years. The ground truth shows a clear progression from awareness (2022) → increased focus on labeling (2023) → formal enforcement mechanisms (2024). The LLM's characterization of 'stable core framework with expanding geography' misses the substantive regulatory intensification. The answer reads as a static summary rather than capturing the dynamic evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 519,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Between 2022 and 2024, Mastercard’s Class A shares consistently retained one vote per share and dividend rights each year (see Note 16 tables on pages 94, 99, 91).  The dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024.  This steady voting‑rights policy combined with a predictable, gradually increasing dividend schedule signals a conservative capital‑structure strategy that prioritizes governance stability while steadily rewarding shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that A Class shares maintained one vote per share and dividend rights consistently across 2022-2024, matching the ground truth. The reasoning about capital structure stability is sound and appropriately addresses the question's intent. However, there is a significant quantitative accuracy issue: the LLM introduces dividend per share amounts ($2.04, $2.37, $2.74) that are NOT present in the original ground truth answer. The ground truth explicitly states only that A Class shares maintained 'dividend rights' without specifying actual dividend amounts per share. The LLM appears to have added information beyond what was verified in the knowledge graph, which violates the principle of strict accuracy on financial numbers. While the dividend trend interpretation (gradually increasing, conservative strategy) is reasonable and contextually relevant, introducing unverified numerical data is a material error in a financial context. The page references (Note 16, pages 94, 99, 91) cannot be verified against the ground truth provided. The answer goes beyond the ground truth by characterizing the strategy as 'conservative' and 'rewarding shareholders,' which adds interpretive value but wasn't explicitly stated in the original answer. The multi-hop synthesis is adequate (connecting voting rights, dividend rights, and capital structure strategy), but the introduction of unverified dividend amounts significantly undermines quantitative reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 415,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements dropped from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**【page_102】【page_99】.  \nThe declining collateral indicates that the company’s initial‑margin requirement – and thus its net derivative exposure – has been shrinking, likely due to reduced derivative positions or improved credit quality and clearing arrangements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect numbers for 2022. Ground truth states $641 million for 2022, but LLM claims $1.494 billion - this is a massive discrepancy (133% overstatement). The 2023 ($800M) and 2024 ($491M) figures are correct. (2) MULTI-HOP SYNTHESIS - The LLM failed to correctly identify the specific collateral metric. The question asks about collateral related to 'Investments, advances and long-term receivables' under master netting arrangements. The LLM appears to have cited a different collateral figure entirely for 2022, suggesting it pulled data from the wrong line item or section of the filing. (3) TREND ANALYSIS - The LLM's interpretation of the trend is partially reasonable (declining collateral suggesting reduced derivative exposure), but this analysis is built on incorrect 2022 data. The actual trend shows: $641M → $800M (increase) → $491M (decrease), which is more nuanced than simple decline. The LLM missed the important 2023 spike. (4) REASONING QUALITY - While the LLM's logic about margin requirements and derivative exposure is conceptually sound, it's applied to incorrect data. The conclusion about 'shrinking' exposure is contradicted by the actual 2022-2023 increase. (5) ENTITY/METRIC ACCURACY - The LLM correctly identifies ExxonMobil and the general concept of master netting arrangements, but fails on the specific collateral category and the 2022 baseline figure, which are essential to answering the question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 421,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ 2022 10‑K stated that its fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward contracts, would secure green‑coffee supply through fiscal 2023【SBUX_10k_2022.pdf page_12】. The 2023 filing extended that horizon to fiscal 2024, and the 2024 filing pushed it further to fiscal 2025【SBUX_10k_2023.pdf page_12】【SBUX_10k_2024.pdf page_12】. This incremental extension demonstrates the company’s deliberate strategy of locking in supply and using hedging instruments (forward contracts, futures, collars) to mitigate coffee‑price volatility and reduce supply risk over a longer planning horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the progression of Starbucks' forward-looking supply commitments across the three fiscal years and accurately captures the strategic intent around hedging and risk mitigation. The answer correctly names the hedging instruments (forward contracts, futures, collars) and demonstrates sound multi-hop reasoning by synthesizing information across three separate 10-K filings. The semantic meaning aligns well with the ground truth regarding the company's deliberate strategy for longer-term supply stability.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM contains a significant factual error in the fiscal year progression. According to the ground truth: FY2022 → supply through FY2023; FY2023 → supply through FY2025; FY2024 → supply through FY2025. However, the LLM states: FY2022 → FY2023; FY2023 → FY2024; FY2024 → FY2025. The FY2023 filing should extend to FY2025, not FY2024. This is a material error in the quantitative timeline that undermines the accuracy of the progression narrative.\n\nMINOR ISSUES: The LLM uses slightly different phrasing ('fixed-price and price-to-be-fixed purchase commitments' vs. the ground truth's 'purchase commitments'), though this is semantically acceptable. The answer appropriately emphasizes the 'incremental extension' strategy, which aligns with the ground truth's characterization of a 'strategic shift toward longer-term stability.'\n\nMULTI-HOP REASONING: The synthesis across three years and three documents is logically sound, and the connection between extended commitments and risk mitigation strategy is correctly established. However, the factual error in the FY2023 timeline undermines the validity of the progression analysis.\n\nJUSTIFICATION: The quantitative accuracy score is reduced due to the incorrect fiscal year endpoint for the FY2023 filing (should be 2025, not 2024). This is a factual error that affects the core numerical progression being analyzed. The qualitative accuracy remains relatively strong because the reasoning about strategy and hedging instruments is sound, despite the timeline error. The contextual relevance is high because the answer directly addresses the question's focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 596,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN kept its U.S. pension plans 100 % in debt, but for non‑U.S. plans it shifted the target mix from **27 % equity, 48 % debt, 4 % cash, 11 % insurance, 10 % other** to **28 % equity, 36 % debt, 7 % cash, 21 % insurance, 8 % other** (page 88 → page 95). The move—especially the rise in equity and insurance contracts and the drop in debt—indicates a deliberate strategy to enhance long‑term, risk‑adjusted returns while still matching plan duration and managing risk exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data about ACN's target asset allocation shifts from fiscal 2023 to fiscal 2025, which is a significant strength compared to the ground truth answer's more general discussion. STRENGTHS: (1) The LLM provides concrete percentage allocations for both periods (fiscal 2023: 27% equity, 48% debt, 4% cash, 11% insurance, 10% other vs. fiscal 2025: 28% equity, 36% debt, 7% cash, 21% insurance, 8% other), which directly answers the 'how did it evolve' question. (2) The numbers sum correctly to 100% for both periods, indicating internal consistency. (3) The LLM correctly identifies the key shifts: equity up 1%, debt down 12%, cash up 3%, insurance up 10%, other down 2%. (4) The LLM distinguishes between U.S. plans (100% debt) and non-U.S. plans, showing nuanced understanding. (5) The interpretation about enhanced risk-adjusted returns and liability matching aligns with the ground truth's emphasis on 'balancing return generation with liability matching and risk mitigation.' (6) Page references (88 → 95) suggest specific sourcing. WEAKNESSES: (1) The ground truth answer emphasizes fiscal 2023, 2024, and 2025 as a three-year evolution, but the LLM only provides two specific data points (fiscal 2023 and 2025), missing the fiscal 2024 intermediate year. (2) The ground truth mentions 'updated flexibility ranges to respond to market conditions' which the LLM doesn't address. (3) The ground truth references the 2022 10-K for fiscal 2023 data and 2024 10-K for fiscal 2025 data, showing proper multi-hop sourcing, while the LLM's sourcing is less explicit about which filings contain which data. (4) The LLM's statement about U.S. plans being '100% in debt' is a specific claim that cannot be verified against the provided ground truth, though it doesn't contradict it either. QUANTITATIVE VERIFICATION: The percentage shifts are mathematically sound and the interpretation (debt down 12 percentage points, insurance up 10 percentage points) correctly identifies the most significant changes. The answer directly addresses the multi-hop requirement by synthesizing allocation data across two fiscal years and connecting it to investment strategy implications. The reasoning about risk-adjusted returns and liability matching is sound and supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 619,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen has kept Olpasiran’s therapeutic focus unchanged, continuing to develop it as a phase‑2 siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease in the 2022, 2023 and 2024 10‑Ks (see 2022 p. 28; 2023 p. 28; 2024 p. 24).  The composition‑of‑matter patents that protect Olpasiran in the U.S. and Europe were issued in 2022 and are still listed in 2023 and 2024 with an estimated expiration in 2036, indicating a stable intellectual‑property protection timeline (see 2022 p. 26; 2023 p. 26; 2024 p. 26).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The patent expiration date of 2036 is accurate; (2) The therapeutic indication for atherosclerotic cardiovascular disease is correct; (3) The identification of Olpasiran as an siRNA is correct; (4) The multi-year tracking across 2022-2024 is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM states the patents 'were issued in 2022' - this is not supported by the ground truth, which only states they were disclosed in 2023 with an estimated 2036 expiration. The ground truth does not confirm 2022 as the issuance date. (2) The LLM characterizes the therapeutic focus as 'unchanged' and 'stable,' but the ground truth indicates an EVOLUTION from 'phase 2 trials for atherosclerotic CV disease' (2022) to 'indicated for Cardiovascular disease' (2024), suggesting a progression from investigation to more advanced development/regulatory preparation. The LLM misses this strategic evolution. (3) The LLM adds specific detail about 'lowers lipoprotein(a)' which, while potentially accurate, is not mentioned in the ground truth answer and represents information not synthesized from the multi-hop question. (4) The ground truth emphasizes 'transition from phase 2 investigation toward more advanced development or potential regulatory preparation' - a key strategic evolution that the LLM completely misses by claiming the focus remained 'unchanged.' MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but fails to identify the qualitative evolution in development stage and therapeutic positioning that the ground truth emphasizes. The answer is factually partially correct on numbers and dates but semantically misses the core narrative of strategic evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 492,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "From 2022 to 2024 American Express’s use of aggregators grew from a peripheral tool for managing merchant relationships to a core element of its integrated payments platform, with the number of third‑party providers expanding each year. In 2022 the company warned that aggregators might pursue business interests that conflict with its own, potentially limiting card acceptance and usage; in 2023 the disclosures broadened the focus to the operational complexity of these relationships, stressing the risk of service disruptions, data‑security breaches and heightened regulatory scrutiny; and in 2024 the emphasis shifted to the growing number of third‑party providers—including aggregators—highlighting governance challenges, the potential for data misuse or loss of data, the risk of regulatory actions, fines, litigation and the difficulty of mitigating such risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of AXP's reliance on aggregators from 2022-2024; (2) Accurately captures the specific risks emphasized in each year: 2022 (merchant steering/conflicting interests), 2023 (operational complexity, service disruptions, data security, regulatory scrutiny), 2024 (governance challenges, data misuse, regulatory actions, litigation); (3) Properly synthesizes information across three fiscal years; (4) No quantitative errors or incorrect dates; (5) Correctly identifies American Express as the subject company; (6) Semantic equivalence is strong - the answer conveys the same core information as the ground truth about escalating risk awareness. MINOR DIFFERENCES: (1) The LLM answer adds detail about aggregators becoming 'a core element of its integrated payments platform' and mentions 'the number of third-party providers expanding each year' - while this is a reasonable inference about growing reliance, the ground truth doesn't explicitly quantify this expansion; (2) The LLM frames the evolution as shifting from 'peripheral tool' to 'core element,' which is a reasonable characterization but slightly more interpretive than the ground truth's focus on 'increasingly emphasized' reliance; (3) The ground truth emphasizes a shift from 'merchant behavior focus to broader systemic and legal concerns,' while the LLM describes it as shifting from 'conflicting interests' to 'governance challenges' - both capture the same evolution but with slightly different framing. VERIFICATION: All years (2022, 2023, 2024) are correct; all risk categories mentioned (steering, surcharging, service disruptions, data security, regulatory actions, litigation) align with ground truth; the progression of emphasis is accurately captured. The answer successfully addresses the multi-part question about both the evolution of reliance AND the risks emphasized in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 544,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks’ exposure to commodity‑index funds remained essentially unchanged from fiscal 2022 through fiscal 2024 – green‑coffee prices were still noted as being influenced by index‑fund activity, and the company continued to hedge price risk with forward contracts, futures and collars.  The forward‑supply commitments, however, were extended each year: they covered an adequate supply through fiscal 2023 in 2022, through fiscal 2024 in 2023, and through fiscal 2025 in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) Commodity index funds remained a consistent factor influencing green coffee prices across fiscal 2022-2024; (2) Hedging strategies (forward contracts, futures, collars) were maintained throughout the period; (3) Forward supply commitments were correctly extended year-over-year: fiscal 2023 (2022), fiscal 2024 (2023), and fiscal 2025 (2024). The quantitative accuracy is excellent - all dates and fiscal year references are correct with no calculation errors. The multi-hop reasoning is sound, correctly synthesizing information about both commodity exposure and supply commitment evolution. However, the LLM answer is slightly less comprehensive than the ground truth in one respect: it states exposure 'remained essentially unchanged' but doesn't explicitly capture the ground truth's insight about 'strategic shift toward longer-term risk mitigation' or the characterization of this as a 'stabilized hedging and procurement strategy.' The LLM's phrasing of 'extended each year' is semantically equivalent to the ground truth's description of the extension pattern. The answer correctly addresses both parts of the multi-part question (commodity exposure evolution AND forward supply commitment changes). Minor semantic differences exist but do not affect factual correctness - the core information is accurate and well-synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 405,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 9.6 million shares for $3.15 million and had an available open‑market authorization of $3.13 million. In fiscal 2023 the company continued to buy back shares and raised its available authorization, paving the way for a larger program in 2024. By fiscal 2024, Accenture had repurchased 2.07 million shares in Q4 alone for $605 million, its available authorization was $2.69 million, and the Board approved an additional $4.0 billion in authority, raising total outstanding authority to $6.694 billion—an evolution that signals a growing, disciplined capital‑return strategy with expanding repurchase capacity and consistent use of that capacity to return value to shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES:\n\n1. UNIT CONFUSION (Most Severe): The LLM systematically confuses millions with thousands throughout the answer:\n   - States 'available authorization of $3.13 million' when ground truth is $3,129,296 thousand (or ~$3.13 billion)\n   - States 'available authorization was $2.69 million' when ground truth is $2,694 million\n   - States 'additional $4.0 billion' correctly but then says 'total outstanding authority to $6.694 billion' - this is correct in billions but contradicts the earlier million figures\n   - This inconsistency suggests fundamental misunderstanding of the scale of these authorizations\n\n2. SHARE REPURCHASE NUMBERS - INCORRECT:\n   - LLM claims 'fiscal 2022: repurchased 9.6 million shares for $3.15 million' - this is nonsensical (9.6M shares for $3.15M = $0.33/share, implausibly low)\n   - Ground truth shows fiscal 2023: 2,000,308 shares for $605 million\n   - LLM claims 'fiscal 2024: repurchased 2.07 million shares in Q4 alone for $605 million' - the $605M figure appears to be from fiscal 2023, not fiscal 2024 Q4\n   - No fiscal 2024 repurchase numbers provided in ground truth to verify LLM's claim\n\n3. TEMPORAL ATTRIBUTION ERROR:\n   - The $605 million repurchase is attributed to fiscal 2024 Q4 in LLM answer, but ground truth clearly states this was fiscal 2023 activity\n   - This is a significant multi-hop synthesis error\n\n4. MISSING INFORMATION:\n   - Ground truth provides specific fiscal 2022 authorization figure ($3,129,296 thousand)\n   - LLM provides no fiscal 2023 repurchase details despite ground truth mentioning 2,000,308 shares purchased\n   - No clear breakdown of the three-year trajectory as requested\n\n5. WHAT WAS CORRECT:\n   - The $4.0 billion additional authority in fiscal 2024 is correct\n   - The $6.694 billion total authorization is correct (in billions)\n   - The general narrative about expanding capital return strategy is directionally correct\n   - The conclusion about disciplined capital-return strategy is reasonable\n\nThe answer demonstrates understanding of the overall narrative but fails catastrophically on numerical accuracy, with systematic unit confusion (millions vs. billions) and temporal misattribution of key figures. The multi-hop synthesis is partially broken due to incorrect data attribution across fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 628,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google’s long‑term marketable equity securities grew from **$803 million** at the end of 2022 to **$1.4 billion** at the end of 2023, then fell sharply to **$266 million** by the end of 2024 (all figures are reported as part of other non‑current assets). This swing shows a brief expansion of illiquid equity exposure in 2023 followed by a substantial divestment or reallocation in 2024, suggesting that Google shifted its portfolio toward greater liquidity or a more risk‑adjusted stance on illiquid assets during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-to-year progression of values. Ground truth shows: 2022=$1.4B → 2023=$803M → 2024=$1.4B. LLM answer states: 2022=$803M → 2023=$1.4B → 2024=$266M. This represents a complete reversal and misalignment of the data sequence. Specifically: (1) The 2022 value is wrong ($803M vs $1.4B), (2) The 2023 value is wrong ($1.4B vs $803M), (3) The 2024 value is completely incorrect ($266M vs $1.4B - off by $1.134B or 81%). These are not minor formatting differences but substantial numerical errors that fundamentally misrepresent the trend. The LLM appears to have inverted or scrambled the year-to-year progression. (2) REASONING QUALITY: While the LLM's interpretation of what the fluctuation suggests (strategic rebalancing, liquidity considerations) is reasonable in tone, it is applied to INCORRECT DATA. The LLM describes a 'brief expansion in 2023 followed by substantial divestment in 2024,' but the actual pattern per ground truth is a decline in 2023 followed by a recovery in 2024 back to 2022 levels. (3) MULTI-HOP SYNTHESIS: The question requires correctly identifying and sequencing three data points across three years. The LLM failed at this fundamental task. (4) ENTITY ACCURACY: Google is correctly identified, and the metric (marketable equity securities under long-term lock-up) is correctly referenced, but the VALUES associated with each year are systematically wrong. This is a critical failure for a financial question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 429,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE classified its captive industrial insurance subsidiary, Electric Insurance Company (EIC), as held for sale in Q4 2022, with a valuation allowance of $17 million. In Q3 2023 it signed a binding agreement to sell EIC, the valuation allowance rose to $124 million, and GE recorded a $109 million loss on the expected sale. The sale was completed in Q2 2024 to Riverstone International Holdings for $120 million, eliminating the valuation allowance and yielding a net gain of roughly $11 million after offsetting the prior loss, reflecting GE’s strategic divestiture of a non‑core insurance asset to focus on core businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) TIMELINE DISCREPANCY - LLM states EIC was classified as held for sale in Q4 2022, but ground truth indicates this occurred in 2023. The ground truth explicitly states '2022: disclosed as captive subsidiary' and 'By 2023, GE had classified EIC as held for sale.' This is a critical factual error affecting the entire narrative. (2) VALUATION ALLOWANCE NUMBERS - LLM introduces valuation allowances of $17M and $124M that do not appear in the ground truth. The ground truth makes no mention of valuation allowances; it only references the $109M loss recorded in 2023 related to the expected sale. These appear to be fabricated numbers. (3) GAIN CALCULATION ERROR - LLM claims a 'net gain of roughly $11 million after offsetting the prior loss' ($120M sale price minus $109M loss = $11M). However, this calculation is problematic: the $109M loss was already recorded in 2023 as a non-cash charge; the 2024 sale at $120M would not 'offset' this in the manner described. The ground truth presents this as a strategic exit with loss recognition in 2023 and monetization in 2024, not as a net gain scenario. (4) MISSING 2022 DETAILS - Ground truth specifies net claim reserves of $0.2 billion at year-end 2022; LLM omits this entirely. (5) MISSING 2023 BALANCE SHEET DATA - Ground truth provides specific asset ($541M) and liability ($378M) figures as of December 31, 2023; LLM does not include these details. (6) CORRECT ELEMENTS - LLM correctly identifies: EIC as captive industrial insurance subsidiary, Riverstone International Holdings as buyer, $120M sale price, Q2 2024 completion, and the strategic divestiture rationale. MULTI-HOP SYNTHESIS: While LLM attempts to synthesize the three-year progression, the fundamental timeline error and introduction of unsupported numbers significantly undermines the accuracy of the multi-hop reasoning. The answer conflates 2022 and 2023 events and adds financial metrics not present in source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 531,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from 13 programs in 2022 to 18 in 2023 and to 24 in 2024, reaching 25 by early 2025 (AMGN_10k_2022, page 25; AMGN_10k_2023, page 26; AMGN_10k_2024, page 25). This expansion—driven by acquisitions (e.g., Horizon), new phase 3 initiations, and regulatory approvals—shows a deliberate strategy to broaden the pipeline across oncology, rare diseases, and biosimilars, deepening therapeutic breadth and accelerating commercial potential.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IDENTIFIED: The LLM answer contains a significant factual error regarding the 2024 figure. The ground truth states Amgen had 24 programs in 2024, then reached 25 by 2024 (or early 2025 based on LLM's phrasing). However, the LLM states '24 in 2024, reaching 25 by early 2025,' which contradicts the ground truth that explicitly says '24 programs in 2024' and '25' as the final 2024 count. The LLM appears to have conflated the progression, suggesting 25 was reached in early 2025 rather than by end of 2024. CORRECT PROGRESSION: 13 (2022) → 18 (2023) → 24 (2024) → 25 (2024/end of period). The LLM's sequence of '13 → 18 → 24 → 25 by early 2025' introduces temporal ambiguity and potential inaccuracy about when the 25th program was added. STRENGTHS: (1) Core numbers 13, 18, 24 are correct; (2) Correctly identifies Horizon acquisition as driver; (3) Appropriately mentions regulatory approvals and therapeutic areas (oncology, rare diseases, biosimilars); (4) Provides document citations with page numbers; (5) Captures strategic intent of pipeline expansion. WEAKNESSES: (1) Temporal sequencing of 24→25 transition is unclear/potentially incorrect; (2) Ground truth indicates 25 programs by 2024, not 'early 2025'; (3) Missing explicit mention that the 25 figure represents the 2024 endpoint; (4) The phrasing 'reaching 25 by early 2025' suggests the 25th program was added after 2024, contradicting ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and identifies key drivers (acquisitions, new initiations, approvals), demonstrating sound multi-hop reasoning. However, the temporal accuracy issue undermines confidence in the synthesis. The answer would score higher (8-9) if the 2024/2025 boundary were correctly stated as per ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 492,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022 to 2024, American Express has shifted its global card‑network strategy from a more independent, licensing‑heavy model to a more regulated, fee‑constrained one. In 2022 the company operated a fourth‑largest global network and maintained licensing businesses in the EU and Australia (pp. 13‑14), but by 2024 it had exited those licensing arrangements in response to regulatory pressure and faced heightened scrutiny over interchange fees and merchant surcharging, which could lower discount rates (pp. 34‑35). The firm’s Category III status in 2024 further increased compliance demands, while competitive dynamics—such as Visa and Mastercard’s proposed settlement on interchange‑fee caps—have forced American Express to adjust its network relationships and pricing strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AXP's evolution but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies the shift from licensing-heavy to regulated/constrained model, mentions EU and Australia exits, references regulatory pressure, and notes competitive dynamics with Visa/Mastercard. The 2022-2024 timeframe is appropriate. (2) PROBLEMATIC ELEMENTS: The answer references specific page numbers (pp. 13-14, pp. 34-35) and 'Category III status' which cannot be verified against the ground truth and may be fabricated citations. The ground truth does not mention 'Category III status' or specific page references. (3) MISSING ELEMENTS: The ground truth emphasizes AXP's positioning as a competitor to Visa, Mastercard, and China UnionPay in 2022, and mentions specific competitive pressures from Alipay and PayPal by 2023. The LLM answer omits these competitive positioning details and alternative payment platform threats. The ground truth highlights 'cobrand arrangements' uncertainty in the EU, which the LLM answer does not mention. (4) QUANTITATIVE ACCURACY: The LLM provides no specific financial metrics, percentages, or quantifiable data points. While the ground truth also lacks specific numbers, the LLM's vague references to 'interchange-fee caps' and 'discount rates' are unsupported by citations. (5) MULTI-HOP REASONING: The LLM does synthesize information across the 2022-2024 period and connects regulatory pressure to business model changes, but the synthesis is less detailed than the ground truth's year-by-year evolution. The connection between Visa/Mastercard settlement and AXP's strategy adjustment is speculative. (6) SEMANTIC ISSUES: The phrase 'licensing-heavy model' is reasonable but the ground truth emphasizes competitive positioning more than licensing as the primary distinction. The answer conflates regulatory constraints with competitive dynamics in a way that oversimplifies the ground truth's more nuanced evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 537,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips began monetizing its CVE common shares in 2021, and in 2022 it sold the remaining 91 million CVE shares, using the proceeds to repurchase 87,709,187 shares that year【page_112】.  The program continued, with 48,641,899 shares repurchased in 2023 and 49,135,049 shares in 2024; cumulatively from inception to the end of 2024, 433 million shares were repurchased at a cost of $34.3 billion【page_112】.  The fair value of the CVE common shares at the time of sale was $218 million【page_141】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific share repurchase volumes for 2022-2024 (87.7M, 48.6M, and 49.1M shares respectively) and correctly identifies the cumulative total of 433 million shares at $34.3 billion cost through 2024. However, there is a significant discrepancy in the 2022 share repurchase data: the ground truth states 383 million shares were repurchased in 2022 at $29 billion, while the LLM only reports 87.7 million shares for that year. This represents a major factual error - the LLM appears to have provided only a portion of 2022 repurchases or misidentified the data. The LLM correctly identifies the CVE monetization (91 million shares in 2022) and the $218 million fair value figure. The cumulative figures (433M shares, $34.3B) are correct, but the year-by-year breakdown for 2022 is substantially incomplete or incorrect. The LLM also fails to mention the $65 billion authorization increase in October 2024, which is part of the ground truth answer showing program evolution. The multi-hop reasoning is partially sound - the LLM connects CVE monetization to share repurchases - but the quantitative accuracy is compromised by the 2022 discrepancy. The answer addresses the three-year period requested but with incomplete/inaccurate data for the critical 2022 baseline year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 361,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "From 2022 through 2023, the Home Depot Omnibus Stock Incentive Plans (the 2005 Plan) had about 117 million shares available for future grants. By 2024, after the plan was amended in May 2022, the available pool fell to roughly 77 million shares under the new Omnibus Plan authorized for 80 million shares plus up to 10 million related to outstanding awards. This decline shows the company has been actively exercising its stock‑based compensation capacity, depleting the authorized share pool and moving toward a more constrained or targeted grant strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2024 share availability. The ground truth states that by 2024, shares declined to 70 million, but the LLM answer states 77 million shares were available in 2024 (claiming this was the 2023 figure). This is a major quantitative error that undermines the core answer. TIMELINE CONFUSION: The LLM conflates the 2023 and 2024 figures. Ground truth shows: 2022 = 117M, 2023 = 77M, 2024 = 70M. The LLM states '2022 through 2023...117 million shares' and 'by 2024...77 million shares,' which reverses the 2023-2024 progression. PARTIAL CREDIT FOR REASONING: The LLM correctly identifies the overall trend of share depletion and provides reasonable interpretation about active utilization of stock-based compensation capacity. The mention of the May 2022 amendment and the 80 million + 10 million structure adds some contextual detail, though this detail is not clearly verified against the ground truth. MISSING ELEMENT: The LLM fails to complete the full three-year progression clearly (2022→2023→2024), instead presenting confusing temporal references. The ground truth explicitly shows the 70 million figure for 2024, which is entirely absent from the LLM answer. SEMANTIC ALIGNMENT: The interpretation about 'constrained or targeted grant strategy' aligns reasonably with the ground truth's assessment of 'steady utilization,' though the LLM's framing is slightly different. The reasoning about equity award usage is sound but undermined by the numerical errors. OVERALL: While the LLM demonstrates understanding of the general trend and provides some relevant context, the incorrect 2024 figure (77M instead of 70M) and the confused timeline presentation represent fundamental factual errors that significantly reduce the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 500,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture raised the maximum shares authorized under its Amended 2010 Share Incentive Plan from **127 million** in 2022 (page 91) to **141 million** by 2024 (page 98; the 2023 filing reflects the same 141 million level). This 14 million‑share expansion shows the company’s deliberate broadening of its equity‑based incentive pool to better attract, retain, and align talent with shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 127 million shares in 2022, 141 million in 2023-2024, and the 14 million share increase calculation is accurate. The answer correctly identifies the progression across the three-year period. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the 2022 baseline, (2) the 2023-2024 levels, and (3) the strategic implications. The LLM correctly notes that 2023 and 2024 both reflect the 141 million level, matching the ground truth. ENTITY ACCURACY: Accenture plc, Class A ordinary shares, and the Amended 2010 SIP are all correctly identified. The fiscal years (2022, 2023, 2024) are properly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM connects the numerical progression to strategic implications (talent attraction, retention, alignment with shareholder value), which aligns with the ground truth's interpretation. The reasoning about equity-based incentives as part of long-term compensation strategy is appropriate and well-supported. MINOR CONSIDERATIONS: The LLM includes page references (91, 98) which add credibility but are not part of the ground truth verification. The wording differs slightly from the ground truth (e.g., 'deliberate broadening' vs. 'strategic expansion') but conveys equivalent meaning. The answer is slightly more concise than the ground truth but captures all essential information. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 424,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted average yield on American Express’s foreign government bonds and obligations rose sharply from about **2.1 % in 2022** (the 2022 10‑K shows a 2.08 % overall yield for that category) to roughly **7.8 % in 2024** (the 2024 10‑K lists a 7.8 % average yield for non‑U.S. interest‑earning assets, which includes foreign government bonds)【page_121】【page_176】. This jump indicates that the company’s exposure to international interest‑rate movements has increased, as higher yields on foreign debt reflect rising global rates and a greater sensitivity to foreign market rate changes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims 2022 yield was 2.1% (or 2.08%), but ground truth shows 5.86%. The LLM claims 2024 yield was 7.8%, but ground truth shows 5.86%. These are massive discrepancies (off by 3.7-4.0 percentage points), not minor rounding differences. (2) INCOMPLETE ANALYSIS - The LLM completely omits the 2023 data point (6.45%), which is critical to understanding the trend. The ground truth explicitly identifies 2023 as a peak year, showing the trajectory: 5.86% (2022) → 6.45% (2023) → 5.86% (2024). The LLM's narrative of a continuous rise from 2022 to 2024 is factually incorrect. (3) MISIDENTIFICATION OF METRICS - The LLM appears to conflate 'foreign government bonds and obligations' with 'non-U.S. interest-earning assets,' which are different categories. The ground truth specifically references weighted average yield on foreign government bonds due within one year, a precise metric the LLM misrepresents. (4) FLAWED REASONING - The LLM's conclusion that 'higher yields reflect rising global rates' is contradicted by the actual data showing yields declining from 2023 to 2024, suggesting stabilization rather than continued rate increases. (5) MISSING CONTEXT - The ground truth emphasizes volatility with a peak in 2023 and reversal by 2024, suggesting strategic portfolio adjustments. The LLM presents a one-directional trend that doesn't exist in the actual data. The answer demonstrates fundamental failure in multi-hop synthesis and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 435,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond holdings were heavily short‑term in 2022 – $630 million of fair value, with $628 million due within one year – implying a low‑yield, high‑liquidity focus.  The weighted‑average yield for those securities rose to 6.45 % in 2023, reflecting a shift toward higher‑yielding, longer‑dated foreign bonds as global rates climbed, and fell to 5.85 % in 2024, indicating a rebalancing toward lower yields or higher‑quality assets as rates eased or risk appetite tightened.  This progression shows a dynamic investment strategy that adjusts maturity and risk exposure to capture favorable yields while managing market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All key numbers are correct: $630 million total fair value in 2022, $628 million maturing within one year, 6.45% yield in 2023, 5.85% yield in 2024. (2) Correctly identifies the short-duration focus in 2022. (3) Accurately captures the yield progression from 2023 to 2024. (4) Properly synthesizes multi-hop information across three years. WEAKNESSES: (1) SIGNIFICANT INTERPRETATION ERROR: The LLM states the 2022 holdings represented a 'low-yield, high-liquidity focus,' but the ground truth indicates the 2023 yield of 6.45% was 'the highest among all categories,' implying these were actually higher-yielding instruments relative to other bond categories. The LLM's characterization as 'low-yield' contradicts this. (2) SPECULATIVE REASONING: The LLM speculates about 'shift toward higher-yielding, longer-dated foreign bonds as global rates climbed' in 2023, but the ground truth simply states the 6.45% was the highest yield without explaining causation. The LLM adds interpretive layers not supported by the source data. (3) INCOMPLETE ANALYSIS: The ground truth explicitly notes the 2024 decline 'suggests a potential shift in market conditions or a strategic adjustment' and mentions 'possibly reducing exposure to higher-yielding, shorter-duration instruments.' The LLM's explanation of 'rebalancing toward lower yields or higher-quality assets' is somewhat different and less precise about the strategic implications. (4) TONE ISSUE: The LLM's characterization of the 2022 position as 'low-yield' is factually misleading given that 6.45% in 2023 was the highest among categories. QUANTITATIVE VERIFICATION: All dollar amounts and percentages are numerically correct. The calculations and comparisons are accurate. MULTI-HOP REASONING: The model correctly synthesizes information across 2022, 2023, and 2024, but the interpretation of what 'low-yield' means in context is problematic. The answer would score higher if it had acknowledged that the 6.45% yield in 2023 was comparatively high, making the 2022 short-duration position potentially strategic for capturing higher yields.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 565,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "ConocoPhillips has presented its 7 % Debentures due 2029 in the same way in each filing: the “Securities registered pursuant to Section 12(b) of the Act” section lists the instrument as “Common Stock, $.01 Par Value 7 % Debentures due 2029” with trading symbol COP, NYSE as the exchange, and CUSIP 718507BK1 (COP_10k_2022.pdf page 1; COP_10k_2023.pdf page 1; COP_10k_2024.pdf page 1). The unchanged, consistent disclosure over three years shows the company’s deliberate, standardized approach to reporting this debt, ensuring transparency and compliance with SEC requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim. The ground truth explicitly states that the presentation EVOLVED across the three years: in 2022, the debentures were disclosed alongside Common Stock in the same row; in 2023, they were separated into their own row with distinct CUSIP 718507BK1; and in 2024, this structured separation was maintained. The LLM answer claims the disclosure was 'the same way in each filing' and 'unchanged, consistent disclosure over three years,' which directly contradicts the ground truth's central finding of evolution and separation. The LLM incorrectly describes the 2022 presentation as listing 'Common Stock, $.01 Par Value 7% Debentures due 2029' together in a single entry, when the ground truth indicates they were initially presented together but then separated. The LLM also fails to capture the key insight that the evolution from combined to separated disclosure represents 'a growing emphasis on clarity and specificity in debt disclosure practices.' While the CUSIP number (718507BK1) is correct, and the company name (ConocoPhillips/COP) is correct, the fundamental narrative about how the disclosure evolved is wrong. The LLM misses the multi-hop synthesis required: comparing presentation across three years and identifying the structural change that occurred between 2022 and 2023. The answer demonstrates a failure to recognize the progression that is central to answering the question about how the disclosure 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 419,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s net carrying amount of the 2.00% Notes Due 2031 was $1,044 million at the end of FY 2023 and rose to $1,250 million at the end of FY 2024, indicating a modest increase in long‑term debt exposure (FY 2023: page 69; FY 2024: page 72). The FY 2022 amount is not disclosed in the supplied pages, but the subsequent years show a stable base that is gradually expanded, reflecting a deliberate strategy of incremental debt issuance to fund growth while keeping leverage conservative.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the FY 2023 and FY 2024 amounts ($1,044M and $1,250M respectively), which align with the ground truth values ($1.057B and $1.25B when converted). The answer appropriately acknowledges the limitation of not having FY 2022 data from the supplied pages. The reasoning about stable debt management and conservative leverage is sound and relevant to the question. WEAKNESSES: (1) QUANTITATIVE DISCREPANCY - The ground truth explicitly states FY 2022 was $1.2 billion, but the LLM claims this data is 'not disclosed in the supplied pages.' This is a significant gap since the original answer includes this data point. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution 'from fiscal year 2022 through 2024,' requiring all three years. The LLM only addresses 2023-2024, missing the critical 2022 baseline. (3) MINOR NUMBER VARIANCE - The LLM states $1,044M for FY 2023 while ground truth shows $1.057B ($1,057M). This 13M difference is relatively minor but represents a discrepancy. (4) INCOMPLETE TREND ANALYSIS - The ground truth shows: 2022 ($1.2B) → 2023 ($1.057B, a decrease) → 2024 ($1.25B, an increase). The LLM only captures the 2023-2024 increase, missing the 2022-2023 decrease that provides important context for understanding the company's debt management strategy. The LLM's conclusion about 'incremental debt issuance' is reasonable but based on incomplete data. The answer demonstrates good reasoning quality but fails to fully address the multi-hop requirement of synthesizing all three years of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 431,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has kept Marvel as a flagship brand on its streaming platform, featuring it as a top‑level tile on Disney+ (2023 10‑K, page 7) and preserving its status as an indefinite‑lived intangible asset valued at $1,792 million (2024 10‑K, page 114).  The brand’s prominence on Disney+ and its intangible‑asset valuation have remained essentially unchanged across fiscal 2022‑24, underscoring Disney’s continued strategic emphasis on Marvel as a core content pillar and key brand equity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Marvel's prominent positioning on Disney+ as a top-level tile in 2023 and its status as an indefinite-lived intangible asset. However, there are significant issues with the quantitative accuracy and completeness of the response. (1) QUANTITATIVE ISSUES: The LLM provides a specific valuation of $1,792 million for Marvel's intangible assets in 2024, but the ground truth does not mention this specific figure. This introduces an unverified number that cannot be confirmed against the original answer. The ground truth does not provide specific dollar valuations for Marvel's intangible assets. (2) COMPLETENESS GAPS: The LLM answer fails to address fiscal year 2022 explicitly, only mentioning the 2022-24 period generally. The ground truth specifically states that Marvel was listed in 2022 alongside ESPN and Pixar as part of indefinite-lived intangible assets, which is an important detail for showing the evolution across the three-year period. The LLM states the status 'remained essentially unchanged' but doesn't provide evidence of 2022 positioning. (3) MULTI-HOP REASONING: The answer does synthesize information across fiscal years and connects streaming branding to intangible asset classification, which is appropriate. However, it misses the comparative analysis across all three years that the ground truth emphasizes. (4) SEMANTIC ACCURACY: The core claim about Marvel's strategic importance is correct, and the connection between streaming prominence and brand equity is sound. The statement about 'flagship brand' and 'core content pillar' aligns with the ground truth's emphasis on strategic importance. However, the introduction of an unverified specific dollar amount ($1,792 million) without confirmation in the ground truth is problematic for a financial evaluation task where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 503,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "In 2022, American Express recognized discount revenue at the time a Card Member transaction occurred, and when a third‑party acquirer was involved, the negotiated network‑rate fee was also recorded as discount revenue (see Note 4, page 103 of the 2022 10‑K). The 2024 filing keeps the same transaction‑based discount‑revenue model and notes that the network‑rate fee is individually negotiated with each third‑party acquirer, but it adds a pronounced emphasis on expanding merchant coverage worldwide through new agreements with third‑party acquirers, aggregators and processors (see the “merchant coverage” discussion in the table of contents, page 93 of the 2024 10‑K). Thus, while the core revenue recognition and fee‑negotiation mechanics remained consistent, the company’s 2024 strategy foregrounds broader merchant‑acquisition partnerships to grow acceptance globally.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key structural elements of American Express's revenue model and accurately captures the consistency of discount revenue recognition mechanics from 2022 to 2024. The reference to Note 4 on page 103 of the 2022 10-K and the merchant coverage discussion on page 93 of the 2024 10-K demonstrates proper document citation. The core claim that network-rate fees are individually negotiated and recorded as discount revenue is accurate and aligns with the ground truth.\n\nHowever, the answer has significant gaps in completeness. The ground truth explicitly mentions the 2023 evolution, which introduced 'processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners.' The LLM answer completely omits 2023 and the processed revenue stream, which represents a material evolution in American Express's revenue structure during the 2022-2024 period. This is a critical omission for a question specifically asking about evolution 'from 2022 through 2024.'\n\nAdditionally, the LLM answer lacks specificity about the OptBlue program and GNS partners mentioned in the ground truth, and does not adequately characterize the strategic shift toward 'deeper collaboration with third-party acquirers' as comprehensively as the ground truth does. The answer focuses primarily on consistency rather than evolution, which understates the actual changes that occurred.\n\nThe multi-hop reasoning is partially sound—the answer does synthesize information across 2022 and 2024 filings—but fails to complete the full three-year synthesis required by the question. The characterization of the 2024 strategy as 'foreground[ing] broader merchant-acquisition partnerships' is accurate but represents only partial fulfillment of the question's requirements regarding 'merchant coverage expansion strategies.'\n\nNo quantitative errors are present (no specific numbers are cited that could be wrong), but the qualitative incompleteness—particularly the omission of the 2023 processed revenue development—significantly undermines the answer's value for understanding the full evolution of American Express's revenue structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 591,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 10‑K risk factor only noted that a subset of its products are used with drug‑delivery or companion‑diagnostic devices that carry their own regulatory and manufacturing risks.  By 2023 the disclosure expanded to explain that device approval, supply and safety can create clinical‑trial dependencies and trigger post‑marketing obligations, and that device malfunctions or adverse events could prompt regulatory action.  The 2024 filing further detailed ongoing monitoring of device complaints and adverse events, the need for post‑marketing studies and REMS compliance, and the potential impact of single‑source device suppliers on product approvals and clinical‑trial timelines.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Amgen's regulatory risk disclosures across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression with appropriate temporal markers (2022, 2023, 2024); (2) Accurately captures the shift from general risk acknowledgment to more specific post-marketing and safety compliance concerns; (3) Properly synthesizes multi-hop information about drug delivery devices, clinical trial dependencies, and regulatory oversight; (4) Correctly identifies key regulatory concepts like REMS compliance, pharmacovigilance, and post-marketing studies; (5) Appropriately notes the expansion of disclosure detail over time. MINOR GAPS: (1) The LLM answer does not explicitly mention LUMAKRAS or the Complete Response Letter from the FDA, which the ground truth specifically references as a concrete example of the regulatory scrutiny shift in 2023; (2) The ground truth emphasizes 'accelerated approval' as a specific regulatory pathway, which the LLM answer doesn't explicitly address; (3) The ground truth mentions 'marketing authorization withdrawal' as a potential enforcement action, while the LLM answer uses more general language about 'regulatory action.' VERIFICATION: All dates (2022, 2023, 2024) are correct. The characterization of disclosure evolution is accurate and semantically equivalent to the ground truth. The multi-hop reasoning correctly synthesizes information about how regulatory risk framing changed across the three-year period. The answer appropriately addresses all three components of the question: clinical trial dependencies, post-marketing requirements, and device-related safety reviews. The omission of specific product examples (LUMAKRAS) and specific enforcement consequences (marketing authorization withdrawal) prevents this from being a perfect 9-10 score, but the core analytical framework and factual content are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 522,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has stayed focused on business units and staff groups, but the 2024 filing re‑brands it as a “Corporate HSE audit” program, underscoring corporate‑level oversight.  In all years, improvement actions identified in audits are tracked to completion, with the 2024 text explicitly stating this tracking.  Governance reporting remains unchanged, with audit progress reported to the Executive Leadership Team and the Board of Directors.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but significantly undershoots the depth and nuance of the ground truth answer. CORRECT ELEMENTS: (1) The identification of 'Corporate HSE audits' terminology in 2024 is accurate; (2) The statement that improvement actions are tracked to completion across all years is correct; (3) The governance reporting to ELT and Board is accurately maintained. SIGNIFICANT OMISSIONS: (1) The LLM completely fails to address the 2023 evolution, which is a critical middle point showing the transition from 2022 to 2024. The ground truth explicitly describes 2023 as an expansion to include human capital management framework, Life Saving Rules, Process Safety Fundamentals, and stop work policy - none of this is mentioned; (2) The LLM misses the scope definition evolution entirely. The ground truth describes a progression from 'localized conformance checks' (2022) to 'integrated safety systems' (2023) to 'corporate-level standardization' (2024). The LLM only mentions the 2024 rebranding without explaining the underlying scope changes; (3) The LLM fails to capture the strategic narrative of the evolution - the ground truth emphasizes a 'shift toward greater cohesion and institutionalization of HSE practices,' which is absent from the LLM response. MULTI-HOP REASONING: The question asks about evolution across three years (2022-2024) with three dimensions (scope definition, improvement tracking, governance). The LLM only addresses one year's change (2024 rebranding) and treats improvement tracking and governance as static rather than evolving. This represents incomplete multi-hop synthesis. The answer reads as a summary of 2024 status rather than an evolution narrative. CONTEXTUAL RELEVANCE: While the LLM answer is relevant to the question, it provides only a partial answer that would leave a reader without understanding the full evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 519,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022, 2023 and 2024 10‑K filings all stress that cloud, data and AI innovations are displacing legacy services and that the firm must develop and launch new pricing or commercial models that capture the value of these technologies (see page 22 of each filing).  The messaging has evolved only marginally—adding more emphasis on generative‑AI and regulatory compliance—yet the core approach of adapting pricing to reflect new tech and mitigating revenue loss from delayed client spend has remained unchanged.  Across all three years the risk factors consistently highlight that failure to introduce appropriate pricing models, coupled with clients’ delayed or reduced spending on new technologies and the regulatory, ethical and cybersecurity risks of AI, could materially harm Accenture’s results of operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Accenture's pricing model approach across 2022-2024 and correctly identifies the consistent risks highlighted. Strengths: (1) Accurately identifies the three-year progression from general acknowledgment to more strategic/investment-driven approach; (2) Correctly names the key technologies (cloud, AI, data, generative AI); (3) Properly synthesizes the consistent risk theme across years regarding failure to introduce appropriate pricing models and client adoption delays; (4) Appropriately notes the addition of regulatory/ethical/cybersecurity concerns in later years. Weaknesses: (1) The reference to 'page 22 of each filing' is unverified and potentially inaccurate—this specific page citation cannot be confirmed from the ground truth; (2) The claim that messaging evolved 'only marginally' is somewhat contradictory to the ground truth's description of evolution from 'general acknowledgment' (2022) to 'more strategic and investment-driven' (2024), suggesting more substantive evolution than 'marginal'; (3) Missing some specific details from ground truth: the 2023 focus on 'delays in client spending due to evaluation of new technologies' and the 2024 emphasis on 'significant investments already being made in AI-based services' are not explicitly mentioned; (4) The phrasing 'mitigating revenue loss from delayed client spend' is present but less detailed than ground truth's multi-year breakdown. The answer demonstrates solid multi-hop reasoning across the three years and correctly identifies both the evolution trajectory and consistent risk themes, but the unverified page citation and slightly oversimplified characterization of the evolution reduce confidence in full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 474,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior note grew from $900 million at 12/31/2022 to $944 million at 12/31/2023 and to $982 million at 12/31/2024 (page 74, page 70).  The unrealized gain on the note swung from a loss of $865 million in 2022 to a gain of $129 million in 2023 and $38 million in 2024 (page 72).  Coupled with the sale of its equity stake in AerCap (page 73), this trend shows GE is moving from equity exposure to a more conservative, income‑generating debt position in AerCap.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM claims the AerCap note holdings INCREASED from $900M (12/31/2022) to $944M (12/31/2023) to $982M (12/31/2024), showing growth. However, the ground truth explicitly states holdings DECREASED from $993M (end of 2021) to $944M (end of 2023), showing a consistent decline. The LLM's numbers for 2024 ($982M) are not mentioned in the ground truth at all, and the 2022 starting point ($900M) differs from the ground truth baseline ($993M at end of 2021). (2) DIRECTIONAL CONTRADICTION: The LLM's narrative of increasing holdings contradicts the ground truth's narrative of decreasing holdings - this is a fundamental misrepresentation of the investment trend. (3) UNREALIZED GAINS/LOSSES: While the LLM provides unrealized gain/loss figures, these cannot be verified against the ground truth provided, and the inclusion of 2024 data suggests the LLM may be fabricating or confusing data points. (4) STRATEGIC INTERPRETATION: The LLM's conclusion that GE is 'moving from equity exposure to a more conservative, income-generating debt position' may be reasonable logic, but it's built on incorrect foundational numbers. The ground truth suggests a strategic REDUCTION in AerCap exposure overall, not a shift in composition. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution of holdings across the 2022-2024 period as requested. The answer demonstrates a clear misunderstanding or misreporting of the actual data trajectory. The page references provided cannot be verified but appear to be fabricated given the numeric discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 459,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen had Bemarituzumab listed as a Phase 3 candidate for GEJ adenocarcinoma in its 2022 10‑K, with composition‑of‑matter patents in the U.S. and Europe estimated to expire in 2029【page_25】.  In the 2023 filing the program remained Phase 3 while a Phase 2 study for “other tumors” was added, and the same 2029 expiration dates were reported【page_25】.  The 2024 filing kept the same status—Phase 3 for GEJ adenocarcinoma and Phase 2 for other tumors—with the patent expirations unchanged at 2029【page_25】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified key numeric facts: Phase 3 status for GEJ adenocarcinoma in 2022, patent expiration dates of 2029 for U.S. and European patents, and the consistency of these dates across 2022-2024 filings. The quantitative data (years, phases, expiration dates) are accurate. WEAKNESSES: (1) The LLM answer is overly narrow and mechanical, focusing primarily on clinical phase status and patent dates without adequately addressing the 'evolution' aspect emphasized in the question. (2) The ground truth emphasizes a significant shift from 'clinical development focus to broader therapeutic positioning and IP strategy' - the LLM mentions Phase 2 for 'other tumors' but fails to capture the meaningful expansion to 'gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC' that occurred by 2024. (3) The LLM answer lacks synthesis of the intellectual property positioning evolution - it merely reports the same expiration date across years rather than explaining how Amgen's IP strategy evolved. (4) The answer misses the qualitative evolution: the ground truth notes a shift from 'active development' (2022) to 'broader therapeutic positioning' (2024), which the LLM doesn't capture. (5) The phrase 'composition-of-matter patents' is technically accurate but the LLM doesn't contextualize what this means for Amgen's IP positioning strategy. MULTI-HOP REASONING: The LLM successfully synthesized information across three years (2022-2024) but did so in a purely factual, chronological manner without addressing the 'evolution' or strategic implications. The answer reads as a timeline rather than an analysis of how positioning evolved. CALCULATION/VERIFICATION: All numeric values are correct (2022, 2023, 2024, 2029, Phase 2, Phase 3). No calculation errors. The answer is factually sound but incomplete in addressing the full scope of the question regarding intellectual property positioning evolution and strategic shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 533,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "From 2022‑23, American Express framed alternative payment mechanisms—digital wallets, buy‑now‑pay‑later, real‑time settlement platforms and other fintechs—as a growing threat that required “speed of innovation and investment in systems, technologies, and product and service offerings” (2022/23 p. 12‑14). By 2024, the company’s filings show a shift from merely describing the pressure to actively investing in technology—AI, machine learning, tokenization, real‑time settlement, open‑banking and digital‑wallet integration—to defend merchant‑discount‑rate erosion, surcharging and the loss of merchant relationships (2024 p. 29‑31). This evolution signals a long‑term strategy of leveraging technology and differentiated value propositions to counter fintech disruption while preserving its premium brand.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the strategic evolution and correctly identifies the core narrative shift from defensive positioning (2022-23) to proactive investment (2024). The qualitative reasoning about the shift from threat acknowledgment to technology integration is sound and aligns with the ground truth. However, there are several issues: (1) QUANTITATIVE CONCERNS: The LLM cites specific page numbers (2022/23 p. 12-14, 2024 p. 29-31) without verification against actual filings—these cannot be confirmed as accurate and represent potential fabrication of citations. (2) INCOMPLETE ENTITY COVERAGE: The ground truth explicitly mentions 2023 as a distinct inflection point where American Express expanded its list of alternative payment mechanisms to include open banking platforms and payment facilitators. The LLM answer conflates 2022-23 as a single period and doesn't clearly delineate the 2023 expansion of threat categories. (3) TECHNOLOGY SPECIFICITY: The LLM correctly identifies key technologies (tokenization, real-time settlement, open banking, AI/ML) but adds 'real-time settlement platforms' as a threat category in 2022-23, which the ground truth attributes to 2024 as an investment priority. (4) SEMANTIC ACCURACY: The LLM's characterization of the shift is directionally correct—from defensive to proactive—but misses the nuance that by 2024, the company shifted to a 'dependency posture' (recognizing necessity of integration) rather than just 'active investment.' (5) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and connects competitive pressure to technological response, though the timeline granularity is less precise than the ground truth. The answer is substantially correct in its core thesis but lacks the temporal precision and citation accuracy expected for financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 510,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "ConocoPhillips’ weighted‑average grant‑date fair value for cash‑settled PSUs rose from **$91.58** in 2022 to **$112.50** in 2023, then fell modestly to **$110.39** in 2024 (2023 10‑K, page 124; 2024 10‑K, page 126). The upward jump followed by a slight dip indicates the company keeps its cash‑settled PSU awards at a high valuation, underscoring a strategy that prioritizes performance‑linked equity compensation to align executive pay with shareholder value while adjusting award levels in response to market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error in the 2024 value. The ground truth states the weighted-average grant date fair value was $112.50 in 2024, but the LLM claims it was $110.39 in 2024. This is a material discrepancy of $2.11 per share. The LLM correctly identifies the 2022 value ($91.58) and provides a 2023 intermediate value ($112.50), but the 2024 figure is incorrect. QUANTITATIVE ACCURACY: The 2022 and 2023 values are correct, but the 2024 value is wrong, representing a 1.9% error on that critical data point. The LLM also inverts the trend narrative - it describes an 'upward jump followed by a slight dip,' but the ground truth indicates a consistent upward trend from 2022 ($91.58) through 2024 ($112.50). MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple years and provide strategic interpretation, which is appropriate for the question. However, the incorrect 2024 figure undermines the entire trend analysis. The reasoning about performance-linked compensation and market conditions is reasonable but is based on a false premise about the actual trend. COMPLETENESS: The answer addresses the evolution question and attempts to provide strategic interpretation, but the factual error regarding the 2024 value means it fails to accurately capture the actual trend. The ground truth shows consistent growth, while the LLM answer shows growth then decline. SEMANTIC EQUIVALENCE: While the LLM's interpretation about compensation strategy is reasonable in tone, it contradicts the actual data trend, making it semantically incorrect regarding the core factual question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 452,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s 10‑K risk‑factor disclosures from 2022 through 2024 consistently flag growing exposure to abusive behaviors, especially via its PayPal‑branded credit products and third‑party fraud schemes such as synthetic identities and stolen‑card transactions. The company repeatedly cautions that credit‑risk models can misjudge borrower creditworthiness and that fraud tactics are evolving, requiring costly, continuously improved mitigation efforts. This persistent emphasis on high exposure and the admission that controls may not fully contain losses suggest that PayPal’s risk‑management effectiveness remains challenged and needs further strengthening.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of PayPal's evolving exposure to abusive behaviors across 2022-2024, mentions credit products and third-party fraud schemes, and appropriately characterizes the trend as showing challenged risk management effectiveness. The qualitative reasoning about synthetic identities, stolen-card transactions, and the need for continuous mitigation efforts aligns with the ground truth narrative. The answer demonstrates good understanding of the multi-hop synthesis required.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to include the specific €40 billion multi-year receivables sale agreement mentioned in the ground truth as a key strategic response in 2023. This is a material omission of a concrete, quantifiable fact that demonstrates PayPal's risk mitigation strategy. The LLM provides no specific numbers, dates, or financial metrics, whereas the ground truth includes the €40 billion figure as evidence of strategic mitigation.\n\nWEAKNESSES - COMPLETENESS: The answer lacks the temporal progression detail that the ground truth emphasizes. The ground truth specifically traces: (1) 2022 focus on third-party fraud and fictitious accounts, (2) 2023 expansion to credit products with the €40B receivables sale, and (3) 2024 emphasis on regulatory uncertainties like the 'valid-when-made doctrine.' The LLM treats these years more generically without this structured progression.\n\nMISSING CONTEXT: The LLM does not mention the 'valid-when-made doctrine' regulatory uncertainty that the ground truth identifies as a 2024 concern. This is a specific regulatory risk factor that demonstrates the evolution of PayPal's risk landscape.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects credit products to fraud schemes, but fails to fully integrate the strategic responses (receivables sales) that demonstrate how the company is attempting to manage these risks. The ground truth shows a more complete picture of risk evolution AND mitigation strategy.\n\nSCORING JUSTIFICATION: The answer is directionally correct (6/10) but incomplete in quantitative specifics (4/10) and missing key strategic details. The qualitative reasoning is sound (7/10) and the response is contextually relevant (8/10), but the omission of the €40 billion figure and regulatory doctrine details prevents a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 644,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "Cyramza’s therapeutic portfolio has stayed the same from 2022 through 2024, continuing to be sold as a second‑line therapy for gastric, NSCLC, colorectal and hepatocellular cancers and as a first‑line option for EGFR‑mutated NSCLC【page_5】.  Its intellectual‑property protection has also remained unchanged, with compound patents expiring 2026‑2028, data‑protection in the EU ending in 2024 (Japan in 2023) and biologics data protection lasting to 2026【page_11】.  This steady positioning and robust, but approaching‑expiration, exclusivity signals Lilly’s long‑term oncology strategy of expanding a broad, multi‑cancer indication set while preserving patent life to secure revenue streams.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Cyramza's therapeutic indications (gastric, NSCLC, colorectal, hepatocellular cancers) and accurately notes the stable positioning from 2022-2024 with no new indications added. The answer appropriately synthesizes multi-hop information about both therapeutic positioning and IP protection. The reasoning about Eli Lilly's strategy (maintaining market presence while preparing next-generation products) aligns with the ground truth interpretation.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM provides patent expiration dates of 2026-2028, but the ground truth specifies compound patents extending through 2026 only. This is a factual discrepancy. The LLM correctly identifies data protection expiring in 2023 in Japan and 2024 in EU, and biologics data protection to 2026, which matches ground truth.\n\nPARTIAL ISSUES: The LLM adds detail about 'first-line option for EGFR-mutated NSCLC' which is not mentioned in the ground truth answer. While this may be accurate from the source documents cited, it represents information beyond what the ground truth explicitly confirms, creating a minor inconsistency in scope.\n\nREASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects therapeutic positioning data with IP protection timelines to draw conclusions about strategy. However, the interpretation differs slightly: the LLM emphasizes 'expanding a broad, multi-cancer indication set while preserving patent life,' whereas ground truth emphasizes 'maintaining market presence while preparing next-generation products to succeed it.' Both are reasonable interpretations, but the ground truth's emphasis on succession planning is more directly supported.\n\nCOMPLETENESS: The answer addresses all parts of the question (therapeutic positioning evolution, IP protection evolution, and strategic implications), though with the noted discrepancies in patent dates and additional detail not in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 534,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris has kept the 3.875 % Notes due 2042 as a core long‑term debt anchor in every filing (2022‑2024) while actively issuing and extending other notes to diversify maturities and optimize cost. In 2022 the debt mix included short‑term notes due 2022‑2025 plus the 3.875 % Notes due 2042 (PM_10k_2022.pdf page 1); in 2023 it added notes due 2024‑2028, and by 2024 it had further extended its maturity profile to include notes due 2029‑2044, reflecting a deliberate shift toward longer‑dated debt while maintaining the 3.875 % Notes due 2042 as a stable anchor (PM_10k_2023.pdf page 1; PM_10k_2024.pdf page 1).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT DEBT INSTRUMENTS: The ground truth clearly identifies specific notes (4.125% Notes due 2043, 4.875% Notes due 2043, 4.250% Notes due 2044) that were present in specific years and then retired/refinanced. The LLM answer vaguely references 'short-term notes due 2022-2025' and 'notes due 2024-2028' and 'notes due 2029-2044' without naming the actual instruments, which is factually inaccurate. (2) MISCHARACTERIZATION OF STRATEGY: The ground truth indicates a strategy of RETIRING/REFINANCING other instruments while maintaining the 3.875% Notes due 2042 as stable. The LLM incorrectly characterizes this as 'actively issuing and extending other notes' and 'further extended its maturity profile to include notes due 2029-2044,' which contradicts the ground truth that states newer 2043 and 2044 tranches were RETIRED by 2024. (3) TIMELINE ERRORS: The LLM suggests notes were added through 2024 ('by 2024 it had further extended'), but the ground truth shows the opposite - by 2024, the newer tranches had been retired. (4) MISSING CRITICAL DETAILS: The LLM fails to mention the specific retirement/refinancing of the 4.125% Notes due 2043 and 4.875% Notes due 2043, which is central to understanding the capital structure evolution. (5) VAGUE SOURCING: While the LLM cites PDF pages, the specific debt instruments mentioned are not accurately reflected in the ground truth data. The core narrative is inverted - the ground truth shows consolidation and retirement of debt, while the LLM describes expansion and extension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 447,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 risk disclosures highlighted growing exposure to abusive behaviors from third‑party lenders and processors and the risk of defaults on its credit products (page 26). In 2023, the company mitigated credit‑risk exposure by selling a majority of its UK and European BNPL loan receivables and began selling those receivables in October 2023 (page 25). In 2024, PayPal further reduced third‑party concentration risk by diversifying its payment‑processor base and moving its U.S. arrangements to new processors in a phased transition (page 22).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant gaps and misalignments with the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 as highlighting growing risk of abusive behaviors in credit products\n- Correctly mentions the sale of UK and European BNPL loan receivables in 2023\n- Correctly dates the beginning of receivables sales to October 2023\n- Correctly identifies 2024 as a period of continued risk management efforts\n\nSIGNIFICANT GAPS AND ERRORS:\n1. MISSING CRITICAL DETAIL: The ground truth specifies the sale was for \"up to €40 billion\" of receivables - a specific quantitative metric that the LLM completely omits. This is a material omission for a financial question.\n\n2. INCOMPLETE 2024 ANALYSIS: The LLM shifts focus to third-party processor concentration risk and payment processor diversification in 2024, which is NOT mentioned in the ground truth answer. The ground truth specifically states 2024 efforts focused on \"improving detection mechanisms and reducing fraud at scale, particularly as it expanded its credit offerings in international markets.\" The LLM's answer about processor transitions appears to address a different risk category entirely.\n\n3. MISSING FRAUD PREVENTION INFRASTRUCTURE: The ground truth explicitly mentions \"enhancing fraud prevention infrastructure\" and \"improving detection mechanisms\" as 2024 actions. The LLM answer does not address these at all.\n\n4. MISSING INTERNATIONAL EXPANSION CONTEXT: The ground truth notes expansion of credit offerings in international markets as part of 2024 strategy. The LLM does not mention this.\n\n5. INCOMPLETE SYNTHESIS: The ground truth provides a clear narrative arc (2022: identify problem → 2023: offload risk through asset sales → 2024: enhance infrastructure). The LLM breaks this narrative by introducing processor diversification, which is a different risk mitigation strategy not mentioned in the ground truth.\n\nQUANTITATIVE ACCURACY: The €40 billion figure is completely absent, which is a critical omission. The dates (October 2023) are correct.\n\nQUALITATIVE ACCURACY: The LLM demonstrates partial understanding but conflates different risk management strategies and misses the core 2024 narrative about fraud detection and prevention.\n\nCONTEXTUAL RELEVANCE: While the answer addresses some aspects of the question, it diverges significantly from the ground truth's focus on credit products and fraud/abusive behavior mitigation, instead emphasizing payment processor risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 673,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD has consistently listed the risk of loss or modification of tax and tariff exemptions in its risk‑factor disclosures for 2022, 2023 and 2024, with the wording and emphasis unchanged (2022 page 37, 2023 page 39, 2024 page 38). The fact that the company continues to highlight this exposure in every filing indicates that it remains a material concern, underscoring persistent and potentially escalating regulatory uncertainty across its global operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORE FACTUAL ERROR: The LLM claims the wording and emphasis were 'unchanged' across 2022-2024, directly contradicting the ground truth which explicitly states the risk was 'emphasized more strongly' in 2023 and 'elevated further' in 2024 with explicit linking to geopolitical conflicts. This is a fundamental mischaracterization of the evolution described in the original answer. (2) PAGE NUMBER VERIFICATION: The LLM provides specific page numbers (2022 page 37, 2023 page 39, 2024 page 38) but these cannot be verified against the ground truth and appear to be potentially fabricated details, which is a serious accuracy concern. (3) MULTI-HOP REASONING FAILURE: The question asks how the exposure 'evolved' and what the 'trend' suggests. The ground truth identifies a clear progression: 2022 (noted as one of several risks) → 2023 (emphasized more strongly, listed alongside critical exposures) → 2024 (elevated further, explicitly linked to geopolitical conflicts). The LLM completely misses this evolution by claiming consistency rather than change. (4) SEMANTIC CONTRADICTION: While the LLM correctly identifies that the risk remains material and indicates regulatory uncertainty, it fundamentally misrepresents the nature of the evolution by claiming unchanged emphasis when the ground truth clearly documents increasing emphasis and elevation. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information about how the risk's prominence changed relative to other factors (geopolitical tensions, supply chain disruptions) and how it became more explicitly linked to specific global conflicts. The answer demonstrates a failure to understand the core question about evolution and trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 491,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and a **$91 million gain in FY 2024**.  The notional amount of these swaps rose from **$651 million in FY 2022 to $985 million in FY 2024**, indicating that Cisco has increased its hedging activity.  The shift to positive gains and the larger notional suggest a deliberate strategy to actively manage deferred‑compensation risk, with the derivatives proving effective and the exposure being more tightly controlled.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the core progression of gains/losses: $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024. The answer properly addresses the multi-hop question by synthesizing the evolution across three fiscal years and providing interpretation about strategy. The reasoning about reversal from losses to gains and improved market conditions/strategic shift is sound and matches the ground truth interpretation.\n\nWEAKNESSES: The LLM introduced additional information about notional amounts ($651M in FY2022 rising to $985M in FY2024) that was NOT present in the original ground truth answer. While this information may be factually correct from the filings, it goes beyond what was provided in the ground truth and represents an addition rather than a synthesis of the required information. The ground truth specifically focused on gains/losses progression and what it indicates about exposure/strategy, not on notional amounts. This addition, while potentially valuable, suggests the LLM may have drawn from different sections of the filings than the knowledge graph source.\n\nQUANTITATIVE ACCURACY: The core numbers (losses and gains) are correct and properly formatted. However, the introduction of notional amount figures that weren't in the ground truth creates uncertainty about whether all numeric data is being drawn from the same authoritative source. The gains/losses figures themselves are accurate (5/10 due to the unexplained additional data).\n\nQUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly interprets the shift from losses to gains as indicating improved performance or strategic effectiveness. The multi-hop synthesis across three years is properly executed. The interpretation about hedging activity and risk management is logical, though the notional amount discussion goes beyond the original answer's scope (7/10).\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution and what it indicates about strategy. The focus on deferred compensation-linked derivatives is maintained throughout. The additional notional amount information, while not in ground truth, is contextually relevant to understanding derivative exposure (8/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 598,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "Disney’s DTC strategy shifted from a 2022 focus on launching an ad‑supported Disney+ and cost‑realignment (page 29, page 27) to a 2024 reorganization of its media and entertainment business, a strategic content‑curation shift, and the launch of ESPN+ and a Star India joint venture amid intensified competition (page 21, page 23). This evolution highlights mounting financial risks—substantial content and marketing outlays, potential goodwill and content impairments, and higher debt and borrowing costs—while underscoring market pressures such as pricing sensitivity, advertising‑revenue volatility, and the challenge of scaling subscriber growth in a crowded streaming landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements of Disney's DTC evolution but has significant gaps and some inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2022 launch of ad-supported Disney+ and cost-realignment efforts; (2) Accurately notes the 2024 reorganization and intensified competition; (3) Properly identifies financial risks including content/marketing costs and debt concerns; (4) Correctly identifies market pressures like pricing sensitivity and subscriber growth challenges. WEAKNESSES: (1) The answer mentions ESPN+ launch and Star India joint venture as 2024 developments, but these are not clearly positioned as part of the 2022-2024 progression narrative required by the question; (2) Missing the critical 2023 pivot point that the ground truth emphasizes—the shift toward 'more active investment in DTC offerings' and focus on 'subscription and advertising revenues' in 2023 is not explicitly addressed; (3) The answer lacks quantitative specificity about losses, subscriber trends, or financial metrics that would strengthen the analysis; (4) Does not clearly articulate the progression of strategic thinking from 2022 (uncertainty about returns) → 2023 (active investment push) → 2024 (competitive pressures), which is central to the ground truth; (5) Page citations (29, 27, 21, 23) are provided but cannot be verified against the ground truth, and their relevance to the specific claims is unclear. MULTI-HOP REASONING: The answer attempts to synthesize information across three fiscal years but fails to clearly establish the causal progression and strategic pivot points that define the evolution. The ground truth emphasizes a deliberate strategic shift despite growing risks, while the LLM answer presents the evolution more as a series of tactical changes without clearly connecting the strategic intent. SEMANTIC EQUIVALENCE: While the LLM identifies many correct elements (DTC investment, competition, financial risks), it does not fully capture the nuance of Disney's 'doubling down on investment even as it faced rising costs and uncertain profitability' that characterizes the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 582,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  The company continues to have full discretion in setting transaction fees independent of the costs it incurs for payment processors, and it bears full margin risk as a principal in each payment transaction (disclosed in the 2023 10‑K on pages 75–77 and the 2024 10‑K on page 77).  The 2022 10‑K pages provided (78–82) do not contain a separate margin‑risk disclosure, indicating the same risk profile persisted.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that PayPal's margin risk exposure remained stable across 2022-2024, with consistent full margin risk bearing and independent fee-setting discretion. The answer accurately cites specific page references (2023 10-K pages 75-77, 2024 10-K page 77) and correctly notes that processor fees are recognized as transaction expenses. The multi-hop synthesis across three years is sound and the reasoning is logically coherent. However, there are minor gaps: (1) The LLM notes that the 2022 10-K pages provided (78-82) do not contain a separate margin-risk disclosure, but the ground truth explicitly states that in 2022 PayPal 'explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense,' suggesting the disclosure may have been present but the LLM didn't locate it in the provided pages. (2) The LLM does not mention the adoption of ASU 2023-07 segment reporting standards in 2024, which the ground truth identifies as a potential structural change point that PayPal navigated without altering its margin risk position. (3) The answer could have been more explicit about the consistency of accounting treatment across all three years. The quantitative accuracy is strong (page numbers appear correct based on typical 10-K structures), and the qualitative reasoning about fee discretion and processor cost treatment is accurate. The answer appropriately addresses the multi-part question about evolution, fee discretion, and transaction expenses, though with slightly less comprehensive coverage than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 441,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "From 2022 through 2024, Honeywell’s Aerospace risk‑factor language consistently warned that downturns in air‑travel demand could delay or cancel new aircraft orders (2022: page 31; 2023: page 31; 2024: page 28). The unchanged wording indicates that the risk of order cancellations remains a persistent concern, even as the commercial aviation sector shows signs of gradual recovery and growing stability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer has significant gaps in addressing the multi-part question about how the risk evolved from 2022-2024. STRENGTHS: (1) Correctly identifies that order cancellations remained a persistent concern across all three years; (2) Acknowledges the sector showed signs of recovery; (3) Correctly cites page numbers for reference. CRITICAL WEAKNESSES: (1) INCOMPLETE EVOLUTION ANALYSIS: The ground truth shows a clear progression in risk characterization - from pandemic-specific concerns (2022) → broader macroeconomic/geopolitical risks (2023) → structural/competitive shifts with new entrants (2024). The LLM answer states 'unchanged wording' which directly contradicts the ground truth's documented evolution of language and risk factors. This is a fundamental misreading of the multi-hop synthesis required. (2) MISSING KEY CONTEXTUAL DETAILS: The answer omits the specific evolution of risk triggers: COVID-19 pandemic effects → regional conflicts and environmental issues → new entrants and non-traditional players. These distinctions are central to understanding how the sector's challenges shifted. (3) WEAK INTERPRETATION: The LLM concludes the 'unchanged wording indicates persistent concern' but this misses the nuanced point that while the risk remained, its CHARACTER and SOURCES changed significantly, indicating a sector transitioning from pandemic recovery to structural market shifts. (4) OVERSIMPLIFICATION: The answer reduces a complex 3-year narrative to 'unchanged wording' when the ground truth explicitly documents how language 'expanded' and shifted focus. The LLM failed to perform the required multi-hop analysis across three years of filings to identify and synthesize the evolution pattern. The answer is partially correct on the basic fact that cancellations remained a concern, but fundamentally fails to address the 'how did it evolve' core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 512,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "PMI’s 2022 risk disclosures (page 15) warned that product regulation could blunt differentiation and restrict adult consumers’ access to truthful information for both RRPs and SFPs. The 2023 risk factors (pages 18‑22) repeated this warning with added detail on how regulation could impede the commercialization of RRPs and SFPs. By 2024, the risk on pages 17‑21 expands to include specific regulatory challenges—product classification, advertising restrictions, corporate communications, scientific substantiation, liability, antitrust and unfair competition—while still noting that such regulation limits product differentiation and adult‑consumer communication, underscoring an intensifying regulatory clamp‑down on PMI’s competitive positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year evolution (2022-2024) and acknowledges the progression of regulatory concerns. (2) Page references are provided (pages 15, 18-22, 17-21) which adds specificity. (3) The LLM correctly identifies that regulation restricted adult consumer access to information about both RRPs and SFPs. (4) The answer captures the core theme of intensifying regulatory pressure on competitive positioning. WEAKNESSES: (1) CRITICAL SEMANTIC ISSUE: The LLM states that 2022 warnings covered 'both RRPs and SFPs,' but the ground truth indicates that in 2022, the company emphasized RRPs specifically, with the SFP terminology emerging later. The ground truth shows a strategic shift from RRPs (2022-2023) to SFPs (2024), but the LLM conflates these timelines. (2) MISSING KEY EVOLUTION: The ground truth emphasizes that by 2023, the company highlighted 'the growing influence of digital media in spreading misleading information about RRPs'—a specific regulatory concern that the LLM completely omits. (3) INCOMPLETE SYNTHESIS: The ground truth notes that regulation 'disproportionately impacted the commercialization of PMI's products relative to competitors,' emphasizing competitive asymmetry. The LLM mentions 'unfair competition' but doesn't clearly articulate this comparative disadvantage framing. (4) STRUCTURAL DIFFERENCE: The ground truth presents a clear narrative arc showing how PMI's product focus shifted from RRPs to SFPs while regulatory concerns persisted. The LLM treats RRPs and SFPs as parallel concerns throughout all three years rather than showing this strategic transition. (5) MISSING NUANCE: The ground truth's phrase 'signaling a strategic shift in product focus' in 2024 is not captured in the LLM answer, which treats the evolution as merely additive rather than transformative. QUANTITATIVE ACCURACY: Page numbers are cited but cannot be independently verified from the question context. The years (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The LLM attempts to synthesize across three years of filings but fails to capture the temporal evolution of product focus (RRPs→SFPs) that is central to the ground truth's argument. The answer reads as a list of regulatory concerns rather than a coherent narrative of strategic adaptation under regulatory pressure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 622,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s exposure to margin risk has stayed essentially the same from 2022 through 2024.  In each filing the company notes that it is the principal in every payment transaction, sets the fee schedule (a tiered, volume‑based model) and bears the full margin risk regardless of the variable fee component or the proportion of transactions processed by third‑party processors.  Incentives to merchants and consumers – discounts, rebates, rewards and coupons – are still treated as revenue reductions and have not changed in scope or accounting treatment.  Thus, the use of payment processors remains a cost component of transaction expense, and the overall margin‑risk exposure, pricing structure, and incentive framework have remained consistent over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that PayPal bears full margin risk across all three years (2022-2024), accurately notes the tiered volume-based fee model, and correctly states that incentives (discounts, rebates, rewards, coupons) are treated as revenue reductions. The answer properly recognizes that payment processors are cost components of transaction expense. No numerical errors or date inaccuracies are present. WEAKNESSES: The LLM answer significantly understates the evolution of PayPal's disclosure. The ground truth explicitly states there was 'increasing detail around incentives and transaction pricing' and 'more nuanced disclosure' from 2022 to 2024, reflecting an evolution in how the company communicated margin risk management. The LLM characterizes the exposure as 'essentially the same' and 'remained consistent,' which contradicts the ground truth's emphasis on 'increasing detail' and 'more nuanced disclosure.' The ground truth notes that in 2023 the company 'added details about incentives' and in 2024 'highlighted the independence of the fee charged to customers from the costs incurred,' suggesting a progression in disclosure sophistication. The LLM misses this important evolution in how PayPal communicated its margin risk exposure, instead presenting a static picture. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the consistent underlying risk exposure, but fails to capture the evolution in disclosure detail that the ground truth emphasizes. The answer addresses the core question but incompletely captures how the company's communication about margin risk evolved. SEMANTIC ISSUE: While the LLM's statement that margin risk 'stayed essentially the same' is technically accurate regarding the underlying exposure, it misses the ground truth's key point about evolving disclosure and increasing nuance in how this risk was communicated and managed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 526,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s policy toward AIB manufacturers stayed essentially the same from 2022 through 2024: the company continued to protect AIB inventory from price reductions and, in all filings, stressed that system integrators use discrete graphics solutions to differentiate their products. The relationship with AIBs remained stable, with no substantive changes to inventory‑protection terms or the strategic role of discrete GPUs for SIs. (See AMD 10‑K 2022, page 13; AMD 10‑K 2023, page 12; AMD 10‑K 2024, page 13)",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant qualitative inaccuracies despite getting some basic facts right. CORRECT ELEMENTS: (1) The LLM correctly identifies that AMD maintained inventory protection policies across 2022-2024, (2) Correctly notes that discrete graphics solutions were emphasized as differentiators for SIs throughout the period, (3) Page references appear plausible (though not verified against actual filings), (4) Correctly identifies the three years in question. CRITICAL ERRORS: (1) The LLM states 'no substantive changes' to the relationship, which directly contradicts the ground truth's key finding that there WAS a 'subtle shift in language' and 'deepening of the value proposition' by 2024, (2) The LLM misses the important evolution in emphasis: 2022-2023 focused on AIBs building/selling board-level products to SIs/retailers/sub-distributors, while 2024 shifted to emphasize SIs selling based on regional/product strengths and responding to new technologies, (3) The LLM fails to capture the strategic alignment shift toward SIs integrating AMD-based AIB products into differentiated offerings, (4) The answer oversimplifies the relationship as 'stable' when the ground truth indicates meaningful strategic evolution. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the three years. The question specifically asks 'how did...evolve' (implying change), but the LLM concluded there was no evolution. This represents a fundamental misunderstanding of the multi-hop synthesis required. The ground truth demonstrates nuanced changes in strategic emphasis and language that the LLM completely missed. QUANTITATIVE ACCURACY is high because there are no numeric claims to verify, but QUALITATIVE ACCURACY is low because the core analytical finding is inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 496,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s policy on investment‑credit exposure has remained essentially unchanged from fiscal 2022 through 2024: it only enters derivative transactions with counterparties rated A‑ or better, requires collateral when a counterparty’s rating falls below A‑ or when aggregate exposures exceed contractual limits, and limits exposure to any single institution 【page_117】.  The concentration threshold—no more than 10 % of total cash and cash equivalents with any one institution—has stayed the same, but the actual concentration rose from none in 2023 (no balances exceeded 10 % of total cash and cash equivalents) to 24 % of total cash and cash equivalents in 2024 【page_120】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies the consistent A- or better counterparty credit rating requirement across fiscal 2022-2024; (2) Accurately states collateral requirements when ratings fall below A- or exposures exceed contractual limits; (3) Correctly reports the 24% concentration in fiscal 2024; (4) Accurately notes the shift from no concentration in fiscal 2023 to 24% in 2024; (5) Properly identifies the 10% threshold policy; (6) Provides appropriate page citations. MINOR ISSUES: (1) The ground truth states 'no such concentration in fiscal 2022' while the LLM specifies 'no balances exceeded 10% of total cash and cash equivalents in 2023' - this is a slight temporal discrepancy. The LLM references 2023 data while the ground truth compares 2022 to 2024. However, the LLM's statement about 2023 appears to be accurate based on the context provided, suggesting the ground truth may have simplified the comparison or the LLM accessed more granular year-by-year data. (2) The LLM answer is more detailed and precise in distinguishing between the policy threshold (10%) and actual concentration (24%), which adds clarity but wasn't explicitly required. QUANTITATIVE VERIFICATION: All percentages (A-, 10%, 24%) are correct. The comparison logic (none in 2023 vs 24% in 2024) is sound. MULTI-HOP REASONING: The answer successfully synthesizes information about policy consistency, threshold requirements, and actual concentration changes across the three-year period. The reasoning correctly identifies the paradox of consistent policy with changing actual concentration. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth, with slightly more precision on the year-to-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 486,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "Across 2022, 2023, and 2024 PayPal’s exposure to the 2029‑maturing Fixed‑Rate 2.850 % notes remained unchanged at **$1.5 billion** (the principal amount listed in each year’s debt‑summary table). This steady level of exposure indicates a deliberate long‑term debt‑management strategy that preserves a consistent debt mix and maturity profile, balancing interest‑rate risk and liquidity while keeping the company’s long‑term financing structure stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the principal amount as $1.5 billion (equivalent to $1,500 million in ground truth) and accurately states it remained unchanged across 2022, 2023, and 2024. (2) Number formatting is acceptable ($1.5 billion = $1,500 million). (3) The core quantitative fact—no principal reduction or refinancing activity—is correct. WEAKNESSES: (1) The LLM answer is INCOMPLETE regarding the multi-hop synthesis required by the question. The ground truth explicitly mentions that PYPL issued NEW DEBT in 2023 and 2024, including higher-interest notes (5.150% and 5.500% in 2024), which provides critical context for understanding the debt management strategy. The LLM fails to mention these new issuances, which are essential to the multi-year pattern analysis. (2) The reasoning about strategy is vague and generic ('preserves a consistent debt mix and maturity profile, balancing interest-rate risk and liquidity'). The ground truth provides more specific strategic insight: PYPL maintained the 2029 notes DESPITE issuing new higher-interest debt, suggesting a deliberate choice to retain favorable interest terms. (3) The LLM does not synthesize the comparative context—that while maintaining the 2029 notes, the company was simultaneously taking on higher-cost debt, which is a key insight into the overall strategy. (4) Missing the specific detail that the 2029 notes carry a favorable 2.850% rate compared to the newer 5.150%-5.500% notes issued later, which explains WHY the company would retain this instrument. CALCULATION VERIFICATION: No calculations required; the stated amount is correct. MULTI-HOP SYNTHESIS: Partially failed—the LLM identified the 2029 notes correctly but did not synthesize information about concurrent debt issuances that provide essential context for understanding the strategic pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 501,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s Performance Materials and Technologies segment has seen only a marginal rise in contract‑based supply coverage, from 63 % of its raw‑material base in 2022 to 64 % in 2023 and a “majority” under contract by 2024 (page 32 2022, page 32 2023, page 32 2024).  Nonetheless, the risk‑factor disclosures on pages 31 2023 and 31 2024 repeatedly warn that price swings and supply‑chain disruptions for copper, fluorspar, tungsten salts, ethylene, aluminum and molybdenum can still lift costs and hurt margins.  The slight increase in contract coverage therefore only modestly dampens, but does not eliminate, Honeywell’s vulnerability to commodity‑market volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM introduces specific quantitative claims (63% contract coverage in 2022, 64% in 2023, 'majority' in 2024) that are NOT present in the ground truth answer. The ground truth makes no mention of contract-based supply coverage percentages at all. This appears to be fabricated data or hallucinated from the source documents. (2) SEGMENT NAMING: The ground truth explicitly notes the segment was 'rebranded as Energy and Sustainability Solutions' by 2024, but the LLM fails to mention this important contextual evolution and continues referring to it as 'Performance Materials and Technologies' throughout. (3) RISK FACTORS: While the LLM correctly identifies specific commodities (copper, fluorspar, tungsten salts, ethylene, aluminum, molybdenum) as risk factors, the ground truth focuses on broader categories (raw material demand/supply, product commoditization, illegal imports, oil/natural gas price volatility). The LLM's specificity here may be accurate to the filings but represents a different level of detail than the ground truth synthesis. (4) MISSING CONTEXT: The LLM completely omits the 2022 mention of illegal imports of hydrofluorocarbons into Europe, which the ground truth identifies as a specific risk. (5) REASONING QUALITY: The LLM's conclusion about 'marginal rise' in contract coverage and its dampening effect is logical, but this entire analytical framework is absent from the ground truth, which focuses on the consistency and evolution of risk disclosure framing rather than quantitative hedging metrics. (6) MULTI-HOP SYNTHESIS: The ground truth synthesizes the evolution of risk disclosure across three years with attention to strategic repositioning; the LLM attempts a different synthesis based on contract coverage metrics that cannot be verified against the provided ground truth. The answer fundamentally misinterprets what the question is asking about (evolution of exposure/framing vs. quantitative hedging metrics).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 557,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "PMI’s peer group list stayed unchanged from 2022 through 2024, with Imperial Brands PLC appearing on the list in the 2022 filing (page 21), the 2023 filing (page 26), and the 2024 filing (page 26). This steady inclusion shows that PMI deliberately anchors its benchmarking against a consistent set of global tobacco and consumer‑products peers, treating Imperial Brands as a key comparative benchmark to gauge performance in the sector.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Imperial Brands PLC remained consistently included across all three years (2022, 2023, 2024), matching the ground truth; (2) Accurately conveys the key insight that this consistency reflects a stable benchmarking strategy; (3) Properly synthesizes the multi-hop information about peer group composition across three years; (4) Uses appropriate terminology ('benchmarking strategy,' 'comparative benchmark') that aligns with the ground truth's characterization. MINOR ISSUES: (1) The LLM uses 'PMI' while the ground truth uses 'PM' - these are equivalent (Philip Morris International ticker), but the inconsistency with the question's terminology is a minor deviation; (2) The LLM provides specific page numbers (21, 26, 26) which add helpful detail but cannot be verified against the ground truth provided; (3) The LLM's phrasing 'deliberately anchors' and 'key comparative benchmark' is slightly more assertive than the ground truth's more measured 'maintained a stable benchmarking strategy' and 'viewed Imperial Brands as a relevant comparator,' though semantically equivalent. QUANTITATIVE ACCURACY: The years (2022, 2023, 2024) are correct, and the core fact that Imperial Brands appeared in all three years matches the ground truth perfectly. QUALITATIVE ACCURACY: The reasoning about what this consistency reveals (stable strategy, strategic alignment) is sound and matches the ground truth's interpretation. The answer correctly synthesizes information across the three-year period to draw conclusions about PM's benchmarking approach. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about trajectory and what it reveals about benchmarking strategy in the global tobacco sector.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 497,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850% notes remained unchanged at **$1.5 billion** in each of the 2022, 2023 and 2024 10‑Ks (page 107 for 2022‑23; page 104 for 2024‑23). The unchanged exposure indicates that the company is keeping a steady portion of long‑term, fixed‑rate debt rather than aggressively refinancing or paying it down, reflecting a strategy of maintaining a predictable debt‑service profile and hedging against interest‑rate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All numeric values are correct - the $1.5 billion principal amount is accurately stated for all three years (2022, 2023, 2024), with no changes across the period. The page references provided (page 107 for 2022-23; page 104 for 2024) add credibility and specificity. ENTITY ACCURACY: PayPal/PYPL correctly identified, the 2.850% fixed-rate notes properly specified, and all fiscal years correctly referenced. COMPLETENESS: The answer addresses both parts of the question - the evolution of exposure (stable at $1.5B across all three years) and what this indicates about debt management strategy. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies that the unchanged balance indicates no repayments or refinancing, and provides reasonable strategic interpretation (maintaining predictable debt-service profile, hedging against interest-rate volatility). This reasoning aligns with and slightly expands upon the ground truth's interpretation about maintaining consistent liability position and leveraging the low fixed rate. SEMANTIC EQUIVALENCE: The LLM's explanation of the strategy is semantically equivalent to the ground truth - both convey that PYPL maintained the debt without aggressive refinancing or paydown, and both suggest this reflects deliberate capital structure management. The LLM's additional detail about 'hedging against interest-rate volatility' is a reasonable inference from maintaining a fixed-rate debt position and doesn't contradict the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more strategic detail than the ground truth (interest-rate hedging), which is appropriate elaboration rather than error. The page citations add value without introducing inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 492,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "From 2022 to 2024 ConocoPhillips broadened its HSE audit scope to explicitly include staff‑group reviews, added a formal tracking system that ensures all identified improvement actions are followed through to completion, and reinforced corporate governance by reporting audit results and progress to the Executive Leadership Team and Board of Directors (see page 18 of the 2023 and 2024 10‑Ks, which note “HSE audits … tracked to completion” and “Progress is tracked and reported to our ELT and the Board”).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misrepresentations compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that HSE audits were tracked to completion, (2) correctly notes reporting to ELT and Board of Directors, (3) correctly identifies 2023 and 2024 as relevant years, (4) appropriately cites 10-K filings. SIGNIFICANT GAPS AND ERRORS: (1) The answer claims ConocoPhillips 'broadened' audit scope to 'explicitly include staff-group reviews' - but the ground truth indicates staff groups were already included in 2022, so this is not an evolution/broadening but rather a continuation. This mischaracterizes the nature of change. (2) The answer fails to capture the key 2023 evolution: the explicit linking of audit outcomes to annual objectives, targets, and deadlines - a critical governance integration point mentioned in ground truth. (3) The answer misses the 2024 refinement regarding centralized corporate-level audits, which represents a shift from localized to centralized oversight - a key structural evolution. (4) The answer does not adequately convey the progression from 'localized conformance checks toward a more integrated, governance-driven audit model' that the ground truth emphasizes. MULTI-HOP REASONING: The LLM answer attempts to synthesize across years but fails to properly identify the distinct evolutionary steps in 2022→2023→2024. It presents changes as simultaneous rather than sequential. The answer also lacks the nuanced understanding that the evolution represents a shift in governance integration and centralization, not just scope broadening. SEMANTIC ISSUES: The framing of 'broadened scope' is misleading when the actual evolution involves governance integration and centralization rather than scope expansion. The answer reads more like a static description of 2024 practices rather than a true evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 520,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across 2022, 2023, and 2024 AMD continued to cite its 2011 Executive Incentive Plan as an exhibit incorporated by reference, underscoring that the plan remains a foundational governance document. In each year’s 10‑K the plan is listed in the “Exhibit” section (2023: page 101; 2024: page 96; 2022: in the 2022 10‑K’s exhibit list), and it is referenced alongside broader executive‑compensation disclosures, indicating a stable reliance on the 2011 plan as a core governance framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AMD consistently referenced the 2011 Executive Incentive Plan across 2022, 2023, and 2024 as a foundational governance document. The answer accurately conveys the multi-hop synthesis across three years and correctly notes the plan's listing in exhibit sections. However, there are notable differences from the ground truth: (1) The LLM provides specific page numbers (2023: page 101; 2024: page 96) which are not mentioned in the ground truth, and these cannot be verified against the provided information. (2) The LLM omits the specific exhibit designation (*10.1*) that appears consistently in the ground truth across all three years—this is a material detail that the ground truth emphasizes as a key indicator of continuity. (3) The LLM does not mention the specific companion plans (AMD Executive Severance Plan, AMD Deferred Income Account Plan) that the ground truth references as context for the 2011 plan's role. (4) The LLM's phrasing 'incorporated by reference' differs from the ground truth's emphasis on the plan being 'listed as *10.1*' in the exhibit section. The reasoning is sound and the answer demonstrates understanding of the multi-hop nature of the question (tracking evolution across three years), but the omission of the *10.1* designation and companion plan context represents incomplete synthesis of the available information. The page numbers provided add specificity but cannot be verified and may introduce unverified details. Overall, the answer captures the essential finding but lacks some key details that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 445,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s 10‑Ks consistently describe the same indemnification framework: the company’s wholly‑owned subsidiary (the Seller) agreed to indemnify Stellantis for losses arising from any inaccuracy of representations or warranties in the 2017 sale, plus “certain other liabilities” that include emissions‑related claims, product liabilities and recalls.  The disclosures note that the indemnity is subject to time limits, thresholds and caps, that GM has already paid an immaterial amount for some legacy Opel recalls (including Takata inflators), and that any further indemnification for Takata recalls is considered remote.  The unchanged language and continued “immaterial” assessment indicate that GM’s exposure to post‑sale liabilities from the Opel/Vauxhall sale has remained limited and has not materially increased over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth progression. MAJOR ISSUES: (1) The LLM claims the indemnification framework and disclosures remained 'unchanged' and 'consistent' from 2022-2024, directly contradicting the ground truth which explicitly documents an EXPANSION of geographic and legal scope (Germany, UK, Netherlands in 2023; Austria added in 2024; new European Commission and UK CMA investigations in 2024). This is a fundamental mischaracterization of the evolution requested in the question. (2) The LLM fails to mention the critical 2024 development: the European Commission and UK CMA regulatory investigation into end-of-life vehicle practices at Opel, which represents a material escalation in regulatory exposure. (3) The LLM incorrectly concludes that 'exposure has remained limited and has not materially increased,' which directly contradicts the ground truth's finding that 'the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities.' (4) While the LLM correctly identifies that immaterial amounts were paid and that further indemnification is considered remote, it uses this to support an incorrect conclusion about stasis rather than recognizing the expanding scope of claims. (5) The LLM misses the year-by-year progression that is central to answering 'how did...evolve' - it treats all years as equivalent rather than documenting the 2022→2023→2024 escalation. CORRECT ELEMENTS: The LLM accurately describes the basic indemnification framework (representations/warranties, time limits, thresholds, caps) and correctly notes that Takata inflator amounts were immaterial and further Takata indemnification is remote. However, these correct details are used to support an incorrect overall narrative. The answer fundamentally fails the multi-hop synthesis requirement by not tracking the expansion of legal jurisdictions and regulatory actions across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 544,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Lilly’s collaboration with AbCellera on bamlanivimab and bebtelovimab involved tiered royalties in the mid‑teens to mid‑twenties, and the product generated $2.01 B in revenue that year [page_69]. By 2023 and 2024 the product no longer appears in Lilly’s revenue tables and no royalty obligation to AbCellera is disclosed, indicating that sales and royalty payments have ceased [page_69]. This decline from a pandemic‑driven $2 B revenue stream to zero demonstrates that bamlanivimab was a short‑term asset with limited long‑term strategic importance for Lilly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about Eli Lilly's bamlanivimab exposure. STRENGTHS: (1) Quantitative accuracy is excellent - the $2.01B revenue figure for 2022 matches the ground truth's $2,008.9 million (minor formatting difference acceptable), the tiered royalty range of mid-teens to mid-twenties is correctly stated, and the timeline progression (2022→2023→2024) is accurate. (2) Multi-hop synthesis is sound - the answer correctly traces the product's evolution across three years and connects royalty obligations to AbCellera with revenue trends. (3) Entity identification is correct - Eli Lilly, AbCellera, bamlanivimab, and bebtelovimab are all properly identified. (4) The conclusion about strategic importance aligns with ground truth - both recognize this as a short-term pandemic-driven asset with declining relevance. MINOR CONSIDERATIONS: (1) The LLM mentions bebtelovimab alongside bamlanivimab, which is reasonable given they were part of the same collaboration, though the ground truth focuses primarily on bamlanivimab. (2) The LLM doesn't explicitly mention the shift to cardiometabolic health as a strategic priority area, which the ground truth includes as context for where Lilly's focus moved. However, this is a minor contextual detail rather than a factual error. (3) The answer correctly notes that by 2023 revenue dropped to zero and by 2024 the product was no longer mentioned, matching the ground truth's description of 'full phase-out' and 'complete exit.' The reasoning is logically sound and the financial narrative is coherent and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 451,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, PMI continues to list Jackpot as a local Philippine brand with no change in its strategic emphasis. The brand’s consistent inclusion in the local‑market portfolio shows that PMI’s three‑year trajectory has been to maintain a stable local‑brand presence in key markets, complementing its international brands and reinforcing its focus on local consumer preferences.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Jackpot was consistently listed as a local Philippine brand across 2022-2024 with no strategic change, which aligns with the ground truth. The quantitative elements (years 2022, 2023, 2024) are accurate. However, the LLM answer has significant omissions and lacks depth in several critical areas: (1) It fails to mention Fortune as another key local brand in the Philippines that was referenced alongside Jackpot in 2022, which the ground truth explicitly includes. (2) It does not capture the nuanced evolution described in the ground truth - specifically that 2023 emphasized Jackpot's role in 'complementing international brands and sustaining market share,' and that 2024 showed Jackpot's persistence 'despite a broader strategic pivot toward smoke-free products and wellness.' (3) The LLM answer states there was 'no change in its strategic emphasis,' which is technically accurate but misses the important contextual insight that the ground truth provides: PMI's dual strategy of maintaining local cigarette brands while transitioning toward smoke-free products. (4) The LLM answer is more superficial, stating only that the brand's 'consistent inclusion' shows a 'stable' presence, whereas the ground truth reveals a more sophisticated strategic positioning - that PMI valued Jackpot's role despite broader portfolio shifts. The answer is partially correct on the core finding (consistent presence of Jackpot) but significantly incomplete in capturing the strategic nuances and contextual evolution that the question specifically asks about ('how did...evolve' and 'what does this trajectory reveal'). The multi-hop reasoning is present but shallow, failing to synthesize the tension between maintaining local cigarette brands and the broader smoke-free pivot.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 491,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "From 2022 to 2024 PayPal’s exposure to bad transactions shifted as it moved most of its U.K. and European BNPL receivables off its books – a multi‑year sale of up to €40 billion announced in 2023 that transferred the majority of that portfolio and a forward‑flow of future originations, thereby reducing BNPL‑related credit risk. Credit‑product defaults and fraud remain persistent concerns, with filings noting rising non‑payment rates, significant losses from buyer‑seller protection programs and the potential for chargeback and fraud‑related losses to increase. Across all three years, PayPal continues to highlight third‑party processing disruptions as a key operational risk that could amplify bad‑transaction exposure if payment‑processor relationships falter.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about PayPal's bad transaction exposure evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the €40 billion BNPL receivables sale in 2023 as a key risk mitigation strategy; (2) Accurately notes the multi-year nature of the agreement and forward-flow component; (3) Properly synthesizes the shift from managing growing credit/BNPL exposure to offloading risk through the sale; (4) Correctly identifies persistent fraud and third-party processing risks across all three years; (5) Appropriately characterizes the reduction in direct BNPL-related credit exposure while acknowledging remaining underlying risks. QUANTITATIVE ACCURACY: The €40 billion figure is correct and properly contextualized. No calculation errors detected. MINOR GAPS: (1) The answer could have been slightly more explicit about the 2022 baseline (fraud, synthetic identities, stolen instruments) before discussing the 2023 transition, though this is implied; (2) Does not explicitly mention 'account takeover attempts' as a specific fraud vector noted in 2023, though fraud is covered broadly; (3) Could have emphasized more the 'uncertainty around regulatory challenges' mentioned in ground truth, though this is a minor omission. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk categories (credit defaults, fraud, third-party dependencies), showing sound logical progression from 2022 exposure → 2023 sale → 2024 residual risks. The connection between the sale and risk reduction is clearly articulated. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth with slightly different emphasis and organization, which is appropriate for a summary response. The characterization of 'shifted' vs 'evolved' is semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 514,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022, Honeywell’s Safety and Productivity Solutions segment was flagged as vulnerable to retail‑market swings, with the company noting that such fluctuations could erode market share, lower selling prices and compress margins (Risk Factors, page 31 2022). In 2024, the same risk was identified for the Industrial Automation segment, where retail‑market volatility was again cited as a potential drag on sales and profitability (Risk Factors, page 31 2024). The 2023 filing’s risk disclosures (page 31 2023) underscore that this sensitivity to retail demand volatility remains a persistent concern across Honeywell’s industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three key years (2022, 2023, 2024) and the relevant segments (Safety and Productivity Solutions in 2022, Industrial Automation in 2024). (2) The core factual claim that retail market fluctuations were cited as risks across these periods is accurate. (3) The LLM correctly notes that the risk involved impacts on margins, selling prices, and market share. (4) The reference to Risk Factors page 31 for multiple years is appropriately cited. WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM answer is significantly shorter and less comprehensive than the ground truth. It fails to adequately explain the 2023 risk posture evolution, merely stating it 'underscores' the concern without detailing how the risk was 'reiterated as part of broader macroeconomic and industry risks' with emphasis on global economic instability and customer investment behavior. (2) MISSING CONTEXTUAL DETAIL - The ground truth emphasizes that the risk was 'reiterated' in 2023 as part of broader macroeconomic context, showing an evolution in how the risk was framed. The LLM answer doesn't capture this nuance. (3) INCOMPLETE MULTI-HOP REASONING - While the LLM identifies the three years and segments, it doesn't fully synthesize the 'progression' or 'evolution' aspect that the ground truth emphasizes. The ground truth explicitly notes the company 'reorganized its business units' while maintaining this concern, suggesting structural persistence of the risk. The LLM doesn't address this organizational context. (4) VAGUE CONCLUSION - The LLM's conclusion that sensitivity 'remains a persistent concern' is accurate but underdeveloped compared to the ground truth's more detailed explanation of what this persistence means for the company's portfolio sensitivity. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this is based on date accuracy (all years correct: 2022, 2023, 2024) and proper citation references. QUALITATIVE ACCURACY: The LLM captures the basic facts but misses the deeper analytical framework of how the risk evolved and what it suggests about structural vulnerabilities. The reasoning is present but shallow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 588,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024 the Incyte collaboration stayed structurally unchanged: milestone payments were still capitalized as intangible assets and amortized (no new milestone amounts were reported), and the royalty terms remained tiered double‑digit rates up to 20 % on worldwide net sales with an additional low‑teens royalty on COVID‑19 sales above a threshold.  Olumiant’s net product revenue grew from $830.5 million in 2022 to $957.4 million in 2024, making it an increasingly important revenue driver for LLY while royalty payments to Incyte are recorded as cost of sales.  The partnership therefore continued to focus on expanding Olumiant sales and follow‑on compounds without altering its core financial structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the royalty structure (tiered rates up to 20% on general sales with additional low-teens royalty for COVID-19 sales above threshold). (2) Correctly notes that royalty payments are recorded as cost of sales. (3) Provides accurate Olumiant revenue figures ($830.5M in 2022 and $957.4M in 2024), demonstrating the product's growing importance. (4) Correctly identifies that the partnership focused on expanding Olumiant sales and follow-on compounds. WEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to mention the $260.0 million in capitalized milestone payments tied to regulatory approvals (U.S., Europe, Japan) that were explicitly documented in 2022. This is a significant financial detail that directly addresses the 'milestone payments' component of the question. (2) CRITICAL OMISSION: The LLM completely omits the $200.0 million in contingent/additional milestone payments (split between regulatory and sales milestones) that Incyte was eligible to receive. This represents a major gap in addressing the financial structure evolution. (3) The LLM states 'no new milestone amounts were reported' but this misses the point that the original answer discusses the EXISTING milestone structure and its implications for the partnership's financial framework. (4) The claim that the collaboration 'stayed structurally unchanged' is partially correct but oversimplifies the evolution described in the ground truth, which emphasizes a shift from capitalized milestones (2022) to ongoing revenue recognition (2023-2024). (5) Missing the strategic evolution narrative: the ground truth emphasizes how the partnership matured from milestone-driven (2022) to revenue-recognition-focused (2023) to strategically expanded (2024 with EUA and follow-on compounds). The LLM presents this as static rather than evolving. QUANTITATIVE VERIFICATION: Revenue figures are accurate ($830.5M 2022, $957.4M 2024). Royalty percentages (up to 20%, low-teens) are correct. However, the absence of the $260M and $200M milestone figures represents a major quantitative gap. MULTI-HOP REASONING: The LLM successfully synthesizes information about revenue growth and its relationship to royalty obligations, but fails to synthesize the complete financial picture across the three-year period, particularly regarding how milestone obligations evolved into revenue recognition obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 640,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria kept UST wholly owned through its subsidiary USSTC, with no change in ownership structure between 2022 and 2024 (page 60, page 4).  The intangible assets tied to UST—MST and snus trademarks—were valued at $8.8 billion and $2.6 billion in 2021, and no impairment or re‑valuation was reported in 2024, indicating stable valuation (page 66).  UST’s MST and snus products remain a core part of Altria’s oral‑tobacco segment, which the company identifies as a key pillar of its smoke‑free transition strategy (page 4).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses several key aspects of the question but contains a significant quantitative error and incomplete temporal analysis. STRENGTHS: (1) Correctly identifies UST as wholly owned subsidiary through USSTC with no ownership structure change 2022-2024; (2) Correctly identifies MST and snus trademarks as core intangible assets; (3) Appropriately notes stable valuation with no impairment reported; (4) Correctly identifies oral-tobacco segment as part of smoke-free transition strategy; (5) Properly synthesizes ownership and operational integration across the period. CRITICAL ERRORS: (1) QUANTITATIVE ERROR - States trademark values as '$8.8 billion and $2.6 billion in 2021' but ground truth specifies '$8.8 billion in MST and snus trademarks' in 2022 (not 2021, and the $2.6 billion figure is not mentioned in ground truth). The LLM appears to have conflated or misidentified the valuation data; (2) INCOMPLETE TEMPORAL ANALYSIS - Ground truth emphasizes the 3-year trajectory showing evolution from 2022→2023→2024, but LLM treats the period more statically, missing the strategic evolution narrative; (3) MISSING STRATEGIC CONTEXT - Ground truth highlights the strategic shift toward Helix (oral nicotine pouches) and NJOY (e-vapor) as complementary to UST's traditional business. LLM mentions oral-tobacco segment but doesn't capture this diversification strategy or the 'increasingly complemented by newer alternatives' evolution. REASONING QUALITY: The multi-hop synthesis is partially sound (connecting ownership, valuation, and strategy) but lacks the temporal dimension and strategic evolution that the question specifically asks about. The answer is factually defensible on ownership and general strategy but fails on precise valuation data and misses the key insight about how UST's role evolved within Altria's broader portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 503,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% Senior Note had an effective rate of **3.20 % in FY 2022**, which jumped to **6.38 % in FY 2023** and rose slightly further to **6.66 % in FY 2024** (see the long‑term debt tables on page 89). The coupon stayed at 3.50 %, but the higher effective rates show the note was issued at a discount as market rates climbed, indicating that Cisco’s borrowing costs rose and capital markets became more expensive and risk‑averse over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three effective interest rates are correct - 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024). The coupon rate of 3.50% is also correctly stated. The progression and magnitude of increases match the ground truth exactly. ENTITY ACCURACY: Cisco (CSCO) correctly identified, fiscal years 2022-2024 properly referenced, and the 3.50% Senior Note correctly specified. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and correctly interprets the relationship between the fixed coupon (3.50%) and rising effective rates, explaining this as a discount issuance phenomenon. The conclusion about tightening capital markets and increased borrowing costs is logically sound and matches the ground truth interpretation. COMPLETENESS: The answer addresses all parts of the question - the evolution of rates across the three-year period and what this indicates about borrowing costs and capital market conditions. MINOR STRENGTHS: The LLM provides additional context by explaining the discount issuance mechanism (coupon vs. effective rate divergence), which adds analytical depth beyond the ground truth while remaining accurate. The reference to page 89 adds source specificity. SEMANTIC EQUIVALENCE: The wording differs slightly from ground truth but conveys identical meaning - both describe the upward trend, the magnitude of change, and the implications for capital markets. No factual errors or calculation mistakes detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 426,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017‑issue notes have been steadily paid down: the balance fell from **$16.0 billion at December 31 2022** to **$15.0 billion at December 31 2023** and further to **$13.0 billion at December 31 2024**【page_58】【page_57】. This downward trajectory shows a deliberate deleveraging effort—Amazon is actively reducing or refinancing that tranche, which lowers interest expense and preserves liquidity, reflecting a disciplined debt‑management strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct—$16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The dates are properly specified as December 31 for each year. The total reduction from 2022 to 2024 is $3.0 billion, which is mathematically consistent with the stated figures. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the 2017 Notes balance across the three-year period, and (2) what this indicates about debt management strategy. ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes are properly referenced, and the fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly identifies the pattern (consistent year-over-year reduction), characterizes it as deliberate deleveraging, and explains the strategic implications (reducing interest expense, preserving liquidity). The reasoning aligns with the ground truth's characterization of 'deliberate debt management strategy.' MINOR DIFFERENCES: The LLM answer does not include the broader context about total long-term debt reduction ($67.2B to $52.6B) that appears in the ground truth. However, this is a minor omission that doesn't affect the core accuracy of the answer to the specific question asked. The LLM's explanation of the strategic implications (interest expense reduction, liquidity preservation) provides additional useful context beyond the ground truth. SEMANTIC EQUIVALENCE: The phrase 'deliberate deleveraging effort' and 'disciplined debt-management strategy' convey the same meaning as the ground truth's 'deliberate debt management strategy.' The inclusion of citation markers [page_58][page_57] adds credibility and traceability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 490,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "In fiscal 2022 the 5.000% notes due April 2030 had not yet been issued, so the outstanding principal balance was $0 and no interest rate applied (page 101).  In fiscal 2023 AVGO issued $606 million of these notes at an effective interest rate of 5.18% (page 80), and the balance and rate remained unchanged in fiscal 2024 (page 81).  This steady, moderate‑rate issuance indicates that AVGO is using the notes as a long‑term, fixed‑rate financing tool to lock in a predictable cost and keep its debt mix stable rather than expanding or refinancing the instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that in fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. The LLM incorrectly claims these notes had not yet been issued in fiscal 2022 (balance of $0). This is a critical quantitative error that undermines the entire answer. The LLM correctly identifies that the balance remained at $606 million in fiscal 2023 and 2024 with a 5.18% interest rate, but the false claim about fiscal 2022 is a major factual inaccuracy. The multi-hop reasoning about debt management strategy is reasonable in both answers, but the LLM's conclusion is based on an incorrect premise (that the notes were newly issued in 2023 rather than already outstanding in 2022). The ground truth indicates a three-year static approach (2022-2024), while the LLM describes a two-year static approach (2023-2024) following a new issuance. This represents a significant mischaracterization of the company's debt management for this instrument. The citation references (pages 101, 80, 81) cannot be verified against the ground truth but the factual claims about the principal balance and timing are demonstrably incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 366,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "In 2022, Netflix’s Performance Bonus Plan was the original 2014 plan (Exhibit 10.6†, page 65). In 2023, the company amended and restated the plan on December 9, 2022, formalizing it as Exhibit 10.5† and incorporating it into the executive‑compensation framework (page 68). In 2024, the restated plan remained in effect and was again referenced as Exhibit 10.5†, while the 10‑K integrated it with updated executive‑compensation agreements—including the amended and restated Executive Severance and Retention Incentive Plan (Exhibit 10.6†, page 68).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates, exhibit numbers, and the evolution of Netflix's Performance Bonus Plan. Strengths: (1) Correctly identifies the December 9, 2022 amendment and restatement date; (2) Accurately references exhibit numbers (10.6 for 2022, 10.5 for 2023-2024); (3) Properly synthesizes the multi-hop information showing progression from original 2014 plan through amendment to integration with other compensation agreements; (4) Correctly identifies related plans (Executive Severance and Retention Incentive Plan); (5) Maintains chronological accuracy across 2022-2024. Minor weaknesses: (1) The LLM answer is more specific and detailed than the ground truth (citing specific exhibit numbers and page references), which could be seen as either more precise or potentially introducing details not verified in the ground truth; (2) The ground truth mentions 'Executive Officer Severance Plan' while LLM references 'Executive Severance and Retention Incentive Plan'—these appear to be the same plan with slightly different naming conventions, but the discrepancy is minor; (3) The LLM answer provides more granular detail about exhibit locations, which enhances specificity but wasn't explicitly required by the question. The core narrative of formalization, restatement, and integration is accurately conveyed in both answers. The multi-hop reasoning correctly synthesizes information across three years and multiple compensation documents. No calculation errors or factual inaccuracies detected in the core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 435,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s approach to international terrorism exposure did not materially change between 2022 and 2024.  All three filings (2022 page 169, 2023 page 119, 2024 page 86) describe the same framework: scenario‑based modeling of potential losses, targeted reinsurance purchases for selected lines, and reliance on government‑sponsored terrorism reinsurance pools outside the U.S.; TRIPRA continues to cover U.S. exposures.  No new modeled loss estimates or reinsurance limits are disclosed, and the risk‑mitigation strategy remains the same—monitoring exposure concentration, using TRIPRA for U.S. coverage, and participating in country terrorism pools.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS ON CORE CLAIMS: The LLM states 'AIG's approach to international terrorism exposure did not materially change between 2022 and 2024' and 'No new modeled loss estimates or reinsurance limits are disclosed.' This directly contradicts the ground truth which documents specific evolution: the $1.3 billion loss estimate for 2022, the shift to 'routine monitoring' and 'targeted reinsurance purchases' in 2023, and the specific 2024 attachment points ($200M for Japan, $125M for rest of world) and $20.1B collateral holdings. (2) MISSING QUANTITATIVE DATA: The LLM completely fails to identify or report the specific financial figures that demonstrate evolution: $1.3 billion (2022 modeled loss), $200 million (2024 Japan attachment), $125 million (2024 rest of world attachment), and $20.1 billion (collateral). These are concrete, disclosed numbers that show material changes. (3) INCOMPLETE SYNTHESIS: The question asks specifically about 'modeled loss estimates, reinsurance protections, and risk mitigation strategies' across three years. The LLM provides only generic descriptions of the framework without the specific evolution metrics. The ground truth shows clear progression: from specific loss modeling (2022) → emphasis on monitoring and targeted purchases (2023) → specific attachment points and collateral holdings (2024). (4) LOGICAL REASONING FAILURE: The LLM's conclusion that there was 'no material change' is contradicted by the presence of specific, different reinsurance attachment points and collateral figures across years. The ground truth explicitly states 'This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time'—the opposite of the LLM's claim. (5) CITATION ISSUES: While the LLM cites page numbers, it appears to have misread or misinterpreted the content, as the specific figures in the ground truth are not reflected in the LLM's answer. The LLM's characterization of consistency is factually incorrect given the documented evolution in reinsurance structures and collateral management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 584,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth Group’s venture portfolio grew from **$3.7 billion in equity securities in 2022 to $4.9 billion in 2023, a level it maintained in 2024** (UNH 10‑K 2023, page 50; UNH 10‑K 2024, page 52).  Equity‑method stakes in healthcare operating businesses fell slightly from **$1.5 billion in 2022 to $1.4 billion in 2023** but then **more than doubled to $3.8 billion in 2024**, signaling a renewed focus on equity‑method investments in the sector (UNH 10‑K 2023, page 50; UNH 10‑K 2024, page 52).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are central to answering this question. (1) EQUITY SECURITIES 2022: LLM states $3.7 billion, but ground truth is $3.5 billion - a $200 million discrepancy. (2) EQUITY METHOD INVESTMENTS 2022: LLM states $1.5 billion, but ground truth is $1.3 billion - a $200 million error. (3) EQUITY METHOD INVESTMENTS 2023: Both sources agree on $1.4 billion - this is correct. (4) EQUITY SECURITIES 2023-2024: Both sources agree on $4.9 billion maintained - this is correct. (5) EQUITY METHOD INVESTMENTS 2024: Both sources agree on $3.8 billion - this is correct. MULTI-HOP REASONING: The LLM correctly synthesized the evolution narrative across three years and identified the strategic pivot toward equity-method investments in 2024. The interpretation that this signals 'renewed focus on equity-method investments' is reasonable and aligns with the ground truth's observation about 'strategic pivot toward deeper involvement.' COMPLETENESS: The answer addresses both components of the question (equity securities and equity method investments) across the 2022-2024 period. SEMANTIC EQUIVALENCE: The characterization of the trend is semantically sound - the doubling of equity-method investments and maintenance of equity securities is accurately described. CRITICAL ISSUE: The two errors in 2022 baseline figures ($3.7B vs $3.5B for equity securities, and $1.5B vs $1.3B for equity method) are material discrepancies that undermine the credibility of the answer, even though the trend analysis and 2023-2024 figures are correct. These are not formatting variations but actual factual errors in reported financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 471,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 10‑K filings for 2022, 2023 and 2024 all list the 1.700 % Notes due 2025 (MO25) as a registered security (see each filing’s securities section on page 1).  The coupon, maturity and absence of any reported repayment or refinancing across the three years show that the instrument remained a stable, low‑cost component of the company’s debt base.  This steady presence indicates a disciplined debt‑management strategy that prioritizes predictable interest costs and long‑term financing rather than frequent refinancing or restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.700% 2025 Notes as present across all three years (2022, 2023, 2024) and accurately characterizes it as a stable debt instrument. The numeric values (1.700%, 2025 maturity date) are correct. However, the answer has significant weaknesses in completeness and multi-hop synthesis: (1) The LLM fails to address the key multi-year progression element that is central to the question. The ground truth explicitly discusses how the 1.000% 2023 Notes matured and were removed from the capital structure by 2023, which is a critical data point showing active debt management. The LLM completely omits this comparative analysis across years. (2) The LLM does not synthesize information about other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for understanding Altria's overall capital structure evolution. (3) While the LLM correctly infers a 'disciplined debt-management strategy,' it does so without the supporting evidence of the matured 2023 Notes, which is the concrete demonstration of that strategy. (4) The answer is somewhat generic in its characterization of the debt management strategy ('prioritizes predictable interest costs and long-term financing') without grounding it in the specific multi-year progression data. The LLM demonstrates partial understanding but fails to fully synthesize the multi-hop information required to answer the question comprehensively. The answer would score higher if it had explicitly compared the debt portfolio composition across the three years and highlighted the removal of maturing instruments as evidence of active management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock grew steadily: it was $51.354 billion at December 31, 2022, rose to $60.429 billion at December 31, 2023, and climbed further to $71.431 billion at December 31, 2024.  The corresponding purchases of treasury stock were $9.088 billion in 2022, $11.025 billion in 2023, and $11.025 billion in 2024.  This upward trend reflects a deliberate, ongoing share‑repurchase program—an effort to return excess cash to shareholders, support the share price, and enhance earnings per share as part of Mastercard’s capital‑allocation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental misunderstandings of the treasury stock figures. The ground truth shows treasury stock balances as NEGATIVE values: $(36,658)M in 2022, $(60,429)M in 2023, and $(71,431)M in 2024. These negative values represent accumulated treasury stock (a contra-equity account). The LLM incorrectly presents these as positive values ($51.354B, $60.429B, $71.431B), which is factually wrong. Additionally, the LLM introduces entirely new figures for 'purchases of treasury stock' ($9.088B, $11.025B, $11.025B) that are not present in the ground truth answer and cannot be verified. The ground truth specifically cites the treasury stock balance figures with negative signs, indicating these are accumulated amounts, not annual purchases. MULTI-HOP REASONING: While the LLM correctly identifies the upward trend in absolute magnitude and appropriately connects this to capital allocation strategy (share repurchases, shareholder returns, EPS enhancement), the fundamental misrepresentation of the data undermines the entire analysis. The reasoning about capital allocation strategy is sound in concept but built on incorrect numerical foundations. ENTITY ACCURACY: Mastercard and Class A Treasury Stock are correctly identified. Years 2022-2024 are correct. SEMANTIC ISSUES: The LLM's interpretation of treasury stock as a positive balance growing from $51.354B is contradictory to standard accounting where treasury stock is a negative equity item. The ground truth clearly uses negative notation, which the LLM failed to preserve or explain. The introduction of separate 'purchase' figures suggests confusion about whether the answer should report balances or annual transactions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 474,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure produced a **$92 million loss in FY 2022** (page 92). In FY 2023 the swaps generated a **$58 million gain** (page 91), and in FY 2024 the gain rose to **$91 million** (page 91). Thus, the exposure swung from a sizable loss to progressively larger gains, with the notional amount of the swaps increasing from $651 million in FY 2022 to $985 million in FY 2024 while the net effect turned positive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024. The answer correctly identifies the evolution pattern (loss to gains) and accurately characterizes the trend as a reversal and strengthening. The LLM goes beyond the ground truth by providing additional context: (1) notional amounts of swaps increasing from $651M to $985M, and (2) page references to source documents. These additions enhance credibility and demonstrate multi-hop synthesis across the filing. The reasoning is sound - correctly identifying the swing from negative to positive performance and the progressive increase in gains. The semantic meaning aligns perfectly with the ground truth, using equivalent phrasing ('sizable loss to progressively larger gains' vs 'reversal and strengthening'). Minor consideration: the LLM provides supplementary information (notional amounts) not explicitly in the ground truth, but this is factually accurate and adds value without contradicting the original answer. The answer fully addresses all parts of the multi-year evolution question with proper entity identification (Cisco, Total Return Swaps-Deferred Compensation, fiscal years 2022-2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 356,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s 2022 risk factors already flagged that its library “depends on obtaining various rights from third parties” and that a refusal or withdrawal of those rights could hurt the business (NFLX_10k_2022, p. 11). In 2023 the filing added that rights holders are increasingly launching their own streaming platforms, making it harder to secure exclusive titles and driving up licensing costs (NFLX_10k_2023, p. 4). By 2024 the risk narrative broadened to include growing regulatory pressures—content quotas, levies, and ownership‑rights restrictions that can force removal or limit availability—further tightening Netflix’s dependence on negotiated licenses (NFLX_10k_2024, p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate temporal sequencing of Netflix's evolving dependency on rights holders. (2) Accurately captures the core risk factors: 2022 baseline dependency on third-party rights, 2023 emergence of rights holders launching competing platforms and cost pressures, 2024 regulatory constraints (content quotas, levies, ownership restrictions). (3) Properly synthesizes multi-hop information across three separate 10-K filings, showing how risks compounded over time. (4) Uses appropriate semantic language ('refusal or withdrawal,' 'harder to secure exclusive titles,' 'driving up licensing costs,' 'tightening Netflix's dependence') that matches the ground truth's conceptual framework. (5) Correctly identifies regulatory pressures as a 2024-specific development, distinguishing it from earlier competitive and licensing concerns. (6) Includes specific page references (p. 11, p. 4, p. 4) that add credibility, though these cannot be independently verified. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential elements without omission. (2) The phrase 'ownership-rights restrictions' is a reasonable interpretation of regulatory constraints on content control. (3) The answer could have explicitly mentioned 'intellectual property disputes' as noted in the ground truth's 2023 reference, though this is a minor omission that doesn't affect overall accuracy. QUANTITATIVE ACCURACY: No numerical data, percentages, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and documents, correctly identifying how Netflix's strategic challenges evolved from dependency concerns → competitive pressures → regulatory constraints. The logical progression is sound and matches the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 565,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s 10‑K notes (see Note 4 on page 81) state that “None of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022.” Thus, the company’s financial exposure to service‑level guarantees did not materially change over the three‑year period, indicating a stable and low‑risk commitment to service delivery across its subsidiaries.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantees were immaterial across all three years (2022-2024), which matches the ground truth. However, the answer is significantly incomplete and misses critical information required to fully answer the question. Specifically: (1) The LLM correctly states the service level guarantees were immaterial in all three years, which is accurate. (2) The LLM fails to address the second major component of the ground truth answer regarding the parent company's notes payable to subsidiaries, which showed significant fluctuation: $8.1B (2022) → $9.9B (2023) → $2.0B (2024). This is a material omission that directly relates to understanding the evolution of financial obligations and the stability of service delivery commitments. (3) The LLM's conclusion that the immateriality of service level guarantees indicates 'stable and low-risk commitment' is incomplete reasoning. The ground truth reveals that while service level guarantees were immaterial, the internal financing structure supporting these guarantees experienced 'notable variation,' suggesting the full picture is more complex than the LLM presents. (4) The LLM provides a citation (Note 4, page 81) which adds credibility but doesn't compensate for the incomplete analysis. (5) The question explicitly asks about a '3-year trend' and what it 'suggests about stability' - the LLM addresses only half of this by discussing service level guarantees but ignoring the subsidiary financing trends that provide crucial context. The answer demonstrates partial understanding but fails to synthesize the complete multi-hop information necessary to fully address the question's intent regarding the evolution and stability of financial obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 477,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s pension plan cut its exposure to below‑investment‑grade securities from roughly 13 % of fixed‑income holdings in 2022 to 11 % in 2023 and to 8 % in 2024, while the post‑retirement plan’s allocation stayed near 8–9 % in 2022, rose to 9 % in 2023, and fell to 8 % in 2024【page_86】【page_90】. This gradual tightening in the pension portfolio, with a relatively stable but slightly lower exposure in the post‑retirement portfolio, signals a cautious, risk‑averse approach to managing long‑term obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) PENSION PLAN 2022: Ground truth states 16% of fixed income holdings; LLM claims ~13%. This is a material 3-percentage-point discrepancy. (2) PENSION PLAN 2024: Ground truth explicitly states 'specific percentages for below investment grade allocations were not disclosed in 2024'; LLM fabricates a specific figure of 8%, which is not supported by the source material. (3) POSTRETIREMENT PLAN 2022: Ground truth states 8% of fixed income holdings; LLM claims 8-9%, which is imprecise and inconsistent with the ground truth's specific 8% figure. (4) POSTRETIREMENT PLAN 2024: Ground truth does not provide 2024 data; LLM invents an 8% figure. The LLM appears to have hallucinated 2024 data that was explicitly not disclosed according to the ground truth. (5) MISSING CONTEXT: The LLM fails to mention the important distinction between 'percentage of fixed income holdings' versus 'percentage of total plan assets' that the ground truth carefully distinguishes (e.g., 16% of fixed income = ~11% of total assets for pension in 2022). This dual-metric context is important for understanding the actual exposure levels. (6) REASONING: While the LLM's conclusion about a 'cautious, risk-averse approach' aligns directionally with the ground truth's assessment, it is based on incorrect underlying numbers, making the reasoning unsound. The multi-hop synthesis fails because the foundational data points are wrong. The LLM demonstrates a pattern of inventing specific 2024 figures when the ground truth explicitly states these were not disclosed, which is a serious factual error that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 475,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard continued to estimate gross settlement exposure by multiplying the average daily payment volume of the preceding three months by the estimated number of days of exposure and then subtracting risk‑mitigation adjustments—this calculation was unchanged from 2022 through 2024 (page_104, page_106).  While the exposure grew as payment volumes rose and risk‑mitigation limits were adjusted, the unchanged methodology shows the company’s disciplined, stable risk‑management framework, which remains resilient amid mounting regulatory scrutiny and litigation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core methodology (average daily payment volume × estimated days of exposure) and accurately states it remained unchanged from 2022-2024. The mention of risk-mitigation adjustments is accurate. The characterization of the framework as 'disciplined' and 'stable' aligns with the ground truth's interpretation. Page citations (104, 106) appear reasonable for 10-K filings. WEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It fails to mention specific regulatory investigations (FTC, DOJ in 2023; European Commission in 2024) and specific litigation risks (U.S. Liability Shift Litigation, TCPA class action) that are central to the question's focus on 'increasing regulatory scrutiny and litigation risks.' (2) The ground truth explicitly discusses the unchanged risk mitigation approach (requiring cash collateral or credit enhancements based on individual risk assessments), while the LLM only vaguely references 'risk-mitigation adjustments' without explaining the actual mitigation mechanisms. (3) The LLM's statement about 'exposure grew as payment volumes rose and risk-mitigation limits were adjusted' introduces a claim about changing limits that isn't clearly supported by the ground truth, which emphasizes consistency. (4) The answer lacks the nuanced interpretation that the consistent methodology 'suggests that Mastercard viewed its existing risk management practices as robust and sufficient' despite external pressures. MULTI-HOP REASONING: The LLM successfully synthesizes the methodology consistency across three years but fails to adequately connect this consistency to the specific regulatory and litigation context mentioned in the question. The answer addresses the 'how' of methodology evolution (or lack thereof) but incompletely addresses the 'what does this indicate' portion regarding risk management approach in context of specific regulatory and litigation challenges. SEMANTIC EQUIVALENCE: The core factual claim about methodology consistency is correct, but the answer loses important contextual details that directly answer the question's second part about what this consistency indicates about risk management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 599,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90 % senior note has remained at a constant $2.0 bn of outstanding principal in FY 2022, FY 2023 and FY 2024, and its effective interest rate has stayed at 6.11 % each year (see the long‑term debt tables in the 10‑Ks). The unchanged utilization and stable effective rate show that Cisco is keeping this long‑term, fixed‑rate debt on its balance sheet without active refinancing or reduction, reflecting a conservative debt‑management strategy that prioritizes predictable interest costs and a steady maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - the $2.0 billion (or $2,000 million) principal balance is accurate for all three fiscal years (2022-2024), and the 6.11% effective interest rate is correctly stated as remaining constant throughout the period. The format variation ($2.0 bn vs $2,000 million) is acceptable and properly handled. COMPLETENESS: The answer addresses all components of the multi-part question: (1) utilization evolution (constant at $2.0bn), (2) effective interest rate evolution (stable at 6.11%), and (3) what this indicates about debt management strategy. ENTITY ACCURACY: Cisco is correctly identified, the 5.90% Note is properly referenced, and all three fiscal years (2022-2024) are correctly included. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and correctly draws the logical conclusion that the unchanged balance and stable rate indicate a strategic decision to maintain this debt instrument without refinancing or reduction. The characterization of this as reflecting 'conservative debt-management strategy' and 'predictable interest costs' aligns well with the ground truth's assessment of 'strategic intent to maintain predictable interest obligations.' MINOR DIFFERENCES: The LLM uses slightly different phrasing ('conservative debt-management strategy' vs 'strategic intent to maintain predictable interest obligations') but these are semantically equivalent and both accurately capture the strategic implication. The LLM's mention of 'steady maturity profile' adds a minor contextual detail not explicitly in the ground truth but is reasonable inference from the data. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 487,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million at the end of FY 2022**, and this balance remained unchanged at **$495 million at the end of FY 2023 and FY 2024** (as shown in the debt schedule of the 2023 and 2024 10‑K, page 81). The unchanged balance indicates that the company has deliberately retained this low‑rate, long‑term debt, reflecting a strategy to preserve a stable, low‑cost debt base rather than refinancing or repaying it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All financial figures are correct - the $495 million principal balance is accurately stated for FY 2022, 2023, and 2024. The consistency of the amount across all three years matches the ground truth exactly. No calculation errors present. ENTITY ACCURACY: AVGO (Broadcom) is correctly identified, the 3.125% notes due January 2025 are correctly specified, and all fiscal years (2022, 2023, 2024) are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years to identify the trend (unchanged balance), which is the core requirement of the multi-hop question. COMPLETENESS: The answer addresses both parts of the question - the evolution of the balance (showing it remained constant) and what this indicates about debt management strategy. The LLM provides slightly more interpretive detail than the ground truth (describing it as a \"low‑rate, long‑term debt\" strategy and noting the company \"deliberately retained\" it), which adds reasonable context without contradicting the ground truth. SEMANTIC EQUIVALENCE: The LLM's interpretation that the unchanged balance indicates \"a consistent approach to managing this portion of its fixed-rate debt portfolio\" (ground truth) is semantically equivalent to the LLM's statement about preserving \"a stable, low‑cost debt base.\" Both convey the same strategic intent. MINOR CONSIDERATIONS: The LLM includes a specific page reference (page 81) which adds credibility, though this wasn't in the ground truth. The characterization of the debt as \"low‑rate\" is reasonable given the 3.125% coupon rate in a higher-rate environment. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 470,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2023, CMCSA’s wireless lines offered shared data plans only within bundled packages for residential broadband subscribers (and eligible small‑business customers), with customers able to activate multiple lines and choose unlimited, shared, or per‑GB options (see 2022‑23 10‑Ks, e.g., page 7). In 2024 the bundling strategy stayed the same, but the company added a new prepaid unlimited data plan under the NOW brand, giving customers an additional prepaid option and further flexibility while still requiring broadband qualification for wireless service (2024 10‑K, page 4‑5). Thus, the core bundled‑service model persisted, but 2024 expanded customer choice by introducing prepaid unlimited plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core evolution: shared data plans bundled with broadband in 2022-2023, with NOW brand prepaid unlimited plans added in 2024. (2) Accurately captures the bundling strategy requirement (broadband qualification) across all three years. (3) Properly notes customer flexibility options (unlimited, shared, per-GB) in 2022-2023. (4) Correctly identifies the NOW brand prepaid unlimited offering as the 2024 innovation. (5) Appropriately cites 10-K filings with page references, demonstrating source verification. (6) Multi-hop reasoning is sound: synthesizes evolution across three years and two service dimensions (bundling strategy and customer flexibility). MINOR WEAKNESSES: (1) The LLM answer adds detail about 'eligible small-business customers' which is not explicitly mentioned in the ground truth answer, though this may be accurate from the filings. (2) The phrasing 'still requiring broadband qualification for wireless service' in 2024 is slightly stronger than the ground truth's 'qualifying broadband bundles,' though semantically similar. (3) The ground truth emphasizes 'deepening service integration' as a strategic theme, which the LLM answer touches on but doesn't explicitly highlight. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Dates (2022, 2023, 2024) are all correct. ENTITY ACCURACY: CMCSA correctly identified, wireless services correctly identified, NOW brand correctly identified. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different emphasis and organization. The core narrative of evolution from bundled shared data plans to expanded flexibility with prepaid options is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 526,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment changes stayed high from 2022 through 2024, as CMS repeatedly reduced or froze benchmarks, altered risk‑adjustment calculations, and continued to audit coding practices that could trigger retrospective payment adjustments (2022 page 20; 2023 page 20; 2024 page 20). In each year the company responded by adjusting members’ benefits and premiums on a selective basis, discontinuing plans in certain counties, and intensifying medical and operating‑cost management to offset the funding pressures (2022 page 20; 2023 page 20).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several key elements correctly but has notable gaps in completeness and depth compared to the ground truth. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the core issue of CMS benchmark reductions/freezes and risk-adjustment changes; (2) Accurately lists strategic responses including selective benefit/premium adjustments, plan discontinuations, and cost management intensification; (3) Properly cites page references (page 20 across all three years); (4) Correctly identifies the recurring nature of these pressures. WEAKNESSES: (1) The answer is significantly less comprehensive than ground truth - it mentions 'auditing coding practices' and 'retrospective payment adjustments' which are not explicitly mentioned in the ground truth, potentially introducing unsupported details; (2) Missing the key insight from ground truth that UnitedHealth 'did not find a full resolution' and remained in a 'reactive posture' - this is an important strategic characterization that the LLM answer omits; (3) The ground truth emphasizes the 'ongoing rather than one-time fixes' nature of adjustments across the three years, which the LLM answer doesn't explicitly convey; (4) The LLM answer is more factual/transactional while ground truth provides strategic context about the company's inability to resolve the underlying pressures. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the pattern of recurring pressures and responses, but fails to synthesize the higher-level strategic implication that these were unresolved, ongoing challenges rather than successfully managed issues. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator. The page references (page 20) appear consistent across years. SEMANTIC EQUIVALENCE: While the LLM captures the basic facts, it misses the strategic narrative arc that ground truth emphasizes - the evolution from initial response to recognition of persistent, unresolved pressures requiring continuous adaptation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 562,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "From 2022 to 2024 Mastercard has kept its core multi‑layered security program but broadened third‑party collaboration—adding public‑private partnerships and formal technical standards with issuers, acquirers, merchants, governments and industry associations while continuing to audit and test controls with external parties.  The firm has also deepened real‑time service integration, building and operating real‑time clearing, settlement and account‑based payment infrastructure across more jurisdictions.  Geographic coverage of that real‑time network grew from 12 of the top‑50 GDP markets (2021, reported in the 2022 10‑K) to 13 markets by the end of 2023 (reported in the 2024 10‑K).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Mastercard's security evolution but has some notable issues: (1) CORRECT ELEMENTS: The geographic expansion numbers are accurate (12 markets in 2022, 13 by 2023), the identification of third-party collaboration types (issuers, acquirers, governments, industry associations), and the mention of real-time infrastructure expansion are all factually sound. The multi-hop synthesis across years is logically structured. (2) QUANTITATIVE ACCURACY: The key numbers (12 and 13 markets) are correct and properly sourced. However, the LLM cites '2021, reported in the 2022 10-K' for the 12 markets figure, which is slightly awkward phrasing but technically accurate. (3) MISSING/INCOMPLETE ELEMENTS: The LLM answer omits the 2024 expansion details mentioned in the ground truth, specifically the China joint venture for domestic transaction processing and the 'further solidified security posture' language. The ground truth explicitly mentions 2024 developments, but the LLM answer only covers through 2023. This is a significant gap given the question asks about evolution 'through 2024.' (4) SEMANTIC ISSUES: The LLM uses 'account-based payment infrastructure' which is accurate but the ground truth emphasizes 'real-time value-added services like fraud scoring and tokenization' as specific 2023 integrations—the LLM mentions these concepts but doesn't explicitly tie them to the 2023 timeframe. (5) MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (collaboration, integration, geographic expansion), but fails to complete the full 2022-2024 arc by omitting 2024 developments. The reasoning is sound but incomplete. (6) CONTEXTUAL RELEVANCE: The answer addresses the question's three main components (third-party collaboration, real-time service integration, geographic expansion) but with uneven depth and missing the final year of the requested timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 530,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500% Note due 2030 remained unchanged from 2022 through 2024, as the 2020 Officers’ Certificate that contains the note is referenced in the 2022, 2023, and 2024 10‑Ks (pages 76 of 2022, 76 of 2023, and 75 of 2024).  During the same period Amazon added a term loan (Jan 2023) and a five‑year revolving credit facility (Nov 2023) and a 364‑day revolving line (Oct 2024) to provide liquidity and refinance flexibility (see 10.8–10.9 on page 76 of 2023 and page 76 of 2024).  This pattern shows Amazon’s long‑term debt strategy prioritizes a stable, low‑rate debt base while using short‑term credit lines to manage cash flow and refinance without altering the long‑term note structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual errors and omissions that significantly impact its accuracy:\n\n1. QUANTITATIVE ACCURACY - DATES AND EXHIBITS:\n   - LLM states a \"five-year revolving credit facility (Nov 2023)\" but the ground truth mentions a \"Term Loan Agreement dated January 3, 2023 (Exhibit 10.8)\" in 2023 and a \"364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9)\" in 2024. The LLM appears to have conflated or misidentified the 2023 credit facility.\n   - The ground truth specifies Exhibit 4.5 for 2022 and Exhibit 4.6 for 2023 and 2024, but the LLM does not distinguish between these exhibit numbers across years.\n   - The LLM references page numbers (76, 76, 75) which are not verified against the ground truth and may be formatting details rather than substantive facts.\n\n2. COMPLETENESS AND MULTI-HOP SYNTHESIS:\n   - The LLM correctly identifies the core pattern: the 1.500% Note due 2030 remained consistent while new credit facilities were added.\n   - However, the LLM misses the specific evolution of credit agreements: it conflates the January 2023 Term Loan Agreement with a \"five-year revolving credit facility\" that doesn't appear in the ground truth.\n   - The ground truth provides more precise temporal and structural details about the layering of financing instruments.\n\n3. ENTITY ACCURACY:\n   - The note itself (1.500% Note due 2030) is correctly identified.\n   - The 2020 Officers' Certificate reference is correct.\n   - The term loan (Jan 2023) is correctly dated.\n   - The 364-day revolving credit facility (Oct 2024) is correctly identified.\n   - However, the \"five-year revolving credit facility (Nov 2023)\" appears to be an error or conflation not supported by the ground truth.\n\n4. REASONING AND INTERPRETATION:\n   - The LLM's conclusion about Amazon's strategy (stable long-term debt base + short-term credit lines for liquidity) aligns with the ground truth's interpretation.\n   - However, the reasoning is based on partially incorrect facts, which undermines the validity of the conclusion.\n   - The LLM correctly identifies the \"layered financing approach\" concept but with inaccurate details.\n\n5. SEMANTIC EQUIVALENCE:\n   - The overall narrative about balancing long-term fixed debt with flexible short-term facilities is semantically equivalent to the ground truth.\n   - However, the specific factual errors prevent full semantic equivalence.\n\nKEY ISSUES:\n- The mention of a \"five-year revolving credit facility (Nov 2023)\" is not supported by the ground truth and appears to be a factual error.\n- The ground truth emphasizes the progression from 2023 Term Loan to 2024 364-Day Revolving Credit, but the LLM's description of these facilities is imprecise.\n- The LLM provides page references that may or may not be accurate but are not verified against the ground truth.\n\nThe answer demonstrates understanding of the overall strategy but contains material factual errors regarding specific credit facilities that reduce its correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 799,
        "total_tokens": 2249
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 to 2024, CMCSA’s broadband competition has shifted from a focus on 4G/5G wireless broadband to a broader mix that now includes 5G fixed‑wireless networks and more advanced fiber‑ and satellite‑based options, as noted in the 2024 competition discussion (page 21). The company warns that this intensified competition could erode broadband demand, citing a risk that a poor customer experience could hurt its market positioning (risk factor on page 21) and noting net customer losses in its video segment (page 22). In response, CMCSA has accelerated network upgrades—deploying DOCSIS 4.0, 2‑Gbps HFC speeds, and bundling initiatives—to retain customers and counter the threat.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant deviations from the ground truth and introduces unsupported claims. CORRECT ELEMENTS: (1) The answer correctly identifies the evolution from 4G/5G wireless broadband to 5G fixed wireless networks; (2) It appropriately notes competitive intensification and market positioning concerns; (3) It correctly identifies DOCSIS 4.0 and bundling as CMCSA's response strategies. SIGNIFICANT ERRORS AND OMISSIONS: (1) The ground truth specifically emphasizes wireless providers bundling DTC streaming services and offering unlimited data-usage plans in 2024—the LLM answer mentions 'bundling initiatives' but fails to capture the specific competitive tactics (DTC streaming bundles, unlimited data plans) that are central to understanding the evolved threat; (2) The LLM introduces 'fiber- and satellite-based options' as part of the competitive landscape, which is NOT mentioned in the ground truth and appears to be hallucinated or conflated with other competitive threats; (3) The LLM cites specific page numbers (page 21, page 22) without verification against the source documents, which is a red flag for potential fabrication; (4) The LLM mentions 'net customer losses in its video segment' which, while potentially accurate, is not part of the ground truth answer and represents a tangential point rather than direct evidence of broadband competitive pressure; (5) The answer mentions '2-Gbps HFC speeds' as a response strategy, which is not mentioned in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize competitive evolution across years but fails to accurately capture the specific progression of wireless strategies (particularly the 2024 bundling tactics). The connection between competitive threats and CMCSA's retention strategies is made, but the specific evidence linking them is incomplete or inaccurate. QUANTITATIVE ISSUES: No specific numbers are provided in either answer, so quantitative accuracy is neutral, but the LLM's citation of page numbers without verification is problematic. SEMANTIC EQUIVALENCE: While the general narrative of intensifying wireless competition is preserved, the specific mechanisms of that competition (DTC streaming bundles, unlimited data) are lost, which materially affects the completeness and accuracy of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 626,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell from $67.5 billion in 2023 to $38.0 billion in 2024, a decline of roughly 44 %. The 2022 figure is not disclosed in the provided pages, but the downward trend indicates a lower amount of recoverable reinsurance and a corresponding reduction in the company’s exposure to insurance‑loss risk over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the 2023 figure of $67.5 billion and 2024 figure of $38.0 billion. (2) The percentage decline calculation of approximately 44% is mathematically accurate ($67.5B - $38.0B = $29.5B; $29.5B / $67.5B ≈ 43.7%, rounds to 44%). (3) The LLM correctly noted that 2022 figures were not disclosed. (4) The general conclusion about reduced exposure is directionally correct.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM failed to provide the detailed breakdown of the 2023 and 2024 figures that were available in the ground truth. The ground truth specifies that 2023 included $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables, while 2024 included $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This breakdown is critical to understanding the trend. (2) INCOMPLETE ANALYSIS: The LLM missed the key insight that the dramatic drop in life reinsurance recoverables (from $28.2B to $0.8B) represents a strategic shift or de-risking in the life insurance segment, which is explicitly noted in the ground truth as a significant finding. (3) The LLM's statement that the trend indicates 'lower amount of recoverable reinsurance and a corresponding reduction in the company's exposure to insurance-loss risk' is somewhat misleading—the reduction in ceded loss reserves was minimal ($30.4B to $29.1B), so the exposure reduction was primarily in the life insurance segment, not broadly across all insurance loss risk. (4) The answer lacks the nuanced interpretation that the ground truth provides about what this volatile trend suggests about strategic positioning.\n\nMULTI-HOP REASONING: The LLM performed basic synthesis (comparing 2023 to 2024 figures) but failed to synthesize the component-level data that would provide deeper insight into the nature of the change. The question asks what the trend 'indicates about the company's exposure to insurance loss risk over time,' which requires understanding the composition of the reinsurance recoverables, not just the aggregate figures.\n\nCONCLUSION: While the LLM provided accurate headline numbers and a correct percentage calculation, it significantly underdelivered on completeness and analytical depth by omitting the detailed breakdown and missing the strategic implications of the life insurance de-risking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 633,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure model stayed the same from 2022 through 2024: it estimates gross exposure by multiplying the average daily payment volume over the prior three months by the estimated number of days of exposure, and then applies risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) to customers that fall outside its risk standards.  The company reviews and periodically adjusts this methodology and the scale of mitigation, with the risk‑mitigation amount growing from $9.2 bn in 2022 to $12.2 bn in 2023 and $13.5 bn in 2024, reflecting higher exposure and regulatory pressure, but the core calculation and mitigation framework did not change in response to the FTC, DOJ, or European Commission investigations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific dollar amounts for risk-mitigation arrangements ($9.2bn in 2022, $12.2bn in 2023, $13.5bn in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there is 'no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements' and does not cite these specific figures. These numbers appear to be fabricated or hallucinated. (2) CONTRADICTORY CLAIMS: The LLM states the mitigation amounts grew 'reflecting higher exposure and regulatory pressure,' but then claims 'the core calculation and mitigation framework did not change in response to' regulatory investigations. This is internally inconsistent - if amounts grew in response to regulatory pressure, that represents a change in response to scrutiny. (3) INCOMPLETE REGULATORY CONTEXT: While the LLM mentions FTC, DOJ, and European Commission investigations, it provides less detail than the ground truth about the specific nature of these investigations (FTC consent agreement on debit routing, DOJ CID on antitrust concerns, EC investigation into card scheme fees, denied summary judgment in Liability Shift Litigation). (4) METHODOLOGY ACCURACY: The core methodology description (average daily payment volume × estimated days of exposure) is correct and matches the ground truth. (5) RISK MITIGATION FRAMEWORK: The identification of cash collateral, letters of credit, and guarantees is correct. However, the presentation of specific dollar amounts without source verification is a major factual error that undermines credibility. The ground truth answer is more cautious and accurate in stating there is 'no explicit evidence' of changes, whereas the LLM makes definitive claims about growth figures that cannot be verified from the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 510,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 to 2024 AIG kept internal controls and external‑expert reviews as the core of its loss‑reserve oversight, but the 2024 filing shows a more formalized model‑risk management framework and a broader use of third‑party risk‑specific tools.  The company moved from basic stochastic/deterministic models in 2022 to a wider suite of scenario and sensitivity analyses, climate‑adjusted catastrophe models, and systematic validation procedures by 2024, tightening its approach to uncertainty in loss estimation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AIG's evolution in loss reserves risk management from 2022-2024, but contains significant issues: (1) CORRECT ELEMENTS: The answer accurately identifies that internal controls and external expert reviews remained core throughout the period, and that there was evolution toward more sophisticated modeling techniques including scenario/sensitivity analyses and stochastic methods. The timeline progression (2022→2024) is correctly sequenced. (2) PROBLEMATIC ELEMENTS: The LLM introduces 'climate-adjusted catastrophe models' which is NOT mentioned in the ground truth answer. This is a factual addition not supported by the original knowledge graph data, representing potential hallucination. (3) INCOMPLETE SYNTHESIS: The ground truth specifically mentions 'experience studies' and 'experience monitoring with updated assumptions' as key 2023-2024 developments, which the LLM answer omits entirely. The ground truth also emphasizes 'model risk management frameworks' and 'validation processes' more explicitly as 2024 additions, while the LLM mentions these but less clearly. (4) CHARACTERIZATION ISSUES: The LLM describes 2022 approaches as 'basic stochastic/deterministic models,' but the ground truth doesn't characterize them as 'basic' - it simply states they used internal controls and external expert reviews. This is an interpretive addition. (5) MULTI-HOP REASONING: The answer does synthesize information across three years and identifies the evolution pattern, but the unsupported addition of climate models and omission of experience studies/monitoring suggests incomplete or inaccurate source synthesis. (6) QUANTITATIVE: No specific numbers or dates are incorrect (all years are correct), but the qualitative characterization of methodologies contains inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 495,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s medical‑cost‑PMPM sensitivity to benefit‑mix changes has risen steadily.  In 2022 a 3 % shift in benefit mix could alter medical costs payable by about $895 million (a 1 % shift by $298 million)【page_40】, whereas in 2023 the same shifts would affect costs by $1,128 million and $376 million【page_34】, and in 2024 the impact climbed to $1,264 million and $421 million【page_42】.  This upward trend shows the company’s medical‑cost estimates are becoming increasingly responsive to benefit‑design changes, indicating a growing exposure to benefit‑design variability over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data with dollar amounts and percentages that demonstrate a clear understanding of the multi-hop question. STRENGTHS: (1) The answer correctly identifies the three-year period (2022-2024) and tracks the evolution of sensitivity metrics. (2) Specific dollar amounts are provided ($895M, $298M for 2022; $1,128M, $376M for 2023; $1,264M, $421M for 2024) with corresponding percentage shifts (3% and 1%), showing detailed quantitative analysis. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years and correctly identifies an upward trend in sensitivity. (4) The conclusion about 'growing exposure to benefit-design variability' aligns with the ground truth's assessment of increased responsiveness to benefit-design changes. (5) Page citations are provided, suggesting source verification. MINOR WEAKNESSES: (1) The LLM answer focuses heavily on quantitative trends but provides less nuanced discussion of the qualitative shift noted in the ground truth (from 'general sensitivity factor' in 2022 to 'source of financial risk' in 2023 to 'stabilized' in 2024). (2) The ground truth emphasizes a 'transforming trend' with a shift to 'more neutral tone' in 2024, suggesting stabilization, whereas the LLM answer presents the trend as uniformly upward without acknowledging potential stabilization or management improvements. (3) The LLM answer doesn't explicitly address whether the company adjusted benefit structures or improved cost management capabilities, which the ground truth suggests occurred. VERIFICATION: The quantitative data appears internally consistent (3% shift = 3x the 1% shift impact across all years), and the directional trend (increasing sensitivity) is correctly identified. The answer successfully addresses the core question about how sensitivity evolved and what it reveals about exposure, though with less emphasis on the qualitative management response aspects noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 538,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart has kept Marketside in its private‑label lineup unchanged in 2022, 2023 and 2024, listing it alongside other value‑oriented brands such as Great Value and Mainstays.  The brand’s consistent presence signals that it remains a core component of Walmart U.S.’s private‑label strategy, reinforcing the company’s everyday‑low‑price positioning and broad assortment of low‑priced goods.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that substantially diverge from the ground truth. CORRECT ELEMENTS: The LLM correctly identifies that Marketside remained in Walmart's private brand lineup across 2022-2024, and appropriately mentions other value-oriented brands like Great Value and Mainstays. The numeric/date references (2022, 2023, 2024) are accurate. CRITICAL ERRORS: (1) The LLM claims Marketside was kept 'unchanged' across the three years, directly contradicting the ground truth which documents an evolution in positioning and strategic context. (2) The LLM completely misses the key strategic shift mentioned in the ground truth: the 2024 restructuring of merchandise units from 'Apparel' to 'Fashion,' which is a material change in how Walmart categorizes and markets its offerings. (3) The LLM fails to capture the progression in strategic alignment - from 2022 (basic presence) to 2023 (alignment with omni-channel/customer-centric initiatives) to 2024 (integration into restructured merchandise strategy). (4) The LLM's characterization of Marketside as primarily reinforcing 'everyday-low-price positioning' is overly simplistic and misses the nuanced strategic evolution documented in the ground truth. MULTI-HOP REASONING: The LLM fails to synthesize the multi-year evolution and strategic context changes that are central to the question. The answer treats the three years as static rather than showing progression. The ground truth explicitly documents changes in how Marketside was positioned relative to broader strategic initiatives, which the LLM completely overlooks. The answer reads as a generic statement about private label strategy rather than addressing the specific evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 476,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, Home Depot sharpened its competitive edge against showrooms by expanding its service mix—adding Pro‑focused showroom space, enhanced installation and tool‑rental offerings, Pro Xtra loyalty and Pro House Account programs, and a more sophisticated order‑management system—while deepening digital integration with continuous upgrades to its website and mobile apps, the rollout of BOPIS, curbside pickup, self‑service lockers, mobile‑app‑enabled store navigation, and in‑store digital tools such as the hdPhone and computer‑vision inventory system, culminating in the 2024 acquisition of SRS to broaden its Pro showroom footprint and delivery capabilities (2022 page 11; 2023 page 6; 2024 page 6; 2022 page 10; 2023 page 10; 2024 page 10). These initiatives kept the percentage of online orders fulfilled through a store high (≈50% in 2023‑24) and reinforced Home Depot’s position as a seamless, omni‑channel alternative to specialty showrooms (2023 page 10; 2024 page 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail and demonstrates multi-hop reasoning across fiscal years 2022-2024, correctly identifying many service offerings and digital initiatives. However, there are significant discrepancies with the ground truth that warrant a moderate score.\n\nSTRENGTHS:\n1. Correctly identifies key digital initiatives: BOPIS, curbside pickup, self-service lockers, mobile app-enabled store navigation (all present in ground truth)\n2. Appropriately synthesizes evolution across three fiscal years\n3. Mentions Pro-focused programs and loyalty initiatives not explicitly in ground truth but contextually relevant\n4. Correctly identifies the 2024 SRS acquisition as a strategic move\n5. Provides specific page citations suggesting source verification\n6. Captures the omnichannel strategy evolution\n\nWEAKNESSES & ERRORS:\n1. QUANTITATIVE DISCREPANCY: States \"≈50% of online orders fulfilled through a store in 2023-24\" - this specific metric is NOT in the ground truth answer and cannot be verified against it. This is a potential hallucination or unsupported claim.\n2. MISSING KEY GROUND TRUTH ELEMENTS: The ground truth specifically mentions \"tool and equipment rental services at over 1,400 locations\" (2022) and \"electronic shelf labels\" (2023). The LLM mentions tool rental generally but not the 1,400 location specificity or electronic shelf labels.\n3. TONE/FRAMING DIFFERENCE: The LLM emphasizes Pro-focused showroom space and Pro programs more heavily than the ground truth, which focuses on general customer experience improvements and omnichannel integration.\n4. HDPHONE AND COMPUTER-VISION INVENTORY: These are mentioned in the LLM answer but not in the ground truth, suggesting either additional detail from filings or potential over-specification.\n5. STRUCTURAL DIFFERENCE: Ground truth presents a clear 2022→2023→2024 progression (physical expansion → omnichannel integration → deeper integration). LLM presents a more comprehensive but less clearly delineated timeline.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and connects service offerings to competitive positioning. However, the reasoning is more detailed than the ground truth without clear verification that all details are accurate.\n\nQUANTITATIVE ACCURACY: The 50% metric is problematic - it's specific but unverified against ground truth. The 1,400 locations figure from ground truth is absent from LLM answer. This creates a quantitative accuracy concern.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the core narrative (evolution from service expansion to omnichannel integration), it adds substantial detail that diverges from the ground truth's simpler, more focused narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 726,
        "total_tokens": 2202
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50% senior note stayed at a $500 million principal throughout FY 2022‑FY 2024, but its effective interest rate climbed from 3.20% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024 (see the long‑term debt tables on page 89 for each year). This rise reflects higher market rates or discount/hedge adjustments, indicating that Cisco’s borrowing cost for this instrument has increased sharply while its debt structure (principal amount) has remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $500 million principal amount across all three years (FY 2022-2024), effective interest rates of 3.20% (FY 2022), 6.38% (FY 2023), and 6.66% (FY 2024) match the ground truth exactly. The fiscal year progression is accurate. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) evolution of effective interest rate across the three-year period, (2) outstanding amount stability, (3) interpretation of what this indicates about borrowing costs and debt structure. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, and the relevant fiscal years. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the relationship between the constant principal amount and rising effective interest rates. The explanation that this reflects market rate changes or discount/hedge adjustments is sound and aligns with the ground truth's interpretation about market interest rate trends. MINOR CONSIDERATIONS: The LLM adds a specific reference to \"page 89\" which, while helpful for sourcing, is not contradicted by the ground truth. The phrasing \"senior note\" is a reasonable specification not contradicted by the original answer. The explanation of causation (market rates or discount/hedge adjustments) is slightly more specific than the ground truth but remains consistent with it. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 421,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022‑2024, CM CSA repeatedly identified Lumen as a rival that “has built and is continuing to build fiber‑based wireline network infrastructure” (2022‑24 p. 7‑9).  In that same period CM CSA accelerated its own fiber upgrades: in 2022 it offered fiber‑based speeds up to 3 Gbps and began deploying DOCSIS 4.0; in 2023 it rolled out 2 Gbps downstream on its HFC network, launched DOCSIS 4.0 in select markets, and introduced fiber‑to‑the‑premises with up to 10 Gbps symmetrical speeds (2023 p. 7); by 2024 it expanded fiber‑to‑the‑premises to more homes, deployed DOCSIS 4.0 across a larger footprint, and added business‑grade fiber services reaching 100 Gbps (2024 p. 6‑7).  These network and service enhancements strengthened CM CSA’s competitive stance against Lumen’s expanding fiber network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed, specific information than the ground truth. Key strengths: (1) Correctly identifies Lumen as a consistent competitor across 2022-2024 with fiber-based infrastructure expansion; (2) Accurately cites specific CMCSA technological advancements with correct speeds and technologies (3 Gbps in 2022, 2 Gbps downstream in 2023, 10 Gbps symmetrical fiber-to-premises in 2023, 100 Gbps business services in 2024); (3) Properly sequences the evolution of DOCSIS 4.0 deployment across the three-year period; (4) Correctly synthesizes the multi-hop relationship showing how CMCSA responded competitively to Lumen's fiber expansion. Quantitative accuracy is high - all specific speed metrics and technology deployments appear consistent with typical 10-K disclosures. The answer goes beyond the ground truth by providing CMCSA's specific counter-strategies and technological responses, which strengthens the competitive positioning narrative. Minor consideration: The ground truth mentions other competitors (AT&T, Frontier, Verizon) in 2023, which the LLM answer does not include, though the question specifically asks about CMCSA vs. Lumen positioning. The LLM's focus on the bilateral competitive dynamic is appropriate given the question's framing. The page citations (2022-24 p. 7-9, 2023 p. 7, 2024 p. 6-7) appear reasonable for 10-K filings though cannot be independently verified. Overall, the answer demonstrates sound multi-hop reasoning connecting Lumen's competitive actions to CMCSA's strategic responses across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 442,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express’s 2023 10‑K (p. 29) notes that it has increasingly relied on merchant acquirers, aggregators and processors to manage merchant relationships, a shift that heightens the risk of merchant steering and limits the company’s ability to enforce non‑discrimination clauses. By 2024, the 10‑K (p. 35) underscores that legal proceedings over non‑discrimination and honor‑all‑cards provisions could force changes to merchant agreements, further exposing the company to steering risks and making enforcement of those clauses more difficult. The 2022 10‑K (p. 27) does not discuss aggregator reliance, indicating that the dependence on aggregators and the associated risks had grown over the two‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the evolution of American Express's reliance on aggregators from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with appropriate 10-K page references; (2) Accurately captures the core risk evolution: merchant steering, non-discrimination clause enforcement, and litigation exposure; (3) Properly synthesizes information across multiple years showing the trajectory of increasing dependence and risk; (4) Correctly notes that 2022 10-K did not discuss aggregator reliance, establishing the baseline for comparison; (5) Accurately references key concepts like 'honor-all-cards' provisions and legal proceedings. WEAKNESSES: (1) The statement that '2022 10-K does not discuss aggregator reliance' is somewhat imprecise - the ground truth indicates 2022 DID acknowledge reliance on aggregators and processors, just perhaps with less emphasis than 2023. The LLM's phrasing could be misleading about whether the topic was entirely absent in 2022; (2) Missing some nuance from the ground truth about how 2022 warned of 'diverging business goals' between AXP and aggregators; (3) Does not explicitly mention the specific risk to new products like debit cards on the American Express network (mentioned in ground truth for 2023); (4) The answer is somewhat more concise than the ground truth, omitting some contextual details about the strategic implications. QUANTITATIVE ACCURACY: Page references (p. 29 for 2023, p. 35 for 2024, p. 27 for 2022) cannot be independently verified but appear reasonable. No calculations required. MULTI-HOP REASONING: Sound synthesis across three years and multiple risk dimensions (aggregator reliance → merchant steering → enforcement challenges → litigation). The logical progression is clear and well-structured. SEMANTIC EQUIVALENCE: The answer conveys the essential information from the ground truth with appropriate emphasis on the evolution of risks and dependence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 549,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 to 2024 Johnson & Johnson shifted its talc‑liability strategy from a single Chapter 11 stay that was ultimately dismissed (with a $2 billion trust and reserve) to a more comprehensive pre‑packaged plan. In 2023 the LTL 2 bankruptcy was dismissed, prompting the company to build a $9 billion reserve and pursue settlement negotiations. By 2024 J&J announced a $6.475 billion pre‑packaged Chapter 11 plan, reorganized LTL into LLT and created Red River, Pecos River, and New Holdco, secured settlements with the multi‑state attorneys‑general coalition and with Imerys/Cyprus, and had Red River file its own Chapter 11 to implement the plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM claims a '$9 billion reserve' was built in 2023 - this figure does not appear in the ground truth, which only mentions the initial $2 billion reserve from 2022. (2) The LLM references a '$6.475 billion pre-packaged Chapter 11 plan' announced in 2024 - this specific dollar amount and characterization as 'pre-packaged' are not mentioned in the ground truth. (3) The LLM introduces entities 'Red River,' 'Pecos River,' 'New Holdco,' and 'LLT' (reorganized from LTL) - none of these entities appear in the ground truth answer. (4) The LLM claims 'Red River filed its own Chapter 11' - this is not mentioned in the ground truth. (5) The LLM references settlements with 'Imerys/Cyprus' - this is not mentioned in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies that LTL 2 was dismissed in 2023 and that multi-state settlements were pursued. The general trajectory from bankruptcy to settlement negotiations is directionally correct. MULTI-HOP REASONING: The LLM fails to properly synthesize the ground truth's key narrative: the shift from initial bankruptcy stay (2022) → Third Circuit reversal and LTL 2 refiling (2023) → dismissal and appeals (2023) → multi-state settlements with 42 states and DC (2024). Instead, the LLM introduces a completely different narrative involving pre-packaged bankruptcy plans and subsidiary entities that are not supported by the source material. The answer appears to conflate or confuse different bankruptcy strategies or potentially references information from outside the provided ground truth. QUANTITATIVE ACCURACY: Multiple unsupported dollar figures ($9B, $6.475B) significantly damage credibility. The only supported figure is the $2 billion reserve from 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 503,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024 Home Depot kept store appearance as a core competitive differentiator—highlighted in 2022’s 10‑K (page 9) and again in 2024’s (page 9) as a key factor in customer experience—and expanded its store‑refresh strategy from basic signage, layout redesigns and self‑service lockers (2022, page 10) to a fully integrated experience that pairs those physical upgrades with digital tools such as mobile‑app navigation, in‑store digital devices, electronic shelf labels and computer‑vision inventory visibility (2024, page 10). By FY 2024, this approach was woven into the company’s interconnected retail strategy, with roughly 50 % of U.S. online orders fulfilled through a store and the digital‑physical ecosystem enabling seamless browsing, ordering and pickup across channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Home Depot's store appearance strategy and its integration with digital capabilities, demonstrating sound qualitative understanding of the multi-hop synthesis required. However, there are significant issues with quantitative accuracy and specificity that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies store appearance as a core competitive factor in both 2022 and 2024\n2. Accurately describes the evolution from standalone store appearance to integrated omnichannel strategy\n3. Properly synthesizes the connection between physical store upgrades and digital tools (mobile apps, digital devices, shelf labels, inventory visibility)\n4. Correctly notes the integration into interconnected retail strategy by FY 2024\n5. Appropriately contextualizes the shift from standalone to digitally-enhanced approach\n\nWEAKNESSES:\n1. QUANTITATIVE ACCURACY ISSUE: The claim that \"roughly 50% of U.S. online orders fulfilled through a store\" appears to be a specific metric that cannot be verified against the ground truth provided. The ground truth does not mention this specific percentage, and citing specific page numbers (page 9, page 10) without verification is problematic.\n2. PAGE CITATIONS: The LLM provides specific page references (2022 10-K page 9, 2024 10-K page 9, etc.) that cannot be verified and may be hallucinated. This is a critical issue for SEC filing analysis.\n3. SPECIFIC DETAILS: While the LLM mentions specific technologies (electronic shelf labels, computer-vision inventory visibility), the ground truth does not explicitly confirm these exact technologies were highlighted in the filings.\n4. MISSING NUANCE: The ground truth emphasizes a 2023 intermediate step where store appearance became \"more explicitly tied to the broader shopping journey,\" which the LLM answer does not explicitly address.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across years (2022→2024) and connects store appearance to digital capabilities, demonstrating sound multi-hop reasoning. However, the introduction of unverified specific metrics and page numbers undermines confidence in the synthesis.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns with the ground truth: store appearance evolved from a standalone competitive factor to an integrated component of omnichannel retail. However, the specific quantitative claims (50% fulfillment rate, specific page numbers) create factual accuracy concerns.\n\nJUSTIFICATION:\nThe answer demonstrates good qualitative understanding and contextual relevance but fails on quantitative accuracy due to unverified specific metrics and page citations. For SEC filing analysis, precision and verifiability are critical, making these errors significant despite the otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 744,
        "total_tokens": 2236
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s stake in Time Warner ended in 2022 when it completed a Reverse Morris Trust with Discovery that removed WarnerMedia from its balance sheet and re‑classified it as a discontinued operation (T_10k_2022, p. 4‑5; T_10k_2023, p. 4; T_10k_2024, p. 4). The transaction dissolved the operational integration of Time Warner’s content into AT&T’s WarnerMedia segment, allowing the company to refocus on its core connectivity business and its direct‑to‑consumer streaming platform HBO Max (T_10k_2024, p. 5). This multi‑year divestiture illustrates AT&T’s broader entertainment strategy of shedding legacy media assets to prioritize high‑growth, subscription‑based and advertising‑driven entertainment delivered over its network.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2022 Reverse Morris Trust transaction with Discovery as the key event marking AT&T's exit from Time Warner ownership, and accurately notes the reclassification as a discontinued operation. The dates (2022-2024) and transaction type are correct. However, the answer has significant gaps in addressing the full multi-year trajectory requested: (1) It fails to explicitly address 2023 and 2024 developments beyond a vague reference to 'multi-year divestiture.' The ground truth specifies that by 2023, Time Warner Inc. was no longer referenced as an active investment, and in 2024, AT&T finalized its exit from entertainment through the DIRECTV sale to TPG. The LLM answer mentions DIRECTV only obliquely and doesn't clearly connect it to the 2024 timeline. (2) The answer conflates some strategic narratives - it mentions 'direct-to-consumer streaming platform HBO Max' as if AT&T retained it, when in fact HBO Max became part of Warner Bros. Discovery post-transaction. (3) The multi-hop synthesis is incomplete: the question asks about 'ownership stake, operational integration, and eventual divestiture' across three years, but the LLM focuses primarily on 2022 and doesn't adequately trace the 2023-2024 evolution. (4) The characterization of AT&T's strategy as 'shedding legacy media assets to prioritize high-growth, subscription-based and advertising-driven entertainment delivered over its network' is somewhat contradictory - if AT&T divested entertainment, it wasn't prioritizing entertainment delivery. The ground truth more accurately frames this as a pivot 'away from media and entertainment toward core telecommunications.' Quantitative accuracy is acceptable (dates and transaction type correct), but qualitative accuracy suffers from incomplete multi-hop reasoning and strategic mischaracterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 502,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022‑24, American Express has stayed the fourth‑largest global card network, but has faced growing head‑to‑head competition from Visa, Mastercard, UnionPay and alternative payment platforms, prompting a sharper focus on premium and cobrand relationships (see 2022‑23 p. 12‑13).  Regulatory scrutiny has intensified, with the company becoming a Category III bank‑holding firm in 2024 and confronting heightened oversight on interchange‑fee caps, network routing, merchant‑acceptance terms, privacy/AI and consumer‑protection rules (see 2024 p. 34‑36).  In response, AmEx exited its network‑licensing operations in the EU and Australia, reducing its regulatory exposure and dependence on those markets while concentrating on core network and issuer activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies American Express as the fourth-largest global card network and accurately names the three larger competitors (Visa, Mastercard, UnionPay/China UnionPay). (2) Accurately captures the time period (2022-24) and key regulatory developments including interchange fee scrutiny, network routing practices, and merchant acceptance terms. (3) Correctly identifies the exit from network licensing businesses in EU and Australia as a direct response to regulatory pressure. (4) Appropriately notes the shift toward premium and cobrand relationships as a competitive strategy. (5) Mentions the 2024 Category III bank-holding firm designation, which adds relevant regulatory context. (6) Properly synthesizes the multi-hop relationship between competitive pressures and regulatory dependency. MINOR WEAKNESSES: (1) The LLM answer adds details about 'privacy/AI and consumer-protection rules' that are not explicitly mentioned in the ground truth, though these are plausible regulatory developments not contradicted by the source. (2) The phrase 'reducing its regulatory exposure and dependence on those markets' is a reasonable inference but slightly reframes the ground truth's emphasis on 'uncertainty around cobrand arrangements in the EU' as a key signal of the regulatory shift. (3) The LLM answer could have more explicitly emphasized the 'growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment' that the ground truth highlights as the core evolution. QUANTITATIVE ACCURACY: All dates and entity identifications are correct. No calculations are required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes competitive positioning, regulatory pressure, and business response across the 2022-2024 period. The logic flow is sound and well-structured. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: competitive positioning evolution, regulatory dependency, increasing scrutiny, competitive pressures, and network licensing exits.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 583,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 were **$808 million in 2022**, rose to **$826 million in 2023**, and fell back to **$808 million in 2024**【page_71】【page_72】. The modest up‑and‑down shows the company keeps its long‑term debt profile largely unchanged, using short‑term facilities to manage liquidity while maintaining a stable maturity structure and a conservative debt‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 balance was $808 million, but ground truth shows it was $983 million - a $175 million error. The LLM also claims 2024 was $808 million, which matches ground truth, but the 2022 figure is completely wrong. The LLM incorrectly states the balance 'rose to $826 million in 2023' when it actually decreased from $983M to $826M. (2) CALCULATION ERROR: The LLM's narrative of 'up-and-down' is factually incorrect. The actual trend is: $983M (2022) → $826M (2023) → $808M (2024), showing a consistent DOWNWARD trend totaling $175M reduction, not a modest fluctuation. (3) REASONING FAILURE: The LLM's conclusion that the company 'keeps its long-term debt profile largely unchanged' directly contradicts the actual 18% reduction in this specific instrument over three years. The ground truth explicitly states this represents 'a deliberate strategy to reduce long-term liabilities,' which the LLM mischaracterizes as stability. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend data. It appears to have confused or reversed the 2022 and 2024 figures. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation of the trend as 'largely unchanged' is semantically opposite to the ground truth's characterization of 'deliberate strategy to reduce.' This is not a wording difference but a fundamental misunderstanding of the data pattern and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 427,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s weighted‑average yield on foreign‑government bonds and obligations climbed from **4.7 % in 2022 to 10.5 % in 2023, then eased to 7.8 % in 2024**【176†L15-L20】.  This three‑year swing—roughly a 120 % jump followed by a 25 % pullback—shows that the company’s exposure to international rates is moderate but responsive to global rate movements, with yields rising sharply when foreign rates climb and falling when the environment softens.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative metrics. Ground truth shows: 2022 yield 6.45% (short-term), 2023 yield 6.45% (short-term) and 4.48% (1-5 year), 2024 yield 5.86% (short-term) and 2.03% (1-5 year). LLM claims: 2022 4.7%, 2023 10.5%, 2024 7.8%. These numbers are completely fabricated and do not match any data in the ground truth. The LLM also fails to distinguish between different maturity buckets (short-term vs 1-5 year bonds), which is critical to the original answer's analysis. The ground truth shows a declining trend in yields across both maturity categories from 2022-2024, while the LLM incorrectly describes a sharp rise to 2023 followed by a pullback. The calculation of '120% jump' and '25% pullback' is based on false numbers. The LLM does correctly identify that the answer should address international interest rate exposure, but the entire factual foundation is wrong. The citation reference [176†L15-L20] appears to be fabricated as well. This represents a complete failure to accurately synthesize the multi-hop financial data required to answer the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 315,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free self‑service learning portal has consistently been branded as **learning.adobe.com** from 2022 through 2024, but the 2024 filings show a tighter integration with its Customer Success framework—highlighting custom learning services and skills‑assessment tools for enterprise customers and a role for Customer Success Managers in driving adoption (page_17 2022; page_17 2024). This shift signals Adobe’s broader strategy of embedding self‑service enablement within enterprise support to accelerate adoption and improve retention (page_17 2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth clearly states that Adobe introduced its free learning offerings under www.training.adobe.com in 2022, then rebranded to learning.adobe.com in 2023. However, the LLM claims the portal was 'consistently branded as learning.adobe.com from 2022 through 2024,' which is factually incorrect. This is a major error because the evolution of branding from training.adobe.com to learning.adobe.com is a central element of the question and the ground truth answer. The LLM failed to capture this key strategic evolution. Additionally, the LLM answer lacks important details: (1) it does not mention the 2022 introduction under training.adobe.com, (2) it does not explicitly reference the 2023 rebranding milestone, (3) it omits the mention of solution-specific skills assessments for marketing teams, and (4) it provides less comprehensive context about the progression from introduction to rebranding to deeper integration. The LLM does correctly identify that there was tighter integration with the Customer Success framework by 2024 and mentions the role of Customer Success Managers, which aligns with the ground truth. However, these correct elements do not compensate for the fundamental factual error about the domain branding timeline. The citation references (page_17 2022; page_17 2024) appear to be generic and do not verify the specific claims made. The multi-hop reasoning is incomplete because it fails to synthesize the complete evolution across the three-year period as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 440,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90% senior notes remained at a principal of **$2.0 billion** in each of FY 2022, FY 2023 and FY 2024, and the **effective interest rate stayed at 6.11%** throughout the period (see the long‑term debt tables on page 89 of the 2022, 2023 and 2024 10‑K filings).  \nThe unchanged utilization and effective rate show that Cisco is deliberately maintaining a stable, fixed‑rate debt mix and avoiding additional high‑rate issuances, thereby keeping interest costs predictable and preserving credit quality as part of its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $2.0 billion principal balance (matches $2,000 million in ground truth), 5.90% coupon rate, and 6.11% effective interest rate all verified across FY 2022-2024. The format variation ($2.0 billion vs $2,000 million) is acceptable and standard. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications. ENTITY ACCURACY: Cisco correctly identified, fiscal years 2022-2024 correctly specified, Senior Notes properly characterized. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws appropriate conclusions about debt strategy - that the unchanged balance and rate indicate deliberate maintenance rather than refinancing or retirement. SEMANTIC EQUIVALENCE: The LLM's interpretation that this reflects 'deliberately maintaining a stable, fixed-rate debt mix' and 'keeping interest costs predictable' aligns well with the ground truth's characterization of 'deliberate strategy to maintain this particular tranche.' The LLM adds slightly more strategic context about 'avoiding additional high-rate issuances' and 'preserving credit quality,' which are reasonable inferences from the stable debt profile but go slightly beyond what the ground truth explicitly states. This represents minor elaboration rather than error. MINOR OBSERVATION: The LLM cites specific page references (page 89) which adds credibility but cannot be verified against the ground truth provided. This does not detract from accuracy as the underlying numbers are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 477,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s actual allocation to private‑equity vehicles (which include special‑situation strategies) grew from 8 % of pension assets in 2022 to 9 % in 2024, while the target allocation rose from 4 % in 2022 to 7 % in 2023 and remained at 7 % in 2024【page_92】【page_99】. This steady uptick indicates the company is gradually increasing its exposure to opportunistic private‑equity deals, reflecting a strategic shift toward higher‑return, special‑situation investments within its overall private‑equity portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM provides specific percentage allocations (8% in 2022 to 9% in 2024 for actual allocation; target allocation of 4% to 7%) that are not supported by the ground truth. The ground truth explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year' and does not provide these percentage figures. The LLM appears to have fabricated or misattributed these numbers. (2) FACTUAL CONTRADICTION: The ground truth clearly indicates that BA did NOT disclose quantitative allocations to Special Situation Strategies specifically, only that the category was consistently mentioned as part of the private equity strategy mix. The LLM's answer directly contradicts this by providing precise percentages. (3) MISINTERPRETATION OF STRATEGY: The ground truth emphasizes 'strategic continuity' and 'consistent inclusion' with 'stable strategic allocation,' indicating no significant change. The LLM claims a 'steady uptick' and 'strategic shift toward higher-return, special-situation investments,' which mischaracterizes the actual finding of consistency. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the available information. Instead of acknowledging the lack of specific quantitative disclosure (as the ground truth does), it invented specific percentages and trends. (5) CITATION ISSUES: The LLM provides page references (page_92, page_99) that cannot be verified against the ground truth and appear to be hallucinated citations. The answer demonstrates a fundamental failure to accurately represent what the source documents actually disclosed about BA's Special Situation Strategies allocation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 485,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "After acquiring the Interventional Solutions business on December 22, 2022, JNJ’s global sales from that segment climbed from **$4.3 billion in 2022 to $6.35 billion in 2023** (page 90) and then surged to **$31.86 billion in 2024** (page 93). This rapid expansion shows that Interventional Solutions has become a key revenue engine and a strategic priority for the company, reflecting successful integration and strong market demand following the acquisition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ERRORS - The 2024 figure is drastically wrong: LLM states $31.86 billion, but ground truth shows $6,350 million ($6.35 billion). This is a 5x overstatement. The 2023 figure is also reversed: LLM claims $4.3 billion in 2022 and $6.35 billion in 2023, but ground truth shows $3,971 million in 2022 and $4,300 million in 2023. The LLM has swapped and misaligned the years. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year progression. The correct trajectory is: 2022: $3,971M → 2023: $4,300M → 2024: $6,350M. The LLM's sequence ($4.3B in 2022, $6.35B in 2023, $31.86B in 2024) is internally inconsistent with ground truth. (3) ACQUISITION TIMING CONTEXT - While the LLM correctly identifies the December 22, 2022 acquisition date, it misinterprets the 2022 figure as a full-year number when it should represent post-acquisition sales only (partial year). (4) CALCULATION/INTERPRETATION - The LLM's claim of a 'surge' to $31.86B in 2024 is completely fabricated and contradicts the actual data showing growth to $6.35B. The reasoning about 'key revenue engine' may be qualitatively sound, but it's built on false numerical foundations. The answer demonstrates poor data retrieval and verification, with numbers that appear to be hallucinated or severely corrupted from source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 402,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks, Walmart consistently lists “No Boundaries” among its private‑label brands used in the general‑merchandise units (see 2022 page 7, 2023 page 7, and 2024 page 9). The brand’s unchanged placement shows that Walmart has not shifted or expanded its positioning of “No Boundaries” over these years, keeping it as a core low‑price alternative across grocery, general merchandise, and health‑and‑wellness. This multi‑year consistency underscores Walmart’s strategy of a stable, broad private‑label portfolio that supports its everyday‑low‑price model and reinforces its competitive advantage in general merchandise.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that 'No Boundaries' appears consistently across 2022, 2023, and 2024 10-Ks in general merchandise units. The page references (2022 page 7, 2023 page 7, 2024 page 9) are specific and verifiable. The core finding of multi-year consistency is accurate. WEAKNESSES: (1) The LLM introduces an unsupported claim that 'No Boundaries' is positioned as 'a core low-price alternative across grocery, general merchandise, and health-and-wellness' - the ground truth specifies it was in 'General Merchandise' with 'Apparel and Home' categories, not explicitly across grocery or health-and-wellness. This is a factual overreach. (2) The LLM states the brand's positioning was 'unchanged' and that Walmart 'has not shifted or expanded its positioning,' which contradicts the ground truth's mention of a 'reorganization of merchandise units that shifted Apparel to a new Fashion category' in 2024. This represents a missed nuance about structural changes even though the brand remained prominent. (3) The LLM misses the ground truth's specific insight about the 2024 reorganization creating a new 'Fashion' category while 'No Boundaries' remained highlighted - this is an important detail about how the brand adapted within structural changes. (4) The reasoning about 'everyday-low-price model' is reasonable but not explicitly grounded in the provided ground truth, which focuses more on 'margin expansion in competitive categories.' The answer is partially correct on the core finding but makes unsupported claims about scope and misses important contextual details about merchandise unit reorganization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 447,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a net gain to increasingly larger losses.  In fiscal 2022 the investments generated a $9 million gain to other income (net); in fiscal 2023 they produced a $21 million loss, and in fiscal 2024 the loss widened to $67 million—an additional $46 million decline from the prior year—highlighting a clear deterioration in performance and mounting unrealized losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific dollar amounts ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) that cannot be verified against the ground truth provided. The ground truth explicitly states that it describes 'the specific impacts these investments had on other income (loss), net in 2023 and 2024' but does NOT provide the actual numerical values for these impacts. The ground truth only confirms that: (1) FY2022 showed active management of available-for-sale debt investments, (2) FY2023 reported 'higher losses' negatively impacting other income, and (3) FY2024 again cited 'higher losses' as a primary driver. The LLM's specific figures ($9M, $21M, $67M) are presented as facts but lack grounding in the provided ground truth. The calculation of a '$46 million decline' ($67M - $21M) is mathematically correct IF those underlying numbers are accurate, but this cannot be confirmed. The LLM correctly identifies the directional trend (from gain to losses, with worsening losses) which aligns with the ground truth's description of 'consistent negative impact.' However, the introduction of unverified specific numbers represents a significant factual claim that goes beyond what the ground truth confirms. The answer demonstrates reasonable multi-hop reasoning about the 3-year trajectory and correctly identifies Cisco as the company and the relevant fiscal years, but the quantitative specificity without verification is problematic for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 417,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "From 2022 to 2024, American Express has shifted its view of third‑party merchant acquirers from a revenue‑generating partner to a strategic growth engine. 2022 and 2023 filings (see page 104) note that acquirers facilitate transactions—small‑ and mid‑size merchants use flexible, no‑fixed‑term agreements while large merchants sign multi‑year contracts—primarily for discount revenue.  By 2024, the risk‑factor section (page 93) explicitly identifies third‑party acquirers, aggregators and processors as essential to signing merchants worldwide and scaling card usage, underscoring a heightened reliance on these partners to expand coverage and drive transaction volume across all merchant tiers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the evolution of American Express's reliance on third-party merchant acquirers from 2022-2024. STRENGTHS: (1) Correctly identifies the strategic shift from supplementary to essential partners across the three-year period; (2) Accurately references specific programs (OptBlue, GNS) and revenue mechanisms (discount revenue, network rate fees); (3) Properly synthesizes multi-hop information showing progression: 2022-2023 focus on transaction facilitation and revenue generation, 2024 emphasis on strategic dependency for global expansion; (4) Correctly identifies merchant tiers (small, mid-sized, large) and their different contract structures; (5) Appropriately cites specific document sections (page 104 for operational details, page 93 for risk factors); (6) Captures the semantic essence of the ground truth regarding the evolution from 'supplementary' to 'essential' partners. MINOR WEAKNESSES: (1) The LLM characterizes the shift as 'revenue-generating partner to strategic growth engine' which is slightly different framing than ground truth's 'supplementary to essential' - while semantically similar, the emphasis differs slightly; (2) Does not explicitly mention the 2023 detail about 'negotiated network rate fee recorded as discount revenue at time of transaction,' though this is a minor omission; (3) The phrase 'heightened reliance' in the final clause is accurate but slightly less emphatic than ground truth's 'deeper strategic dependency.' QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is based on correct identification of years (2022, 2023, 2024) and merchant categories - all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple document sections, correctly showing progression and causal relationships. The logic connecting merchant coverage expansion to third-party partner success is sound and matches ground truth reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 554,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s 10‑K filings from 2022 through 2024 consistently describe the same multi‑year, enterprise‑wide initiative that “integrates, simplifies and standardizes processes and systems for the human resources, information technology, procurement, supply chain and finance functions” to grow its financial shared‑service capabilities and standardize financial systems.  Each year’s filing (2022 p.117‑119; 2023 p.117‑120; 2024 p.117‑120) reiterates that the effort is proactive—not a response to deficiencies—and that the company continues to align and streamline its financial control environment as part of this ongoing integration.  In short, the initiative has remained a steady, evolving focus rather than a new program, with a sustained emphasis on cross‑functional standardization to support shared‑service expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative spanning 2022-2024; (2) Accurately lists all five functional areas (HR, IT, procurement, supply chain, finance); (3) Properly characterizes the initiative as proactive rather than reactive to deficiencies; (4) Correctly notes the consistent narrative across all three years; (5) Appropriately emphasizes the focus on financial shared-service capabilities and standardization; (6) Provides specific page references (p.117-119 for 2022, p.117-120 for 2023 and 2024) that add credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, condensing the year-by-year evolution into a summary statement rather than explicitly detailing each year's emphasis; however, this is a stylistic choice that doesn't diminish accuracy. (2) The ground truth emphasizes that in 2023 the company 'reiterated' and 'highlighted' continuation, and in 2024 'maintained the same narrative'—the LLM captures this through 'reiterates' and 'ongoing integration' but with less explicit year-by-year differentiation. (3) The phrase 'steady, evolving focus rather than a new program' effectively captures the multi-year continuity described in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple functional domains, correctly identifying the consistent strategic direction and the integration of process standardization with financial shared-service enhancement. QUANTITATIVE ACCURACY: Page numbers are provided and appear reasonable for 10-K filings; no calculations are required for this question. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate professional tone and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 514,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "From 2022‑23, American Express framed alternative payment mechanisms—digital wallets, payment facilitators, and real‑time settlement systems—as a growing competitive threat that required continual technology investment (see 2022‑23 10‑K, p. 12). By 2024 the company had moved to a more proactive stance, explicitly incorporating open banking, digital‑wallet integration and real‑time settlement into its core technology strategy to keep pace with fintech innovation and preserve its competitive edge (see 2024 10‑K, p. 31). This shift signals a transition from merely reacting to new payment models to actively shaping its own payment ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of American Express's strategic evolution from 2022-2024 regarding alternative payment mechanisms. STRENGTHS: (1) Correctly identifies the core narrative arc - from viewing alternatives as threats (2022-23) to strategic incorporation (2024); (2) Accurately names specific technologies: digital wallets, payment facilitators, open banking, real-time settlement systems; (3) Properly synthesizes multi-hop information across three fiscal years; (4) Captures the semantic essence of the transformation from reactive to proactive positioning; (5) Correctly identifies American Express as the subject company. WEAKNESSES: (1) The LLM cites specific page numbers (p. 12 for 2022-23, p. 31 for 2024) that cannot be verified against the ground truth and may be fabricated - this is a minor concern as page numbers vary by document format; (2) Uses slightly different terminology ('payment facilitators' vs 'payment aggregators' in ground truth) - these are semantically similar but not identical; (3) The ground truth explicitly mentions 'dynamic and rapid growth' language from 2022 filings, which the LLM does not quote or reference; (4) Ground truth emphasizes 'strategic dependence' on adopting technologies by 2024, while LLM frames it as 'proactive stance' - similar concepts but different emphasis. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple technology domains, correctly establishing the progression and causal logic. CALCULATION/NUMERIC ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative verification is not applicable here. The answer is qualitative in nature. OVERALL ASSESSMENT: The LLM answer captures the essential narrative and strategic evolution accurately, with minor differences in terminology and emphasis rather than fundamental factual errors. The answer demonstrates solid understanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 539,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "From 2022 to 2024, Adobe shifted Frame.io from a broad, cloud‑native collaboration platform to a tightly integrated, video‑centric engine within its Creative Cloud ecosystem. The 2023 10‑K highlighted integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and camera‑to‑cloud uploads, while the 2024 10‑K narrowed the focus to Premiere Pro and After Effects (still supporting still images, design files and PDFs) and omitted references to Express, Firefly Services and other apps (page 98 2022; page 12 2023; page 12 2024). This evolution signals Adobe’s strategy to embed Frame.io as a core, scalable collaboration layer for video workflows, prioritizing real‑time, on‑set and remote collaboration while consolidating its creative tools around a unified cloud platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer directly contradicts the ground truth by claiming the 2024 10-K 'narrowed the focus to Premiere Pro and After Effects' and 'omitted references to Express, Firefly Services and other apps.' The ground truth explicitly states that in 2024, Adobe EXPANDED Frame.io's integration to include Photoshop, Lightroom, and Workfront - the opposite of what the LLM claims. (2) MISCHARACTERIZATION OF EVOLUTION - The LLM describes a narrowing/consolidation strategy ('shifted from broad...to tightly integrated, video-centric'), but the ground truth shows expansion and broadening ('expanded Frame.io's capabilities beyond post-production into broader video workflows'). (3) INCOMPLETE SCOPE - The LLM fails to mention Frame.io's expansion into casting, location scouting, and marketing campaign management in 2024, which are key indicators of Adobe's strategy. (4) CITATION ISSUES - The LLM cites specific page numbers (page 98 2022; page 12 2023; page 12 2024) without verification against actual filings, and these appear to be fabricated details. (5) CORRECT ELEMENTS - The LLM correctly identifies 2023 integration with Premiere Pro and After Effects, and correctly characterizes the overall strategic direction as embedding Frame.io as a collaboration layer, but the directional analysis of the 2024 evolution is fundamentally wrong. The core narrative of the answer is inverted from the ground truth, making this a significantly flawed response despite some correct intermediate facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 426,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 senior notes were reduced from **$16.0 billion at December 31 2022** to **$15.0 billion at December 31 2023** and further to **$13.0 billion at December 31 2024** (Table 6, 2023 10‑K and 2024 10‑K). This steady decline shows Amazon is actively paying down the 2017 Notes (and likely refinancing them at lower rates), underscoring a disciplined debt‑management strategy that prioritizes reducing long‑term debt and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All three key financial figures are correct - $16.0 billion (Dec 31, 2022), $15.0 billion (Dec 31, 2023), and $13.0 billion (Dec 31, 2024). The dates are precise and match the ground truth exactly. The progression shows consistent year-over-year reductions ($1.0B in 2023, $2.0B in 2024). (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it tracks the evolution across all three years and interprets what this indicates about debt management strategy. (3) ENTITY ACCURACY: Correctly identifies Amazon's 2017 Notes (senior notes), the specific fiscal year-ends, and references appropriate source documents (2023 and 2024 10-Ks). (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesizes data across multiple years and documents to show a trend, then interprets this trend as evidence of deliberate debt management. The additional insight about potential refinancing at lower rates and prioritization of reducing long-term debt and interest expense is reasonable inference from the observed pattern, though slightly beyond the ground truth statement. (5) SEMANTIC EQUIVALENCE: The core message matches perfectly - consistent reduction indicating deliberate debt paydown strategy. Minor enhancement: The LLM adds interpretive detail about refinancing and interest expense reduction that, while logical, goes slightly beyond what the ground truth explicitly states, but this is a reasonable and accurate inference rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 433,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 10‑K descriptions for 2022, 2023 and 2024 all list “upgrades and conversions” as a core offering of its Global Services segment (see 2022 p. 5, 2023 p. 1, 2024 p. 1).  The wording and placement of the phrase have remained unchanged, underscoring a steady emphasis on extending and modernizing existing aircraft rather than shifting focus to new product development.  This 3‑year consistency signals that Boeing’s strategic priority is to sustain and enhance its aerospace platforms through recurring service revenue and long‑term customer relationships.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies 'Upgrades and Conversions' as a consistent core offering across all three years (2022, 2023, 2024) in Boeing's Global Services segment; (2) Accurately captures the key insight that this service remained unchanged across the 3-year period, indicating sustained strategic focus; (3) Properly synthesizes the multi-hop reasoning by connecting the consistency of the offering to Boeing's strategic priorities (lifecycle management, service-based revenue, platform sustainability); (4) Correctly interprets the trajectory as reflecting deliberate long-term strategy rather than tactical shifts; (5) Appropriately emphasizes the significance of consistency across filings as evidence of strategic commitment. MINOR CONSIDERATIONS: (1) The LLM provides specific page references (2022 p. 5, 2023 p. 1, 2024 p. 1) which add credibility but cannot be independently verified in this evaluation context - these appear reasonable but are not contradicted by ground truth; (2) The LLM's phrasing 'wording and placement of the phrase have remained unchanged' is slightly more specific than the ground truth statement, but this is a reasonable inference from the consistency claim and does not contradict the source; (3) The ground truth mentions 'supply chain management and maintenance' as accompanying services in 2022, which the LLM does not explicitly reference, though this is a minor omission that doesn't affect the core answer about Upgrades and Conversions. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no calculations required; no numerical claims made that could be inaccurate. QUALITATIVE ACCURACY: The reasoning correctly identifies the multi-hop synthesis (tracking a service offering across three years and interpreting what consistency means strategically); the logic is sound and well-articulated. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution/trajectory and strategic implications, providing appropriate context about lifecycle management and service-based revenue streams.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 579,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy did not change between 2022 and 2024; the company continued to apply the Retirement Value formula to all eligible U.S. non‑union employees regardless of hire date, effective January 1, 2026, as originally announced in 2021【page_73】. The 2022, 2023, and 2024 10‑K filings reaffirm this amendment and confirm that the 2026 implementation date and employee‑eligibility criteria remain unchanged, with the company continuing to communicate the change to employees【page_76】【page_77】【page_78】【page_75】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) the 2026 implementation date for the Retirement Value formula, (2) application to all U.S. non-union employees, (3) original announcement in January 2021, and (4) consistency across 2022-2024 filings. However, there are significant omissions and incomplete synthesis:\n\nSTRENGTHS:\n- Correctly states the 2026 implementation date\n- Accurately identifies the formula applies to all eligible U.S. non-union employees\n- Correctly notes the original 2021 announcement\n- Properly identifies that the strategy remained unchanged across the three-year period\n- Appropriate citation references to multiple years' filings\n\nWEAKNESSES:\n- CRITICAL OMISSION: The LLM answer fails to address a key distinction from the ground truth - that employees hired after 2014 were ALREADY under the Retirement Value formula (not waiting until 2026). The ground truth explicitly states \"employees hired after 2014 were already under the Retirement Value formula\" while the LLM says the formula applies \"effective January 1, 2026\" without clarifying the pre-2015 hire distinction.\n- INCOMPLETE SYNTHESIS: The ground truth clarifies the evolution of communication - 2022 had minimal context, 2023 clarified the post-2014 hire status, and 2024 repeated the same language. The LLM treats all three years as identical without capturing this nuanced evolution.\n- MISSING DETAIL: The ground truth specifies that the Final Average Pay formula still applies to pre-2015 hires for service before 2026. The LLM does not mention this important distinction.\n- The LLM answer is somewhat circular - it states the strategy \"did not change\" but doesn't explain what the actual strategy evolution was in terms of communication and clarification.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings but fails to capture the nuanced differences in how the information was communicated and clarified across those years. The answer treats the three years as monolithic rather than showing the evolution requested in the question.\n\nSEMANTIC ACCURACY: While the core facts about dates and applicability are correct, the answer misses the essential point about the distinction between pre-2015 and post-2014 hires, which is central to understanding the pension strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 625,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 had an outstanding principal balance of **$606 million at the end of FY 2022**, and that balance remained unchanged at **$606 million at the end of FY 2023** and **$606 million at the end of FY 2024**【page_80】. The unchanged balance indicates that AVGO has neither issued additional principal nor redeemed any of this instrument during the period, reflecting a strategy of maintaining a stable debt level for this note while using other debt instruments for refinancing or capital‑structure adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was $606 million at the end of FY 2022, but the ground truth clearly indicates it was $1,086 million in FY 2022. This is a $480 million discrepancy - a 44% error in the opening balance. The LLM correctly identifies $606 million for FY 2023 and FY 2024, but misses the critical $480 million reduction that occurred between FY 2022 and FY 2023. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question specifically asks about the evolution 'from fiscal year 2022 through 2024.' The ground truth shows a three-year progression: $1,086M (2022) → $606M (2023) → $606M (2024). The LLM only captures the flat period (2023-2024) and misses the significant reduction event (2022-2023). (3) REASONING FAILURE: The LLM's interpretation that 'AVGO has neither issued additional principal nor redeemed any of this instrument during the period' is incorrect. The ground truth explicitly indicates a deliberate reduction occurred, suggesting 'a targeted debt repayment or refinancing strategy.' The LLM's conclusion about maintaining stable debt contradicts the actual $480 million reduction. (4) ENTITY/METRIC ACCURACY: While AVGO and the 5.000% notes due April 2030 are correctly identified, the fiscal year data is misaligned - the LLM appears to have shifted the timeline by one year. This is a critical error in multi-hop financial analysis where precise year-to-year tracking is essential. The LLM answer demonstrates a fundamental misunderstanding of the debt evolution pattern and provides an incorrect interpretation of the company's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 471,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "In 2022 AT&T was still integrating its 2018 Time Warner acquisition by combining the WarnerMedia segment with a Discovery subsidiary, while simultaneously restructuring its media operations—separating the Video business into DIRECTV and disposing of Otter Media assets. The integration was completed in a Reverse Morris Trust transaction that, in April 2022, spun off WarnerMedia as a separate, discontinued operation, effectively divesting the Time Warner assets within the broader WarnerMedia segment. This divestiture closed the integration phase and left AT&T focused on its core telecommunications business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The April 2022 date for the Reverse Morris Trust transaction is accurate. (2) The identification of WarnerMedia divestiture as a key strategic move is correct. (3) The reference to DIRECTV and the pivot back to telecommunications is accurate. PROBLEMATIC ELEMENTS: (1) The LLM conflates the timeline and sequence of events. It states 'In 2022 AT&T was still integrating' the Time Warner acquisition, but the ground truth indicates the Reverse Morris Trust transaction (which divested WarnerMedia) was completed in April 2022, meaning integration was already ending, not ongoing. (2) The LLM describes the transaction as 'combining the WarnerMedia segment with a Discovery subsidiary' which is imprecise—the Reverse Morris Trust created a merger between WarnerMedia and Discovery, not a combination within AT&T. (3) The LLM fails to adequately address the 2023-2024 evolution requested in the question. The ground truth explicitly mentions that by 2023 the separation was complete and by 2024 the DIRECTV divestiture was finalized. The LLM answer focuses primarily on 2022 events and doesn't clearly delineate the progression through 2024. (4) The phrase 'disposing of Otter Media assets' is mentioned but not in the ground truth, introducing potentially extraneous detail. MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting Time Warner acquisition → WarnerMedia integration → Reverse Morris Trust divestiture → return to telecommunications focus. However, it fails to properly synthesize the complete 2022-2024 timeline evolution as requested. The answer would benefit from clearer temporal sequencing showing the progression from 2022 through 2024, including the 2024 DIRECTV divestiture as the final step. QUANTITATIVE ACCURACY: The April 2022 date is correct; no other specific numbers are provided in either answer, so this dimension is limited. QUALITATIVE ACCURACY: The reasoning about strategic pivot is sound, but the temporal organization and completeness of the 2022-2024 evolution is insufficient.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 570,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024 AIG’s international terrorism strategy remained essentially the same.  In each filing (2022 page 167, 2023 page 119, 2024 page 86) the company used scenario‑based modeling from a third‑party vendor, relied on TRIPRA for U.S. coverage and on targeted private reinsurance plus government‑sponsored terrorism pools for overseas exposure, and did not change its geographic attachment points—U.S. losses are concentrated in New York City while international coverage is maintained through country‑specific terrorism pools.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM fails to mention the specific $1.3 billion modeled loss for a five-ton bomb attack in New York City (2022), which is a key quantitative metric in the ground truth. The LLM also fails to identify the specific geographic attachment points mentioned in the ground truth: $200 million for Japan and $125 million for rest of world (2024). These are concrete numbers that should have been extracted from the filings. (2) CORE FACTUAL ERROR: The LLM claims AIG's strategy 'remained essentially the same' from 2022-2024, directly contradicting the ground truth which explicitly states there was 'a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.' The ground truth describes clear evolution and increasing sophistication, while the LLM characterizes it as static. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies some elements (scenario-based modeling, TRIPRA, reinsurance pools), it fails to synthesize the evolution across the three-year period. The ground truth shows progression: 2022 (specific loss modeling), 2023 (scenario focus + international pools), 2024 (structured geographic attachment points). The LLM misses this temporal progression entirely. (4) MISSING KEY DETAILS: The LLM does not mention the specific evolution in reinsurance protections or the shift toward region-specific risk segmentation that the ground truth emphasizes. (5) PAGE REFERENCES: While the LLM provides page numbers, these cannot be verified against the actual content, and the characterization of what's on those pages appears inconsistent with the ground truth's description of evolving strategies. The answer demonstrates a fundamental misunderstanding of the question's focus on 'evolution' and fails to capture the strategic progression that is central to the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 537,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s pipe‑working tools portfolio, including pipe wrenches, stayed essentially the same from 2022 to 2024 – the company continued to offer pipe wrenches, cutters, threading and diagnostic equipment (page_9, page_73). This steady product mix signals Emerson’s strategy to sustain a core professional‑tools line, reinforcing its position as a reliable, diversified supplier in the professional tools market.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) CORE FACTUAL ERROR: The LLM claims the product portfolio 'stayed essentially the same from 2022 to 2024,' directly contradicting the ground truth which documents significant evolution and expansion. The ground truth explicitly states the company 'expanded in sophistication and integration with battery-powered and diagnostic technologies' and introduced 'battery hydraulic tools for press connections' in 2023. (2) MISSING KEY DEVELOPMENTS: The LLM completely omits the introduction of battery-powered hydraulic tools in 2023, which represents a major strategic shift from traditional to advanced technology. It also fails to mention the enhanced diagnostic systems like sewer inspection cameras introduced in 2023. (3) MISCHARACTERIZATION OF STRATEGY: The LLM characterizes the strategy as 'sustain a core professional-tools line' suggesting stasis, when the ground truth indicates a deliberate 'strategic shift toward modernizing its professional tools segment.' This is a fundamental misinterpretation of the company's direction. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about 'multi-year progression' and what it 'indicates about strategic positioning.' The LLM fails to synthesize the 2022→2023→2024 progression that shows clear modernization and technological integration. (5) CITATION ISSUES: The LLM cites 'page_9, page_73' but provides no specific evidence supporting its claim of stasis. The ground truth provides year-by-year evolution details that the LLM completely misses. (6) SEMANTIC MISALIGNMENT: The LLM's conclusion about 'reliable, diversified supplier' misses the strategic narrative of digital transformation and technological advancement that the ground truth emphasizes. The answer demonstrates a failure to understand the question's focus on portfolio evolution and strategic positioning through technological advancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 532,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has applied the same lease‑accounting policy to free‑rent periods for 2022, 2023 and 2024.  In each filing the company states that free‑rent periods (and any step‑rent provisions) are recognized on a straight‑line basis over the original lease term and any extension options that the company is reasonably certain to exercise from the date it takes control of the property.  Because the lease payments during the free‑rent period are zero, the present value of the discounted minimum lease payments – and therefore the right‑of‑use asset – is lower than it would be without the free‑rent period.  No change in the recognition methodology or disclosure was reported across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer explicitly states that disclosure depth and specificity around ROU asset valuation DECREASED over time, with detailed explanations of the discounting process and ARO treatment in 2022 that were NOT repeated in 2023 and 2024 filings. The LLM answer directly contradicts this by stating 'No change in the recognition methodology or disclosure was reported across the three years.' This is a fundamental misrepresentation of the evolution of Costco's disclosures. The LLM correctly identifies: (1) the consistent straight-line recognition methodology across all three years, (2) the treatment of free-rent periods and step-rent provisions, (3) the extension options language, and (4) the impact on ROU asset valuation (lower due to zero payments during free-rent periods). However, the LLM completely misses the key finding about the SHIFT in disclosure practices - specifically that 2022 contained explicit, detailed explanations of the discounting process using incremental borrowing rates and ARO treatment that were absent from subsequent years. This represents a material omission of the primary evolution the question asks about. The quantitative aspects (dates, methodology descriptions) are accurate, but the qualitative assessment of how disclosure evolved is inverted from the ground truth. The answer fails to address the 'evolution' aspect of the question, which is central to what was asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 417,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % Notes were issued under the tenth supplemental indenture dated November 3, 2015 (Exhibit 4.13 in each of the 2022, 2023 and 2024 10‑K filings).  The indenture sets a maturity of 2020, and none of the three filings report a new issuance or amendment of those notes, so the maturity timeline stayed fixed at 2020 and the indenture documentation did not change across 2022‑2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) INDENTURE DATE ERROR: LLM states 'tenth supplemental indenture dated November 3, 2015' but ground truth clearly indicates 'Eleventh Supplemental Indenture dated August 8, 2016' - this is a fundamental factual error on both the supplemental number and date. (2) MATURITY DATE ERROR: LLM claims maturity of 2020, but ground truth explicitly states maturity of 2023 - this is a critical 3-year discrepancy in a key financial metric. (3) EXHIBIT REFERENCE ERROR: LLM references 'Exhibit 4.13' but ground truth does not mention this specific exhibit number. (4) LOGICAL INCONSISTENCY: LLM's statement that 'the maturity timeline stayed fixed at 2020' contradicts the fact that these notes appear in 2024 filings - if they matured in 2020, they would not logically appear in 2024 filings as active debt instruments. The ground truth correctly explains this by noting the 2023 maturity date and that the documentation remained in exhibits even after maturity. (5) SYNTHESIS FAILURE: The LLM failed to properly synthesize the multi-hop information across three years, providing incorrect dates and indenture references that do not match the actual filing data. The only correct element is that the notes were referenced in 2022, 2023, and 2024 filings and that documentation remained consistent, but the specific details are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 399,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon has continued to recognize commissions and fulfillment fees from third‑party seller services when the services are rendered—generally upon delivery of the product to a carrier or the customer—through 2024. The revenue mix has remained a blend of a percentage‑of‑sales commission and fixed or per‑unit fulfillment and shipping fees, with no change in timing or allocation across the three years (2022‑2024) (AMZN_10k_2023.pdf: page 43).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the timing of revenue recognition (upon delivery to carrier or customer) and accurately describes the revenue composition (commissions as percentage of sales, plus fulfillment/shipping fees). However, there are significant issues with completeness and synthesis: (1) The LLM claims 'no change in timing or allocation across the three years (2022-2024)' which contradicts the ground truth that shows evolution and increasing clarity in disclosures. The ground truth explicitly states that 2023 provided 'specific' timing details that were not mentioned in 2022, indicating a change in disclosure clarity if not actual practice. (2) The LLM fails to adequately address the 'evolution' aspect of the question - it presents a static picture rather than showing how disclosures evolved from 2022 through 2024. (3) The ground truth notes that 2024 'continued offering similar seller programs' with 'no specific changes in revenue recognition timing mentioned,' which is different from claiming there was 'no change' across all three years. (4) The LLM provides only one source citation (AMZN_10k_2023.pdf page 43) when the question asks about evolution across three years, suggesting incomplete multi-hop synthesis across 2022, 2023, and 2024 filings. (5) The LLM's statement about 'no change in timing or allocation' is too definitive given that the ground truth indicates increasing clarity in disclosures over time, which itself represents an evolution. The core revenue recognition mechanics are correctly described, but the answer misses the key narrative of how Amazon's disclosures became more specific and detailed over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 456,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings for 2022, 2023 and 2024 all include Exhibit 4‑b (the “guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.”).  By carrying the same guarantee forward each year, AT&T signals a deliberate strategy of retaining long‑term guarantees on legacy telecom entities—keeping those obligations off its balance sheet while maintaining control over potential liabilities and managing risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that AT&T's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4-b, and correctly notes the repeated inclusion of the guarantee across all three years. The dates and years are accurate. The LLM also correctly identifies that this represents a deliberate strategy of maintaining long-term guarantees on legacy telecom entities.\n\nWEAKNESSES AND ERRORS: (1) ENTITY ACCURACY ISSUE: The LLM states the exhibit covers \"Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.\" while the ground truth specifically mentions only \"Southwestern Bell Telephone Co.\" The inclusion of Pacific Bell appears to be an addition not supported by the ground truth, which focuses solely on Southwestern Bell. This is a factual error in entity identification. (2) INTERPRETATION DIVERGENCE: The LLM introduces an interpretation about \"keeping those obligations off its balance sheet\" which is not present in the ground truth. The ground truth focuses on AT&T maintaining \"full financial responsibility\" and the \"unchanging commitment,\" while the LLM shifts emphasis to balance sheet treatment and risk management framing that goes beyond what the ground truth establishes. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the \"no indication of reduction or restructuring\" aspect more explicitly, while the LLM focuses more on control and risk exposure management, which is a different analytical angle. (4) MISSING NUANCE: The ground truth's key insight about \"no alteration of terms or scope\" is not explicitly captured in the LLM response.\n\nQUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The years (2022, 2023, 2024) are correct.\n\nQUALITATIVE ACCURACY: The reasoning about deliberate strategy is sound, but the inclusion of Pacific Bell without ground truth support and the balance sheet interpretation represent reasoning that goes beyond or diverges from the established facts.\n\nCONTEXTUAL RELEVANCE: The answer addresses the core question about long-term liability management strategy, but the framing around balance sheet treatment and the inclusion of Pacific Bell reduce alignment with the ground truth's specific focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 605,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 were $808 million at year‑end 2022, rose to $826 million in 2023, and fell back to $808 million in 2024. The modest increase and subsequent repayment indicate the company is actively managing its debt mix—using long‑term notes to refinance or adjust balances—while keeping the overall debt level and cost (2.29 % effective rate) stable and maintaining a diversified maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-by-year progression of the 2.250% Notes due 2050. Ground truth shows: 2022=$983M, 2023=$826M, 2024=$808M. LLM states: 2022=$808M, 2023=$826M, 2024=$808M. This is a complete reversal of the 2022 and 2024 figures. The LLM incorrectly claims the notes 'rose to $826 million in 2023' when they actually declined from $983M to $826M. The LLM also incorrectly characterizes the 2023-2024 movement as a 'subsequent repayment' when in fact the values remained relatively stable ($826M to $808M). REASONING ISSUES: While the LLM correctly identifies the effective rate (2.29%) and attempts to discuss debt management strategy, the analysis is built on incorrect numbers. The characterization of 'modest increase and subsequent repayment' contradicts the actual pattern of consistent decline from 2022-2024. The ground truth indicates a 'gradual decline' reflecting a 'cautious approach,' not the volatile pattern the LLM describes. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression, which is the core requirement of this multi-hop question. The answer demonstrates a fundamental misunderstanding or misreading of the underlying data. The only correct element is the effective rate of 2.29%, which is insufficient to salvage an answer with inverted year-to-year figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 388,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying amount of $1.25 billion in each of the 2022, 2023, and 2024 filings (page_52, 2022; page_52, 2023; page_52, 2024).  While total long‑term debt fell from $6.59 billion in 2022 to $5.92 billion in 2024 (page_52, 2022; page_52, 2023; page_52, 2024), the company neither issued new 1.375% notes nor repaid the existing ones, indicating a conservative capital strategy that preserves low‑cost, long‑term debt and uses cash to retire higher‑rate obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - 1.375% Senior Notes remained at $1.25 billion (or $1,250 million) across 2022-2024; total long-term debt decreased from $6.59 billion (2022) to $5.92 billion (2024), with intermediate 2023 figure of $6.484 billion mentioned in ground truth but not explicitly stated in LLM answer. The format variations ($1.25 billion vs $1,250 million) are acceptable and consistent. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three fiscal years and identified the key pattern - constant specific debt instrument while overall debt declined. REASONING QUALITY: The LLM's interpretation of capital management strategy is sound and semantically equivalent to ground truth. Both identify that Costco maintained the low-cost 1.375% notes while reducing other debt obligations. The LLM's characterization as 'conservative capital strategy that preserves low-cost, long-term debt and uses cash to retire higher-rate obligations' is logically sound and captures the same strategic insight as the ground truth's 'selective capital management strategy that prioritized repayment of other debt tranches.' MINOR OMISSION: The LLM does not explicitly mention the 2023 intermediate figure ($6.484 billion), though this is a minor detail that doesn't affect the core narrative about the three-year trend. The answer fully addresses the question's components regarding debt structure evolution and capital management strategy implications. All entities (Costco, specific debt instrument, years, metrics) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 456,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 2022 10‑K (p. 11) already outlined a multi‑layered security program that combined cyber‑security, fraud‑scoring, tokenisation and third‑party assessments, and real‑time account‑based payment capabilities across 12 markets. By 2023 the same framework was expanded to include AI‑driven governance and privacy‑by‑design controls, while real‑time infrastructure had grown to 13 markets (2023 10‑K, p. 11). The 2024 filing reiterated the 13‑market reach and added further resilience layers such as an enterprise‑resilience program and enhanced monitoring (2024 10‑K, p. 11). This parallel evolution shows that Mastercard is scaling its risk‑management architecture in lockstep with its global payment‑network expansion, ensuring that security and resilience keep pace with increased volume and geographic reach.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2024 real-time payments infrastructure expansion. The ground truth explicitly states that by 2024, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world' (a qualitative shift from the specific market counts of prior years), NOT 13 markets as the LLM claims. The LLM states '2024 filing reiterated the 13-market reach' which directly contradicts the ground truth's description of a shift to 'several countries around the world.' This is a material error in a key data point. PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies the 2022 baseline (12 markets) and 2023 expansion (13 markets), and accurately captures the general concept of parallel evolution between security and infrastructure expansion. The mention of specific security components (tokenization, fraud-scoring, third-party assessments) aligns with the ground truth's description of multi-layered approaches. REASONING QUALITY: The LLM's synthesis of the parallel development concept is sound and well-articulated, correctly inferring that Mastercard scaled security in tandem with infrastructure expansion. However, the reasoning is undermined by the factual error about 2024 market reach. MISSING CONTEXT: The LLM does not acknowledge the important qualitative shift in 2024 toward 'broader global deployment' language, which is a key insight in the ground truth about how Mastercard's strategy evolved. The LLM also adds specific security features (AI-driven governance, privacy-by-design, enterprise-resilience program) that are not mentioned in the ground truth, raising questions about whether these details are accurate to the actual filings or represent hallucination. SEMANTIC ISSUES: While the overall narrative structure is appropriate, the factual inaccuracy about 2024 market numbers is not a wording difference but a substantive error that affects the credibility of the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 547,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 were issued in 2011 under the Third Supplemental Indenture (4.6) and matured in 2021, so by FY 2022 they were no longer outstanding.  The 4.6 exhibit appears unchanged in the 2023, 2024, and 2022 10‑Ks, and no new 4.000 % Notes due 2021 were issued in FY 2023 or FY 2024.  This pattern shows Microsoft is actively managing its debt maturity profile—maturing older debt and issuing new notes with longer maturities and varied rates to maintain a balanced, cost‑effective capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.000% Notes due 2021 did mature in 2021, so they were past maturity by FY 2022. (2) The Third Supplemental Indenture (Exhibit 4.6) reference is accurate. (3) The observation that no new 4.000% Notes due 2021 were issued in FY 2023 or 2024 is correct. (4) The general concept of debt maturity management is relevant. PROBLEMATIC ELEMENTS: (1) The LLM states the notes 'were no longer outstanding' by FY 2022, but the ground truth explicitly states Microsoft 'continued to disclose the 4.000% Notes due 2021 in its exhibit list' through 2024, suggesting they remained on the books despite being past maturity. (2) The LLM's interpretation that this represents 'actively managing its debt maturity profile—maturing older debt and issuing new notes' is speculative and not supported by the ground truth, which emphasizes 'consistent and transparent approach to debt disclosure, even post-maturity' and 'disciplined long-term debt management.' (3) The LLM misses the key insight from the ground truth: the continued disclosure of past-maturity debt suggests either delayed settlement, rollover, or ongoing disclosure requirements—not simply that the debt was retired. (4) The LLM's reasoning about 'issuing new notes with longer maturities and varied rates' goes beyond what the ground truth supports regarding this specific instrument. The answer partially addresses the question but fails to capture the nuanced pattern of continued disclosure post-maturity and misinterprets what this indicates about Microsoft's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 445,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated citation of the 1.500% Note due 2030 in its 2022, 2023 and 2024 10‑Ks shows that the company keeps this low‑coupon, 10‑year debt as a core, long‑term financing tool.  In contrast to its higher‑rate, shorter‑term notes (e.g., 2.730% due 2024, 3.000% due 2025, 3.300% due 2027) and very long‑term, higher‑rate notes (e.g., 3.950% due 2052, 4.100% due 2062), the 1.500% Note provides a stable, low‑cost base that anchors Amazon’s capital structure and helps manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.500% Note due 2030 as a core, long-term financing tool and provides sound reasoning about its role in Amazon's capital structure. However, there are significant issues with factual accuracy and completeness:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific debt instruments (2.730% due 2024, 3.000% due 2025, 3.300% due 2027, 3.950% due 2052, 4.100% due 2062) that are NOT mentioned in the ground truth answer. These appear to be fabricated or incorrectly sourced details.\n   - The ground truth specifically mentions the 4.700% Note due 2024 and 4.700% Note due 2032, which the LLM does not reference.\n   - The LLM does not cite the 2060 maturity instrument mentioned in the ground truth as part of the broader 2022 issuance.\n\n2. COMPLETENESS ISSUES:\n   - The LLM answer lacks the temporal progression analysis provided in the ground truth (how the Note was introduced in 2022, reiterated in 2023, and continued in 2024).\n   - Missing the specific context about the 2022 issuance that included instruments maturing as far out as 2060.\n   - Does not address the simultaneous management of near-term and long-term obligations as explicitly noted in the ground truth.\n   - Lacks discussion of refinancing risk mitigation and long-term investment support mentioned in the ground truth.\n\n3. REASONING QUALITY:\n   - The LLM's reasoning about low-cost capital anchoring the structure is sound and aligns with the ground truth.\n   - However, the introduction of unverified debt instruments undermines the credibility of the analysis.\n   - The comparison framework (short-term vs. long-term, lower vs. higher rates) is conceptually correct but uses incorrect specific examples.\n\n4. ENTITY AND FACTUAL ACCURACY:\n   - Correctly identifies Amazon and the 1.500% Note due 2030.\n   - Correctly identifies the years 2022, 2023, 2024.\n   - Incorrectly cites debt instruments not mentioned in the ground truth.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core insight about the 1.500% Note as a stable, low-cost base is semantically equivalent to the ground truth's description of \"strategic emphasis on long-dated, fixed-rate debt.\"\n   - However, the factual errors in supporting details significantly undermine this equivalence.\n\nThe answer demonstrates understanding of the conceptual framework but fails on factual accuracy by introducing unverified debt instruments and omitting key details from the ground truth. This is a critical failure in a financial analysis context where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 680,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "In 2022 AT&T held a 41.3 % stake in SKY Mexico and accounted for it under the equity method (page 92). The stake and equity‑method accounting remained unchanged in 2023, with equity in net income of affiliates recorded (page 66, T_10k_2023). In 2024 AT&T sold its 41.3 % interest in June, removing the investment from its equity‑method balance sheet (page 66, T_10k_2024). This three‑year trajectory illustrates AT&T’s systematic divestiture of international pay‑TV assets—evidenced also by the sale of Vrio and DIRECTV—to refocus on core operations and reduce exposure to foreign markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key quantitative facts: the 41.3% ownership stake in 2022, equity method accounting treatment in 2023, and the June 2024 sale. All numeric values and dates are accurate. The answer correctly synthesizes the multi-hop information across three years and identifies the strategic divestiture pattern. However, there are minor areas where the answer could be more complete: (1) The ground truth explicitly states AT&T 'maintained' the 41.3% interest in 2022 'following the sale of Vrio,' providing important context about the prior divestiture that set up the SKY Mexico position. The LLM mentions Vrio and DIRECTV sales but doesn't clearly establish the chronological relationship. (2) The ground truth emphasizes that SKY Mexico was 'still part of AT&T's equity method investments alongside DIRECTV and Gigapower' in 2023, providing portfolio context that the LLM doesn't explicitly state. (3) The phrase 'removing the investment from its equity-method balance sheet' is slightly imprecise—the investment was removed because it was sold, not merely reclassified. The reasoning about systematic divestiture and refocusing on core U.S. operations is sound and well-supported. The multi-hop synthesis across 2022-2024 is correct, and the connection to broader international pay-TV market exit strategy is appropriately identified. The answer is well-structured and directly addresses the question's core inquiry about the 3-year trajectory and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 425,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path framework—described in the 2022 and 2023 10‑Ks—ties the allocation of the return‑seeking portion of the U.S. pension portfolio to the plan’s funded ratio and prevailing interest rates, shifting assets from growth to liability‑hedging as the plan becomes better funded (2022 10‑K p. 310; 2023 10‑K p. 252).  The target allocations illustrate this de‑risking: the plan moved from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 to 9 % equity, 80 % fixed‑maturity and 11 % other in 2024 (2023 10‑K p. 252), a clear reduction in growth exposure and increase in fixed‑maturity assets as the funded status improved.  The 2023 target (not disclosed here) would have fallen between these two points, confirming a gradual glide‑path adjustment in line with the plan’s funding trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy. STRENGTHS: (1) Correctly identifies the glide path framework and de-risking strategy; (2) Properly synthesizes the concept that allocations shift from growth to liability-hedging assets as funded status improves; (3) Appropriately cites 10-K pages; (4) Correctly identifies the general trend of reduced equity and increased fixed-maturity allocations. CRITICAL ISSUES: (1) The specific allocation percentages provided (15% equity, 75% fixed-maturity, 10% other for 2022 and 9% equity, 80% fixed-maturity, 11% other for 2024) cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth mentions 'reductions in growth assets and increased allocations to liability-hedging assets' but does not cite exact percentages. (2) The LLM states these figures come from the 2023 10-K p. 252, but the ground truth does not confirm these specific allocations or page references. (3) The answer acknowledges the 2023 target 'would have fallen between these two points' but admits it was 'not disclosed here,' which is problematic since the question specifically asks about the progression through 2022, 2023, and 2024. MULTI-HOP REASONING: The LLM correctly synthesizes the concept of glide path evolution and de-risking strategy, but fails to provide the complete three-year progression requested. The ground truth emphasizes that each year's target allocation was based on the funded status at year-end (2021 for 2022 targets, 2023 for 2024 targets, 2024 for 2025 targets), which the LLM does not explicitly address. SEMANTIC ALIGNMENT: The LLM's characterization of the strategy aligns with the ground truth's description of 'liability-driven investing principles' and methodical de-risking, but the specific numbers lack verification. The answer is well-reasoned but potentially contains unverified quantitative claims that significantly undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 539,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk mitigation has shifted from a dedicated “qualified cash settlement fund” in 2022 to a broader, higher‑level risk‑mitigation framework by 2024.  The company increased the amount of risk‑mitigation arrangements applied to settlement exposure from $6.0 billion in 2022 to $12.2 billion in 2023 and $13.5 billion in 2024, while the fund itself was eliminated by 2023 and no new fund was created in 2024.  Risk‑mitigation for guarantees (e.g., travelers‑cheque guarantees) remained roughly flat ($272–$273 million), and the liability for the U.S. MDL litigation fell modestly from $596 million in 2023 to $559 million in 2024.  These changes show Mastercard’s ability to scale and integrate its credit‑risk safeguards in response to mounting regulatory scrutiny and litigation exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces specific numbers that cannot be verified against the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($6.0B in 2022, $12.2B in 2023, $13.5B in 2024 for risk-mitigation arrangements, $272-273M for guarantees, $596M and $559M for MDL litigation) that are not mentioned in the ground truth. The ground truth does not provide these specific numerical figures, making it impossible to verify their accuracy. The LLM appears to have fabricated or hallucinated these numbers. (2) CONCEPTUAL DIVERGENCE: The ground truth emphasizes Mastercard's consistent framework for credit risk mitigation (cash collateral, letters of credit, guarantees) and notes that the company maintained effective core strategies despite escalating external pressures. The LLM instead focuses on a 'qualified cash settlement fund' that was allegedly eliminated by 2023, which is not mentioned in the ground truth. (3) INCOMPLETE REGULATORY CONTEXT: The ground truth explicitly mentions the FTC consent agreement (2023), DOJ antitrust investigation (2023), U.S. Liability Shift Litigation (2024), and European Commission investigation (2024). The LLM answer mentions 'regulatory scrutiny and litigation exposure' generically but fails to identify these specific regulatory events and their timeline. (4) MISSING CORE INSIGHT: The ground truth emphasizes that despite mounting external pressures, Mastercard 'consistently reported a low level of losses from customer settlement failures across all three years,' demonstrating effective risk management. The LLM does not address this critical finding about actual settlement failure losses. (5) MULTI-HOP REASONING: The LLM fails to synthesize the relationship between specific regulatory events and risk management adaptations across the three-year period. The ground truth shows a clear progression: 2022 (baseline monitoring), 2023 (response to FTC/DOJ actions), 2024 (response to additional litigation/investigations). The LLM provides no such temporal synthesis. The answer reads as if specific financial data was retrieved from a different source or fabricated entirely, rather than derived from the actual 10-K filings referenced in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 608,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "Home Depot’s share pool for future grants under the Omnibus Stock Incentive Plan fell from about 117 million shares in 2022 (page 65) to roughly 77 million shares by the end of 2023 (page 64) and further to around 70 million shares at the close of 2024 (page 70). This downward trend indicates the company is tightening its equity award pool, suggesting a more conservative stock‑based compensation strategy aimed at limiting dilution and preserving capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three key numeric values (117M in 2022, 77M in 2023, 70M in 2024) and accurately captured the downward trend. The numbers match the ground truth exactly. The multi-hop synthesis across three fiscal years is properly executed. WEAKNESSES: (1) CRITICAL INTERPRETATION ERROR - The LLM's conclusion about strategy is fundamentally incorrect. The ground truth states the trend 'suggests increased reliance on equity incentives to retain and motivate associates and directors,' indicating ACTIVE ISSUANCE of stock-based compensation. The LLM instead interprets this as 'tightening its equity award pool' and 'more conservative stock-based compensation strategy aimed at limiting dilution,' which is the opposite conclusion. A declining share pool due to active grants indicates increased use of equity, not decreased use. (2) The LLM provides page references (65, 64, 70) which add specificity but cannot be verified against the ground truth. (3) The reasoning about 'preserving capital' is misleading - the decline reflects consumption of the pool through grants, not conservation. The LLM correctly identified the numerical trend but misinterpreted what it signifies about the company's compensation strategy, which is the core analytical component of the question. This represents a significant analytical error despite correct data extraction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 385,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "The 3.625 % notes due October 2024 had a principal balance of $622 million at the end of FY 2023 (the same balance that was outstanding at the end of FY 2022) and were fully repaid by the end of FY 2024, leaving $0 outstanding (page 81). This steady balance until 2024 followed by a complete payoff demonstrates Broadcom’s proactive debt‑management strategy of retiring the notes before maturity to reduce interest expense and strengthen its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. All quantitative facts are correct: $622 million balance in FY 2022 and FY 2023, and $0 in FY 2024. The multi-hop synthesis is sound, correctly tracking the evolution of this specific debt instrument across three fiscal years. The reasoning about Broadcom's debt management strategy is logically sound and supported by the data progression. The answer correctly identifies that the notes were fully repaid by FY 2024, ahead of the October 2024 maturity date. Minor strengths of the LLM answer include the addition of specific context (page reference, mention of interest expense reduction and balance sheet strengthening) that enhances understanding, though these details go slightly beyond what was explicitly stated in the ground truth. The characterization of the strategy as 'proactive' is a reasonable inference from the data pattern. No calculation errors or factual inaccuracies are present. The answer demonstrates clear understanding of the multi-hop requirement by synthesizing information across three fiscal years and drawing appropriate conclusions about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 331,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T integrated Time Warner into its WarnerMedia segment after the 2018 acquisition, then announced a 2021 plan to merge WarnerMedia with Discovery to divest the entertainment assets; the transaction closed in April 2022 via a Reverse Morris Trust, effectively exiting the business (page 5). The 2023 and 2024 10‑Ks no longer reference WarnerMedia and instead emphasize AT&T’s focus on 5G, fiber, and network infrastructure, underscoring a strategic pivot from entertainment to core telecommunications services (page 4).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN DATES AND TIMELINE: The LLM answer contains a significant factual error regarding the timing of the WarnerMedia-Discovery transaction. The LLM states the transaction 'closed in April 2022,' but the ground truth indicates it was 'completed...in 2023.' This is a major chronological error that fundamentally misrepresents the timeline of AT&T's strategic evolution. The question specifically asks about evolution 'from 2022 through 2024,' and placing the transaction in 2022 rather than 2023 distorts the entire narrative. INCOMPLETE COVERAGE: The LLM answer fails to address the DIRECTV divestiture to TPG in 2024, which is explicitly mentioned in the ground truth as a critical final step in AT&T's 'full retreat from the media investments.' This omission is significant because the question asks about the 'final exit strategy' and what the progression reveals. The answer stops short of capturing the complete 2022-2024 arc. PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies (1) the 2018 Time Warner acquisition and WarnerMedia integration, (2) the Reverse Morris Trust structure, (3) the strategic pivot from entertainment to telecommunications, and (4) the emphasis on 5G, fiber, and network infrastructure in 2023-2024. The semantic understanding of the strategic shift is generally sound. MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, the date error undermines the multi-hop analysis. The answer should have traced: 2022 (holding WarnerMedia) → 2023 (WarnerMedia-Discovery separation completed) → 2024 (DIRECTV sale to TPG). Instead, it compresses the timeline incorrectly. The answer demonstrates partial understanding of the strategic reversal but fails on precision of execution and completeness of the exit strategy narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 491,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "Emerson kept its Pipe Cutters in the Safety & Productivity segment, but over the period it sharpened the positioning around battery‑powered hydraulic tools and diagnostic systems.  The 2022 10‑K described the line as “pipe‑working tools … battery hydraulic tools for press connections … and diagnostic systems, including sewer inspection cameras and locating equipment”【page_9】, and the 2024 10‑K repeats that same description, underscoring the continued integration of battery‑powered technologies and diagnostic capabilities as a core differentiator within the Safety & Productivity segment【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims that both the 2022 and 2024 10-Ks contain identical descriptions of Pipe Cutters as including 'battery hydraulic tools for press connections and diagnostic systems, including sewer inspection cameras and locating equipment.' However, the ground truth explicitly states that in 2022, Pipe Cutters were described as 'standalone tools used by plumbing professionals' with NO mention of battery-powered technologies or diagnostic systems integration. (2) The LLM fails to capture the evolution/progression that is central to the question. The ground truth shows a clear trajectory: 2022 (standalone tools) → 2023 (linked with battery hydraulic tools) → 2024 (integrated ecosystem with diagnostic systems). The LLM incorrectly suggests the positioning remained static from 2022 to 2024. (3) The LLM misses the 2023 data point entirely, which is crucial for demonstrating the evolution over the 2022-2024 period. (4) The page citations provided (page_9 and page_73) appear to be fabricated or misattributed, as they don't align with the actual content described in the ground truth. (5) The phrase 'sharpened the positioning' suggests change, but the LLM then contradicts this by claiming the same description appears in both 2022 and 2024. The answer demonstrates a fundamental failure to synthesize the multi-hop information across three years and misrepresents the strategic evolution that actually occurred. The core narrative of increasing integration and ecosystem positioning is lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 440,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "From 2022 through 2024, J&J has repeatedly described the same multi‑year, enterprise‑wide initiative to “integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance,” aimed at expanding its financial shared‑service capabilities and aligning the financial control environment. The unchanged, persistent emphasis across three consecutive filings signals a deliberate, long‑term strategy to standardize financial processes, improve efficiency, and strengthen internal controls as a core pillar of the company’s operational architecture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the multi-year enterprise-wide initiative and its consistent emphasis from 2022-2024. The answer correctly captures the core strategic focus on process standardization and financial systems modernization. However, there are notable differences from the ground truth: (1) The LLM expands the scope of functions to include 'HR, IT, procurement, supply chain and finance' whereas the ground truth specifically emphasizes 'key functions including finance' without explicitly listing all these functions. This expansion, while potentially accurate, goes beyond what the ground truth explicitly states. (2) The LLM uses slightly different phrasing ('integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance') which appears to be a direct quote or paraphrase, but the ground truth uses 'integrating, simplifying, and standardizing processes and systems across key functions.' (3) The LLM's characterization of the initiative as 'a core pillar of the company's operational architecture' is interpretive and goes slightly beyond the ground truth's statement about it being 'foundational to its operational efficiency and control framework.' The quantitative accuracy is high as there are no specific numbers, dates, or calculations to verify - only years (2022-2024) which are correct. The qualitative accuracy is solid in capturing the multi-hop synthesis across three years and the consistent messaging theme, though the added functional scope details create minor divergence. The contextual relevance is strong as the answer directly addresses the question about evolution and strategic focus. The answer successfully synthesizes information across multiple years and conveys the same essential message about long-term commitment to process optimization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 509,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco consistently filed the Executive Health Plan as Exhibit 10.1* in all three fiscal years, with the same filing status “Filed Herewith” and period ended 9/2/2012 (page_66 2022, page_66 2023, page_66 2024). This unchanged filing status shows the company’s stable, long‑term commitment to executive benefits, ensuring continuity and transparency in the plan’s administration.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Costco consistently filed the Executive Health Plan as Exhibit 10.1* across fiscal years 2022, 2023, and 2024, with the same period ended date of 9/2/2012. The dates are accurate and the filing consistency is properly noted. However, there are notable omissions and inaccuracies: (1) The LLM states 'Filed Herewith' as the filing status, but the ground truth specifies the filing date as October 19, 2012, which is a more precise disclosure detail that should have been included. (2) The LLM does not explicitly mention that the filing date remained October 19, 2012 across all three years, which is a key element of the ground truth's evidence of stability. (3) The LLM's interpretation about 'Filed Herewith' status is somewhat ambiguous - the ground truth emphasizes the consistent 'Filing Date' of October 19, 2012, not necessarily a 'Filed Herewith' designation. (4) The reasoning about 'no material updates or amendments' from the ground truth is absent from the LLM answer, which would have strengthened the explanation of what the consistency indicates. The LLM correctly synthesizes that the unchanged status indicates stable executive benefit strategy, but misses the specific detail about the filing date consistency and the implication about lack of amendments. The page references (page_66) are helpful but not verified against the ground truth. Overall, the answer captures the main conclusion but lacks precision in the supporting details that define the ground truth's evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 425,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A shares kept the same voting structure—one vote per share—while the dividend per share steadily rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【page_96】【page_99】【page_94】.  The unchanged voting rights coupled with progressively higher dividends show that the company preserves a stable governance framework for its primary shareholders while consistently enhancing shareholder returns, underscoring a strategy of predictable, value‑driven governance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that A Class Shares maintained 'identical dividend and voting rights' across all three years with 'standard dividend rights'—meaning no change in dividend rights structure, not increasing dividend amounts. The LLM has fundamentally misinterpreted the question by conflating dividend per share amounts (which may have increased) with dividend RIGHTS (which remained constant). The ground truth focuses on the RIGHTS associated with shares (voting rights and dividend rights as structural features), not the dollar amounts paid. The LLM's citation references (page_96, page_99, page_94) cannot be verified but appear to reference dividend payment amounts rather than dividend rights. The LLM correctly identifies that voting rights remained at one vote per share, but this is only half the answer. The core insight from the ground truth—that BOTH dividend rights AND voting rights remained unchanged, indicating a stable governance strategy—is partially lost. The LLM's interpretation that 'progressively higher dividends' represent enhanced shareholder returns is a different concept than the ground truth's focus on unchanged dividend RIGHTS. This represents a significant conceptual error in understanding what 'dividend rights' means in a governance context versus actual dividend payments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 417,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across FY 2022, FY 2023, and FY 2024 Broadcom’s Security Insights Platform is described in the same way: it “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis, with the data available for use with in‑house tools for security information and event management.” The identical wording in each 10‑K indicates that the platform’s integration with customers’ SIEM tools and its risk‑identification capabilities remained unchanged during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the Security Insights Platform description remained consistent across FY 2022, FY 2023, and FY 2024, and accurately quotes the platform's functionality regarding mainframe security posture assessment, risk identification, remediation steps, and SIEM tool integration. The dates and entities (Broadcom, Security Insights Platform) are correct. However, there are significant qualitative issues: (1) The LLM claims 'identical wording in each 10-K' which is a stronger assertion than the ground truth supports. The ground truth indicates the platform 'maintained core functionality' and 'retained the same description,' but also notes that in FY 2023 it was 'more explicitly tied to ongoing and ad hoc remediation planning,' suggesting some evolution in emphasis or description, not complete identity. (2) The LLM's conclusion that capabilities 'remained unchanged' contradicts the ground truth's nuanced observation about the FY 2023 shift toward explicit remediation planning focus. (3) The LLM provides a direct quote but doesn't adequately address the subtle evolution described in the ground truth - that while core functionality remained stable, the framing and emphasis evolved across the three years. The answer is partially correct in identifying stability but oversimplifies the narrative by claiming identical wording when the ground truth suggests more nuanced changes in how the platform was described and positioned. The multi-hop reasoning is incomplete because it doesn't capture the year-over-year evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 440,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 to 2024 AIG’s loss‑reserve risk management shifted from a largely actuarial‑control framework to a more model‑driven, risk‑specific approach.  In 2022 (p. 165‑169) the 10‑K described internal controls, actuarial profitability and reserve reviews, and “reviews by external experts” to validate reserve adequacy.  By 2023 (p. 118‑121) and 2024 (p. 86‑87) the company added sensitivity, scenario and stochastic analyses, third‑party catastrophe models, and a formal escalation process, while continuing to rely on external experts to independently assess and confirm the reserve setting process and underlying assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022-2024 as a progression toward more structured, model-driven approaches; (2) Accurately captures the key methodological shifts: internal controls/external reviews (2022) → expanded modeling techniques including stochastic/deterministic analysis (2023) → multi-tiered oversight with ERM reviews (2024); (3) Properly synthesizes the multi-hop information across three years; (4) Correctly identifies the consistent role of external experts throughout the period; (5) Page citations (165-169 for 2022, 118-121 for 2023, 86-87 for 2024) appear reasonable for 10-K documents; (6) Semantic equivalence is strong - 'actuarial-control framework' maps to internal controls/actuarial reviews, 'model-driven, risk-specific approach' captures the expansion to stochastic/deterministic modeling. MINOR WEAKNESSES: (1) The LLM characterizes the 2022 approach as 'largely actuarial-control framework' which is slightly more reductive than the ground truth's description of 'uncertainty in loss development' management - though not factually incorrect; (2) The answer mentions 'third-party catastrophe models' which is not explicitly mentioned in the ground truth, though this could represent valid detail from the actual filings; (3) The phrase 'formal escalation process' is not mentioned in the ground truth, though again this could be accurate filing detail. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple methodological dimensions, correctly identifying the progression and the consistent thread of external expert involvement. The reasoning is sound and logical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 526,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In 2022 Emerson described electrical distribution equipment as part of its Industrial Solutions product offering within the Automation Solutions segment【page_77】. By 2023 the company had repositioned that product line into the Discrete Automation segment—a sub‑segment of Automation Solutions【page_73】, and the 2024 filing retains this same classification【page_73】. This shift from a broad Industrial Solutions focus to a discrete‑automation‑centric segment underscores Emerson’s strategic emphasis on discrete automation markets, treating electrical distribution equipment as a core discrete‑automation capability.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution of Electrical Distribution Equipment across the three years (2022, 2023, 2024) and accurately captures the shift from Industrial Solutions to Discrete Automation segment. The dates and years are correct. The LLM appropriately recognizes this as a strategic repositioning toward discrete automation markets. CRITICAL ISSUES: (1) SEGMENT CLASSIFICATION ERROR: The LLM states in 2022 that Electrical Distribution Equipment was part of 'Industrial Solutions product offering within the Automation Solutions segment.' The ground truth indicates it was positioned as part of 'Industrial Solutions segment' (not as a sub-segment of Automation Solutions). This is a material distinction in how Emerson's organizational structure is characterized. (2) INCOMPLETE CONTEXTUAL DETAIL: The ground truth provides richer context about what products Electrical Distribution Equipment was grouped with in each year (fluid control and materials joining in 2022; solenoid valves and programmable automation systems in 2023; electric linear motion solutions and programmable control systems in 2024). The LLM omits these specific product groupings, which are important for understanding the 'deepening strategic focus on integrated automation solutions.' (3) DEPTH OF ANALYSIS: The ground truth emphasizes the 'continued and deepening strategic focus' and describes the 2024 positioning as showing 'a continued and deepening strategic focus on integrated automation solutions.' The LLM's analysis is more surface-level, stating the classification 'retains this same classification' without capturing the evolution in how the product was being integrated with complementary offerings. (4) MISSING SYNTHESIS: The ground truth explicitly notes the grouping with 'electric linear motion solutions and programmable control systems' in 2024, suggesting a more integrated product portfolio approach. The LLM misses this nuance. QUANTITATIVE ACCURACY: No calculations or specific financial metrics are involved, so this dimension is less critical. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM does synthesize information across three years and correctly identifies the segment transition, but fails to fully capture the evolving product groupings that demonstrate the strategic emphasis. The reasoning is partially sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 638,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s 2022, 2023 and 2024 10‑Ks all state that employees hired after 2014 are already covered by the Retirement Value formula, and that a 2021 amendment will extend that formula to all eligible U.S. non‑union employees effective Jan 1 2026—shifting the company from a dual‑formula (Final Average Pay for pre‑2015 hires) to a single, uniform Retirement Value system【page_73】【page_74】【page_76】【page_77】. This multi‑year transition reflects a long‑term workforce strategy to standardize pension benefits, simplify administration, and better manage future pension liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the key dates: 2022-2024 period, January 1, 2026 effective date, and the 2021 amendment; (2) Accurately describes the dual-formula structure (Final Average Pay for pre-2015 hires vs. Retirement Value for post-2014 hires); (3) Properly synthesizes the multi-year consistency across three 10-K filings; (4) Correctly interprets the strategic implications: standardization, administrative simplification, and liability management; (5) Provides appropriate page citations. MINOR WEAKNESSES: (1) The LLM answer states employees hired 'after 2014' are covered by Retirement Value, while the ground truth says 'regardless of hire date' the formula applies to 'all eligible employees' effective 2026—the LLM's phrasing about post-2014 hires is accurate for current coverage but could be clearer that the 2026 change applies universally; (2) The ground truth emphasizes 'consistent messaging across all three years' and 'no reversal or delay,' which the LLM captures implicitly but doesn't explicitly state the consistency finding as prominently; (3) The ground truth mentions 'broader workforce inclusivity' as a strategic element, which the LLM doesn't explicitly address, though 'standardize' implies this. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and connects the pension structure evolution to workforce strategy. The logic linking standardization to cost predictability and administration is sound. QUANTITATIVE ACCURACY: All dates and numeric references are correct (2022, 2023, 2024, 2026, 2014/2015, 2021). No calculation errors. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with slightly different emphasis but no factual contradictions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 503,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K excerpts you provided do not disclose the specific percentage of Fabric & Home Care sales that come from Downy for 2022, 2023 or 2024, so the trend in that metric cannot be determined from the available pages.  What is clear is that Downy is listed as a major brand in the Fabric & Home Care segment in each year’s MD&A, indicating it remains a key part of P&G’s portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The original answer provides specific, verifiable data: Downy's contribution to P&G's Fabric & Home Care segment was 35% in 2022 and 36% in both 2023 and 2024. The LLM claims this information is not disclosed in the 10-K excerpts and cannot be determined from available pages. This is factually wrong - the ground truth explicitly states these percentages were disclosed. The LLM's assertion that 'the trend in that metric cannot be determined' directly contradicts the documented 3-year trend showing stability (35% → 36% → 36%). While the LLM correctly identifies that Downy is listed as a major brand in the Fabric & Home Care segment, this partial correctness does not compensate for the complete failure to provide the core quantitative data requested. The question specifically asks about percentage contribution evolution from 2022-2024 and what the trend suggests about strategic importance. The LLM provides neither the percentages nor the trend analysis. The answer demonstrates a fundamental misunderstanding or inability to access/synthesize the required multi-hop financial data across the three-year period. This is a critical failure on a straightforward factual question with clear numerical answers in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 367,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from **$27.2 billion** at December 31 2022 to **$30.8 billion** at December 31 2023, then eased slightly to **$30.7 billion** at December 31 2024 (Table 8.1, 2022 & 2023 & 2024). The jump in 2023 reflects a period of debt expansion—likely to fund growth or refinance—while the modest decline in 2024 signals a shift toward more conservative debt management or a focus on reducing leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. Ground truth shows: 2022=$27,219M, 2023=$31,248M, 2024=$31,248M. LLM reports: 2022=$30.8B (correct as $30.8B≈$30,800M but this is 2023 data), 2023=$30.8B (WRONG - should be $31,248M or $31.2B), 2024=$30.7B (WRONG - should be $31,248M or $31.2B). The LLM fundamentally misrepresents the 2023-2024 values, showing a decline from $30.8B to $30.7B when ground truth shows the values remained flat at $31,248M. This is a major factual error. Additionally, the LLM's interpretation of the trend is incorrect: it suggests a 'modest decline in 2024' when the ground truth shows 2023 and 2024 had identical values ($31,248M), indicating a plateau rather than decline. The 2022 figure of $27.2B is approximately correct (ground truth $27,219M), but the subsequent years are materially wrong. The reasoning about debt expansion in 2023 and conservative management in 2024 is contradicted by the actual data showing flat values 2023-2024. The LLM failed to accurately synthesize the multi-hop data across the three-year period, resulting in an incorrect characterization of the company's debt financing strategy. The citation to 'Table 8.1' appears fabricated or misidentified. POSITIVE: The answer correctly identifies Capital One (COF), addresses the time period, and attempts to provide strategic interpretation. However, the numerical errors are too severe to overlook.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 412,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 and 2023, T maintained a 41.3 % ownership stake in SKY Mexico, which was accounted for under the equity‑method (page 66, page 93). In June 2024 it sold that 41.3 % interest, thereby exiting the investment (page 66). This 3‑year path—holding the stake, using equity‑method accounting, and then divesting—underscores T’s broader strategy of shedding Latin‑American pay‑TV assets (e.g., the Vrio sale in 2021) to refocus on core businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core elements of the question. STRENGTHS: (1) All key numeric values are accurate: 41.3% ownership stake is correct, June 2024 exit date is correct. (2) The equity method accounting treatment is correctly identified for 2022-2023. (3) The multi-hop synthesis is sound: the answer traces the 3-year trajectory from holding the stake through equity method accounting to divestiture. (4) The strategic context is appropriately captured—the answer correctly identifies this as part of T's broader Latin American pay-TV exit strategy and references the Vrio sale in 2021 as supporting evidence. (5) Page citations (66, 93) add credibility. MINOR WEAKNESSES: (1) The answer is slightly less detailed than the ground truth in describing the 2023 positioning (ground truth mentions SKY Mexico was listed among T's key equity method investments alongside DIRECTV and Gigapower, providing more context about T's investment portfolio). (2) The phrase 'shedding Latin-American pay-TV assets' is accurate but slightly less precise than the ground truth's 'exit non-core international assets and focus on core domestic operations.' (3) The answer could have been more explicit about the 'holding steady' characterization in 2022 (though this is implied). CALCULATION/FACT VERIFICATION: All numbers check out—41.3% is consistent across all years, June 2024 is the correct exit date, equity method accounting is correctly applied to 2022-2023 period. The reasoning chain (hold → equity method → divest) is logically sound and reflects the actual 3-year trajectory. The answer successfully synthesizes information across multiple years and connects it to broader strategic themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 469,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s 10‑K risk‑factor disclosures on capital‑return constraints have remained essentially unchanged, consistently stating that the Board’s discretion to return capital is limited by U.S. banking laws, capital‑planning rules, Delaware law, and the obligation to pay dividends on preferred stock (BK_10k_2022 page_5; BK_10k_2023 page_7; BK_10k_2024 page_7). The 2024 filing reiterates the same language but adds a brief reference to maintaining “well‑capitalized” status and capital‑adequacy/liquidity rules, underscoring the unchanged regulatory emphasis while keeping the dividend‑policy language unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant gaps and mischaracterizations compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies BNY Mellon as the subject company\n2. Correctly identifies the 2022-2024 timeframe\n3. Correctly notes that capital return constraints are governed by U.S. banking laws, capital-planning rules, and Delaware law\n4. Correctly identifies preferred dividend obligations as a constraint\n5. Page references appear plausible (though not verified against actual filings)\n\nSIGNIFICANT ERRORS AND OMISSIONS:\n1. MISCHARACTERIZATION OF EVOLUTION: The LLM states disclosures \"remained essentially unchanged\" and \"reiterates the same language,\" directly contradicting the ground truth which explicitly states the language \"evolved\" with \"expanding\" risk discussions and \"increasing contextual complexity.\"\n\n2. MISSING KEY 2023 DEVELOPMENTS: The ground truth specifically notes that 2023 saw expansion of risk discussion to include \"ESG-related regulatory pressures\" and \"impact of new strategic initiatives on capital allocation.\" The LLM completely omits these important developments.\n\n3. MISSING KEY 2024 DEVELOPMENTS: The ground truth emphasizes that 2024 added \"emphasis on the Parent company's reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning.\" The LLM mentions only a vague reference to \"well-capitalized\" status without capturing the strategic transformation context.\n\n4. INCOMPLETE SYNTHESIS: The question asks specifically about evolution \"particularly in relation to regulatory requirements, dividend policies, and capital adequacy.\" While the LLM touches on these, it fails to capture how they evolved across the three-year period. The ground truth shows a progression from basic regulatory constraints (2022) → expanded ESG/strategic context (2023) → strategic transformation impact (2024).\n\n5. TONE MISMATCH: The LLM's conclusion that disclosures show \"unchanged regulatory emphasis\" contradicts the ground truth's finding of \"stable regulatory framework with increasing contextual complexity.\" These are semantically different - one suggests stagnation, the other suggests evolution within stability.\n\nQUANTITATIVE ACCURACY: The page numbers provided (page_5 for 2022, page_7 for 2023 and 2024) cannot be verified but appear internally consistent. No calculations are required for this question.\n\nMULTI-HOP REASONING: The LLM failed to synthesize the evolution across three years. It treated the three years as essentially identical rather than identifying the progression of disclosure complexity noted in the ground truth.\n\nCONCLUSION: While the LLM correctly identifies basic facts about capital return constraints, it fundamentally mischaracterizes the nature of the evolution (claiming no change when there was increasing complexity) and omits critical contextual developments in 2023 and 2024 related to ESG pressures, strategic initiatives, and subsidiary dividend reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 804,
        "total_tokens": 2219
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "From 2022 through 2024 3M kept structural adhesives in the Safety and Industrial segment, but in 2024 it moved the line from the standalone Industrial Adhesive & Tapes division into a new Industrial Specialties division that also houses closure and masking systems, personal‑safety products and other industrial specialty items. This bundling—integrating adhesives with complementary sealing, bonding and safety solutions—highlights how 3M views adhesives as a core enabler that underpins a broad range of industrial applications, from construction and automotive repair to packaging and personal protection.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims that in 2024, structural adhesives 'moved from the standalone Industrial Adhesive & Tapes division into a new Industrial Specialties division.' The ground truth explicitly states that structural adhesives remained 'a core part of the Safety and Industrial segment' throughout 2022-2024, with no mention of a divisional reorganization or movement to a new division. This is a fundamental mischaracterization of the evolution. (2) ENTITY CONFUSION: The LLM introduces 'Industrial Adhesive & Tapes division' and 'Industrial Specialties division' as distinct entities, but the ground truth consistently references the 'Safety and Industrial segment' as the consistent home for structural adhesives across all three years. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that adhesives were bundled with complementary products and that this reflects strategic positioning, it misrepresents the nature and timing of this bundling. The ground truth shows evolution within the same segment (2022: with abrasives/autobody/electrical; 2023: similar with expanded packaging emphasis; 2024: with specialized industrial/construction materials), not a divisional move. (4) REASONING FLAW: The LLM's conclusion about adhesives as 'core enabler' is reasonable but is built on an incorrect structural premise about organizational changes. (5) MISSING CONTEXT: The LLM fails to capture the nuanced evolution described in the ground truth—the shift from metalworking/OEM emphasis (2022) to more specialized industrial applications (2024). The answer demonstrates partial understanding of the strategic role but fundamentally misrepresents the organizational structure and evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 492,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024 Lilly kept Cyramza’s therapeutic portfolio unchanged—monotherapy or combination second‑line therapy for gastric, gastro‑esophageal junction, NSCLC, colorectal, and hepatocellular carcinoma, plus first‑line EGFR‑mutated NSCLC (page 6).  However, the company’s IP strategy shifted: the compound patents remain in force until 2026 in the U.S. and Japan and 2028 in major European countries, while data‑protection exclusivity in those European markets expires in 2024 and in Japan in 2023 (page 11).  This evolution signals a focus on extending exclusivity in the U.S. and Europe while anticipating biosimilar competition in Japan and Europe once data protection lapses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and specific response than the ground truth, but contains significant factual discrepancies that undermine its accuracy. STRENGTHS: (1) Correctly identifies therapeutic indications (gastric, gastro-esophageal junction, NSCLC, colorectal, hepatocellular carcinoma) and their consistency across 2022-2024; (2) Appropriately addresses both therapeutic positioning and IP strategy components; (3) Correctly identifies Japan data protection expiration in 2023 and European expiration in 2024; (4) Properly synthesizes the multi-hop relationship between therapeutic indications and IP protections. CRITICAL ERRORS: (1) COMPOUND PATENT DATES - LLM states compound patents remain in force until 2026 in U.S./Japan and 2028 in Europe. Ground truth only mentions U.S. biologics data protection expiring in 2026, with no mention of 2028 European patent expiration or 2026 Japan patent expiration. This is a significant factual error on patent timelines; (2) The LLM conflates 'compound patents' with 'data protection exclusivity' - these are distinct IP mechanisms with different expiration dates. Ground truth clearly separates data protection expirations (2023 Japan, 2024 Europe, 2026 U.S.) from patent protections; (3) The statement about 'compound patents remain in force until 2026 in Japan' contradicts the ground truth's emphasis on Japan data protection expiring in 2023. QUANTITATIVE ACCURACY ISSUES: The patent expiration dates (2026 U.S./Japan, 2028 Europe) appear to be inaccurate or unsupported by the ground truth. The data protection dates (2023 Japan, 2024 Europe) are correct. REASONING: The LLM demonstrates sound multi-hop reasoning by connecting therapeutic indications to IP strategy and market competition implications, but the factual foundation is compromised by incorrect patent dates. The conclusion about 'extending exclusivity in the U.S. and Europe while anticipating biosimilar competition in Japan and Europe' is logically sound but based on partially incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 547,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from a carrying value of **$19.975 billion** at 12/31/2022 (weighted‑average rate **2.91 %**) to **$27.168 billion** at 12/31/2023 (4.45 %) and then fell modestly to **$26.930 billion** at 12/31/2024 (4.84 %). The steady rise in the weighted‑average rate, coupled with the peak in carrying value in 2023, indicates the firm has been issuing newer, higher‑rate debt—likely to refinance maturing obligations or fund growth—while the slight drop in 2024 suggests some repayment or refinancing at a marginally lower rate. Overall, the trend points to a gradual increase in financing costs as Capital One adjusts its debt mix in a tightening interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct: 2022 carrying value of $19.975 billion (matches $19,975 million), 2022 rate of 2.91% (correct), 2023 carrying value of $27.168 billion (not in ground truth but appears accurate based on progression), 2023 rate of 4.45% (reasonable intermediate value), 2024 carrying value of $26.930 billion (matches $26,930 million exactly), and 2024 rate of 4.84% (matches exactly). The format variation ($19.975 billion vs $19,975 million) is acceptable. MULTI-HOP SYNTHESIS: The answer correctly synthesizes three years of data (2022-2024) and identifies the key trend: carrying value increased overall from 2022 to 2024 while weighted-average rates rose consistently. The intermediate 2023 data point (not explicitly in ground truth but logically consistent) adds valuable context showing the peak in carrying value occurred in 2023 before a modest decline in 2024. REASONING QUALITY: The interpretation is sound—the answer correctly identifies this as a strategic shift toward higher-rate debt issuance, likely reflecting market conditions and refinancing activities. The explanation of the 2024 decline as \"some repayment or refinancing at a marginally lower rate\" is reasonable inference. The conclusion about \"tightening interest-rate environment\" appropriately contextualizes the rising rates. COMPLETENESS: The answer addresses all aspects of the question: carrying value evolution, weighted-average interest rate evolution, and strategic implications. The multi-year trend analysis is thorough. MINOR CONSIDERATION: The ground truth answer is more concise and focuses on the 2022-2024 endpoints, while the LLM answer provides additional 2023 intermediate data. This is not an error but rather an enhancement that provides more complete information. The slight semantic difference in phrasing (\"gradual increase in financing costs\" vs \"strategic shift\") is complementary rather than contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 550,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024.  The fair‑value impact swung from a $92‑million loss in FY 2022 to gains of $157 million in FY 2023 and $91 million in FY 2024, showing that the instrument’s value can move sharply in either direction.  This pattern highlights the high volatility of the swaps’ fair‑value changes over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error in the FY 2023 gain figure. Ground truth states a gain of $58 million in FY 2023, but the LLM reports $157 million - a discrepancy of $99 million. This is a material error that substantially undermines the answer's credibility. The FY 2022 loss of $92 million and FY 2024 gain of $91 million are correctly stated. ADDITIONAL ISSUES: The LLM introduces notional exposure amounts ($651M, $792M, $985M) that are not mentioned in the ground truth answer. While these figures may be accurate from the source documents, they represent additional information beyond what the ground truth synthesized, and their inclusion doesn't address the core question about gains/losses evolution. The ground truth focuses specifically on the P&L impact (gains/losses), not notional amounts. STRENGTHS: The LLM correctly identifies the three-year period (FY 2022-2024), correctly names Cisco, correctly identifies the instrument as Total Return Swaps tied to Deferred Compensation, and appropriately characterizes the pattern as volatile with swings between losses and gains. The reasoning about volatility is sound and relevant. MULTI-HOP SYNTHESIS: The answer demonstrates understanding that this requires synthesizing data across three fiscal years and comparing the pattern, which is correct. However, the factual error in one of the three key data points (FY 2023) represents a failure in accurate data extraction/synthesis. The $99 million discrepancy in FY 2023 is not a rounding or formatting difference - it's a fundamental factual error that would mislead stakeholders about the actual financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 457,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "In 2022, Home Depot’s strategy centered on “store refresh packages” and visual‑merchandising upgrades to improve the look and feel of its retail locations (page 8).  By 2024 the focus had broadened to a full‑store‑experience program that added way‑finding signage, electronic shelf labels, curb‑side pickup, self‑service lockers and mobile‑app navigation, all aimed at making the in‑store visit more seamless (page 10).  These investments translated into measurable gains—higher customer‑satisfaction scores in 2024 and a strong share of online orders fulfilled through stores (≈50 % in 2024 versus 55 % in 2022, page 11)—helping Home Depot maintain a competitive edge over multichannel and online rivals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific percentages (≈50% in 2024 vs 55% in 2022) that are NOT present in the ground truth answer. These appear to be fabricated metrics with no supporting evidence from the knowledge graph. The direction of change (55% to 50%) also contradicts the claim of 'measurable gains.' (2) FACTUAL INACCURACIES - The ground truth makes no mention of 'store refresh packages,' 'way-finding signage,' 'electronic shelf labels,' 'curb-side pickup,' or 'self-service lockers' as specific 2022-2024 initiatives. The LLM appears to have invented specific tactical details not supported by the source material. (3) INCOMPLETE SYNTHESIS - While the LLM attempts to address the evolution from 2022-2024, it fails to capture the ground truth's key insight: the strategic pivot from standalone in-store experience to a hybrid omnichannel model. The ground truth emphasizes integration with digital capabilities (faster delivery, pickup options, mobile platforms, in-store digital tools) as the core evolution, not just physical store improvements. (4) MISSING 2023 CONTEXT - The ground truth explicitly discusses 2023 as a transitional year where store appearance became 'increasingly tied to a broader interconnected retail strategy.' The LLM jumps from 2022 to 2024, missing this important intermediate evolution. (5) CONTRADICTORY METRICS - The claim of 'higher customer-satisfaction scores in 2024' is unsupported by the ground truth, which does not provide specific satisfaction metrics. The online fulfillment percentages appear fabricated. (6) REASONING QUALITY - While the LLM attempts multi-hop reasoning, it does so based on invented data points rather than actual filing information, fundamentally undermining the analysis. The core strategic insight about omnichannel integration versus online-only competition is largely absent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 511,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 have carried a constant $2,000 million balance: $2,000 million in FY 2022, $2,000 million in FY 2023, and $2,000 million in FY 2024 (see the 2024 10‑K table for FY 2024). This unchanged carrying amount shows that NVIDIA has neither issued additional amounts nor repaid any of this long‑term debt, underscoring a stable long‑term debt profile and a consistent financing strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ERRORS - The LLM states the carrying value was constant at $2,000 million across all three years (FY 2022, FY 2023, FY 2024), but the ground truth shows: FY 2022: $2,147 million, FY 2023: $1,637 million, FY 2024: $2,000 million. The LLM got FY 2024 correct ($2,000M) but completely misrepresented FY 2022 ($2,000M vs. actual $2,147M) and FY 2023 ($2,000M vs. actual $1,637M). These are material errors in financial data. (2) MULTI-HOP SYNTHESIS FAILURE - The question explicitly asks about the evolution/progression from 2022 through 2024. The ground truth shows a clear pattern: decline from $2,147M to $1,637M (a $510M decrease), then recovery to $2,000M. The LLM completely missed this dynamic evolution and incorrectly characterized the debt as 'unchanged' and 'constant.' (3) REASONING QUALITY - The LLM's conclusion that 'NVIDIA has neither issued additional amounts nor repaid any of this long-term debt' is contradicted by the actual carrying value changes. The ground truth explicitly notes 'temporary reduction in the short term, followed by a strategic repositioning,' which the LLM entirely missed. (4) ENTITY/METRIC ACCURACY - While the company (NVIDIA) and instrument (3.50% Notes Due 2050) are correctly identified, the financial metrics (carrying values) are substantially wrong for 2 of 3 years. This is a critical failure for a financial question requiring precise numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 411,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022‑2024, 3M’s Scotchgard litigation broadened geographically—new suits were filed in Michigan, Alabama, and Georgia alleging improper disposal of Scotchgard and other PFAS products【page_95】【page_98】.  The cases now involve 3M plus a growing roster of co‑defendants—including DuPont, Chemours, Wolverine, and various carpet, paper, and textile manufacturers—yet no new settlements specific to Scotchgard were reported during this period; the broader PWS Settlement for water‑system claims was approved in 2024, leaving Scotchgard cases pending【page_97】【page_98】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and inaccuracies when compared to the ground truth. CORRECT ELEMENTS: (1) Geographic expansion to Michigan, Alabama, and Georgia is accurate; (2) Multiple co-defendants including DuPont, Chemours, and Wolverine are correctly identified; (3) The general characterization of growing litigation complexity is appropriate. CRITICAL OMISSIONS AND ERRORS: (1) The LLM completely fails to mention the 2022 Baker case settlement for $65 million involving 3M, Saint-Gobain, and Honeywell—a major quantifiable settlement that directly answers the 'case settlements' part of the question; (2) The 2023 Michigan settlement involving Wolverine World Wide is not mentioned, despite being explicitly part of the ground truth timeline; (3) The LLM states 'no new settlements specific to Scotchgard were reported during this period,' which directly contradicts the ground truth showing two settlements (2022 Baker case and 2023 Michigan case); (4) The answer mentions a 'broader PWS Settlement for water-system claims approved in 2024' but this is not part of the ground truth answer about Scotchgard litigation specifically; (5) Specific plaintiffs mentioned in ground truth (municipal water utilities, individual landowners, Mohawk Industries) are not identified in the LLM answer. QUANTITATIVE ACCURACY: The LLM provides no specific dollar amounts or settlement figures, missing the $65 million Baker settlement entirely. This is a major factual gap for a question specifically asking about settlements. MULTI-HOP REASONING: The LLM fails to synthesize the complete timeline of settlements and litigation expansion. It addresses geographic expansion and defendant involvement but misses the critical settlement component that shows how legal exposure evolved. The answer is incomplete in addressing all three sub-questions (settlements, geographic expansion, number of defendants). SEMANTIC ISSUES: The statement about 'no new settlements' is factually incorrect based on ground truth, representing a fundamental error rather than a wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 568,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From 2022 through 2024 the AbCellera collaboration kept a tiered royalty structure of mid‑teens to mid‑twenties on worldwide net sales of bamlanivimab and bebtelovimab, with royalty payments recorded as cost of sales (page 73, 2022 10‑K; page 73, 2024 10‑K). No milestone payments were reported for AbCellera during this period (page 73, 2024 10‑K). Net product revenue fell sharply from $2.02 billion in 2022 to $0 in both 2023 and 2024, reflecting the cessation of EUA‑driven sales (page 73, 2024 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All quantitative data is correct - $2.02 billion in 2022 revenue, $0 in 2023 and 2024 are accurate; (2) Royalty structure correctly identified as tiered mid-teens to mid-twenties on worldwide net sales; (3) Correctly notes no milestone payments were made during the period; (4) Properly synthesizes the multi-hop information showing the evolution from 2022-2024; (5) Accurately identifies the products (bamlanivimab and bebtelovimab) and the reason for cessation (EUA-driven sales ending); (6) Correctly cites page references to 10-K filings; (7) Semantic equivalence is maintained - 'cessation of commercial activity' and 'cessation of EUA-driven sales' convey the same meaning as the ground truth's 'complete cessation of commercial activity.' MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific than ground truth by naming the actual products (bamlanivimab and bebtelovimab) and explaining the EUA context, which adds helpful detail without contradicting the ground truth; (2) The answer is well-structured and clearly presents the evolution across the three-year period. The answer fully addresses all components of the question: financial terms (royalty structure), commercial performance (revenue trajectory), milestone payments (none), and the evolution across the specified time period. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 420,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Dawn has stayed a core brand in P&G’s Fabric & Home Care segment.  Across the 2022‑24 filings the brand is listed among the segment’s major brands (Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) and the segment’s share of net sales rose from 35 % in 2022 to 36 % in 2024, while its share of net earnings climbed from 31 % to 34 %.  This steady positioning and the segment’s incremental growth show that Dawn remains a strategically important, growth‑driving product in P&G’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - Fabric & Home Care segment net sales share: 35% (2022) → 36% (2024); net earnings share: 31% (2022) → 34% (2024). The LLM correctly identifies the incremental growth trajectory. ENTITY ACCURACY: Correctly identifies P&G, Fabric & Home Care segment, Dawn, and lists other major brands in the segment accurately. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and connects segment performance metrics to Dawn's strategic positioning. The logic is sound: consistent brand listing + segment growth = strategic importance. COMPLETENESS: Addresses both parts of the question - how positioning evolved (remained consistent/core) and what it reveals about strategic importance (growth-driving, strategically important). MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer is slightly more concise and uses slightly different phrasing ('growth-driving product' vs. 'core contributor'), but these are semantic variations that don't affect factual accuracy. The LLM also explicitly lists peer brands, which adds helpful context not in the ground truth but doesn't contradict it. The characterization of the segment's growth as 'incremental' is appropriate given the 1 percentage point increase in net sales share and 3 percentage point increase in earnings share. No calculation errors detected. The answer correctly conveys that Dawn's positioning remained stable and strategically important throughout the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 432,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt declined from $47.8 billion in 2022 to $49.3 billion in 2023 and then to $44.9 billion in 2024 (Table 9.1 2024; Table 8.1 2023). Over the same period, floating‑unsecured senior debt was cut from $1.6 billion in 2022 to $349 million in 2023 and eliminated by 2024, reflecting a shift away from floating‑rate debt toward higher‑rate fixed‑rate debt and a rise in the weighted‑average interest rate (2.76%→4.48%→4.84%). This trend reduces floating‑rate exposure but increases fixed‑rate exposure and overall debt cost.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that undermine its credibility. (1) TOTAL DEBT FIGURES: Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), $45.551B (2024). The LLM provides component breakdowns ($883M + $47.8B = $48.683B for 2022; $538M + $49.3B = $49.838B for 2023; $562M + $44.9B = $45.462B for 2024) that don't align with ground truth totals. The 2022 figure is off by ~$0.6B, 2023 by ~$1.1B, and 2024 by ~$0.1B. These are material discrepancies. (2) FLOATING UNSECURED SENIOR DEBT: LLM states $1.6B (2022) vs. ground truth $1.709B - a $109M error. The 2023 figure of $349M matches ground truth exactly. The 2024 elimination is correct. (3) WEIGHTED-AVERAGE INTEREST RATES: LLM shows 2.76%→4.48%→4.84% vs. ground truth 2.91%→4.45%→4.84%. The 2022 rate is off by 15 basis points (2.76% vs 2.91%), and the 2023 rate is off by 3 basis points (4.48% vs 4.45%). While the 2024 rate is correct, the cumulative errors suggest data extraction problems. (4) MULTI-HOP REASONING: The LLM correctly identifies the strategic shift from floating to fixed-rate debt and recognizes the interest rate trend implications. The synthesis of debt composition changes with interest rate movements is sound. However, the numerical foundation is compromised. (5) COMPLETENESS: The LLM addresses all required elements (short-term borrowings, long-term debt, floating unsecured senior debt, interest rates, and trend analysis), but the accuracy of the underlying numbers is insufficient. The answer demonstrates understanding of the question's multi-hop nature but fails on the quantitative precision required for financial analysis. The 3-year trend narrative is directionally correct but built on flawed numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 491,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a $2 billion principal and an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024 (see the long‑term debt tables on page 89 for each year).  As Cisco issued additional debt—most notably the $13.5 billion senior notes in 2024—the 5.90% note’s share of total debt fell from roughly 23 % of long‑term debt in FY 2022 to about 10 % in FY 2024, reflecting a larger overall debt base.  The note remained classified as long‑term debt throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key claims: (1) Principal amount: LLM correctly states $2 billion maintained across FY 2022-2024, matching ground truth of $2,000 million. (2) Effective interest rate: LLM correctly identifies 6.11% throughout the period, matching ground truth exactly. (3) Debt composition shift: LLM provides specific percentages (23% in FY 2022 declining to 10% in FY 2024) which logically align with ground truth data showing long-term debt growing from $8,416M to $19,621M. Calculation verification: $2,000M / $8,416M ≈ 23.8% (rounds to ~23%), and $2,000M / $19,621M ≈ 10.2% (rounds to ~10%), confirming LLM's percentage calculations are accurate. (4) Classification: LLM correctly notes the note remained classified as long-term debt throughout. (5) Additional context: LLM provides valuable supplementary detail about the $13.5 billion senior notes issued in 2024, which explains the debt expansion and strengthens the multi-hop reasoning. The answer addresses all three sub-questions (total debt composition, effective interest rate, long-term debt classification) with sound synthesis across the three-year period. Minor note: LLM uses '$2 billion' while ground truth uses '$2,000 million'—this is a standard format variation and not an error. The answer is well-structured, cites sources (page 89), and demonstrates clear understanding of how the note's relative importance diminished as Cisco's overall debt portfolio expanded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 411,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "From 2022 through 2024 NVIDIA’s 1.55% Notes Due 2028 held a carrying value that rose only modestly—from roughly $1.10 billion in 2023 (fair‑value table) to $1.25 billion in 2024 (debt schedule, page 72)—while the effective interest rate stayed consistently low at 1.64% (page 72).  The steady balance and low rate show that NVIDIA is deliberately issuing long‑term debt at attractive, stable rates and keeping the debt level predictable, underscoring a disciplined, low‑cost long‑term financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the carrying value progression. Ground truth shows: FY2022: $1,200M → FY2023: $1,099M → FY2024: $1,250M. The LLM answer omits the FY2022 figure entirely ($1,200M) and incorrectly states the 2023 value as 'roughly $1.10 billion' (should be $1,099M, which is close but presented without the full 2022 baseline). More problematically, the LLM claims the effective interest rate 'stayed consistently low at 1.64%' throughout the period, when ground truth indicates it increased FROM an implied rate in 2022 TO 1.64% in 2024—this is a material misrepresentation of the trend. The LLM fails to capture the key insight that the effective rate INCREASED over time, which is central to understanding the company's financing strategy in a changing interest rate environment. MULTI-HOP SYNTHESIS ISSUES: The answer does not properly synthesize the three-year trend (2022-2024) as required by the question. It jumps from 2023 to 2024 without establishing the full trajectory. The reasoning about 'deliberately issuing long-term debt at attractive, stable rates' contradicts the ground truth finding that rates actually increased from 2022 to 2024. COMPLETENESS: The answer addresses the carrying value and effective interest rate but fails to properly characterize the evolution/trend across all three fiscal years. The strategic interpretation is partially correct (disciplined financing) but based on incomplete/incorrect data about rate stability. POSITIVE ASPECTS: The answer correctly identifies the 2024 carrying value ($1.25B) and effective rate (1.64%), and the general characterization of NVIDIA's disciplined debt management approach has merit, though it's undermined by the factual errors about rate trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 491,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "Google kept Pixel device sales in the same “devices” line of its Google Services revenue from 2022 through 2024 – first described in 2022 as part of its growing hardware family (Pixel 5a 5G, Pixel 6, etc.) and later reiterated in 2023 (Google subscriptions, platforms, and devices) and 2024 (devices, primarily Pixel sales)【page_7】【page_33】【page_59】.  While the revenue category stayed unchanged, the company’s 2024 10‑K shows a sharp rise in capital‑expenditure on property and equipment (from $31.5 bn in 2022 to $52.5 bn in 2024) and a continued emphasis on new Pixel models and AI‑driven hardware, underscoring a growing strategic focus on Pixel devices as a long‑term innovation and revenue driver【page_57】【page_7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Pixel devices remained in the same revenue categorization across 2022-2024, which aligns with the ground truth. It appropriately notes the evolution from hardware investment focus to a mature product line. The answer demonstrates good multi-hop synthesis by connecting revenue categorization with capital expenditure trends and AI-driven innovation. The contextual framing about Pixel's strategic importance is relevant and well-articulated.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific capex numbers ($31.5B in 2022 to $52.5B in 2024) that cannot be verified against the ground truth provided. While these numbers may be accurate from the 10-K filings, they represent unverified claims in this evaluation context. The ground truth does not provide these specific figures, making it impossible to confirm accuracy. This is a significant issue for a financial evaluation where precision is critical.\n\nWEAKNESSES - QUALITATIVE: The LLM answer states Pixel devices were in 'Google Services revenue' in 2022, but the ground truth indicates they were listed among key devices without explicit segment categorization in 2022. The ground truth shows the explicit 'devices' segment categorization emerged in 2023, not 2022. This represents a subtle but important distinction in the evolution narrative. The LLM also uses the phrase 'devices, primarily Pixel sales' for 2024, which is slightly different from the ground truth's description of 'Subscriptions, Platforms, and Devices' segment.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects revenue categorization with capital expenditure and AI innovation strategy. However, the reasoning about the 2022-2023 transition could be more precise regarding when the explicit 'devices' segment categorization actually occurred.\n\nOVERALL ASSESSMENT: The answer captures the essential narrative of Pixel's evolution and strategic importance, but the unverified capex figures and slight mischaracterization of 2022 categorization prevent a higher score. The core insight about transformation from investment focus to mature product line is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 589,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K Item 14 has been identical in 2022, 2023 and 2024: each filing states that the required information is in the proxy under “Item 3 – Ratification of KPMG LLP” and cites KPMG’s PCAOB firm ID 185. The unchanged wording and continued reference to the same ratification section show that the firm has retained KPMG as its principal accountant without any change in auditor or fee structure, underscoring a stable audit relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core finding that BNY Mellon maintained a stable audit relationship with KPMG LLP across 2022-2024 with consistent disclosure language. STRENGTHS: (1) Correctly identifies KPMG LLP as the principal accountant across all three years; (2) Accurately cites PCAOB firm ID 185; (3) Correctly notes the identical/unchanged nature of disclosures across the three-year period; (4) Properly synthesizes the multi-hop information (disclosure consistency → audit relationship stability); (5) Appropriately references Item 14 of 10-K and Item 3 of Proxy, showing understanding of filing structure. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'fee structure' that is not explicitly confirmed in the ground truth answer - while this is a reasonable inference from consistency, it goes slightly beyond what the ground truth explicitly states; (2) The ground truth emphasizes 'by reference' incorporation in the Proxy, while the LLM answer focuses on Item 14 of the 10-K referencing the Proxy - both are correct but represent slightly different framing of the same disclosure mechanism; (3) The LLM answer could have been more explicit about the 'by reference' language mentioned in the ground truth. QUANTITATIVE VERIFICATION: The PCAOB ID 185 is correct; the three-year period (2022, 2023, 2024) is correct; no calculations are required. MULTI-HOP REASONING: The answer correctly synthesizes that consistent disclosure language across multiple years indicates stable audit relationship - this logical connection is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with only minor variations in emphasis and framing rather than substantive factual differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 484,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Across the three reporting years, LLY’s pension plan held roughly $13.2 billion in private‑alternative investments in 2022, rose to $13.71 billion in 2023, and then settled at $13.66 billion in 2024—an overall increase of about $500 million followed by a modest $50 million decline, keeping the allocation near 80 % of the plan’s assets. This steady, high‑level exposure to hedge funds, equity‑like funds, real estate, and other private alternatives underscores the company’s long‑term strategy of maintaining a substantial illiquid asset allocation to diversify risk and pursue moderate‑to‑high long‑term returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) QUANTITATIVE FAILURES: Ground truth shows 2022: $10,542.5M, 2023: $10,335.2M, 2024: $10,051.0M. LLM reports 2022: $13.2B ($13,200M), 2023: $13.71B ($13,710M), 2024: $13.66B ($13,660M). These are approximately 25-35% higher than actual values - a massive discrepancy, not a minor formatting difference. (2) DIRECTIONAL ERROR: Ground truth shows a DECLINING trend (10,542.5 → 10,335.2 → 10,051.0), but LLM describes an INCREASING trend (13.2B → 13.71B → 13.66B). This is a fundamental misrepresentation of the multi-year trajectory. (3) CALCULATION ERROR: LLM claims 'overall increase of about $500 million followed by a modest $50 million decline' based on incorrect numbers. The actual trajectory is a consistent decline of ~$491.5M (2022-2023) and ~$284.2M (2023-2024). (4) PERCENTAGE CLAIM: LLM states allocation is 'near 80% of the plan's assets' - this contextual claim cannot be verified against ground truth and appears unsupported. (5) MULTI-HOP SYNTHESIS: While the LLM correctly identifies this as pension plan data and mentions relevant asset categories (hedge funds, equity-like funds, real estate), the core numerical synthesis is completely wrong. The answer demonstrates a fundamental failure to accurately extract and report the actual allocation figures from the source documents. This is not a semantic or wording issue - the numbers are materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 416,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Across 2022, 2023 and 2024 Tampax stayed in the same place in P&G’s portfolio: it is listed as a major brand under the Baby, Feminine & Family Care segment, within the Feminine Care sub‑category of Menstrual Care (alongside Adult Incontinence). The MD&A tables for each year (2022 page 18, 2023 page 18, 2024 page 18) show Tampax (Tampax Bounty) consistently as a key brand, with no re‑classification or shift in product‑line emphasis over the three years.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every key point. Specific errors: (1) CATEGORY CLASSIFICATION: The LLM claims Tampax remained in 'Feminine Care' sub-category throughout all three years with no reclassification. Ground truth shows: 2022 = 'Feminine Care', 2023 = transition to 'Menstrual Care' (explicit replacement), 2024 = 'Menstrual Care'. This is a critical factual error - there WAS a reclassification from 'Feminine Care' to 'Menstrual Care' between 2022-2023. (2) SEGMENT COMPOSITION: The LLM incorrectly states Adult Incontinence remained grouped with Tampax throughout. Ground truth shows that by 2024, 'Baby Care' was removed entirely from the segment, signaling a strategic shift. The LLM missed this structural change. (3) SALES CONTRIBUTION: The LLM provides no sales percentages. Ground truth shows: 2022 = 25% of net sales, 2023 = 24% of net sales, 2024 = 24% of net sales. The LLM completely omitted these quantitative metrics. (4) STRATEGIC EVOLUTION: The LLM claims 'no re-classification or shift in product-line emphasis' - this directly contradicts the ground truth which explicitly documents the evolution from 'Feminine Care' to 'Menstrual Care' nomenclature and the removal of Baby Care, representing a strategic shift toward feminine and family care products away from infant lines. (5) MULTI-HOP SYNTHESIS: The question asks about evolution ACROSS three years - the LLM failed to synthesize the temporal progression and instead claimed static positioning. The ground truth demonstrates clear evolution that the LLM completely missed. The LLM answer appears to conflate or misread the data, claiming consistency where the ground truth shows deliberate strategic repositioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 477,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) fair‑value rose from $19 million at Dec 31 2022 to $58 million at Dec 31 2023 and to $69 million at Dec 31 2024, reflecting a growing derivative portfolio.  The valuation method remained a discounted‑cash‑flow model throughout, with vendor‑based pricing and significant unobservable inputs; the key unobservable input for the derivative portfolio was swap rates, whose weighted average stayed at roughly 4 % (range 3‑5 % in 2023, 4 % in 2024).  Default rates were not a primary input for the derivative assets, but were used for retained interests in securitizations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 2024 fair value as $69 million, but the ground truth states it remained at $58 million. This is a significant factual error ($11 million discrepancy). The 2022 ($19M) and 2023 ($58M) figures are correct. (2) DEFAULT RATES MISCHARACTERIZATION - The LLM states 'Default rates were not a primary input for the derivative assets, but were used for retained interests in securitizations.' This directly contradicts the ground truth, which explicitly states that in 2023-2024, default rates ranging from 53-163% were key unobservable inputs for the derivative valuation. This is a fundamental misunderstanding of the valuation methodology. (3) SWAP RATES - The LLM correctly identifies the 3-5% range for 2023 and mentions 4% for 2024, which aligns with ground truth. (4) VALUATION METHOD - The LLM correctly identifies discounted cash flow models as the valuation technique, which matches the ground truth starting in 2023. (5) MULTI-HOP SYNTHESIS - The answer fails to properly synthesize the evolution of valuation practices from 2022 to 2024. The ground truth emphasizes a 'shift toward more transparent and methodologically consistent valuation practices starting in 2023,' which the LLM does not capture. (6) MISSING CONTEXT - The LLM fails to mention the net unrealized loss of $20 million in 2022 and does not adequately explain the progression of disclosure practices. The answer demonstrates partial understanding but contains material factual errors that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 428,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments produced a $9 gain to other income (loss), net in fiscal 2022, but turned into $21 and $67 losses in fiscal 2023 and 2024, respectively, driving a $76 decline in that metric over the period. This shift shows the portfolio’s performance deteriorated, with mounting unrealized losses and a higher credit/market‑risk profile as interest rates rose and credit quality slipped.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims specific dollar amounts ($9 gain in 2022, $21 loss in 2023, $67 loss in 2024) that are not supported by the ground truth. The ground truth explicitly states that fiscal 2022 had 'no specific performance metrics provided' and 'no immediate material impact on financial results,' directly contradicting the LLM's claim of a $9 gain. (2) CALCULATION ERROR: The LLM calculates a $76 decline over the period ($9 - $21 - $67 = -$79, not -$76), and this calculation is based on unsupported numbers. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the correct information from the ground truth. The ground truth indicates: (a) 2022 had no disclosed performance metrics, (b) 2023 showed material negative impact from AFS losses, (c) 2024 continued the negative trend. The LLM invented specific numbers rather than acknowledging the lack of 2022 data. (4) ENTITY/METRIC ACCURACY: While the company (Cisco), metric (other income/loss, net), and years (2022-2024) are correct, the financial data attributed to these entities is fabricated. (5) SEMANTIC MISMATCH: The ground truth emphasizes 'no specific performance metrics' for 2022 and a 'growing financial risk,' while the LLM presents false precision with specific dollar amounts and attributes the decline to 'interest rates rose and credit quality slipped' without ground truth support. The answer demonstrates a fundamental failure to accurately represent the source material and instead presents invented data as fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 441,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks’ 10‑K filings show a clear, year‑over‑year extension of its green‑coffee supply coverage. In the 2022 10‑K, the company stated that its purchase commitments and inventory would provide an adequate supply through **fiscal 2023** (page 12, 2022 10‑K). The 2023 10‑K extended that horizon to **fiscal 2024** (page 12, 2023 10‑K), and the 2024 10‑K pushed it further to **fiscal 2025** (page 12, 2024 10‑K). This progressive extension reflects a deliberate sourcing strategy that relies on long‑term contracts, hedging of price exposure, and strong supplier relationships to proactively mitigate supply‑chain risk and ensure continuous access to high‑quality coffee.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the three-year progression of Starbucks' green coffee supply adequacy projections. The key numeric/temporal facts are accurate: FY2022 projection through FY2023, FY2023 projection through FY2024, and FY2024 projection through FY2025. However, there is a critical discrepancy in the FY2023 projection. The ground truth states that by fiscal 2023, the company extended its supply adequacy projection to fiscal 2025 (a two-year extension), but the LLM answer claims the 2023 10-K extended the horizon to fiscal 2024 (only a one-year extension). This is a factual error that affects the accuracy of the multi-year progression narrative. The LLM correctly identifies the overall trend of extending supply coverage and accurately characterizes the sourcing strategy elements (long-term contracts, hedging, supplier relationships). The reasoning about supply chain resilience and risk mitigation is sound and semantically equivalent to the ground truth. The answer is well-structured and provides appropriate context. The error in the FY2023 projection detail prevents a higher score, as this is a specific factual claim that contradicts the ground truth. The quantitative accuracy score reflects the one incorrect year-to-year projection, while the qualitative reasoning about strategy and risk mitigation remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 388,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s exposure to the 2.00 % Notes Due 2031 grew steadily: it was about $1.0 B in FY 2022, rose to $1.044 B in FY 2023, and reached $1.250 B in FY 2024【page 67】【page 72】. This incremental increase shows a deliberate long‑term debt strategy that adds modest amounts of low‑to‑mid‑rate debt to fund growth while keeping the overall debt profile stable and manageable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the FY 2022 figure. Ground truth states $1,200 million for FY 2022, but the LLM claims 'about $1.0 B' (approximately $1,000 million). This is a $200 million discrepancy, representing a 16.7% error on the opening value. The FY 2023 figure of $1,044 million is correct (matching ground truth). The FY 2024 figure of $1,250 million is correct. MULTI-HOP SYNTHESIS: The LLM correctly identifies the three-year trend across fiscal years 2022-2024 and attempts to synthesize this into a narrative about debt strategy. However, the incorrect FY 2022 baseline undermines the entire trend analysis. The ground truth shows: $1,200M → $1,044M (decrease of $156M) → $1,250M (increase of $206M), revealing a 'dynamic approach' with fluctuations. The LLM's characterization of 'steady growth' and 'incremental increase' is inaccurate given the actual 2022-2023 decline. REASONING QUALITY: The LLM's interpretation about 'deliberate long-term debt strategy' and 'modest amounts of low-to-mid-rate debt' is reasonable inference, but it's based on a mischaracterized trend. The ground truth's description of 'fluctuation' and 'dynamic approach' is more accurate than the LLM's 'steady' characterization. ENTITY ACCURACY: Company (NVIDIA), metric (2.00% Notes Due 2031), and years (2022-2024) are all correctly identified. NUMBER FORMAT: The conversion to billions (B) is acceptable format variation, but the actual values must be correct. OVERALL: The answer fails on the primary quantitative requirement due to the $200M error in FY 2022, which cascades into an incorrect trend narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 455,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 10‑K, Fall Protection Solutions is not separately identified within the Safety and Industrial segment’s product categories (pages 129‑133). By the 2023 filing, 3M began grouping it under the “Respiratory, hearing, eye and fall protection solutions” sub‑category of Safety and Industrial (page 107), and this grouping persisted in the 2024 filing (page 110). The change signals a clearer emphasis on fall‑protection PPE relative to other industrial safety products such as abrasives, adhesives, and electrical components.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual contradictions with the ground truth that undermine its credibility. MAJOR ISSUES: (1) The LLM claims Fall Protection Solutions were 'not separately identified' in 2022, directly contradicting the ground truth which states they were 'listed alongside respiratory, hearing, and eye protection' in 2022. This is a fundamental factual error about the 2022 positioning. (2) The LLM presents the 2023-2024 grouping as a 'change' from 2022, but the ground truth indicates the 'listing order remained consistent' through 2023, suggesting continuity rather than a shift. (3) The LLM's characterization of the evolution differs substantially from ground truth: LLM emphasizes a 'clearer emphasis on fall-protection PPE' starting in 2023, while ground truth describes a 'subtle shift' in 2024 toward 'broader industrial safety systems' rather than standalone categorization. (4) Page citations (129-133 for 2022, 107 for 2023, 110 for 2024) cannot be verified but the factual claims about content are contradicted by ground truth. PARTIAL CREDIT: The LLM correctly identifies that Fall Protection Solutions remained within the Safety and Industrial segment across all three years, and correctly notes the grouping with respiratory, hearing, and eye protection in 2023-2024. However, the core narrative about the evolution is inverted—the LLM suggests emphasis increased when ground truth suggests a de-emphasis (moving from standalone to part of broader systems). The multi-hop reasoning fails because the LLM mischaracterizes the 2022 baseline, making the subsequent comparison invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 444,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s revenue from bamlanivimab (included in the aggregated COVID‑19 antibody revenue) was **$2.01 billion in 2022** (page 67).  In 2023 and 2024 the company reported **$0 million** from bamlanivimab, reflecting the product’s discontinuation and the end of sales under EUAs (footnote on page 67).  This sharp decline shows that Lilly has effectively moved away from relying on its COVID‑19 antibody portfolio for revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All financial figures are correct - $2.01 billion in 2022, $0 in 2023, and $0 in 2024 match the ground truth exactly. The numeric progression is accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) revenue evolution across the three-year period, (2) the trend pattern (sharp decline), and (3) what this indicates about company reliance. ENTITY ACCURACY: Eli Lilly is correctly identified, bamlanivimab is correctly named, the COVID-19 antibody portfolio context is accurate, and all years (2022-2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the revenue figures to the broader narrative about pandemic response maturation and demand waning. The conclusion that Lilly has moved away from reliance on this portfolio is logically supported by the data. MINOR STRENGTHS: The LLM answer provides additional context (EUA discontinuation, page references) that enhances credibility without contradicting the ground truth. SEMANTIC EQUIVALENCE: The phrasing 'sharp decline' and 'effectively moved away from relying' conveys the same meaning as the ground truth's 'rapid decline' and 'decline in reliance.' The answer is factually correct, complete, well-reasoned, and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 379,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 2022 and 2024 10‑Ks both note that coffee price volatility is affected by trading activity from hedge funds and commodity index funds, indicating a steady exposure to index‑fund‑driven price swings (SBUX_10k_2022.pdf page_12; SBUX_10k_2024.pdf page_12). The company has maintained a consistent hedging mix—fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars—to mitigate that volatility, and has extended its total purchase commitments and inventory coverage to secure green coffee through fiscal 2025, underscoring a proactive, long‑term risk‑management approach (SBUX_10k_2024.pdf page_12).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core elements of Starbucks' commodity price exposure and risk management strategy, with generally accurate information. STRENGTHS: (1) Correctly identifies that commodity index funds affect arabica coffee futures prices in both 2022 and 2024; (2) Accurately lists the hedging instruments used (fixed-price commitments, forward contracts, futures, collars); (3) Correctly notes extension of supply commitments through fiscal 2025; (4) Appropriately characterizes the approach as 'proactive, long-term risk management'; (5) Proper citation format with document references. WEAKNESSES: (1) The answer states 'steady exposure' but misses the temporal evolution aspect emphasized in the ground truth—the original answer highlights a progression from 'adequate supply through fiscal 2023' (in 2022) to 'adequacy through fiscal 2025' (in 2024), showing strengthening over time; (2) Does not explicitly mention the 2023 fiscal year data point, which is part of the three-year trend analysis; (3) Omits mention of 'remote delivery risk assessments' that were maintained across all three years per the ground truth; (4) The phrase 'steady exposure' could be misinterpreted as static, whereas the ground truth emphasizes 'improving supply chain resilience' and 'strengthening of risk management practices.' MULTI-HOP REASONING: The answer successfully synthesizes information across fiscal years and documents, but doesn't fully capture the temporal progression that reveals the strategic evolution. The answer is factually sound on the hedging mechanisms and supply extension but lacks the nuanced understanding of how the company's risk management strategy evolved and strengthened over the three-year period. The answer would benefit from explicitly noting the progression in supply visibility extension (2023→2025) as evidence of improving risk management rather than just 'steady' exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 517,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Google Ad Manager was a core part of the Google Network properties, generating impression‑based revenue that the company tracked with metrics such as impressions and cost‑per‑impression (page 31). The 2023 filing confirms the same role for Ad Manager while noting a 2023 accounting change that extended the useful life of servers and network equipment from 4‑5 to 6 years, cutting depreciation by $3.9 B and raising net income by $3.0 B, thereby strengthening long‑term profitability (page 57). By 2024 Ad Manager remains integral to the network, and the profitability boost from the depreciation adjustment is reflected in a $100.1 B net income, supporting continued investment in impression‑based monetization (page 57).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the depreciation schedule adjustment. Strengths: (1) All quantitative data is accurate - the $3.9B depreciation reduction and $3.0B net income increase are correctly stated; (2) The 2023 depreciation adjustment details (servers from 4 to 6 years, network equipment from 5 to 6 years) are precisely correct; (3) The multi-hop synthesis across 2022-2024 is sound, connecting Ad Manager's role to the depreciation adjustment's impact on profitability; (4) The mention of $100.1B net income in 2024 provides concrete evidence of the profitability trend. Minor areas for improvement: (1) The answer cites specific page numbers (31, 57) which adds credibility but cannot be verified against the ground truth; (2) The ground truth emphasizes 'impression-based monetization' and 'display advertising' more explicitly as the strategic context, while the LLM answer focuses more on the financial mechanics; (3) The ground truth's framing of 'multi-year trend of optimizing cost structures' is slightly more strategic than the LLM's more mechanical presentation. The LLM answer correctly addresses all three time periods (2022, 2023, 2024) and properly synthesizes the relationship between the depreciation adjustment and long-term profitability implications. The reasoning is logically sound and the entity identification (Google, Ad Manager, Google Network properties) is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 412,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK has issued a new Performance Share Unit Agreement each year from 2022 through 2024, all granted under its 2019 Long‑Term Incentive Plan (see Exhibits 10.21, 10.26, 10.28 on page 19 and the 2019 LTP on page 18). This steady use of PSUs demonstrates a deliberate shift toward performance‑based equity awards, underscoring a compensation strategy that prioritizes aligning executive incentives with long‑term shareholder value and rewarding the achievement of performance targets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent the ground truth. (1) EXHIBIT NUMBERS INCORRECT: The LLM cites Exhibits 10.21, 10.26, and 10.28, but the ground truth specifies Exhibits 10.45 (2022), 10.14 (2023), and 10.18 (2024). These are completely different exhibit numbers and represent a major factual error. (2) AGREEMENT FORMS MISIDENTIFIED: The LLM claims new PSU agreements were issued each year (2022, 2023, 2024), but the ground truth shows: 2022 referenced the 2021 Form, 2023 re-filed the 2019 Plan itself (not a new agreement form), and 2024 included the 2022 Form. The LLM incorrectly suggests three new agreement forms when the actual pattern shows only two new forms (2021 and 2022) with a plan re-filing in between. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the actual evolution pattern. The ground truth shows a deliberate progression: 2021 agreements → 2019 plan re-filing → 2022 agreements, indicating adaptive refinement while maintaining foundational structure. The LLM oversimplifies this to 'steady use of PSUs' without capturing the nuanced evolution. (4) STRATEGIC INTERPRETATION INCOMPLETE: While the LLM correctly identifies the general strategy of aligning with shareholder value, it misses the key insight from the ground truth: the pattern reflects 'consistent but adaptive approach' that 'maintains the core of the 2019 plan while iteratively refining incentive mechanisms.' The LLM's interpretation is generic and doesn't reflect the specific evolution documented. (5) PAGE REFERENCES UNVERIFIED: The LLM provides page references (page 19, page 18) that cannot be verified against the ground truth and may be incorrect. The ground truth provides specific exhibit numbers which are the authoritative references. This is a critical failure in a multi-hop financial question requiring precise document synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 513,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "3M’s Safety and Industrial segment has kept the same, highly specific wording for its electrical portfolio—“Electrical products and materials for construction and maintenance, power distribution and electrical OEMs”—through 2022, 2023 and 2024 (2023 page 107; 2024 page 110).  The only change in product categorization was the shift of a non‑electrical line from a “Closure systems” label in 2023 to an “Industrial specialty products such as personal hygiene products, masking, and packaging materials” label in 2024 (2023 page 107 vs 2024 page 110).  This steady, precise focus on electrical OEMs, coupled with the re‑classification of other items, indicates that 3M is keeping its electrical OEM offering front‑and‑center while reorganizing its broader product mix to better align with evolving market segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. The ground truth explicitly states that 3M's electrical product descriptions EVOLVED and CHANGED across 2022-2024, with specific refinements: (1) 2022: 'construction and maintenance, power distribution and electrical OEMs', (2) 2023: refined to 'electrical original equipment manufacturers (OEMs)' with increased precision, (3) 2024: 'power distribution and electrical original equipment manufacturers (OEMs)' with added continuity. The LLM claims the wording remained 'the same, highly specific' across all three years, which is factually incorrect. The LLM states the exact same phrase was used in 2022, 2023, and 2024, but the ground truth shows clear evolution in language and specificity. The LLM's core assertion—that there was no meaningful change in electrical product description language—directly contradicts the ground truth's central finding that the progression 'indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity.' The LLM does correctly identify that there was a reclassification of non-electrical products (Closure systems to Industrial specialty products), but this is a secondary point that doesn't compensate for the major factual error on the primary question about electrical product evolution. The LLM misses the key insight about increasing precision and strategic emphasis that the ground truth emphasizes. The page citations provided (2023 page 107; 2024 page 110) cannot be verified but the claimed consistency of wording contradicts the documented evolution in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 452,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried **$24.1 billion** at year‑end 2022, rose to **$27.2 billion** in 2023, and fell slightly to **$26.9 billion** in 2024.  The weighted‑average interest rate remained at **4.45 %** in 2022 and 2023, then increased to **4.84 %** in 2024.  This pattern indicates the company is keeping its debt balance largely flat while gradually shifting to newer, slightly higher‑rate debt—reflecting a conservative, maturity‑aligned refinancing strategy that balances cost and risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CARRYING VALUE FOR 2022 IS WRONG: LLM states $24.1 billion, but ground truth shows $19,975 million ($19.975 billion). This is a significant $4.125 billion discrepancy (20.6% error). (2) WEIGHTED-AVERAGE INTEREST RATE FOR 2022 IS WRONG: LLM claims 4.45% in 2022, but ground truth shows 2.91% in 2022. The LLM appears to have confused 2022's rate with 2023's rate. (3) 2023 AND 2024 NUMBERS ARE CORRECT: The $27.2 billion (2023) and $26.9 billion (2024) carrying values match ground truth, as does the 4.84% rate for 2024. However, the 4.45% rate should be attributed to 2023, not both 2022 and 2023. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression. The ground truth shows a clear upward trajectory in rates (2.91% → 4.45% → 4.84%), indicating aggressive debt issuance during rising rate environment. The LLM's interpretation of 'keeping debt balance largely flat' is incorrect—there was substantial growth from 2022 to 2023 (+$7.193 billion or +36%). (5) STRATEGIC INTERPRETATION MISMATCH: Ground truth emphasizes 'strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs.' LLM's characterization as 'conservative, maturity-aligned refinancing strategy' misses the aggressive debt accumulation pattern. The 2022 baseline error cascades through the entire analysis, making the trend interpretation fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 414,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "In FY 2022 NVIDIA’s 3.50% Notes Due 2040 carried $1 billion on the balance sheet.  In FY 2023 and FY 2024 the carrying amount stayed at $1 billion, the effective interest rate remained 3.54 %, and the fair value fell modestly from $870 million in 2023 to $851 million in 2024 (page 67).  The notes are unsecured senior obligations that can be redeemed early, and the overall long‑term debt mix stayed stable while the net carrying amount of long‑term debt declined from $9.71 billion to $8.46 billion (page 72), illustrating NVIDIA’s disciplined use of long‑dated debt to finance growth with predictable costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) FY 2022 valuation: LLM states '$1 billion on the balance sheet' but ground truth shows fair value of $1,066 million - this is a material misrepresentation of the opening position. (2) FY 2023 fair value: LLM claims '$870 million' but ground truth explicitly states '$851 million' - this is a direct factual error. (3) FY 2024 treatment: LLM incorrectly states fair value 'fell...to $851 million in 2024' but ground truth indicates the company 'no longer reported a fair value' in FY 2024, instead reporting a carrying amount of $1,000 million. This is a fundamental misunderstanding of the accounting treatment change. (4) The LLM conflates fair value and carrying amount across years, creating confusion about what metric applies when. (5) The progression narrative is inverted - the ground truth shows fair value declining from $1,066M (2022) to $851M (2023), then shifting to carrying amount reporting in 2024. The LLM's claim that fair value 'fell modestly from $870 million in 2023 to $851 million in 2024' misses the critical accounting shift and contains an incorrect 2023 figure. (6) While the LLM provides additional context about effective interest rates, redemption features, and debt mix changes (which may be accurate), these additions don't compensate for the core numerical errors. (7) The multi-hop synthesis is partially attempted but undermined by factual inaccuracies in the primary data points. The answer demonstrates a fundamental failure to accurately report the key financial metrics that form the basis of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 454,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion** at December 31, 2022 to **$15.0 billion** at December 31, 2023 and further to **$13.0 billion** at December 31, 2024 [page_58], [page_57]. The steady decline indicates that Amazon is actively repaying or redeeming the 2017 Notes, reflecting a conservative debt‑management strategy aimed at reducing long‑term leverage and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The dates are properly specified as December 31 for each year, matching the ground truth. The year-over-year reductions ($1.0 billion from 2022-2023, $2.0 billion from 2023-2024) are accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the evolution of the outstanding balance AND interprets what this trajectory suggests about debt management strategy. (3) ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes are properly referenced, and all fiscal years are correct. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the pattern (consistent reduction) and draws a logical inference about deliberate debt management. The characterization as 'conservative debt-management strategy aimed at reducing long-term leverage and interest expense' is semantically equivalent to the ground truth's 'deliberate debt management strategy to gradually retire this issuance over time' and adds reasonable contextual interpretation. (5) MINOR DIFFERENCES: The LLM provides slightly more detailed interpretation (mentioning 'actively repaying or redeeming' and specific benefits like 'reducing long-term leverage and interest expense') compared to the ground truth's more concise phrasing. This represents value-added analysis rather than error. The citation references [page_58], [page_57] add credibility though cannot be verified in this context. Overall, the answer is factually accurate, complete, well-reasoned, and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 475,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 2022‑, 2023‑ and 2024 10‑Ks all list the same “Floating Rate Notes due 2019” in the description of securities (see the Officer’s Certificate list on page 56 of each filing).  This shows that Apple continues to issue short‑term, variable‑rate debt and therefore retains an ongoing exposure to interest‑rate fluctuations.  In a rising‑rate environment the coupon on those notes would climb, increasing Apple’s interest expense and making its overall cost of debt more sensitive to rate hikes.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its core claim. The ground truth explicitly states that the Floating Rate Notes were due in 2019, meaning they matured in 2019 and would not have been outstanding in 2022, 2023, or 2024. The LLM incorrectly interprets the repeated disclosure of these notes as evidence that 'Apple continues to issue short-term, variable-rate debt,' which is factually wrong. The notes were not being issued in 2022-2024; rather, their inclusion in the Officer's Certificate (incorporated by reference) represents a disclosure artifact or ongoing contractual reference obligation, not active debt exposure. This is a fundamental misunderstanding of what the repeated disclosures actually indicate. The ground truth correctly identifies that the persistence of these notes in disclosures suggests 'rollover obligations or continuing commitments tied to this debt structure' rather than ongoing issuance. The LLM's statement that Apple 'continues to issue short-term, variable-rate debt' is incorrect and contradicts the 2019 maturity date. The LLM does correctly identify that floating rate notes would increase interest expense in a rising rate environment, which is accurate reasoning about the mechanics of floating rate debt. However, this reasoning is applied to a mischaracterized situation. The reference to 'page 56' is unverified and may be inaccurate. The LLM answer demonstrates partial understanding of interest rate sensitivity mechanics but fails on the critical factual interpretation of what the repeated disclosures actually mean, resulting in a fundamentally flawed conclusion about Apple's current debt exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 458,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "Google’s 2022 10‑K framed the Pixel 5a 5G and Pixel 6 as part of a new‑generation hardware push that “invests in platforms like Android, Chrome, and growing our family of hardware devices” (page 7). By 2023 the Pixel line had become a defined revenue stream, with devices revenue—“primarily include sales of the Pixel family of devices”—constituting a modest but stable portion of Google Services (page 33). In 2024 the Pixel family remains a component of devices revenue, but the language shifts toward sustaining the line rather than aggressively expanding it (page 59), indicating a long‑term view of hardware as a complementary platform to core services rather than a primary growth engine.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the 2022 positioning with Pixel 5a 5G and Pixel 6 as long-term investments; (2) Accurately notes the 2023 transition to a defined revenue stream under 'devices' category; (3) Properly characterizes the 2024 status as a sustained component of devices revenue; (4) The multi-hop reasoning is sound—tracing the evolution from investment phase to revenue contribution to mature positioning; (5) Page citations (7, 33, 59) add credibility and specificity. MINOR WEAKNESSES: (1) The LLM introduces interpretive language ('sustaining the line rather than aggressively expanding it') that goes slightly beyond what the ground truth explicitly states—the ground truth focuses on the factual progression (investment → revenue stream → stable portfolio component) without characterizing the 2024 stance as 'sustaining' vs. 'expanding'; (2) The phrase 'complementary platform to core services rather than a primary growth engine' is a reasonable inference but represents analytical interpretation beyond the ground truth's more straightforward observation about 'increased confidence in its position'; (3) No quantitative metrics (revenue figures, percentages, growth rates) are provided, though the question doesn't explicitly require them. VERIFICATION: All core facts align with ground truth—the device progression is accurately captured, the categorization changes are correct, and the timeline is accurate. The answer successfully addresses all parts of the multi-part question regarding investment focus, revenue contribution, and product maturity. The conclusion about long-term positioning is supported by the evidence presented, though slightly more interpretive than the ground truth baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 503,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "From 2020 to 2021 Schwab expanded its use of client securities as collateral, with the fair value of securities available for pledge rising from $84 B to $120 B and those pledged for margin lending and securities lending increasing from $23 B to $31 B (page 108). By 2024 the firm had reduced the amount of client securities pledged for CS&Co lines of credit (from $950 M to $500 M) and terminated TDAC lines, while boosting collateral pledged for FHLB borrowings (from $63.1 B to $59.8 B) and discount‑window access (from $6.2 B to $30.5 B) (pages 97‑101), indicating a shift toward a more diversified, conservative collateral strategy that balances client exposure with liquidity needs and keeps net securities‑loaned amounts modest (about $4 M in 2021 vs $760 M in 2020) (page 107).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the question and ground truth in multiple critical ways: (1) TEMPORAL MISMATCH: The question explicitly asks about evolution from 2022-2024, but the LLM answer discusses 2020-2021 data and then jumps to 2024, missing the 2022-2023 period entirely that the ground truth emphasizes. (2) WRONG METRICS: The LLM cites specific dollar amounts ($84B, $120B, $23B, $31B, $950M, $500M, $63.1B, $59.8B, $6.2B, $30.5B, $4M, $760M) that cannot be verified against the ground truth and appear to reference different collateral categories (CS&Co lines, FHLB borrowings, discount-window access) not mentioned in the original answer. The ground truth explicitly states 'no specific dollar value was provided' for 2022. (3) INCOMPLETE SYNTHESIS: The LLM fails to address the core narrative arc of the ground truth: the progression from undisclosed amounts (2022) → formalized collateral management (2023) → active pledging for margin requirements and securities lending (2024). Instead, it focuses on different collateral sources and borrowing facilities. (4) ENTITY CONFUSION: The LLM introduces entities like 'CS&Co lines of credit,' 'TDAC lines,' and 'FHLB borrowings' that are not part of the ground truth's discussion of margin lending and securities lending activities. (5) LOGICAL DISCONNECT: The LLM's conclusion about 'diversified, conservative collateral strategy' contradicts the ground truth's narrative of 'growing reliance on client securities.' (6) MISSING KEY ELEMENTS: The LLM completely omits discussion of Options Clearing Corporation margin requirements and the strategic evolution toward broader use of client assets for operational needs, which are central to the ground truth answer. The answer appears to reference different sections of a filing or potentially conflates multiple unrelated collateral discussions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 506,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 2022 10‑K already disclosed that it “often collaborates with the primary insurers … to file proposed premium‑rate‑increase actions” (page 51).  The same language appears in the 2023 10‑K (page 21) and 2024 10‑K (page 20), showing that the collaboration has remained a consistent part of GE’s run‑off strategy.  However, the sensitivity analysis of the potential impact of a 25 % adverse change in the success rate of such filings rose from $200 million in 2023 (page 22) to $300 million in 2024 (page 53), indicating that GE now anticipates larger reserve effects from premium‑rate increases and is proactively incorporating that risk into its reserve and capital planning.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and misses key aspects of the ground truth. STRENGTHS: (1) Correctly identifies that GE collaborated with primary insurers on premium rate increases across 2022-2024; (2) Accurately cites the consistent language about collaboration appearing in all three years' 10-Ks; (3) Correctly identifies the sensitivity analysis figures ($200M in 2023, $300M in 2024) and the page numbers; (4) Properly interprets the increase in sensitivity analysis as indicating GE's proactive risk management. WEAKNESSES: (1) The answer focuses heavily on quantitative sensitivity analysis but largely ignores the qualitative evolution described in the ground truth - specifically the progression from 'indirect role' (2022) to 'formalized collaboration under reinsurance contractual terms' (2023) to 'reinforced collaborative framework with recent experience and regulatory precedents' (2024); (2) Misses the key insight about the strategic shift toward 'tighter integration with primary insurers to stabilize future policy benefit reserves'; (3) Does not adequately address how the collaboration 'evolved' - the answer treats it as static ('remained consistent') rather than showing the progression from informal to formalized to reinforced; (4) The interpretation that the sensitivity analysis increase shows GE 'now anticipates larger reserve effects' is reasonable but doesn't fully capture the ground truth's emphasis on the strategic shift in risk management approach. CALCULATION VERIFICATION: The sensitivity analysis numbers ($200M to $300M) are correct and properly cited. The 25% adverse change reference is accurate. MULTI-HOP REASONING: The answer successfully connects the collaboration language across years and links it to the sensitivity analysis, but fails to synthesize the qualitative evolution of the collaboration framework itself. The answer is partially correct on facts but incomplete on the strategic narrative that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 544,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed‑security (RMBS) holdings grew from **$721 million** at 12/31/2022 to **$810 million** at 12/31/2023, then fell sharply to **$71 million** in separate accounts at 12/31/2024 (page_149, page_161, page_160). The three‑year trend shows a deliberate shift away from structured credit, indicating a more conservative risk posture in that asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the 2023 figure. Ground truth shows CVS RMBS holdings decreased from $721M (2022) to $614M (2023), but the LLM claims they increased to $810M in 2023. This is a $196M discrepancy and represents a fundamental misreading of the data trend. The 2024 figure of $71M is correct. MULTI-HOP REASONING FAILURE: The LLM's interpretation of the trend is inverted. Ground truth indicates a cautious reduction in 2023 (from $721M to $614M) followed by further reduction in 2024 ($614M to $71M), suggesting a deliberate de-risking strategy. The LLM incorrectly characterizes 2023 as showing growth, which contradicts the actual data and misrepresents CVS's risk management approach. PARTIAL CREDIT: The LLM correctly identifies the 2022 starting point ($721M) and 2024 ending point ($71M), and appropriately recognizes the overall downward trajectory from 2022-2024. The characterization of a 'more conservative risk posture' is semantically aligned with the ground truth's 'cautious reduction' and 'dynamic risk management.' However, the intermediate year error is severe enough to undermine the credibility of the entire analysis. The LLM also provides page references which adds some contextual value, though accuracy of those citations cannot be verified. SYNTHESIS ISSUE: The answer fails to properly synthesize the three-year evolution, missing the key insight that 2023 represented a significant reduction (not increase) in exposure, making the overall trend a two-stage de-risking process rather than a simple growth-then-decline pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 444,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024** (Table 8.1/9.1, page 188).  Long‑term debt increased from **$47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024** (Table 8.1/9.1, page 188).  The combined debt level stayed roughly flat—$48.7 billion (2022), $49.9 billion (2023), $45.6 billion (2024)—indicating a deliberate shift to refinance long‑term obligations while keeping short‑term borrowings low to preserve liquidity and hedge interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall debt trajectory pattern (increase then decrease) and provides accurate combined debt totals ($48.7B → $49.9B → $45.6B) that match the ground truth ($43.086B → $49.856B → $45.551B when properly reconciled). The breakdown of short-term borrowings ($883M → $538M → $562M) and long-term debt ($47.8B → $49.3B → $44.9B) appears internally consistent and the combined figures are mathematically sound. The reasoning about deliberate refinancing and liquidity preservation is logical and relevant.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to address the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a key component of the ground truth answer and directly relevant to understanding debt management strategy in a rising rate environment. (2) MISSING DETAIL: No mention of the floating unsecured senior debt reduction ($1,709M → $349M → $0), which the ground truth identifies as a strategic shift away from variable-rate instruments. (3) INCOMPLETE ANALYSIS: The LLM's explanation of capital structure strategy is superficial compared to ground truth's characterization of 'dynamic capital structure with peak in 2023 followed by strategic deleveraging.' (4) RECONCILIATION ISSUE: The ground truth shows total debt starting at $43.086B (not $48.7B), suggesting the LLM may be using different debt components or definitions, though the 2023-2024 figures align reasonably well.\n\nQUANTITATIVE VERIFICATION: Combined totals check out ($883M + $47.8B ≈ $48.7B, etc.). Short-term and long-term breakdowns are plausible. However, the starting point discrepancy ($43.086B vs $48.7B) suggests potential classification differences that weren't explained.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes short-term and long-term debt into a combined narrative but fails to integrate interest rate data and debt composition changes, which are essential for a complete 3-year progression analysis.\n\nCONTEXTUAL RELEVANCE: While the answer addresses debt evolution, it misses critical context about rising borrowing costs and strategic debt composition shifts that directly explain the company's capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 593,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s long‑term liability for the 3.50% Notes Due 2050 was $2,000 million in FY 2023 (Jan 29 2023) and remained unchanged at $2,000 million in FY 2024 (Jan 28 2024)【page 69】【page 72】. The 2022 10‑K also reported the same $2,000 million balance【page 78】, indicating that the company has maintained a stable long‑term debt commitment over this period. This trend reflects a capital‑structure strategy that prioritizes predictable, long‑term financing and avoids frequent refinancing or debt issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. Ground truth shows: FY2022: $2,147M, FY2023: $1,637M, FY2024: $1,604M. The LLM claims all three years were $2,000M, which is factually wrong on every data point. Specifically: (1) FY2023 should be $1,637M, not $2,000M (error of $363M or 22%); (2) FY2024 should be $1,604M, not $2,000M (error of $396M or 25%); (3) FY2022 should be $2,147M, not $2,000M (error of $147M or 7%). The LLM's interpretation of the trend is also completely inverted - it claims the debt 'remained unchanged' and reflects 'stable' financing, when the ground truth shows a deliberate 25% reduction from $2,147M to $1,604M over the period. This is a critical mischaracterization of NVIDIA's capital structure strategy. The LLM failed to synthesize the multi-hop data correctly across the three fiscal years, and the conclusion about 'avoiding frequent refinancing' contradicts the actual pattern of systematic debt reduction. The page citations provided cannot be verified but the numerical claims are demonstrably false against the ground truth knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 316,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 were issued in 2013 and remained outstanding through 2022, 2023 and 2024.  Each year’s 10‑K lists the same notes in the “Description of Securities” section, with no new issuances, maturities or changes reported.  This consistency shows Apple’s long‑term debt disclosure strategy of transparently reporting all existing debt in every filing, rather than focusing only on new issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that the 0.45% Notes due 2016 'remained outstanding through 2022, 2023 and 2024,' which is factually incorrect. According to the ground truth, these notes were issued in 2013 and MATURED in 2016 - meaning they were no longer outstanding by 2022, 2023, or 2024. The ground truth explicitly states these are 'historical debt instruments' that matured in 2016. The LLM's claim that they 'remained outstanding' through the later years is a major factual error. Additionally, the LLM mischaracterizes the disclosure pattern. The ground truth indicates Apple continued to REFERENCE these historical notes in exhibits for 'transparency and legal continuity,' not because they were 'existing debt' as the LLM implies. The LLM's interpretation that this shows Apple's strategy of 'transparently reporting all existing debt' is misleading - the notes were not existing/outstanding debt, they were legacy disclosures. The LLM does correctly identify the 0.45% rate and 2016 maturity date, and correctly notes the consistent disclosure pattern across years, but fundamentally misunderstands what that pattern means. The reasoning about 'rather than focusing only on new issuances' is not supported by the ground truth explanation. The answer fails to capture the key insight about legacy debt disclosure for legal continuity purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 399,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) grew from $5 million at year‑end 2022 to $58 million at year‑end 2023 and to $69 million at year‑end 2024, reflecting a sharp expansion of derivative exposure.  The swap‑rate inputs used in the Level‑3 valuation models rose from 1‑2 % (average 2 %) in 2022 to 3‑5 % (average 4 %) in 2023 and 4 % (average 4 %) in 2024, indicating that the company has updated its assumptions to a higher‑rate, higher‑credit‑risk environment while continuing to rely on significant unobservable inputs in its internal models.  This multi‑year trend signals a growing reliance on derivative hedging and a shift toward more conservative, higher‑rate valuation assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MAJOR NUMBER ERRORS: The LLM states net derivative assets were $5M in 2022, $58M in 2023, and $69M in 2024. The ground truth shows $31M in 2022, $58M in 2023, and $58M in 2024 (not $69M). The 2022 figure is off by $26M and the 2024 figure is off by $11M. (2) SWAP RATE INPUTS MISCHARACTERIZATION: The LLM claims swap-rate inputs were 1-2% (avg 2%) in 2022, 3-5% (avg 4%) in 2023, and 4% in 2024. The ground truth indicates that in 2023, the significant unobservable input was 'default' at 4%, not swap rates. In 2024, it shifted TO swap rates at 4%. The LLM incorrectly attributes swap rates to 2022-2023 when the ground truth shows default was the key input in 2023. (3) MISIDENTIFIED RISK DRIVER EVOLUTION: The LLM claims a shift toward higher-rate assumptions, but the ground truth shows a shift FROM default assumptions (2023) TO swap rates (2024) - a shift in which risk metric is significant, not necessarily toward higher rates. (4) INCOMPLETE CONTEXT: The LLM misses the important detail about the $20M net unrealized loss in 2022 and the reduction in realized losses from $43M in 2022 to stable values in 2023-2024, which the ground truth identifies as indicating improved risk management. (5) INCORRECT INTERPRETATION: The LLM's conclusion about 'growing reliance on derivative hedging' and 'more conservative, higher-rate valuation assumptions' is not supported by the ground truth, which emphasizes a shift in which risk input is significant while maintaining consistent valuation levels. The answer demonstrates fundamental misunderstanding of the multi-year progression and contains multiple material factual errors in both absolute values and the characterization of risk inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 489,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s carrying amount of the 1.55% Notes Due 2028 rose from **$1.099 B at the end of FY 2022** (Jan 29 2023) to **$1.115 B at the end of FY 2023** (Jan 28 2024) and then to **$1.250 B at the end of FY 2024** (Jan 26 2025)【page_67】【page_72】. The steady, incremental build‑up of this low‑rate, 3‑year‑plus maturity debt shows a deliberate strategy to fund growth and capital projects while keeping interest costs low and maintaining a diversified, long‑term debt profile【page_72】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that contradict the ground truth. Ground truth states: FY2022=$1.2B, FY2023=$1.1B, FY2024=$1.25B. LLM reports: FY2022=$1.099B, FY2023=$1.115B, FY2024=$1.250B. The FY2022 figure is off by ~$100M (8.3% error), and FY2023 is off by ~$15M (13.6% error). While FY2024 matches ($1.25B), the trajectory narrative is fundamentally wrong. Ground truth shows a DECREASE from 2022 to 2023 (1.2B→1.1B), then an INCREASE to 2024 (1.1B→1.25B). LLM incorrectly characterizes this as a 'steady, incremental build-up,' when the actual pattern shows a dip in 2023 followed by recovery. The LLM's description of 'steady, incremental' growth is factually incorrect given the 2023 decline. QUALITATIVE ISSUES: While the LLM provides reasonable strategic interpretation (low-rate debt, capital funding, diversified profile), this interpretation is based on incorrect numbers and mischaracterizes the actual debt trajectory. The reasoning about debt strategy is plausible but built on a flawed quantitative foundation. POSITIVES: Correct identification of the instrument (1.55% Notes Due 2028), correct final year amount ($1.25B), appropriate fiscal year dating conventions, and reasonable strategic context. However, these cannot overcome the fundamental numerical errors in 2022-2023 data that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 389,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 10‑K disclosures show a consistent, unchanged exposure to trailing legal liabilities from 2022 through 2024.  Each year’s filing notes the same legacy matters from the 2015 Alstom acquisition—settlements, judgments and anti‑competitive claims—and the same shareholder lawsuits over past financial reporting, with no indication that the number or nature of those claims has diminished.  The 2024 filing adds that reserves are maintained “when and as appropriate,” but stresses that estimating those reserves involves significant judgment and that actual losses could exceed the current estimates, underscoring the persistence and potentially sizable financial impact of these contingent liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements but with some notable differences in emphasis and completeness compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2015 Alstom acquisition as the source of legacy matters; (2) Accurately notes the persistence of shareholder lawsuits tied to historical financial reporting across all three years (2022-2024); (3) Correctly captures the key insight that these liabilities have remained consistent and unchanged in nature; (4) Accurately reflects the 2024 disclosure about reserves being maintained 'when and as appropriate' and the acknowledgment that actual losses could exceed estimates; (5) No quantitative errors in dates or financial references. WEAKNESSES: (1) The LLM answer states the exposure was 'unchanged' and 'consistent' but provides less nuance than the ground truth regarding the evolution—the ground truth notes that by 2023 GE 'emphasized that such legal matters could exceed current estimates,' suggesting a progression in disclosure emphasis rather than complete stasis; (2) The LLM answer omits specific mention of 'anti-competitive conduct or corruption' claims as explicitly noted in the ground truth; (3) The LLM answer does not explicitly address the 'reputational risks' dimension emphasized in the ground truth; (4) The LLM answer is somewhat more terse in describing the 'material financial and reputational risks' that persist. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the connection between Alstom acquisition legacy matters and shareholder lawsuits. However, it characterizes the progression as 'unchanged' rather than showing how the company's disclosure of risk evolved. SEMANTIC EQUIVALENCE: The core message—that these liabilities persist and could exceed current estimates—is conveyed accurately. The characterization of 'consistent and costly burden' in the ground truth is semantically equivalent to the LLM's 'persistence and potentially sizable financial impact.' The answer is fundamentally sound but slightly less comprehensive in capturing the full evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 578,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan’s hedge‑fund limited partnership exposure rose from **$225 million in 2022** to **$280 million in 2024** (page 168 and page 167).  The target allocation for hedge funds increased from **3 % to 4 %** (page 169), reflecting a deliberate shift toward higher‑risk, higher‑return alternative investments to boost returns and diversify risk as part of a more aggressive pension‑fund strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility: (1) QUANTITATIVE ERRORS: The 2022 figure is stated as $225 million when the ground truth shows $214 million - a $11 million discrepancy (5.1% error). The 2024 figure is stated as $280 million when ground truth shows $252 million - a $28 million discrepancy (11.1% error). These are not minor rounding differences but material misstatements of pension fund allocations. (2) MISSING DATA: The LLM completely omits the 2023 intermediate year ($225 million), which is critical for demonstrating the 'consistent upward trend' that characterizes CVS's strategy. The ground truth shows: $214M (2022) → $225M (2023) → $252M (2024), revealing a measured, gradual increase. The LLM's figures ($225M → $280M) suggest a much more aggressive jump that doesn't match actual filings. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to address the strategic implications (mentioning target allocation shift from 3% to 4%), it fails to properly synthesize the three-year trend that is essential to answering how exposure 'changed from 2022 to 2024.' (4) REASONING QUALITY: The characterization of the strategy as 'more aggressive' may be overstated given the actual measured increases shown in ground truth, though the general direction toward alternative investments is correct. (5) PAGE CITATIONS: The LLM provides specific page references (168, 167, 169) which cannot be verified against the ground truth but appear to be fabricated or misread given the numerical discrepancies. The answer demonstrates partial understanding of the question's intent but fails on the primary metric of factual accuracy for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 473,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022, Africa/Eurasia generated $228 million in operating profit (page 116).  In 2023, the company allocated about $1.6 million—5 % of the $32 million Global Productivity Initiative charges—to the region (page 86), underscoring a focus on cost‑efficiency.  By 2024, depreciation and amortization spending in Africa/Eurasia was $8 million (page 117), indicating modest capital investment while sustaining profitability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) OPERATING PROFIT ERROR: LLM states $228 million for 2022, but ground truth is $203 million—a $25 million discrepancy (12% error). This is a critical factual error on a core metric. (2) RESTRUCTURING CHARGES ERROR: LLM claims $1.6 million allocated to Africa/Eurasia (5% of $32 million total), but ground truth states $20-24 million (10% of expected charges). This is a massive underestimation—off by a factor of 12-15x. The percentage is also wrong (5% vs 10%). (3) DEPRECIATION/AMORTIZATION: LLM correctly states $8 million for 2024, which matches ground truth. However, LLM fails to mention the prior years' comparison ($9 million in 2022 and 2023), missing important context about the trend. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across three years, the fundamental errors in 2022 and 2023 data severely compromise the analysis. The narrative about 'cost-efficiency' is undermined by incorrect numbers. (5) MISSING CONTEXT: The LLM fails to capture the ground truth's key insight that the 3-year trajectory reflects 'limited growth investment and a focus on cost optimization rather than expansion.' The LLM's conclusion about 'sustaining profitability' is vague and doesn't capture the strategic implications. (6) PAGE REFERENCES: While the LLM provides page citations, the underlying data is incorrect, suggesting either misreading of source material or hallucination. The quantitative errors are too large to be formatting differences or rounding variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 444,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "From 2022 to 2024 AIG’s approach to international terrorism exposure shifted mainly in its reinsurance attachment points and recoverable assets.  In 2022 the company disclosed a $1.3 billion modeled loss for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, with Japan and Rest‑of‑World attachment points at $200 M and $100 M per occurrence and aggregate.  By 2024 those attachment points were lowered to $150 M for Japan and raised to $125 M for Rest‑of‑World, while no new modeled terrorism loss figure was provided; reinsurance recoverable assets fell from $67.5 billion at 2023 to $38.0 billion at 2024 (the 2022 figure is not disclosed in the provided pages).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) ATTACHMENT POINT ERRORS: LLM states 2022 attachment points were '$200M Japan and $100M Rest-of-World' but ground truth shows $200M Japan and $125M elsewhere. LLM then claims these were 'lowered to $150M for Japan and raised to $125M for Rest-of-World' by 2024, but ground truth indicates they remained at $200M Japan and $125M elsewhere - no change occurred. This is a critical factual error in the core claim about evolution. (2) REINSURANCE RECOVERABLE ASSETS: LLM states assets 'fell from $67.5 billion at 2023 to $38.0 billion at 2024' but provides no source for the $67.5B 2023 figure and this appears to be fabricated data not in ground truth. Ground truth only confirms $38.0 billion in 2024 with $29.1 billion in ceded loss reserves. (3) INCOMPLETE INFORMATION: LLM correctly identifies the $1.3 billion modeled loss for 2022 and $1.7 billion TRIPRA deductible, but fails to mention AIG's continued active monitoring and third-party vendor models in 2023, or the strategic expansion of reinsurance protections mentioned in ground truth. (4) MULTI-HOP REASONING: The answer attempts to synthesize across years but does so incorrectly by inventing attachment point changes that didn't occur. The core narrative of 'evolution' is undermined by these fabrications. (5) POSITIVE ELEMENTS: Correctly identifies the $38.0 billion 2024 reinsurance recoverable assets figure and acknowledges the $1.3 billion modeled loss scenario. The general structure of comparing across years is appropriate but execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 425,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 liability fell from about $1.20 billion in FY 2022 to $1.044 billion in FY 2023, then rose to $1.25 billion in FY 2024 (see 2024 10‑K, page 72; 2023 10‑K, page 65; 2022 10‑K, page 78). This pattern shows a deliberately stable long‑term debt profile: the company repaid or refinanced a portion of the notes in 2023, then rolled over or issued additional debt in 2024 to maintain liquidity and support growth while keeping the overall debt level roughly constant. The trend reflects a conservative strategy that balances debt repayment with new issuances to manage interest costs and maturity schedules.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key financial figures correct: $1.20 billion (2022), $1.044 billion (2023), and $1.25 billion (2024). The fiscal year references and note designation (2.00% Notes Due 2031) are accurate. The multi-hop synthesis across three fiscal years is sound, correctly identifying the pattern of decrease followed by increase. However, there are notable differences in interpretation and emphasis compared to the ground truth: (1) The LLM characterizes the 2023 decrease as 'repaid or refinanced a portion' and the 2024 increase as 'rolled over or issued additional debt,' which are speculative interpretations not explicitly stated in the ground truth. The ground truth more conservatively describes these as 'minor debt repayments or reclassifications' and 'maintained its long-term capital structure.' (2) The LLM's explanation about 'balancing debt repayment with new issuances' and 'manage interest costs and maturity schedules' goes beyond what the ground truth supports, introducing assumptions about refinancing activities. (3) The ground truth emphasizes 'consistent long-term debt strategy' and 'strategic intent to preserve stable long-term liabilities,' while the LLM frames it as 'deliberately stable' with more active management. The core insight about stability is present in both, but the LLM adds interpretive layers about specific debt management actions that aren't grounded in the provided data. The answer is fundamentally correct on facts and numbers but slightly overreaches in its causal explanations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 433,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were issued in 2014 and are still listed in the description of securities (Exhibit 4.4) in the 2022, 2023, and 2024 10‑Ks, with no changes in terms or new issuances. The unchanged disclosure across three consecutive filings shows that Apple consistently tracks and reports all debt instruments, providing long‑term visibility and continuity in its debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The notes are correctly identified as 1.05% Notes due 2017, (2) The answer correctly identifies that they appear in 2022, 2023, and 2024 filings, (3) The conclusion about consistent disclosure and debt tracking is sound, (4) The reference to Exhibit 4.4 is appropriate for debt instrument descriptions. PROBLEMATIC ELEMENTS: (1) The LLM states the notes were 'issued in 2014' - this is a specific factual claim not verified in the ground truth, which only confirms the notes existed and were referenced across the three years. The ground truth does not provide the issuance date, so this addition is unverified and potentially incorrect. (2) The LLM claims 'no changes in terms or new issuances' - while this aligns with the ground truth's statement of consistency, the LLM presents this as definitive fact when the ground truth is more cautious about what the persistence means (suggesting possible rollover, refinancing, or historical documentation). (3) The ground truth explicitly notes the paradox that despite maturity in 2017, the notes continued to be referenced, suggesting possible rollover or refinancing. The LLM does not address this important nuance about why mature notes would still appear in filings. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022, 2023, 2024) and identifies the consistent pattern. However, it misses the deeper analytical insight from the ground truth about what the persistence of mature debt in filings reveals about Apple's debt management practices. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'long-term visibility and continuity' aligns with the ground truth's conclusion about 'stable and transparent debt management strategy,' though the LLM is less nuanced about the implications. The answer is partially correct but introduces an unverified date claim and oversimplifies the analytical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 533,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022 Schwab could migrate up to $10 billion of IDA balances each year under the 2019 IDA agreement, limited to floating‑rate balances and subject to a $50 billion minimum and an 80 % fixed‑rate requirement through 2026. The 2023 IDA agreement, effective May 2023, removed the $10 billion cap and the fixed‑rate percentage rule, and introduced new minimum/maximum balance thresholds—balances had to stay above the total unmatured fixed‑rate amount with a $30 billion ceiling until September 10 2025, then a $60 billion minimum and $90 billion maximum thereafter—while also changing withdrawal rules. As a result, Schwab migrated roughly $10 billion in 2021–2022 but moved no balances in 2023 or 2024 under the new terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more detailed technical specifications than the ground truth but contains several problematic elements that reduce its overall correctness score:\n\nSTRENGTHS:\n1. Correctly identifies the 2019 IDA agreement allowed up to $10 billion annual migration\n2. Correctly notes the 2023 IDA agreement removed the $10 billion cap\n3. Correctly states that Schwab migrated roughly $10 billion in 2021-2022\n4. Correctly confirms no migrations occurred in 2023 or 2024\n5. Accurately captures the strategic shift from active migration to constrained off-balance sheet management\n6. Provides helpful context about minimum/maximum balance thresholds under the 2023 agreement\n\nWEAKNESSES AND ERRORS:\n1. QUANTITATIVE ISSUE: The LLM introduces specific constraints ($50 billion minimum, 80% fixed-rate requirement through 2026) that are NOT mentioned in the ground truth. These appear to be additional details that may or may not be accurate, but their inclusion without verification against the source documents creates uncertainty.\n2. QUANTITATIVE ISSUE: The LLM provides specific threshold dates and amounts ($30 billion ceiling until September 10, 2025, then $60 billion minimum/$90 billion maximum) that are NOT in the ground truth. While these may be accurate filing details, they go beyond what the ground truth confirms.\n3. The ground truth states Schwab \"had already moved $10.1 billion by year-end\" (2022), while the LLM says \"roughly $10 billion in 2021-2022.\" The $10.1 billion figure is more precise and the timing attribution differs.\n4. The LLM's additional technical details, while potentially accurate, cannot be verified against the provided ground truth and may introduce unverified information.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution across three years and identifies the key transition point (2023 agreement change). The reasoning about the shift from active migration to constrained management is sound.\n\nSEMANTIC EQUIVALENCE:\nThe core narrative matches the ground truth: migration capability existed in 2022, changed in 2023, and no migrations occurred in 2023-2024. However, the additional specificity creates ambiguity about whether all details are accurate.\n\nJUSTIFICATION:\nThe answer is partially correct on core facts but introduces unverified technical details that cannot be confirmed against the ground truth. This creates a moderate correctness score (6/10) - the main narrative is right, but the additional specificity raises concerns about accuracy without source verification. The quantitative accuracy is reduced due to the unverified specific thresholds and dates. Qualitative accuracy is higher because the reasoning and synthesis are sound, even if some details are questionable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 732,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "GE’s exposure to Bank BPH’s borrower litigation grew from a $1.359 billion estimated loss in 2022 to $2.669 billion in 2023, then fell to $2.461 billion in 2024. Capital support shifted from a $530 million cash contribution in 2022 to a $1.797 billion non‑cash intercompany loan forgiveness in 2023, with no further cash injections in 2024. The mortgage portfolio’s carrying value dropped from $1.799 billion at the end of 2021 to zero by the end of 2023 and remained zero in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of GE's exposure to Bank BPH but contains a critical factual error regarding the mortgage portfolio carrying value timeline. CORRECT ELEMENTS: (1) Estimated losses progression: $1.359B (2022) → $2.669B (2023) → $2.461B (2024) - all correct; (2) Capital contributions: $530M cash in 2022 and $1.797B non-cash intercompany loan forgiveness in 2023 - both correct; (3) No further contributions in 2024 - correct; (4) Overall narrative of worsening through 2023 then stabilization in 2024 - correct. CRITICAL ERROR: The LLM states the mortgage portfolio carrying value 'dropped from $1.799 billion at the end of 2021 to zero by the end of 2023 and remained zero in 2024.' The ground truth indicates the carrying value reached zero 'by the end of 2024,' not 2023. This is a significant factual error in the timeline of the write-down. MISSING CONTEXT: The LLM omits mention of the Q2 2023 settlement program charge of $1.014 million, which is an important detail explaining the spike in estimated losses. The LLM also doesn't explicitly characterize the full valuation write-down as indicating GE's exit from active involvement, though it does mention the zero carrying value. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple financial metrics (estimated losses, capital contributions, portfolio value), demonstrating adequate multi-hop reasoning. However, the mortgage portfolio timeline error undermines the accuracy of the synthesis. The quantitative accuracy score is reduced due to the year discrepancy on the portfolio write-down, which is a factual error despite correct dollar amounts elsewhere.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 463,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities fell sharply in both size and loss exposure: fair value dropped from $1.17 B in 2022 to $1.07 B in 2023 and to only $3 M in 2024 (page_147, page_147, page_160), while unrealized losses fell from $155 M in 2022 to $100 M in 2023 (page_149). This steep contraction indicates the company is actively trimming its exposure to these interest‑rate‑sensitive assets, reflecting a risk‑averse strategy that limits potential losses from rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all years: (1) 2022: LLM states $1.17B fair value vs. ground truth $574M (off by ~$596M or 104% error); LLM states $155M unrealized losses vs. ground truth $12M (off by $143M or 1,192% error). (2) 2023: LLM states $1.07B fair value vs. ground truth $675M (off by ~$395M or 59% error); unrealized losses of $100M matches ground truth. (3) 2024: LLM correctly states $3M fair value. The LLM's 2022 and 2023 fair value numbers are approximately double the actual values, suggesting a fundamental data retrieval or calculation error. The 2022 unrealized losses figure is wildly inaccurate (155M vs 12M). While the LLM correctly identifies the overall trend of declining exposure and provides reasonable risk management interpretation, the quantitative foundation is severely compromised. The reasoning about de-risking strategy is sound, but it's built on incorrect numbers. The page citations provided (page_147, page_149, page_160) cannot be verified but the numbers themselves are demonstrably wrong compared to the ground truth knowledge graph. This represents a major failure in quantitative accuracy that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 357,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑brand lineup, which includes Marketside, stayed the same from FY 2022 through FY 2024 – the brand is listed on the private‑label roster in the 2022, 2023 and 2024 10‑K filings (page 7). The unchanged portfolio signals that Walmart is maintaining a broad, stable private‑label assortment in grocery, reinforcing its everyday‑low‑price strategy and using private labels to drive volume and margin growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Marketside appeared in Walmart's private brand portfolio across all three fiscal years (2022, 2023, 2024), which matches the ground truth. The numeric/date accuracy is sound - the years are correct and the filing reference (page 7) is appropriately cited. However, the answer has significant qualitative shortcomings: (1) It characterizes the portfolio as 'unchanged' and 'the same,' which contradicts the ground truth's key insight that Walmart introduced NEW brands like 'bettergoods' during this period, representing strategic expansion and modernization. (2) The answer misses the crucial dual-strategy insight: maintaining legacy brands (Marketside) while innovating with new offerings. (3) It fails to capture the evolution aspect of the question - the ground truth emphasizes progression and strategic intent, while the LLM answer presents a static view. (4) The reasoning about 'everyday-low-price strategy' and 'volume and margin growth' is generic and doesn't address the specific strategic evolution asked about. The answer is partially correct on the factual presence of Marketside across years but fundamentally misses the strategic narrative about portfolio modernization and the introduction of new brands alongside legacy ones. This represents incomplete multi-hop synthesis - the answer identifies one element (Marketside's consistency) but fails to synthesize the broader portfolio evolution that defines the 3-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 410,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 through 2024, Lowe’s expanded its supplier‑monitoring framework by tightening its human‑rights, conflict‑minerals and Vendor Code of Conduct standards and, in 2023, overhauling its wood‑sourcing policy to add country‑specific risk levels, enhanced monitoring, and a new forestry grievance process (updated again in 2024 with a risk‑based approach). The company also broadened supplier engagement—encouraging CDP emissions reporting, partnering to cut scope‑3 GHGs, and investing in recycling, waste‑diversion audits, and energy‑efficiency/renewable‑energy projects (over $550 million in the past three years) to reinforce supply‑chain sustainability. These policy upgrades and capital investments collectively strengthened Lowe’s enforcement of environmental and human‑rights standards across its supply chain.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's supplier monitoring from 2022-2024 and correctly identifies key policy enhancements (wood sourcing policy updates in 2023, risk-based approach in 2024, forestry grievance process). However, there are significant quantitative accuracy issues: (1) The LLM states 'over $550 million in the past three years' which conflates two separate investment figures from the ground truth. The ground truth specifies '$550 million by 2022' (cumulative through 2022) and 'over $400 million through 2023' (cumulative through 2023)—these are not the same as a three-year total. The LLM's phrasing is ambiguous and potentially misleading about the investment timeline. (2) The ground truth provides specific investment milestones ($550M by 2022, $400M+ through 2023) that establish a progression, but the LLM collapses these into a single vague figure. (3) The LLM introduces additional details about 'CDP emissions reporting' and 'scope-3 GHGs' that are not mentioned in the ground truth, which could represent either extrapolation or information from different sources not validated here. (4) The LLM correctly identifies the core policy elements (human rights, conflict minerals, Vendor Code of Conduct, wood sourcing enhancements, grievance mechanisms) and the multi-year progression. The qualitative reasoning about policy tightening and enforcement strengthening is sound. The answer demonstrates good understanding of the multi-hop synthesis required (connecting policy changes across years with investment commitments), but the quantitative handling of investment figures is imprecise and potentially misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 453,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2022 and 2023 Form 10‑Ks list the 2.40% Notes due 2023 in Exhibit 4.3 (the officer’s certificate) as part of its outstanding debt. By the 2024 filing the same certificate still references the notes, but the debt schedule no longer lists them, indicating the notes had matured or been retired. This three‑year pattern shows Apple’s disciplined short‑term debt strategy—issuing notes with brief maturities and promptly repaying them to keep leverage low and liquidity high.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The identification of the 2.40% Notes due 2023 across 2022-2024 filings is accurate; (2) The reference to Exhibit 4.3 and the officer's certificate is correct; (3) The observation that the notes matured/were retired by 2024 aligns with the ground truth's acknowledgment they were 'set to mature within that year'; (4) The numeric values (2.40%, 2023 maturity date) are accurate. PROBLEMATIC ASPECTS: (1) The LLM claims 'the debt schedule no longer lists them' in 2024, but the ground truth states Apple 'still included the 2.40% Notes due 2023 in its exhibit list' in 2024, suggesting continued disclosure despite maturity—this is a factual contradiction; (2) The LLM's interpretation of the pattern differs significantly from ground truth: LLM emphasizes 'disciplined short-term debt strategy' and 'brief maturities,' while ground truth emphasizes 'sustained transparency' and 'stable and transparent debt disclosure strategy'—these represent different strategic conclusions; (3) The LLM's characterization of Apple 'issuing notes with brief maturities' is not supported by the ground truth, which focuses on disclosure consistency rather than issuance strategy; (4) The LLM's inference about 'keeping leverage low and liquidity high' goes beyond what the ground truth supports. MULTI-HOP REASONING: The LLM attempts to synthesize the 3-year pattern but reaches a different conclusion than the ground truth. The ground truth emphasizes transparency and legacy debt management, while the LLM emphasizes debt repayment discipline. The factual claim about 2024 disclosure (whether notes remained in exhibits) is the critical discrepancy. OVERALL: The answer demonstrates partial understanding with correct identification of key facts but misinterprets the significance of the disclosure pattern and makes an unsupported claim about 2024 exhibit removal.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 522,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note grew from **$900 million at 12/31/2022** to **$944 million at 12/31/2023** and to **$982 million at 12/31/2024** (page_73, page_74, page_70).  After divesting its AerCap equity, GE retained only the senior note, and the incremental increase in the note’s fair value reflects a deliberate shift from equity to a higher‑yielding debt position, underscoring a more income‑focused, risk‑managed investment strategy during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 baseline figure. The LLM states $900 million at 12/31/2022, but the ground truth clearly indicates $976 million in 2022. This is a $76 million discrepancy (7.8% error), which is material and unacceptable for financial data. The 2023 and 2024 figures ($944M and $982M) are correct and match the ground truth. MULTI-HOP REASONING ISSUES: The LLM's interpretation of the progression is fundamentally flawed. The ground truth describes a DECREASE from 2022 to 2023 ($976M to $944M), followed by an INCREASE to 2024 ($982M). The LLM incorrectly characterizes this as a continuous growth pattern ('grew from $900 million...to $944 million...to $982 million'), which misrepresents the actual trajectory. The correct pattern shows initial decline then recovery, not monotonic growth. STRATEGIC INTERPRETATION PROBLEMS: The LLM's narrative about 'incremental increase in the note's fair value' and 'shift from equity to higher-yielding debt position' is speculative and not supported by the ground truth answer. The ground truth emphasizes 'dynamic approach' and 'slight overall stability' with 'fluctuation,' whereas the LLM suggests a deliberate strategic shift with income-focused positioning. The ground truth also mentions broader portfolio changes (U.S. corporate debt and mortgage-backed securities), which the LLM completely omits. COMPLETENESS: The LLM fails to capture the full context of GE's investment strategy evolution, missing the reference to broader portfolio composition changes that the ground truth includes. The answer is incomplete in addressing the full scope of what the progression suggests about GE's strategy. CORRECT ELEMENTS: The 2023 and 2024 figures are accurate, and the general concept of managing financial assets is mentioned, though the execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 510,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—“reduce growth assets and increase liability‑hedging assets as the plan’s funded ratio rises” (see 2022 10‑K, p. 310)—remains unchanged, but the target mix has shifted.  In 2022 the target allocation was 15 % equity, 75 % fixed‑maturity and 10 % other (based on the Dec 31 2021 funded ratio), whereas the 2024 target (based on the Dec 31 2023 funded ratio) is 9 % equity, 80 % fixed‑maturity and 11 % other (p. 252).  The progressive drop in equity and rise in fixed‑maturity securities illustrate a deliberate de‑risking of the portfolio as the plan’s funded status improved.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AIG's pension plan glide path evolution. STRENGTHS: (1) Correctly identifies the glide path principle (reduce growth assets, increase liability-hedging as funded ratio improves), (2) Provides specific target allocations with correct percentages: 2022 allocation (15% equity, 75% fixed-maturity, 10% other) and 2024 allocation (9% equity, 80% fixed-maturity, 11% other), (3) Correctly links allocations to the appropriate funded status dates (Dec 31, 2021 for 2022 target; Dec 31, 2023 for 2024 target), (4) Accurately characterizes the de-risking strategy and its alignment with liability-driven investing, (5) Provides page references to source documents. MINOR WEAKNESSES: (1) The answer could have been more explicit about the 2023 intermediate year (target allocation for 2024 based on Dec 31, 2022 funded status), though this is implied in the progression, (2) The answer focuses on the 2022-2024 comparison rather than explicitly discussing all three years mentioned in the question (2022, 2023, 2024), though the core evolution is captured. QUANTITATIVE VERIFICATION: The percentages sum correctly (15+75+10=100 for 2022; 9+80+11=100 for 2024), and the directional changes are accurate (equity down 6 percentage points, fixed-maturity up 5 percentage points). The answer correctly synthesizes information across multiple years and documents to show the progression of the glide path strategy. The semantic meaning aligns well with the ground truth regarding the deliberate de-risking approach based on improving funded status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 449,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "From 2022 through 2024 Texas Instruments consistently reiterated that its core strategy is “analog + embedded processing” and that it places extra emphasis on industrial and automotive markets (2022 MD&A page 18; 2023 MD&A page 20; 2024 MD&A page 19).  The filings repeatedly note that this focus “allows us to generate strong cash flow from operations” and is the foundation of the company’s free‑cash‑flow‑per‑share growth strategy (2023 MD&A page 20; 2024 MD&A page 19).  The unchanging emphasis therefore signals that embedded‑processing products are a key lever for sustaining long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Texas Instruments' strategic evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core strategic narrative of 'analog + embedded processing' across all three years, matching the ground truth's emphasis on consistency; (2) Accurately cites specific MD&A page numbers (2022 page 18, 2023 page 20, 2024 page 19) which adds credibility and specificity; (3) Properly synthesizes the multi-hop connection between strategic emphasis and free cash flow per share growth, demonstrating understanding that this is a foundational pillar; (4) Correctly identifies industrial and automotive markets as key focus areas; (5) Uses appropriate quotations about cash flow generation that align with ground truth messaging. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'industrial and automotive markets' more prominently than the ground truth, which focuses more on the four sustainable competitive advantages and the value proposition ('more opportunity per customer'); (2) The ground truth explicitly mentions 'four sustainable competitive advantages' and 'supply chain control, customer reach, and diversified returns' as contextual elements that the LLM answer doesn't capture; (3) The LLM answer could have been slightly more explicit about the 'foundational pillar' language that appears in the ground truth. QUANTITATIVE ACCURACY: No numerical calculations are required for this question, but the page number citations appear reasonable and consistent with typical MD&A structure. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects strategic emphasis to financial outcomes (free cash flow per share growth), demonstrating sound multi-hop reasoning. The conclusion that this represents a 'key lever' rather than a 'tactical shift' aligns well with the ground truth's characterization of it as foundational. SEMANTIC EQUIVALENCE: The LLM's statement that embedded processing is 'a key lever for sustaining long-term free-cash-flow-per-share growth' is semantically equivalent to the ground truth's assertion that it's 'a foundational pillar in TI's long-term cash flow generation strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 600,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024, Lowe’s IP strategy continued to protect its private‑brand trademarks—Kobalt, STAINMASTER, and allen+roth—while shifting toward a more active brand‑portfolio focus (see page 7, 2022‑24).  In 2023 and 2024 the company highlighted high‑value private brands in its product selection (page 6, 2023‑24) and embedded them in its digital‑transformation agenda, using omnichannel, digital‑inspiration, design, and project‑management tools to promote private‑brand products across online and in‑store channels (page 7, 2023‑24).  This evolution moved the strategy from a purely protective stance to a digitally‑enabled brand‑promotion focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three core private brands (Kobalt, STAINMASTER, allen+roth) that remained consistent across the period. (2) The answer accurately captures the shift toward digital transformation and omnichannel integration in 2023-2024. (3) The characterization of evolution from 'protective stance to digitally-enabled brand-promotion focus' aligns with the ground truth narrative. (4) The fiscal year references (2022-24) are correct. WEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the removal of 'RONA' and 'Reno Depot' from the IP disclosure between fiscal 2022 and 2023, which is a key factual element in the ground truth. This represents a significant streamlining of brand portfolio emphasis that the ground truth explicitly highlights. (2) The LLM provides page references ('page 7, 2022-24', 'page 6, 2023-24') that cannot be verified against the ground truth and appear to be fabricated or hallucinated citations. (3) The answer lacks specificity about the 'simplification or refocusing' aspect mentioned in the ground truth regarding the removal of retail names. (4) While the LLM mentions digital tools (omnichannel, digital-inspiration, design, project-management), it doesn't explicitly connect these to 'remote customer support and mobile checkout' mentioned in the ground truth. MULTI-HOP REASONING: The LLM demonstrates partial synthesis across the three-year period but misses a critical data point (the brand portfolio reduction) that is essential to understanding the IP strategy evolution. The connection between brand streamlining and digital integration is incomplete. SEMANTIC EQUIVALENCE: The core narrative about digital transformation integration is semantically equivalent to the ground truth, but the omission of the brand portfolio reduction represents a material factual gap rather than a wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 512,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a core competitive differentiator in its 10‑K filings (2022 p. 4; 2023 p. 3; 2024 p. 3).  In 2024 the company expands that emphasis by explicitly tying trust to security in its hybrid‑cloud and AI platform narrative (2024 p. 5), underscoring that reliable, secure AI deployments are a key part of the value it delivers.  This steady, deepening focus signals IBM’s intent to leverage its long‑standing client trust as a strategic advantage, positioning itself as the trusted partner for enterprises moving to hybrid cloud and AI.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM consistently emphasized client relationships and trust across 2022-2024, and accurately notes the expansion of this emphasis to include security in 2024. However, the answer has significant gaps in completeness and multi-hop synthesis compared to the ground truth. Strengths: (1) Correctly identifies the core theme of trust as a differentiator across all three years; (2) Accurately captures the 2024 evolution linking trust to security; (3) Page references appear reasonable (though not verified against actual filings). Weaknesses: (1) MAJOR OMISSION - Fails to mention the 2023 strategic partnerships with AWS, Microsoft, and SAP, which the ground truth identifies as a key evolution point showing ecosystem-driven approach; (2) INCOMPLETE SYNTHESIS - Does not capture the progression from 2022 (hybrid cloud/AI platform integration with industry expertise) to 2023 (partnership ecosystem expansion) to 2024 (security partners like Palo Alto Networks); (3) MISSING CONTEXT - Does not explain how the strategic partnerships represent a broader ecosystem-driven approach to client value delivery; (4) INCOMPLETE TRAJECTORY ANALYSIS - The ground truth emphasizes a 3-year trajectory showing trust increasingly tied to both technical capabilities AND partner ecosystem, but the LLM answer only addresses the security dimension in 2024. The LLM answer provides a narrower, less comprehensive view of the strategic evolution. While the answer is not factually incorrect in what it states, it significantly underrepresents the multi-hop complexity of the question by omitting the critical 2023 partnership evolution that demonstrates IBM's strategic positioning shift. The answer reads more as a summary of 2024 positioning rather than a true multi-year progression analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 493,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In 2022 the El Segundo, California site was used only for clinical manufacturing of cell‑therapy products. By 2023 it had expanded to handle both clinical and commercial manufacturing and processing of cell‑therapy products (page 11). The 2024 10‑K confirms the continued dual role, with the facility supporting both clinical and commercial production of cell‑therapy products (page 11).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the key evolution of the facility's role. The LLM claims that in 2022 the El Segundo facility was used ONLY for clinical manufacturing, and then EXPANDED in 2023 to handle both clinical and commercial manufacturing. However, the ground truth explicitly states that in 2022, the facility was already described as being utilized for BOTH clinical and commercial manufacturing and processing. This is a fundamental factual error that inverts the actual timeline. The ground truth indicates NO significant changes in responsibilities across 2022-2024, with the facility maintaining a consistent dual role throughout. The LLM's narrative of expansion from clinical-only to dual-role is factually incorrect. While the LLM correctly identifies that by 2023-2024 the facility had a dual role, it incorrectly characterizes 2022 as clinical-only, creating a false narrative of evolution. The LLM also provides page references (page 11) which cannot be verified but appear to be fabricated or misinterpreted. The question asks about evolution from 2022-2024, and the correct answer is that there was NO significant evolution - the facility maintained consistent responsibilities. The LLM's answer fundamentally misrepresents this stability as a change/expansion, which is the opposite of the ground truth conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 385,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowe’s issued its 4.550% notes in 2019 (Fifteenth Supplemental Indenture, April 5 2019) with a maturity of April 5 2049, and the notes remained unchanged through 2022‑2024—no new 4.550% issuances or maturity changes were disclosed in the 2022‑2024 10‑Ks. This steady, long‑term debt profile shows the company’s strategy of locking in a fixed coupon and extending maturities to reduce refinancing risk and maintain a stable capital structure. (Source: page_76, 4.16)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. STRENGTHS: (1) All numeric values are correct - 4.550% coupon rate, April 5, 2019 issuance date, April 5, 2049 maturity date are all accurate. (2) Correctly identifies the Fifteenth Supplemental Indenture as the governing document. (3) Accurately synthesizes the multi-year pattern (2022-2024) by noting no new issuances or maturity changes occurred. (4) Provides sound strategic interpretation: the stability of this debt instrument across three years indicates a deliberate long-term debt strategy focused on fixed coupons, extended maturities, and refinancing risk reduction. (5) The reasoning about capital structure stability is logically sound and matches the ground truth's emphasis on 'long-duration debt' and 'avoiding near-term refinancing risks.' MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, focusing on the key strategic insight rather than elaborating on 'capital flexibility' mentioned in the original. However, this is not an error—it's a matter of emphasis. (2) The LLM correctly notes that the instrument 'remained unchanged' across the period, which is the core finding. (3) The citation to 'page_76, 4.16' provides specific sourcing, adding credibility. VERIFICATION: The multi-hop synthesis correctly combines: (a) the issuance details from 2019, (b) the consistent presence across 2022-2024 filings, and (c) the strategic implications of this stability. No calculation errors or factual inaccuracies detected. The answer fully addresses the question about how the structure 'evolved' (answer: it didn't change, which is itself informative) and what this indicates about long-term debt strategy (answer: commitment to long-duration, fixed-rate debt with reduced refinancing risk).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 494,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 to 2024, 3M’s legal exposure over its Scotchgard product grew markedly as the number of PFAS‑related lawsuits climbed from roughly 2,000 in 2021 to about 6,800 by the end of 2023, and the company entered into a $10.5‑$12.5 billion public‑water‑system settlement that was recorded as a $10.3 billion pre‑tax charge in Q2 2023 【page_98】【page_93】.  This steep rise in litigation and the size of the settlement underscore the substantial financial toll PFAS litigation has taken on 3M, with large, ongoing exposure and significant cash‑flow impacts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about Scotchgard-specific legal exposure evolution from 2022-2024. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites a $10.5-$12.5 billion public water system settlement recorded as $10.3 billion in Q2 2023, which appears to conflate 3M's broader PFAS litigation settlement with Scotchgard-specific cases. The ground truth identifies specific Scotchgard settlements: $65 million in 2022 (Michigan/Wolverine) and $65 million in 2024 (New York), not the multi-billion dollar figure cited. The LLM's numbers relate to 3M's overall PFAS exposure, not Scotchgard specifically. (2) INCOMPLETE SYNTHESIS: The LLM fails to track the year-by-year evolution requested. Ground truth shows: 2022 (Michigan consolidated action, $65M settlement), 2023 (68 AFFF suits, Illinois case, Canadian class action, Michigan settlement finalized), 2024 (Alabama/Georgia expansion, municipal utilities, $65M New York settlement, 2026 trial dates). The LLM provides none of this granular progression. (3) ENTITY CONFUSION: The answer conflates general PFAS litigation numbers (2,000 to 6,800 suits) with Scotchgard-specific exposure, which are different legal matters. (4) MISSING CONTEXT: The answer omits the geographic expansion pattern (NY, MI, IL, Canada, then AL, GA), the specific defendant categories (municipalities, property owners, carpet manufacturers), and the escalating complexity noted in ground truth. (5) REASONING FLAW: While the LLM correctly identifies an escalating financial burden, it does so using incorrect data points that don't specifically address Scotchgard litigation. The answer reads as a generic PFAS settlement discussion rather than a Scotchgard-focused analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 481,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 through 2024 Gilead’s Foster City, California site has remained the core hub for clinical‑trial R&D and manufacturing.  The 2024 10‑K confirms that the facility is used for process‑chemistry research, analytical‑method development, formulation, device development and for manufacturing API and drug product for clinical trials, a role that has not changed from earlier filings (GILD_10k_2024, pages 11‑12).  Thus, the facility’s R&D focus and manufacturing responsibilities have stayed consistent, and it continues to be strategically aligned with Gilead’s global network of sites that support both clinical development and commercial manufacturing.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUE - CONTRADICTS GROUND TRUTH: The LLM answer fundamentally misrepresents the evolution of the Foster City facility by claiming it 'has remained...consistent' and 'has not changed from earlier filings.' This directly contradicts the ground truth, which explicitly documents a TRANSITION from 2022 to 2023-2024. The ground truth states: 'transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development...' This represents a strategic shift, not consistency. CORRECT ELEMENTS: (1) The LLM correctly identifies the 2024 facility functions (process chemistry research, analytical method development, formulation, device development, API and drug product manufacturing for clinical trials). (2) The page references (pages 11-12 of 2024 10-K) appear reasonable. (3) The identification of Foster City as a clinical-trial R&D and manufacturing hub is accurate. CRITICAL ERRORS: (1) The LLM fails to recognize the evolution/transition that occurred between 2022 and 2023-2024. (2) The LLM misses the strategic shift toward consolidating R&D and clinical production in Foster City. (3) The LLM does not acknowledge the distinction between Foster City's role versus other locations (La Verne, Oceanside, international sites) for commercial-scale manufacturing. (4) The claim that the role 'has not changed from earlier filings' is factually incorrect based on the ground truth documentation. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the 2022-2024 period, instead treating the facility's role as static. This is a fundamental failure in addressing the core question about how utilization 'evolved.' The answer reads as if only 2024 data was consulted, missing the comparative analysis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 520,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 through 2024 AIG maintained a consistent, formalized loss‑reserve oversight framework that includes risk‑committee reviews, escalation procedures, and a model‑risk management and validation process. The company continued to use both stochastic and deterministic models for reserve estimation, supplementing them with third‑party catastrophe models and scenario analysis, and it kept an external‑expert review of reserve assumptions and results to provide independent validation. While the core oversight and modeling approach remained largely unchanged, 2024 filings emphasize tighter integration of these reviews within the broader risk‑measurement and monitoring system and a more explicit focus on experience‑based updates and scenario‑driven adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AIG's loss reserves risk management evolution but has significant gaps in completeness and reasoning quality. STRENGTHS: (1) Correctly identifies the time period (2022-2024) and company (AIG); (2) Accurately mentions key oversight mechanisms (risk-committee reviews, escalation procedures, model-risk management); (3) Correctly identifies modeling approaches (stochastic and deterministic models, scenario analysis, third-party catastrophe models); (4) Properly notes external expert reviews for independent validation; (5) Recognizes the integration trend toward broader risk-measurement systems. WEAKNESSES: (1) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a clear progression from 'reactive oversight' (2022) to 'proactive, model-driven, enterprise-wide risk governance' (2024), but the LLM states the approach 'remained largely unchanged,' which contradicts the actual evolution described in the ground truth; (2) MISSING KEY 2023 DEVELOPMENTS - The ground truth specifically highlights 2023 as a turning point where AIG 'expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies,' but the LLM does not distinguish this intermediate evolution; (3) MISSING ERM FRAMEWORK INTEGRATION - The ground truth emphasizes 2024's integration into 'enterprise risk management (ERM) framework' with 'second-line review and challenge of reserving models,' which the LLM only vaguely references as 'tighter integration'; (4) MISSING ENHANCED REPORTING EVOLUTION - The ground truth notes 'enhanced reporting to committees and regulators' in 2024, which is absent from the LLM answer; (5) SEMANTIC MISCHARACTERIZATION - By stating the core approach 'remained largely unchanged,' the LLM fundamentally misrepresents the ground truth's characterization of a meaningful progression toward sophistication and enterprise-wide integration. The LLM answer reads more as a static description of 2024 practices rather than a dynamic evolution across the three-year period. QUANTITATIVE ACCURACY is high (no incorrect numbers or dates), but QUALITATIVE ACCURACY suffers from incomplete synthesis of the multi-hop evolution narrative and failure to capture the progression from reactive to proactive governance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 618,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 through 2024 TI’s Melaka site remained an analog‑only manufacturing location, with no embedded‑processing operations added [page_18] [page_18] [page_18]. The facility’s ownership status shifted from partly owned to fully leased, as the footnote changed from “* Portions of the facilities are leased and owned” in 2022 to “** Leased” in 2024 [page_18] [page_18] [page_18]. This steady analog focus, coupled with a move to leasing, signals TI’s intent to maintain analog capacity in Melaka while reducing capital commitments and not expanding embedded‑processing capacity there.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. CORRECT ELEMENTS: (1) Core fact verified - Melaka remained analog-only manufacturing from 2022-2024 with no Embedded Processing operations added, matching ground truth exactly. (2) Ownership status evolution correctly identified - shift from partial ownership/leasing in 2022 to full leasing in 2024, with specific footnote references provided. (3) Multi-hop reasoning sound - the answer synthesizes facility type (analog-only), ownership changes, and strategic implications across the 3-year period. (4) Entity accuracy confirmed - Texas Instruments (TI/TXN), Melaka Malaysia, Analog vs. Embedded Processing correctly identified. (5) Temporal accuracy - 2022-2024 period correctly analyzed. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by adding interpretive analysis about 'reducing capital commitments' and 'not expanding embedded-processing capacity' - while these are logical inferences from the ownership shift and product focus data, they represent analytical interpretation rather than explicit ground truth statements. However, this interpretation is reasonable and well-supported by the facts presented. The answer is more detailed than the ground truth while remaining factually accurate. No calculation errors present. The semantic meaning aligns perfectly with the original answer regarding the 'stable but specialized role' of Melaka in TXN's manufacturing strategy. Page references provided add credibility to sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 427,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In FY 2022 Lowe’s had $2.56 billion of forward‑rate‑swap notional amounts (Note 9, page 45).  The fair value of those swaps fell to $251 million in FY 2023 and to $0 in FY 2024 (page 54).  This trend shows the company used forward‑rate swaps as cash‑flow hedges for forecasted debt issuances and then scaled them back as its borrowing plans diminished (page 46).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $251 million fair value for FY 2023 forward interest rate swaps, matching the ground truth. (2) The progression from positive notional amounts to $0 in FY 2024 is accurately captured. (3) The LLM correctly identifies these as cash-flow hedges for forecasted debt issuances. (4) The general conclusion about scaling back is directionally correct.\n\nWEAKNESSES: (1) The $2.56 billion notional amount for FY 2022 is provided but not verified against ground truth - the original answer does not specify this number, making it difficult to confirm accuracy. (2) The LLM answer is incomplete in addressing the full evolution: it mentions FY 2022-2024 but lacks the historical context (2019-2021) that the ground truth emphasizes as important context for understanding the hedging strategy. (3) The LLM answer misses the strategic shift narrative: the ground truth emphasizes a transition FROM hedging forecasted debt issuances TO managing interest rate exposure on existing debt via fixed-to-floating swaps. The LLM only mentions the scaling back due to diminished borrowing plans, which is a partial explanation. (4) The LLM answer lacks discussion of the shift to fixed-to-floating interest rate swaps as fair value hedges on existing debt in FY 2024, which is a key element of the strategic shift. (5) The answer is somewhat superficial in explaining what the progression 'indicates' - it states borrowing plans diminished but doesn't fully capture the strategic reorientation toward managing existing debt rather than hedging future issuances.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and connects the numerical progression to a business strategy explanation. However, the reasoning is incomplete because it doesn't fully synthesize the shift in hedging instruments (from forward swaps to fixed-to-floating swaps) or the broader strategic context.\n\nNUMERIC VERIFICATION: The $251 million for FY 2023 is confirmed correct. The $0 for FY 2024 is confirmed correct. The $2.56 billion for FY 2022 cannot be contradicted by the ground truth but also cannot be verified as it's not mentioned in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 592,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022, 2023 and 2024 10‑K filings all reference the 6.50% Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8 1998” (page 31 of the 2022 filing, page 19 of the 2023 filing, page 19 of the 2024 filing). The unchanged wording across three consecutive years shows that the debt instrument has not been amended, re‑issued or otherwise restructured since its original 1998 filing. This consistency indicates a stable, long‑term debt structure that IBM continues to rely on the original 1998 documentation for ongoing reference.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All numeric values are correct - the 6.50% interest rate, the 2028 maturity date, and the January 8, 1998 filing date are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies that the same exhibit reference appears across all three years (2022, 2023, 2024) and draws the appropriate conclusion about stability and lack of amendments. (3) The reasoning is logical and well-articulated - the connection between unchanged documentation references and stable debt structure is valid. (4) Page number citations (31 for 2022, 19 for 2023, 19 for 2024) add specificity and demonstrate careful sourcing. (5) The semantic meaning matches the ground truth perfectly - both answers convey that the consistency of the 1998 filing reference indicates no material changes to the debt instrument over the three-year period. MINOR CONSIDERATIONS: The LLM answer includes page number citations that, while helpful for verification, are not explicitly mentioned in the ground truth answer. However, this represents added value rather than an error. The phrasing \"IBM continues to rely on the original 1998 documentation for ongoing reference\" is a slightly more interpretive statement than the ground truth's \"indicating a stable and long-standing debt instrument,\" but both convey equivalent meaning about the stability and continuity of the debt structure. No calculation errors, no factual inaccuracies, and the multi-hop reasoning across three years of filings is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 433,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective signage has stayed within 3M’s Transportation and Electronics segment throughout the three‑year period.  In the 2023 10‑K it is listed as a key product of that segment (page 107), and it appears unchanged in the 2024 10‑K product table (page 110) even after the creation of the new Commercial Branding and Transportation division.  The absence of any re‑classification or removal across 2022‑24 indicates that 3M treats reflective signage as a stable, core element of its transportation‑safety portfolio, underscoring its strategic importance in the company’s product mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally fails to address the core question about how Reflective Signage's positioning evolved across 2022, 2023, and 2024. CRITICAL ERRORS: (1) The LLM provides NO positional data for any of the three years - it does not mention that Reflective Signage was 5th in 2022, 4th in 2023, or 4th in 2024. (2) The LLM does not identify the specific products that preceded or followed Reflective Signage in each year (advanced ceramics, attachment tapes, light management films, sound and temperature management, etc.). (3) The LLM completely misses the key finding that Reflective Signage moved from 5th position in 2022 to 4th position in 2023 - a significant positional shift that the ground truth identifies as 'a slight early boost in prominence.' (4) The LLM's claim about 'absence of any re-classification or removal' is vague and does not capture the nuanced positional changes documented in the ground truth. (5) The LLM references page numbers (107, 110) without providing the actual positional data that would support the analysis. The LLM answer is essentially a generic statement about Reflective Signage remaining in the segment without the specific multi-hop synthesis of positional data across three years that the question requires. While the LLM correctly identifies that Reflective Signage remained in the Transportation and Electronics segment, it fails to provide the detailed positional evolution that is the heart of the question and the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 412,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead has kept its Hoofddorp, Netherlands site as a core commercial manufacturing hub for cell‑therapy products throughout 2022‑2024.  Each 10‑K lists the facility as “used for commercial manufacturing and processing of our cell‑therapy products” (2022 p. 35; 2023 p. 11; 2024 p. 12), and no filings report a change in capacity, scope, or a shift in strategic priority.  Thus, the facility’s role and strategic importance to commercial production have remained stable over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the facility's role EVOLVED from 2022 through 2024, with 2022 showing it as 'one of its principal manufacturing facilities' (general designation), 2023 showing explicit description as 'utilized for commercial manufacturing and processing of cell therapy products,' and 2024 retaining this designation with 'growing strategic importance.' The LLM answer claims the facility's role 'remained stable over the period' with 'no change in capacity, scope, or shift in strategic priority,' which directly contradicts the ground truth's narrative of evolution and increasing emphasis. Additionally, the LLM provides specific page citations (2022 p. 35; 2023 p. 11; 2024 p. 12) that cannot be verified and appear to be fabricated, as the ground truth does not provide these specific page references. The LLM misses the key insight that the facility's strategic importance GREW over the period, moving from general principal facility status to explicit cell therapy manufacturing focus to recognized 'growing strategic importance.' The question specifically asks about evolution 'particularly in terms of its strategic importance,' which the LLM fails to address correctly. While the LLM correctly identifies the facility location (Hoofddorp, Netherlands) and general function (cell therapy manufacturing), it fundamentally mischaracterizes the trajectory of change, presenting stability where the ground truth indicates progression and increasing strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 437,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 2003 Director Compensation Plan has no shares available for future issuance in the 2022, 2023, and 2024 tables (see note (c) on pages 63, 61, and 59). This consistent absence indicates that Texas Instruments has phased out or no longer uses the 2003 plan for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims there are 'no shares available' in 2022, 2023, and 2024, but the ground truth explicitly states specific share counts: 1,843,134 shares (2022), 1,786,785 shares (2023), and 1,745,284 shares (2024). These are precise, documented figures that the LLM completely misrepresented. (2) FACTUAL ERROR: The LLM's core claim that the plan has 'no shares available for future issuance' directly contradicts the ground truth data showing declining but positive share availability each year. (3) REASONING FAILURE: The LLM drew an incorrect conclusion (plan phased out/no longer used) based on a false premise (no shares available). The actual trend shows the opposite - consistent active use with shares being issued annually, as evidenced by the year-over-year decline in available shares. (4) MULTI-HOP SYNTHESIS: The question required tracking share availability across three years (2022-2024) and interpreting the trend. The LLM failed to identify the correct numbers from any year and therefore could not perform the required multi-hop analysis. (5) SEMANTIC EQUIVALENCE: There is no semantic equivalence here - the answers are contradictory. The ground truth shows active ongoing use with declining available shares; the LLM claims the plan is phased out with zero shares. This is a complete factual inversion. The LLM appears to have misread or misinterpreted the source material, possibly confusing 'no shares available' with a different metric or misunderstanding footnote (c).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 437,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 10‑K the 0.950% Notes due 2025 are not referenced, indicating the instrument had not yet been issued or publicly disclosed (page 28). By 2023 the notes appear only as an exhibit, confirming issuance but still lacking a public listing (page 20). In 2024 they are listed as a registered security with NYSE symbol IBM25B, reflecting full market transparency and signaling IBM’s broader strategy to diversify its capital structure, enhance liquidity, and engage investors with more accessible debt offerings (page 1).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - 2022 Status: The LLM claims the notes were 'not referenced' in 2022, but the ground truth explicitly states IBM 'referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments' in 2022, citing the May 22, 2017 Form 8-K filing. This is a major factual inaccuracy. (2) CRITICAL ERROR - 2023 Status: The LLM states notes 'appear only as an exhibit, confirming issuance but still lacking a public listing,' but the ground truth indicates IBM 'continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence.' The LLM mischaracterizes the 2023 treatment. (3) CORRECT - 2024 Status: The LLM correctly identifies that by 2024 the notes were 'listed as a registered security with NYSE symbol IBM25B,' which aligns with the ground truth's statement about 'explicit listing with a dedicated trading symbol (IBM25B) on the New York Stock Exchange.' (4) REASONING ERROR: The LLM's narrative of progression from 'not referenced' → 'exhibit only' → 'registered security' is fundamentally wrong. The correct progression is 'referenced in debt list' → 'increased prominence alongside newer instruments' → 'explicit market listing with ticker.' (5) INTERPRETATION ERROR: The LLM's conclusion about 'capital structure diversification' and 'liquidity enhancement' may be reasonable inferences, but they are built on incorrect factual foundations about the 2022-2023 treatment. The ground truth emphasizes a progression toward 'greater transparency and investor accessibility,' which the LLM partially captures for 2024 but misses the earlier evolution. The answer fails on multi-hop synthesis by incorrectly characterizing the 2022-2023 baseline and trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 505,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply after 2022: deposit assets rose from roughly $1.8 billion (reported for 2021/2020) to $5.1 billion in 2023 and $4.6 billion in 2024, while deposit liabilities fell from $1.4 billion to $1.3 billion in 2023 and $1.2 billion in 2024【page_216】【page_206】. The 2023 Global Atlantic transaction—an in‑force block transfer that created $10.3 billion of deposit receivables and a $770 million net cost recorded as a deposit liability【page_206】—illustrates a strategic pivot to larger, modified‑coinsurance risk‑transfer deals that leverage the deposit method to manage both recoverables and asset transfers.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core numbers and multi-hop synthesis, but contains one significant error and some minor issues:\n\nSTRENGTHS:\n1. All deposit asset figures are correct: $1.8B (2022), $5.1B (2023), $4.6B (2024)\n2. All deposit liability figures are correct: $1.4B (2022), $1.3B (2023), $1.2B (2024)\n3. The $10.3 billion reinsurance recoverables/deposit receivables figure is accurate\n4. Correctly identifies the 2023 Global Atlantic transaction as a strategic shift\n5. Properly synthesizes multi-hop information across years and transaction types\n6. Good contextual framing of the deposit method evolution and strategic implications\n7. Appropriate use of citations to source pages\n\nWEAKNESSES:\n1. SIGNIFICANT ERROR: The LLM states the Global Atlantic transaction created \"a $770 million net cost recorded as a deposit liability.\" The ground truth does not mention a $770 million figure in this context. This appears to be either fabricated or misattributed information that cannot be verified against the ground truth.\n2. MINOR ISSUE: The LLM parenthetically notes \"(reported for 2021/2020)\" when discussing the $1.8 billion 2022 figure, which is confusing and potentially inaccurate. The ground truth clearly states this was the 2022 figure, not 2021/2020.\n3. The ground truth mentions \"reinsurance recoverables and deposit receivables\" while the LLM only mentions \"deposit receivables\" for the $10.3B figure, though this is a minor semantic difference.\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes information across three years (2022-2024) and connects the Global Atlantic transaction to the broader evolution of deposit method accounting. The reasoning that this represents a \"strategic pivot to larger, modified-coinsurance risk-transfer deals\" is sound and well-supported.\n\nCALCULATIONS:\nNo explicit calculations are required, but the trend analysis (assets rising then slightly declining, liabilities declining) is accurate.\n\nOVERALL ASSESSMENT:\nThe answer is substantially correct on the main quantitative facts and demonstrates good multi-hop synthesis. However, the unexplained $770 million figure and the confusing parenthetical about 2021/2020 reduce confidence in the response's reliability. The core answer about the evolution of deposit method accounting and the strategic significance of the Global Atlantic transaction is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 645,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "From 2022 through 2024, 3M’s Safety and Industrial segment consistently listed fall‑protection solutions as a core product line (see 2022 10‑K page 107, 2023 10‑K page 108, and 2024 10‑K page 108).  In 2024 the company reorganized the segment by creating an Industrial Specialties division that absorbed the former Personal Safety division (which houses fall‑protection products) along with Closure and Masking Systems and Industrial Adhesive & Tapes products (2024 10‑K page 110).  This 3‑year evolution—maintaining the product offering while consolidating it into a dedicated safety‑focused division—signals 3M’s sustained and intensified emphasis on workplace safety solutions, especially fall protection.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that fall protection solutions were consistently listed in MMM's Safety and Industrial segment from 2022-2024, matching the ground truth. The citation of specific 10-K page numbers (107, 108, 108) adds credibility and demonstrates multi-hop synthesis across three years of filings. The conclusion about sustained emphasis on workplace safety is semantically aligned with the ground truth.\n\nWEAKNESSES: (1) The LLM introduces significant new information not present in the ground truth about a 2024 reorganization creating an 'Industrial Specialties division' that absorbed the 'Personal Safety division' along with other product lines. While this may be factually accurate from the 2024 10-K, the ground truth makes no mention of this reorganization, suggesting either the LLM added unsupported detail or the ground truth was incomplete. (2) The LLM's interpretation that the reorganization signals 'intensified emphasis' on workplace safety is a stronger claim than the ground truth's more measured 'stable strategic focus.' This represents a difference in analytical interpretation. (3) The ground truth emphasizes 'consistency' and 'stable focus' across the three years, while the LLM emphasizes 'evolution' and 'consolidation,' which are different framings of the same period.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the product line's presence in each year. However, the introduction of the divisional reorganization detail creates ambiguity about whether this is supported by the ground truth or represents additional information the LLM sourced.\n\nNUMERIC/DATE ACCURACY: All years (2022, 2023, 2024) are correct. Page numbers cited (107, 108, 108) cannot be independently verified against ground truth but appear plausible.\n\nSEMANTIC EQUIVALENCE: The core message differs slightly—ground truth emphasizes stability and consistency, while LLM emphasizes evolution and intensification. Both reach similar conclusions about sustained focus on safety, but through different analytical lenses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 570,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST in the same ownership chain throughout 2022‑2024: Altria owns UST LLC, which in turn wholly owns U.S. Smokeless Tobacco Company LLC (USSTC)【page_4】【page_60】【page_64】.  The 2024 filing still lists UST as a wholly‑owned subsidiary and places it in the “oral tobacco products” segment, the same treatment it received in 2023 and 2022【page_4】【page_60】【page_64】.  This continuity shows that Altria is treating UST as a core, long‑term asset in its smokeless‑tobacco portfolio while expanding other smokeless and heated‑tobacco ventures (Helix, Horizon, NJOY) to reinforce its strategic shift toward a smoke‑free future.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate structural information about Altria's ownership of UST (Altria owns UST LLC, which owns USSTC) and correctly identifies UST's consistent classification as a wholly-owned subsidiary in the oral tobacco products segment across 2022-2024. However, the answer has significant gaps compared to the ground truth: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifically mentions UST trademarks valued at $8.8 billion in 2022 and amortization expenses - the LLM answer omits these important financial metrics entirely. (2) INCOMPLETE STRATEGIC NARRATIVE: The ground truth emphasizes Altria's 'Moving Beyond Smoking' initiative and strategic pivot toward reduced-risk tobacco offerings as a key evolution. The LLM answer mentions 'smoke-free future' but doesn't capture the specific strategic framing of transitioning adult smokers to less harmful products with the same emphasis. (3) PARTIAL MULTI-HOP SYNTHESIS: While the LLM correctly identifies the ownership structure continuity, it doesn't fully synthesize how the strategic positioning evolved from 2022 to 2024 in terms of Altria's broader vision. The answer focuses heavily on structural continuity but underemphasizes the strategic evolution aspect of the question. (4) CONTEXTUAL FRAMING: The LLM mentions other ventures (Helix, Horizon, NJOY) which adds context but wasn't in the ground truth answer, suggesting some independent reasoning. The answer is factually sound on what it covers but incomplete in addressing the full scope of the original question about strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 436,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the same exhibit – “One Hundred‑Sixteenth Supplemental Indenture, dated as of August 24 2015, … SolarCity’s 5.45% Solar Bonds, Series 2015/C92‑15” (see page_102 lines 52‑53 in each filing). The repeated inclusion shows that Tesla still holds this long‑term, fixed‑rate debt as a core part of its solar‑energy financing, indicating a deliberate strategy to use stable, low‑cost debt rather than issuing new equity or fresh debt for its solar initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial instrument (SolarCity 5.45% Solar Bonds, Series 2015/C92-15) and accurately cites the date (August 24, 2015) and its repeated appearance across 2022, 2023, and 2024 filings. The numeric values and dates are all correct. However, the answer has some limitations compared to the ground truth: (1) It provides specific page references (page_102 lines 52-53) which adds precision but cannot be verified against the ground truth; (2) The reasoning is somewhat more superficial than the ground truth - it focuses on the debt being 'low-cost' and 'stable' but doesn't fully explore the broader strategic implications about 'securitized solar debt as a core funding source' or Tesla's 'confidence in the bond's performance'; (3) The answer correctly synthesizes the multi-hop information (same bond across three years) but frames it primarily as a financing choice (avoiding new equity/debt) rather than as evidence of sustained reliance on structured solar financing mechanisms. The semantic meaning is largely equivalent - both answers conclude that Tesla maintains strategic commitment to this bond series - but the ground truth provides more comprehensive context about what this suggests about Tesla's long-term solar energy strategy. The answer is factually sound and addresses the core question, but lacks some of the deeper strategic analysis present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 395,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor disclosures in 2022, 2023 and 2024 all consistently state that “governmental and stock‑exchange regulations” can affect the value of its debt and equity securities, with no change in wording or emphasis. This steady language shows that IBM treats regulatory risk as a persistent factor and relies on ongoing monitoring and mitigation rather than altering its financing strategy over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about IBM's evolving exposure to stock exchange regulations from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and IBM as the subject company; (2) Accurately notes that regulatory risk language appears consistently across all three years; (3) Correctly identifies that the disclosures mention 'governmental and stock-exchange regulations' affecting debt and equity securities. CRITICAL WEAKNESSES: (1) The LLM claims 'no change in wording or emphasis' across the three years, which directly contradicts the ground truth that shows clear EVOLUTION - the 2024 disclosure expanded to link regulatory risk to 'broader market liquidity conditions and customer credit risks,' representing a more integrated view. This is a fundamental factual error about the multi-year progression. (2) The LLM fails to capture the ground truth's key finding that IBM showed 'increasing recognition of regulatory dynamics as a persistent and systemic component' - instead claiming static consistency. (3) The LLM misses the important distinction that 2023 emphasized 'external regulatory environments' as 'uncontrollable factors,' while 2024 showed integration with other risk factors. (4) The LLM's conclusion about 'ongoing monitoring and mitigation rather than altering financing strategy' is not supported by the ground truth, which explicitly states 'no material reduction in dependency or mitigation strategy' - a different and more critical assessment. (5) The answer fails to adequately address the question's core ask about what the 'multi-year progression reveals about capital market risk management strategy' - the ground truth shows increasing systemic integration, while the LLM suggests static monitoring. The LLM provides a superficially plausible but factually incomplete answer that misses the evolution narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 527,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022, 2023 and 2024, 3M’s Safety and Industrial segment consistently lists “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core offering (see pages 129, 107 and 110).  While net sales for the segment fell slightly from $11.60 B in 2022 to $10.96 B in 2024, operating income rose from $1.13 B to $2.49 B, indicating a shift toward higher‑margin electrical solutions (pages 108, 111).  This steady focus and improving profitability signals 3M’s deliberate positioning as a leading industrial supplier of electrical and power‑distribution components, reinforcing its footprint in construction and maintenance markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer has significant issues with both quantitative accuracy and completeness relative to the ground truth. QUANTITATIVE PROBLEMS: (1) The financial figures provided cannot be verified against the ground truth, which does not include specific net sales or operating income numbers. The LLM cites $11.60B in 2022 declining to $10.96B in 2024, and operating income rising from $1.13B to $2.49B - these numbers are presented as facts but are not confirmed in the ground truth and appear potentially inaccurate given the magnitude of the claimed operating income increase (120% growth). (2) Page references (129, 107, 110, 108, 111) are provided but cannot be verified against the ground truth source material. COMPLETENESS ISSUES: (1) The LLM answer completely omits the multi-year evolution of product descriptions that is central to the ground truth. The ground truth explicitly details how 2022 included 'Closure systems for personal hygiene products, masking, and packaging materials', how 2023 added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions', and how 2024 rephrased the segment description. (2) The LLM fails to capture the nuanced strategic evolution showing how MMM's portfolio shifted and expanded across the three years. (3) The ground truth emphasizes the 'subtle evolution' and 'shift toward emphasizing broader industrial specialties' - the LLM only mentions 'steady focus' without capturing this evolution. REASONING QUALITY: The LLM's inference that improving profitability signals 'deliberate positioning' is logical but is based on unverified financial data. The connection between margin improvement and strategic positioning is reasonable but not grounded in the actual product portfolio evolution that the ground truth emphasizes. WHAT WAS CORRECT: The LLM correctly identifies that electrical products remained a consistent core offering across all three years, and correctly names 3M/MMM and the Safety and Industrial segment. However, the answer fundamentally misses the core of the question by focusing on financial metrics rather than the actual evolution of product offerings and strategic positioning that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 594,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "Gilead’s Oceanside, California site has continued to serve the same dual role over the past three years: it is used for commercial retroviral‑vector manufacturing and for clinical manufacturing and process development of biologics candidates.  The 2024 10‑K (page 12) and the 2023 10‑K (page 12) both describe the facility in exactly the same terms, indicating no change in its utilization.  The 2022 10‑K (pages 31‑35) does not report a different use, implying that the facility’s role remained consistent from 2022 through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth clearly documents an evolution of the Oceanside facility's role from 2022-2024: (1) 2022: General R&D role as part of broader operational footprint, (2) 2023: Specifically highlighted for clinical manufacturing and process development of biologics, (3) 2024: Further emphasized as dedicated site for commercial retroviral vector manufacturing PLUS clinical manufacturing and process development. The LLM claims the facility's role 'remained consistent from 2022 through 2024' and that 2023 and 2024 10-Ks describe it 'in exactly the same terms,' which directly contradicts the ground truth's documented progression. The LLM also claims the 2022 10-K 'does not report a different use,' but the ground truth indicates 2022 referenced it only as part of general R&D footprint, not specifically for the specialized biologics and retroviral vector manufacturing roles highlighted in 2023-2024. The LLM failed to identify the strategic shift from general R&D to specialized, scaled-up manufacturing functions. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required—comparing facility utilization across three different fiscal years to identify evolution and strategic changes. The LLM's citation of specific page numbers (pages 12 and 31-35) cannot be verified but the substantive claim of no change is contradicted by the ground truth's explicit documentation of progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 413,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy for its U.S. pension plan has gradually tightened the “Return‑Seeking” (growth‑asset) target: it was 15 % of the portfolio in 2022, fell to 8 % in 2023, and then modestly rose to 9 % in 2024【page_310】【page_252】【page_252】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative data (15% in 2022, 8% in 2023, 9% in 2024) for the Return-Seeking portion target allocations, which directly addresses the core question about how the glide path evolved. The numbers appear plausible and are presented with page citations. However, the answer has several limitations: (1) It focuses narrowly on the percentage allocations without explaining the underlying mechanism of the glide path approach (forward-looking adjustments based on funded status), which is central to the ground truth answer. (2) The ground truth emphasizes that the glide path remained 'consistent in strategy' while evolving in target allocations based on funded status at specific dates, but the LLM answer only presents the numerical trend without this contextual framework. (3) The LLM answer characterizes the movement as 'gradually tightened' then 'modestly rose,' which is a reasonable interpretation of the data but doesn't capture the dynamic, funded-status-driven nature of the adjustments. (4) The answer lacks the temporal precision of the ground truth (e.g., 'target allocation set for 2024 based on funded status at December 31, 2023'). The quantitative accuracy is strong if the percentages are correct, but the qualitative understanding of the glide path mechanism is incomplete. The answer is partially correct and addresses the question but misses important nuances about how the approach works.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 399,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN kept its U.S. pension plans at 100 % debt securities, but shifted its non‑U.S. plans toward higher‑return assets: equity rose from 27 % to 28 %, debt fell from 48 % to 36 %, cash and short‑term investments grew from 4 % to 7 %, and insurance contracts jumped from 11 % to 21 % (with other assets dropping from 10 % to 8 %). This gradual move away from fixed‑income toward equity and insurance contracts indicates a more aggressive, higher‑risk tolerance for long‑term returns, while still maintaining a conservative stance for U.S. plans. The multi‑year shift reflects ACN’s willingness to accept interim market volatility in pursuit of higher long‑term performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth in multiple critical ways: (1) FACTUAL MISMATCH: The ground truth discusses ACN's target asset allocation strategy evolution and planning horizon extension (fiscal 2023→2024 to fiscal 2024→2025), emphasizing flexibility, risk-adjusted returns, and a measured approach. The LLM answer instead provides specific percentage allocations for U.S. and non-U.S. pension plans with concrete numbers (equity 27%→28%, debt 48%→36%, etc.). These specific percentages do not appear in the ground truth and represent a completely different interpretation of the data. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise percentage figures (27%, 28%, 48%, 36%, 4%, 7%, 11%, 21%, 10%, 8%) that cannot be verified against the ground truth. The ground truth makes no mention of these specific allocations or any numerical breakdown by asset class. This is a critical error for a financial question requiring precision. (3) CONCEPTUAL DIVERGENCE: The ground truth emphasizes strategic planning horizon extension and flexibility language as indicators of confidence and less reactive positioning. The LLM answer focuses on asset allocation shifts toward higher-return/higher-risk assets, characterizing the move as 'more aggressive.' These are fundamentally different interpretations of what the evolution suggests about risk tolerance. (4) MULTI-HOP REASONING: The ground truth's reasoning involves synthesizing information about planning horizons and strategic language across years. The LLM's reasoning involves synthesizing specific allocation percentages across asset classes and geographies—a different analytical framework entirely. (5) MISSING CONTEXT: The LLM answer completely ignores the ground truth's emphasis on matching debt security durations to liabilities, diversifying equities, and the significance of extending planning horizons. Instead, it focuses on asset class percentage shifts that aren't supported by the ground truth. The LLM answer appears to be based on different source data or a misinterpretation of the actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 568,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15 were issued in 2015 by SolarCity and appear unchanged in Tesla’s debt schedule in the 2022, 2023, and 2024 10‑K filings (Exhibit 4.36 on pages 104, 102, and 101). Across these years the bond series remains the same, showing that Tesla has retained the original long‑term, fixed‑rate debt rather than refinancing or restructuring it. This consistency underscores Tesla’s solar‑financing strategy of relying on stable, long‑term debt to fund solar projects, providing predictable interest costs and a steady capital base.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C25-15), the 2015 issuance date by SolarCity, and the consistent presence across 2022, 2023, and 2024 filings. (2) The numeric references to page numbers (104, 102, 101) and Exhibit 4.36 appear plausible for 10-K filings. (3) The core insight about long-term fixed-rate debt and stable financing strategy is sound. WEAKNESSES: (1) The LLM answer is narrower in scope than the ground truth - it focuses only on the C25-15 series remaining unchanged, while the ground truth reveals an EVOLUTION showing expansion of the financing framework with newer bond series (C28-15, C33-15) appearing by 2023. The question explicitly asks about 'evolution' and 'multi-year pattern,' which the LLM largely misses. (2) The LLM states the bond 'appears unchanged' and 'remains the same,' which is technically accurate for that specific series but fails to capture the broader strategic evolution of Tesla's solar financing approach across the three-year period. (3) The ground truth indicates an expansion of financing instruments (from C5-15, C10-15, C20-15 in 2022 to adding C28-15, C33-15 by 2023), suggesting a dynamic strategy, not merely retention of original debt. (4) The LLM's conclusion about 'relying on stable, long-term debt' is correct but incomplete - it doesn't address the strategic expansion evident in the multi-hop analysis across years. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but only at a surface level (same bond present each year). It fails to synthesize the deeper pattern of how the financing framework evolved with new series additions. SEMANTIC EQUIVALENCE: The LLM's interpretation of 'consistency' as 'no change' is technically correct for the C25-15 series specifically, but misses the broader evolution question. The answer is partially correct but significantly incomplete in addressing the multi-year evolution aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 537,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s overall approach to international terrorism exposure stayed consistent: it continues to use third‑party scenario‑based modeling, monitor exposure concentration, and rely on TRIPRA for U.S. losses, limited private reinsurance, and government‑sponsored terrorism pools abroad. The 2022 filing disclosed a specific $1.3 billion loss estimate for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, whereas the 2024 filing omits a single‑scenario figure and instead emphasizes a broader scenario‑based estimate and routine concentration monitoring. Reinsurance strategies remained unchanged—TRIPRA, targeted reinsurance for high‑concentration lines, and participation in non‑U.S. terrorism pools—while risk‑mitigation mechanisms across global jurisdictions continued to focus on scenario analysis, exposure concentration oversight, and targeted reinsurance purchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's terrorism exposure management evolution but has some notable gaps and omissions compared to the ground truth. STRENGTHS: (1) Correctly identifies the $1.3 billion loss estimate for the five-ton bomb attack in New York City net of TRIPRA and reinsurance in 2022; (2) Accurately captures the shift from specific scenario disclosure in 2022 to broader scenario-based estimates in 2024; (3) Properly synthesizes the consistent reliance on TRIPRA, government-sponsored pools, and scenario-based modeling across the period; (4) Correctly identifies the multi-hop evolution across three years. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions AIG enhanced global property per risk covers and retained core attachment points for Japan at $200 million in 2024—the LLM answer completely omits this important 2024-specific detail; (2) CRITICAL OMISSION: The ground truth states reinsurance recoverable assets reached $38.0 billion by end of 2024, indicating significant scaling of risk transfer mechanisms—the LLM answer fails to include this quantitative metric entirely; (3) The LLM answer states reinsurance strategies 'remained unchanged' which is somewhat imprecise given the ground truth indicates evolution in 'reinsurance structure and global coverage specificity'; (4) The LLM characterizes 2023 focus as 'active management and monitoring' but the answer doesn't explicitly highlight this as a distinct evolution point. QUANTITATIVE ACCURACY: The $1.3 billion figure is correct and properly contextualized. However, the complete absence of the $38.0 billion reinsurance recoverable assets figure and the $200 million Japan attachment point represents significant quantitative omissions. QUALITATIVE ACCURACY: The reasoning about the shift from specific to broader scenario modeling is sound, and the synthesis of consistent mechanisms is logical. However, the failure to identify and explain the 2024 enhancements (Japan attachment points, global property per risk covers) represents incomplete multi-hop synthesis. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on evolution from 2022-2024 and covers the three requested dimensions (modeled loss estimates, reinsurance strategies, risk mitigation mechanisms), but incompletely on the 2024 specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 629,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 2022‑2024 risk‑factor disclosures for the Safety and Productivity Solutions segment all use the same wording, indicating that the company’s exposure to adverse industry economic conditions remained consistently high over that period.  Each filing lists the same set of margin‑pressure drivers—reduced investment in process automation, safety monitoring and plant capacity initiatives; retail‑market volatility; a slowdown in safety‑product demand; competitive pressure and technology‑driven commoditization; and broader adverse industry economic conditions—as key risks that could lower market share, selling prices and margins.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the consistent nature of risks across 2022-2024 and accurately lists the specific margin-pressure drivers (reduced process automation investment, retail volatility, commoditization, adverse industry conditions). However, there are significant issues with completeness and multi-hop synthesis: (1) The LLM claims 'the same wording' was used across all three years, which is an overstatement—the ground truth indicates risks were 'reiterated' and 'similar' but with year-specific variations (e.g., 2023 added explicit mention of 'lower market share and reduced selling prices,' 2024 involved segment restructuring). (2) The LLM fails to address the temporal evolution aspect of the question—it presents the risks as static rather than showing how they evolved or were emphasized differently across the three-year period. (3) The LLM misses the important contextual detail about the 2024 restructuring where Safety and Productivity Solutions became the Industrial Automation segment, which is relevant to understanding how the segment's risk profile was presented. (4) The LLM adds 'safety monitoring and plant capacity initiatives' as a specific risk driver, which is not explicitly mentioned in the ground truth's characterization of the risks. (5) The answer lacks the nuanced understanding that the ground truth provides about the 'persistent vulnerability' despite restructuring. Quantitatively, no numbers or dates are incorrect (all years 2022-2024 are correct), but the qualitative synthesis of how risks evolved is incomplete and somewhat misleading by suggesting identical wording across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 448,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "From 2022 through 2024 Pfizer’s share‑based‑payment notes (page 95, page 99, page 96) all state that **no Breakthrough Performance Awards were granted or outstanding** in any of those years.  The valuation method for BPAs is consistently described as the **intrinsic‑value method using the closing price of Pfizer’s common stock**, and any compensation cost that would have been recognized is **amortized on a straight‑line basis over the probable vesting term into operating expenses, with periodic adjustments for stock‑price changes and performance‑criteria probability** (page 95, page 99, page 96).  Consequently, the treatment of BPAs remained unchanged across the three years—zero grant activity and identical accounting guidance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core factual claims. The ground truth explicitly states that in 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained nonvested at year-end. The LLM claims 'no Breakthrough Performance Awards were granted or outstanding in any of those years' - this directly contradicts the documented 2022 grant activity. The LLM also misses the key evolution described in the ground truth: (1) 2022 had active grant activity (1,165k granted), (2) 2023 showed complete wind-down (no BPAs outstanding), and (3) 2024 focused on valuation methodology. The LLM incorrectly characterizes the treatment as 'unchanged across the three years' when the ground truth shows a clear progression from active issuance to complete elimination. While the LLM correctly identifies the intrinsic value method and amortization approach, this accuracy on methodology cannot offset the major quantitative errors regarding grant amounts and the failure to capture the program's evolution. The answer demonstrates a fundamental misreading of the source documents and fails to synthesize the multi-hop information about how the program changed over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 357,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture’s share‑repurchase program has expanded dramatically from fiscal 2022 to fiscal 2024. In 2022 the company bought 12 million shares for about $4.1 million and had an aggregate available authorization of $3.1 million (page 94). By fiscal 2024, share purchases totaled $4.5 billion (cash returned to shareholders) and the remaining available authorization had fallen to $2.7 billion, although the Board added $4.0 billion of new authority, raising total outstanding authorization to $6.7 billion (pages 39‑40). This trend shows Accenture is aggressively returning capital to shareholders while simultaneously increasing its repurchase ceiling to preserve flexibility for future capital‑return decisions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR QUANTITATIVE ERRORS: The LLM states 'In 2022 the company bought 12 million shares for about $4.1 million' - this is off by a factor of 1,000. The actual figure should be approximately $4.1 BILLION, not $4.1 million. Similarly, the LLM states 'aggregate available authorization of $3.1 million' when the ground truth clearly states $3,129,296,000 (i.e., $3.1 BILLION). This is a catastrophic error in magnitude. (2) CALCULATION/SYNTHESIS ISSUES: The LLM correctly identifies the $2.7 billion remaining authorization and $4.0 billion new authority totaling $6.7 billion, which matches ground truth. However, the foundational errors about fiscal 2022 figures undermine credibility. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize information across fiscal years and connect it to capital return strategy, which is appropriate. The conclusion about 'aggressively returning capital to shareholders' is reasonable given the data, though based on incorrect premises. (4) ENTITY ACCURACY: Accenture is correctly identified, fiscal years are correct, and financial metrics are appropriately labeled. (5) SEMANTIC ISSUES: While the LLM's interpretation of the trend (increasing commitment to shareholder returns) aligns with ground truth, the foundational numerical errors are disqualifying. The statement about 'expanding dramatically' is undermined by the fact that the base numbers are wrong by orders of magnitude. The answer demonstrates understanding of the question structure and general capital allocation concepts, but fails on basic numerical accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 450,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer’s 2022 10‑K still treated Meridian as a discontinued operation, reporting its operating results and a $167 million net‑of‑tax loss from the sale (page 115).  In the 2023 10‑K the sale was described as complete and the company disclosed that it had entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) to provide a post‑sale framework, with the TSAs finished by 2023 and the amounts not material (page 73).  By the 2024 10‑K no reference to Meridian appears, indicating that the TSAs/MSA had ended or become non‑material and the post‑sale relationship had effectively dissolved (page 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline progression. STRENGTHS: (1) Correctly identifies the $167 million net-of-tax loss from the 2022 10-K; (2) Accurately describes the 2023 transition with TSAs and MSA agreements; (3) Properly notes the absence of Meridian references in 2024; (4) Effectively synthesizes the multi-hop relationship evolution across three fiscal years; (5) Correctly characterizes the strategic disengagement progression. MINOR ISSUES: (1) The original answer specifies the sale completion date as December 31, 2021, and sale proceeds of approximately $51 million in cash - the LLM answer does not explicitly mention the $51 million proceeds or the specific 2021 completion date, though it correctly references the 2022 reporting of the loss; (2) The LLM answer adds detail about TSAs/MSA agreements that provides helpful context about post-divestiture relationships, which is relevant but not explicitly mentioned in the ground truth; (3) Page citations (115, 73, 6) are provided by LLM but cannot be verified against ground truth. QUANTITATIVE VERIFICATION: The $167 million loss figure is correct and matches ground truth exactly. The timeline (2022 discontinued ops → 2023 complete sale with agreements → 2024 no reference) aligns with ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression from operational status to divestiture to complete disengagement. The reasoning about TSAs/MSA agreements ending or becoming non-material by 2024 is logical and well-supported. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth regarding strategic disengagement, though with slightly different emphasis (ground truth emphasizes the loss amount and divestiture completion; LLM emphasizes post-sale agreements). Overall, this is a high-quality answer with accurate core facts and sound reasoning, with only minor omissions regarding the specific sale proceeds amount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 561,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "From FY 2022 to FY 2024, the authorized pool for the Amended 2010 Share Incentive Plan grew from 127 million shares in FY 2022 (page 91) to 141 million shares in FY 2024 (page 98), with no change reported in FY 2023 (pages 81‑85). This incremental expansion shows Accenture is deliberately enlarging its share‑based compensation capacity to better attract, retain, and align talent with shareholders over the long term.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding FY 2023 that significantly undermines its accuracy. According to the ground truth, the authorized shares were 141,000,000 in BOTH FY 2023 and FY 2024, not unchanged from FY 2022 as the LLM states. The LLM explicitly claims 'no change reported in FY 2023' which directly contradicts the ground truth showing a 14 million share increase from FY 2022 (127M) to FY 2023 (141M). The LLM correctly identifies the FY 2022 figure (127M) and FY 2024 figure (141M), but mischaracterizes the FY 2023 progression. The statement 'with no change reported in FY 2023' is factually incorrect—there WAS a change in FY 2023 (from 127M to 141M), and the change was maintained into FY 2024. The qualitative interpretation about Accenture's strategic intent is reasonable and aligns with the ground truth's assessment of deliberate expansion for talent attraction and retention. However, the quantitative error regarding the year-by-year progression is a significant flaw in a question specifically asking about how the numbers 'evolved' across the three-year period. The LLM demonstrates partial understanding of the multi-hop synthesis required but fails on the core factual accuracy of the timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 349,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52‑10 in all three filings – it appears as Exhibit 4.42 on page 101 of the 2022, 2023 and 2024 10‑Ks. The unchanged description and continued inclusion indicate the bond remains outstanding and that Tesla still carries the associated interest obligation, suggesting a strategic priority to maintain this long‑term debt rather than refinance or retire it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) EXHIBIT NUMBER ERROR: The LLM claims the bond appears as Exhibit 4.42 in all three years (2022, 2023, 2024), but the ground truth shows it was Exhibit 4.49 in 2022, Exhibit 4.42 in 2023, and Exhibit 4.40 in 2024. This is a critical error in multi-hop synthesis across years. (2) MISSING SUPPLEMENTAL INDENTURE REFERENCE: The ground truth specifically identifies this as the 'Seventieth Supplemental Indenture' with a filing date of June 16, 2015, which the LLM completely omits. This is important context for understanding the bond's legal structure. (3) PAGE NUMBER CLAIM: The LLM states the bond appears on 'page 101 of the 2022, 2023 and 2024 10-Ks' without verification against ground truth, and this specific page reference is not mentioned in the original answer. (4) INCOMPLETE YEAR-BY-YEAR ANALYSIS: While the ground truth provides specific exhibit numbers for each year showing the pattern of disclosure changes (4.49→4.42→4.40), the LLM incorrectly claims all three years show the same exhibit number. (5) REASONING QUALITY: The LLM's conclusion about strategic priorities is reasonable but is built on incorrect factual premises. The ground truth's emphasis on 'consistent re-disclosure' with 'same filing date' is more precise than the LLM's vague claim about 'unchanged description.' The answer demonstrates poor multi-hop synthesis across the three filing years and contains verifiable factual errors in exhibit numbering that are central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 431,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning portal (learning.adobe.com) was already highlighted in the 2022 10‑K as a core element of its Digital Learning Services, positioned to help customers and partners adopt Adobe products (page 17). The 2023 filing reiterated this positioning, underscoring the portal’s role within the broader learning‑and‑enablement portfolio to accelerate customer time‑to‑value (page 18). While the 2024 10‑K does not explicitly re‑describe the free portal, it continues to frame learning and enablement—including free self‑service content—as integral to Adobe’s customer‑success and adoption strategy, reinforcing its ongoing emphasis on supporting customers’ use of Adobe’s cloud solutions (page 20).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's free online self-service learning evolution across 2022-2024, with mostly accurate information. STRENGTHS: (1) Correctly identifies the platform names (learning.adobe.com and www.training.adobe.com) across years; (2) Accurately captures the positioning within Digital Learning Services and customer adoption strategy; (3) Properly synthesizes multi-hop information showing evolution across three years; (4) Correctly notes the 2024 10-K's continued emphasis despite less explicit description; (5) Appropriately contextualizes the offering within broader learning-and-enablement portfolio. WEAKNESSES: (1) The LLM cites specific page numbers (17, 18, 20) which cannot be verified against the ground truth and may be inaccurate or fabricated; (2) Introduces the phrase 'accelerate customer time-to-value' which is not explicitly mentioned in the ground truth, though semantically reasonable; (3) Slightly less comprehensive than ground truth in emphasizing the 'consistent presence across all three years' as a strategic commitment indicator; (4) Does not explicitly mention the 'fee-based and custom learning programs' that complement the free offerings, which the ground truth includes. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects the free self-service learning to broader customer adoption and success strategies. The reasoning is sound and logical. ENTITY ACCURACY: All entities (Adobe, learning platforms, years 2022-2024, Digital Learning Services) are correctly identified. The answer maintains semantic equivalence with the ground truth while using slightly different phrasing. The core factual content aligns well with the original answer, though with minor omissions and unverifiable page citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 494,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy moved the U.S. qualified pension plan toward a more conservative mix as the plan’s funded ratio improved.  In 2022 the target allocation for the Return‑Seeking (equity) portion was 15 % (Target 2022 table, page 310).  By the 2024 target allocation, the plan had shifted to only 9 % equity (Target 2024 table, page 252), reflecting a lower growth‑asset target as the plan became better funded and the glide path reduced growth exposure in favor of liability‑hedging assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific percentages (15% in 2022, 9% in 2024) and page references that cannot be verified against the ground truth provided. The ground truth explicitly states that 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts,' which directly contradicts the LLM's claim of having exact figures. This is a critical factual error. The LLM does correctly identify the general concept that AIG used a glide path approach to de-risk the pension plan as funded status improved, and the directional logic (moving from higher to lower equity allocation) is sound. However, the introduction of specific unverified numbers (15% and 9%) with page citations represents a significant accuracy problem - the model appears to have fabricated or hallucinated these specific data points. The reasoning about the relationship between funded status and de-risking is qualitatively correct, but the quantitative claims are unsupported by the ground truth. The answer does address the multi-hop nature of the question (evolution from 2022-2024, funded status changes, allocation shifts), but the factual inaccuracy of the specific percentages is a fundamental flaw that undermines the entire response. The ground truth's acknowledgment that specific percentages are unavailable makes the LLM's confident assertion of exact figures particularly problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 388,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s Performance Materials and Technologies segment has consistently flagged raw‑material demand and supply as a major risk, with the 2022, 2023, and 2024 10‑Ks all listing “raw material demand and supply” as a key operating‑risk factor (pages 33, 32, 31).  Contract coverage of the segment’s raw‑material base rose modestly—from 63 % in 2022 to 64 % in 2023 and to a majority in 2024 (pages 33, 32, 31), reflecting incremental hedging and long‑term agreements.  Despite this improvement, the continued emphasis on price volatility and supply constraints indicates the segment remains vulnerable to commodity‑market swings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific quantitative claims (contract coverage percentages: 63% in 2022, 64% in 2023, majority in 2024) that are NOT present in the ground truth answer and cannot be verified from the provided context. This is a major factual error - the LLM appears to have fabricated specific metrics that were never mentioned in the original answer. The ground truth makes NO mention of contract coverage percentages or hedging metrics whatsoever. PARTIAL CREDIT FOR: (1) Correctly identifying that raw material demand and supply was flagged as a key risk across all three years (2022-2024), (2) Correctly noting the segment is Performance Materials and Technologies, (3) Correctly identifying the risk remained prominent across the period, (4) Appropriately concluding the segment remains vulnerable to commodity market swings. MISSING ELEMENTS: The LLM answer fails to capture the evolution of risk framing across the three years - specifically: (a) 2022's COVID-19 pandemic context and supply chain disruptions, (b) 2023's emphasis on chemical, refining, and semiconductor plant utilization rates, (c) 2024's specific focus on oil and natural gas price volatility and customer investment behavior. The ground truth emphasizes how the risk profile INTENSIFIED as energy markets became more volatile - this progression is not adequately captured. FABRICATION CONCERN: The citation of specific page numbers (33, 32, 31) and contract coverage percentages suggests the LLM may have hallucinated supporting details rather than synthesizing from actual filing data. This is a serious accuracy violation that significantly undermines the response's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 460,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit pension plans’ mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then rebounded to **$273,699** in 2024 (page 89 for 2022; page 96 for 2023‑24). This 3‑year swing—down one year, up the next—indicates the company is actively rebalancing its pension‑plan portfolio to keep equity exposure within its target range (≈20‑27 %) and to adjust to changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2024 value of $273,699 million, which directly contradicts the ground truth stating the 2023 value of $196,226 million 'remained unchanged in 2024.' This is a fundamental factual error. The correct 2024 value should be $196.226 million, not $273,699 million. The LLM's claim of a 'rebound' in 2024 is factually incorrect. (2) INTERPRETATION ERROR - The LLM mischaracterizes the trend as 'down one year, up the next' when the actual pattern is 'down in 2023, then stable in 2024.' This represents a significant misreading of the data. (3) REASONING FLAW - The LLM's conclusion about 'active rebalancing' and adjusting to 'changing market conditions' is not supported by the ground truth, which indicates a 'stabilized allocation approach' with no further adjustments after 2023. The LLM invents a narrative of ongoing rebalancing that doesn't match the actual data pattern. (4) PARTIAL CREDIT - The 2022 ($239,293 thousand) and 2023 ($196,226 thousand) figures are correct, and the general context about pension plans and equity exposure is appropriate. However, the incorrect 2024 figure and the resulting misinterpretation of the 3-year trend are fatal flaws that undermine the entire answer. The LLM appears to have confused or fabricated the 2024 data point, leading to an entirely incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 387,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "Between 2022 and 2024 Adobe shifted Adobe Document Cloud from a mainly PDF‑and‑e‑signature platform to an AI‑enabled document‑workflow engine. The 2022 10‑K (pages 68‑72) describes Document Cloud as a unified PDF platform with Acrobat and Acrobat Sign but makes no reference to AI features. By 2024, the 10‑K (pages 12‑13) shows Firefly generative‑AI tools embedded in Acrobat, an Acrobat AI Assistant that summarizes and creates content, and enterprise‑grade Firefly Services and Custom Models that automate content generation and integrate with APIs, thereby expanding Document Cloud’s role in end‑to‑end enterprise digital workflows.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe Document Cloud's evolution and correctly identifies the core transformation narrative. STRENGTHS: (1) Accurately captures the shift from PDF/e-signature platform to AI-enabled workflow engine; (2) Correctly identifies Firefly integration as a key differentiator between 2022 and 2024; (3) Properly names specific features (Acrobat AI Assistant, Firefly Services, Custom Models); (4) Appropriately cites 10-K page references (2022: pages 68-72, 2024: pages 12-13) showing document sourcing; (5) Correctly synthesizes multi-hop information about AI integration across years. WEAKNESSES: (1) The answer is more feature-focused and less strategic than the ground truth, which emphasizes Document Cloud's repositioning within Adobe's segment structure (from Publishing/Advertising to Digital Media); (2) Missing the explicit mention of Document Cloud's elevation as a 'core component' of the Digital Media segment in 2023, which is a key strategic positioning detail; (3) Does not explicitly address the 'legacy infrastructure component' to 'strategically positioned productivity suite' framing that the ground truth emphasizes; (4) The 2023 positioning is entirely absent from the LLM answer, creating a gap in the 2022-2024 progression narrative. QUANTITATIVE ACCURACY: Page references appear reasonable for 10-K documents, though cannot be independently verified. No specific financial metrics or percentages are provided in either answer, so quantitative comparison is limited. MULTI-HOP REASONING: The LLM successfully synthesizes information across two years and multiple product features, but misses the organizational/strategic dimension of the transformation. The answer focuses on product features rather than strategic portfolio positioning. SEMANTIC EQUIVALENCE: The core message aligns with ground truth (transformation from legacy to AI-enabled), but the LLM answer is narrower in scope, emphasizing product features over strategic business positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 543,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 2022‑24 10‑Ks consistently flag new entrants and technology disruption across all reportable segments.  In Aerospace, the risk language notes that “new entrants and non‑traditional players” could erode market share; in Building Technologies, Energy & Sustainability Solutions, and Safety & Productivity Solutions the disclosures warn that emerging technologies and new market entrants threaten pricing power, with Safety & Productivity Solutions specifically citing product commoditization that could lower selling prices and margins.  The 2024 filings add emphasis on commoditization in Safety & Productivity Solutions, indicating a growing concern that technology disruption could further erode market share and pricing power across the business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and lacks the temporal progression analysis that is central to the ground truth answer. STRENGTHS: (1) Correctly identifies key segments (Aerospace, Building Technologies, Safety & Productivity Solutions) and competitive threats (new entrants, technological disruption, commoditization, pricing power erosion). (2) Accurately notes that 2024 filings emphasize commoditization concerns. (3) Correctly identifies the risk factors and their consequences (lower market share, reduced selling prices, lower margins). WEAKNESSES: (1) CRITICAL OMISSION - The LLM answer fails to capture the essential 3-year progression/evolution that is the core of the question. The ground truth explicitly traces how exposure evolved FROM 2022 TO 2024, showing expansion from 2 segments (HBT, SPS) in 2022 to 4 segments (adding PMT and Aerospace) in 2023, then restructuring in 2024. The LLM answer presents a static snapshot rather than dynamic evolution. (2) Missing Performance Materials and Technologies (PMT) as a segment where competitive pressures expanded in 2023. (3) Lacks the analytical insight about 'growing emphasis,' 'broader recognition,' and 'strategic shift' that characterizes the ground truth's temporal analysis. (4) Does not clearly articulate the 2022 baseline (only HBT and SPS) versus 2023 expansion versus 2024 restructuring. (5) The phrase 'consistently flag...across all reportable segments' is imprecise - the ground truth shows this was NOT consistent across all segments in 2022, but rather expanded over time. QUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this is not a differentiator. Both correctly reference 2022-2024 timeframe. MULTI-HOP REASONING: The LLM answer fails the multi-hop synthesis requirement by not connecting the temporal evolution across years and segments. It reads as a summary of 2024 conditions rather than a 3-year trajectory analysis. The ground truth demonstrates proper multi-hop reasoning by synthesizing segment-level data across three fiscal years to show progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 569,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s post‑spin‑off relationship with Viatris was governed by transition‑service, MSA and TSA agreements that enabled Pfizer to bill, collect and remit rebates on Viatris’ behalf.  In 2022 the net intercompany balance owed to Viatris under those agreements was $94 million, which dropped to $33 million in 2023 as the TSAs were largely completed【page_12】.  By 2024 the 10‑K contains no Viatris reference (pages 3‑7), indicating the transition arrangements had been fully resolved and the intercompany balances were no longer material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Pfizer's evolving relationship with Viatris from 2022-2024. QUANTITATIVE ACCURACY: All financial figures are correct - $94 million in 2022 and $33 million in 2023 match the ground truth exactly. The year-by-year progression is accurate. ENTITY ACCURACY: Correctly identifies Pfizer and Viatris, properly references TSAs (transition service agreements), MSAs, and the post-spin-off context. MULTI-HOP REASONING: Successfully synthesizes information across three years, showing the progression of declining intercompany balances and winding down of TSAs. The logic is sound - connecting the 2022 baseline ($94M) to 2023 reduction ($33M) to 2024 resolution (no material references). COMPLETENESS: Addresses all key aspects of the question: (1) financial relationship evolution, (2) operational relationship evolution, (3) transition service arrangements status, (4) intercompany balances trajectory. The answer captures the core narrative of gradual decline and eventual resolution. SEMANTIC EQUIVALENCE: The LLM's phrasing 'transition arrangements had been fully resolved and the intercompany balances were no longer material' effectively conveys the same meaning as the ground truth's 'operational interdependencies had been fully resolved.' The mention of rebate billing/collection adds relevant operational context. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (rebate billing/collection mechanisms) than the ground truth, which is supplementary rather than contradictory. The citation references (page numbers) add credibility. No calculation errors or factual inaccuracies detected. The answer fully addresses the three-year evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 488,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s 2022 10‑K listed four note series—1.000% Notes due 2023, 1.700% Notes due 2025, 2.200% Notes due 2027 and 3.125% Notes due 2031【page_1】. By 2023 the 1.000% 2023 notes were retired, leaving a three‑note structure that persisted into 2024【page_1】. The 1.700% Notes due 2025 now serve as the sole short‑ to mid‑term debt, positioned between the higher‑coupon 2027 and 2031 notes, reflecting a deliberate laddered maturity strategy that balances liquidity with moderate interest costs and a gradual shift toward longer‑term financing【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All specific debt instruments and dates are correct—1.000% Notes due 2023, 1.700% Notes due 2025, 2.200% Notes due 2027, and 3.125% Notes due 2031. The timeline progression (2022→2023→2024) is accurate, with correct identification that the 1.000% 2023 notes were retired by 2023. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly tracking which instruments existed in each period and identifying the structural shift from four notes to three notes. ENTITY ACCURACY: All company references (Altria), note percentages, maturity dates, and fiscal years are correct. SEMANTIC EQUIVALENCE: The LLM's characterization of the 1.700% Notes as 'sole short- to mid-term debt' aligns with the ground truth's description of it as 'the shortest-dated instrument.' The interpretation of a 'laddered maturity strategy' is a reasonable and accurate inference from the data progression. MINOR STRENGTHS: The LLM provides additional analytical insight by explicitly naming the coupon rates of the 2027 and 2031 notes and characterizing the strategy as 'laddered maturity,' which adds valuable context beyond the ground truth while remaining factually sound. The answer fully addresses the question's three components: composition evolution, the 1.700% Notes' role, and strategic implications. No calculation errors or factual inaccuracies detected. The only minor consideration is that the ground truth uses slightly more cautious language ('suggests a strategy') while the LLM is more assertive ('deliberate laddered maturity strategy'), but this represents a reasonable interpretive difference rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 482,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $19.975 billion at a weighted‑average rate of 2.91 % in 2022 to $27.168 billion at 4.45 % in 2023, then fell slightly to $26.93 billion at 4.84 % in 2024 【page_188】【page_178】【page_188】. The upward shift in both balance and rate indicates the company is expanding its fixed‑rate debt base while accepting higher rates, suggesting a strategy to lock in financing before further rate hikes and to diversify its funding mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are accurate - carrying values of $19.975B (2022), $27.168B (2023), and $26.93B (2024) match ground truth exactly (format variation from millions to billions is acceptable). Weighted-average interest rates of 2.91% (2022), 4.45% (2023), and 4.84% (2024) are all correct. The directional trends are properly captured: debt increased 2022-2023 then slightly decreased 2023-2024; rates increased 2022-2023 then increased again 2023-2024 (note: ground truth says 'slightly declined' to 4.84% but this appears to be an error in the ground truth itself, as 4.84% > 4.45%). MULTI-HOP SYNTHESIS: The answer correctly synthesizes data across three fiscal years and two metrics (carrying value and interest rate), properly identifying the relationship between them. REASONING QUALITY: The LLM provides sound strategic interpretation - the explanation about 'locking in financing before further rate hikes' and 'diversifying funding mix' is reasonable and well-supported by the data trends. The interpretation differs slightly from ground truth (which mentions 'capitalizing on investor demand or funding growth initiatives') but both are plausible strategic explanations. MINOR ISSUES: (1) The ground truth contains an apparent inconsistency stating rates 'slightly declined' from 4.45% to 4.84%, when 4.84% is actually higher - the LLM correctly interprets this as an increase. (2) The LLM's strategic interpretation is slightly different but not contradictory to ground truth. COMPLETENESS: All required elements addressed - carrying values, interest rates, time period (2022-2024), and strategic implications. Citation references provided appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 489,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla continues to list the 5.45% Solar Bonds, Series 2015/C92‑15 as an outstanding long‑term debt instrument in its 2022, 2023, and 2024 10‑K filings (see Exhibit 4.6 in each filing)【page_103】【page_102】【page_102】.  The bond has remained in use for financing solar projects throughout this period, with no indication of repayment or new issuance of this series, underscoring Tesla’s strategy of leveraging long‑term, fixed‑rate SolarCity debt to fund its solar expansion rather than shifting to equity or short‑term financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility: (1) EXHIBIT REFERENCE ERROR: The LLM claims the bond appears in 'Exhibit 4.6' for all three years (2022, 2023, 2024), but the ground truth specifies different exhibit numbers: Exhibit 4.61 (2022), Exhibit 4.54 (2023), and Exhibit 4.52 (2024). This is a critical factual error in document citation. (2) INCOMPLETE ANALYSIS: The LLM fails to capture the key insight from the ground truth - the 'declining prominence' and 'shift toward more recent financing structures' with newer bond series (C102-15, C106-10) appearing in subsequent filings. The ground truth explicitly notes this evolution, while the LLM merely states the bond 'remained in use' without acknowledging the strategic shift. (3) MISSING CONTEXT: The ground truth provides crucial context about how the bond was 'listed among key supplemental indentures' and its changing position in capital structure disclosures across years. The LLM oversimplifies this to just 'outstanding long-term debt' without capturing the nuanced progression. (4) UNSUPPORTED CLAIMS: The LLM states 'no indication of repayment or new issuance' - while technically not contradicted by ground truth, this misses the actual story of strategic evolution toward newer instruments. (5) REASONING QUALITY: The ground truth demonstrates sophisticated multi-hop synthesis showing how Tesla honored existing obligations while shifting strategy. The LLM's reasoning is superficial and doesn't capture this evolution. The answer is partially correct in identifying the bond's continued presence across three years, but fundamentally fails in exhibit citations and misses the strategic narrative about declining prominence and shift to newer financing structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 482,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 to 2024 AIG moved from a largely internal review and escalation framework (review and challenge of reserves, model‑risk validation, actuarial profitability reviews and experience monitoring) to a more formal governance structure that includes ERM Second‑Line review, internal audit oversight and risk‑committee reporting.  Modeling practices remained consistently sophisticated—pricing and risk‑selection models, stochastic and scenario analyses, and third‑party catastrophe models with bias and data‑quality adjustments—while 2024 added explicit sensitivity and scenario tools to the risk‑measurement suite.  External review integration evolved from implicit internal checks in 2022–23 to a structured ERM‑and‑audit oversight process in 2024, providing a clearer, more formalized external‑review component even though explicit external expert reviews are not highlighted.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024; (2) Accurately captures the progression toward more formal governance structures (ERM Second-Line review, internal audit oversight, risk-committee reporting); (3) Correctly notes that modeling practices remained sophisticated across all three years; (4) Properly identifies specific tools like stochastic/scenario analyses and third-party catastrophe models; (5) Appropriately characterizes the shift toward more structured oversight. WEAKNESSES: (1) The LLM states 'explicit external expert reviews are not highlighted' in 2024, which contradicts the ground truth that explicitly mentions 'audits by the Internal Audit Group' and 'external expert reviews' continuing through 2024. The ground truth clearly indicates external reviews remained integrated, not diminished; (2) The LLM characterizes external review integration as evolving from 'implicit internal checks' to 'structured ERM-and-audit oversight,' but this misrepresents the ground truth which shows external expert reviews were explicitly present in 2022-2023 and continued in 2024, not merely implicit; (3) The answer lacks explicit mention of 'sensitivity and scenario analyses' as new additions in 2024 (though it mentions these tools generally); (4) The characterization of 2022-23 external reviews as 'implicit' is inaccurate—the ground truth states they were 'complemented by reviews from external experts' in 2022 and continued in 2023. MULTI-HOP REASONING: The answer attempts to synthesize information across three years and multiple dimensions (oversight, modeling, external reviews), but the synthesis regarding external reviews is flawed. The LLM appears to have conflated 'internal audit' with 'external expert reviews,' creating a misleading narrative about the evolution of external review integration. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension scores well (8/10) due to no errors, though there's limited quantitative content to evaluate. QUALITATIVE ACCURACY: Moderate (6/10) due to the significant mischaracterization of external review evolution and the implicit vs. explicit distinction error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 617,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan allocation to U.S. Treasury and foreign government securities fell from $1,147 million in 2023 (U.S. government and agencies $1,114 m + foreign $33 m) to $562 million in 2024 (U.S. government and agencies $508 m + foreign $54 m) – a decline of roughly 51 %【page_87】【page_90】. While the 2022 figure is not disclosed in the excerpts, the downward trend from 2023 to 2024 indicates a deliberate shift away from these low‑yield, highly liquid instruments as part of Altria’s liability‑driven investment strategy that balances pension liability hedging with asset growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete information that substantially diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM provides dollar amounts ($1,147M in 2023, $562M in 2024) rather than the percentage allocations (19% in 2022, 16% in 2023, 8% in 2024) that are the core metric in the ground truth\n   - The 51% decline calculation is based on dollar amounts, not the percentage point changes (19%→16%→8%) that better characterize the strategic shift\n   - The LLM explicitly states \"2022 figure is not disclosed in the excerpts\" when the ground truth clearly shows 19% for 2022\n   - No mention of the expected rate of return changes (6.6%→6.1%→6.1%), which is a key supporting metric in the ground truth\n\n2. COMPLETENESS ISSUES:\n   - Missing the 2022 allocation data (19%) entirely\n   - Missing the below-investment-grade securities trend (11% in 2023 to 9% in 2024) that the ground truth identifies as part of the broader strategic pattern\n   - Missing the expected rate of return analysis, which provides important context for understanding the pension asset strategy shift\n   - The answer focuses narrowly on 2023-2024 dollar amounts rather than the full 2022-2024 percentage trend\n\n3. REASONING AND SYNTHESIS:\n   - The LLM correctly identifies a \"deliberate shift away\" from these instruments, which aligns with the ground truth's \"strategic shift\"\n   - However, the reasoning is incomplete: the ground truth explains this reflects \"recalibration of risk exposure and return expectations\" and a \"more conservative or diversified investment posture\"\n   - The LLM's characterization of these as \"low-yield, highly liquid instruments\" is reasonable but doesn't capture the full strategic context\n   - The LLM fails to synthesize the multi-hop connection between the government securities decline and the broader pension asset strategy evolution\n\n4. ENTITY AND METRIC ACCURACY:\n   - Company (Altria) correctly identified\n   - Years partially addressed (2023-2024 only, missing 2022)\n   - The metric shift from percentages to dollar amounts represents a fundamental misunderstanding of what the question asks for\n\n5. SEMANTIC EQUIVALENCE:\n   - While dollar amounts and percentages can both be valid ways to express allocation, the ground truth specifically uses percentages as the primary metric\n   - The ground truth's focus on percentage allocation trends is more appropriate for analyzing strategic shifts in asset allocation\n   - The LLM's dollar-based approach obscures the actual percentage-point changes that define the strategic evolution\n\nThe answer demonstrates partial understanding of the trend direction but fails to provide the correct quantitative framework, misses critical data points (2022, expected returns, below-investment-grade securities), and doesn't fully synthesize the multi-hop reasoning about what this trend indicates about pension asset strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 783,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and then fell to $44.9 billion in 2024, resulting in a net decline in total borrowings from $48.7 billion to $45.6 billion over the three years. The company eliminated its floating unsecured senior debt (from $1.6 billion in 2022 to zero in 2024, carrying a 6.75% rate) and shifted toward fixed‑rate senior debt (carrying value ~ $27 billion, weighted average rate rising from 4.45% to 4.84%), while securitized debt obligations fell from $18.0 billion to $14.3 billion with a modest increase in weighted average rate (3.01% to 3.48%). These changes indicate a deliberate move to a more fixed‑rate, lower‑volume debt structure that reduces exposure to floating‑rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. MAJOR ERRORS: (1) Total debt figures are substantially wrong - LLM states $48.7B to $45.6B range, but ground truth shows $43.086B (2022), $48.715B (2023), $45.551B (2024). The 2022 figure is off by ~$4.8B. (2) Short-term borrowings are drastically understated - LLM claims $883M-$562M range, but this appears to conflate short-term borrowings with a subset of debt. The ground truth shows total short-term borrowings as part of the larger $43-48B figures. (3) Floating unsecured senior debt trajectory is incorrect - LLM states it fell from $1.6B in 2022 to zero, but ground truth shows $1.709B in 2022, $349M in 2023, and $0 in 2024. The 2022 figure is off by ~$100M. (4) Fixed-rate senior debt starting point wrong - LLM implies ~$27B in 2024 (correct) but doesn't clearly state the 2022 figure of $19.975B, making the trend analysis incomplete. (5) Securitized debt 2022 figure incorrect - LLM states $18.0B, but ground truth shows $14.994B in 2022 and $18.043B in 2023. The LLM appears to have confused the years. CORRECT ELEMENTS: The directional trends are partially correct (floating debt elimination, shift to fixed-rate, securitized debt decline from 2023 to 2024), and the interest rate progression (3.01% to 3.48% for securitized debt) is accurate. The conclusion about moving to fixed-rate structure is directionally sound. MULTI-HOP REASONING: The LLM failed to properly synthesize the complete 3-year evolution, missing the 2022 baseline entirely for several key metrics and conflating different debt categories. The answer demonstrates incomplete data gathering across the three-year period required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 468,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022 (Exhibit 4.29, page 100), 2023 (Exhibit 4.36, page 102), and 2024 (Exhibit 4.29, page 100) all list the 5.45% Solar Bonds, Series 2015/C25‑15, showing that the company continues to use this long‑term debt to finance its SolarCity‑derived solar assets. The repeated inclusion signals that the bond remains an outstanding obligation and a key component of Tesla’s debt mix, underscoring its ongoing role in the company’s capital structure and its strategy to fund solar projects through a stable, fixed‑rate instrument.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and confirms their repeated appearance across 2022, 2023, and 2024 10-K filings. The bond series designation and interest rate are accurate. The LLM appropriately synthesizes the multi-hop information by noting the consistent inclusion across three years and correctly interprets this as indicating ongoing reliance and active status in Tesla's capital structure. The answer also appropriately contextualizes the bonds within Tesla's solar financing strategy and mentions SolarCity, which is relevant context. However, there are some minor issues: (1) The LLM provides specific exhibit numbers and page numbers (Exhibit 4.29, page 100 for 2022 and 2024; Exhibit 4.36, page 102 for 2023) that cannot be verified against the ground truth provided, and these details may or may not be accurate; (2) The ground truth specifically mentions the 'Thirty-Sixth Supplemental Indenture' dated April 14, 2015, which the LLM answer does not reference, representing a minor omission of specific documentary detail; (3) The LLM answer uses slightly different phrasing ('outstanding obligation' vs. the ground truth's 'active and integral component') but conveys essentially the same meaning. The core reasoning is sound - both answers conclude that the repeated inclusion indicates ongoing reliance and strategic importance. The LLM successfully addresses the multi-part question about what the repeated references suggest and how they reflect the bond's role in capital structure. The answer is semantically equivalent to the ground truth despite minor wording differences and the omission of the supplemental indenture detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 462,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s balance‑sheet shows a steady rise in its Class A treasury‑stock balance: it was $51.4 billion at year‑end 2022, grew to $60.4 billion in 2023, and reached $71.4 billion by 2024 【page_72】【page_71】【page_68】. This upward trend reflects an expanding share‑repurchase program, indicating that the company is actively returning capital to shareholders and using buybacks as a key tool to manage its capital structure and support share value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) SIGN ERROR - The original answer correctly shows treasury stock as negative values ($(51,354) million, $(60,429) million, $(71,431) million), which is the standard accounting convention for treasury stock (a contra-equity account). The LLM answer incorrectly presents these as positive values ($51.4 billion, $60.4 billion, $71.4 billion), fundamentally misrepresenting the financial data. Treasury stock is a deduction from shareholders' equity and should be shown as negative. (2) YEAR MISMATCH - The original answer contains an internal inconsistency stating '2023 to $(60,429) million in 2023' (same year twice), but the LLM correctly interprets this as 2022-2023-2024 progression. However, the LLM's positive sign convention is still incorrect. (3) NUMBER VERIFICATION - The absolute values are correct ($51.4B ≈ $51,354M, $60.4B ≈ $60,429M, $71.4B ≈ $71,431M), but the sign is wrong. (4) REASONING QUALITY - The LLM's interpretation of the trend (increasing buybacks, capital allocation strategy) is semantically sound and addresses the question appropriately. The explanation about returning capital to shareholders and managing capital structure is reasonable. (5) MULTI-HOP SYNTHESIS - The LLM correctly synthesized the three-year progression and connected it to capital allocation strategy, which is appropriate reasoning. The main failure is the fundamental accounting representation error (positive vs. negative sign), which is a material factual error in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 419,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions risk factor was identical in the 2022, 2023 and 2024 10‑Ks (2022 page 33; 2023 page 31; 2024 page 32), all warning that “reduced investments in process automation, safety monitoring and plant capacity‑utilization initiatives…could lower market share, selling prices and margins.” The unchanged wording shows that the segment’s exposure to adverse industry economic conditions—particularly the slowdown in automation and capacity‑utilization spending—remained high throughout the period, reflecting persistent macro‑economic headwinds such as inflation, high borrowing costs and supply‑chain uncertainty that kept industrial customers cutting back on capital investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific page references and exact quoted language from the 10-K filings, which demonstrates document-level accuracy. However, there are significant issues with the core interpretation and synthesis of the question:\n\n(1) WHAT WAS CORRECT:\n- The LLM correctly identifies that the risk factor language was consistent across 2022, 2023, and 2024\n- Page references appear plausible (2022 page 33; 2023 page 31; 2024 page 32)\n- The quoted text about \"reduced investments in process automation, safety monitoring and plant capacity-utilization initiatives\" is accurate\n- Correctly identifies the segment as Safety and Productivity Solutions\n- Correctly notes the risks relate to market share, selling prices, and margins\n\n(2) WHAT WAS INCORRECT/INCOMPLETE:\n- The LLM claims the wording was \"identical\" across all three years, but the ground truth indicates the language \"remained largely consistent\" in 2023 with \"ongoing global economic uncertainty emphasized,\" and by 2024 there was a \"sharper focus on broader macroeconomic volatility, including geopolitical instability and trade policy shifts\"\n- The LLM's conclusion that the risk \"remained high throughout the period\" contradicts the ground truth's characterization of an \"evolving\" exposure with \"deepening concern\" and \"potentially worsening\" conditions\n- The LLM adds context about \"inflation, high borrowing costs and supply-chain uncertainty\" that is not explicitly mentioned in the ground truth, suggesting potential extrapolation beyond the filing data\n- The LLM fails to capture the temporal evolution the question specifically asks about (\"how did...evolve\")\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes information across three years of filings\n- However, it misses the nuanced evolution in emphasis and framing across the period\n- The ground truth suggests a progression from 2022 (lower market share/margins) → 2023 (global uncertainty context) → 2024 (geopolitical/trade policy focus), but the LLM treats all three years as static\n\n(4) SEMANTIC EQUIVALENCE:\n- The LLM's interpretation that \"unchanged wording shows...remained high\" is logically sound if the wording truly was identical\n- However, the ground truth suggests the wording was NOT identical in emphasis or context, making this conclusion partially incorrect\n- The question asks about evolution/trends, and the LLM's answer suggests stasis rather than evolution\n\nThe core issue is that while the LLM provides accurate document references and quotes, it fundamentally misinterprets the nature of the evolution being described in the ground truth. The ground truth emphasizes a trajectory of deepening concern and evolving macroeconomic context, while the LLM emphasizes consistency and stasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 739,
        "total_tokens": 2196
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "Cyramza’s approved therapeutic indications remained unchanged from 2022 through 2024, covering second‑line treatment of gastric, NSCLC, colorectal cancers and hepatocellular carcinoma, and first‑line EGFR‑mutated NSCLC (2022 10‑K p. 5; 2024 10‑K p. 6).  However, its intellectual‑property exclusivity is winding down: the compound patent expires in 2026 in the U.S. and Japan and 2028 in Europe, while biologics data protection ends in 2026 in the U.S., 2024 in Europe and already expired in Japan (2023 10‑K p. 11).  These dates signal a transition toward the end of Cyramza’s lifecycle and the potential arrival of generic competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Cyramza's therapeutic indications (gastric, NSCLC, colorectal, hepatocellular carcinoma) and appropriately notes they remained unchanged 2022-2024. The answer correctly synthesizes IP protection timelines across multiple jurisdictions and years, demonstrating sound multi-hop reasoning. The conclusion about lifecycle transition and generic competition risk is logically sound and contextually relevant.\n\nCRITICAL ERRORS: (1) The LLM introduces 'first-line EGFR-mutated NSCLC' as an indication, which is NOT mentioned in the ground truth answer. This represents either a factual error or an unsupported addition not present in the original knowledge graph. (2) The LLM states compound patent expires in 2026 in Japan, but ground truth indicates data protection expired in Japan in 2023 - the LLM conflates different IP protection mechanisms and provides incorrect dates for Japan specifically.\n\nMINOR DISCREPANCIES: (1) Ground truth emphasizes 'data protection expiring in Japan in 2023' and 'set to expire in major European countries in 2024' as key timeline shifts between 2023-2024. The LLM provides comprehensive dates but doesn't emphasize this 2023-2024 transition as clearly. (2) Ground truth uses 'data protection' terminology while LLM uses 'biologics data protection' - while semantically similar, the precision differs.\n\nQUANTITATIVE ACCURACY ISSUES: The Japan patent/data protection dates are problematic. Ground truth: data protection expired in Japan 2023. LLM: compound patent expires 2026 in Japan. These are different IP mechanisms with different dates, and the LLM appears to have conflated them or provided incorrect information.\n\nMULTI-HOP REASONING: Generally sound - the LLM correctly synthesizes information across years (2022-2024) and jurisdictions (U.S., Europe, Japan), though with the noted errors on Japan-specific dates.\n\nOVERALL: The answer demonstrates good structural understanding and mostly correct information, but the introduction of unsupported indications and the Japan date errors prevent a higher score. The answer is substantially correct on the core narrative but contains factual inaccuracies that would mislead on specific IP timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 598,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets grew markedly from 2022 to 2024 – $5 million at year‑end 2022, $58 million at year‑end 2023, and $69 million at year‑end 2024 (Table 16.2/17.2, page 216 & 206 & 217).  The fair‑value measurement of these derivatives remained primarily Level 3, with vendor‑based models that rely on significant unobservable inputs such as discount rates and swap rates; the discount rate used rose from 1‑2 % in 2022/23 to 4 % in 2024 (Table 17.3, page 217).  Correspondingly, net unrealized gains shifted from a $33 million loss in 2022 to a $63 million gain in 2023 and a $25 million loss in 2024, reflecting the evolving valuation assumptions (Table 16.2/17.2, page 216 & 206 & 217).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally contradict the ground truth. (1) CRITICAL NUMBER ERRORS: The LLM states net derivative assets were $5 million in 2022, $58 million in 2023, and $69 million in 2024. The ground truth clearly states $19 million in 2022, $58 million in 2023, and $58 million in 2024. The 2022 figure is off by $14 million (5 vs 19), and the 2024 figure is off by $11 million (69 vs 58). These are not minor rounding differences but substantial errors. (2) MISCHARACTERIZATION OF TREND: The LLM describes growth from 2022-2024, but the ground truth shows growth from 2022-2023 followed by STABILIZATION in 2024 (not continued growth to $69M). This fundamentally misrepresents the evolution pattern. (3) UNOBSERVABLE INPUTS DISCREPANCY: The LLM mentions discount rates of 1-2% in 2022/23 rising to 4% in 2024, but the ground truth specifies swap rates (3-5%, weighted at 4%) and default rates (53-163%) as the key unobservable inputs. The LLM conflates discount rates with swap rates and provides different percentage ranges than documented. (4) UNREALIZED GAINS/LOSSES: The LLM provides specific figures ($33M loss in 2022, $63M gain in 2023, $25M loss in 2024) that are not mentioned in the ground truth, which only references net losses of $20 million in 2022. These appear to be fabricated or from incorrect sources. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across years and metrics, the synthesis is built on incorrect foundational numbers, making the overall analysis unreliable. The answer does address the question's components (fair value evolution, unobservable inputs, valuation methodology) but with fundamentally wrong data points. The contextual relevance is moderate because the answer structure addresses the right topics, but the execution is severely compromised by quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 518,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "Qualcomm’s charitable match program kept a “thousands‑of‑employees” participation level in both fiscal 2022 and 2024, but the breadth of impact narrowed from more than 1,500 charities in 2022 to over 1,300 in 2024. This sustained employee engagement is part of the company’s human‑capital strategy, with progress on charitable giving serving as a non‑financial modifier of executive bonuses under the HR and Compensation Committee’s oversight in each year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - correctly states 'thousands of employees' participation in both 2022 and 2024, correctly identifies the decline from 'over 1,500 organizations' to 'over 1,300 organizations', and accurately notes the non-financial modifier range (0.9 to 1.1) for executive bonuses. (2) Multi-hop synthesis is sound - properly connects charitable program metrics to executive compensation linkage and identifies HR and Compensation Committee oversight. (3) Entity identification is correct - Qualcomm, fiscal years 2022 and 2024, charitable match program all properly identified. WEAKNESSES: (1) Incomplete contextual alignment - the LLM answer mentions the non-financial modifier but does not explicitly state the range (0.9 to 1.1) that appears in the ground truth, though it does reference the concept. (2) Missing broader strategic context - the ground truth explicitly connects the program to 'Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion,' which the LLM answer omits. This is a significant omission as the question specifically asks how the progression 'aligns with the company's broader human capital goals.' (3) Slightly less comprehensive framing - while the LLM answer correctly identifies the sustained engagement as part of human capital strategy, it doesn't elaborate on the strategic importance of maintaining this despite the organizational decline. The answer is factually sound on numbers and core relationships but lacks the fuller contextual picture of how this fits into broader DEI and human capital objectives that the ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 453,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 filing (page 7) Adobe described Acrobat as the flagship PDF engine of its Document Cloud, emphasizing web‑ and mobile‑first functionality, a single‑click “Acrobat Web” experience, expanded task‑based actions, and tight integration with Adobe Sign and Sensei‑driven AI, all of which were being made available through APIs to unlock business workflows. The 2023 filing (page 5) reiterated Acrobat’s core role within Document Cloud and its integration with Sign and other services, but did not list any new product enhancements beyond the ongoing web and mobile focus. The 2024 filing (pages 94‑98) continues to present Acrobat as the central PDF experience in Document Cloud, with a continued emphasis on web functionality, AI, and API integration, although the specific pages provided contain no additional Acrobat‑specific enhancements.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant issues when compared to the ground truth:\n\n1. MAJOR OMISSIONS: The LLM answer fails to capture critical elements from the ground truth:\n   - Missing the 2022 emphasis on market adoption and leadership in document-intensive industries (legal, financial services, publishing)\n   - Missing the 2022 context about trillions of PDF documents created annually\n   - Missing the 2023 introduction of AI-powered innovation positioning\n   - Missing the 2023 integration with Creative Cloud tools\n   - Missing the 2024 'Acrobat AI Assistant' trademark introduction, which is a KEY evolution point\n   - Missing the characterization of the evolution as a trajectory from \"document standard to AI-enhanced productivity platform\"\n\n2. INCOMPLETE SYNTHESIS: The LLM answer provides surface-level descriptions of features (web-first, mobile-first, APIs, Sign integration) but fails to synthesize the STRATEGIC EVOLUTION across the three years. The ground truth shows a clear narrative arc: core document component → AI-powered innovation → AI-branded product. The LLM answer treats each year independently without capturing this progression.\n\n3. FACTUAL ACCURACY ON WHAT IS STATED: The specific features mentioned (web/mobile functionality, Sign integration, Sensei AI, APIs) appear consistent with filing content, but the LLM's claim that \"2023 filing did not list any new product enhancements\" contradicts the ground truth's statement about \"forward-looking statements about new or enhanced offerings, including AI-driven features.\"\n\n4. PAGE REFERENCES: The LLM provides specific page numbers (page 7 for 2022, page 5 for 2023, pages 94-98 for 2024) but these cannot be verified against the ground truth, which doesn't cite specific pages. The LLM's caveat that \"the specific pages provided contain no additional Acrobat-specific enhancements\" suggests incomplete document review.\n\n5. MISSING STRATEGIC NARRATIVE: The ground truth emphasizes the strategic positioning evolution and market context. The LLM answer focuses on technical features without capturing the business strategy shift toward AI-enhanced productivity, which is the core of the question.\n\n6. QUANTITATIVE ELEMENTS: No specific numbers, dates, or calculations are present in either answer, so quantitative accuracy is neutral but the LLM's lack of contextual details (like the \"trillions of PDF documents\" metric) represents missing relevant information.\n\nThe LLM answer demonstrates partial understanding of Acrobat's features but fundamentally fails to capture the strategic evolution narrative that the ground truth emphasizes, particularly the critical 2024 shift to 'Acrobat AI Assistant' branding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 721,
        "total_tokens": 2244
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 the AbCellera collaboration generated $2.02 billion in net product revenue from bamlanivimab and bebtelovimab sales, with AbCellera receiving mid‑to‑mid‑twenty‑percent royalties recorded as cost of sales【page_73】. By 2023 and 2024, the company had no sales of these antibodies, so net product revenue fell to zero and no royalty payments were recorded【page_73】【page_72】, marking a sharp decline in the collaboration’s financial impact after 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All key financial figures are correct: $2.02 billion in 2022 net product revenue, zero revenue in 2023 and 2024. (2) Royalty percentage range is accurately captured as 'mid-to-mid-twenty-percent' (semantically equivalent to ground truth's 'mid-teens to mid-twenties percentage range'). (3) The three-year progression is clearly articulated with proper synthesis across 2022-2024. (4) Correctly identifies both products (bamlanivimab and bebtelovimab) and the collaboration partner (AbCellera). (5) Properly characterizes the sharp decline and wind-down of the product line. (6) Correctly notes that royalty payments ceased when sales ceased. MINOR CONSIDERATIONS: (1) The LLM uses 'mid-to-mid-twenty-percent' which is slightly less precise than the ground truth's 'mid-teens to mid-twenties percentage range' - the ground truth explicitly includes the lower end (mid-teens), while the LLM's phrasing could be interpreted as starting from mid-range. However, this is a minor semantic variation that doesn't materially affect accuracy. (2) The answer appropriately cites page references, adding credibility. (3) The reasoning about EUA-based sales and regulatory changes is not explicitly mentioned in the LLM answer, but this represents contextual interpretation rather than factual error. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and multiple financial metrics (revenue, royalty percentages, payment status), demonstrating proper multi-hop reasoning. The conclusion about the collaboration's financial trajectory is logically sound and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 485,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "From 2022 through 2024, MetLife consistently reinsured **59 % of its closed block** through a modified coinsurance agreement (page 227, page 204, page 206). This unchanged percentage shows the company’s deliberate, long‑term risk‑transfer strategy—maintaining a stable, predictable approach to managing closed‑block exposure rather than shifting the mix of reinsurance arrangements over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding: MetLife maintained approximately 59% reinsurance of its closed block through modified coinsurance across 2022-2024. The answer demonstrates sound multi-hop reasoning by synthesizing data across three years and correctly interpreting the strategic implications of consistency. However, there are minor precision issues: (1) The ground truth specifies 59.25% in 2022, while the LLM rounds to 59%, losing some precision in the year-over-year evolution narrative. The question asks how reliance 'evolved,' and the precise 59.25% → 59% → 59% progression is more informative than simply stating '59%' throughout. (2) The LLM correctly cites page references (227, 204, 206) which adds credibility. (3) The semantic interpretation is accurate—the LLM correctly identifies this as evidence of 'deliberate, long-term risk-transfer strategy' and 'strategic continuity,' which aligns with the ground truth's characterization. (4) The answer appropriately addresses both parts of the multi-part question: the evolution (consistency) and what it reveals (strategic intent). The quantitative accuracy is slightly reduced due to the rounding of 59.25% to 59%, though this is a minor deviation. The qualitative reasoning about strategic intent is sound and well-articulated. Overall, this is a strong answer with minor precision loss on the specific 2022 percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 389,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s 2022 10‑K outlined a multi‑layered security program that relied mainly on internal controls and industry‑standard safeguards. By 2023 the filing expanded that narrative to explicitly include collaboration with third‑party providers and public‑private partnerships and to detail the rollout of real‑time account‑based payment infrastructure to 13 markets. In 2024 the approach further emphasized monitoring threats from third‑party services, added domestic processing in China, and continued real‑time coverage, underscoring a shift toward a proactive, partnership‑driven cybersecurity strategy that prioritizes real‑time threat detection and rapid response.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Mastercard's security approach from 2022-2024 and correctly identifies the shift toward third-party collaboration and real-time payment infrastructure expansion. However, there are significant quantitative inaccuracies and some missing details:\n\nQUANTITATIVE ISSUES:\n1. The LLM states 2022 relied 'mainly on internal controls' - the ground truth indicates 2022 already emphasized multi-layered approach WITH third-party partnerships, not primarily internal controls. This is a material mischaracterization.\n2. The LLM correctly identifies 13 markets for 2023 real-time infrastructure (matches ground truth).\n3. The LLM states 2024 had 'several countries globally' for real-time coverage - ground truth also says 'several countries globally' so this is consistent, though less specific than the 2022 baseline of '12 of top 50 GDP markets' and 2023's '13 markets'.\n4. The LLM introduces 'domestic processing in China' which is NOT mentioned in the ground truth answer and appears to be extraneous information not supported by the source material.\n\nQUALITATIVE ISSUES:\n1. The characterization of 2022 as 'mainly internal controls' contradicts the ground truth which explicitly states 2022 included 'partnerships through public-private collaborations and third-party providers.'\n2. The LLM correctly identifies the progression toward more explicit third-party risk management.\n3. The conclusion about 'proactive, partnership-driven cybersecurity strategy' aligns with ground truth.\n4. The mention of 'rapid response' and 'real-time threat detection' is reasonable inference but not explicitly stated in ground truth.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern. However, the baseline characterization of 2022 is incorrect, which undermines the accuracy of the comparative analysis.\n\nMISSING ELEMENTS:\n- The ground truth emphasizes 'increasing specificity and integration' - the LLM captures this but less explicitly\n- The ground truth mentions 'resilience programs' in 2024 - the LLM does not mention this\n- The ground truth's emphasis on 'strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity' is present but less clearly articulated in LLM answer\n\nThe introduction of China domestic processing appears to be a factual error or hallucination not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 655,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 to 2023, LLY’s equity‑like fund allocation grew from $4.014 B to $4.094 B (2023 table, page 100), then fell to $3.932 B in 2024 (2024 table, page 99). The modest rise and subsequent slight decline indicate a stable, long‑term commitment to illiquid equity‑like investments, with periodic rebalancing to manage risk and liquidity while pursuing moderate‑to‑high returns (2022 table, page 99). This trend suggests the company views illiquid assets as a core, diversified component of its growth strategy rather than a transient allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) 2022: LLM states $4.014B but ground truth is $2,844.7M - this is a massive error of ~$1.17B or 41% overstatement. (2) 2023: LLM states $4.094B but ground truth is $4,014.1M - this is closer but still incorrect ($80M error). (3) 2024: LLM states $3.932B but ground truth is $4,093.7M - this is backwards, showing a decline when the actual trend shows growth. The LLM appears to have confused or transposed the 2022 and 2023 figures, and completely misreported 2024. The ground truth shows a clear upward trajectory: $2,844.7M (2022) → $4,014.1M (2023) → $4,093.7M (2024), indicating strategic growth in equity-like fund allocation. The LLM's narrative of 'modest rise and subsequent slight decline' is factually incorrect - the actual trend shows significant growth from 2022-2023 and continued growth into 2024. The reasoning about 'stable, long-term commitment' and 'periodic rebalancing' contradicts the actual data showing consistent growth. While the LLM correctly identifies this as part of pension/retiree benefit strategy and discusses illiquid assets appropriately, the quantitative foundation is severely compromised, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 364,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade remained positioned as a major laundry‑detergent brand under the **Fabric Care** sub‑category of the Fabric & Home Care segment.  The segment’s share of net sales rose from **35 % in 2022** to **36 % in 2023 and 2024**, indicating a stable or slightly higher relative contribution (2022 = page 18, 2023 = page 18, 2024 = page 18).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data. All percentages are accurate: 35% in 2022, 36% in 2023 and 2024. The answer correctly identifies Cascade as a laundry detergent brand within the Fabric & Home Care segment and accurately tracks the segment's contribution evolution across the three-year period. The multi-hop synthesis is sound, connecting Cascade's positioning to segment performance metrics across years. The addition of specific page references (page 18) adds credibility, though these cannot be independently verified. One minor enhancement would be more explicit discussion of 'product categorization' evolution as mentioned in the question - the LLM identifies the 'Fabric Care sub-category' which addresses this aspect but could have been more detailed about any categorical changes or reclassifications. The characterization of the trend as 'stable or slightly higher' is appropriate and matches the ground truth's assessment of 'stable positioning.' The answer is well-structured, uses proper financial terminology, and successfully synthesizes information across the 2022-2024 period. No calculation errors detected. The only minor gap is that the ground truth emphasizes Cascade's 'continued strategic importance' and 'consistent contribution,' which the LLM answer implies but doesn't explicitly state with the same emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 385,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024, Lowe’s moved from a baseline supplier‑sustainability framework—requiring compliance with its human‑rights, conflict‑minerals, and Vendor Code of Conduct policies—to a risk‑based wood‑sourcing policy that added country‑specific risk levels, enhanced monitoring practices, and a new forestry grievance process (2023 and 2024 updates).  The company also broadened its monitoring by encouraging suppliers to report emissions to CDP and partnering to cut scope‑3 emissions.  Parallel to these policy upgrades, Lowe’s ramped up its investment strategy, spending over $300 million in the past three years on renewable‑energy projects, solar panel installations (100+ sites by fiscal 2024), and the SmartWay transportation program, thereby deepening its commitment to a low‑carbon supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and omissions that substantially undermine its accuracy. CRITICAL ERRORS: (1) Investment figures are substantially wrong - LLM states 'over $300 million in the past three years on renewable-energy projects' but ground truth specifies 'over $550 million in environmental facility upgrades' in 2022 alone, plus a '$50 million Gable Grants program over five years' in 2023. The LLM's $300M figure is significantly lower and conflates different investment categories. (2) The LLM fails to mention the $50 million Gable Grants program entirely, which is a specific and important commitment mentioned in the ground truth. (3) The LLM provides vague investment details ('100+ sites by fiscal 2024' for solar) without the comprehensive context of the $550M environmental facility upgrades. PARTIAL CORRECTNESS: The LLM correctly identifies policy evolution elements including: country-specific risk levels in wood sourcing policy, enhanced monitoring practices, and the forestry grievance process (2023-2024). It also correctly mentions the Vendor Code of Conduct and human rights policies. However, it adds information about CDP emissions reporting and SmartWay transportation that, while potentially accurate, are not mentioned in the ground truth and may represent hallucination or information from different sources. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the evolution from baseline framework to risk-based approach, but fails to accurately synthesize the investment strategy component across the three-year period. The answer structure is logical but the execution is flawed due to missing and incorrect numbers. COMPLETENESS: The answer addresses policy framework evolution adequately but significantly underrepresents the investment strategy component with wrong figures and missing the Gable Grants program. The question asks for 'specific enhancements' and 'investment strategy' - the LLM provides some policy enhancements but fails on investment accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 549,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "From 2022‑2024 Honeywell’s risk disclosures for Safety and Productivity Solutions (page 29, 30, 31) and Building Technologies/Automation (page 29, 30, 31) consistently warned that new entrants, emerging technologies and product commoditization could erode market share, lower prices and margins.  In 2024 the newly‑created Industrial Automation segment added a similar risk, explicitly noting “product commoditization” and “new market entrants” (page 31), underscoring a broader exposure to competitive pressures across the business.  This steady escalation in the language and scope of the risk factors signals that Honeywell is confronting intensifying market competition and commoditization risks over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core progression of competitive landscape risks across Honeywell's three business segments (Safety and Productivity Solutions, Building Technologies/Honeywell Building Technologies, and Industrial Automation) from 2022-2024. The answer accurately captures the key themes: new entrants, emerging technologies, product commoditization, and margin pressure. The conclusion about 'intensifying and broadening market pressures' and 'commoditization risks becoming more systemic' aligns well with the ground truth's assessment. However, there are some notable differences: (1) The LLM answer groups Safety and Productivity Solutions with Building Technologies/Automation somewhat ambiguously in the opening, whereas the ground truth clearly delineates the progression as 2022 (Safety and Productivity Solutions), 2023 (Honeywell Building Technologies), and 2024 (Industrial Automation). (2) The LLM answer mentions page numbers (29, 30, 31) which cannot be verified against the ground truth and may be inaccurate or irrelevant. (3) The LLM answer states the Industrial Automation segment was 'newly-created' in 2024, which is a detail not present in the ground truth and may be extraneous. (4) The ground truth emphasizes a clear 3-year temporal progression with specific year-by-year evolution, while the LLM answer uses more general language like 'steady escalation' without explicitly mapping each year to each business segment. The core factual content is sound, but the presentation lacks the precise chronological clarity of the ground truth. The reasoning about systemic risks and broadening pressures is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 456,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 MD&A framed the automotive transformation as a key growth area, positioning its high‑performance, low‑power mobile chips as the foundation for a software‑defined vehicle and digital cockpit (page 8).  In 2023 the company’s segment reporting (Note 8, page 73) showed automotive revenue of $1.872 bn—up 24 % from $1.509 bn in 2022—indicating early traction, with the revenue recognized at point‑in‑time for equipment sales.  By 2024 automotive revenue rose to $2.910 bn (a 55 % increase from 2023) and became a larger share of the QCT segment’s $33.2 bn total revenue, underscoring Qualcomm’s shift from a strategic enabler to a primary supplier of digital‑cockpit hardware.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific financial data and demonstrates multi-hop reasoning across 2022-2024, but has significant quantitative issues that undermine its credibility. STRENGTHS: (1) Correctly identifies the progression from strategic positioning (2022) to revenue recognition (2023) to operational integration (2024), matching the ground truth narrative arc. (2) Appropriately cites specific document locations (MD&A page 8, Note 8 page 73). (3) Correctly identifies automotive revenue figures for 2023 ($1.872bn) and 2024 ($2.910bn). (4) Accurately calculates the 2023-2024 growth rate (55% increase). (5) Properly contextualizes digital cockpit as part of QCT segment reporting. (6) Demonstrates sound multi-hop synthesis across segment reporting and revenue recognition. CRITICAL WEAKNESSES: (1) The 2022 automotive revenue figure of $1.509bn cannot be verified against the ground truth, which does not provide this specific number. (2) The stated 24% growth calculation from $1.509bn to $1.872bn is mathematically correct (1.872/1.509 = 1.241), but the base figure's accuracy is unverified. (3) The LLM answer provides specific financial metrics not present in the ground truth, which raises questions about whether these are accurate SEC filing data or potentially hallucinated numbers. (4) While the ground truth emphasizes the 70% analyst projection and explicit digital cockpit product recognition, the LLM answer focuses primarily on revenue figures without mentioning these key strategic markers. (5) The ground truth's emphasis on 'explicit recognition' of digital cockpit products as a distinct revenue stream in 2023 is not clearly addressed in the LLM answer. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects strategic positioning to financial performance, but the lack of verification for specific numbers creates uncertainty about the reliability of the synthesis. The reasoning structure is sound, but the factual foundation is questionable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 542,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "From 2022 to 2024, Frame.io’s core media support stayed the same—video, still images, design files and PDFs—while its key integrations with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront remained unchanged (ADBE_10k_2022, p. 98; ADBE_10k_2023, p. 12; ADBE_10k_2024, p. 12).  The 2023 and 2024 filings added that Frame.io is now positioned within Adobe GenStudio and is integrated with Adobe Express and Adobe Firefly Services, thereby expanding its enterprise‑scale collaboration and content‑production capabilities (ADBE_10k_2023, p. 12; ADBE_10k_2024, p. 12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CORE CLAIM: The LLM states that 'core media support stayed the same' and 'integrations...remained unchanged,' which directly contradicts the ground truth showing clear evolution. The ground truth explicitly documents expansion from 2023 to 2024 in supported use cases (casting, location scouting, marketing campaigns) and new integrations (Photoshop, Lightroom, Workfront). (2) MISSING CRITICAL INFORMATION: The LLM fails to mention the 2024 expansion into casting, location scouting, and marketing campaign management—key functional expansions that are central to the question. (3) INCORRECT INTEGRATIONS TIMELINE: The LLM claims Photoshop, Lightroom, and Workfront integrations were present from 2022-2024 unchanged, but ground truth indicates these were added by 2024 as part of the expansion. (4) PARTIALLY CORRECT ELEMENTS: The LLM correctly identifies Frame.io's inclusion in Adobe GenStudio and mentions Adobe Express and Adobe Firefly Services integrations, which are valid additions. However, these correct elements are overshadowed by the fundamental mischaracterization of the evolution as 'unchanged' when the ground truth clearly shows significant functional expansion. (5) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the year-by-year evolution across the three years (2022, 2023, 2024), instead presenting a static view. The question specifically asks about 'evolution' and 'expansion,' which the LLM's answer contradicts by claiming things 'remained unchanged.' The answer demonstrates poor comprehension of the source material and provides misleading information about the trajectory of Frame.io's development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 479,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A shares saw the dividend per share climb from $2.04 (2022) to $2.37 (2023) to $2.74 (2024), while the voting structure—one vote per share and dividend rights—remained unchanged in each filing. The unchanged voting rights and steady dividend growth indicate that the company’s shareholder‑governance framework has been stable, preserving consistent voting power for public investors over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM introduced specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there were 'no changes to these rights in any of the years' and focuses on the RIGHTS STRUCTURE (voting and dividend rights), not dividend payment amounts. The LLM conflated dividend rights (a governance right) with dividend per share payments (a financial metric), which are fundamentally different concepts. (2) MULTI-HOP REASONING ERROR: The question asks about 'dividend and voting rights associated with MA's A Class shares' - this refers to the structural rights granted to the share class, not the dollar amounts paid. The ground truth correctly identifies that both voting rights (one vote per share) and dividend rights remained unchanged. The LLM's answer about dividend per share growth is factually unsupported by the ground truth and represents a misinterpretation of what 'dividend rights' means in a governance context. (3) COMPLETENESS: While the LLM does address the voting structure correctly (one vote per share, unchanged), it introduces unverified financial data that contradicts the ground truth's emphasis on structural stability. (4) SEMANTIC EQUIVALENCE FAILURE: The ground truth emphasizes 'no changes' to rights structure; the LLM emphasizes 'steady dividend growth' - these are contradictory narratives. The LLM's conclusion about 'stable governance' is correct in spirit but is built on incorrect supporting evidence. The answer demonstrates a fundamental misunderstanding of the distinction between shareholder rights (governance) and dividend payments (financial distributions).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 478,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment has been hit by retail‑market swings each year: in 2022 sales dipped 1 % (to $6.91 bn) after the sale of its retail‑footwear business, in 2023 sales fell $1.42 bn (to $5.49 bn) and profit dropped $179 m (to $901 m) as lower demand for projects and products hit Warehouse & Workflow and Productivity Solutions, and in 2024 net sales rose to $6.24 bn with profit $1.49 bn but margin slipped 10 bp to 23.7 %—all underscoring the segment’s persistent vulnerability to consumer‑demand volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific financial figures ($6.91bn in 2022, $5.49bn in 2023, $6.24bn in 2024, profit figures of $901m and $1.49bn, margin of 23.7%) that cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. The ground truth does not provide these specific numbers. (2) SEGMENT NAMING CONFUSION: The LLM conflates different segments and time periods. The ground truth clearly states the segment was called 'Safety and Productivity Solutions' in 2022-2023 and was 'restructured' to 'Industrial Automation' by 2024. The LLM treats these as if they're the same segment throughout without acknowledging the name change. (3) MISSING KEY CONTEXT: The ground truth emphasizes that the segment's vulnerability stems from risk disclosures about retail market fluctuations leading to reduced investments in process automation, safety monitoring, and commoditization risks. The LLM focuses on sales/profit figures without addressing the qualitative risk factors that were the core of the ground truth answer. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks what the exposure 'reveals about the segment's vulnerability to consumer demand volatility over time.' The ground truth concludes that 'the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.' The LLM merely states vulnerability exists but doesn't synthesize the three-year trend to draw conclusions about mitigation or lack thereof. (5) FACTUAL MISALIGNMENT: The LLM mentions 'sale of its retail-footwear business' in 2022, which is not mentioned in the ground truth and may be incorrect context. The ground truth focuses on risk disclosures and segment restructuring, not specific business divestitures. The LLM answer appears to have invented or hallucinated specific financial metrics rather than synthesizing from actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 544,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Olumiant collaboration with Incyte kept the same tiered royalty framework: Incyte receives double‑digit royalties up to 20 % on worldwide net sales of Olumiant, plus an additional low‑teens royalty on COVID‑19 sales that exceed a specified threshold (added in the 2020 amendment). Milestone payments were capitalized as intangible assets each year, but after 2022 the amounts were not material (the 2022 filing noted $260 M and $210 M capitalized, while 2023‑24 filings report no material milestone payments), and Incyte remained eligible for up to $100 M in potential sales‑based milestones. The COVID‑19 indication remained part of the agreement throughout this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several key elements correctly but contains significant quantitative errors and incomplete synthesis. CORRECT ELEMENTS: (1) Royalty rates up to 20% on worldwide net sales are accurate; (2) Additional low-teens royalty on COVID-19 sales above threshold is correct; (3) COVID-19 indication added in 2020 amendment is accurate; (4) Milestone payments capitalized as intangible assets is correct; (5) Up to $100M in sales-based milestones is accurate; (6) General shift from milestone-driven to royalty-based model is conceptually sound. CRITICAL ERRORS: (1) The LLM states '$260M and $210M capitalized' in 2022, but the ground truth does not mention these specific numbers - this appears to be fabricated or misattributed data not supported by the original answer; (2) The claim that '2023-24 filings report no material milestone payments' contradicts the ground truth which indicates milestone payments were 'capitalized as intangible assets and amortized into cost of sales' in 2023, suggesting ongoing capitalization; (3) The LLM fails to explicitly mention the $100M in regulatory milestones that was part of the 2022 structure, only referencing sales-based milestones. SYNTHESIS ISSUES: The LLM answer does not clearly articulate the evolution from 2022 to 2024 as requested - it presents the structure as relatively static rather than showing how obligations evolved. The ground truth emphasizes a shift in focus from milestone-driven to royalty-based payments, but the LLM's presentation of specific dollar amounts ($260M, $210M) without proper sourcing undermines credibility. The answer is contextually relevant and addresses the question's main components, but the quantitative inaccuracies and unsupported claims significantly reduce its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 484,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "Procter & Gamble has kept Always as a core brand in the Feminine‑Care sub‑category of its Baby, Feminine & Family Care segment, where it appears among the segment’s major brands in 2022 and 2023 (Always, Always Discreet, Tampax Bounty, Charmin, Puffs)【page 18 of 2022】【page 18 of 2023】. In 2024 the segment’s product mix broadened to add a Baby‑Care sub‑category (Baby Wipes, Taped Diapers and Pants) and two new major brands—Luvs and Pampers—yet Always remained a key brand alongside the new additions (Luvs, Pampers, Always, Always Discreet, Tampax Bounty, Charmin, Puffs)【page 18 of 2024】, indicating that while the brand mix expanded, Always retained its prominence as a leading menstrual‑care brand.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Always as a core brand in the Feminine Care sub-category across 2022-2024. (2) Correctly notes the expansion of the segment in 2024 to include Baby-Care sub-category with Luvs and Pampers. (3) Accurately lists major brands in each year (Always, Always Discreet, Tampax, Bounty, Charmin, Puffs). (4) Properly cites page references to 2022, 2023, and 2024 documents. (5) Correctly identifies that Always retained prominence despite segment expansion.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to capture the key evolution in product categorization that is central to the ground truth answer. The ground Truth explicitly states the categorization shifted from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023-2024. This is a significant strategic positioning change that the LLM completely misses. (2) The LLM does not adequately explain the 'sharpening of Always' positioning around menstrual care' that the ground truth emphasizes as the core evolution. (3) The LLM's statement about 'menstrual-care brand' in 2024 is somewhat vague and doesn't clearly articulate the shift in categorization framework. (4) The LLM conflates brand listing with categorization changes - it focuses on which brands appear together rather than how the product categories themselves were redefined.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting brand presence across three years and noting the segment expansion. However, it fails to synthesize the more nuanced evolution in product categorization frameworks, which requires understanding how P&G's internal classification of Always shifted from emphasizing 'Adult Incontinence' alongside 'Feminine Care' to emphasizing 'Menstrual Care' specifically. This is a critical gap in the multi-hop analysis.\n\nNUMERIC/FACTUAL VERIFICATION: All years (2022, 2023, 2024) are correct. All brand names are correctly identified. The page references appear consistent with typical 10-K formatting. No calculation errors present.\n\nSEMANTIC EQUIVALENCE: While the LLM conveys that Always remained prominent, it does not convey the strategic repositioning around menstrual care that is the core insight of the ground truth answer. The answer is partially correct but misses the primary evolution being asked about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 638,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s 2023 target allocation (reported in the 2022 filing, page 88) was 100 % debt for U.S. plans and 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other for non‑U.S. plans. In the 2023 filing (page 95), the 2024 target shifted to 94 % debt and 6 % cash for U.S. plans and to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other for non‑U.S. plans. The 2025 target (also on page 95) returned U.S. plans to 100 % debt and increased non‑U.S. equity to 28 %, debt to 36 %, cash to 7 %, insurance to 21 % and other to 8 %. These gradual, incremental changes—especially the steady rise in equity exposure for non‑U.S. plans while keeping U.S. plans heavily debt‑weighted—show ACN’s intent to enhance risk‑adjusted returns in foreign plans while preserving a conservative, duration‑matching strategy for U.S. liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, detailed allocation percentages across three fiscal years. STRENGTHS: (1) Provides concrete numerical data for both U.S. and non-U.S. plans across fiscal 2023, 2024, and 2025 targets, with specific percentages for equity, debt, cash, insurance, and other categories. (2) Correctly identifies the multi-year progression showing U.S. plans returning to 100% debt in 2025 after a 94%/6% allocation in 2024. (3) Accurately captures the non-U.S. plan evolution with equity increasing from 27% (2023) to 23% (2024) to 28% (2025), and debt decreasing from 48% to 42% to 36%. (4) Provides sound reasoning about the strategic intent: enhancing risk-adjusted returns in foreign plans while maintaining conservative duration-matching for U.S. liabilities. (5) Correctly cites specific page numbers (88, 95) from the filings. (6) The synthesis across three fiscal years and multiple filings demonstrates proper multi-hop reasoning. MINOR WEAKNESSES: (1) The ground truth emphasizes 'liability duration matching' and 'tactical flexibility' as key strategic themes, while the LLM answer focuses more on the numerical progression itself. The LLM does mention 'duration-matching strategy' but could have elaborated more on how the allocation changes reflect this principle. (2) The ground truth notes that the 2024 filing 'reaffirmed' the fiscal 2025 target, suggesting consistency across filings—the LLM doesn't explicitly address this cross-filing consistency. (3) The ground truth mentions 'flexibility based on market conditions and cash flow needs,' which the LLM doesn't explicitly discuss. QUANTITATIVE VERIFICATION: All percentages appear internally consistent (e.g., 2023 non-U.S.: 27+48+4+11+10=100%; 2024 non-U.S.: 23+42+5+21+9=100%; 2025 non-U.S.: 28+36+7+21+8=100%). The progression logic is sound and the numbers are presented with appropriate precision. The answer successfully addresses the multi-part question about evolution across three years and provides insight into strategic intent, though it could have more explicitly connected the numerical changes to the broader themes of liability matching and tactical flexibility mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 595,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s used forward‑interest‑rate swaps as cash‑flow hedges for forecasted debt issuances.  In 2023 the swaps had a Level 2 fair‑value of $251 million, but by the 2024 filing the company had no forward‑swap exposure, indicating the hedges were settled or no longer needed.  The consistent Level 2 classification and cash‑flow hedge accounting—recognizing effective gains and losses in OCI and amortizing them to interest expense—shows that Lowe’s actively manages interest‑rate risk but has scaled back that exposure as its debt‑issuance plans changed.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the $251 million fair value for 2023 swaps and Level 2 classification. (2) Accurately notes that forward interest rate swaps were no longer held by 2024. (3) Correctly describes cash flow hedge accounting treatment with OCI recognition. (4) Properly identifies the shift from active hedging to no forward swap exposure. WEAKNESSES: (1) CRITICAL OMISSION: Fails to mention the 2024 replacement with fixed-to-floating interest rate swaps as fair value hedges on existing debt—this is a key strategic shift that the ground truth emphasizes. The LLM states the company 'had no forward-swap exposure' but doesn't explain what replaced it. (2) INCOMPLETE STRATEGIC ANALYSIS: The ground truth reveals a fundamental strategic transition from cash flow hedges (managing forecasted debt issuance risk) to fair value hedges (managing existing debt exposure). The LLM only notes 'scaled back that exposure as its debt-issuance plans changed' without capturing this deeper strategic pivot. (3) MISSING CONTEXT: Doesn't explain what the shift reveals about capital structure stability or reduced sensitivity to future interest rate volatility. (4) 2022 TREATMENT: The LLM doesn't address the 2022 position clearly—the ground truth notes no current fair value was listed for 2022 itself, though swaps were referenced in historical context. The LLM's statement about 'consistent Level 2 classification' is somewhat misleading since 2022 had no explicit fair value disclosure. QUANTITATIVE: The $251 million figure is correct; the Level 2 classification is correct. However, the answer lacks the complete picture of what happened in 2024 (replacement with different swap type). REASONING: The multi-hop synthesis is incomplete—the answer correctly traces 2023 to 2024 but misses the critical insight that the company didn't simply eliminate hedges but rather changed the type of hedging instrument used, indicating a strategic shift in how it manages interest rate risk. This is a material omission for answering the question about 'evolution' and what it 'reveals about strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 564,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s exposure to the 5.000 % senior notes due April 2030 was **$606 million at the end of FY 2022, FY 2023, and FY 2024** (the debt schedule in each year’s 10‑K lists the same principal balance).  The unchanged balance shows the company is holding the notes to maturity rather than refinancing or repaying early, underscoring a conservative debt‑management strategy that prioritizes predictable, low‑cost long‑term financing and a stable capital structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was '$606 million at the end of FY 2022, FY 2023, and FY 2024' with an 'unchanged balance.' However, the ground truth clearly shows: FY 2022: $1,086 million, FY 2023: $606 million, FY 2024: $606 million. The LLM incorrectly claims the 2022 balance was $606 million when it was actually $1,086 million—a $480 million error. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about the 'evolution' from 2022 through 2024. The ground truth demonstrates a significant $480 million reduction from 2022 to 2023, followed by stability in 2023-2024. The LLM completely missed this critical evolution by claiming the balance was unchanged across all three years. (3) REASONING ERROR: The LLM's interpretation that 'unchanged balance shows the company is holding the notes to maturity' is logically inconsistent with the actual data showing a substantial decline. The ground truth correctly identifies this as 'deliberate reduction' and 'active debt repayment or restructuring strategy.' The LLM's conclusion about a 'conservative debt-management strategy' that 'prioritizes...stable capital structure' is contradicted by the actual $480 million reduction in principal. (4) ENTITY ACCURACY: While the company (AVGO), note rate (5.000%), and maturity date (April 2030) are correct, the core financial metrics are wrong. The LLM fundamentally misread or misinterpreted the debt schedule data across the three fiscal years. This is a complete failure to accurately synthesize multi-year financial data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 464,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620% debentures were first described in the 2022 10‑K as a $276 million issuance that had an 8.375% coupon until April 1, 2020, when the rate was cut to 7.620% for the remaining term (page 120).  The 2023 and 2024 10‑Ks (pages 103 and 108) simply refer to the debentures as 7.620% with no mention of the earlier rate change, but keep the same redemption terms—redeemable at any time at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark treasury yield + 5 bps (plus accrued interest)—and the same semi‑annual interest schedule and maturity of April 1, 2030.  Thus, the coupon shift was noted only in 2022, while the redemption mechanics and maturity structure remained unchanged through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS's 7.620% debentures evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - $276 million principal amount, 7.620% interest rate, 8.375% prior rate, April 1, 2020 rate change date, April 1, 2030 maturity date, and 5 basis points redemption spread. Page references (120, 103, 108) are appropriately cited. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years of filings, identifying the key evolution: (1) 2022 disclosure explicitly mentioned the historical 8.375% rate and its April 2020 reduction to 7.620%, (2) 2023-2024 filings only reference 7.620% without historical context, (3) redemption terms remained consistent across all years. COMPLETENESS: The answer addresses all three sub-components of the question: interest rates (including historical context), redemption terms (callable at any time with specific pricing mechanics), and maturity structure (April 1, 2030). The answer also captures the evolution in disclosure emphasis - noting that 2024 placed more emphasis on semi-annual payment schedule and sinking fund exemption, though this is mentioned more briefly than in the ground truth. MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth in describing the 2024 disclosure enhancements (semi-annual schedule and sinking fund clarification), but still captures the essential point about consistency and clarity evolution. The redemption price description is accurate and complete. SEMANTIC EQUIVALENCE: The core narrative matches the ground truth - stable instrument with consistent terms and evolving disclosure clarity. The LLM's phrasing 'the coupon shift was noted only in 2022' effectively captures the disclosure evolution pattern identified in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 509,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "In 2022 Amgen positioned Olpasiran as a phase‑2 siRNA that lowers lipoprotein(a) to reduce atherosclerotic cardiovascular disease (ASCVD) risk. By 2023 the program had advanced to phase‑3 trials for ASCVD and remained in phase‑3 in 2024, underscoring a sustained focus on cardiovascular indications. The company’s composition‑of‑matter patents for Olpasiran, issued in both the U.S. and Europe, are projected to expire in 2036, giving the program a decade‑plus exclusivity window that supports its strategic positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CLINICAL PHASE PROGRESSION - The LLM claims Olpasiran advanced to phase-3 trials by 2023 and remained in phase-3 in 2024. The ground truth explicitly states it was in phase 2 development in 2022 with NO mention of phase-3 advancement by 2023 or 2024. This is a major factual error that contradicts the source material. (2) THERAPEUTIC INDICATION - The LLM correctly identifies the 2022 indication as lowering lipoprotein(a) for ASCVD treatment, matching ground truth. However, the LLM fails to note the 2024 shift to broader 'cardiovascular disease' indication mentioned in the ground truth, which represents a strategic expansion. (3) INTELLECTUAL PROPERTY - The LLM correctly identifies U.S. and European patents expiring in 2036, matching ground truth exactly. The characterization of 'decade-plus exclusivity window' is accurate. (4) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the temporal evolution across the three-year period. The ground truth shows progression from phase-2 (2022) to defined IP strategy (2023) to broader indication (2024). The LLM's claim of phase-3 advancement is unsupported by the ground truth and represents a fundamental misunderstanding of the clinical development timeline. (5) COMPLETENESS - The LLM addresses IP protection adequately but significantly misrepresents clinical phase progression and omits the important 2024 therapeutic indication expansion. The answer demonstrates partial understanding but contains a major factual error regarding clinical phase status that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 434,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax has remained in the same “Feminine Care (Adult Incontinence, Feminine Care)” sub‑category of the Baby, Feminine & Family Care segment throughout 2022‑2024.  While it stayed listed as a major brand, the 2024 MD&A shows a more focused set of major brands—Always, Always Discreet, Tampax Bounty, Charmin, and Puffs—compared with the broader 2022 list that also included Luvs and Pampers, indicating a shift in brand prominence within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CATEGORIZATION ERROR: The LLM claims Tampax remained in 'Feminine Care (Adult Incontinence, Feminine Care)' throughout 2022-2024, but the ground truth shows it was reclassified to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023 and this categorization was maintained in 2024. This is a fundamental misrepresentation of the evolution being asked about. (2) BRAND LIST ERROR: The LLM lists 'Tampax Bounty' as a single brand, which appears to be a conflation of two separate brands (Tampax and Bounty). The ground truth mentions Always and Bounty as separate major brands alongside Tampax. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the actual evolution - that there was a meaningful reclassification from 'Feminine Care' to 'Menstrual Care' in 2023, which is the core of what the question asks about. The LLM's claim that categorization 'remained consistent' misses this important change. (4) SEGMENT NAME INCONSISTENCY: While the LLM correctly notes the segment name is 'Baby, Feminine & Family Care,' it doesn't accurately reflect the sub-category evolution that occurred between 2022 and 2023. (5) BRAND PROMINENCE ANALYSIS: The LLM's observation about changing brand prominence (mentioning Luvs and Pampers in 2022 vs. a more focused list in 2024) is not substantiated by the ground truth and appears to be an unsupported inference. The ground truth emphasizes consistency in Tampax's prominence, not a shift away from it. The answer demonstrates a fundamental misunderstanding of the categorization changes that occurred and provides incorrect brand information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 463,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s filings show no internally‑developed designations for non‑agency RMBS or CMBS in any of the three years.  In 2022 the RMBS and CMBS totals on page 102 are broken out by NAIC designations 1‑6; the same is true for the 2023 totals on page 96 and the 2024 totals on page 86, where every RMBS and CMBS line is assigned an NAIC category.  The note that “an internally developed designation is used only when no NAIC designation is available” appears in each filing (page 101, 96, 86).  Thus, MetLife’s reliance on internal designations remained essentially zero from 2022 through 2024, indicating that NAIC designations were consistently available for all non‑agency RMBS and CMBS and that the company’s acquisition strategy focuses on securities that are already evaluated by the NAIC (or are evaluated promptly thereafter).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and demonstrates a critical misunderstanding of the question and available evidence. Key issues: (1) FACTUAL CONTRADICTION: The ground truth explicitly states that MetLife 'noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC' and that 'this practice continued in 2023 and 2024.' The LLM claims the opposite—that 'MetLife's filings show no internally-developed designations' and that 'reliance on internal designations remained essentially zero.' (2) MISINTERPRETATION OF EVIDENCE: The LLM correctly cites that the note states 'an internally developed designation is used only when no NAIC designation is available' but then incorrectly concludes this means zero internal designations were used. The presence of this policy statement across all three years, combined with the ground truth's explicit documentation of internal designation usage, indicates the policy was actively applied. (3) LOGICAL ERROR: The LLM's reasoning that 'every RMBS and CMBS line is assigned an NAIC category' does not prove internal designations weren't used—it could mean internal designations were converted to NAIC categories or that some holdings had internal designations while others had NAIC designations. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about the 'evolution' and 'multi-year trend' indicating something about NAIC availability and acquisition strategy. The ground truth correctly synthesizes that the persistence of the policy indicates sustained investment in complex securities where NAIC evaluations lag. The LLM reaches the opposite conclusion without proper evidence. (5) ANSWER INVERSION: The LLM's conclusion that 'NAIC designations were consistently available for all non-agency RMBS and CMBS' directly contradicts the ground truth's finding that internal designations were necessary because NAIC evaluations were not immediately available. This is a complete inversion of the correct answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 554,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased 12.18 million shares in fiscal 2022 for $4.11 million, with $3.13 million of available authorization (page 94). In fiscal 2024 it bought 2.07 million shares (≈$4.11 million) and had $2.69 million of available authorization, while the Board lifted total authorized authority to $6.69 billion (page 39). The trend shows a consistent dollar‑level buy‑back policy amid a higher share price and a larger overall authorization pool, underscoring a flexible, shareholder‑friendly capital‑return strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - Multiple severe quantitative mistakes undermine the entire answer: (1) UNIT ERRORS: LLM states '$3.13 million' and '$2.69 million' of available authorization when ground truth clearly shows '$3.13 billion' and '$2.69 billion' - a 1000x error. This is a fundamental mistake that completely misrepresents the scale of the authorization. (2) SHARE COUNT ERRORS: LLM claims '12.18 million shares in fiscal 2022 for $4.11 million' - this is nonsensical (would imply $0.34/share). Ground truth doesn't provide fiscal 2022 share count, but the price per share is clearly wrong. For fiscal 2024, LLM states '2.07 million shares' when ground truth specifies '2,000,308 shares' (approximately 2.0 million, not 2.07 million - minor but still inaccurate). (3) PRICE ERRORS: LLM states shares were repurchased 'for $4.11 million' in both fiscal 2022 and 2024, which is implausible and contradicts ground truth's $605 million for Q4 FY2024 alone. (4) MISSING INFORMATION: LLM fails to mention the September 25, 2024 authorization increase of $4 billion, which is a key part of the evolution narrative. (5) INCOMPLETE MULTI-HOP SYNTHESIS: While LLM attempts to connect authorization levels across years, the fundamental numerical errors prevent proper synthesis. The reasoning about 'consistent dollar-level buy-back policy' is undermined by incorrect numbers. The only partially correct element is the mention of the $6.69 billion total authorization and the general characterization of shareholder-friendly strategy, but these cannot compensate for the pervasive quantitative failures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 436,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom has consistently listed **industrial fiber optics** as a core product within its industrial end‑market portfolio in all three years—2022 (page 10), 2023 (page 5), and 2024 (page 5)—and the description of the fiber‑optic component line has remained largely unchanged, emphasizing its role in high‑speed Ethernet, storage, and metro/long‑haul telecom applications. This steady positioning shows that Broadcom treats fiber optics as a foundational part of its high‑speed connectivity strategy, maintaining a balanced but not aggressively expanding focus on the industrial market rather than shifting toward a dedicated industrial‑only emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM claims industrial fiber optics were described as having applications in 'high-speed Ethernet, storage, and metro/long-haul telecom applications,' which contradicts the ground truth that explicitly states the 2022-2024 positioning emphasized industrial automation, medical systems, electric vehicle subsystems, factory automation, renewable energy, and automotive electronics. The LLM's description appears to conflate telecom/datacenter fiber optics with industrial fiber optics, fundamentally mischaracterizing the product positioning. (2) INCOMPLETE EVOLUTION ANALYSIS: The ground truth shows a clear evolution from 2022 (broad portfolio description) → 2023 (structured table categorization) → 2024 (explicit application linkage with specific components). The LLM claims the description 'remained largely unchanged,' which directly contradicts the ground truth's narrative of increasing application-focus and strategic alignment over time. (3) MISSING KEY DETAILS: The ground truth identifies specific product groupings (optocouplers, motion encoders, LED devices, Ethernet ICs in 2022; sensors, encoders, LEDs, Ethernet components in 2023; Ethernet PHYs, camera microcontrollers in 2024) that demonstrate product portfolio evolution. The LLM provides none of these details. (4) INCORRECT STRATEGIC CONCLUSION: The LLM concludes Broadcom maintains 'a balanced but not aggressively expanding focus on the industrial market,' while the ground truth indicates 'a maturing and application-focused product strategy' with increasing alignment to strategic industrial applications. These are contradictory interpretations. (5) PAGE REFERENCES: While the LLM provides page numbers, these cannot be verified against the ground truth and appear potentially inaccurate given the fundamental content misalignment. The answer demonstrates a failure to correctly synthesize the multi-hop information about product evolution across three years and misidentifies the core applications and strategic emphasis entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 574,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "UPS SurePost has continued to serve as a residential ground service for non‑urgent, lightweight shipments, but its delivery model shifted over the period.  In 2022 and 2023 the service relied on the U.S. Postal Service for final delivery (“final delivery was often provided by USPS”)【page_5_2022】【page_5_2023】.  By the 2024 filing UPS announced a strategic change: starting January 1 2025 it will insource SurePost, moving final delivery from USPS to UPS’s own network to gain greater control and improve service reliability【page_5_2024】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS SurePost's evolution from 2022-2024. STRENGTHS: (1) All key dates are correct - 2022, 2023, 2024 timeline and the January 1, 2025 implementation date for insourcing are accurate. (2) The core factual claims are correct: SurePost served as a residential ground service for non-urgent, lightweight shipments; USPS handled final delivery in 2022-2023; UPS announced a strategic shift in 2024 to insource final delivery starting 2025. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the strategic inflection point. (4) The reasoning about motivations (gaining greater control, improving service reliability) aligns with the ground truth. (5) Entity identification is accurate (UPS, USPS, SurePost). (6) The answer appropriately uses citations to indicate source documents. MINOR CONSIDERATIONS: (1) The LLM uses quotation marks around 'final delivery was often provided by USPS' which suggests a direct quote, though the ground truth uses slightly different phrasing ('final delivery frequently handled by USPS'). This is a minor semantic variation and doesn't affect factual accuracy. (2) The answer could have slightly elaborated on the 'unchanged' nature of 2022-2023 arrangements, though the current phrasing adequately conveys this. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, January 1 2025) are correct. No calculations are required for this question. QUALITATIVE ASSESSMENT: The answer demonstrates clear understanding of the strategic shift and correctly synthesizes information across multiple filing years to show the evolution of the service model.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 475,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from 13 programs in 2022 to 18 in 2023 and 24 in 2024. In 2022, three programs received regulatory approvals, four entered Phase 3 and one was terminated, while by 2024 five programs were acquired from Horizon, three new Phase 3 studies were initiated, one program received FDA approval and one program concluded. This steady expansion—through internal development, strategic acquisitions and regulatory milestones—underscores Amgen’s deliberate scaling of its R&D pipeline, emphasizing human‑genetics‑driven therapeutics and broader therapeutic breadth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core progression of Amgen's Phase 3 programs (13→18→24) and accurately notes the Horizon Therapeutics acquisition adding five Phase 3 programs in 2023. The answer appropriately synthesizes the multi-hop information about internal development, external acquisitions, and regulatory milestones. However, there are some issues: (1) The LLM provides specific operational details (three programs received regulatory approvals in 2022, four entered Phase 3, one terminated; by 2024 three new Phase 3 studies initiated, one FDA approval, one concluded) that are not explicitly confirmed in the ground truth, making it difficult to verify their accuracy. (2) The ground truth mentions 25 Phase 3 programs as of February 4, 2025, but the LLM stops at 24 in 2024 without mentioning the subsequent growth to 25. (3) The LLM adds interpretive language about 'human-genetics-driven therapeutics' which, while potentially accurate, is not explicitly stated in the ground truth provided. The quantitative progression (13→18→24) is correct, and the identification of Horizon as a source of five Phase 3 programs is accurate. The reasoning about R&D expansion strategy through internal development and external acquisition is sound and well-supported. The answer demonstrates good multi-hop synthesis but lacks complete alignment with the full timeline through February 2025 mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 396,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture increased the maximum number of Class A ordinary shares authorized for the Amended 2010 Share Incentive Plan from **127 million in FY 2022** (page 91) to **141 million in FY 2024** (page 98).  The upward adjustment reflects a deliberate expansion of the share‑based compensation pool, enabling the company to issue larger or more flexible awards to attract, retain, and align talent with long‑term shareholder value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key numbers: 127 million shares in FY 2022 and 141 million shares in FY 2024. The numeric values match the ground truth exactly, and the format variation (127 million vs 127,000,000) is appropriately handled. The answer correctly identifies the Amended 2010 SIP and Accenture plc as the relevant entities. The multi-hop synthesis is sound, connecting the share authorization data across the three-year period (2022-2024) and drawing appropriate conclusions about strategic intent. The reasoning about talent retention, performance alignment, and shareholder value is logically sound and semantically equivalent to the ground truth's characterization of 'long-term talent retention and performance alignment strategy.' One minor observation: the ground truth explicitly mentions FY 2023 as also having 141 million shares (indicating the increase occurred between 2022 and 2023, then remained stable through 2024), while the LLM answer only explicitly references FY 2024 as having 141 million. This is a minor omission of the intermediate year data point, though it doesn't materially affect the accuracy of the core answer about the evolution from 2022 through 2024. The page references (91 and 98) add credibility but cannot be independently verified in this evaluation. Overall, the answer is substantively correct with only minor incompleteness regarding the FY 2023 data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 405,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks’ 2022 and 2023 10‑K filings both stated that purchase commitments and existing inventory would cover green coffee through **fiscal 2023** (page 12, 2022 & 2023).  In the 2024 10‑K the company extended that coverage to **fiscal 2025** (page 12, 2024).  The shift shows Starbucks is maintaining a robust inventory buffer and using long‑term contracts and hedging to extend supply coverage and mitigate price and supply‑risk volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its core accuracy. According to the ground truth, fiscal 2022 showed coverage through fiscal 2023, fiscal 2023 showed coverage through fiscal 2025, and fiscal 2024 maintained coverage through fiscal 2025. However, the LLM states that both 2022 and 2023 10-K filings stated coverage through 'fiscal 2023,' which is incorrect. The 2023 10-K should have stated coverage through fiscal 2025, not fiscal 2023. This is a critical error in the multi-hop synthesis across years. The LLM correctly identifies that the 2024 10-K extended coverage to fiscal 2025, but this misses the key evolution: the extension actually occurred between fiscal 2022 and fiscal 2023, not between 2023 and 2024. The LLM's characterization of the strategy (robust inventory buffer, long-term contracts, hedging) is qualitatively sound and aligns with the ground truth's assessment of 'forward-looking inventory and risk management strategy.' However, the factual error about the timeline of the extension is a major flaw in a question specifically asking about how the projection 'evolved from fiscal 2022 through fiscal 2024.' The answer demonstrates partial understanding but fails on the core quantitative/temporal accuracy needed for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 364,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024 UPS kept the UPS/IBT Full‑Time Employee Pension Plan unchanged, with no plan amendments or remeasurements disclosed for those years (see 2022 filing, p. 90). In 2023 the plan was affected by a new five‑year national master agreement ratified by Teamsters employees, which increased wage and benefit rates for Teamsters in the plan and was reflected in the year‑end measurement (2023 filing, p. 82). No further amendments, remeasurements, or collective‑bargaining changes were reported for the plan in 2024 (2024 filing, p. 86).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. (1) MAJOR ERROR - 2022 Remeasurement: The ground truth explicitly states that in 2022, the plan was remeasured following the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax). The LLM answer claims 'no plan amendments or remeasurements disclosed for those years,' which is factually incorrect and represents a fundamental misunderstanding of the 2022 events. (2) QUANTITATIVE ACCURACY FAILURE: The LLM failed to identify and report the $3.3 billion pre-tax gain (or $2.5 billion after-tax gain), which are significant financial figures that should have been included in any comprehensive answer about the plan's evolution. (3) PARTIAL CREDIT FOR 2023: The LLM correctly identified the 2023 five-year national master agreement with Teamsters and the wage/benefit rate increases reflected in year-end measurement. This is accurate but incomplete. (4) 2024 ASSESSMENT: The LLM's statement about no further amendments or remeasurements in 2024 aligns with the ground truth's indication of 'no indication of further structural changes,' though the ground truth emphasizes continued commitment rather than absence of activity. (5) MULTI-HOP REASONING: The LLM failed to synthesize the complete three-year progression. The answer misses the critical 2022 regulatory event (American Rescue Plan Act) and its substantial financial impact, which is essential to understanding how the plan's treatment 'evolved significantly' as stated in the ground truth. (6) SEMANTIC ISSUES: The LLM's characterization of the plan as 'unchanged' directly contradicts the ground truth's description of 'significant' evolution. The answer demonstrates incomplete research or misinterpretation of source documents, particularly regarding the 2022 remeasurement event.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 511,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has kept “Holiday Time” in the same place in its private‑label lineup for three consecutive years—listed alongside Great Value, Mainstays, and Way to Celebrate on the private‑brand roster in the 2022, 2023 and 2024 10‑Ks【page_7】【page_7】【page_7】.  The brand’s name and placement imply it is used for holiday‑season items, and its unchanged categorization shows Walmart treats seasonal merchandise as a stable, low‑price component of its broader private‑label strategy rather than shifting it into a new category or brand.  This consistency signals the company’s intent to rely on a dedicated seasonal private brand to capture holiday demand while maintaining the overall EDLP positioning of its private‑label portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims 'Holiday Time' remained in the 'same place' with 'unchanged categorization' across all three years, directly contradicting the ground truth which explicitly states that by fiscal 2024, Walmart 'explicitly restructured its merchandise units to include seasonal merchandise as a defined category under General Merchandise.' This is a fundamental misunderstanding of the evolution. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the critical shift in fiscal 2024 where 'Holiday Time' moved from being listed among private brands without strategic emphasis to being positioned within a dedicated 'seasonal merchandise' category. This represents a major strategic restructuring that the LLM completely missed. (3) INCORRECT INTERPRETATION - The LLM states the brand's 'unchanged categorization shows Walmart treats seasonal merchandise as a stable, low-price component,' which contradicts the ground truth's finding of an explicit restructuring and strategic repositioning. (4) MISSING CONTEXT - The ground truth emphasizes that the evolution 'reveals' a shift toward 'optimizing private label offerings for time-sensitive retail cycles' and 'structured seasonal planning,' but the LLM's conclusion that nothing changed fundamentally misses this strategic insight. (5) CITATION ISSUES - While the LLM provides page references, the actual content interpretation appears incorrect based on the ground truth's explicit statement about fiscal 2024 restructuring. The answer demonstrates a failure to synthesize the multi-hop information across the three fiscal years and identify the key turning point in fiscal 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 482,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "The fair value of the pension plan’s mutual‑fund equity securities was **$239,293 million in 2022**, declined to **$196,226 million in 2023**, and then increased to **$273,699 million in 2024** (all figures as of August 31 each year). This pattern shows a deliberate rebalancing of the plan’s equity allocation—after a contraction in 2023 the company restored and exceeded prior levels in 2024, indicating a strategic shift toward higher equity exposure to meet long‑term return objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental and severe quantitative error that completely invalidates the response. The 2022 figure is stated as '$239,293 million' when the ground truth shows '$239.293 million' - this is a 1,000x magnitude error ($239.293M vs $239,293M). This appears to be a decimal point misplacement error. More critically, the 2024 figure is stated as '$273,699 million' when the ground truth indicates the value 'remained unchanged in 2024' from 2023's $196.226 million. The LLM has provided an entirely incorrect 2024 value that contradicts the ground truth. The reasoning about 'strategic shift toward higher equity exposure' is therefore based on false data. The LLM correctly identifies 2023's $196.226 million figure and correctly notes the 2022-to-2023 decline, but the 2024 data is completely wrong. The answer also adds contextual interpretation about 'long-term return objectives' that may be reasonable but is built on incorrect factual premises. The multi-hop synthesis fails because the core factual data for 2024 is incorrect, leading to an inverted conclusion (the LLM suggests increasing exposure when the ground truth shows flat/unchanged allocation). This is a case where the LLM appears to have hallucinated or misread the 2024 figure entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 362,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 2022, 2023, and 2024 10‑K filings all note that green‑coffee price volatility is influenced by commodity‑index and hedge‑fund trading in the arabica futures market and that the company hedges “C”‑price exposure with forward contracts, futures contracts and collars [page_12]. The supply‑commitment horizon expanded from covering the next fiscal year in 2022 (through fiscal 2023) to extending two years ahead in 2024 (through fiscal 2025) [page_12, page_14], indicating a more forward‑looking risk‑management stance. This evolution underscores Starbucks’ disciplined use of structured hedging in the futures market to mitigate commodity‑price risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the three fiscal years (2022-2024). STRENGTHS: (1) Correctly identifies the key entities: Starbucks, green coffee price volatility, arabica futures market, commodity index funds, and hedging instruments (forward contracts, futures contracts, collars). (2) Accurately captures the temporal evolution: 2022 hedging through fiscal 2023, expanding to fiscal 2025 by 2024, showing a two-year extension. (3) Properly synthesizes multi-hop information across three years of filings to demonstrate the maturing risk management approach. (4) Correctly identifies hedging instruments used (forward contracts, futures contracts, collars). (5) Appropriately characterizes the risk management stance as 'disciplined' and 'forward-looking.' MINOR WEAKNESSES: (1) The answer mentions 'collars' as a hedging instrument, which is not explicitly mentioned in the ground truth answer, though this is not necessarily incorrect—it may be a valid detail from the actual filings. (2) The phrase 'structured hedging in the futures market' is slightly more specific than the ground truth's 'reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments,' though both convey similar meaning. (3) The answer could have been slightly more explicit about the 'maturing' or 'consistent' nature of the approach across all three years, though this is implied. QUANTITATIVE VERIFICATION: The timeline claims are accurate—2022 through fiscal 2023 coverage, expanding to fiscal 2025 by 2024, represents the correct two-year extension mentioned in ground truth. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple filing documents to show the evolution of hedging strategy, correctly identifying the progression from shorter-term to longer-term commitments. The connection between commodity index fund trading and Starbucks' hedging response is properly established.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 548,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO had $622 million of 3.625% notes due October 2024 outstanding in FY 2023 (and still present in FY 2022). By FY 2024 the company had eliminated that exposure, as the notes were fully repaid or refinanced, leaving zero outstanding. This progression indicates a near‑term debt strategy focused on retiring maturing short‑term debt and using proceeds from new senior note issuances to reduce short‑term debt and improve liquidity【page 81】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: $622 million principal outstanding in FY 2022 and FY 2023, with complete elimination by FY 2024. The fiscal year progression is correctly identified. The answer properly synthesizes the multi-hop information showing the evolution across three fiscal years and correctly identifies that the notes were either repaid or refinanced. The debt management strategy interpretation is sound and supported by the data. Minor areas for improvement: (1) The ground truth explicitly states the amount 'remained unchanged at $622 million' in 2023, emphasizing no repayments occurred that year - the LLM answer could have been slightly more explicit about this stasis period. (2) The LLM answer adds contextual detail about 'proceeds from new senior note issuances' which, while plausible and consistent with typical debt management strategies, goes slightly beyond what the ground truth explicitly states (the ground truth only says 'repaid or refinanced'). This is a minor enhancement rather than an error, but represents a slight inference beyond the stated facts. (3) The citation reference 【page 81】 cannot be verified against the ground truth provided. Overall, the answer demonstrates correct understanding of the debt evolution, accurate number reporting, and sound reasoning about the company's debt management strategy. The semantic meaning aligns well with the ground truth despite minor wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 416,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s gross settlement exposure grew from $64.9 bn in 2022 to $78.4 bn in 2024, with net exposure rising from $55.7 bn to $64.9 bn and risk‑mitigation arrangements applied increasing from $9.2 bn to $13.5 bn (pages 106, 105). In response to heightened regulatory scrutiny—FTC investigations of the Durbin Amendment, DOJ civil‑investigative demands, European Commission probes, and ongoing U.S. and U.K. litigation over liability shifts, interchange fees and ATM rules—the company tightened its credit‑risk framework by expanding cash‑collateral, letter‑of‑credit and guarantee requirements for customers that do not meet its risk standards and regularly reviewing its risk‑management methodology (page 102). These steps helped keep settlement‑related losses low despite the increased exposure and legal uncertainties (pages 109, 104).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable financial metrics and regulatory details. STRENGTHS: (1) Quantitative data is precise and well-documented: gross settlement exposure $64.9bn (2022) to $78.4bn (2024), net exposure $55.7bn to $64.9bn, risk-mitigation arrangements $9.2bn to $13.5bn - all with proper page citations. (2) Multi-hop synthesis is sound: correctly identifies regulatory pressures (FTC Durbin Amendment investigations, DOJ civil-investigative demands, European Commission probes) and links them to Mastercard's response (expanded collateral/guarantee requirements, refined risk methodology). (3) Entity accuracy is correct: proper identification of Mastercard, regulatory bodies (FTC, DOJ, European Commission), and litigation risks (liability shifts, interchange fees, ATM rules). (4) The answer effectively demonstrates evolution from 2022-2024 by showing both quantitative growth in exposure and qualitative tightening of risk controls. MINOR WEAKNESSES: (1) The original answer mentions a specific '$1+ billion liability' related to EMV liability shift class-action lawsuit, which the LLM answer does not quantify (though it references 'liability shifts' generally). (2) The original answer emphasizes 'historical experience of low losses from customer failures' as a 2022 baseline, which the LLM answer addresses only implicitly through 'kept settlement-related losses low.' (3) The original answer notes the FTC consent agreement on debit transaction routing transparency specifically, while the LLM answer references Durbin Amendment investigations more broadly without the specific consent agreement detail. CALCULATION VERIFICATION: The growth metrics are internally consistent (exposure increased ~20.8%, net exposure increased ~16.5%, risk-mitigation arrangements increased ~46.7%), suggesting accurate data synthesis. The answer successfully bridges quantitative and qualitative dimensions of the question, showing how regulatory/litigation pressures prompted measurable changes in risk management posture. Overall, this is a strong answer that prioritizes concrete financial data and regulatory specifics while maintaining appropriate multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 601,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "In 2022 Amgen’s 10‑K risk factors only noted that “some of our products are used with drug‑delivery or companion diagnostic devices that have their own regulatory, manufacturing and other risks” (page 34). By 2023 the disclosure expanded to require the company to collect and assess user complaints, adverse events and malfunctions, to conduct routine monitoring and inspections, and to implement device‑ and labeling‑enhancements in response to FDA evaluations (page 51). In 2024 the risk factors further emphasized compliance with reporting and pharmacovigilance requirements, post‑marketing obligations, and safety oversight, warning that non‑compliance could trigger additional inspections, warning letters, fines, recalls or withdrawal of marketing authorization (pages 50‑54).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Amgen's regulatory risk disclosures across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression with accurate year-by-year evolution; (2) Accurately cites specific page numbers (34, 51, 50-54) which adds credibility; (3) Correctly identifies key regulatory concepts: surrogate endpoints, conditional approvals, post-marketing obligations, safety oversight, and enforcement actions; (4) Properly synthesizes multi-hop information showing how disclosures expanded in scope and detail; (5) Accurately captures specific products mentioned (Repatha, LUMAKRAS) and regulatory mechanisms (confirmatory studies, adverse event monitoring, pharmacovigilance); (6) Correctly identifies consequences of non-compliance (inspections, warning letters, fines, recalls, withdrawal of authorization). MINOR WEAKNESSES: (1) The LLM answer provides more specific operational details (user complaints, adverse events, malfunctions, routine monitoring, device/labeling enhancements) compared to the ground truth's more general framing, though these details appear consistent with actual 10-K disclosures and enhance rather than contradict the answer; (2) The ground truth emphasizes 'growing emphasis on post-market compliance' as a trend statement, while the LLM provides more granular disclosure evolution without explicitly stating this as a trend, though the progression clearly demonstrates this; (3) No quantitative metrics or percentages are provided in either answer, so quantitative accuracy is based on dates and page references which are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, correctly identifying how each year's disclosure built upon and expanded the previous year's disclosures. The logical progression from basic acknowledgment (2022) → detailed requirements (2023) → comprehensive compliance framework (2024) is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 539,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Parent’s Choice has remained consistently positioned within Walmart’s grocery unit—specifically under the “baby products and consumables” segment—in the 2022, 2023, and 2024 10‑K filings. This unchanged categorization signals Walmart’s deliberate strategy to treat Parent’s Choice as a core private‑label brand for baby and consumable items, underscoring its focus on offering everyday‑low‑price alternatives to national brands in these high‑volume categories.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Parent's Choice positioning within Walmart's grocery unit across fiscal years 2022, 2023, and 2024. The core claim about consistent categorization is accurate and well-supported. However, there are notable differences from the ground truth that affect the overall score: (1) The LLM uses the phrase 'baby products and consumables' as a single combined segment, while the ground truth indicates 'baby products' was explicitly defined as a separate category within Grocery by fiscal 2024, suggesting a more nuanced evolution than the LLM conveys. (2) The LLM states the categorization was 'unchanged,' which is technically accurate but misses the ground truth's emphasis on the explicit inclusion of 'baby products' as a defined category by 2024—a subtle but meaningful distinction in Walmart's merchandise categorization strategy. (3) The LLM correctly captures the strategic intent around EDLP positioning and private-label strategy, though it doesn't explicitly mention the omni-channel convenience strategy mentioned in the ground truth. (4) Quantitatively, there are no numeric errors—all years (2022, 2023, 2024) are correctly cited. The reasoning is sound and the multi-hop synthesis across three fiscal years is logically coherent. The answer is semantically equivalent in most respects but lacks the granular detail about the evolution of category definitions that the ground truth emphasizes. The answer would have scored higher (8-9) if it had captured the distinction between 'baby products' being part of Grocery versus being explicitly defined as a separate category within Grocery by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 460,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla issued the 4.70 % Solar Bonds, Series 2015/C24‑10 in 2015. The 2022 10‑K lists the bond as Exhibit 4.35 (a supplemental indenture dated April 14 2015), indicating it remained an outstanding liability at year‑end 2022. The 2023 and 2024 10‑K exhibit lists contain no separate reference to the C24‑10 bond, implying it was either fully amortized, restructured, or absorbed into broader debt disclosures. This pattern shows Tesla’s solar‑financing strategy relies on long‑term, low‑coupon debt that is periodically consolidated or retired, keeping a stable, low‑cost financing base for its solar assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core question about multi-year evolution. (1) FACTUAL CONTRADICTION: Ground truth states Tesla 'continued to reference this bond' in 2023 and 'again referenced' it in 2024, indicating consistent presence across all three years. LLM claims the bond has 'no separate reference' in 2023 and 2024 10-Ks, suggesting it was 'fully amortized, restructured, or absorbed.' This is directly contradicted by the ground truth. (2) QUANTITATIVE ACCURACY: The 4.70% coupon rate is correct, the April 14, 2015 date is correct, and the Series 2015/C24-10 designation is correct. However, the LLM incorrectly infers the bond's status in 2023-2024 without evidence. (3) MULTI-HOP REASONING FAILURE: The question asks about evolution 'across 2022, 2023, and 2024' and what the pattern suggests about strategy. Ground truth shows consistent referencing across all three years, indicating a 'consistent and scalable securitization strategy.' LLM concludes the opposite—that the bond disappeared from disclosures in later years—which is factually wrong per the ground truth. (4) SEMANTIC MISALIGNMENT: Ground truth emphasizes 'multi-year presence and repeated referencing' as evidence of a 'consistent and scalable securitization strategy.' LLM's narrative of consolidation/retirement contradicts this entirely. (5) MISSING CONTEXT: LLM fails to mention that newer series (C27-10, C32-10) were introduced alongside C24-10 in 2023, which the ground truth identifies as key evidence of ongoing reliance on this structure. The LLM's conclusion about 'periodic consolidation or retirement' is unsupported speculation that contradicts the ground truth's documented pattern of continued referencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 477,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Broadcom has kept the same positioning for its Security Insights Platform: a mainframe‑centric tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and “provides data for use with in‑house tools for security information and event management”【page_11】【page_10】【page_10】.  The description is identical in each filing, indicating a sustained emphasis on mainframe risk assessment and consistent integration with enterprise SIEM and other security tools, with no major changes in the platform’s positioning over the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the platform's positioning EVOLVED across the three years, with 2024 showing 'a slightly stronger emphasis on integration' and 'a more deliberate alignment with enterprise-wide security strategies.' The ground truth describes meaningful differences: 2022 emphasized 'quickly interprets and assesses mainframe security posture,' 2023 highlighted 'identify risks and proactively respond to potential threats,' and 2024 showed 'a more deliberate alignment with enterprise-wide security strategies.' However, the LLM answer claims 'The description is identical in each filing' and 'no major changes in the platform's positioning over the three years.' This is a critical mischaracterization of the evolution described in the ground truth. The LLM correctly identifies the core functionality (mainframe risk assessment, SIEM integration) and the general positioning, but completely misses the nuanced evolution narrative that is central to the question. The question specifically asks 'How has...evolved' (implying change), and the ground truth documents this evolution, but the LLM denies it occurred. The quantitative accuracy is reasonable (dates and company name correct), but the qualitative reasoning fails to capture the subtle but meaningful shifts in emphasis across the three years that the ground truth emphasizes. The answer is internally consistent but factually incorrect regarding the premise of evolution versus stasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 430,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022‑2024, Mastercard’s Class A shares continued to carry **one vote per share and dividend rights** (see the “Classes of Capital Stock” tables on pages 94, 97, 90).  The unchanged voting and dividend status shows the company’s capital‑structure strategy is deliberately stable—maintaining consistent shareholder rights and a predictable dividend policy to support governance continuity and investor confidence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that MA's Class A shares maintained one vote per share and dividend rights consistently across 2022-2024 with no changes; (2) Accurately cites the source documents (Classes of Capital Stock tables on pages 94, 97, 90); (3) Properly synthesizes the multi-hop information across three years to demonstrate consistency; (4) Correctly interprets the strategic implication—that the unchanged status reveals a deliberate, stable capital structure strategy. The answer uses 'Mastercard' (full name) rather than 'MA' (ticker), which is semantically equivalent and actually more formal. The reasoning about governance continuity and investor confidence is sound and logically derived from the factual consistency. Minor consideration: The LLM adds interpretive language ('deliberately stable,' 'predictable dividend policy,' 'investor confidence') that goes slightly beyond the ground truth's more straightforward statement, but this represents reasonable inference from the facts rather than factual error. All core facts match the ground truth exactly: one vote per share, dividend rights, consistency across 2022-2024, and the strategic implication of stability. No quantitative errors, calculation errors, or entity misidentifications present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 376,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "From 2022 through 2024 Amgen kept bemarituzumab in a Phase 3 trial for gastro‑esophageal junction adenocarcinoma, adding a Phase 2 program for “other tumors” in 2023 and 2024.  The company’s composition‑of‑matter patents in the U.S. and Europe have remained unchanged, all set to expire in 2029, giving a stable 7‑year exclusivity window that has not shifted over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2029 patent expiration date for composition-of-matter patents in both U.S. and Europe, matching the ground truth. (2) Correctly identifies Bemarituzumab as targeting gastroesophageal junction adenocarcinoma. (3) The Phase 3 trial information for 2022-2024 is accurate. (4) The 7-year exclusivity window calculation (2029 minus 2022) is mathematically sound.\n\nWEAKNESSES: (1) The LLM introduces information about a 'Phase 2 program for other tumors' in 2023-2024 that is NOT mentioned in the ground truth answer. This appears to be either fabricated or from sources not reflected in the knowledge graph baseline. (2) The LLM fails to mention the 2023 disclosure of patent expiration timelines, which is a key milestone in the evolution of Amgen's strategy. (3) The LLM does not address the 2024 context about monoclonal antibody targeting FGFR2b or the potential regulatory exclusivity periods mentioned in the ground truth. (4) The answer lacks the narrative progression showing transition from early-phase to mature pipeline asset that the ground truth emphasizes.\n\nMULTI-HOP REASONING: The LLM partially synthesizes information across years but misses key temporal milestones. It focuses narrowly on patent dates and trial phases while omitting the strategic evolution and IP disclosure timeline that demonstrates how the strategy evolved.\n\nFACTUAL ACCURACY: Patent expiration date (2029) is correct. Phase 3 trial information is correct. However, the introduction of Phase 2 'other tumors' program without ground truth support is problematic and suggests either hallucination or reliance on information outside the verified knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 463,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "No Boundaries has been listed as a private‑label brand in Walmart’s general‑merchandise lineup every year (2022, 2023, 2024) – appearing in the 2022 10‑K (pages 5‑9), the 2023 10‑K (pages 6‑10) and the 2024 10‑K (pages 5‑9).  In 2022 the apparel sub‑unit was described as “Apparel,” but by 2023–24 it was renamed “Fashion,” reflecting a broader, trend‑driven focus on clothing and accessories.  This renaming, while keeping No Boundaries in the same private‑label slot, signals Walmart’s strategic shift toward expanding its fashion‑centric private‑label assortment to capture a larger share of the apparel market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core facts and correctly identifies the key strategic shift from 'Apparel' to 'Fashion' categorization between 2022 and 2024. The answer accurately captures that No Boundaries remained a consistent private-label brand across all three years (2022-2024) and correctly notes the renaming of the merchandise unit. The page references provided (2022 10-K pages 5-9, 2023 10-K pages 6-10, 2024 10-K pages 5-9) appear reasonable for 10-K filings, though cannot be independently verified here.\n\nSTRENGTHS:\n- Correctly identifies the category shift from 'Apparel' to 'Fashion'\n- Accurately notes No Boundaries' presence across all three years\n- Properly synthesizes the strategic implication (fashion-centric expansion)\n- Correctly interprets the renaming as reflecting broader, trend-driven focus\n- Maintains semantic equivalence with ground truth regarding strategic realignment\n\nWEAKNESSES:\n- The LLM answer is somewhat less detailed than the ground truth regarding what the 'Fashion' unit encompasses (the ground truth explicitly mentions \"adult and children's apparel, shoes, jewelry, and accessories\" while the LLM only says \"clothing and accessories\")\n- Omits mention of omni-channel offerings and customer-centric experiences as context for the strategic shift\n- The phrase \"keeping No Boundaries in the same private-label slot\" is slightly ambiguous - the ground truth clarifies that the categorization itself evolved (from Apparel to Fashion), not just the naming\n- Does not explicitly mention the broader merchandising strategy context as thoroughly as ground truth\n\nFACTUAL VERIFICATION:\n- Years (2022, 2023, 2024): Correct\n- Category shift (Apparel → Fashion): Correct\n- Continuity of No Boundaries brand: Correct\n- Strategic interpretation (fashion-centric expansion): Correct and aligned with ground truth\n\nThe answer successfully addresses the multi-hop question by synthesizing information across three years and connecting the categorization change to strategic intent. The core narrative is accurate, though some contextual richness from the ground truth is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 578,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM’s 10‑K filings from 2023 (IBM_10k_2023.pdf page 3) and 2024 (IBM_10k_2024.pdf page 3) both list client relationships and trust as a core competitive differentiator, underscoring its importance in the hybrid‑cloud and AI strategy. The consistent emphasis signals that IBM views trusted client partnerships as essential to distinguishing itself from hyperscalers and accelerating adoption of its hybrid‑cloud and AI portfolio. In 2022 the company also highlighted client relationships and trust, but the 2023 and 2024 filings explicitly tie the differentiator to hybrid‑cloud and AI, reflecting a growing focus on leveraging trust to drive digital transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized client relationships and trust as a competitive differentiator across 2022-2024, and accurately notes the explicit connection to hybrid cloud and AI in the 2023 and 2024 filings. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years and connecting the differentiator to IBM's strategic positioning. However, there are notable gaps compared to the ground truth: (1) The LLM answer does not mention the 2023 reinforcement of linking client relationships/trust to delivering business value and solving complex challenges through integrated technologies - a key evolution point. (2) The LLM answer omits the 2024 expansion showing strategic partnerships with hyperscalers and global system integrators, which represents an important evolution in how trust is being leveraged through ecosystem collaboration. (3) The answer lacks the nuanced progression showing how trust evolved from a foundational differentiator (2022) to being explicitly tied to business value delivery (2023) to being extended through partnerships (2024). The LLM correctly cites page 3 of both 2023 and 2024 filings and accurately characterizes the general trend, but misses important contextual details about the specific evolution of the strategy. The reasoning about trust distinguishing IBM from hyperscalers is sound and relevant. The answer is partially complete - it captures the core narrative but omits significant details about the progression and ecosystem partnership dimension that the ground truth emphasizes as revealing about IBM's positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 445,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 were issued by SolarCity in 2015 and are still listed as outstanding debt in the 2022, 2023 and 2024 10‑K filings, with no new issuance or maturity changes noted in those years【page 102 of 2022】【page 102 of 2023】.  The unchanged indenture across three consecutive years shows that Tesla continues to rely on long‑term, fixed‑rate solar‑specific debt to finance its solar projects, underscoring a stable, long‑term financing strategy for its solar portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the bond as 5.45% Solar Bonds, Series 2015/C25-15 issued by SolarCity in 2015; (2) Accurately states the bond appears in 2022, 2023, and 2024 10-K filings with no new issuance or maturity changes; (3) Properly synthesizes the multi-year pattern to conclude Tesla maintains a stable, long-term solar financing strategy; (4) Correctly interprets the persistence of the same bond series across three years as indicating consistent reliance on this financing instrument; (5) Provides specific page references (page 102) for verification. MINOR WEAKNESSES: (1) The LLM answer does not mention the Thirty-Sixth Supplemental Indenture dated April 14, 2015, which the ground truth specifically references as being introduced in 2022 filings - this is a minor omission of contextual detail; (2) The phrase 'unchanged indenture' could be slightly misleading as it refers to the bond remaining outstanding rather than the indenture document itself being unchanged; (3) The answer could have been more explicit about the 'legal and financial linkage' aspect mentioned in the ground truth. QUANTITATIVE VERIFICATION: All numbers are correct (5.45%, 2015, 2022-2024 years). MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings to identify a pattern and draw a conclusion about Tesla's financing strategy. The logic is sound: persistent reference to the same bond series across multiple years indicates ongoing reliance on this financing mechanism. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'stable, long-term financing strategy' is semantically equivalent to the ground truth's 'consistent solar asset-backed financing strategy.' Overall, this is a strong answer with minor gaps in completeness but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 507,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In 2022 Emerson’s Tools & Home Products segment described pipe‑working tools that included wrenches, cutters, threading and roll‑grooving equipment, mechanical crimping tube joining systems, drain cleaners, tubing tools, and closed‑circuit TV pipe‑inspection and locating equipment (page 9). By 2024 the Safety & Productivity segment had added battery‑hydraulic tools for press connections and for cutting/crimping electrical cable, and upgraded its diagnostic suite to include sewer‑inspection cameras and locating equipment (page 73). This shift toward battery‑powered, portable, and advanced diagnostic tools demonstrates Emerson’s strategic emphasis on safety, productivity, and technology leadership in the professional tools market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the segment name evolution (Tools & Home Products in 2022 to Safety & Productivity by 2024), which is an important detail. (2) Product offerings are accurately listed for both years - pipe wrenches, cutters, threading equipment, closed-circuit TV inspection in 2022; battery-hydraulic tools for press connections and cutting/crimping electrical cable, sewer inspection cameras in 2024. (3) The core narrative about shift toward battery-powered, portable tools is correct. (4) Page references (9 and 73) suggest proper source documentation. (5) The conclusion about strategic positioning in professional tools market is sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to address 2023 data, which is explicitly mentioned in the ground truth as a key transitional year showing battery hydraulic tools for press connections. The question specifically asks about evolution \"from 2022 to 2024,\" which implies a three-year progression. The ground truth emphasizes 2023 as showing \"a clear shift toward cordless, high-efficiency solutions.\" The LLM jumps from 2022 to 2024, missing this important intermediate step in the evolution narrative. (2) INCOMPLETE PRODUCT DETAILS: The ground truth mentions additional 2022 products (roll-grooving equipment, mechanical crimping tube joining systems, drain cleaners, tubing tools) that the LLM omits. While the LLM mentions some of these, it's less comprehensive. (3) MISSING STRATEGIC INSIGHT: The ground truth emphasizes that pipe wrenches' \"consistent mention across all three years underscores their foundational role\" - this temporal consistency analysis is absent from the LLM answer. (4) LESS NUANCED ANALYSIS: The ground truth provides more detailed reasoning about the \"deliberate effort to strengthen competitive position\" through specific technology integration patterns, while the LLM's conclusion is more generic.\n\nMULTI-HOP REASONING: The question requires synthesizing product evolution across three years (2022, 2023, 2024) to identify strategic positioning. The LLM only synthesizes two years, breaking the multi-hop chain. This is a significant failure in addressing the full scope of the question.\n\nNUMERIC/DATE ACCURACY: Years are correct (2022, 2024), but the omission of 2023 is a factual gap in temporal coverage, not a calculation error per se.\n\nSEMANTIC EQUIVALENCE: While the LLM's wording differs from ground truth, the semantic meaning is partially equivalent for the 2022 and 2024 data points, but the missing 2023 analysis represents a substantive gap in understanding the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 698,
        "total_tokens": 2258
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s capital‑allocation strategy for its El Segundo, California site shifted from a primarily clinical cell‑therapy focus in 2022 to a combined clinical‑and‑commercial manufacturing role by 2024, reflecting a deliberate investment to scale its cell‑therapy pipeline.  The facility’s expanded commercial capacity aligns with the company’s broader biologics agenda—retrofitting for retroviral vector production and other biologics candidates—underscoring a strategic emphasis on biologics development (see 2023 MD&A manufacturing facilities page 11 and 2024 MD&A manufacturing facilities page 12).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DIRECTIONAL ERROR ON 2022 STATUS: The LLM claims El Segundo had a 'primarily clinical cell-therapy focus in 2022,' but the ground truth explicitly states that in 2022, El Segundo was listed as a general manufacturing facility WITHOUT specific emphasis on cell therapy. This is a fundamental factual error that reverses the actual evolution. (2) PAGE NUMBER DISCREPANCY: The LLM cites '2023 MD&A manufacturing facilities page 11' and '2024 MD&A manufacturing facilities page 12,' but the ground truth references GILD_10k_2023.pdf:page_11:chunk_1 and GILD_10k_2024.pdf:page_10:chunk_1. The 2024 page number is incorrect (claims page 12, should be page 10). (3) INCOMPLETE SYNTHESIS: The LLM mentions 'retroviral vector production' which is not mentioned in the ground truth answer, suggesting potential hallucination or unsupported detail. (4) MISSING KEY CONTEXT: The LLM fails to capture the ground truth's important point about Gilead's reliance on 'internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies,' which is a significant strategic element indicating increased investment in securing proprietary processes. (5) CORRECT ELEMENTS: The LLM correctly identifies the progression toward commercial manufacturing by 2024 and the alignment with biologics development priorities. The semantic understanding of capital allocation strategy shift is partially correct. The core narrative of transformation from general to specialized cell therapy manufacturing is present but with the 2022 baseline incorrectly characterized. This represents a significant factual error in the foundational premise of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 463,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM disclosed the 1.250% Notes due 2027 in its 2022 10‑K, referencing the 2019 8‑K exhibit that defines the rights of holders (see 2022 10‑K Exhibit list). The 2023 10‑K continued to cite the same 2019 8‑K exhibit for the notes (see page 20). By 2024, the notes were listed as a registered security in the 10‑K’s securities table, indicating they remained outstanding but no new issuance or amendment was reported (see page 1).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key dates and documents (2019 8-K exhibit, 2022 and 2023 10-K references) and accurately notes the progression from disclosure to registered security status. However, there are significant gaps in completeness and synthesis compared to the ground truth. Strengths: (1) Correctly identifies the 1.250% Notes due 2027 across all three years (2022-2024), (2) Accurately references the January 30, 2019 8-K exhibit, (3) Correctly notes the shift from disclosure to registered security status. Weaknesses: (1) The LLM answer fails to capture the critical 2024 development - the ground truth emphasizes that the notes were 'formally listed...on the New York Stock Exchange' with trading symbol IBM27B, indicating 'a shift from disclosure to active market presence.' The LLM only mentions 'registered security in the 10-K's securities table' without noting the NYSE listing or trading symbol, which represents a material omission of the key evolution point. (2) The LLM answer lacks the specific filing dates mentioned in the ground truth (February 8, 2022, and February 3, 2023), which provide important temporal context. (3) The LLM's characterization of 2024 as showing 'no new issuance or amendment' is incomplete - the ground truth indicates this was when the notes transitioned to active NYSE trading, a significant development. (4) The multi-hop synthesis is weaker - the LLM doesn't effectively convey the progression narrative from 'internal documentation' to 'public issuance and trading' that the ground truth emphasizes. The answer is partially correct on facts but misses the key insight about the 2024 NYSE listing and trading symbol, which is central to understanding how the relationship 'evolved' across these years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 479,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings from 2022‑2024 consistently list the 5.45% Solar Bonds, Series 2015/C45‑15 (Exhibit 4.41 in 2022, 2023 and 2024) alongside a growing array of supplemental indentures for other SolarCity bonds and newer debt instruments such as convertible senior notes (see the 2024 filing’s convertible notes and the 2023 filing’s additional supplemental indentures). This continuity shows the company still relies on the 2015 bond while simultaneously expanding its debt mix, indicating a shift from a single long‑term SolarCity bond to a more diversified, flexible financing strategy that can better manage interest rates and liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT: The 5.45% Solar Bonds, Series 2015/C45-15 is correctly identified and its continued presence across 2022-2024 filings is accurate. The reference to Exhibit 4.41 appears reasonable. The general observation about diversified financing strategy is partially valid. INCORRECT/INCOMPLETE: (1) The LLM fails to identify the specific subsequent bond series mentioned in the ground truth (C53-15, C62-15, C72-15) with their respective dates (June 16, 2015; June 29, 2015; July 21, 2015). This is a critical omission for a multi-hop question about evolution. (2) The LLM's characterization of the strategy as a 'shift from single long-term SolarCity bond to diversified financing' contradicts the ground truth, which emphasizes an 'iterative approach to expanding securitization' and 'leveraging standardized, asset-backed instruments.' The ground truth shows Tesla building upon the original framework with newer issuances of the SAME bond series (different tranches), not shifting away from it. (3) The LLM mentions 'convertible senior notes' and 'additional supplemental indentures' but these are not the focus of the ground truth answer, which specifically traces the evolution of the 5.45% Solar Bonds series. (4) The ground truth's key insight about 'scalable, repeatable financing model' and 'reducing reliance on traditional corporate debt' is absent from the LLM answer. The LLM's interpretation of 'diversification' misses the actual pattern of standardized asset-backed securitization. The answer demonstrates partial understanding but fails to capture the specific multi-hop synthesis of bond series evolution and the strategic implications of the securitization model.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 474,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "Adobe has kept Acrobat as the centerpiece of its Document Cloud, but the 2024 filing shows a sharper push to make the platform more AI‑driven and broadly integrated.  In 2022, Acrobat was already described as a leader in document‑intensive sectors (government, finance, legal, aerospace, insurance, pharma, publishing) and as a “best PDF experience” powered by Adobe Sensei, with plans to expand Acrobat Web, Adobe Sign integration and APIs for workflow automation【page_7】【page_6】.  By 2024, the same AI emphasis remains—Sensei is still cited as the engine that makes PDFs “more intelligent and responsive”—but the strategy now foregrounds a wider digital‑document services platform, adding more task‑based actions, deeper API‑driven workflows, and targeted vertical‑market go‑to‑market motions (education, telecom, government) to grow adoption across all business sizes【page_94】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's Acrobat evolution from 2022-2024 with generally accurate information, but has some notable gaps and inconsistencies compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the three-year evolution trajectory (2022→2023→2024)\n2. Accurately mentions key 2022 positioning: market leadership in document-intensive sectors (legal, financial, publishing, etc.), Adobe Sensei integration, and Document Cloud platform\n3. Correctly identifies AI as a strategic pivot point\n4. Accurately notes the 2024 emphasis on broader digital document services platform\n5. Properly synthesizes multi-hop information across years\n6. Mentions relevant details like API-driven workflows and vertical market strategies\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The ground truth specifically mentions the formal introduction of 'Acrobat AI Assistant' as a trademark in 2024—a concrete, named product innovation. The LLM answer mentions AI emphasis but does not reference this specific product launch, which is a key factual detail\n2. The LLM answer mentions 2023 less explicitly than the ground truth, which specifically notes Adobe's \"forward-looking statements about AI innovation\" and \"vision to embed artificial intelligence\" as a distinct 2023 milestone\n3. The LLM answer adds details about \"task-based actions\" and specific vertical markets (education, telecom, government) that aren't in the ground truth, though these don't contradict it\n4. The reference to \"Adobe Sensei\" in 2024 is mentioned but the ground truth emphasizes the shift to \"Acrobat AI Assistant\" as the branded innovation\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes information across three years and identifies the progression from market leadership → AI vision → AI product realization. However, it misses the specific naming of the AI product (Acrobat AI Assistant) which is a concrete manifestation of the strategy.\n\nNUMERIC/FACTUAL ACCURACY:\nNo quantitative errors detected. All years, company names, and industry sectors mentioned are accurate. The page references provided appear reasonable though cannot be independently verified.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM captures the overall narrative arc, it fails to highlight the specific 'Acrobat AI Assistant' product introduction as the culmination of the AI strategy, which is a material difference from the ground truth's emphasis on this concrete realization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 658,
        "total_tokens": 2144
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "In 2022, Schwab’s Advisor Services website offered interactive tools and the free Schwab Advisor Portfolio Connect, while enabling integration with third‑party CRM, portfolio, trade‑order, and financial‑planning systems (page_10). By 2023, the platform was enhanced with Schwab Trading Powered by Ameritrade, adding real‑time charting, advanced trading, and educational features (page_9). In 2024, Schwab further integrated TD Ameritrade’s thinkpipes trading platform and iRebal portfolio‑rebalancing into the RIA offering, expanding its integration ecosystem and delivering a more modern, scalable experience for RIAs (page_8).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) INCORRECT TIMELINE: The LLM claims Schwab Advisor Portfolio Connect was available in 2022, but the ground truth indicates it was first highlighted in 2024 as a maintained/continued offering. This is a major chronological error. (2) UNSUPPORTED CLAIMS: The LLM introduces 'Schwab Trading Powered by Ameritrade' in 2023 and 'thinkpipes trading platform' in 2024 - these specific product names and their integration timeline are not mentioned in the ground truth, suggesting potential hallucination or misattribution. (3) INCOMPLETE SYNTHESIS: While the LLM does mention third-party integrations (CRM, portfolio, trade-order, financial-planning systems), it fails to accurately capture the core narrative of the ground truth: the consistent emphasis on the Advisor Services website as the central platform across all three years, and the focus on supporting RIA independence and scalability. (4) MISSING CONTEXT: The ground truth emphasizes educational content and support for RIA transitions to independence in 2023, which the LLM answer omits entirely. (5) ACCURACY OF CORE FACTS: The ground truth's statement about 2022 proprietary software and third-party integrations is partially reflected, but the LLM's specific product names (thinkpipes, iRebal) and their introduction dates cannot be verified against the provided ground truth. The answer shows some understanding of the evolution concept but fundamentally misrepresents the timeline and introduces unverified product details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 442,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In 2022, Emerson positioned air‑preparation equipment as part of its Industrial Solutions offering within Automation Solutions, describing it as one of several “pneumatic mechanisms” that work alongside solenoid valves, cylinders and actuators to deliver integrated control solutions【page_7】.  In both the 2023 and 2024 10‑Ks the product is listed under the Discrete Automation segment, where it is explicitly grouped with solenoid valves, pneumatic valves, valve‑position indicators, cylinders, actuators, pressure/temperature switches and “programmable automation control systems and software,” underscoring its continued integration with other pneumatic and control technologies【page_73】.  The core positioning remained unchanged, though the 2024 filing’s broader emphasis on Plantweb and IIoT connectivity hints at a deeper digital integration of air‑preparation equipment with control systems.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant discrepancies with the ground truth regarding the evolution of Air Preparation Equipment positioning across the three-year period. CORRECT ELEMENTS: (1) The LLM correctly identifies that in 2022, air preparation equipment was positioned alongside pneumatic mechanisms, solenoid valves, cylinders, and actuators; (2) Correctly notes that in 2023 and 2024, the product appears under the Discrete Automation segment; (3) Accurately mentions integration with programmable automation control systems and software; (4) Correctly references Plantweb and IIoT connectivity in 2024. CRITICAL ERRORS: (1) The LLM states 'The core positioning remained unchanged' across all three years, which directly contradicts the ground truth's central thesis that there was a 'clear shift from a mechanical focus to a digitally integrated component.' The ground truth explicitly describes a 3-year progression showing evolution, not stasis; (2) The LLM fails to capture the 2023 transition point where positioning became 'more explicitly embedded within the Discrete Automation segment's portfolio' with 'stronger alignment with digital and automated control ecosystems'; (3) The LLM misses the 2024 evolution highlighting 'interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication' and alignment with 'Industry 4.0 and digital transformation'; (4) The LLM's characterization of 2024 as merely 'hints at a deeper digital integration' significantly understates the explicit positioning evolution described in the ground truth. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the three years, instead treating the positioning as largely static with only minor digital hints in 2024. The ground truth demonstrates a deliberate strategic progression from mechanical integration (2022) → digital ecosystem alignment (2023) → Industry 4.0 capabilities (2024). The LLM's answer is partially factually accurate on individual components but fundamentally misses the core narrative of strategic evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 572,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 2022 10‑K shows that Coca‑Cola had already issued the 0.125% Notes due 2029 in 2020 and amended them in 2021 (see Exhibit 4.23 and 4.31)【page_136】.  The 2023 and 2024 10‑Ks continue to reference the same notes with no new issuances or amendments (Exhibit 4.23 and 4.31 in both 2023【page_130】 and 2024【page_128】).  This unchanged, low‑interest, short‑term debt instrument suggests the company prefers to keep a small, stable near‑term financing tool while relying on longer‑term, higher‑rate notes for larger capital needs, reflecting a conservative, steady‑state approach to debt management.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about issuance strategy evolution. Key issues: (1) FACTUAL ERRORS: The LLM claims the 0.125% Notes due 2029 were 'issued in 2020 and amended in 2021' - this is not supported by the ground truth, which discusses the notes being referenced consistently across 2022-2024 without mentioning 2020 issuance or 2021 amendments. The LLM provides specific exhibit references (4.23, 4.31) with page numbers that cannot be verified against the ground truth. (2) MISINTERPRETATION OF QUESTION: The question asks about how the issuance STRATEGY EVOLVED from 2022-2024, focusing on the company's approach to managing near-term debt obligations. The ground truth shows a clear evolution: passive disclosure in 2022 → consolidated format in 2023 → strategic pivot toward higher-yielding, longer-term instruments in 2024. The LLM incorrectly characterizes the notes as 'unchanged' and 'short-term' (the 2029 maturity is medium-term, not short-term), missing the strategic evolution entirely. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the introduction of significantly higher-yielding instruments (5.000% Notes due 2034, 5.400% Notes due 2064) in 2024 as evidence of strategic refinancing. The LLM completely omits this critical multi-hop synthesis across debt instruments. (4) CONTRADICTORY CONCLUSIONS: The LLM concludes the company takes a 'conservative, steady-state approach' when the ground truth explicitly identifies a 'strategic pivot' and 'deliberate effort to refinance.' These are fundamentally different interpretations. (5) UNSUPPORTED CLAIMS: The LLM's characterization of the 0.125% Notes as a 'small, stable near-term financing tool' lacks support in the ground truth and misses the context that this note is approaching maturity (2029) and being strategically managed through longer-term refinancing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 514,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY’s 2022 10‑K risk‑factor disclosed that its ability to return capital—through dividends or share repurchases—was limited by U.S. banking laws, capital‑planning rules, Delaware law, and the obligation to pay dividends on preferred stock. The identical wording appears unchanged in the 2023 and 2024 filings, indicating that regulatory constraints on dividends and share repurchases remained essentially the same over that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the framing and language evolved from 2022 through 2024, with increasing specificity and formalization—moving from general caution in 2022 to more specific references to regulatory standards like 'well capitalized' status and capital adequacy rules in 2024. The LLM answer claims the 'identical wording appears unchanged in the 2023 and 2024 filings,' which is the opposite of what the ground truth indicates. This is a critical error in multi-hop reasoning and synthesis across the three-year period. The LLM correctly identifies the 2022 constraints (U.S. banking laws, capital-planning rules, Delaware law, preferred stock dividend obligations), and the numeric/date references are accurate (2022, 2023, 2024). However, the core claim about evolution—the central focus of the question—is completely inverted. The question specifically asks how exposure 'evolved,' and the ground truth demonstrates clear evolution in regulatory framing and specificity, while the LLM answer asserts stasis ('remained essentially the same'). This represents a failure in qualitative reasoning and synthesis across multiple years of filings, making the answer fundamentally incorrect despite accurate identification of individual components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 379,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McGriddles is described in each filing simply as one of the breakfast sandwiches on the full or limited breakfast menu, with no new product launch or repositioning noted (2022 page 7; 2023 page 7; 2024 page 7).  The wording remains unchanged, while the broader menu‑innovation narrative in all three years continues to emphasize ongoing product testing and limited‑time promotions elsewhere.  This consistency shows that McDonald’s breakfast strategy has stayed stable, treating McGriddles as a core, long‑standing offering rather than a focus of frequent innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core insight about McGriddles' consistency across years and the stable breakfast strategy, which aligns with the ground truth's main conclusion. However, there are significant issues with page number accuracy and citation specificity. The ground truth explicitly cites specific pages and chunks (2022: page 7 chunk 1; 2023: page 6 chunk 1; 2024: page 6 chunk 1), while the LLM claims all three years appear on 'page 7' - this is factually incorrect for 2023 and 2024 according to the ground truth. This represents a quantitative/factual error in document location citations. The LLM also lacks the specific contextual details from the ground truth, such as the explicit mention of 'continuous evolution' language in 2023 or the 'testing new products on an ongoing basis' language in 2024, which are important for demonstrating how the company's broader narrative contrasts with McGriddles' static positioning. The LLM's reasoning about the consistency and stability of the breakfast strategy is sound and semantically equivalent to the ground truth's conclusion. The answer correctly identifies that McGriddles remained a core offering without significant innovation focus, and properly synthesizes the multi-hop comparison across three years. However, the citation errors and missing specific textual evidence from the filings reduce confidence in the factual accuracy of the response, even though the overall analytical conclusion appears correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 408,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe continued to highlight a large portfolio of free online self‑service learning on **learning.adobe.com** in all three years, positioning it as a core offering of **Adobe Digital Learning Services** under Adobe Customer Solutions (2022 page 17; 2023 page 17; 2024 page 18). The platform and delivery method remained unchanged—students accessed the courses through the same learning.adobe.com website, while fee‑based programs were also offered via that channel. Consequently, there was no significant shift in positioning or platform usage for free self‑service learning across 2022‑2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. Key issues: (1) PLATFORM EVOLUTION ERROR: The LLM claims learning.adobe.com was used in all three years (2022-2024), but the ground truth explicitly states that in 2022, Adobe used www.training.adobe.com, not learning.adobe.com. This is a critical factual error about the platform evolution. (2) DOMAIN SHIFT MISSED: The ground truth clearly documents a domain transition from training.adobe.com (2022) to learning.adobe.com (2023-2024), representing a strategic rebranding/centralization. The LLM completely missed this important evolution. (3) POSITIONING CHANGE OVERLOOKED: The ground truth emphasizes that the shift in domain indicates 'a more centralized or rebranded approach' and 'a maturing and more structured approach to digital education.' The LLM incorrectly concludes 'there was no significant shift in positioning or platform usage,' which directly contradicts the ground truth's assessment of strategic evolution. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies learning.adobe.com as part of Adobe Digital Learning Services and mentions fee-based programs, it fails to synthesize the multi-hop information about the platform evolution across the three-year period. (5) CITATION ACCURACY: The LLM provides page references (2022 page 17; 2023 page 17; 2024 page 18) but these appear to support an incorrect narrative about platform consistency rather than the documented evolution. The core answer fundamentally misrepresents the trajectory of Adobe's learning platform strategy by claiming no significant change when the ground truth documents a clear platform migration and strategic repositioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 469,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In 2022 Emerson grouped commercial vacuums under its Tools & Home Products segment as part of the “Professional Tools” line, where they were listed alongside pipe‑working, electrical, and other professional tools for both professionals and homeowners【page_10】. By 2024 the same product was repositioned inside the Safety & Productivity segment, still described as a professional tool but now framed as part of a portfolio that “supports infrastructure, promotes safety and enhances productivity” for professionals【page_73】. This shift signals a strategic emphasis on integrating commercial vacuums into Emerson’s safety‑and‑productivity strategy while keeping them aligned with the broader professional tools offering.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) MISSING 2023 DATA: The LLM answer completely omits the 2023 transition year, which is explicitly mentioned in the ground truth as a key milestone where Commercial Vacuums were 'explicitly included in the Safety & Productivity segment.' The ground truth describes a three-year evolution (2022→2023→2024), but the LLM only addresses 2022 and 2024, missing the intermediate and important 2023 positioning. (2) INCOMPLETE PRODUCT CATEGORIZATION: The ground truth specifies that in 2023, Commercial Vacuums were grouped with 'battery hydraulic tools and sewer inspection cameras' and in 2024 with 'programmable automation control systems and electrical distribution equipment.' The LLM answer provides vague references to 'pipe-working, electrical, and other professional tools' for 2022 but fails to specify the actual product groupings for 2023 and the specific technological alignment shift in 2024. (3) STRATEGIC EMPHASIS EVOLUTION: The ground truth emphasizes a clear strategic shift from 'general tools category to more integrated part of Emerson's industrial safety and productivity solutions' with increasing technological sophistication. The LLM answer describes this more superficially as simply moving from one segment to another without capturing the nuanced evolution toward 'technologically advanced and industrial productivity tools.' (4) ACCURACY OF DETAILS: The LLM correctly identifies the 2022 Tools & Home Products segment placement and the 2024 Safety & Productivity segment placement, but the characterization of product companions and strategic framing is incomplete. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the evolution, it fails to properly connect all three years and the specific product category alignments that demonstrate the strategic repositioning. The answer reads as a simplified two-point comparison rather than a comprehensive three-year evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 522,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "In the 2022 10‑K, the Hoofddorp, Netherlands site is not listed among Gilead’s manufacturing facilities, indicating it was not yet used for cell‑therapy production (see pages 31‑35). By 2023, Gilead began utilizing the Hoofddorp facility for commercial manufacturing and processing of its cell‑therapy products (page 12). The same role is maintained in the 2024 10‑K, with the facility again described as a commercial cell‑therapy manufacturing and processing site (page 11).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, GILD's Hoofddorp facility was 'identified as a principal manufacturing site,' indicating it was already in use. However, the LLM answer claims 'In the 2022 10-K, the Hoofddorp, Netherlands site is not listed among Gilead's manufacturing facilities, indicating it was not yet used for cell-therapy production.' This is a fundamental misrepresentation of the 2022 status. The LLM correctly identifies that by 2023 and 2024 the facility was used for commercial manufacturing and processing of cell therapy products, which aligns with the ground truth. However, the incorrect characterization of the 2022 baseline significantly undermines the answer's accuracy. The LLM also provides specific page references (pages 31-35 for 2022, page 12 for 2023, page 11 for 2024), which cannot be verified but the claim about 2022 contradicts the established ground truth. The multi-hop reasoning fails at the first step by mischaracterizing the facility's status in 2022, which prevents proper assessment of the 'evolution' requested in the question. The answer does address the three-year period and attempts to show progression, but the foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 361,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 2022‑2024 10‑Ks repeatedly cite the 1.000% Notes due 2028 (see page 136 and page 134 for 2022, and page 130 for 2024), underscoring its continued use of a low‑coupon, long‑term debt instrument as a core, low‑cost element of its capital structure.  In 2024 the company also incorporated higher‑yield notes—5.000% Notes due 2034 and 5.400% Notes due 2064 (page 130)—reflecting a strategic shift to diversify its debt mix and extend maturities, even at a higher financing cost, to better match long‑term investment horizons and market conditions.  Together, these filings show Coca‑Cola balancing a stable, inexpensive debt base with newer, higher‑yield instruments to optimize its overall cost of capital and maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All financial instruments and their characteristics are correctly identified - 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064. The percentages and maturity years are accurate. The temporal scope (2022-2024) is correctly referenced. ENTITY ACCURACY: Coca-Cola is correctly identified, and all debt instruments are properly named with accurate coupon rates and maturity dates. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings (2022, 2023, 2024) and correctly identifies the pattern of persistent low-cost debt alongside the introduction of higher-yield instruments in 2024. The reasoning about strategic implications is sound - the shift reflects portfolio diversification and capital structure optimization. COMPLETENESS: The answer addresses all aspects of the original question: (1) persistent reference to 1.000% Notes, (2) introduction of higher-yield notes in 2024, (3) implications for debt financing costs, and (4) capital structure management. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive meaning as the ground truth, using slightly different phrasing ('recalibration' vs 'balancing') but maintaining factual accuracy. The LLM adds specific page references (136, 134, 130) which, while not contradicted by the ground truth, cannot be verified against it but do not detract from accuracy. MINOR OBSERVATIONS: The LLM's explanation of the strategic rationale ('to better match long-term investment horizons and market conditions') is slightly more specific than the ground truth's 'favorable market conditions or to fund new strategic initiatives,' but both are reasonable interpretations of the same underlying strategy. No calculation errors detected. No factual contradictions identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 518,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s 2022 10‑K described its pipe‑cutting line simply as part of a “pipe‑working tools” set that included wrenches, cutters, threading and roll‑grooving gear, with diagnostics such as closed‑circuit television inspection cameras (page 9).  By 2023 and 2024 the segment description was updated to note that the line now also contains “battery hydraulic tools for press connections” and diagnostic systems (e.g., sewer‑inspection cameras and locating equipment) (page 73).  This evolution shows Emerson’s deliberate shift toward cordless, battery‑powered cutters and integrated diagnostic features, underscoring its positioning as a technology‑driven leader in the professional plumbing‑tools market that prioritises convenience, efficiency and smart‑tool capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) showing evolution from traditional tools to battery-powered and diagnostic-integrated offerings. (2) Accurately captures the key technological shifts: traditional pipe-working tools in 2022, battery hydraulic technology introduction in 2023, and diagnostic system integration by 2024. (3) Properly identifies specific diagnostic tools (sewer inspection cameras, locating equipment) mentioned in ground truth. (4) Correctly synthesizes the strategic positioning as technology-driven and focused on professional plumbing market. (5) Page references (9, 73) add credibility though not verifiable from ground truth. MINOR ISSUES: (1) The LLM answer includes specific product details ('press connections') and page citations that go slightly beyond the ground truth scope, though these don't contradict it. (2) The ground truth emphasizes 'high-value, technology-enhanced tools aimed at improving productivity and safety' while the LLM emphasizes 'convenience, efficiency and smart-tool capabilities' - semantically similar but with slightly different emphasis. (3) The LLM's mention of 'closed-circuit television inspection cameras' in 2022 is more specific than ground truth which states 'no emphasis on battery-powered or diagnostic capabilities' in 2022 - this could suggest diagnostics existed earlier than the ground truth implies, though it may reflect accurate filing language. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects product evolution to market positioning. The logical flow from traditional→battery-powered→diagnostic-integrated is sound and matches ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The dates (2022, 2023, 2024) are all correct. Overall, the answer is substantially correct with minor nuances in interpretation that don't materially affect the core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 568,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024 Gilead has consistently used its Santa Monica, California site for **clinical manufacturing and processing of cell‑therapy products** (2022 p. 35; 2023 p. 11; 2024 p. 10).  The unchanged role—without a shift to commercial production—underscores the facility’s strategic position as a dedicated clinical hub that supports the development of Gilead’s cell‑therapy pipeline within its broader manufacturing network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the key factual claim. Ground truth states that in 2022, the Santa Monica facility was NOT specifically highlighted for cell therapy processing, and only by 2023 was it explicitly noted for this role. The LLM claims the facility was 'consistently used' for clinical manufacturing and processing of cell-therapy products from 2022 through 2024, which is factually incorrect according to the knowledge graph. This is a fundamental misrepresentation of the facility's evolution. The LLM also cites specific page numbers (2022 p. 35; 2023 p. 11; 2024 p. 10) without verification, and these citations cannot be confirmed against the ground truth. The core narrative of the answer—that there was NO CHANGE in the facility's role across the three years—directly contradicts the ground truth's clear statement that the facility TRANSITIONED from a general R&D site to a dedicated cell therapy manufacturing hub. The LLM's conclusion that the facility maintained an 'unchanged role' is the opposite of what the ground truth indicates. While the LLM correctly identifies the company (GILD/Gilead), location (Santa Monica, California), and general product focus (cell therapy), it fails on the most critical aspect: the temporal evolution and strategic shift that the question specifically asks about. The answer demonstrates a failure to synthesize the multi-hop information about how the facility's utilization evolved over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 412,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s 2022 10‑K (pages 95‑99) does not mention Frame.io as a core Creative Cloud component, indicating that its integration was limited or not emphasized at that time. By the 2024 10‑K, Frame.io is positioned as a cloud‑native collaboration platform that supports video, still images, design files and PDFs, and is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, while also offering Camera‑to‑Cloud uploads from cameras and still‑image devices—expanding both media support and cross‑application collaboration. (2022 pages 95‑99; 2024 page_12)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Frame.io from 2022 to 2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies that Frame.io was not prominently featured in 2022 10-K, (2) Accurately lists 2024 supported media types (video, still images, design files, PDFs), (3) Correctly identifies integrated applications (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront), (4) Mentions Camera-to-Cloud feature which adds specificity. WEAKNESSES: (1) The answer skips the 2023 intermediate state entirely, which is a significant omission since the ground truth explicitly describes 2023 as a distinct evolution point with frame-specific feedback integration with Premiere Pro and After Effects, (2) Does not mention Adobe GenStudio positioning in 2024, which is part of the ground truth's description of enterprise-scale content production positioning, (3) The answer conflates 2022 and 2024 without properly addressing the 2023 transition year, (4) Missing the specific mention of frame-specific feedback capability that was introduced in 2023. MULTI-HOP REASONING: The answer attempts to synthesize across years but fails to properly address the three-year evolution arc. It jumps from 2022 (minimal mention) to 2024 (full capabilities) without the intermediate 2023 step that shows the progression. SEMANTIC EQUIVALENCE: The factual claims made are generally accurate where stated, but the incompleteness regarding 2023 and GenStudio positioning represents a material gap in addressing the full scope of the question about evolution from 2022 to 2024. The answer is directionally correct but incomplete in its temporal coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 454,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson has positioned electrical‑distribution equipment (EDE) as a core element of its Discrete Automation portfolio, consistently listing it alongside programmable automation control systems and software in the segment description.  From 2022 through 2024 the company has deepened that integration—adding more EDE and related solutions (e.g., electric linear‑motion and materials‑joining products) to the discrete‑automation suite to deliver a fully‑connected automation stack for discrete manufacturers【page_73】.  This evolution reflects Emerson’s strategy to embed automation technologies across discrete manufacturing while expanding the breadth of EDE offerings within the segment【page_73】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Emerson's Electrical Distribution Equipment positioning from 2022-2024 and correctly identifies the key strategic shift toward integration with automation technologies and product scope expansion. The answer accurately reflects that EDE was positioned alongside programmable automation control systems and software, and that additional products (electric linear motion, materials joining) were added over time. However, there are notable differences from the ground truth: (1) The LLM answer lacks the specific 2022 positioning detail that EDE was initially in the Industrial Solutions business before moving to Discrete Automation in 2023. (2) The ground truth provides a clearer year-by-year progression showing the 2023 transition point, while the LLM answer presents the evolution more as a continuous deepening from 2022-2024 without clearly delineating the 2023 shift. (3) The LLM answer uses slightly different terminology ('EDE' abbreviation vs. 'Electrical Distribution Equipment') and phrasing ('fully-connected automation stack' vs. 'smart, integrated automation solutions'), though these are semantically equivalent. (4) The LLM answer correctly identifies the multi-hop synthesis across three years and multiple product categories. No quantitative errors are present (no specific numbers or calculations to verify). The answer demonstrates sound reasoning about the strategic positioning evolution and correctly synthesizes information about product integration and scope expansion. The citation to page_73 adds credibility but cannot be verified against the ground truth. Overall, the answer is substantially correct but omits the important 2022-2023 transition detail that was central to the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 483,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19.98 bn (weighted‑average rate 2.91 %)** at 12/31/2022 to **$27.17 bn (4.45 %)** at 12/31/2023, then fell slightly to **$26.93 bn (4.84 %)** at 12/31/2024【page 188 (2022)】【page 178 (2023)】【page 188 (2024)】. The jump in carrying value and the steep rise in the weighted‑average rate between 2022 and 2023 reflect new issuances at higher market rates, while the modest decline in 2024 indicates partial repayment or refinancing. Together, these trends show that Capital One is actively managing its debt mix—issuing fixed‑rate debt to secure liquidity while hedging against further rate hikes, yet also paying down or restructuring to keep borrowing costs in check in a rising‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - carrying values of $19.975B (2022), $27.168B (2023), and $26.930B (2024) match ground truth exactly (minor formatting variation $19.98B vs $19.975B is acceptable). Weighted-average interest rates of 2.91%, 4.45%, and 4.84% are all accurate. The year-over-year changes are correctly characterized (increase from 2022-2023, slight decline 2023-2024). ENTITY ACCURACY: Capital One (COF) correctly identified, all fiscal years (2022, 2023, 2024) correct, metric terminology (fixed unsecured senior debt, carrying value, weighted-average interest rate) all precise. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two metrics (carrying value + interest rate), correctly identifying the relationship between them. The interpretation that the carrying value increase reflects new issuances at higher rates is sound, and the modest 2024 decline is correctly attributed to partial repayment/refinancing. STRATEGIC INTERPRETATION: The LLM's characterization of Capital One's debt strategy is well-reasoned and goes slightly beyond the ground truth by adding nuance about 'hedging against further rate hikes' and 'keeping borrowing costs in check' - these are logical inferences from the data pattern and enhance rather than contradict the ground truth answer. The progression narrative is clear and accurate. MINOR CONSIDERATIONS: The LLM provides slightly more detailed strategic analysis than the ground truth (which simply states 'proactive approach to anticipated rate hikes'), but this represents value-added interpretation rather than error. Citation references to specific pages are provided, adding credibility. No calculation errors detected. All semantic meanings align with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 505,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million at 12/31/2023 to $993 million at 12/31/2024** (a net decline of $98 million after issuing $216 million in new warranties and settling $247 million).  The balance had already slipped from $1,157 million in 2022 to $1,109 million in 2023, so the trend shows a steady reduction in the company’s long‑term product‑performance exposure in its commercial aerospace business, likely reflecting fewer warranty issuances and higher settlements that improve product reliability or risk management.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. Ground truth shows: 2022: $120M, 2023: $120M, 2024: $101M. LLM reports: 2022: $1,157M, 2023: $1,109M, 2024: $993M. These are completely different numbers - off by a factor of approximately 10x. The LLM's figures are entirely fabricated and do not match the actual RTX liability data from SEC filings. The LLM also provides specific calculations ($98M decline, $216M new warranties, $247M settlements) that cannot be verified and appear to be invented. The directional conclusion (declining trend) happens to align with ground truth, but this is coincidental given the wrong absolute numbers. The LLM failed on: (1) Quantitative accuracy - all dollar amounts are wrong by orders of magnitude, (2) Multi-hop synthesis - appears to have confused or hallucinated data rather than correctly extracting from filings, (3) Factual correctness - the specific liability amounts are demonstrably incorrect. The only partial credit is that the answer correctly identifies RTX, the correct metric (performance and operating cost guarantees), the correct time period (2022-2024), and the correct business segment (commercial aerospace), but the core numerical data is entirely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 350,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "The Coca‑Cola Group’s investment note has consistently listed “estimates of sales proceeds” as one of the valuation methods for non‑public investments, with the same wording and emphasis on the difficulty of forecasting cash flows in emerging markets in 2022 (p. 42), 2023 (p. 79), and 2024 (p. 79). This unchanged reliance shows a stable, market‑participant‑aligned approach to fair‑value measurement, underscoring the company’s cautious stance toward valuing assets in volatile emerging economies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the wording and emphasis were 'unchanged' across 2022-2024, directly contradicting the ground truth which explicitly describes a 3-year progression from 'disclosed' (2022) to 'relies on' (2023) to 'use' with increased caution (2024). This is a fundamental mischaracterization of the evolution. (2) MISSING MULTI-HOP SYNTHESIS: The ground truth describes a strategic progression (disclosure → operational reliance → risk-aware integration), but the LLM flattens this into a static 'stable' approach. The question specifically asks 'how did...evolve' and the LLM fails to capture this temporal dimension. (3) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'deepening dependence' followed by 'more cautious application,' suggesting a non-linear evolution. The LLM's characterization of 'unchanged reliance' and 'stable approach' contradicts this narrative entirely. (4) PAGE REFERENCES: While the LLM provides specific page numbers (42, 79, 79), these cannot be verified against the ground truth and appear to be fabricated details that don't align with the actual evolution described. (5) INCOMPLETE ANALYSIS: The LLM misses the key insight that the company's approach shifted from passive disclosure to active operational reliance to risk-aware integration—a meaningful strategic evolution that the question specifically asks about. The answer demonstrates a fundamental failure to synthesize the multi-year progression and instead presents an incorrect static characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 449,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s 10‑K risk‑factor disclosures consistently repeated the same statement: the Board’s discretion to return capital is subject to U.S. banking laws and regulations, including capital‑and‑capital‑planning rules, Delaware law, and the requirement to pay full, timely dividends on preferred stock. The wording did not change across the three filings, indicating a steady, cautious stance that keeps capital‑distribution decisions within regulatory limits while still allowing the Board to adjust them as needed.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies the core regulatory constraints mentioned in BNY Mellon's disclosures (U.S. banking laws, capital planning rules, Delaware law, preferred stock dividend requirements) and accurately notes that the wording remained consistent across 2022-2024. However, the answer has significant gaps in addressing the full scope of the original question:\n\n(1) MISSING KEY EVOLUTION: The ground truth explicitly states that 2024 added NEW emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends. The LLM answer completely omits this critical evolution, stating instead that 'wording did not change' - this is a major factual gap that misses the core insight about how disclosures evolved.\n\n(2) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution FROM 2022 THROUGH 2024 and what the progression suggests. The LLM identifies consistency but fails to capture the 2024 shift toward emphasizing internal capital flow dependencies, which is the key differentiator in the three-year progression.\n\n(3) STRATEGIC IMPLICATIONS MISSED: The ground truth emphasizes that despite stable regulatory language, there were 'increasing internal structural dependencies shaping its shareholder return strategy.' The LLM's conclusion that the Board can 'adjust them as needed' contradicts the ground truth's finding of growing constraints and dependencies.\n\n(4) QUANTITATIVE ACCURACY: No numbers or calculations are present in either answer, so this dimension scores well (8/10) - the dates and entities are correct where mentioned.\n\n(5) REASONING QUALITY: The LLM's reasoning is superficial - it notes consistency but misses the critical evolution in 2024 that the ground truth identifies as the key insight. This represents incomplete multi-hop synthesis across the three-year period.\n\nThe answer is partially correct on the baseline facts but fundamentally incomplete in addressing the evolution and strategic implications that form the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 557,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 10‑K risk disclosures show that the threat of losing tax and tariff exemptions has been a constant concern since 2022, but the context has broadened over time. In 2022 the risk was framed as a general “loss or modification of exemptions for taxes and tariffs” that could affect operations abroad (see pages 35‑39 of the 2022 filing). By 2023 the same wording appeared, but the description added “changes in tax laws, trade protection measures and import or export licensing requirements” and highlighted the impact of sanctions and export‑control rules (pages 39‑43 of the 2023 filing). In 2024 the language remains, yet it explicitly links the loss of exemptions to a wider array of geopolitical and regulatory pressures—sanctions against Russia, Belarus and Ukrainian regions, and tensions between China and Taiwan—underscoring how sanctions and trade‑policy shifts now directly threaten AMD’s tax and tariff benefits (pages 38‑42 of the 2024 filing). This progression illustrates an increasingly intricate global regulatory environment in which AMD must navigate not only ordinary tax changes but also targeted sanctions and evolving export‑control regimes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the evolution of AMD's risk disclosure regarding tax and tariff exemptions. (2) Accurately captures the key thematic shift: from general awareness in 2022 to expanded discussion of geopolitical events in 2023 to explicit linkage with sanctions and export controls in 2024. (3) Properly synthesizes multi-hop information by connecting specific geopolitical events (Ukraine conflict, China-Taiwan tensions, Russia/Belarus sanctions) to regulatory complexity. (4) Correctly identifies the core insight that regulatory landscape became more volatile and complex over time. (5) Page references (35-39 for 2022, 39-43 for 2023, 38-42 for 2024) are plausible and add specificity, though cannot be verified against ground truth. MINOR WEAKNESSES: (1) The LLM answer provides slightly more granular detail about specific regulatory mechanisms (sanctions against Russia, Belarus, export-control regimes) compared to the ground truth, which is more general. This is not an error but represents a more detailed interpretation. (2) The phrase 'internal expansion and external geopolitical pressures' from the ground truth is not explicitly mirrored in the LLM answer, though the concept is implicitly present. (3) The LLM answer's reference to specific page numbers, while adding credibility, cannot be verified and could be hallucinated, though the content appears consistent with typical 10-K risk factor organization. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension focuses on date accuracy (2022, 2023, 2024 all correct) and logical progression. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct—the answer properly connects regulatory changes across years to geopolitical events and their impact on tax/tariff exemptions. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of exposure and what it suggests about regulatory complexity, with appropriate emphasis on the increasing intricacy of the global regulatory environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 594,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s total debt (short‑term borrowings plus long‑term debt) fell from **$48.7 billion in 2022 to $45.6 billion in 2024**.  Short‑term borrowings dropped sharply from **$883 million in 2022 to $538 million in 2023** and then rose modestly to **$562 million in 2024**, while long‑term debt rose from **$47.8 billion in 2022 to $49.3 billion in 2023** and fell to **$45.0 billion in 2024**.  The floating‑unsecured senior debt component shrank from **$1.6 billion in 2022 to $349 million in 2023 and was eliminated in 2024**, indicating a deliberate shift away from variable‑rate debt and a lower interest‑rate exposure, with the remaining long‑term debt carrying a weighted‑average rate of roughly 4.5‑4.8 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the core financial numbers. Ground truth shows total debt of $43.086B (2022), $49.856B (2023), and $45.551B (2024). The LLM states $48.7B (2022), $45.6B (2024) - the 2022 figure is off by ~$5.6B and the 2024 figure is off by ~$0.05B (minor). Most critically, the LLM completely omits the 2023 figure of $49.856B, which is essential for showing the trajectory. SHORT-TERM BORROWINGS ERROR: Ground truth does not provide specific short-term borrowing breakdowns for 2022-2024 in the context given. The LLM provides specific figures ($883M, $538M, $562M) that cannot be verified against the ground truth and appear to be fabricated or from different data sources. FLOATING UNSECURED SENIOR DEBT: The LLM states $1.6B in 2022, but ground truth shows $1.709B - a minor discrepancy of ~$0.1B. The progression to $349M (2023) and $0 (2024) is correct. FIXED UNSECURED SENIOR DEBT: The LLM does not address this category at all, which is a significant omission. Ground truth shows $21.045B (2022) rising to $27.168B (2023) and $26.930B (2024) - this is critical context for understanding the debt structure shift. INTEREST RATE ANALYSIS: The LLM correctly identifies the strategic pivot from floating to fixed-rate debt and mentions weighted-average rates of 4.5-4.8%, which aligns with ground truth's 4.84% for 2024. However, the LLM misses the detailed rate progression (1.01% in 2022 to 6.75% in 2023 for floating debt, and 2.91% to 4.84% for fixed debt). MULTI-HOP REASONING: The LLM demonstrates understanding of the strategic shift and interest rate risk mitigation, but the foundation is built on incorrect numbers. The reasoning about eliminating floating-rate debt is sound but incomplete without the fixed-debt context. COMPLETENESS: The answer fails to comprehensively address the debt structure evolution, particularly the rise and fall of fixed unsecured senior debt, which is central to understanding Capital One's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 546,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG (IAE) stayed at **57 %** from 2022 through 2024 (the same 61 % program‑share and 49.5 % ownership interests reported in the variable‑interest‑entity notes on pages 112, 98 and 102).  The unchanged majority stake shows that RTX continues to be the primary beneficiary and holds a consistent controlling position in the V2500 engine collaboration, underscoring its strategic leadership and influence over the program’s economics and decision‑making.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims RTX's net program share interest 'stayed at 57% from 2022 through 2024,' but the ground truth clearly states it DECREASED from 61% in 2022 to 57% in 2023 and 2024. This is a major factual error - the LLM missed the key evolution that the question specifically asks about. (2) CONTRADICTORY STATEMENTS: The LLM parenthetically references '61% program-share' but then claims it 'stayed at 57%' - this internal contradiction suggests confusion about the data. The ground truth shows 61% in 2022, then 57% in 2023-2024, representing a clear 4-percentage-point decline. (3) FAILED MULTI-HOP SYNTHESIS: The question asks how the interest 'evolved' from 2022 to 2024 - requiring comparison across three years. The LLM failed to identify this evolution entirely, instead claiming no change occurred. (4) INCORRECT INTERPRETATION: The LLM's conclusion that 'unchanged majority stake shows RTX continues to be the primary beneficiary' is logically flawed because the stake DID change (decreased). The ground truth correctly interprets the decrease as 'a strategic adjustment' and 'gradual dilution' of RTX's exposure. (5) MISSING STRATEGIC INSIGHT: The ground truth provides the correct strategic interpretation - that the reduction indicates RTX shifted financial burden/risk to sub-collaborators. The LLM's interpretation of 'consistent controlling position' contradicts the actual data showing a declining stake. The LLM fundamentally misread or misunderstood the underlying data, making this answer substantially incorrect on the primary factual claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 461,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade remains a key brand in P&G’s Fabric & Home Care segment, which has grown in importance over the last three years.  The segment’s share of net sales rose from 35 % in 2022 to 36 % in 2024 (35 % in 2023) and its earnings share climbed from 31 % to 34 % (31 % in 2023), indicating an expanding role for home‑care products.  Cascade’s continued listing among the segment’s major brands in each filing shows its sustained prominence within the portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Cascade's positioning evolution. QUANTITATIVE VERIFICATION: All numeric values are correct - Fabric & Home Care segment net sales percentages (35% in 2022, 35% in 2023, 36% in 2024) and earnings percentages (31% in 2022, 31% in 2023, 34% in 2024) match the ground truth exactly. The LLM correctly identifies the trend of segment growth from 2022 to 2024. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and correctly identifies Cascade's consistent positioning within the Home Care sub-category of the Fabric & Home Care segment. The reasoning that Cascade 'remained a core brand' across all periods is sound and supported by the data. COMPLETENESS: The answer addresses the core question about how Cascade's positioning evolved, noting both consistency (maintained listing as major brand) and change (segment's growing earnings contribution). However, the LLM slightly simplifies the ground truth's more explicit statement about 'stable strategic importance' by using the phrase 'expanding role for home-care products' which is a reasonable inference but slightly shifts emphasis. MINOR DIFFERENCES: The ground truth explicitly states the segment 'maintained its prominence' in 2023 and notes the earnings increase 'from 31% to 34% over the period,' while the LLM presents this as growth from 2022 to 2024. Both characterizations are accurate, though the ground truth provides slightly more nuanced year-by-year detail. The LLM's phrasing about 'expanding role' is a reasonable interpretation of the data trend. ENTITY ACCURACY: All entities correctly identified (P&G, Cascade, Fabric & Home Care segment, Home Care sub-category). The answer maintains semantic equivalence with the ground truth while using slightly different wording that remains factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 516,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "BNY Mellon’s 2022 10‑K listed the Directors’ Code of Conduct at a URL on **www.bnymellon.com** with a non‑standard path that included a space (“in relations”). By 2023 the filing corrected the link to a clean investor‑relations folder (**https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf**). In 2024 the employee code moved to a new domain (**bny.com**), while the directors’ code remained on **bnymellon.com** but was referenced as a relative path within the investor‑relations section, and the filing explicitly ties the code to broader governance items—insider‑trading policies, board‑committee charters, and the corporate governance framework—underscoring its integration into the company’s governance architecture.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth on key details: (1) CRITICAL ERROR - URL PATH DISCREPANCY: The ground truth states the 2022 path was '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' (with 'in relations'), the 2023 path was '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf' (with 'inv relations'), and the 2024 path was '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' (with 'investor-relations'). The LLM incorrectly claims the 2023 filing 'corrected the link to a clean investor-relations folder' and provides a 2023 URL with 'investor-relations' - this is factually wrong. The ground truth shows 'investor-relations' only appeared in 2024, not 2023. (2) DOMAIN TRANSITION ERROR: The ground truth indicates the transition to 'bny.com' occurred in 2024, but the LLM states 'the employee code moved to a new domain (bny.com), while the directors' code remained on bnymellon.com' - this conflates different codes and misrepresents the evolution. The ground truth shows the Directors' Code URL itself transitioned to the new domain structure in 2024. (3) PARTIAL CREDIT: The LLM correctly identifies the general evolution from bnymellon.com to bny.com and recognizes the integration with broader governance frameworks (insider-trading policies, board-committee charters). However, the specific URL path evolution is materially misrepresented. (4) MULTI-HOP REASONING: The answer attempts to synthesize across three years but fails to accurately track the incremental URL changes, which is the core of the question. The claim about 2023 'correcting' to 'investor-relations' is demonstrably false per the ground truth. The answer shows understanding of the conceptual evolution but fails on the specific technical details that are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 515,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across 2022‑2024 AMD’s approach to add‑in‑board (AIB) manufacturers stayed essentially the same.  In each year’s 10‑K, AMD’s agreements with AIBs explicitly protected their inventory from price reductions (page 13, 2022; page 13, 2023; page 13, 2024) and continued to encourage system integrators to use discrete graphics solutions as a key differentiation and value‑adding tool (same pages).  No substantive change in inventory‑protection policy or the role of discrete GPUs is noted over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core finding that AMD's approach remained consistent across 2022-2024, matching the ground truth's emphasis on stability; (2) Accurately captures the two key strategic elements: inventory protection policies and discrete graphics as differentiation tools; (3) Properly synthesizes multi-hop information by connecting AIB manufacturer relationships across three fiscal years; (4) Appropriately cites page references (page 13 for each year) showing document-level verification; (5) Uses semantically equivalent language ('add-in-board' vs 'AIBs', 'value-adding tool' vs 'value-add') that conveys the same meaning. MINOR WEAKNESSES: (1) The LLM answer is slightly more terse than the ground truth, which provides slightly more contextual detail about the role of system integrators and retail buyers in 2022; (2) The phrase 'No substantive change' is accurate but could have been slightly more explicitly framed as 'consistent positioning' to match the ground truth's emphasis on 'stable, long-term partnership model'; (3) The answer doesn't explicitly mention that this consistency 'suggests a stable, long-term partnership model,' though this is a minor interpretive element rather than a factual omission. QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or calculations are required for this qualitative question about strategic positioning. The years (2022, 2023, 2024) and page references are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the relationship between inventory protection policies and discrete graphics strategies as complementary elements of AMD's AIB strategy. The reasoning is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 504,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "McDonald’s 2022 10‑K listed the Egg McMuffin as a core breakfast item and noted an ongoing commitment to test new products, while also announcing a digital‑transformation project to improve data‑driven quality and food‑safety metrics (page 7‑2022, page 6‑2022). The 2023 and 2024 filings keep the same emphasis on the Egg McMuffin and continuous menu innovation but drop the digital‑transformation detail, instead reinforcing the same high‑standard supply‑chain framework—supplier visits, third‑party verification, a Food Safety Advisory Council, and sustainability initiatives—to ensure consistent quality and meet customer expectations (page 7‑2023, page 6‑2023, page 6‑2024, page 7‑2024). Across all three years, the Egg McMuffin is portrayed as a flagship breakfast product whose quality and consistency are underpinned by rigorous supply‑chain controls.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims the digital transformation project was mentioned in 2022 but then 'dropped' in 2023-2024. The ground truth explicitly states the opposite: the digital transformation emphasis was INTRODUCED/EXPANDED in 2024, not present in 2022. This is a fundamental reversal of the evolution narrative. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key evolution described in the ground truth: the shift FROM general quality assurance (2022) TO technologically integrated and supply chain-driven approach (2024). Instead, it presents a static picture across all three years. (3) MISSING CRITICAL DETAIL - The ground truth emphasizes that 2023 expanded the narrative around 'innovation and supply chain collaboration' with specific mention of a Global Chief Supply Chain Officer, which the LLM does not capture. (4) CONTRADICTORY NARRATIVE - The LLM states 2023-2024 'drop the digital-transformation detail' when the ground truth indicates digital transformation became MORE prominent in 2024 as part of the evolution. (5) PAGE REFERENCES - The LLM provides specific page citations (page 7-2022, page 6-2022, etc.) that cannot be verified and appear to be fabricated, which is a serious accuracy concern. (6) INCOMPLETE ANSWER - The LLM does not adequately address how the disclosure 'evolved' from 2022 to 2024; instead it presents a static view. The ground truth clearly shows progression: 2022 (basic quality/nutrition focus) → 2023 (supply chain collaboration expansion) → 2024 (digital transformation for food safety). The LLM fundamentally misrepresents this evolution trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 467,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30% Note due 2034 is listed in each filing—Exhibit 4.11 in the 2022 10‑K (page 113) and Exhibit 4.09 in both the 2023 and 2024 10‑Ks (page 110).  Its repeated appearance shows that the note remains an outstanding long‑term debt instrument and that Oracle has not altered its maturity or coupon, underscoring a financing priority to keep a stable, diversified debt profile with predictable, moderate‑rate interest expense across these periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.30% Note due 2034 as a consistent disclosure across 2022, 2023, and 2024. (2) The core insight that the note remained outstanding and unchanged is accurate. (3) The reference to exhibit numbers and page numbers adds specificity, though these cannot be fully verified against the ground truth. (4) The conclusion about maintaining a stable, diversified debt profile is reasonable and aligns with the ground truth's emphasis on strategic long-term financing.\n\nWEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It fails to mention the comparative context provided in the original answer—specifically the other debt instruments disclosed alongside the 4.30% Note in each year (e.g., 3.625% Note due 2023, 4.50% Note due 2044 in 2022; 2.950% Notes due 2024 in 2023). (2) The ground truth explicitly discusses how Oracle's debt portfolio evolved across the three years, showing the issuance of newer instruments while maintaining the 4.30% Note. The LLM answer does not capture this dynamic evolution. (3) The LLM answer lacks the multi-hop synthesis that the ground truth demonstrates—comparing the maturity profiles and financing strategies across all three years. (4) While the LLM mentions 'diversified debt profile,' it does not substantiate this with the specific examples provided in the ground truth.\n\nMULTI-HOP REASONING: The question requires synthesizing information about Oracle's debt structure across three years. The ground truth does this effectively by showing how the 4.30% Note persisted while other instruments changed. The LLM answer acknowledges persistence but fails to synthesize the comparative evolution across years, which is a key aspect of the multi-hop requirement.\n\nNUMERIC/FACTUAL VERIFICATION: The 4.30% coupon rate and 2034 maturity date are correct. The years 2022, 2023, 2024 are correct. The exhibit references (4.11 for 2022, 4.09 for 2023 and 2024) cannot be contradicted by the ground truth but also cannot be verified as they are not mentioned in the original answer.\n\nSEMANTIC EQUIVALENCE: While the LLM's conclusion about 'stable, diversified debt profile with predictable, moderate-rate interest expense' is semantically aligned with the ground truth's emphasis on strategic long-term financing, the LLM fails to provide the supporting evidence and comparative analysis that makes the ground truth answer more compelling and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 656,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net derivative assets/liabilities rose from **$5 million at Dec 31 2022** (Table 16.2, 2022 column) to **$58 million at Dec 31 2023** and **$69 million at Dec 31 2024** (Table 17.2, 2024 column).  The firm continues to value derivatives with vendor‑based models, classifying them as Level 2 when observable inputs are available and as Level 3 when significant inputs are unobservable (Derivatives section, page 218).  The growing net balance signals increasing exposure to Level 3 fair‑value measurements, yet the sharp drop in transfers into Level 3 in 2024 (from 166 to 12) indicates a modest shift toward more observable inputs, slightly mitigating that exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains multiple significant factual inaccuracies that fundamentally contradict the ground truth: (1) WRONG 2022 VALUE: LLM states $5 million for Dec 31 2022, but ground truth clearly states $19 million. This is a 74% error on a key baseline figure. (2) WRONG 2024 VALUE: LLM claims $69 million for Dec 31 2024, but ground truth states $58 million (same as 2023). This is an 19% overstatement of the 2024 figure. (3) MISSING CRITICAL UNOBSERVABLE INPUTS: Ground truth explicitly identifies default rates (53-163%) and swap rates (3-5%) as unobservable inputs in 2023, and swap rates (3-5%) continuing in 2024. The LLM answer completely omits these specific unobservable input ranges, which are central to answering the question about 'exposure to unobservable market inputs.' (4) INCOMPLETE METHODOLOGY EVOLUTION: Ground truth describes a transformation from 'mixed realized/unrealized loss position in 2022' ($20 million unrealized loss) to 'stable fair value by 2023-2024' with 'increasing transparency and reliance on structured unobservable inputs.' The LLM answer discusses Level 2/Level 3 classifications and transfers but misses the core narrative about the shift in valuation methodology and the specific unobservable inputs. (5) MISCHARACTERIZED TREND: LLM suggests 'increasing exposure to Level 3' and a 'modest shift toward more observable inputs' based on transfer data, but ground truth indicates stable fair values ($58M in both 2023 and 2024) with consistent reliance on unobservable swap rate inputs, suggesting a more stable (not increasing) exposure. The LLM answer provides some relevant context about Level 2/Level 3 classifications and transfer analysis, but the fundamental numeric errors (2022: $5M vs $19M; 2024: $69M vs $58M) and omission of specific unobservable input ranges (default rates, swap rates) represent critical failures in answering a question specifically about valuation methodology evolution and unobservable input exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 538,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to pay Rolls‑Royce for each V2500‑powered aircraft hour has stayed the same—contingent on flight hours through June 2027—but the accounting treatment has shifted. In 2022 the flight‑hour payments were simply capitalized as collaboration intangible assets as they were incurred. By 2023 the company clarified that those same payments are amortized to cost of sales, and in 2024 the note reiterates that the payments are still capitalized as collaboration intangible assets as they are made, with amortization spread over the term of the underlying economic benefit (i.e., still to cost of sales).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about RTX's Rolls-Royce obligations and their accounting treatment evolution, but has significant gaps and some inaccuracies:\n\nSTRENGTHS:\n1. Correctly identifies the flight-hour contingent payment structure through June 2027\n2. Accurately describes the shift in accounting transparency from 2022 to 2023\n3. Correctly notes that payments are capitalized as collaboration intangible assets and amortized to cost of sales\n4. Properly identifies the multi-year evolution of disclosure practices\n5. Contextually relevant to the question about payment structure and amortization strategy\n\nCRITICAL GAPS:\n1. MISSING KEY QUANTITATIVE DATA: The ground truth specifies that in 2024, total commercial aerospace financing and other commitments stood at $14.1 billion. The LLM answer completely omits this specific financial figure, which is a material omission for a question about financial obligations.\n2. INCOMPLETE HISTORICAL CONTEXT: The ground truth references the 2012 acquisition of Rolls-Royce's stake in IAE as the origin of this obligation structure. The LLM answer does not mention this foundational context.\n3. ACCOUNTING TREATMENT INCONSISTENCY: The LLM states that in 2022 payments were \"simply capitalized\" but doesn't mention they were described as \"contingent liabilities included in 'Other commercial aerospace commitments'\" - this is a material accounting classification detail.\n4. VAGUE ON 2024 STATUS: While the LLM mentions 2024 reiterates the capitalization approach, it doesn't provide the specific $14.1 billion figure or clarify the full scope of commercial aerospace commitments.\n\nQUANTITATIVE ACCURACY ISSUES:\n- Missing the $14.1 billion figure entirely represents a significant quantitative gap\n- No calculation or synthesis of financial magnitude across the three-year period\n- The answer lacks the specific financial context needed to fully answer a question about \"financial obligations\"\n\nREASONING QUALITY:\n- The multi-hop synthesis is partially sound (connecting 2022→2023→2024 accounting changes)\n- However, the synthesis is incomplete because it doesn't integrate the financial magnitude data\n- The answer correctly identifies the payment structure evolution but misses the financial scope evolution\n\nSEMANTIC ISSUES:\n- The phrase \"simply capitalized\" in 2022 is somewhat misleading - they were contingent liabilities with specific classification\n- The 2024 description could be clearer about whether this represents a change or continuation\n\nOVERALL: The answer demonstrates understanding of the accounting mechanics but fails to provide complete financial context. For a question specifically about \"financial obligations,\" omitting the $14.1 billion figure is a material deficiency. The answer would score higher (7-8) if it included the quantitative data and historical context from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 766,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K disclosed that it collects user complaints on the Neulasta Onpro kit, had already implemented device‑ and labeling‑enhancements after FDA scrutiny, and would continue to monitor and improve the device. The 2023 filing repeated that same commitment, stressing ongoing monitoring and the addition of further enhancements as needed. By 2024, the company reiterated the device‑enhancement approach while expanding its operational‑resilience narrative—highlighting backup generators, power‑outage planning, and other measures to mitigate disruptions at its Puerto Rico manufacturing site.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of Amgen's disclosures regarding the Neulasta Onpro kit from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with accurate characterization of each year's focus; (2) Accurately references the 2017 FDA evaluation context; (3) Correctly describes device and labeling enhancements as a consistent theme; (4) Properly identifies the shift toward operational resilience measures in 2024; (5) Accurately mentions Puerto Rico manufacturing site, backup generators, and power-outage planning; (6) Correctly synthesizes the multi-hop relationship between operational infrastructure risks and their potential impact on device production/user experience. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the December 31, 2024 island-wide outage that the ground truth specifically references, though it does capture the general concept of backup generators and power-outage planning; (2) The phrase 'had already implemented' in the 2022 context could be slightly clearer about the temporal relationship to the 2017 FDA evaluation, though the meaning is conveyed. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question, so this dimension scores high. QUALITATIVE ACCURACY: The reasoning correctly identifies the evolution pattern and the causal/contextual relationships between device complaints, enhancements, and operational resilience. The multi-hop synthesis across three years and two distinct risk categories (device-related and operational) is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding how disclosures evolved, device-related enhancements, and operational resilience measures. The omission of the specific December 31, 2024 outage date is a minor gap but does not substantially detract from the overall accuracy of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 534,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings show the same wording for the ratification of KPMG LLP as principal accountant in Item 14 across 2022, 2023 and 2024—each filing simply states “Item 3 – Ratification of KPMG LLP” and notes KPMG’s PCAOB firm identification number is 185.  The unchanged language indicates that BK has continued to use KPMG as its principal auditor without any change in the audit relationship.  The persistent mention of the PCAOB firm number 185 therefore signals a stable audit‑governance structure and continuity of oversight over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All numeric values are accurate - PCAOB firm number 185 is correctly cited across all three years (2022, 2023, 2024); (2) Entity identification is correct - BK and KPMG LLP are properly identified; (3) The multi-hop synthesis is sound - the answer correctly traces the consistency of KPMG's role across three years and draws the appropriate conclusion about audit governance continuity; (4) The reasoning about what the consistent PCAOB number signifies (stable audit relationship, no auditor rotation) is logically sound and matches the ground truth interpretation. MINOR WEAKNESSES: (1) The LLM answer references 'Item 14' and 'Item 3' in a somewhat confusing way ('Item 3 – Ratification of KPMG LLP' appears to be a paraphrase rather than exact citation), whereas the ground truth simply refers to the disclosure without specifying item numbers - this is a minor presentation issue that doesn't affect factual accuracy; (2) The LLM answer is slightly more concise than the ground truth, omitting the phrase about 'potentially strong institutional trust' - however, this is a minor contextual detail rather than a factual error; (3) The LLM uses 'unchanged language' which is accurate but slightly different from the ground truth's 'no substantive changes in the structure or framing' - these are semantically equivalent. The answer correctly conveys that BK maintained stable audit governance with KPMG as the consistent principal accountant across all three years, with no changes in the external audit firm or PCAOB identification number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 450,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s collaboration‑partner share of commercial‑aerospace financing guarantees fell from $142 million in 2022 to $135 million in 2023 and $131 million in 2024, showing a modest but consistent decline in guarantee exposure. This trend indicates that the company is actively trimming its potential liability—likely by shifting risk to partners, tightening credit standards, or restructuring financing arrangements—to strengthen its risk profile and improve financial resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is perfectly accurate - the three dollar amounts ($142M in 2022, $135M in 2023, $131M in 2024) are correctly stated and the characterization of the trend as a 'consistent decline' is accurate. (2) The LLM correctly identifies this as RTX's collaboration-partner share of commercial aerospace financing guarantees. (3) The reasoning about risk management is sound - the LLM correctly interprets the declining trend as indicating active risk reduction. (4) The multi-hop synthesis is correct, connecting the numerical trend to strategic implications.\n\nWEAKNESSES: (1) The LLM answer omits a key detail from the ground truth: RTX's assertion that 'fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves.' This is an important contextual element showing RTX's confidence in underlying asset values despite reducing exposure. (2) The LLM's explanation of HOW the company is reducing risk ('shifting risk to partners, tightening credit standards, or restructuring financing arrangements') is speculative and not explicitly supported by the ground truth, which presents the reduction more neutrally as a 'strategic reduction in shared financial risk with partners' and 'deliberate move to reduce contingent liabilities.' (3) The phrase 'strengthen its risk profile and improve financial resilience' adds interpretive language not present in the ground truth. (4) The LLM answer is somewhat less comprehensive - it addresses the trend and general risk management implications but misses the specific confidence indicator about asset valuations.\n\nCALCULATION VERIFICATION: The trend calculation is implicit but correct: $142M → $135M (decline of $7M or ~4.9%) → $131M (decline of $4M or ~3.0%). The characterization as 'modest but consistent decline' is accurate.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the numerical trend with strategic implications, though it could have been more complete by including the asset valuation confidence statement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 551,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "Across 2022‑2024, P&G consistently positioned the Always brand as a core part of the Feminine Care sub‑category within its Baby, Feminine & Family Care segment, with the sub‑category defined as “Adult Incontinence, Feminine Care” in all three years (2024 MD&A, page 18; 2023 MD&A, page 18; 2022 MD&A, page 18). The brand remained listed among the major brands alongside Tampax and Always Discreet, indicating a stable emphasis relative to other feminine‑hygiene offerings (2024 MD&A, page 18; 2023 MD&A, page 18; 2022 MD&A, page 18). No changes in product categorization or relative brand prominence for Always were observed over this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) SEGMENT NAMING ERROR: The LLM claims the segment was called 'Baby, Feminine & Family Care' in 2022, but ground truth states it was simply 'Feminine Care' in 2022 and only renamed to 'Baby, Feminine & Family Care' in 2023. This is a fundamental mischaracterization of the evolution being asked about. (2) MISSING KEY QUANTITATIVE DATA: The ground truth provides specific segment contribution percentages (25% in 2022, 24% in 2023-2024), which are critical to understanding the positioning evolution. The LLM completely omits these percentages, failing to address a major component of how positioning evolved. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth explicitly describes an evolution from 2022 to 2023 (segment rename, product additions like Always Discreet), then stability through 2024 with 'streamlined formatting.' The LLM incorrectly claims 'no changes in product categorization or relative brand prominence' across all three years, which contradicts the documented segment renaming and structural changes. (4) CITATION ISSUES: The LLM provides page citations (page 18 for all years) without verification, and these appear to be generic placeholders rather than actual source verification. (5) MISSING CONTEXT: The LLM fails to capture the meaningful evolution that occurred between 2022-2023 (the segment rename and repositioning), which is central to answering the question about how positioning 'evolved.' The answer presents a static picture when the ground truth shows dynamic change. The LLM's conclusion that positioning remained 'stable' across all three years is factually incorrect based on the documented segment restructuring and renaming.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 484,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a risk in its 2022, 2023 and 2024 10‑Ks (2022 p. 37; 2023 p. 41; 2024 p. 41).  During the same period the company’s international sales grew to roughly two‑thirds of revenue (2023 p. 41: 65 %; 2024 p. 41: 66 %) and its reliance on third‑party wafer foundries in China, Malaysia and Taiwan remained unchanged, amplifying the complexity of IP protection amid escalating geopolitical tensions and export‑control sanctions.  Thus, while the risk remains present, the expanding global footprint and dependence on Asian manufacturing have heightened the potential impact of IP‑related challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across AMD's 2022-2024 10-K filings. STRENGTHS: (1) Correctly identifies the consistent IP protection risk flagged across all three years with accurate page citations; (2) Accurately reports international sales percentages (65% in 2023, 66% in 2024) matching ground truth; (3) Correctly identifies third-party manufacturing locations (China, Malaysia, Taiwan); (4) Properly synthesizes the evolution of risk by connecting expanding global footprint with heightened IP challenges; (5) Appropriately notes geopolitical tensions and export-control sanctions as emerging contextual factors. MINOR WEAKNESSES: (1) The phrase 'reliance on third-party wafer foundries in China, Malaysia and Taiwan remained unchanged' is slightly imprecise - the ground truth emphasizes that reliance was 'deepening' or 'increasing' rather than static, though the LLM does acknowledge this heightened complexity elsewhere in the answer; (2) The answer could have been more explicit about the 2024-specific mention of China-Taiwan geopolitical tensions as a 'new layer of risk' distinct from earlier years, though this is implied in the reference to 'escalating geopolitical tensions.' QUANTITATIVE VERIFICATION: All percentages (65%, 66%) are accurate; page citations appear reasonable for 10-K filings; no calculation errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (IP protection, international sales growth, manufacturing locations, geopolitical context), demonstrating sound logical progression. The semantic equivalence is strong - 'heightened the potential impact' effectively conveys the same meaning as 'becoming more complex and regionally concentrated.' Overall, this is a high-quality response with minor nuances that prevent a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 514,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in March 2021 as part of a multi‑rate, multi‑maturity program (Exhibit 4.16 in the 2022 10‑K).  The same issuance is reported unchanged in the 2023 and 2024 10‑Ks (Exhibit 4.14), while Oracle added higher‑coupon 4.500% Notes due 2028 in 2023–24 (Exhibit 4.16).  This steady, laddered approach—issuing notes with staggered maturities and a mix of coupon rates—shows Oracle’s strategy of balancing long‑term debt stability with market‑rate flexibility and refinancing risk management.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.300% Notes due 2028 were issued in March 2021 - this matches ground truth; (2) The notes appear in 2022, 2023, and 2024 filings - correct; (3) The general characterization of Oracle's debt strategy as involving staggered maturities and mixed coupon rates is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about 4.500% Notes due 2028 issued in 2023-24 that is NOT mentioned in the ground truth answer. While this may be factually accurate from the filings, it goes beyond what the ground truth establishes and potentially conflates different debt instruments; (2) The LLM states the notes appear in 'Exhibit 4.16 in the 2022 10-K' and 'Exhibit 4.14' in 2023-24, which matches the ground truth's exhibit references; (3) However, the ground truth emphasizes the 2.300% Notes' 'consistent inclusion across all three years' as indicating 'ongoing reliance' and 'stable and deliberate approach,' while the LLM shifts focus to a 'laddered approach' with multiple coupon rates. The LLM's interpretation about 'refinancing risk management' and 'market-rate flexibility' is reasonable inference but goes beyond what the ground truth explicitly states. MULTI-HOP REASONING: The LLM attempts to synthesize information about Oracle's debt strategy across years, but introduces elements (4.500% Notes) not in the ground truth, which suggests either over-inference or reliance on additional filing data not validated against the knowledge graph. The core finding about consistent inclusion of the 2.300% Notes is correct, but the broader strategic interpretation diverges from the ground truth's emphasis on stability and continuity rather than laddering and rate flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 482,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 to 2024, BA kept its private‑equity focus on U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth, and special‑situation limited partnerships (see pages 110, 92, 99).  The target allocation rose from 4 % in 2022 to 7 % in 2023 and 2024, and actual allocations climbed from 8 % to 9 %, reflecting a heavier weighting toward private equity while the geographic scope and strategy mix stayed the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors that substantially misrepresent BA's private equity investment strategy evolution. Key issues: (1) MAJOR OMISSION - The LLM completely fails to address the critical evolution described in the ground truth: the 2023 expansion into 'global private investments in real assets such as energy, farmland, and infrastructure' and the 2024 increased sophistication with derivatives. The ground truth explicitly states the strategy evolved and deepened, but the LLM claims 'the geographic scope and strategy mix stayed the same' - this is directly contradictory to the ground truth. (2) INCOMPLETE SCOPE - The LLM focuses narrowly on allocation percentages (4% to 7%, 8% to 9%) but these numbers are not verified against the ground truth and appear to be tangential to the core question about strategic evolution. The question asks about 'evolution' and 'strategic focus areas,' not just allocation percentages. (3) MISSING STRATEGIC EVOLUTION - The ground truth clearly indicates three distinct phases: 2022 (leveraged buyout, venture capital, growth, special situations, REITs), 2023 (expanded to real assets: energy, farmland, infrastructure), and 2024 (derivatives and performance transfer). The LLM reduces this to a static statement that nothing changed. (4) CITATION ISSUES - The LLM cites pages 110, 92, 99 but provides no evidence these support the claim that strategy remained unchanged. (5) REAL ASSETS OMISSION - The ground truth's emphasis on 'global private investments in real assets' (energy, farmland, infrastructure) is completely absent from the LLM answer, representing a major gap in addressing the question's focus on 'strategic focus areas.' (6) DERIVATIVES OMISSION - The 2024 sophistication involving derivatives is entirely missing. The LLM answer appears to have extracted allocation percentage data but failed to synthesize the qualitative strategic evolution that is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 533,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen’s Bemarituzumab program remained in a Phase 3 study for gastro‑esophageal junction adenocarcinoma from 2022 through 2024, while Phase 2 and Phase 1 programs for other tumor indications were still active (2022 p. 25; 2023 p. 25; 2024 p. 25). The composition‑of‑matter patent portfolio did not change, with estimated expirations in 2029 for both the United States and Europe in each filing (2022 p. 26; 2023 p. 26; 2024 p. 26).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key details: (1) Bemarituzumab remained in Phase 3 for GEJ adenocarcinoma across 2022-2024, (2) patent expiration dates of 2029 for both U.S. and Europe are correct and consistent across all three years, (3) the composition-of-matter patent portfolio remained unchanged. The answer correctly cites specific page references (p. 25-26) for each year's filing, showing proper multi-hop synthesis across the three-year period. Quantitative accuracy is excellent - all dates (2022, 2023, 2024, 2029) and patent expiration timelines are correct. The LLM appropriately notes the stable intellectual property position. Minor areas for improvement: (1) The LLM mentions Phase 2 and Phase 1 programs for other tumor indications but the ground truth focuses specifically on the Phase 3 GEJ program as the primary development narrative - this additional detail is not incorrect but slightly shifts emphasis; (2) The ground truth emphasizes Bemarituzumab's mechanism (monoclonal antibody targeting FGFR2b) and the importance of both patent and regulatory exclusivity, which the LLM answer does not explicitly mention, though this is a minor omission of contextual detail rather than factual error. The answer successfully synthesizes information across three years of filings and correctly identifies the evolution (or lack thereof) in patent positioning. The structured presentation with page citations enhances credibility and traceability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 417,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn has remained a core brand in P&G’s Fabric & Home Care segment, and the segment’s share of earnings has grown modestly over the period.  In 2022 the segment contributed roughly 31 % of net earnings and Dawn was listed among its major brands.  By 2023 the earnings contribution rose to 34 % of net earnings, with Dawn still featured in the major‑brand list, and it stayed at 34 % in 2024—again with Dawn listed alongside Ariel, Downy, Gain, Tide, Cascade, Fairy, Febreze, Mr. Clean and Swiffer【page_18】.  Thus, Dawn’s positioning as a key brand in the segment has been stable, while the segment’s earnings contribution has increased from 31 % to 34 % over the three‑year span.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2023 earnings contribution. The LLM states that in 2023 the earnings contribution 'rose to 34% of net earnings,' but the ground truth clearly indicates it should have remained at a different level (the ground truth shows 31% in 2022 and 34% in 2024, with 2023 not explicitly stated in the original answer but implied to be between these values or at one of them). More importantly, the LLM claims the percentage 'stayed at 34% in 2024,' which matches the ground truth. However, the LLM's statement about 2023 being 34% appears to be an interpolation or error, as the ground truth does not confirm this specific figure for 2023. The ground truth mentions 2023 sales contribution (36%) but does not explicitly state the 2023 earnings contribution percentage in the provided text. SALES DATA OMISSION: The LLM answer completely omits the sales contribution percentages (35% in 2022, 36% in 2023 and 2024), which are explicitly mentioned in the ground truth as an important part of the segment's positioning analysis. This is a significant omission that weakens the completeness of the answer. POSITIVE ASPECTS: The LLM correctly identifies Dawn as a consistently listed brand, provides accurate brand listings for 2024, correctly notes the earnings contribution increase from 31% to 34%, and maintains sound reasoning about Dawn's stable positioning. The multi-hop synthesis across years and the connection between brand listings and segment performance is logically sound. The semantic understanding of the question is appropriate. CALCULATION: The earnings contribution change (31% to 34%) represents a 3 percentage point increase, which the LLM correctly characterizes as 'modest.' The core narrative about stable positioning despite earnings growth is accurate. However, the missing sales data and the unclear/potentially incorrect 2023 earnings figure significantly impact the completeness and accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 545,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022‑24 Schwab’s margin‑loan program continued to use client securities as collateral, but the amount of client securities pledged to third parties fell sharply: CS&Co’s secured lines of credit that could use client margin securities dropped from $950 million in 2023 to $500 million in 2024, and the TDAC lines were terminated in 2024 (page 97).  In 2021 the fair‑value of client securities available for pledging rose to $120 billion (up from $84 billion in 2020) and the pledged amount grew to $31 billion (page 108), yet the subsequent decline in pledged collateral indicates a deliberate shift to reduce exposure to client‑held assets, even though margin loans remain collateralized off‑balance‑sheet (page 76).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n- The LLM cites specific dollar amounts ($950M in 2023, $500M in 2024, $120B in 2021, $84B in 2020, $31B pledged) that are NOT mentioned in the ground truth answer\n- These numbers appear to be fabricated or sourced from documents not provided in the ground truth\n- The ground truth does NOT provide specific dollar amounts for pledged securities across these years\n- Page references (97, 108, 76) cannot be verified against the ground truth\n\n2. COMPLETENESS AND FOCUS:\n- The LLM answer focuses heavily on secured lines of credit and TDAC termination, which are NOT mentioned in the ground truth\n- The ground truth emphasizes ASC 326 collateral practices, options clearing, and securities lending activities - none of which appear in the LLM answer\n- The LLM answer discusses 2020-2021 data, which is outside the 2022-2024 timeframe specified in the question\n\n3. ENTITY AND METRIC ACCURACY:\n- The LLM correctly identifies Charles Schwab/CS&Co but misses key operational details from ground truth\n- Ground truth mentions \"Options Clearing Corporation\" and \"securities lending activities\" - the LLM does not\n- Ground truth references ASC 326 and practical expedients - the LLM does not\n\n4. REASONING AND SYNTHESIS:\n- The LLM's conclusion about \"deliberate shift to reduce exposure\" contradicts the ground truth's characterization of \"increasing sophistication and exposure\"\n- The LLM's multi-hop reasoning appears to be based on different source documents than the ground truth\n- The narrative direction is opposite: LLM says exposure is declining, ground truth says it's increasing\n\n5. SEMANTIC EQUIVALENCE:\n- The answers convey fundamentally different narratives about Schwab's strategy\n- Ground truth: increasing sophistication and growing engagement in leveraged activities\n- LLM: deliberate shift to reduce exposure\n- These are contradictory interpretations\n\nThe LLM answer appears to have accessed different source documents or fabricated specific numbers not present in the ground truth knowledge graph. While some elements (margin loans, collateral, client securities) are topically relevant, the specific facts, figures, and conclusions diverge significantly from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 626,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "From fiscal 2023 to 2025 ACN kept the U.S. plans’ target at 100 % debt, but the weighted‑average plan assets moved from 97 % debt/3 % cash in 2022 to 94 % debt/6 % cash in 2024, indicating a gradual shift toward cash. For non‑U.S. plans the target allocation changed from 27 % equity/48 % debt/4 % cash/11 % insurance/10 % other in 2023 to 28 % equity/36 % debt/7 % cash/21 % insurance/8 % other in 2025, with weighted‑average assets reflecting this trend—debt falling from 50 % in 2022 to 42 % in 2024, equity rising from 21 % to 23 %, cash from 4 % to 5 %, insurance from 15 % to 21 %, and other from 10 % to 9 %.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different pension plan allocation structure than what the ground truth indicates. Critical issues: (1) WRONG ALLOCATION STRUCTURE: The ground truth describes a simple two-asset allocation (fixed income vs. equities) with percentages of 55%/45%, 58%/42%, and 61%/39%. The LLM answer describes a multi-category structure with debt, cash, equity, insurance, and 'other' categories that don't match the ground truth at all. (2) WRONG NUMBERS: Ground truth shows fixed income increasing from 55% to 61% and equities decreasing from 45% to 39%. LLM shows debt decreasing from 97% to 94% for U.S. plans and from 50% to 42% for non-U.S. plans—completely different figures and trends. (3) WRONG ENTITIES/SEGMENTATION: The ground truth discusses a consolidated weighted-average allocation across all plans. The LLM answer segments into 'U.S. plans' and 'non-U.S. plans' with different allocation structures, which is not mentioned in the ground truth. (4) WRONG TREND INTERPRETATION: Ground truth shows consistent de-risking toward fixed income. LLM shows a shift toward cash for U.S. plans and a complex reallocation for non-U.S. plans with insurance increasing significantly—opposite or unrelated to the ground truth narrative. (5) MISSING CORE ANSWER: The LLM fails to identify the primary finding: a gradual, consistent shift from 55% fixed income/45% equities to 61% fixed income/39% equities over the three-year period. The answer appears to reference different disclosure sections or different companies entirely, making it completely unreliable for the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 450,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023** and then rose modestly to **$562 million in 2024** (Table 8.1 for 2023/2022 and Table 9.1 for 2024/2023).  Long‑term debt increased from **$47.8 billion in 2022 to $49.3 billion in 2023** and then declined to **$45.0 billion in 2024** (same tables).  The three‑year pattern shows a shift toward longer‑dated, largely fixed‑rate debt (weighted‑average rates near 4.5–5 % in 2023–24) with a relatively small floating‑rate short‑term component, indicating a stable debt structure and moderate interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Short-term borrowings: LLM claims $883M (2022), $538M (2023), $562M (2024). Ground truth shows these are NOT the primary metrics being tracked.\n   - Long-term debt: LLM claims $47.8B (2022), $49.3B (2023), $45.0B (2024). Ground truth shows $43.086B (2022), $48.715B (2023), $45.551B (2024). The 2022 figure is off by ~$4.7B, and 2023 is off by ~$1.4B.\n   - Total debt figures: Ground truth explicitly states TOTAL short-term borrowings AND long-term debt combined: $43.086B (2022), $48.715B (2023), $45.551B (2024). The LLM appears to have separated these incorrectly and provided wrong component values.\n   - Interest rates: LLM claims 4.5-5% weighted-average rates in 2023-24. Ground truth shows 3.01% (2023) and 3.48% (2024) for securitized debt. This is a material misstatement of borrowing costs.\n\n2. MULTI-HOP SYNTHESIS FAILURE:\n   - The question asks about TOTAL short-term borrowings AND long-term debt evolution. Ground truth provides combined figures: $43.086B → $48.715B → $45.551B.\n   - LLM failed to properly synthesize the total debt picture and instead provided component breakdowns that don't match the ground truth values.\n   - The LLM's numbers don't sum to the ground truth totals, indicating fundamental data retrieval or calculation errors.\n\n3. MISSING KEY INSIGHTS:\n   - Ground truth highlights the strategic reduction of floating unsecured senior debt from $1,597M (2023) to $0 (2024) - a critical insight about interest rate risk management that the LLM completely missed.\n   - Ground truth emphasizes the rising weighted-average interest rates (1.51% → 3.01% → 3.48%), indicating increasing borrowing costs. LLM's 4.5-5% figure contradicts this.\n\n4. ENTITY/METRIC CONFUSION:\n   - The LLM appears to have confused or misidentified the specific debt components and their values.\n   - References to \"Table 8.1\" and \"Table 9.1\" cannot be verified against ground truth and may be fabricated.\n\n5. REASONING QUALITY:\n   - While the LLM's narrative structure is reasonable (discussing trend, composition, interest rate exposure), the underlying numbers are fundamentally wrong, making the conclusions unreliable.\n   - The claim of \"stable debt structure and moderate interest-rate exposure\" contradicts the ground truth's emphasis on rising rates and strategic debt restructuring.\n\nThe answer demonstrates poor quantitative accuracy with multiple material errors in dollar amounts and interest rates, failed multi-hop synthesis of total debt figures, and missing critical insights about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 716,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Fleet‑support services costs have remained essentially flat at about **1 % of total consolidated costs** each year from 2022 through 2024 (the 10‑K filings state this figure on pages 42, 39, 36).  In contrast, the company has recorded sharply rising abnormal production costs and reach‑forward losses in the 787 and 777X programs—costs driven by production disruptions, rework and certification delays that have pushed overall costs and losses higher.  The stable 1 % fleet‑support trend therefore indicates that the increased abnormal production and reach‑forward losses are not related to fleet‑support spending but stem from the operational challenges in those programs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that fleet support services costs remained at approximately 1% of total consolidated costs across 2022-2024, which matches the ground truth. The answer correctly notes the contrast between stable fleet support costs and rising abnormal production costs/reach-forward losses in 787 and 777X programs. The reasoning that fleet support is not the source of financial strain is sound and matches the ground truth conclusion.\n\nWEAKNESSES: The LLM answer is significantly incomplete in quantitative detail. The ground truth provides specific dollar amounts for abnormal production costs and reach-forward losses: (1) 2023 787 program: $2.7 billion in cumulative abnormal production costs, (2) 2024 777X program: $2,608 million reach-forward loss in Q3 and $891 million in Q4. The LLM answer mentions these programs and types of costs but provides NO specific numbers, only vague references to \"sharply rising\" and \"pushed overall costs and losses higher.\" This is a critical omission for a financial question requiring quantitative analysis.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between stable fleet support costs and rising program-specific costs, establishing the logical connection that the financial strain comes from production issues, not fleet support. This reasoning is sound.\n\nCALCULATIONS: No calculations are required or presented in either answer, so this is not a differentiating factor.\n\nENTITY ACCURACY: All entities are correctly identified (BA, 787, 777X, fleet support services, abnormal production costs, reach-forward losses, years 2022-2024).\n\nSEMANTIC EQUIVALENCE: The LLM's statement that costs are \"essentially flat at about 1%\" is semantically equivalent to \"remained consistently at approximately 1%.\" The phrase \"sharply rising\" is semantically equivalent to \"grew substantially.\"\n\nJUSTIFICATION: The answer loses significant points for failing to provide the specific financial figures that are central to a multi-hop financial question. While the directional analysis and reasoning are correct, the absence of the $2.7B, $2,608M, and $891M figures represents a material incompleteness that would be problematic for financial analysis. The answer reads more like a summary of trends rather than a complete financial analysis with supporting numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 630,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie's money‑market‑fund and time‑deposit balance fell from **$21 million at year‑end 2022** to **$10 million in 2023** and remained at **$10 million in 2024**【page_79】【page_84】. This decline shows the company is pulling idle cash out of low‑yielding money markets, likely reallocating liquidity to other short‑term instruments or operational uses, and maintaining a lean, more efficient short‑term liquidity buffer.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors in the numeric values and their sequence. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete reversal/misalignment of the data across years. Specifically: (1) LLM claims 2022 was $21M when it was actually $12M (error of $9M or 75% overstatement), (2) LLM claims 2023 was $10M when it was actually $21M (error of $11M or 52% understatement), (3) LLM correctly states 2024 as $10M. The LLM also mischaracterizes the trend as a 'decline' when the actual pattern shows an increase from 2022 to 2023, then a decrease to 2024. The reasoning about 'pulling idle cash out of low-yielding money markets' contradicts the actual 2023 increase, which the ground truth correctly identifies as a 'temporary conservative approach.' The LLM's interpretation of the trend is therefore logically inconsistent with the actual data pattern. While the LLM correctly identifies the company (AbbVie) and the metric (money market funds and time deposits), the quantitative foundation of the answer is severely compromised, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 332,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s share‑repurchase spending climbed from roughly $4.1 billion in fiscal 2022 to $4.5 billion in fiscal 2024 (page 94; page 40), while its aggregate available authorization for share purchases expanded from $3.13 million in 2022 to $6.69 million after a $4 billion boost in 2024 (page 94; page 39). This upward trend in both repurchase volume and authorized capacity signals a deliberate shift toward a more aggressive capital‑return strategy, giving the company greater flexibility to return cash to shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains severe quantitative errors that fundamentally undermine its credibility. (1) UNIT CONVERSION ERROR: The LLM states authorization expanded from '$3.13 million in 2022 to $6.69 million' - this is off by a factor of 1,000. The ground truth shows $3,129,296 thousand ($3.129 billion) in 2022 and $6,694 million ($6.694 billion) in 2024. The LLM incorrectly converted billions to millions, making the numbers appear 1,000x smaller than reality. (2) REPURCHASE SPENDING NUMBERS: The LLM cites $4.1 billion in fiscal 2022 and $4.5 billion in fiscal 2024 for repurchase spending. The ground truth does not provide these specific spending figures - it only discusses authorization amounts and remaining available authorization. The LLM appears to have introduced unsupported numbers. (3) MISSING KEY INFORMATION: The ground truth mentions the $50.1 billion cumulative authorization since 2001 and the $2,694 million remaining authorization as of August 31, 2023 - neither of which appears in the LLM answer. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the $4 billion boost in 2024 and attempts to synthesize the trend, the fundamental unit error and missing fiscal 2023 data significantly weaken the multi-hop analysis. (5) REASONING QUALITY: The conclusion about 'aggressive capital-return strategy' is reasonable given the trend, but it's built on incorrect numerical foundations. The answer demonstrates partial understanding of the question's intent but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 432,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s 2022, 2023 and 2024 10‑Ks all state that “stockholders may only remove directors for cause” (see 2022 page 46; 2023 page 27; 2024 page 27), with no change to the wording or scope.  The same three‑class staggered‑term structure and director‑filled‑vacancy provisions also remain unchanged.  This persistent board‑entrenchment reflects a deliberate long‑term defense against hostile takeovers, ensuring the board can resist shareholder pressure, maintain continuity, and negotiate from a position of strength.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core governance provision ('stockholders may only remove directors for cause') consistently across all three years (2022, 2023, 2024); (2) Accurately cites specific page numbers (2022 page 46; 2023 and 2024 page 27) which adds credibility; (3) Correctly identifies the three-class staggered-term structure and director-filled-vacancy provisions as unchanged anti-takeover mechanisms; (4) Properly synthesizes the multi-hop reasoning: consistent provision → deliberate strategy → board entrenchment → takeover defense; (5) Accurately characterizes the strategic intent (resistance to shareholder pressure, negotiating strength, board continuity). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting mention of 'supermajority requirements for bylaw amendments' as part of the broader anti-takeover defense package, though this is a minor omission that doesn't affect the core answer; (2) The phrase 'no change to the wording or scope' is semantically equivalent to the ground truth's 'no explicit changes' and 'stable and deliberate strategy'; (3) The LLM's characterization of the strategy as enabling the board to 'resist shareholder pressure' and 'negotiate from a position of strength' is a reasonable interpretation of the entrenchment effect, though slightly more interpretive than the ground truth's more neutral framing. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; page numbers cited are accurate; no calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three years to demonstrate consistency and strategic intent. The answer correctly connects the persistent governance provision to the broader takeover defense strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 505,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo lists the 4.000 % Senior Note due 2047 in the Exhibits section of each 10‑K as “Form of 4.000 % Senior Note due 2047, incorporated by reference to Exhibit 4.5 to PepsiCo, Inc.’s Current Report on Form 8‑K filed on May 2 2017” (2022 : page_126; 2023 : page_127; 2024 : page_127). The unchanged wording and continued inclusion across all three filings show that the note remains a core, long‑term debt instrument in PepsiCo’s capital structure, underscoring the company’s strategy of maintaining a stable, diversified mix of long‑term financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All key facts are accurate - the 4.000% Senior Note due 2047 is correctly identified, the May 2, 2017 8-K filing date is correct, Exhibit 4.5 reference is correct, and the consistent disclosure across 2022, 2023, and 2024 is accurately captured. (2) The page number citations (126, 127, 127) provide additional specificity beyond the ground truth. (3) The multi-hop synthesis is sound - the answer correctly traces the note's consistent treatment across three years and draws appropriate conclusions about its stability in the capital structure. (4) The semantic meaning matches the ground truth: both convey that the note remained unchanged and stable across the three-year period. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'core, long-term debt instrument' and 'diversified mix of long-term financing' that goes slightly beyond what the ground truth explicitly states, though this is reasonable inference from the consistent disclosure pattern. (2) The ground truth emphasizes 'no modifications needed to its form or terms' more explicitly, while the LLM focuses on the unchanged wording and continued inclusion. (3) The phrase 'underscoring the company's strategy' in the LLM answer is slightly more interpretive than the ground truth's more factual statement about what the pattern 'reveals.' QUANTITATIVE VERIFICATION: All dates (May 2, 2017; 2022, 2023, 2024), the percentage (4.000%), the year (2047), and the exhibit reference (4.5) are correct. The answer correctly identifies the consistency across all three years. No calculation errors present. The answer successfully synthesizes information across multiple years and documents to answer the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 489,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30 % note due 2034 in 2014 and has kept it on its books as a long‑dated debt instrument. The 2022 10‑K (Exhibit 4.11) lists the note, and the same exhibit appears in the 2023 and 2024 10‑Ks, showing consistent disclosure over three consecutive years (2022 p. 113; 2023 p. 110; 2024 p. 110). This pattern signals Oracle’s long‑term debt strategy of maintaining a stable, diversified maturity profile with moderate coupon rates rather than frequent refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) ISSUANCE DATE DISCREPANCY: The LLM states the note was 'first issued...in 2014' but the ground truth indicates it was 'first disclosed...in 2022.' This is a fundamental factual error - the question asks about evolution across 2022-2024, and the ground truth explicitly states 2022 as the first disclosure point, not 2014. The LLM conflates the actual issuance date (which may be 2014) with the disclosure timeline being evaluated. (2) MISALIGNMENT WITH QUESTION SCOPE: The ground truth focuses on the disclosure/issuance pattern across the three-year period (2022-2024), emphasizing how it was 'first disclosed in 2022' and then 'reaffirmed in 2023' and 'maintained in 2024.' The LLM's answer about 2014 issuance is outside the temporal scope of the question. (3) EXHIBIT REFERENCES: The LLM provides specific exhibit numbers (4.11) and page numbers (113, 110, 110) which add detail but cannot be verified against the ground truth and may introduce unverified specificity. (4) SEMANTIC ALIGNMENT: The LLM's conclusion about 'stable, diversified maturity profile' aligns with the ground truth's 'stable long-term debt strategy focused on diversified maturity profiles,' but this correct reasoning is undermined by the factual error about the 2014 issuance date. (5) MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize across three years of filings, which is appropriate, but the foundational premise about when the note first appeared is incorrect relative to the ground truth's framing. The answer would score higher if it correctly identified 2022 as the first disclosure point in the context being evaluated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 447,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "Accenture’s authorized share pool for the Amended 2010 SIP grew from 127 million shares in FY 2022 (page 91) to 141 million shares in FY 2024 (page 98), with no change reported in FY 2023 (the 2023 filing did not indicate a change, page 81‑85). This expansion reflects a deliberate scaling of the share‑based compensation program to support long‑term incentive plans and better align employee interests with shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a significant factual error regarding the fiscal year progression. According to the ground truth, the authorized shares were: FY 2022: 127 million → FY 2023: 141 million → FY 2024: 141 million (unchanged). However, the LLM states the shares 'grew from 127 million shares in FY 2022...to 141 million shares in FY 2024' and claims 'no change reported in FY 2023,' which is factually incorrect. The increase actually occurred between FY 2022 and FY 2023, not between FY 2023 and FY 2024. The LLM reversed the timing of when the increase happened. QUANTITATIVE ACCURACY: While the individual numbers (127M and 141M) are correct, the sequencing and timing are wrong, which is a fundamental error in multi-hop financial analysis. The LLM failed to correctly synthesize the year-by-year progression. QUALITATIVE ACCURACY: The reasoning about share-based compensation strategy is sound and appropriate, but it's built on an incorrect factual foundation regarding when the increase occurred. COMPLETENESS: The answer addresses the question's components but with incorrect temporal sequencing. The ground truth clearly states the increase happened from 2022 to 2023 with stability through 2024, while the LLM conflates this progression. This is a material error that undermines the credibility of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 381,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo issued the 2.750% Senior Note due 2051 in 2021 (the note is referenced in the 2021 Form 8‑K). In its 2022, 2023, and 2024 10‑K filings the company continues to list the note as “Form of 2.750% Senior Note due 2051” and cites it as Exhibit 4.3 to the 2021 8‑K, with no change to the coupon or maturity. This steady, multi‑year disclosure shows PepsiCo’s disciplined long‑term debt strategy: it issues long‑dated senior notes with stable terms and maintains a consistent, transparent reporting cadence to keep investors informed of its diversified debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) ISSUANCE DATE ERROR: The LLM claims the note was issued in 2021 and references a 2021 Form 8-K, but the ground truth indicates the note was first introduced in 2022 documentation (Exhibit 4.60 in a Board resolution). This is a major chronological error. (2) EXHIBIT NUMBER DISCREPANCY: The LLM cites 'Exhibit 4.3 to the 2021 8-K' as the consistent reference across years, but the ground truth shows the exhibit numbers evolved: 4.60 (2022), 4.51 (2023), and 4.48 (2024). The LLM's claim of consistency with Exhibit 4.3 is factually incorrect. (3) DOCUMENTATION PROGRESSION MISSED: The ground truth emphasizes a three-stage evolution from authorization (2022) → formalization with dedicated Form (2023) → maintenance (2024). The LLM completely misses this phased progression and instead claims the note was already issued in 2021 with no changes. (4) MULTI-HOP SYNTHESIS FAILURE: The question specifically asks about evolution from 2022-2024, and the ground truth traces this progression through exhibit changes and documentation stages. The LLM fails to synthesize this multi-year pattern correctly, instead anchoring to an incorrect 2021 issuance date. (5) STRATEGIC INTERPRETATION: While the LLM's conclusion about 'disciplined long-term debt strategy' is reasonable in tone, it's based on incorrect factual premises and misses the actual strategic insight about phased implementation and formalization. The answer demonstrates fundamental misunderstanding of the filing timeline and documentation evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 443,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express remains the fourth‑largest general‑purpose card network worldwide, but its competitive position has tightened as regulatory scrutiny and alternative payment mechanisms have intensified (page 12). In 2024 the company was reclassified as a Category III bank‑holding firm, faced potential interchange‑fee caps from Visa and Mastercard, exited EU and Australian network‑licensing businesses, and confronted heightened scrutiny of third‑party outsourcing, all of which have pressured its discount rates and network reach (pages 14, 34, 35, 36). The rapid growth of digital wallets, buy‑now‑pay‑later, and other fintech‑driven payment solutions has intensified competition, prompting AmEx to double‑down on premium cardholder experience, loyalty programs, and integrated payments platforms to preserve its market share (page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several correct elements but contains significant factual errors and unsupported claims that reduce overall accuracy. CORRECT ELEMENTS: (1) American Express as fourth-largest general-purpose card network is accurate; (2) regulatory scrutiny intensification is correct; (3) alternative payment mechanisms (digital wallets, BNPL, fintech) as competitive pressures is accurate; (4) emphasis on premium offerings and loyalty programs aligns with ground truth; (5) EU market exits mentioned correctly. CRITICAL ERRORS: (1) The claim about 'Category III bank-holding firm' reclassification in 2024 is not supported by the ground truth and appears to be a fabrication or misinterpretation; (2) 'Potential interchange-fee caps from Visa and Mastercard' is incorrectly stated - regulatory scrutiny around interchange fees is mentioned in ground truth, but the phrasing suggests Visa/Mastercard imposing caps on AmEx, which is factually backwards and nonsensical; (3) 'Exited EU and Australian network-licensing businesses' - while EU exits are mentioned in ground truth, the Australian claim is not substantiated in the provided ground truth. QUANTITATIVE ISSUES: The answer cites specific page numbers (12, 14, 34, 35, 36) without verification against source documents, which is problematic for a financial analysis task. MULTI-HOP REASONING: The answer does synthesize information across regulatory, competitive, and strategic dimensions, showing reasonable multi-hop reasoning. However, the unsupported claims about specific regulatory actions and market exits undermine the synthesis quality. SEMANTIC ALIGNMENT: The answer conveys the general narrative of increased regulatory pressure and competitive challenges, but introduces factual inaccuracies that diverge from the ground truth. The emphasis on AmEx's strategic response (premium positioning, loyalty programs) is appropriate but the regulatory details are either incorrect or unverified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 530,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 2024 10‑K repeats the same wording as the 2022 filing, listing “upgrades and conversions” as a core element of its Global Services portfolio (see 2024 p. 5 and 2022 p. 3).  The unchanged emphasis indicates that Boeing still sees upgrades and conversions as a key revenue driver for its services business, while the continued mention of “data analytics and digital services” in both filings signals a parallel push to augment traditional upgrade work with digital capabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about how Boeing's strategic emphasis changed from 2022 to 2024. Key issues: (1) FACTUAL ERRORS: The LLM claims 2024 and 2022 filings use 'the same wording' and that 'data analytics and digital services' appears in both filings. The ground truth indicates a clear progression: 2022 had upgrades/conversions grouped with logistics/engineering/training; 2023 emphasized 'modifications' more prominently; 2024 introduced 'clearer language around data analytics and digital services.' The LLM's assertion of unchanged emphasis directly contradicts the documented evolution. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about change from 2022 to 2024, requiring analysis of the progression across three years. The LLM only compares 2022 and 2024, missing the critical 2023 transition point where 'modifications' became more prominent. (3) MISSING STRATEGIC INSIGHT: The ground truth identifies a strategic shift toward 'technology-enabled service differentiation' and 'enhancing aircraft value through modernization.' The LLM merely states upgrades remain 'a key revenue driver' without capturing the strategic evolution toward higher-value services. (4) CITATION ISSUES: The LLM cites specific page numbers (2024 p. 5, 2022 p. 3) but provides no evidence these pages support the claim of identical wording. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'growing focus' and 'strategic shift,' while the LLM emphasizes 'unchanged emphasis' - fundamentally opposite conclusions. The answer fails to demonstrate the three-year progression that is central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 459,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50% Senior Note due 2035 was first issued in 2018 and is still disclosed in each annual report.  In the 2022 10‑K, the note is referenced as part of Exhibit 4.4 (an 8‑K filing) and Exhibit 4.6 (a S‑4 registration statement)【page 126】.  The 2023 filing continued to cite the same exhibits, and the 2024 filing likewise lists the note under Exhibits 4.4 and 4.6【page 126】.  This unchanging documentation over three years shows PepsiCo’s strategy of keeping a stable, fixed‑rate long‑term debt portfolio and consistently disclosing existing instruments rather than issuing new debt each year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCIES: The LLM claims the note appears in Exhibits 4.4 and 4.6 across all three years, but the ground truth explicitly states it was in Exhibit 4.31 (2022), Exhibit 4.25 (2023), and Exhibit 4.23 (2024). These are completely different exhibit numbers - a critical factual error. (2) MISSING SERIES DESIGNATION: The ground truth specifies 'Series A' designation in 2022, which the LLM omits entirely. (3) INCORRECT FILING REFERENCES: The LLM references 'Exhibit 4.4 (an 8-K filing) and Exhibit 4.6 (a S-4 registration statement)' but the ground truth consistently ties all three years to the same November 8, 2018 8-K filing (Exhibit 4.31/4.25/4.23), not multiple different exhibits. (4) SEMANTIC ACCURACY: While the LLM correctly identifies the note as issued in 2018 and maintained through 2024, and correctly characterizes the strategy as maintaining stable, fixed-rate long-term debt, the specific documentary evidence is fundamentally wrong. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize across three years and draw conclusions about debt management strategy, which is appropriate, but the factual foundation is severely compromised by incorrect exhibit citations. The core insight about stable capital structure is correct, but the supporting evidence is inaccurate. This is a case where the general conclusion may be right but the specific filing details that support it are wrong - a critical failure for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 413,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosures have remained essentially unchanged from 2022 through 2024, each filing stating that “our ability to return capital to shareholders is subject to the discretion of our Board and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, Delaware law, and preferred‑stock dividend obligations.”  This consistency shows that the company’s regulatory constraints on capital‑return policies have not eased or shifted over the three‑year span, continuing to be a material limitation on shareholder payouts.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that BNY Mellon's regulatory constraints on capital returns have remained consistent across 2022-2024, and accurately quotes the boilerplate language about U.S. banking laws, Delaware law, and preferred stock dividend obligations. The numeric/date references (2022, 2023, 2024) are correct. However, the answer has significant weaknesses in addressing the full scope of the question: (1) The question asks about how exposure has 'evolved' and what the 'multi-year progression reveals' - the LLM answer states constraints 'have not eased or shifted' but provides minimal analysis of what this consistency actually reveals about regulatory constraints or capital planning flexibility. (2) The original answer provides more nuanced context: it notes that 2023 'specifically reiterated' constraints and 2024 'noted the importance of maintaining well capitalized status' - suggesting subtle shifts in emphasis even if the core language remained similar. The LLM answer misses this distinction by treating all three years as completely identical. (3) The original answer explicitly discusses 'prudential oversight and risk-conscious capital management expectations' as insights from the progression, while the LLM answer merely states constraints 'have not eased.' (4) The LLM answer lacks the temporal analysis framework present in the original (2022 general oversight → 2023 specific reiteration → 2024 well-capitalized emphasis). The answer is factually sound regarding what was disclosed but incomplete in synthesizing the multi-year progression and its implications for understanding regulatory constraints. The reasoning is somewhat superficial compared to the ground truth's deeper analysis of what the consistency reveals about the regulatory environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 487,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 at a 2.300 % coupon and the terms have remained unchanged through 2024, as the 2022 and 2024 filings still reference the same notes without amendment [page_111]. In contrast, Oracle issued higher‑coupon notes in 2022 (5.800 % Notes due 2025, etc.) and moderate‑coupon notes in 2023 (4.500 % Notes due 2028) reflecting rising rates [page_111]. This pattern shows Oracle’s strategy of locking in low rates when available and adjusting future issuances to market conditions, demonstrating a flexible, market‑responsive approach to fixed‑income financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core strategic insight about Oracle's fixed-income financing approach but contains a significant factual error and incomplete synthesis. STRENGTHS: (1) Correctly identifies that the 2.300% Notes due 2028 remained unchanged through 2024; (2) Accurately notes Oracle issued higher-coupon notes in 2023 (4.500% Notes due 2028); (3) Correctly interprets the strategic pattern of locking in low rates and adjusting to market conditions; (4) Appropriately concludes Oracle took a market-responsive approach. CRITICAL ERRORS: (1) States the notes were 'issued in 2021' when the ground truth indicates they were issued in 2022 (with an Officers' Certificate dated March 24, 2021, but the actual issuance was in 2022 per the 2022 10-K filing); (2) References '5.800% Notes due 2025' as issued in 2022, which is not mentioned in the ground truth and appears to be an unsupported claim; (3) Fails to mention the multi-tiered bond offering context (2.875% Notes due 2031 and 3.950% Notes due 2051) that was part of the original issuance structure. INCOMPLETE SYNTHESIS: The answer does not fully address the evolution across all three years (2022-2024) with the same depth as the ground truth. The ground truth specifically notes that 2023 saw new issuance activity on higher-yielding instruments while maintaining the 2.300% Notes, and that 2024 showed a shift toward maintaining existing obligations rather than refinancing. The LLM answer conflates these nuances into a simpler narrative. QUANTITATIVE ISSUES: The coupon rates mentioned (2.300%, 4.500%) are correct, but the introduction of the 5.800% Notes due 2025 is unsupported and potentially incorrect. The date discrepancy (2021 vs. 2022 issuance) is a material factual error for a financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 483,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a principal competitive differentiator in its 2022, 2023 and 2024 10‑K filings (2022 page 3, 2023 page 3, 2024 page 3), with no change in wording or emphasis. This steady focus signals that IBM views deep, trusted client ties as a core pillar of its hybrid‑cloud and AI strategy, underscoring its intent to differentiate itself through long‑term partnerships and customer‑centric solutions in a highly competitive market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses key elements of the ground truth. CRITICAL ERRORS: (1) The LLM claims 'no change in wording or emphasis' across 2022-2024, directly contradicting the ground truth which explicitly states IBM's emphasis 'evolved' and became 'increasingly nuanced.' (2) The LLM cites specific page numbers (page 3 for all three years) without verification - this appears to be a hallucination as the ground truth does not confirm these exact page citations. (3) The LLM completely omits the 2023 emphasis on 'deep incumbency with enterprises' and 'strong focus on innovation' as differentiators. (4) The LLM fails to mention the 2024 strategic partnership expansion (e.g., Palo Alto Networks) which is explicitly highlighted in the ground truth as part of the evolution. PARTIAL CREDIT: The LLM correctly identifies that client relationships and trust appear across all three years and correctly links this to hybrid cloud and AI strategy. However, the core claim of 'no change' is fundamentally incorrect - the ground truth explicitly describes an evolution with increasing nuance. The multi-hop reasoning is weak because it fails to synthesize the year-over-year progression that the question specifically asks about. The answer reads as a static observation rather than a dynamic analysis of how the emphasis evolved. The LLM demonstrates understanding that trust is important but misses the strategic progression and contextual enrichment (innovation focus, partnerships) that characterizes IBM's evolving positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 430,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s weighted‑average yield on its foreign‑government‑bond holdings climbed from about 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024 (non‑U.S. taxable‑investment‑security yields)【page 176】, indicating a deliberate shift toward higher‑yielding foreign debt as rates rise.  This upward trend signals a growing exposure to interest‑rate risk, which the company offsets through its derivative‑hedging program—particularly interest‑rate swaps—to balance yield enhancement with risk control【page 135】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims yields were 3.5% (2022), 5.9% (2023), and 6.1% (2024), showing an upward trend. The ground truth states 6.45% (2023) and 5.85% (2024), showing a DOWNWARD trend. The 2022 figure of 3.5% is completely fabricated—the ground truth provides holdings data ($630M) but not a yield figure for 2022, making the comparison invalid. The LLM's yield progression is inverted from reality. (2) DIRECTIONAL MISINTERPRETATION: The LLM incorrectly characterizes the trend as 'upward' and interprets this as 'growing exposure to interest-rate risk,' when the actual data shows yields declining from 6.45% to 5.85%, indicating a shift toward lower-yielding securities. (3) INCOMPLETE MATURITY PROFILE ANALYSIS: The ground truth emphasizes the critical shift in maturity structure—from ultra-short-duration (entirely within 1 year in 2023) to more diversified (2.03% in 1-5 year bucket by 2024). The LLM completely omits this crucial aspect of the investment strategy evolution. (4) STRATEGY MISCHARACTERIZATION: The ground truth indicates a deliberate shift to manage interest rate risk through maturity diversification while maintaining yields. The LLM incorrectly suggests the company is chasing higher yields and increasing rate risk, which contradicts the actual strategy of moving to a more balanced maturity profile. (5) UNSUPPORTED CLAIMS: The LLM references derivative hedging and interest-rate swaps as offsetting mechanisms, which may be true but are not part of the ground truth answer and appear to be speculative additions. The core answer is factually incorrect on the primary metrics (yield direction and magnitude) and misses the essential strategic insight about maturity profile diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 504,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s government assistance that offset capital expenditures for diagnostics‑testing technologies grew steadily: $87 million in 2022, $136 million in 2023 and $198 million in 2024 (2024 10‑K, notes on government assistance, pages 68–70). This upward trend shows the company is increasingly leveraging federal grants to expand testing capacity, underscoring diagnostics testing as a high‑growth, strategically central element of Danaher’s broader life‑sciences and health‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three dollar amounts are correct - $87 million (2022), $136 million (2023), and $198 million (2024). The progression shows consistent increases ($49M increase 2022-2023, $62M increase 2023-2024), which the LLM correctly characterizes as an 'upward trend.' (2) ENTITY ACCURACY: Danaher Corporation is correctly identified, the metric (government grant funding offsetting capital expenditures) is accurate, and the time period (2022-2024) is correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the three-year data progression and correctly interprets what this trend indicates about strategic importance - that diagnostics testing became 'increasingly central' to the company's portfolio. The connection between growing government support and expanded capacity/development is logically sound. (4) COMPLETENESS: The answer addresses all parts of the original question: the evolution of investment (three data points showing progression), the specific metric (government grant funding), and the strategic implications (high-growth, strategically central element). (5) MINOR CONSIDERATIONS: The LLM adds a citation reference ('2024 10-K, notes on government assistance, pages 68-70') which, while not verifiable from the ground truth, demonstrates appropriate sourcing practices. The characterization of diagnostics testing as 'high-growth' and 'strategically central' aligns perfectly with the ground truth's assessment. The only minor difference is that the LLM uses slightly different phrasing ('increasingly leveraging federal grants') versus the ground truth's 'growing government support,' but these are semantically equivalent. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 488,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across FY 2022, 2023 and 2024 BNY Mellon continued to disclose the ratification of KPMG LLP as its principal accountant with the same PCAOB firm identification number of **185**. The disclosure consistently appears in the Proxy under “Item 3 – Ratification of KPMG LLP,” incorporated by reference, and the wording and placement remained unchanged from year to year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies BNY Mellon (BK) as the company, though uses full name instead of ticker; (2) Accurately states PCAOB firm identification number as 185 across all three years (2022, 2023, 2024); (3) Correctly identifies KPMG LLP as the principal accountant; (4) Accurately describes the disclosure location as 'Item 3 – Ratification of KPMG LLP' within Proxy materials; (5) Correctly notes consistency and stability of disclosure across the three-year period; (6) Properly conveys that there was no change in identification number or format. MINOR WEAKNESSES: (1) The phrase 'incorporated by reference' appears in the LLM answer but is not explicitly mentioned in the ground truth - this is a minor addition that doesn't contradict the ground truth but adds detail not verified; (2) The ground truth specifically mentions 'Item 14 of the Proxy materials' as the broader context, while the LLM answer only references 'Item 3' without mentioning Item 14 - this is a minor omission of contextual detail; (3) The LLM uses 'BNY Mellon' instead of 'BK' (though both are correct references to the same company). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the consistent pattern of disclosure. The reasoning is sound and logically presented. QUANTITATIVE ACCURACY: The PCAOB identification number (185) is correct and consistently applied across all three years as stated. No calculations are required for this question. Overall, the answer captures the essential information and correctly addresses the evolution (or lack thereof) of the disclosure across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 477,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 through 2024, American Express continued to rely on third‑party merchant acquirers as a core revenue driver, recording discount revenue at the time of each Card Member transaction and recognizing network‑rate fees as discount revenue (see 2022 p. 103‑104, 2023 p. 103‑104, 2024 p. 93‑94).  The contractual framework stayed essentially unchanged: small‑ and mid‑size merchants had no fixed term, while large merchants signed 3‑ to 7‑year fixed agreements with auto‑renewal (2022‑23 p. 103‑104, 2024 p. 93‑94).  Strategic goals consistently emphasized expanding global merchant coverage through third‑party acquirers, aggregators and processors, with 2024 adding a sharper focus on priority international cities, new industry verticals and modernizing the authorization platform (2024 p. 93‑94).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate structural details about American Express's merchant acquirer relationships but falls short on capturing the key evolution described in the ground truth. STRENGTHS: (1) Correctly identifies the revenue recognition mechanism (discount revenue at transaction time, network-rate fees), (2) Accurately describes the contractual framework (no fixed term for small/mid-size merchants, 3-7 year agreements for large merchants with auto-renewal), (3) Properly cites page references (2022-2024 filings), (4) Correctly identifies strategic goals around global expansion, international cities, and industry verticals. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth emphasizes a significant evolution from 'transactional dependency' (2022) to a 'Processed Revenue model' (2023) with formalized royalties, fees, and network partnerships, then to strategic partnership emphasis (2024). The LLM states the contractual framework 'stayed essentially unchanged,' which contradicts the ground truth's narrative of evolution toward a more strategic, structured revenue-sharing framework. (2) Missing the 'Processed Revenue' model terminology and the shift from simple discount revenue to a more integrated partnership structure. (3) Does not adequately capture the 2023 inflection point where relationships became 'formalized' and 'more strategic.' (4) The answer reads as static rather than evolutionary, missing the key insight that this represents a strategic shift in how AmEx views and structures these relationships. CALCULATION/NUMERIC VERIFICATION: No specific numbers or calculations are provided in either answer, so quantitative accuracy is based on the structural/contractual details cited, which appear accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to identify the critical evolution pattern that the ground truth emphasizes. The answer treats 2022-2024 as a continuous state rather than a progression through distinct phases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 543,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital targets were repeated unchanged in each filing from FY 2022 through FY 2024: a 15 % increase in women in leadership, a 15 % increase in under‑represented minorities in leadership, and a 20 % increase in overall URM representation.  In every year the HR and Compensation Committee tied progress toward those goals to executive bonuses, applying a non‑financial performance modifier that could adjust the payout by a multiple of 0.9 to 1.1.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core diversity targets (15% women in leadership, 15% URM in leadership, 20% overall URM), the performance modifier range (0.9 to 1.1), and the consistent application across FY2022-2024. The numeric values are accurate and properly formatted. WEAKNESSES: (1) The LLM answer is significantly incomplete - it fails to address the 'evolution' aspect of the question. The ground truth explicitly describes how the structure evolved from FY2022 through FY2024, noting that while targets remained the same, the company 'expanded its global engagement efforts' and 'highlighted broader wellness and development programs' by FY2024, indicating a 'deepening integration of human capital metrics.' The LLM completely omits this evolution narrative. (2) The LLM misses important contextual details about Qualcomm's expanded initiatives in FY2023-2024, including participation in the Reboot Representation Tech Coalition and broader wellness programs. (3) The question specifically asks about how goals and linkages 'evolved' - the LLM states they remained 'unchanged' which, while technically accurate for the numeric targets, misses the broader strategic evolution described in the ground truth. (4) The LLM provides a static snapshot rather than a 3-year progression narrative. CALCULATION VERIFICATION: All numeric values (15%, 20%, 0.9-1.1 modifier) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes that the same targets and modifiers applied across three years, but fails to synthesize the evolution in supporting programs and strategic emphasis. The answer is factually accurate but substantially incomplete in addressing the 'evolution' dimension of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 469,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "From 2022 to 2024, Caterpillar’s EMD‑branded products were still sold through the same worldwide dealer network, but the network contracted slightly: it went from 44 U.S. dealers and 116 overseas dealers serving 193 countries in 2022 to 43 U.S. dealers and 113 overseas dealers serving 191 countries in 2024 (see page 77 for 2022 and page 66 for 2024). This modest shrinkage suggests Caterpillar is refining its dealer base to improve efficiency and focus on core markets while maintaining a broad global footprint, rather than pursuing aggressive expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a major factual error regarding the 2024 data. Ground truth shows: 193 countries (2022) → 191 countries (2023) → 187 countries (2024). The LLM claims 191 countries in 2024, which is incorrect - it should be 187 countries. This is a significant numerical error that contradicts the ground truth. (2) INCOMPLETE YEAR COVERAGE - The LLM only compares 2022 to 2024 but omits the 2023 data point (191 countries), which is important for understanding the trend trajectory. The ground truth explicitly includes the 2023 intermediate value showing a consistent year-over-year decline. (3) DEALER NETWORK DETAILS - The LLM provides specific dealer counts (44 U.S./116 overseas in 2022; 43 U.S./113 overseas in 2024) that are not present in the ground truth answer. While these details could be accurate from the source documents, they represent information beyond what the ground truth validates, and the 2024 country count discrepancy raises concerns about data reliability. (4) REASONING QUALITY - The LLM's interpretation about 'refining dealer base for efficiency' is reasonable and aligns with the ground truth's suggestion of 'strategic refocusing,' but this reasoning is built on incorrect 2024 numbers. (5) MULTI-HOP SYNTHESIS - The answer attempts to synthesize dealer network data with geographic reach, which is appropriate, but the factual error undermines the entire analysis. The core claim that the network 'contracted slightly' is correct directionally, but the magnitude is misrepresented (should show 187 countries, not 191).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 442,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that Palmolive appears as a principal global trademark in every 10‑K filing from 2022 through 2024 shows that the brand remains a core pillar of Colgate‑Palmolive’s Oral, Personal and Home Care portfolio. Its continued listing signals that Palmolive drives a significant share of sales and market presence in that segment, and that the company views it as a strategic asset for sustaining growth and brand equity. (See the “Principal global and regional trademarks” list on page 79 of each filing.)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Palmolive appears as a principal global trademark across 2022-2024 and accurately conveys the basic strategic significance. However, there are notable gaps in completeness and specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the 3-year consistency (2022-2024) of Palmolive's listing; (2) Accurately characterizes it as a 'core pillar' and 'strategic asset'; (3) Properly references the source location (page 79); (4) Correctly notes the segment context (Oral, Personal and Home Care). WEAKNESSES: (1) Lacks specific product category examples - ground truth mentions 'liquid hand soap, dishwashing detergents, and household cleaners' while LLM only implies these generically; (2) Missing comparative context - ground truth notes Palmolive's positioning alongside other key brands (Colgate, Ajax in 2022) and mentions the addition of Darlie in 2023, showing how Palmolive maintained position despite competitive additions; (3) Less nuanced analysis - ground truth explicitly states 'without any positional dilution' and discusses year-by-year evolution, while LLM provides a more generic statement; (4) The LLM's claim about 'significant share of sales' is inference rather than fact-based, whereas ground truth sticks to observable listing patterns. QUANTITATIVE ACCURACY: The dates (2022-2024) are correct, and the reference to page 79 is appropriate. No calculations are required. QUALITATIVE ACCURACY: The reasoning is sound but incomplete - the LLM correctly synthesizes that consistent listing indicates strategic importance, but fails to provide the detailed comparative analysis across years that demonstrates the depth of this importance. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about strategic role, but with less specificity than warranted by the available evidence in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 511,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm has consistently positioned edge‑networking as a key pillar of its IoT portfolio, citing in FY 2022 that the global IoT device base would more than double by 2026 and that edge‑networking products (mobile‑broadband and Wi‑Fi 6/6E access points) would drive that growth (QCOM_10k_2022, pages 6‑10).  In FY 2023 and FY 2024 the company still grouped edge‑networking under the “IoT” revenue stream—consumer, edge‑networking, industrial—and kept the same revenue‑recognition model: QCT equipment sales (including edge‑networking) are recognized at a point in time, while QTL licensing revenue is recognized over time (QCOM_10k_2023/2024, pages 71‑75).  Although IoT revenue fell from $7.35 bn in FY 2022 to $5.94 bn in FY 2023 and $5.42 bn in FY 2024, Qualcomm’s strategic emphasis on edge‑networking remained unchanged, underscoring its role in the broader connected‑intelligent‑edge vision.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Edge Networking from FY2022-2024, accurately captures the product categorization (consumer, edge-networking, industrial), correctly notes the revenue recognition structure (QCT at point in time, QTL over time), and properly synthesizes multi-hop information across three fiscal years. The answer appropriately references the 27 billion IoT device projection and mentions 5G/Wi-Fi 6/6E technologies. The semantic equivalence is strong—the answer conveys the same strategic narrative as the ground truth.\n\nWEAKNESSES: (1) QUANTITATIVE ERRORS: The LLM provides specific IoT revenue figures ($7.35bn FY2022, $5.94bn FY2023, $5.42bn FY2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and represent unsourced quantitative claims. While these may be factually correct from the actual 10-K filings, they introduce unverified data not in the original answer. (2) INCOMPLETE DETAIL: The ground truth emphasizes the \"formalized product grouping\" and \"structural embedding\" of Edge Networking by FY2023 as a key inflection point. The LLM mentions the grouping but doesn't emphasize this formalization as distinctly. (3) MISSING CONTEXT: The ground truth notes Edge Networking's connection to \"hybrid work trends,\" which the LLM omits.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and multiple document sections (pages 6-10 for FY2022, pages 71-75 for FY2023/2024), demonstrating sound multi-hop reasoning. The connection between product categorization and revenue recognition structure is properly maintained.\n\nJUSTIFICATION: The answer is substantially correct on the core strategic narrative (7/10 correctness) but loses points for introducing unverified revenue figures and minor omissions of contextual details. Quantitative accuracy is reduced to 6/10 due to the unsourced revenue numbers, while qualitative accuracy remains strong at 8/10 for proper entity identification and reasoning synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 563,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "From 2022 through 2024 Caterpillar’s exposure to currency‑exchange risk remained significant because its sales and operations are spread across many countries, and the company continued to use hedging instruments to mitigate adverse movements (CAT_10k_2022 p. 19; CAT_10k_2023 p. 19; CAT_10k_2024 p. 19).  The 10‑K disclosures each year note that while hedging can reduce earnings volatility, it also limits upside gains and does not eliminate the risk that currency fluctuations can materially affect results (see the same pages).  Thus, the hedging strategy evolved little, with Caterpillar maintaining a similar approach while acknowledging ongoing volatility in earnings tied to its international exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Caterpillar has significant currency exchange rate exposure due to global operations across 2022-2024. (2) Correctly notes that hedging instruments were used consistently across all three years. (3) Accurately captures the trade-off between hedging (reducing downside risk but limiting upside gains). (4) Page citations (p. 19 for each year) appear reasonable and consistent. (5) Correctly identifies that hedging does not eliminate currency risk entirely.\n\nWEAKNESSES: (1) MAJOR OMISSION: The LLM completely fails to address the evolution of Caterpillar's concerns regarding emerging market risks, exchange controls, and currency devaluation risks that intensified from 2022-2024. The ground truth explicitly notes that by 2023, CAT expanded discussion to include risks from exchange controls and currency devaluations in emerging markets, and that by 2024 these risks intensified. The LLM states the hedging strategy 'evolved little' and maintained 'a similar approach,' which contradicts the ground truth's finding of a 'growing concern over geopolitical and macroeconomic volatility.' (2) INCOMPLETE SYNTHESIS: The LLM fails to capture the multi-year trend showing increasing caution and emphasis on external macroeconomic pressures. It presents a static picture rather than the dynamic evolution described in the ground truth. (3) MISSING CONTEXT: No mention of emerging markets, exchange controls, currency devaluation risks, or geopolitical factors that were increasingly emphasized in later filings. (4) The answer is too narrow in scope—it focuses only on the basic hedging trade-off rather than the broader risk landscape evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to identify the key evolution in risk management focus. It correctly identifies the consistent use of hedging but misses the critical shift in emphasis toward emerging market and macroeconomic risks.\n\nSEMANTIC ACCURACY: While the LLM's statements about hedging mechanics are accurate, the overall narrative is incomplete and misses the primary evolution that the question asks about—how management of currency risk evolved, not just that it remained consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 602,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive reduced its U.S. pension plan’s exposure to Treasury and agency securities from roughly **40 % in 2022** to **30 % in 2023**, and the allocation stayed at **30 % in 2024**【page_102】【page_100】. This shift away from the most conservative fixed‑income asset class indicates a deliberate move to diversify the portfolio and adjust duration/yield exposure, reflecting a more active interest‑rate‑risk management strategy rather than heavy reliance on Treasuries and agencies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 allocation. The LLM states the allocation was '40% in 2022,' but the ground truth clearly indicates it was 30% as of December 31, 2022 (reported in the 2023 filing). The LLM correctly identifies 30% for 2023 and 2024, but the starting point is wrong, which undermines the entire trend analysis. The ground truth shows a more complex evolution: 50% (2020) → 40% (2021) → 30% (2022) → 30% (2023) → 30% (2024). The LLM only captures the final two years of this trend and misrepresents the 2022 figure. COMPLETENESS ISSUES: The LLM answer omits important context from the ground truth, specifically: (1) the earlier decline from 50% in 2020 to 40% in 2021, which is part of the 2022-2024 evolution question; (2) the Level 2 classification detail and its implications for liquidity; (3) the specific mention of 'other government bonds and corporate bonds' as the alternative allocations. REASONING QUALITY: The LLM's interpretation about 'deliberate move to diversify' and 'more active interest-rate-risk management' is reasonable and aligns with the ground truth's characterization, but this reasoning is built on an incorrect starting point (40% vs. 30% in 2022). The semantic understanding of the strategic shift is sound, but the factual foundation is flawed. MULTI-HOP SYNTHESIS: The LLM demonstrates understanding that this is a multi-year trend question and attempts to synthesize across 2022-2024, but fails to accurately capture the data points. The connection between the allocation changes and interest rate management is appropriately made, though the ground truth provides more nuanced context about the stabilization after the initial decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 479,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer’s BPA activity dropped to zero after 2022: BPAs were granted and outstanding in 2022 (PFE_10k_2022.pdf p. 101), but the 2023 and 2024 10‑K notes explicitly state that no BPAs were granted or outstanding (PFE_10k_2023.pdf p. 96; PFE_10k_2024.pdf p. 96).  Across all three years the company consistently valued BPAs using the intrinsic‑value method based on the closing price of its common stock and amortized the expense over the probable vesting term (PFE_10k_2022.pdf p. 101; PFE_10k_2023.pdf p. 96; PFE_10k_2024.pdf p. 96).  Disclosure transparency improved in 2023‑24 by explicitly noting the absence of BPA activity, whereas the 2022 note provided detailed grant and valuation information (PFE_10k_2022.pdf p. 101; PFE_10k_2023.pdf p. 96; PFE_10k_2024.pdf p. 96).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall trajectory of BPA activity (active in 2022, discontinued in 2023-2024) and correctly identifies the valuation methodology (intrinsic value method). However, there are significant quantitative omissions and one factual discrepancy: (1) MISSING SPECIFIC NUMBERS: The ground truth provides concrete figures (1,165 thousand shares granted in 2022 at $38.73 weighted average intrinsic value; 859 thousand shares nonvested by year-end 2022) that the LLM answer completely omits. These are material quantitative details that should have been included. (2) FACTUAL DISCREPANCY: The LLM states 'no BPAs were granted or outstanding' in both 2023 AND 2024, but the ground truth indicates BPAs 'reappeared in disclosures' in 2024 with 'detailed valuation and amortization policies introduced.' This suggests 2024 had some BPA activity or at least renewed disclosure, contradicting the LLM's claim of zero activity in 2024. (3) VALUATION METHODOLOGY: The LLM correctly identifies the intrinsic value method and amortization approach, but misses the evolution mentioned in ground truth—that 2024 introduced 'adjustments based on performance probability and stock price changes,' suggesting a more sophisticated methodology than the consistent approach the LLM describes. (4) DISCLOSURE TRANSPARENCY: The LLM correctly notes improved transparency through explicit disclosure of absence, but this is somewhat contradicted by the ground truth's statement that 2024 introduced 'more transparent and dynamic valuation framework,' implying 2024 had more detailed disclosure than just noting absence. (5) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the strategic shift, but the reasoning is incomplete due to missing quantitative details and the apparent mischaracterization of 2024 activity. The answer is directionally correct but lacks precision and contains a potential factual error regarding 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 532,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "Charles Schwab’s 2022 RIA platform was built around the Advisor Services website, offering interactive tools, educational content, and the free Schwab Advisor Portfolio Connect for portfolio management while supporting third‑party integrations for CRM, trade‑order, and financial‑planning systems (page_8). By 2023, Schwab expanded its interactive toolset by launching Schwab Trading Powered by Ameritrade, adding real‑time charting and trading capabilities for RIAs (page_6). In 2024, the firm deepened third‑party integration by incorporating TD Ameritrade’s thinkpipes trading platform and iRebal rebalancing solution into the RIA offering, further enhancing portfolio‑management functionality while continuing to provide the Advisor Portfolio Connect and a broader suite of interactive tools (page_8, page_6, page_7).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) The LLM claims Schwab launched 'Schwab Trading Powered by Ameritrade' in 2023 with real-time charting and trading capabilities - this specific product name and 2023 launch date are not mentioned in the ground truth. (2) The LLM states that in 2024 Schwab 'incorporated TD Ameritrade's thinkpipes trading platform and iRebal rebalancing solution' - these specific third-party integrations are not mentioned in the ground truth, which only references continued emphasis on third-party integrations generally. (3) The ground truth emphasizes the Advisor Services website as a core platform with document archiving and search capabilities in 2023, which the LLM completely omits. (4) The ground truth notes a refinement in 'intuitive modern experience' in 2024, suggesting usability enhancements, which the LLM does not capture. (5) The LLM correctly identifies Schwab Advisor Portfolio Connect as a free portfolio management solution across the period, which aligns with ground truth. (6) The LLM correctly notes third-party integrations for CRM, trade-order, and financial-planning systems in 2022, matching the ground truth. The LLM appears to have fabricated or conflated specific product names and integration details (thinkpipes, iRebal, 'Schwab Trading Powered by Ameritrade') that are not in the ground truth. While the general narrative of evolution and emphasis on integrations is directionally correct, the specific factual claims are unreliable and introduce false information that would mislead readers about actual product offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 457,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across 2022‑24 TI’s MD&A consistently framed embedded‑processing as a core pillar of its business model, noting “our strategic focus is on analog and embedded processing products” and that it “places additional strategic emphasis on designing and selling our products into the industrial and automotive markets” in 2022 (page 18), 2023 (page 19) and 2024 (page 18).  The segment’s revenue rose modestly from $3.26 B in 2022 to $3.37 B in 2023 but fell to $2.53 B in 2024, while operating‑margin pressure tightened from 38.4 % (2022) to 29.9 % (2023) to 13.9 % (2024) (page 20 of each year).  This unwavering emphasis signals TI’s long‑term strategy to anchor its semiconductor positioning around analog‑and‑embedded solutions—especially for industrial and automotive customers—leveraging its manufacturing strength to sustain cash flow and competitive advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic emphasis on embedded processing products across 2022-2024, accurately captures the consistent framing in MD&A sections, and properly synthesizes the multi-hop reasoning about TI's long-term positioning. The qualitative analysis about leveraging manufacturing strength and targeting industrial/automotive markets aligns well with the ground truth. The answer appropriately addresses all parts of the question.\n\nCRITICAL WEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific financial metrics that cannot be verified against the ground truth and appear problematic: (1) Embedded processing segment revenue figures ($3.26B, $3.37B, $2.53B) are not mentioned in the ground truth, which does not provide segment-level revenue data; (2) Operating margin percentages (38.4%, 29.9%, 13.9%) are similarly unverified and highly specific claims that lack grounding in the provided knowledge graph; (3) Page number citations (page 18, 19, 20) are provided but cannot be verified. These specific numeric claims significantly undermine credibility, as they appear to be either fabricated or sourced from documents not in the knowledge graph.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the strategic emphasis across three years and connects it to long-term positioning, matching the ground truth's core argument. However, the addition of unverified financial data creates a false impression of comprehensive analysis.\n\nSEMANTIC ALIGNMENT: The LLM's framing of embedded processing as a 'core pillar' and connection to competitive advantages aligns with ground truth language about 'sustainable competitive advantages' and embedded processing as a 'key pillar.'\n\nJUSTIFICATION: While the qualitative reasoning is sound and contextually relevant, the introduction of specific financial metrics without verification from the knowledge graph represents a significant factual accuracy problem. The answer would score 8-9 if limited to the qualitative strategic analysis, but the unverified quantitative claims reduce the overall correctness score substantially.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 571,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Fleet‑support costs stayed essentially flat, consistently representing about 1 % of Boeing’s total consolidated product‑and‑service costs in 2022, 2023 and 2024.  In contrast, the 787 program’s abnormal production costs climbed—from roughly $2 billion cumulative through 2023 to $256 million in 2024—because production rates stayed below five per month and extensive rework and inspections were required.  These abnormal costs and the ongoing rework have kept 787 deliveries delayed, with the remaining inventory slated for delivery mainly in 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc of Boeing's 787 program challenges but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) Fleet support services consistently ~1% of consolidated costs across 2022-2024 is accurate; (2) The 2024 rework cost of $256 million is correct; (3) Delivery delays and expectation to deliver majority in 2025 are correct; (4) The general progression showing reduction in abnormal costs is correct; (5) Multi-hop synthesis across years is sound. CRITICAL ERROR: The LLM states abnormal production costs 'climbed—from roughly $2 billion cumulative through 2023 to $256 million in 2024.' This is fundamentally misleading. The ground truth shows cumulative abnormal costs of $2.7 billion through December 31, 2023, and then $256 million in 2024 alone. The LLM's phrasing suggests costs increased from $2B to $256M, when actually the $256M represents 2024 annual costs added to the prior cumulative total. This is a critical misrepresentation of the cost trajectory. ADDITIONAL ISSUES: (1) The LLM omits the specific $2.7 billion cumulative figure, instead using 'roughly $2 billion'; (2) The statement about production rates staying 'below five per month' is not mentioned in the ground truth and appears to be an inference or external knowledge not verified; (3) The answer lacks the nuance that rework was primarily on 'inventoried aircraft' and that most of the 25 aircraft produced prior to 2023 had been reworked by 2024. MULTI-HOP REASONING: The answer does synthesize information across three years and connects fleet support services to 787 program costs, but the quantitative synthesis is flawed. The reasoning about cause-and-effect (abnormal costs causing delays) is sound but not explicitly supported by the ground truth. SEMANTIC ISSUES: The phrasing 'climbed from roughly $2 billion...to $256 million' is semantically incorrect as it suggests an increase when the actual situation shows cumulative costs of $2.7B with additional $256M in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 547,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian subsidiary on December 31 2021 for roughly $51 million in cash, recording a $167 million net‑of‑tax loss (PFE 10‑K 2023, page 73).  After the sale, Pfizer entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑service agreement (MSA) with a two‑year extension; the amounts recorded under those agreements in 2022 and 2023 were immaterial to operations (PFE 10‑K 2023, pages 73‑74).  In 2024 the MSA remains in effect, but no new material amounts are recorded, so the post‑sale relationship continues mainly as a contractual framework with negligible financial impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on core elements but contains one significant issue and some minor gaps. CORRECT ELEMENTS: (1) Sale date of December 31, 2021 is accurate; (2) $167 million net-of-tax loss is correct; (3) TSAs and three-year MSA with two-year extension option are correctly identified; (4) Amounts under agreements being immaterial in 2022-2023 is accurate; (5) 2024 status showing MSA remaining in effect with negligible financial impact is correct; (6) Multi-hop synthesis across 2022-2024 is sound. ISSUES: (1) The LLM states Pfizer sold Meridian for 'roughly $51 million in cash' - this specific sale price figure is not mentioned in the ground truth and appears to be an unsupported claim that introduces potential inaccuracy. The ground truth focuses on the loss recognized ($167M net of tax) rather than the sale proceeds. This is a factual claim that cannot be verified against the provided ground truth and represents a potential error. (2) Minor: The LLM could have been more explicit about the full evolution trajectory (from discontinued operations classification in 2022 to glossary reference in 2024), though the answer does capture the transition from ownership to supplier relationship. QUANTITATIVE ACCURACY: The $167 million loss and the three-year MSA with two-year extension are correct. However, the $51 million sale price claim is unverified and potentially incorrect, reducing confidence in quantitative precision. QUALITATIVE ACCURACY: The reasoning about transition from ownership to supplier relationship is sound and well-articulated. The synthesis across years is logical. CONTEXTUAL RELEVANCE: The answer directly addresses the question about relationship evolution and financial implications, though the unsupported sale price claim slightly undermines relevance. The answer appropriately emphasizes diminishing financial impact over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 515,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, “hello” is consistently listed among the company’s global trademarks in the Oral, Personal and Home Care segment, indicating it remains part of that core portfolio. The filings do not disclose any shift in its strategic positioning or a change in emphasis relative to other brands in the same segment, so its role appears unchanged over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct in its core factual claims but differs in emphasis and interpretation from the ground truth. STRENGTHS: (1) Correctly identifies that 'hello' appears consistently across 2022, 2023, and 2024 10-K filings; (2) Accurately notes the brand's inclusion in the Oral, Personal and Home Care segment; (3) No quantitative errors or incorrect dates/numbers; (4) Properly acknowledges the three-year period. WEAKNESSES: (1) The LLM states 'the filings do not disclose any shift in its strategic positioning' which is more cautious than the ground truth's affirmative claim that 'hello' maintained 'sustained strategic emphasis' and 'continued prioritization'; (2) The ground truth explicitly notes that 'hello' was listed 'alongside major brands like Colgate and Palmolive' and remained highlighted despite competitive additions (like Darlie in 2023), suggesting deliberate strategic positioning - the LLM's answer is more neutral and doesn't capture this nuance; (3) The LLM concludes the role 'appears unchanged' which is technically accurate but misses the ground truth's interpretation that consistent visibility across three years itself implies 'continued prioritization' and 'maintained strategic brand position'; (4) The answer lacks the specific contextual details about how 'hello' was positioned relative to other brands in each year. The LLM answer is defensible as a more conservative interpretation (absence of disclosed change ≠ strategic emphasis), but it doesn't fully capture the ground truth's inference that consistent listing across years indicates sustained strategic importance. The semantic difference is meaningful for a question about 'strategic positioning evolution.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 470,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "From 2022‑24 the non‑qualified defined‑benefit plan remained unfunded and closed to new participants, with the funded status improving only modestly from a $100 million deficit in 2022 to a $93 million deficit in 2024 while the projected benefit obligation fell from $521 million to $493 million. Participant contributions stayed at zero each year, and employer contributions to the non‑qualified plan were $3 million in 2022 and 2023 and $2 million in 2024, showing minimal employee engagement. These trends indicate that Texas Instruments’ long‑term pension obligations remain significant and underfunded, and that employees are not actively participating in the non‑qualified plan, likely favoring defined‑contribution options instead.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific funding deficit figures ($100M in 2022 to $93M in 2024) and projected benefit obligation amounts ($521M to $493M) that do not appear in the ground truth. These numbers cannot be verified and appear to be fabricated. The ground truth provides no such deficit or PBO figures for the non-qualified plan. (2) MISSING KEY DATA: The LLM completely omits the substantial and verifiable data from the ground truth about defined contribution plans: the 6M shares (2022) declining to 5M shares (2023-2024), valuations of $940M/$873M/$852M, dividend payments of $28M/$27M/$26M, and aggregate DC plan expenses of $70M/$75M/$76M. This is the core quantitative evidence in the ground truth. (3) INCOMPLETE SYNTHESIS: The question asks about 'participant engagement' and 'long-term pension obligations.' The ground truth demonstrates engagement through the substantial DC plan holdings and growing DC expenses. The LLM's claim of 'minimal employee engagement' based on zero participant contributions to the non-qualified plan misses the point—employees are engaged through the DC plans, not the closed non-qualified plan. (4) CONTRADICTORY CONCLUSIONS: The ground truth concludes the trend 'indicates a strategic shift away from defined benefit obligations' with the non-qualified plan as a 'legacy liability.' The LLM concludes obligations 'remain significant and underfunded,' which contradicts the ground truth's emphasis on the shift toward DC alternatives. (5) UNVERIFIED CLAIMS: The employer contribution figures ($3M/$3M/$2M) and the assertion about zero participant contributions cannot be verified against the provided ground truth. The LLM appears to have introduced data from a different source or fabricated it. The answer does correctly identify that the plan remained unfunded and closed, but this represents only a small fraction of the required analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 546,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost declined from **$800 million in 2022 to $755 million in 2023 and to $719 million in 2024**—a total drop of $81 million over three years【page_86】【page_83】. This modest downward trend indicates the company is gradually trimming its private‑equity exposure, likely reallocating capital toward other assets or concentrating on core operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states $623 million in 2022, but the LLM claims $800 million—a $177 million discrepancy (28% error). This is a major quantitative accuracy failure. The 2023 ($755M) and 2024 ($719M) figures are correct, and the calculated 3-year decline of $81 million is arithmetically correct based on the LLM's incorrect starting point ($800M - $719M = $81M), but this calculation is built on a false premise. The LLM's interpretation of the trajectory is also fundamentally flawed: it characterizes the data as a 'modest downward trend' suggesting 'gradually trimming' exposure, when the ground truth shows a strategic INCREASE from 2022 to 2023 (+$132M or 21% growth) followed by a partial reduction in 2024. This represents a materially different strategic narrative—the ground truth indicates a deliberate capital allocation increase in 2023, not a consistent downward trend. The LLM failed to capture the multi-hop synthesis required: comparing 2022→2023 (increase) vs 2023→2024 (decrease) to understand the actual strategic pattern. The reasoning about 'gradually trimming' and 'reallocating capital' contradicts the actual data pattern of initial expansion. The citation references (page_86, page_83) cannot be verified but the underlying numbers are demonstrably incorrect against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 389,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022, under the 2019 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each year, but only floating‑rate balances, while maintaining a minimum $50 billion balance and ensuring 80 % of balances were fixed‑rate through 2026 (page 102). The 2023 IDA agreement removed the fixed‑rate requirement, set new minimum/maximum limits ($30 billion above fixed‑rate balances through 2025, then $60–$90 billion after 2025), and restricted withdrawals to customer‑initiated amounts until 2025; Schwab did not migrate any balances in 2023 (page 100). In 2024 the same 2023 terms applied, and Schwab again did not move IDA balances, with migration still constrained by capital adequacy, binding limits, and the new minimum/maximum balance and withdrawal rules (page 100).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - Claims 2022 had a $50 billion minimum balance requirement - NOT in ground truth\n   - Claims 80% fixed-rate requirement through 2026 - NOT in ground truth\n   - Claims 2023 agreement set limits of $30 billion above fixed-rate balances through 2025, then $60-$90 billion after 2025 - Ground truth only mentions $30 billion maximum through September 10, 2025, with no mention of $60-$90 billion post-2025 range\n   - The specific percentages and dollar thresholds appear fabricated or misattributed\n\n2. FACTUAL INACCURACIES:\n   - Ground truth states Schwab had option to migrate \"up to $10 billion annually\" in 2022 under 2019 agreement - LLM correctly states this but adds unsupported constraints\n   - Ground truth mentions Schwab had already moved $10.1 billion by December 31, 2021 - LLM omits this context\n   - LLM claims \"only floating-rate balances\" could be migrated in 2022 - NOT mentioned in ground truth\n   - LLM claims 2023 agreement \"removed the fixed-rate requirement\" - Ground truth doesn't mention a fixed-rate requirement existed to be removed\n   - LLM claims withdrawals restricted to \"customer-initiated amounts until 2025\" - NOT in ground truth\n\n3. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize evolution across three years but introduces unsupported details\n   - Correctly identifies that no balances were migrated in 2023 and 2024\n   - Correctly identifies the shift from 2019 to 2023 agreement\n   - However, the specific constraints cited are either fabricated or misattributed\n\n4. WHAT WAS CORRECT:\n   - 2022: $10 billion annual migration option (correct)\n   - 2023: New agreement with minimum/maximum limits (correct concept, but details wrong)\n   - 2023-2024: No migrations occurred (correct)\n   - General trend of tightening constraints (correct direction)\n\n5. CRITICAL ISSUES:\n   - The answer appears to conflate or invent specific regulatory requirements\n   - Page citations (102, 100) cannot be verified but specific numbers don't match ground truth\n   - The $60-$90 billion range post-2025 is completely unsupported\n   - The 80% fixed-rate and $50 billion minimum for 2022 are not in ground truth\n\nThe LLM answer demonstrates partial understanding of the overall evolution but introduces substantial factual errors that would mislead readers about the actual constraints and terms of the IDA agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 669,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Irradiation has kept a Melaka, Malaysia plant in its analog‑product manufacturing portfolio for three consecutive years.  The 2022 10‑K lists “Melaka, Malaysia†” as an analog site (page 18†), the 2023 10‑K lists “Melaka, Malaysia*” (page 18*), and the 2024 10‑K lists “Melaka, Malaysia**” (page 18**).  The unchanged status and continued analog‑only use across 2022‑2024 indicate that Melaka is a strategically important, stable location for TI’s analog production, likely chosen for cost, supply‑chain proximity or regional market access.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) COMPANY NAME ERROR: The LLM states 'Texas Irradiation' instead of 'Texas Instruments' - this is a fundamental factual error that undermines credibility. (2) MARKING INTERPRETATION ERROR: The LLM claims the markings (†, *, **) indicate 'unchanged status' and 'continued analog-only use,' but the ground truth explicitly states these markings potentially signal 'continued operational emphasis' and 'possible escalation' - the LLM misinterprets the significance of the changing symbols across years. (3) INCOMPLETE ANALYSIS: The ground truth notes the progression from † (2022) to * (2023) to ** (2024) as potentially signaling escalation, but the LLM dismisses this as 'unchanged status,' missing the nuanced interpretation of symbol changes. (4) SPECULATIVE REASONING: The LLM adds unsupported speculation about 'cost, supply-chain proximity or regional market access' that is not present in the ground truth and goes beyond what can be verified from the filings. (5) CORRECT ELEMENTS: The LLM does correctly identify that Melaka was listed in all three years (2022, 2023, 2024) and correctly notes the specific symbols used in each year. The core multi-hop synthesis of tracking the location across three years is sound. The conclusion about strategic importance is reasonable but based on flawed interpretation of the symbol progression. The page references (page 18) appear consistent with typical 10-K formatting but cannot be verified. Overall, while the LLM captures the basic fact that Melaka appears consistently across three years, it fundamentally misinterprets the significance of the changing notation symbols and contains a critical company name error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 460,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "Target’s debit‑card penetration—measured by the share of purchases paid with a Target Circle Card (which includes the debit card)—declined from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (MD&A, page 27). The downward trend shows that fewer guests are using the card, indicating that its ability to generate incremental sales for Target is weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical numerical error that significantly impacts the evaluation. The ground truth shows the 2024 penetration rate was 17.8%, but the LLM states it was 18.6%. This is a factual error of 0.8 percentage points, which is material in the context of tracking a declining metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The LLM correctly identifies the metric as Target Circle Card penetration (which includes the debit card), properly cites the source (MD&A, page 27), and accurately characterizes the downward trend. The reasoning about the trend suggesting weakening ability to generate incremental sales is sound and semantically equivalent to the ground truth's assessment. However, the quantitative error in the final year's data point is a significant flaw that undermines the accuracy of the trend analysis. The answer addresses both parts of the question (evolution of penetration rate and what it suggests about the card's role), but the incorrect 2024 figure means the trend calculation and conclusion are based on partially incorrect data. The qualitative reasoning is appropriate and the contextual relevance is high, but the numerical inaccuracy prevents a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 347,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The table of equity‑compensation plans shows the 2003 Director Compensation Plan’s share pool growing from 29.3 million in 2022 (29,280,162) to 31.3 million in 2023 (31,257,621) and then easing to 30.4 million in 2024 (30,369,933)【TXN_10k_2022 page 63】【TXN_10k_2023 page 61】【TXN_10k_2024 page 59】. This rise‑then‑slight‑decline pattern indicates that Texas Instruments has been actively granting director awards while periodically replenishing the plan’s share reserve.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM reports share counts that are completely opposite to the ground truth. Ground truth shows: 2022: 35,385,153 shares → 2023: 25,296,767 shares → 2024: 24,503,062 shares (consistent DECLINE). LLM claims: 2022: 29,280,162 → 2023: 31,257,621 → 2024: 30,369,933 (INCREASE then slight decline). These are entirely different numbers with opposite directional trends. The LLM's numbers don't match the ground truth at any year. (2) TREND ANALYSIS ERROR: Ground truth correctly identifies a consistent decline across all three years with no replenishment. LLM incorrectly characterizes this as a 'rise-then-slight-decline pattern' and claims 'periodic replenishment' - the exact opposite of what occurred. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize across three years of 10-K filings, it has fundamentally misread or misreported the data from those sources. The citations provided (page numbers) may be correct, but the extracted numbers are wrong. (4) SEMANTIC MEANING: The LLM's conclusion about 'periodic replenishment' directly contradicts the ground truth's finding of 'no replenishment.' This is not a wording difference but a factual contradiction about company behavior. The answer fails on accuracy of the core financial metrics, the directional trend, and the interpretation of what the trend means for corporate strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 402,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022 Visa added virtual‑account capability to its Treasury‑as‑a‑Service offering and expanded Visa Direct with push‑to‑wallet payouts, giving access to roughly 7 billion cards, accounts and digital wallets in 190 + countries.  In 2023 the company integrated its Currencycloud platform into Visa Direct, adding real‑time FX, virtual accounts and enhanced liquidity that broadened the number of supported payment schemes and enabled a wider array of cross‑border B2B and consumer use cases.  By 2024 the platform was processing nearly 10 billion transactions for 550 + partners, with the Currencycloud‑enabled virtual‑account and cross‑border solutions covering more than 11 billion endpoints and supporting an expanded portfolio of cross‑border B2B, B2C and P2P flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Visa's virtual accounts evolution across 2022-2024 with generally accurate information and good multi-hop synthesis. STRENGTHS: (1) Correctly identifies the progression of virtual accounts integration from 2022 (Treasury-as-a-Service) through 2023 (Currencycloud integration into Visa Direct) to 2024 (core digital capability); (2) Accurately mentions the 11 billion endpoints figure for 2024, matching ground truth; (3) Properly synthesizes the expansion of cross-border use cases (B2B, B2C, P2P) across the three-year period; (4) Correctly references Currencycloud platform integration and real-time FX capabilities; (5) Appropriately contextualizes the scale with 550+ partners and nearly 10 billion transactions by 2024. WEAKNESSES/DISCREPANCIES: (1) The 2022 figure of '7 billion cards, accounts and digital wallets' is not mentioned in the ground truth, which states the network could reach 'over 11 billion endpoints' by 2024 - this appears to be an intermediate figure not explicitly confirmed in ground truth; (2) The ground truth emphasizes the $20 trillion B2B cross-border opportunity figure, which the LLM answer omits entirely - this is a significant contextual detail about Visa's strategic focus; (3) The ground truth specifically mentions 'Visa Cross-Border Solutions' as a distinct expansion component in 2023, while the LLM answer references this more implicitly through 'cross-border solutions'; (4) The LLM answer adds specific transaction volume (10 billion transactions) and partner count (550+) that, while plausible, are not explicitly verified in the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple platforms (Treasury-as-a-Service, Currencycloud, Visa Direct), showing proper understanding of how these components evolved together. The logical progression from 2022 introduction → 2023 integration → 2024 scale-up is sound. QUANTITATIVE VERIFICATION: The 11 billion endpoints figure is correct and matches ground truth. The 7 billion figure for 2022 and 10 billion transactions/550+ partners for 2024 cannot be contradicted by ground truth but also aren't explicitly confirmed, creating minor uncertainty. Overall, the answer is substantially correct with minor omissions of strategic context (the $20 trillion opportunity) and some unverified but plausible additional details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 646,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s revenue fell 1 % in 2023, a decline driven by lower net price and channel‑mix shifts (page 45).  In response, Pfizer accelerated lifecycle‑management efforts, culminating in the April 2024 FDA approval of a new combination indication for Xtandi (page 45).  The 2022 intangible‑asset statement shows the asset’s net carrying amount—$19.6 billion of developed‑technology rights—underscoring the substantial value Pfizer seeks to preserve through such lifecycle investments (page 92).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key data points: (1) Xtandi's 1% revenue decline in 2023 is accurate; (2) the April 2024 FDA approval for a new indication is correctly identified; (3) the $19.6 billion intangible asset valuation is accurate and properly contextualized. The answer successfully synthesizes multi-hop information across 2022 (valuation), 2023 (revenue pressures), and 2024 (indication expansion). However, there are minor gaps: (1) The LLM does not explicitly name the new indication (nmCSPC with biochemical recurrence at high risk for metastasis) that was approved in 2024, instead using the generic phrase 'new combination indication'; (2) The answer attributes revenue decline to 'lower net price and channel-mix shifts' but does not explicitly mention 'declining international revenues' as emphasized in the ground truth; (3) The LLM provides page references (45, 92) which add credibility but are not part of the ground truth evaluation. The reasoning is sound—connecting revenue pressure to lifecycle management investment—and the semantic meaning aligns well with the original answer. The quantitative data (1%, $19.6B, 2024 approval date) are all correct. The main weakness is incomplete specificity regarding the indication details, which represents a minor omission rather than a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 381,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard credit‑card penetration fell from **20.5 % of purchases in 2022 to 19.8 % in 2023 and 18.6 % in 2024** (Target Circle Card penetration figures). This downward trend indicates that consumers are increasingly favoring other payment methods and that engagement with Target’s loyalty program is weakening over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three penetration rate figures are correct - 20.5% (2022), 19.8% (2023), and 18.6% (2024). The numbers match the ground truth exactly with no calculation errors. (2) ENTITY ACCURACY: The answer correctly identifies the Target MasterCard Credit Card and appropriately notes the rebranding to Target Circle Card, showing awareness of the product evolution across the period. (3) COMPLETENESS: The answer addresses both parts of the multi-part question - it provides the penetration rate evolution (2022-2024) and interprets the trend's implications for consumer preference and loyalty engagement. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the consistent downward trend across all three years and draws logical conclusions about weakening loyalty program engagement and shifting payment preferences. The interpretation that declining penetration indicates consumers favoring other payment methods is reasonable and well-supported by the data. (5) MINOR OBSERVATION: The LLM uses slightly different phrasing than the ground truth (e.g., 'increasingly favoring other payment methods' vs. 'shift in consumer payment preferences') but the semantic meaning is equivalent and accurate. The parenthetical note about 'Target Circle Card penetration figures' adds helpful context about the product naming convention. No factual errors, calculation errors, or significant omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 420,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022 Visa added virtual accounts to its Currencycloud platform to enable cross‑border payments with real‑time FX, virtual accounts and enhanced liquidity (page 10 2022). In FY 2023 those virtual‑account capabilities were integrated into Visa Direct, expanding cross‑border options and broadening the network (page 10 2023). By FY 2024 the platform leveraged virtual accounts to serve cross‑border payments across more than 195 countries/territories and over 11 billion cards, bank accounts and digital wallets, marking a significant expansion in network reach (page 10 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - LLM states '195 countries/territories' in 2024, but ground truth specifies 'more than 100 countries' for Visa B2B Connect. This is a significant overstatement of geographic reach. (2) NETWORK REACH CONFUSION - LLM conflates two different metrics: the '11 billion endpoints' (cards, bank accounts, digital wallets) is correctly cited but the '195 countries/territories' appears to be fabricated or confused with different data. Ground truth clearly states 'over 100 countries' for the B2B Connect platform. (3) INCOMPLETE SYNTHESIS - LLM mentions Visa Direct integration in 2023 but fails to clearly articulate the strategic progression of virtual account utility across the three-year period as emphasized in ground truth. (4) MISSING CONTEXT - LLM omits the specific mention of 'digitally native Currencycloud capabilities' and 'B2B transactions' optimization that are key to understanding the evolution. (5) POSITIVE ELEMENTS - LLM correctly identifies: FY 2022 introduction of virtual accounts, real-time FX capabilities, 2023 integration into Visa Direct, 11 billion endpoints figure, and the general expansion narrative. However, the geographic reach error (195 vs 100+ countries) is a material factual mistake that significantly undermines answer credibility. The multi-hop reasoning is partially sound but marred by the quantitative inaccuracy on country coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 395,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑K filings all list “difficulties in protecting our intellectual property” as a continuing risk tied to its worldwide operations and reliance on third‑party wafer foundries and manufacturing sites (China, Malaysia, Taiwan) – the wording on pages 37 (2022), 41 (2023) and 40 (2024) is essentially unchanged.  The company’s international sales share has grown from ~72 % in 2021 to 65 % in 2023 and 66 % in 2024, underscoring that the IP‑protection risk remains linked to its expanding global footprint and external manufacturing dependencies.  No new mitigation or shift in the risk’s scope is disclosed, indicating that AMD continues to view IP protection as a persistent challenge in its global supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The international sales percentages are incorrect. The LLM states international sales were '~72% in 2021 to 65% in 2023 and 66% in 2024,' but these figures cannot be verified against the ground truth and appear to be fabricated or misremembered. The ground truth does not provide these specific percentages, and the LLM provides no source documentation for these claims. (2) PAGE NUMBER ERRORS - The LLM cites specific page numbers (37 for 2022, 41 for 2023, 40 for 2024) where the IP protection language appears, but these cannot be verified and may be incorrect. This is a serious issue as it suggests citation fabrication. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that AMD mentions IP protection difficulties across all three years and links them to third-party manufacturing in China, Malaysia, and Taiwan, it FAILS to capture the key evolution described in the ground truth: the 2023 expansion linking IP risks to China-Taiwan geopolitical tensions, and the 2024 addition of export control regulations and sanctions related to Ukraine-Russia and Israel-Hamas conflicts. The LLM states 'No new mitigation or shift in the risk's scope is disclosed,' which directly contradicts the ground truth's finding of 'increasing emphasis on geopolitical tensions' and 'growing specificity around geopolitical and regulatory pressures.' (4) MISSING CRITICAL CONTEXT - The LLM misses the temporal evolution that is central to the question. The ground truth explicitly documents how the risk disclosure became more specific and complex over time, while the LLM dismisses this as 'essentially unchanged.' STRENGTHS: The LLM correctly identifies the core risk (IP protection difficulties), correctly names the manufacturing locations (China, Malaysia, Taiwan), and correctly notes the connection to third-party manufacturing dependencies. The general framing of persistent global supply chain risk is appropriate. However, the fabricated statistics, incorrect page citations, and failure to capture the documented evolution of the risk across years represent fundamental failures in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 613,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s corporate‑stock holdings dropped sharply from $1,111 million in 2022 (mostly Level‑2/3) to $226 million in 2023 (≈220 million Level‑1) and $181 million in 2024 (≈176 million Level‑1)【page 58】【page 57】【page 58】.  The pension plan’s equity target moved from 48‑55 % in 2022 to 20‑30 % in 2024, with actual equity at 24 % in 2022‑2024【page 70】【page 71】【page 54】, reflecting a deliberate de‑risking that reduces corporate‑stock concentration, increases liquidity, and boosts debt exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: (1) QUANTITATIVE FAILURES: The LLM provides completely incorrect numbers for 2022 Corporate Stock valuation. Ground truth states $1,990 million total ($1,980M Level 1 + $10M Level 2), but LLM claims $1,111 million (mostly Level 2/3). This is a $879 million discrepancy - a 44% understatement. For 2023, ground truth shows $181 million ($176M Level 1 + $5M Level 2), but LLM states $226 million - a $45 million overstatement. For 2024, LLM provides no specific dollar figures while ground truth indicates Corporate Stock continued to be held with Level 1/Level 2 classifications. (2) LEVEL CLASSIFICATION ERRORS: Ground truth clearly shows 2022 had $1,980M in Level 1 and $10M in Level 2 (not 'mostly Level 2/3' as LLM claims). This is a fundamental mischaracterization of the valuation hierarchy. (3) INCOMPLETE SYNTHESIS: While LLM attempts to add pension equity target allocation data (48-55% in 2022 to 20-30% in 2024), this information, though potentially relevant to strategy, does not correct the core factual errors about Corporate Stock valuations and classifications. The equity target shift is not mentioned in the ground truth answer. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the basic Corporate Stock data across years before attempting to draw strategic conclusions. The de-risking narrative may be directionally correct, but it's built on incorrect numerical foundations. (5) MISSING CONTEXT: Ground truth notes that 2024 classifications distinguish between common stock (Level 1) and preferred stock (Level 2) without updated dollar figures - the LLM omits this important classification detail. The sharp 2022-2023 decline is the key finding; LLM's numbers don't reflect this magnitude properly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 483,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott continues to disclose the 4.75% Senior Notes due 2043 through the same 2017 Form 8‑K exhibit (Exhibit 4.6) that appears in the exhibits tables of its 2022, 2023, and 2024 10‑K filings (page 86).  No new amendments or issuances of the notes are reflected in these filings, indicating that the terms remain unchanged.  This consistency underscores a stable long‑term debt structure and a priority on transparent, ongoing communication with investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2017 Form 8-K Exhibit 4.6 as the consistent disclosure mechanism across 2022-2024 filings and accurately notes the absence of amendments or new issuances. However, the answer has significant gaps in addressing the multi-year evolution requested by the question. STRENGTHS: (1) Correctly identifies Exhibit 4.6 from the 2017 Form 8-K as the consistent reference point; (2) Accurately notes no amendments or new issuances; (3) Correctly identifies the 4.75% Senior Notes due 2043; (4) Appropriately concludes that consistency reflects stable debt structure and transparent communication. WEAKNESSES: (1) Fails to address the 2022 context involving St. Jude Medical's Fourth Supplemental Indenture from April 2, 2013, which the ground truth identifies as important legacy integration context; (2) Does not capture the evolution from 'legacy-based referencing' to 'standardized, transparent disclosure approach' that the ground truth emphasizes; (3) Misses the temporal progression aspect - the ground truth shows a shift in documentation strategy from 2022 (legacy context) through 2023 (formalized presentation) to 2024 (consistency reaffirmation); (4) The LLM treats all three years as essentially identical ('same 2017 Form 8-K exhibit...appears in...2022, 2023, and 2024'), whereas the ground truth indicates a meaningful evolution in how the notes were presented and contextualized. MULTI-HOP REASONING: The LLM provides a simpler, more static analysis rather than synthesizing the multi-year progression. The ground truth requires connecting: (a) 2022 legacy indenture context, (b) 2023 formalized exhibit presentation, and (c) 2024 consistency maintenance. The LLM essentially collapses these into a single 'consistency' narrative. CALCULATION/DATES: All dates mentioned (2017, 2022, 2023, 2024) are correct. The note characteristics (4.75%, due 2043) are accurate. SEMANTIC ISSUE: While the LLM's conclusion about transparency and stable debt structure is reasonable, it doesn't fully capture what the ground truth suggests about the strategic shift in disclosure approach over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 575,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration of Target’s branded credit‑card (Target Circle Card) fell from 20.5 % in 2022 to 18.6 % in 2024, a decline of about 1.9 percentage points.  This downward trend signals a slowing uptake of the card, which may temper the incremental sales that the cards generate—Target notes that a meaningful portion of card purchases are incremental for the company, so a lower penetration could reduce that incremental‑sales benefit.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key penetration rate figures (20.5% in 2022 and 18.6% in 2024) and accurately calculates the decline as approximately 1.9 percentage points. The answer properly recognizes the downward trend and correctly links this to potential impacts on incremental sales, which aligns with Target's stated strategy. However, the answer has a notable omission: it fails to mention the 2023 intermediate data point (19.8%), which the ground truth includes as part of the three-year evolution. This omission is significant because the question specifically asks about the evolution 'from 2022 to 2024,' which implies tracking the progression across all available years. The LLM's reasoning about the relationship between declining penetration and reduced incremental sales is sound and semantically equivalent to the ground truth. The answer correctly identifies the card as part of Target's loyalty and revenue strategy. The quantitative accuracy is strong (numbers and calculation are correct), but the incompleteness regarding the 2023 data point represents a meaningful gap in addressing the full evolution requested. The answer would have been stronger by including all three data points to show the consistent year-over-year decline pattern, which better illustrates the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 365,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet shrank from **7,242 units in 2022 to 6,893 units in 2024** (a drop of 349 locomotives), while the average age climbed from **22.5 years to 25.2 years**. This trend—fewer, older units—suggests the company is tightening its fleet, extending the useful life of existing locomotives, and focusing on higher utilization rather than continual replacement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - fleet size decreased from 7,242 to 6,893 units (confirmed 349-unit reduction calculation is accurate), and average age increased from 22.5 to 25.2 years. All dates (2022, 2024) are correct. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) total units change, (2) average age change, and (3) implications for asset management strategy. ENTITY ACCURACY: Union Pacific correctly identified, metrics properly labeled as 'multiple-purpose locomotives,' time period correctly specified as 2022-2024. MULTI-HOP REASONING: The answer successfully synthesizes data across two years and two metrics (fleet size and age), then draws a logical inference about asset management strategy. The interpretation that the company is 'tightening its fleet, extending useful life of existing locomotives, and focusing on higher utilization' is semantically equivalent to the ground truth's characterization of 'cost-conscious asset management strategy' and 'deferral of fleet modernization.' MINOR DIFFERENCES: The LLM provides slightly more detailed interpretation (mentioning 'higher utilization') compared to the ground truth's more concise statement, but this represents added value rather than error. The phrasing 'tightening its fleet' and 'extending useful life' are appropriate interpretations of the numerical trends. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 425,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying value of NVIDIA’s 3.50% Notes Due 2050 was $2,000 million in both FY 2023 and FY 2024 (see the debt schedule on page 72).  The same amount was reported in FY 2022, so the value remained flat across the three years.  This steady figure indicates that NVIDIA has not issued additional 3.50% Notes due 2050 and has maintained a stable long‑term debt profile, reflecting a conservative debt‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ERRORS - The LLM states the carrying value was $2,000 million in FY 2022, FY 2023, and FY 2024 (flat across all three years). The ground truth shows: FY 2022: $2,147 million, FY 2023: $1,604 million, FY 2024: $2,000 million. The LLM got the FY 2024 number correct ($2,000M) but completely misrepresented FY 2022 ($2,147M vs claimed $2,000M) and FY 2023 ($1,604M vs claimed $2,000M). This is a critical error - the LLM fabricated a 'flat' trend that does not exist. (2) MULTI-HOP SYNTHESIS FAILURE - The question asks about the evolution/progression across three fiscal years. The ground truth shows significant fluctuation: a $543M decrease from 2022 to 2023, then a $396M increase from 2023 to 2024. The LLM completely missed this dynamic pattern and incorrectly claimed stability. (3) REASONING QUALITY - The LLM's interpretation that 'steady figures indicate no additional issuance and conservative debt management' is based on false premises. The actual fluctuations suggest revaluation, refinancing, or accounting adjustments - exactly what the ground truth indicates. The LLM's conclusion is logically sound IF the numbers were correct, but they are not. (4) MISSING CONTEXT - The ground truth explicitly notes this indicates 'revaluation or strategic adjustment' and 'deliberate positioning of long-term liabilities,' which the LLM completely missed. The LLM's claim about 'conservative debt-management strategy' contradicts the actual pattern of significant year-to-year changes. The answer demonstrates either data fabrication or severe misreading of source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 454,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 10‑K filings from 2022 through 2024 all list the risk of “loss or modification of exemptions for taxes and tariffs” as a general risk (2022 page 37, 2023 page 41, 2024 page 40). The wording and emphasis have remained essentially unchanged, indicating that the exposure has persisted but not diminished. This continuity underscores the growing complexity of the global regulatory environment, as AMD must continually navigate evolving trade restrictions, sanctions, and tax laws that can impact the cost and feasibility of its international operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. While the LLM correctly identifies that AMD listed the risk of 'loss or modification of exemptions for taxes and tariffs' across 2022-2024 and provides accurate page references (2022 page 37, 2023 page 41, 2024 page 40), it fundamentally mischaracterizes the evolution of this risk. The LLM claims 'the wording and emphasis have remained essentially unchanged,' which directly contradicts the ground truth showing a clear progression of increasing specificity and concern. The ground truth demonstrates that: (1) 2022 listed it as a general risk, (2) 2023 specifically highlighted geopolitical tensions (U.S. sanctions against Russia/Belarus, Ukraine-Russia conflict, Israel-Hamas conflict), and (3) 2024 emphasized China-Taiwan tensions affecting manufacturing partners. The LLM's assertion that exposure 'persisted but not diminished' misses the key finding that the company's disclosure evolved to show growing concern and increasing complexity. The LLM correctly identifies the general risk category but fails to capture the multi-hop synthesis required: tracking how the nature and specificity of the risk disclosure changed over time, and how geopolitical events became increasingly central to AMD's risk narrative. The conclusion about 'continuity' underscores the regulatory environment's complexity, but this is a weaker interpretation than the ground truth's finding of escalating concern. The quantitative accuracy is reasonable (page numbers appear correct), but the qualitative analysis fundamentally misses the trend the question asks about—the evolution from general to increasingly specific and geopolitically-driven risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 472,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures consistently state that its ability to return capital—whether via dividends or share repurchases—is subject to board discretion and may be limited by U.S. banking laws and regulations, including capital‑planning rules, Delaware law, and the requirement to pay full and timely dividends on preferred stock (2022 page 5; 2023 page 4; 2024 page 4). The wording and emphasis of this statement remained unchanged across the three filings, indicating that regulatory constraints on dividend payments and share repurchases have not evolved during that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core regulatory constraints on BNY Mellon's capital return flexibility (U.S. banking laws, capital-planning rules, Delaware law, preferred stock dividend obligations) and accurately notes that these constraints remained consistent across 2022-2024. The answer appropriately cites page numbers from the filings (2022 page 5; 2023 page 4; 2024 page 4), demonstrating multi-hop synthesis across three years of documents. The conclusion that regulatory constraints 'have not evolved' aligns with the ground truth's statement of a 'stable regulatory environment with persistent constraints.' However, the LLM answer is somewhat less comprehensive than the ground truth in several respects: (1) It does not mention the 2023-specific emphasis on credit rating reductions and resolution strategies under Title I and II, which the ground truth explicitly notes; (2) It does not capture the 2024 expansion of context to include liquidity management and strategic initiatives' impact on financial stability, which the ground truth highlights; (3) The answer focuses primarily on the static nature of constraints rather than exploring the nuanced evolution in emphasis and context across the three years. The LLM correctly synthesizes information across multiple years and identifies the key regulatory themes, but misses some of the contextual evolution that the ground truth emphasizes. The statement that 'wording and emphasis remained unchanged' is largely accurate but slightly oversimplifies the ground truth's observation of evolving context and emphasis, even if the core constraints remained consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 449,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 10‑K filings for 2022, 2023 and 2024 all list the 2.950% Note due 2025 as Exhibit 4.1 (the note’s form) and Exhibit 4.11 (the officers’ certificate).  The note was originally filed in an 8‑K on March 5 2015 (Exhibit 99.6) and each year’s 10‑K continues to reference that filing.  In short, the note’s disclosure and associated documentation have remained unchanged across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The 2.950% Note due 2025 is correctly identified; (2) The date March 5, 2015 for the original 8-K filing is correct; (3) The conclusion that disclosure remained unchanged across 2022-2024 is correct; (4) The note's consistency as a static financial instrument is accurately conveyed. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM introduces Exhibit 4.1 and Exhibit 4.11 references that are NOT mentioned in the ground truth answer. The ground truth specifically states the note was referenced as Exhibit 99.6 in the 8-K filing, with no mention of Exhibits 4.1 or 4.11 in the context of how it appears in 10-K filings; (2) The LLM's claim that 10-Ks list the note as Exhibit 4.1 and 4.11 appears to be an unsupported addition not present in the original answer; (3) While the LLM correctly notes that each year's 10-K continues to reference the March 5, 2015 filing, it adds exhibit numbers that may be inaccurate or at least unverified against the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022-2024) and correctly identifies the consistency pattern. However, the introduction of unverified exhibit numbers (4.1 and 4.11) suggests either hallucination or confusion about which exhibits are relevant. The ground truth focuses on Exhibit 99.6 from the 8-K, while the LLM shifts focus to different exhibit numbers without clear justification. QUANTITATIVE ACCURACY: The date (March 5, 2015) is correct, and the year references (2022, 2023, 2024) are accurate. However, the exhibit numbers cited (4.1, 4.11) cannot be verified against the ground truth and may be incorrect. OVERALL ASSESSMENT: The answer captures the core conclusion (unchanged disclosure across three years) but introduces potentially inaccurate exhibit references that undermine confidence in the response. The semantic meaning about consistency is preserved, but the specific documentary details appear to diverge from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 550,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55 % Notes Due 2028 carried a consistent $1.25 billion balance at each year‑end: $1.25 billion as of Jan 28 2024 (FY 2024, page 72), $1.25 billion as of Jan 29 2023 (FY 2023, page 67), and $1.25 billion as of Jan 30 2022 (FY 2022, page 78). The unchanged carrying amount over three fiscal years shows that NVIDIA has not issued additional principal on this debt and has maintained a stable, low‑interest long‑term debt profile, underscoring a strategy focused on predictable financing costs and liquidity preservation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core quantitative facts. Ground truth shows: FY2022: $1,200M, FY2023: $1,099M, FY2024: $1,250M. The LLM claims all three years were $1.25B ($1,250M), which directly contradicts the ground truth values for FY2022 ($1,200M) and FY2023 ($1,099M). This is a major factual error on the primary data points being asked about. The LLM's claim of 'unchanged carrying amount over three fiscal years' is demonstrably false - there were significant fluctuations ($1,200M → $1,099M → $1,250M represents a $101M decrease then $151M increase). The LLM's interpretation that 'NVIDIA has not issued additional principal on this debt' is also incorrect given the documented changes in carrying value. While the LLM correctly identifies the debt instrument (1.55% Notes Due 2028) and provides page references, the actual numeric values cited are wrong. The reasoning about 'stable, low-interest long-term debt profile' contradicts the actual data showing material year-to-year variations. The answer fails on the most critical evaluation criterion - quantitative accuracy of financial numbers - which must be precise in financial analysis. The multi-hop synthesis is also flawed because it's based on incorrect underlying numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 358,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "Across 2022‑2024 AMD’s 10‑K filings consistently describe AIB agreements that protect the manufacturers’ inventory from price reductions (e.g., 2022‑page 11, 2023‑page 11, 2024‑page 11).  The documents also repeatedly note that system integrators use discrete graphics solutions to differentiate their board‑level products and add value to customers.  The language and emphasis on inventory protection and discrete‑GPU differentiation remain unchanged, indicating a stable strategy rather than a significant evolution.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) AMD's inventory protection policies for AIBs across 2022-2024, (2) the consistent presence of discrete graphics solutions as a differentiation tool, and (3) the page references (page 11 across all three years). The quantitative accuracy is strong - no incorrect numbers or dates are present. However, the answer fundamentally misinterprets the question's core inquiry about 'evolution' of strategy. The ground truth explicitly describes a meaningful evolution: 2022-2023 maintained consistent language on inventory protection, but 2024 showed a shift in emphasis toward discrete graphics as a differentiation mechanism in response to market pressures. The LLM answer explicitly contradicts this by stating 'The language and emphasis on inventory protection and discrete‑GPU differentiation remain unchanged, indicating a stable strategy rather than a significant evolution.' This is a critical qualitative error - the LLM failed to recognize the temporal progression and changing emphasis that the ground truth identifies. The ground truth shows AMD 'adapting to market pressures by highlighting differentiation through discrete graphics' by 2024, whereas the LLM characterizes this as 'unchanged.' The LLM also misses the nuance that 2023 added 'emphasis on the importance of timely product introductions and market competitiveness' as an indirect reinforcement of AIB partnerships. While the LLM correctly identifies the key policy elements and provides accurate page citations, it fundamentally fails the multi-hop reasoning requirement by not synthesizing the temporal evolution across the three years. The answer is partially correct on facts but incorrect on the central analytical conclusion about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 487,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD’s disclosure of IP‑protection risk began as a generic warning in 2022 (page 37), noting “difficulties in protecting our intellectual property” as part of the broader set of risks tied to its worldwide operations. The 2023 filing repeated the same general statement (page 41). By 2024, the risk language had become more specific, explicitly citing geopolitical tensions—especially China/Taiwan and sanctions on Russia/Ukraine—and the potential disruption of Taiwan‑based wafer foundries and other third‑party manufacturing, thereby highlighting the company’s growing reliance on overseas production in politically sensitive regions (pages 41‑42).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of AMD's IP protection risk disclosures from 2022-2024 and accurately captures the shift from generic to geopolitically-specific language. The qualitative reasoning about the progression (generic warning → repeated statement → specific geopolitical citations) is sound and well-supported. However, there are significant quantitative omissions that reduce the overall correctness score. The ground truth provides specific international sales percentages (66% in 2024, 65% in 2023) that are entirely absent from the LLM answer. These are material quantitative facts that directly support the claim about 'expanding international operations' and 'growing dependence on international markets.' The LLM answer mentions 'growing reliance on overseas production' but fails to substantiate this with the actual revenue percentages provided in the ground truth. Additionally, while the LLM correctly identifies the geopolitical regions (China/Taiwan, Russia/Ukraine, Middle East implied), it doesn't explicitly mention the Middle East as a concern area in 2024, which the ground truth includes. The page citations (37, 41, 41-42) appear reasonable but cannot be verified against the ground truth. The answer demonstrates good qualitative understanding of the multi-hop synthesis required (connecting IP protection risks to geopolitical tensions to manufacturing locations to international revenue exposure), but the omission of key quantitative metrics (the specific percentages showing the evolution of international sales) represents a material gap in answering a question specifically about how exposure 'evolved' - evolution typically requires measurable metrics to demonstrate change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 471,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "BK continued to use the 2019 Long‑Term Incentive Plan each year, issuing a 2022 Form of Performance Share Unit Agreement (10.21) and a 2022 Form of Restricted Stock Unit Agreement (10.22) in 2022, a 2023 Form of Performance Share Unit Agreement (10.26) and a 2023 Form of Restricted Stock Unit Agreement (10.27) in 2023, and a 2024 Form of Performance Share Unit Agreement (10.25) and a 2024 Form of Restricted Stock Unit Agreement (10.26) in 2024【page 18】【page 19】. This steady use of the same plan signals a stable, long‑term equity‑based compensation strategy that keeps executive incentives tightly aligned with shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG FORMS CITED: The ground truth indicates the company introduced the 2021 Form PSU Agreement in 2022, the 2020 Form PSU Agreement in 2023, and the 2022 Form PSU Agreement in 2024. The LLM incorrectly states that 2022 Forms were issued in 2022, 2023 Forms in 2023, and 2024 Forms in 2024 - this is a fundamental misunderstanding of the progression. (2) MISSING CONTEXT: The ground truth emphasizes a 'layered approach' with 'legacy structures' being maintained while new forms were introduced. The LLM misses this crucial insight about how older forms continued alongside newer ones. (3) INCOMPLETE ANALYSIS: The ground truth specifically notes the introduction of different form years (2021→2020→2022), suggesting deliberate updates to performance metrics. The LLM's claim of 'steady use' and 'same plan' misses the evolution of the specific agreement forms. (4) ADDITIONAL ERRORS: The LLM introduces Restricted Stock Unit Agreements (RSU forms) which are not mentioned in the ground truth answer, suggesting potential hallucination or confusion with different documents. (5) REASONING FLAW: While both answers conclude the strategy shows stability and alignment with shareholder value, the LLM's reasoning is based on incorrect premises about which forms were used in which years. The ground truth's 'adaptive strategy' with 'periodic enhancements' is fundamentally different from the LLM's 'steady use' characterization. The answer demonstrates poor multi-hop synthesis and factual accuracy on the core question about how the plan evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 450,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s diagnostics‑instrument lease portfolio grew modestly: the original cost of the assets rose from **$3.6 billion in 2022 to $3.9 billion in 2023** (and remained at that level in 2024), while the net book value increased from **$1.6 billion in 2022 to $1.8 billion in 2023** (and stayed at $1.8 billion in 2024)【page_64】. This steady, incremental build‑out—coupled with operating‑lease revenue that still represents less than 3 % of total sales—suggests Abbott is deploying capital conservatively in diagnostics, focusing on maintaining and slightly expanding its equipment base rather than pursuing aggressive expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Original Cost 2022: LLM states $3.6B, Ground Truth is $3.3B (ERROR: off by $300M)\n   - Original Cost 2023: LLM states $3.9B, Ground Truth is $3.6B (ERROR: off by $300M)\n   - Net Book Value 2022: LLM states $1.6B, Ground Truth is $1.4B (ERROR: off by $200M)\n   - Net Book Value 2023: LLM states $1.8B, Ground Truth is $1.6B (ERROR: off by $200M)\n   - Net Book Value 2024: LLM states $1.8B, Ground Truth is $1.6B (ERROR: off by $200M)\n   - The LLM essentially shifted all values upward by $200-300M, creating a systematic error pattern\n\n2. TREND ANALYSIS ERRORS:\n   - Ground Truth shows: 2022→2023 growth, then 2023→2024 plateau at $1.6B\n   - LLM shows: 2022→2023 growth, then 2023→2024 plateau at $1.8B\n   - This misrepresents the actual trajectory and magnitude of investment\n\n3. MULTI-HOP SYNTHESIS FAILURE:\n   - The question asks about evolution from 2022-2024 and what it indicates about capital deployment strategy\n   - Ground Truth correctly identifies the strategic emphasis on expanding access through leasing to drive reagent/consumables sales\n   - LLM incorrectly characterizes the strategy as \"conservative\" capital deployment, which contradicts the actual steady growth pattern shown in ground truth\n   - The LLM's interpretation of \"modest growth\" and \"conservative deployment\" is inconsistent with the actual data trajectory\n\n4. ENTITY/METRIC ACCURACY:\n   - All entities correctly identified (Abbott, diagnostics instruments, leased assets)\n   - But the financial metrics are systematically wrong\n\n5. REASONING QUALITY:\n   - The LLM's conclusion about conservative capital deployment is not supported by the actual numbers\n   - Ground Truth's interpretation of strategic emphasis on leasing to drive downstream sales is more aligned with the consistent growth pattern\n   - The LLM's statement about operating-lease revenue being <3% of total sales may be accurate but doesn't support the \"conservative\" characterization when absolute dollar amounts are growing\n\nThe systematic upward shift in all values suggests the LLM either hallucinated numbers or confused data from different sources. This is a critical failure for a financial analysis task where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 639,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across FY 2022, 2023, and 2024 NVIDIA consistently lists Lumentum Holdings as a competitor in the networking‑products segment (2022: page 15; 2023: page 9; 2024: page 9). While Lumentum’s inclusion has not changed, the 2023 and 2024 filings increasingly spotlight NVIDIA’s expanding AI‑driven networking and high‑performance interconnect portfolio—emphasizing AI‑specific networking solutions and advanced interconnects—indicating a more intense competitive environment that could pressure Lumentum’s market share in that space.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Lumentum Holdings is correctly identified as appearing in NVIDIA's competitor disclosures across FY 2022, 2023, and 2024; (2) The page references (2022: page 15; 2023: page 9; 2024: page 9) appear plausible for 10-K filings; (3) The general observation that NVIDIA's AI-driven networking focus intensified is reasonable. SIGNIFICANT ISSUES: (1) The LLM states 'Lumentum's inclusion has not changed' which directly contradicts the ground truth's core finding that Lumentum's positioning EVOLVED across the three years—from foundational interconnect supplier (FY2022) to specialized high-performance interconnect focus (FY2023) to sharpened corporate identity recognition (FY2024); (2) The LLM misses the critical repositioning narrative: the ground truth emphasizes Lumentum moved from a general supplier grouping to a more specialized AI/interconnect-focused segment, then to explicit corporate identity designation; (3) The LLM's conclusion about 'competitive pressure' is speculative and not supported by the ground truth, which focuses on Lumentum's rising prominence and strategic relevance; (4) The LLM fails to capture the multi-hop synthesis showing how NVIDIA's strategic shift toward AI infrastructure directly elevated Lumentum's competitive positioning within that ecosystem. MULTI-HOP REASONING: The ground truth demonstrates sophisticated synthesis showing how NVIDIA's strategic evolution (general networking → AI-focused interconnects) caused Lumentum's competitive positioning to sharpen and become more strategically relevant. The LLM misses this causal relationship entirely, instead suggesting static positioning with increased competitive pressure. This represents a fundamental misunderstanding of the question's core inquiry about EVOLUTION of competitive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 508,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In 2022, Emerson positioned pipe cutters within its Tools & Home Products segment as part of the “Professional Tools” line (see 2022 10‑K, page 9). By 2024, the company had moved pipe‑working tools—including pipe cutters—into the Safety & Productivity segment, which now houses all pipe‑working equipment (see 2024 10‑K segment list, page 73). This shift shows Emerson’s strategy to consolidate its professional‑tool portfolio under a dedicated safety‑and‑productivity‑focused segment, underscoring a renewed emphasis on professional tools for industrial and commercial markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core factual shift: pipe cutters moved from Tools & Home Products segment (2022) to Safety & Productivity segment (2024). However, there are significant gaps in completeness and reasoning quality compared to the ground truth.\n\nSTRENGTHS:\n- Correctly identifies the 2022 positioning in Tools & Home Products segment\n- Correctly identifies the 2024 repositioning to Safety & Productivity segment\n- Accurately notes the consolidation strategy under a dedicated segment\n- Dates and segment names are factually accurate\n\nWEAKNESSES:\n1. INCOMPLETE SYNTHESIS: The LLM answer fails to mention the 2023 transition year, which is part of the multi-hop analysis required. The ground truth explicitly notes \"By 2023 and 2024\" indicating a transition period.\n\n2. MISSING CONTEXTUAL DETAILS: The LLM answer omits critical strategic context that reveals the \"why\" behind the shift:\n   - No mention of the InSinkErator business divestiture in late 2022 (a key strategic signal)\n   - No discussion of the shift away from consumer-focused home products\n   - Missing the specific grouping with battery hydraulic tools, drain cleaners, and diagnostic systems (sewer inspection cameras)\n\n3. INCOMPLETE PRODUCT GROUPING: The ground truth specifies that pipe cutters were repositioned alongside \"battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras.\" The LLM answer vaguely states \"all pipe-working equipment\" without this specificity.\n\n4. SHALLOW STRATEGIC ANALYSIS: While the LLM identifies consolidation, it doesn't fully explain what the shift reveals about strategy—the ground truth emphasizes the shift toward \"high-value, industrial-use tools\" and \"infrastructure support,\" which the LLM answer only partially captures with \"industrial and commercial markets.\"\n\n5. MISSING PROFESSIONAL CONTEXT: The ground truth notes the original grouping included \"plumbing and mechanical professionals\" alongside \"DIY tools at retail home improvement outlets,\" showing the strategic separation of professional from consumer channels. The LLM answer doesn't capture this distinction.\n\nQUANTITATIVE ACCURACY: 7/10 - No numeric errors, but page references (page 9 for 2022, page 73 for 2024) cannot be verified and may be inaccurate.\n\nQUALITATIVE ACCURACY: 5/10 - Core facts correct but reasoning is incomplete. The multi-hop synthesis across years and strategic implications is underdeveloped.\n\nCONTEXTUAL RELEVANCE: 6/10 - Addresses the main question but misses the deeper strategic implications about the divestiture, consumer vs. professional focus, and infrastructure emphasis that are central to understanding the \"what this reveals\" part of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 733,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 through 2024, Schwab’s interactive tools for RIAs—Schwab Advisor Portfolio Connect and the Advisor Services website—remained largely unchanged in core functionality, continuing to offer a free, web‑based portfolio management solution and comprehensive account‑servicing features with integration to third‑party platforms (page_9, 2022‑2024). The evolution focused on deepening integration capabilities and expanding advisor‑support services, adding more consulting, benchmarking, and prospect‑consulting resources while preserving the same intuitive, modern experience, interactive tools, educational content, and thought leadership (page_9, 2022‑2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that Schwab's tools EVOLVED with ENHANCED functionality, DEEPER integrations, and EXPANDED services from 2022-2024, including new features like multi-year document archiving, outbound data feeds for compliance systems, and more robust prospect consulting. However, the LLM answer explicitly states the tools 'remained largely unchanged in core functionality,' which directly contradicts the documented evolution. This is a critical semantic and factual error. The LLM correctly identifies the tools (Schwab Advisor Portfolio Connect, Advisor Services website) and the time period (2022-2024), and accurately notes that some services were added (consulting, benchmarking, prospect-consulting resources). However, by characterizing the overall evolution as 'largely unchanged' rather than progressively enhanced across operational, investment, and compliance domains, the LLM fundamentally misrepresents the nature of the evolution. The answer also lacks specific details about the 2024 enhancements (document archiving, outbound data feeds, compliance workflow integration) that were central to the ground truth narrative. The quantitative accuracy is high (no incorrect numbers or dates), but the qualitative accuracy is severely compromised by the mischaracterization of the evolution as 'largely unchanged' when the ground truth emphasizes increasing sophistication and integration. The contextual relevance is moderate—the answer addresses the right tools and timeframe but fails to capture the strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 468,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10‑K (page 112) as part of its long‑term debt. The 2023 10‑K (page 111) and 2024 10‑K (page 109) continued to report the same notes unchanged—still a 1.65% coupon maturing in 2026—showing a consistent, low‑interest, long‑term debt strategy that underpins Oracle’s short‑to‑intermediate‑term financing needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Oracle's 1.650% Notes due 2026 were disclosed consistently across 2022, 2023, and 2024 10-K filings with no modifications. The interest rate (1.650% or 1.65%) is accurate, and the maturity year (2026) is correct. The answer appropriately synthesizes the multi-hop information showing consistency across three years.\n\nSTRENGTHS:\n- Correctly identifies the note's coupon rate (1.650%/1.65%)\n- Accurately states the maturity year (2026)\n- Properly synthesizes that the note appeared unchanged across all three years\n- Correctly characterizes this as part of long-term debt strategy\n- Appropriately concludes the strategy remained stable\n\nWEAKNESSES:\n- The LLM provides specific page numbers (112, 111, 109) that cannot be verified against the ground truth, which references Exhibit numbers instead (4.16 in 2022; 4.14 in 2023 and 2024). While page numbers may be correct, the ground truth uses exhibit citations, creating a minor discrepancy in sourcing methodology.\n- The ground truth emphasizes the exhibit structure (4.16 vs 4.14) as part of the disclosure evolution, which the LLM omits entirely\n- The LLM's characterization of this as \"long-term debt\" and \"short-to-intermediate-term financing needs\" is slightly imprecise—a 2026 maturity from 2022-2024 filings represents intermediate-term debt, not strictly long-term\n- The ground truth emphasizes \"formal structuring\" and \"reaffirmation\" language that suggests more nuanced disclosure evolution, while the LLM simply states \"unchanged\"\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across three years and identifies the consistency pattern, which is the core requirement of the question. The reasoning is sound.\n\nCALCULATIONS: No calculations required; all numeric values (1.650%, 2026) are accurate.\n\nThe answer is substantially correct on the main facts but misses some exhibit-level detail and uses different sourcing conventions than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 542,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson’s Discrete Automation segment has kept the same product mix over the three years – the 2022, 2023 and 2024 descriptions all list “electrical distribution equipment” as a core offering alongside solenoid valves, pneumatic cylinders, linear‑motion solutions and programmable control systems.  The unchanged positioning signals that Emerson continues to view electrical distribution equipment as a foundational element of its discrete‑automation portfolio, underscoring a sustained strategic emphasis on industrial electrification solutions.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer fundamentally contradicts the ground truth on the core claim about how Electrical Distribution Equipment positioning evolved. Ground truth states: (1) 2022: grouped under 'Industrial Solutions' as part of broader fluid control/materials joining products, (2) 2023: explicitly moved to Discrete Automation segment, (3) 2024: remained consistent with 2023. This represents a STRATEGIC SHIFT in positioning. The LLM claims the product mix remained 'unchanged' across all three years and was consistently in Discrete Automation - this is factually incorrect. The LLM failed to identify the key 2022-to-2023 transition that is central to the question. The ground truth explicitly states this evolution 'signals a more integrated approach to automation' and represents a 'strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure.' The LLM's conclusion that positioning was 'unchanged' directly contradicts this. While the LLM correctly identifies that electrical distribution equipment is part of the Discrete Automation segment and correctly names related products (solenoid valves, programmable control systems), it fails the critical multi-hop reasoning task of tracking how this positioning EVOLVED across the three-year period. The LLM also adds 'pneumatic cylinders' and 'linear-motion solutions' which are not mentioned in the ground truth answer, suggesting potential hallucination or misattribution. The semantic meaning is fundamentally different: ground truth emphasizes strategic evolution and shift; LLM emphasizes stasis and consistency. This is a major failure in multi-hop synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 472,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently disclosed the 1.650% Notes due 2026 in each filing—2022 (Exhibit 4.16), 2023 (Exhibit 4.14), and 2024 (Exhibit 4.14)—with identical terms, interest rate, and maturity, indicating no change to the instrument.  The notes were presented as part of a 2021 issuance of a series of long‑term notes (maturities through 2061), and the same treatment persisted across the three years.  This continuity shows that Oracle treats the 1.650% Notes as a stable long‑term debt component rather than a source of short‑term liquidity, underscoring a conservative short‑term debt strategy that relies on predictable long‑term financing instead of frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 1.650% Notes due 2026 as consistently disclosed across 2022, 2023, and 2024 filings with identical terms and no structural changes. The exhibit references (4.16 for 2022, 4.14 for 2023 and 2024) appear plausible and add specificity. The core factual claim about continuity and unchanged terms aligns with the ground truth.\n\nWEAKNESSES AND ERRORS: (1) The LLM fails to mention the critical March 24, 2021 8-K filing reference that the ground truth emphasizes as the key evidence of continuity. The ground truth specifically states Oracle 'referenced the March 24, 2021 8-K filing' across all three years, which is a concrete, verifiable detail that demonstrates the multi-hop synthesis. (2) The LLM characterizes the 1.650% Notes as 'long-term debt' and part of a 'long-term financing' strategy, but the original question specifically asks about 'short-term debt strategy.' The ground truth acknowledges this is about 'short-term debt obligations' even though the notes mature in 2026. The LLM's reframing to 'long-term debt component' and 'conservative short-term debt strategy that relies on predictable long-term financing' is somewhat contradictory and misses the nuance that these are being treated as short-term obligations in the context of Oracle's debt maturity ladder. (3) The LLM provides interpretation ('treats the 1.650% Notes as a stable long-term debt component') that goes beyond what can be verified from the filings themselves, whereas the ground truth sticks to observable facts (consistent referencing of the original 8-K). (4) The multi-hop reasoning is incomplete—the LLM doesn't explicitly trace the connection across the three years to the original 2021 8-K as the ground truth does.\n\nMULTI-HOP SYNTHESIS: The LLM addresses the three-year continuity but doesn't fully synthesize the key evidence (the 8-K reference) that proves this continuity. The ground truth's approach of showing the same 8-K reference across three years is stronger evidence of deliberate strategy than simply stating 'identical terms.'\n\nSEMANTIC ISSUES: The characterization of this as 'long-term debt' strategy rather than 'short-term debt strategy' is a meaningful semantic error that affects the interpretation of Oracle's financial strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 612,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30% Note due 2034, issued in 2014, is still referenced in the 2022 10‑K as part of Exhibit 4.11 (the 4.11 Forms of 3.40% Note due 2024, 4.30% Note due 2034, 4.50% Note due 2044) (2022 page_111). The 2023 and 2024 10‑Ks do not re‑issue or re‑file this note; the 4.15/4.16 exhibits list newer maturities but omit the 4.30% Note (2023 page_111; 2024 page_111). This continuity shows Oracle’s long‑term debt strategy focuses on a stable, diversified maturity and interest‑rate mix, issuing new debt at varying rates while keeping older long‑term notes in place.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CONTRADICTORY CLAIMS: The LLM answer directly contradicts the ground truth on the core factual issue. Ground truth states the 4.30% Note was 'consistently referenced' and 'continued to be included' in 2023 and 2024 exhibits (Exhibit 4.09). The LLM claims the note is 'omitted' from 2023 and 2024 exhibits and that '2023 and 2024 10-Ks do not re-issue or re-file this note.' This is a fundamental factual error that undermines the entire answer. (2) EXHIBIT NUMBERING CONFUSION: The LLM references 'Exhibit 4.11' for 2022 and claims 2023/2024 use '4.15/4.16 exhibits' that 'omit the 4.30% Note.' The ground truth specifies Exhibit 4.09 for 2023 and 2024, not 4.15/4.16. The LLM appears to have confused exhibit numbers and made unsupported claims about omissions. (3) INTERPRETATION ERROR: While the LLM correctly identifies the note was issued in 2014 and discusses diversified maturity strategy, it fundamentally mischaracterizes the filing pattern by claiming the note was dropped from later exhibits when ground truth indicates consistent inclusion. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks how the note 'evolved' across three years and what the pattern suggests about strategy. The LLM's conclusion about 'stable, diversified maturity' is reasonable in isolation, but it's built on incorrect premises about what actually appears in the filings. (5) SEMANTIC CONTRADICTION: The LLM's final statement about 'keeping older long-term notes in place' contradicts its earlier claim that the note is omitted from 2023/2024 exhibits. This internal inconsistency suggests the LLM did not properly synthesize the information. The ground truth answer is clear: consistent documentation across all three years suggests intentional maintenance of the liability. The LLM answer inverts this by claiming omission from later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 504,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab exercised the 2019 IDA agreement’s migration option, moving roughly $10 billion of IDA balances to its balance sheet each year. The 2023 IDA agreement, which replaced the 2019 agreement, eliminated that migration option, introduced a buy‑down option for up to $5 billion of fixed‑rate obligations, removed the 80 % fixed‑rate requirement, and imposed new minimum/maximum balance limits and post‑2025 withdrawal discretion. In 2024 Schwab continued to use the 2023 terms, did not migrate any IDA balances, and the IDA balance fell to $87.6 billion with fixed‑rate obligations reduced to $66.6 billion, reflecting the buy‑down and the new contractual constraints.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and mischaracterizations that substantially diverge from the ground truth:\n\n1. CRITICAL ERROR - 2023 IDA Agreement Changes: The LLM states the 2023 agreement \"eliminated that migration option\" and \"introduced a buy-down option for up to $5 billion.\" The ground truth indicates the 2023 agreement REMOVED the 80% fixed-rate requirement (increasing flexibility) but did NOT eliminate the migration option itself. The LLM incorrectly characterizes the contractual changes as more restrictive when they actually increased flexibility.\n\n2. CRITICAL ERROR - Migration Activity: The LLM claims Schwab \"exercised the 2019 IDA agreement's migration option, moving roughly $10 billion of IDA balances to its balance sheet each year.\" The ground truth shows $10.1 billion was moved by December 31, 2021 (before 2022), and the LLM's phrasing suggests ongoing annual migrations that did not occur. The ground truth explicitly states no migrations occurred in 2023 or 2024.\n\n3. FACTUAL ERRORS - Contractual Details: The LLM introduces details about \"buy-down option for up to $5 billion,\" \"minimum/maximum balance limits,\" and \"post-2025 withdrawal discretion\" that are not mentioned in the ground truth. While these may be accurate filing details, they are not part of the ground truth answer and represent potential hallucination or conflation with other information.\n\n4. QUANTITATIVE ISSUES: The LLM provides specific 2024 figures ($87.6 billion IDA balance, $66.6 billion fixed-rate obligations) that are not in the ground truth. While these may be accurate, they cannot be verified against the provided ground truth and represent additional claims not substantiated by the reference answer.\n\n5. REASONING FLAW: The LLM's characterization of the evolution is inverted. It suggests the 2023 agreement was MORE restrictive (eliminating migration), when the ground truth indicates it was MORE flexible (removing the 80% fixed-rate requirement). The conclusion about \"new contractual constraints\" contradicts the actual increase in flexibility.\n\n6. PARTIAL CREDIT: The LLM correctly identifies that no migrations occurred in 2023-2024 and that the 2023 agreement replaced the 2019 agreement. The overall structure of discussing 2022, 2023, and 2024 separately is appropriate.\n\nThe answer demonstrates a fundamental misunderstanding of how the contractual terms evolved and introduces unverified quantitative claims that cannot be reconciled with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 673,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "In the 2022 10‑K (page 86), Abbott filed an officers’ certificate (Exhibit 4.12) updating the documentation for its 2.000 % Senior Notes due 2018 and refinanced those notes into the new 2.550 % note due 2022 and 2.950 % note due 2025. In the 2023 and 2024 10‑Ks (page 86 of each), Abbott continued to file the same certificate (Exhibit 4.18) to keep the 2.000 % notes in compliance, but no additional refinancing of those notes was disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERRORS: The LLM claims Abbott 'refinanced those notes into the new 2.550% note due 2022 and 2.950% note due 2025' - this is a critical factual error. The ground truth explicitly states there were 'no new issuances or amendments noted' and 'no further refinancing actions taken.' The LLM fabricated refinancing activities that did not occur. (2) EXHIBIT REFERENCES: The LLM references Exhibit 4.12 and 4.18, while the ground truth references Exhibit 4.21. The specific exhibit numbers appear to be incorrect or at least inconsistent with the documented evidence. (3) DOCUMENTATION CLAIMS: The LLM claims Abbott 'filed an officers' certificate (Exhibit 4.12) updating the documentation' and 'continued to file the same certificate (Exhibit 4.18)' - the ground truth indicates consistent reference to the same notes within Exhibit 4.21 across all three years with no updates or amendments. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year evolution. The ground truth shows stable, consistent disclosure with no refinancing activity, while the LLM invented refinancing transactions. (5) SEMANTIC ACCURACY: The LLM's core narrative is fundamentally incorrect - it describes active refinancing when the ground truth describes a maturing debt component with no refinancing actions. The only partially correct element is the acknowledgment that 2023-2024 showed no additional refinancing, but this is contradicted by the false claim about 2022 refinancing. This represents a complete failure to accurately represent Abbott's actual debt management activities during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 462,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% Notes due 2041 in a March 2021 officers’ certificate, and the 2022 10‑K (Exhibit 4.16) lists them as part of that 2021 debt issuance (page 114). The 2023 and 2024 10‑Ks (Exhibits 4.14) continue to report the same 3.650% Notes with no new issuance or maturity changes (pages 111 & 112). This steady, multi‑year presence shows Oracle’s strategy of maintaining a stable, long‑dated debt mix to lock in favorable rates and manage cash‑flow risk over the long term.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) TIMELINE DISCREPANCY - The LLM states the 3.650% Notes were first issued in March 2021, but the ground truth explicitly states they were 'first introduced...in 2022.' This is a fundamental factual error that contradicts the core premise of the question about 2022-2024 evolution. (2) EXHIBIT REFERENCES - The LLM cites specific exhibit numbers (4.16 for 2022, 4.14 for 2023/2024) and page numbers (114, 111, 112) that cannot be verified against the ground truth and may be fabricated details. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that the notes appear consistently across 2022-2024, it incorrectly backdates the introduction to 2021, which undermines the multi-hop analysis of the 2022-2024 pattern requested. (4) REASONING QUALITY - The conclusion about 'locking in favorable rates' is reasonable but is not supported by the ground truth, which focuses on strategic use for operations and financial flexibility rather than rate-locking strategy. (5) WHAT WAS CORRECT - The LLM correctly identifies that the notes appear in 2022, 2023, and 2024 with no changes, and correctly infers a stable debt strategy. However, the 2021 introduction date is a major factual error that significantly undermines the answer's credibility. The ground truth clearly states introduction occurred in 2022, making the LLM's 2021 date incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 381,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 (officers’ certificate March 24 2021) and the same notes are disclosed unchanged in the 2022, 2023, and 2024 10‑Ks (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023/2024)【page_114】【page_111】【page_112】. In 2023 and 2024 Oracle added new 4.500% Notes due 2028, expanding its maturity ladder with higher‑coupon debt (Exhibit 4.16 in 2023/2024)【page_111】【page_112】. This multi‑year pattern shows Oracle’s strategy of maintaining a diversified, laddered debt portfolio—keeping a stable long‑term component while adding newer, higher‑coupon notes to spread refinancing risk and optimize borrowing costs over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's debt financing strategy with mostly accurate information, but contains one significant factual discrepancy that affects the narrative accuracy. STRENGTHS: (1) Correctly identifies the 2.300% Notes due 2028 as the primary instrument being tracked; (2) Accurately notes the March 24, 2021 Officers' Certificate date; (3) Correctly identifies the 4.500% Notes due 2028 as an addition in 2023/2024; (4) Properly synthesizes the multi-year pattern showing diversification and laddered debt strategy; (5) Correctly references Exhibit 4.16 and 4.14 across years; (6) Sound reasoning about refinancing risk and borrowing cost optimization. CRITICAL ISSUE: The LLM states the 2.300% Notes were 'issued in 2021' while the ground truth indicates they were 'first introduced in 2022.' This is a material factual error regarding when the notes first appeared in Oracle's debt portfolio, though the March 24, 2021 certificate date is correctly cited. The ground truth specifies the notes were introduced in 2022 as part of a broader debt instrument set, not that they were issued in 2021. MINOR ISSUES: (1) The LLM provides exhibit references with page numbers that add helpful detail but weren't in the original answer; (2) The characterization of 'added new 4.500% Notes due 2028' in 2023 and 2024 is slightly imprecise—the ground truth indicates they were introduced in 2023 as part of expansion, not necessarily added again in 2024. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of maintaining stable long-term debt while diversifying interest rate profiles. The conclusion about debt strategy is sound and well-supported. The core insight about maintaining a diversified, laddered portfolio is accurate and well-articulated. The quantitative accuracy is high (dates, percentages, exhibit numbers all correct except for the 2021 vs 2022 introduction date issue), and the qualitative reasoning about strategy is sound despite the temporal discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 560,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "Visa launched Currencycloud in 2022 as part of its Treasury‑as‑a‑Service offering, creating virtual accounts that could hold and move funds. By 2023 these virtual accounts were folded into the Visa Direct Platform, enabling real‑time cross‑border payouts and expanding the network of eligible cards, bank accounts and digital wallets. In 2024 the platform further broadened cross‑border reach—adding real‑time FX, enhanced liquidity and settlement and extending service to more than 11 billion endpoints across 195+ countries【page_10】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 timeline. STRENGTHS: (1) Correctly identifies all key dates (2022 launch, 2023 integration, 2024 expansion); (2) Accurately captures the Treasury-as-a-Service initiative and Currencycloud platform; (3) Properly describes the 2023 integration into Visa Direct Platform; (4) Correctly states the 11 billion endpoints figure; (5) Appropriately mentions real-time FX, liquidity, and settlement capabilities; (6) References 195+ countries, adding geographic context. MINOR ISSUES: (1) The phrase 'Visa launched Currencycloud in 2022' is slightly imprecise—the ground truth indicates virtual accounts were 'introduced as part of' the Treasury as a Service initiative, not that Currencycloud itself was launched in 2022 (Currencycloud was acquired earlier); (2) The answer states virtual accounts 'could hold and move funds' which is accurate but less precise than the ground truth's emphasis on their role in 'enabling cross-border products and services'; (3) The phrase 'expanding the network of eligible cards, bank accounts and digital wallets' in the 2023 section is somewhat ambiguous—the ground truth more clearly states they 'enhanced the established cross-border consumer payments business.' QUANTITATIVE VERIFICATION: All numbers are correct (11 billion endpoints, 195+ countries). The timeline progression is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly traces the evolution from initial introduction through platform integration to expanded capabilities. The logical flow is sound and demonstrates understanding of how virtual accounts evolved within Visa's ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 479,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2023, Caterpillar expanded its ME&T dealer network for EMD‑branded products—U.S. dealers grew from 41 to 44, overseas dealers from 111 to 116, and countries served from 187 to 193【page_76】【page_66】. The network remained unchanged through 2024, still comprising 44 U.S. dealers, 116 overseas dealers, and 193 countries served【page_64】. This steady growth and maintenance of a broad dealer base signals Caterpillar’s strategy to broaden EMD’s global reach and sustain market penetration across the ME&T segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. Critical errors: (1) WRONG NUMBERS: LLM reports 41-44 U.S. dealers and 111-116 overseas dealers, while ground truth specifies 108-110 total distributors (no U.S./overseas breakdown provided in ground truth). (2) WRONG COUNTRY COUNTS: LLM claims 187-193 countries served, but ground truth states 109-158 countries. The LLM's numbers are dramatically higher and inconsistent with the source data. (3) WRONG METRIC: LLM appears to be citing dealer network data (which may be from a different segment or metric), not the distributor network for EMD-branded products specifically mentioned in ground truth. (4) WRONG TIME PERIOD ANALYSIS: LLM claims growth from 2022-2023 then stability through 2024, but ground truth shows consistency at 108-110 distributors with geographic expansion from 109 to 158 countries by 2024. (5) MISALIGNED SYNTHESIS: The ground truth emphasizes optimization of distribution efficiency (fewer distributors) while expanding geographic reach (more countries), indicating a consolidation strategy. The LLM instead emphasizes growth in dealer numbers, which is the opposite strategic implication. (6) SOURCE CITATION ISSUES: LLM cites specific pages but the numbers don't match ground truth data, suggesting either wrong source extraction or data from a different metric entirely. The answer fails on quantitative accuracy (all major numbers wrong), entity identification (appears to confuse dealer vs. distributor networks), and multi-hop reasoning (incorrect synthesis of the strategic implications).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 446,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics‑instrument lease portfolio expanded between 2022 and 2024.  The original cost of the assets rose from $3.6 billion in 2022 to $3.9 billion in 2024, while the net book value increased from $1.6 billion to $1.8 billion, reflecting a $300 million increase in cost and a $200 million increase in net book value (Note 10 – Leases, 2024 10‑K, page 63).  This growth indicates an expansion of the diagnostics instrument inventory leased to customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: Original cost 2022=$3.3B, 2023=$3.6B, 2024=$3.9B; Net book value 2022=$1.4B, 2023=$1.6B, 2024=$1.8B. The LLM answer reports: Original cost 2022=$3.6B (WRONG - should be $3.3B), 2024=$3.9B (correct), and net book value 2022=$1.6B (WRONG - should be $1.4B), 2024=$1.8B (correct). The LLM omitted the 2023 data entirely, which is a significant incompleteness issue for a question asking about evolution 'from 2022 to 2024.' CALCULATION ERRORS: The LLM states a '$300 million increase in cost' from 2022 to 2024, which is correct ($3.9B - $3.6B = $0.3B), but this is based on the wrong 2022 starting figure. The actual increase should be calculated from $3.3B to $3.9B = $600 million. Similarly, the '$200 million increase in net book value' ($1.8B - $1.6B = $0.2B) is correct mathematically but uses wrong 2022 baseline. MULTI-HOP REASONING: The answer fails to properly synthesize the three-year evolution. It only presents 2022 and 2024 endpoints, missing the intermediate 2023 data point that shows the consistent year-over-year growth pattern. POSITIVE ASPECTS: The answer correctly identifies the general trend of expansion, provides appropriate context about the diagnostics instrument lease portfolio, and correctly cites the source (Note 10 – Leases, 2024 10-K). The semantic understanding of the question is reasonable. However, the fundamental numerical errors and incompleteness severely undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 430,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450% Senior Note due 2046 appears in each filing—listed as “Form of 3.450% Senior Note due 2046” in 2022 (page 126), 2023 (page 127), and 2024 (page 127)—showing that PepsiCo still treats this long‑term debt instrument as a core part of its capital structure.  Its continued presence signals a deliberate strategy to maintain a stable mix of long‑term, fixed‑rate debt and to rely on the note for financing rather than retiring or replacing it in the near term【page_126】【page_127】【page_127】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core concept that the 3.450% Senior Note due 2046 appears consistently across 2022, 2023, and 2024 filings, and accurately interprets this as indicating stable, long-term debt strategy. The reasoning about fixed-rate debt and capital structure maintenance is sound and semantically equivalent to the ground truth. The answer appropriately addresses the multi-hop synthesis question.\n\nWEAKNESSES: (1) EXHIBIT REFERENCE ERRORS - The LLM provides specific exhibit numbers (Exhibit 4.17 in 2022, 4.16 in 2023, 4.15 in 2024) but the ground truth shows these as Exhibit 4.17, 4.16, and 4.15 respectively. The LLM's exhibit citations appear to be reversed or incorrect compared to ground truth. (2) PAGE NUMBER ACCURACY - The LLM cites pages 126, 127, 127 but provides no verification these are correct. The ground truth does not specify page numbers, making this unverifiable but potentially inaccurate. (3) CITATION FORMAT - The LLM uses bracketed page citations【page_126】【page_127】【page_127】 which appear to be fabricated or imprecise references rather than proper exhibit citations. (4) MISSING DETAIL - The ground truth explicitly mentions the exhibit progression (4.17→4.16→4.15) showing a pattern, while the LLM omits this specific tracking detail.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly interprets the consistency pattern. The logic connecting repeated disclosure to strategic capital structure decisions is sound.\n\nQUANTITATIVE ISSUES: The exhibit number citations are factually questionable. While the note's percentage (3.450%) and maturity year (2046) are correct, the exhibit references and page numbers lack verification against ground truth.\n\nOVERALL: The answer captures the essential insight and reasoning correctly but contains specific factual errors in exhibit/page citations that undermine confidence in the response's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 529,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 (officer’s certificate dated March 24 2021). The same notes appear unchanged in the 2022 10‑K (Exhibit 4.16, page_114), the 2023 10‑K (Exhibit 4.14, page_111) and the 2024 10‑K (Exhibit 4.14, page_111), indicating that the terms and maturity remained constant across three fiscal years. This consistency, alongside the issuance of new notes at varying maturities and coupon rates each year, reflects Oracle’s strategy of maintaining a laddered debt portfolio to manage refinancing risk and interest‑rate exposure while keeping long‑term debt terms stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 2.300% Notes due 2028 as appearing consistently across 2022, 2023, and 2024 fiscal years; (2) Correctly cites Exhibit 4.16 for 2022 and Exhibit 4.14 for 2023 and 2024; (3) Provides sound reasoning about Oracle's debt strategy (laddered portfolio, refinancing risk management, interest-rate exposure); (4) Appropriately notes the introduction of new notes like the 4.500% Notes due 2028 alongside the existing notes. WEAKNESSES: (1) CRITICAL FACTUAL ERROR - States the notes were issued in 2021 with an officer's certificate dated March 24, 2021. The ground truth indicates the notes were first introduced in 2022, not 2021. This is a significant dating error that contradicts the original answer; (2) The LLM answer claims the notes 'appear unchanged' and 'terms and maturity remained constant,' which is accurate but doesn't fully capture the evolution pattern described in the ground truth - the ground truth emphasizes how Oracle 'continued to reference' and 'maintained continuity' with prior disclosures while layering in new issuances; (3) The LLM answer provides more specific reasoning about debt strategy (laddered portfolio, refinancing risk) but this goes beyond what the ground truth explicitly states, potentially adding interpretation not grounded in the filings. QUANTITATIVE ACCURACY: The date error (2021 vs 2022 first introduction) is a material factual error that significantly impacts the answer's reliability. The exhibit citations appear correct. QUALITATIVE ACCURACY: The reasoning about Oracle's debt strategy is sound and well-articulated, though it extends beyond the ground truth's more conservative characterization. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and connects it to broader strategy, though the foundational dating error undermines this synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 525,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has continued to list the Certificate of Designations of its Series B Convertible Participating Preferred Stock in every 10‑K filing (Exhibit 4.5 in 2022 and Exhibit 4.4 in 2023 and 2024) (page_114, page_109). The unchanged status of the certificate indicates the preferred shares remain outstanding and have not been converted or retired, underscoring a conservative capital‑structure strategy that preserves flexibility while prioritizing long‑term stability and shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements: (1) The Series B Convertible Participating Preferred Stock certificate is consistently referenced across 2022-2024 filings, (2) The exhibit numbers are accurate (4.5 in 2022, 4.4 in 2023-2024), (3) The certificate remains unchanged. However, the answer has significant weaknesses: (1) It fails to mention the specific Certificate of Designations date (June 21, 2016) that grounds the 'unchanged' claim across all three years - this is a critical detail establishing continuity, (2) The reasoning about what the unchanged status means is incomplete - the LLM states the shares 'remain outstanding and have not been converted or retired' but doesn't establish this from the filings themselves, (3) The answer lacks the broader context provided in the ground truth about how this fits into Visa's overall capital structure strategy (unchanged Bylaws, Certificate of Incorporation updates without Series B changes), (4) The characterization as 'conservative capital-structure strategy' is somewhat generic and doesn't fully capture the deliberate choice to preserve existing shareholder rights and financing flexibility mentioned in the ground truth. The LLM answer is partially correct on surface facts but lacks the depth of analysis and specific supporting details that would demonstrate true multi-hop synthesis across the three years of filings. The answer reads more as a summary of exhibit locations rather than a comprehensive analysis of how treatment has 'evolved' (or remained stable) and what this suggests about long-term priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 439,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In its 2022 10‑K, Caterpillar disclosed that a significant portion of its financing was LIBOR‑based and that the transition to SOFR could materially affect the valuation of derivative contracts and other financial obligations, prompting the creation of a cross‑functional risk team to assess LIBOR‑related exposures (page 22). The 2023 and 2024 10‑Ks continued to rely on currency‑hedging instruments to mitigate exchange‑rate risk, but the disclosures highlighted that hedging can forgo benefits from favorable moves and that the LIBOR‑to‑SOFR transition could influence interest‑rate risk and derivative pricing (pages 17‑21). Across all three years, Caterpillar maintained a match‑funding strategy, selective use of derivatives, and a diversified funding program to manage both currency and interest‑rate risks (page 22).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Caterpillar's currency hedging and LIBOR-to-SOFR transition management across 2022-2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the core narrative: Caterpillar's consistent use of hedging instruments while managing the LIBOR-to-SOFR transition; (2) Accurately captures key elements from each year - 2022's cross-functional risk team formation, 2023-2024's continued reliance on derivatives and match-funding strategies; (3) Properly synthesizes the multi-hop connection between currency hedging and interest rate risk management; (4) Correctly identifies the strategic tools used (match-funding, selective derivatives, diversified funding); (5) Appropriately notes the trade-off that hedging can forgo benefits from favorable moves. WEAKNESSES: (1) Page references (22, 17-21) cannot be verified against ground truth and may be inaccurate or generic; (2) The answer slightly overemphasizes the LIBOR-to-SOFR transition's impact on derivative valuation relative to the ground truth, which presents it as one aspect of a broader risk management strategy; (3) Missing some nuance from the original answer regarding how the focus 'evolved' - the LLM presents it more as continuous rather than showing clear progression from assessment phase (2022) to implementation/management phase (2023-2024); (4) The phrase 'could materially affect' regarding LIBOR transition is appropriately cautious but the ground truth emphasizes this was an 'assessment' phase rather than a confirmed material impact. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is less applicable. The temporal references (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects currency hedging with interest rate risk management, demonstrating appropriate multi-hop reasoning. The connection between LIBOR transition and derivative pricing is logically sound. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - Caterpillar maintained consistent hedging strategies while adapting to regulatory/market changes. The wording differs but conveys equivalent meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 615,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "From 2022 onward, Johnson & Johnson shifted its talc‑liability strategy from a single $2 billion trust funded by the company to a broader, pre‑packaged bankruptcy plan that expanded that trust to a $9 billion reserve over 25 years. In 2022 the company created the $2 billion trust and set a matching reserve (page 113, 96, 97). In 2023 the original LTL bankruptcy was dismissed, the company refiled a new LTL 2 case, and agreed to add $7 billion to the trust, raising the reserve to $9 billion (page 101, 102). By 2024 the company pursued a consensual “pre‑packaged” Chapter 11 plan that incorporated the expanded trust as the central mechanism for resolving the majority of talc claims, while continually adjusting its reserve to reflect the evolving settlement structure (page 101, 102).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims JNJ 'expanded that trust to a $9 billion reserve over 25 years' and 'agreed to add $7 billion to the trust, raising the reserve to $9 billion.' The ground truth establishes only a $2 billion trust in 2022 with no mention of a $9 billion expansion or $7 billion addition. These numbers appear to be fabricated or confused with other settlements. (2) STRUCTURAL MISCHARACTERIZATION - The LLM describes a 'pre-packaged bankruptcy plan' as the central strategy, but the ground truth indicates JNJ's strategy involved creating a dedicated liability entity (LTL Management LLC) with a $2 billion trust, followed by multiple bankruptcy filings and dismissals. The ground truth does not support the characterization of a 'pre-packaged' Chapter 11 plan as the primary mechanism. (3) TIMELINE INCONSISTENCIES - The LLM suggests the $2 billion trust was created in 2022 and then expanded to $9 billion in 2023, but the ground truth indicates the $2 billion trust was already established by 2022 as part of the original LTL structure, not as a starting point for expansion. (4) MISSING KEY DETAILS - The LLM omits critical elements from the ground truth: (a) the Third Circuit's reversal of the bankruptcy court's decision in 2023, (b) the lifting of the litigation stay, (c) the dismissal of LTL 2 later in 2023, and (d) the appellate efforts in 2024 to uphold bankruptcy protection. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the evolution of JNJ's strategy across the 2022-2024 period. The ground truth shows a progression from initial LTL structure → Third Circuit reversal → LTL 2 refiling → continued appellate efforts, whereas the LLM presents a linear expansion narrative ($2B → $9B) that is not supported by the source material. (6) PAGE CITATIONS - The LLM provides page citations (113, 96, 97, 101, 102) but these cannot be verified against the ground truth and appear to be hallucinated references. The core narrative of the LLM answer diverges fundamentally from the established ground truth regarding both the financial structure and the legal strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 599,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe’s Photography Plan moved from a bundle inside the full Creative Cloud in 2022 to a standalone, cloud‑centric subscription by 2024. In 2022 and 2023 the plan was marketed as a “targeted package” alongside other suites (e.g., Substance 3D) and began to incorporate Adobe’s new generative‑AI tools (Firefly and generative credits) to boost photo‑editing workflows for creative professionals【page_5】【page_7】. By 2024 the plan was repositioned as a more limited, cloud‑based offering that still bundles Photoshop, Lightroom and Lightroom Classic but excludes the broader Creative Cloud apps, offering a simpler, cheaper subscription for photographers and photo enthusiasts while still leveraging integrated AI features【page_11】【page_12】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains a significant factual error and misses key details from the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the core products in the Photography Plan (Photoshop, Lightroom, Lightroom Classic) across all years; (2) Correctly notes the integration of generative AI capabilities (Firefly, generative credits) in 2023-2024; (3) Accurately describes the plan as a more limited alternative to full Creative Cloud; (4) Correctly positions it as a streamlined solution for photographers. CRITICAL ERROR: The LLM states the Photography Plan 'moved from a bundle inside the full Creative Cloud in 2022 to a standalone, cloud-centric subscription by 2024.' This is misleading - the ground truth indicates it was already a 'targeted package' in 2022, not a bundle within the full Creative Cloud. The plan's positioning evolved in terms of AI integration and strategic emphasis, not in its fundamental structure as a standalone offering. MISSING DETAILS: (1) The ground truth specifically mentions 'product-led growth strategy' emphasis in 2023, which the LLM omits; (2) The ground truth lists specific AI features added by 2024 (Generative Fill, Lens Blur, People Masking) that the LLM does not mention; (3) The ground truth emphasizes the strategic shift to 'infuse AI into creative tools' as the core evolution, while the LLM focuses more on structural changes. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but frames the narrative around a structural shift (standalone vs. bundled) that doesn't align with the ground truth's emphasis on AI integration and strategic positioning within the ecosystem. The answer is partially correct but mischaracterizes the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 484,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has kept the same form (8‑A 000‑53572) and filing date (January 28 2009) for its class C common‑stock specimen certificate in the exhibit tables of its 2022, 2023, and 2024 10‑K filings (see page_109 and page_114). This unchanged documentation signals a deliberate commitment to stability and transparency in its securities framework, reinforcing investor confidence and demonstrating a governance approach that values consistency amid evolving regulatory and market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key factual elements: (1) The Form 8-A with File Number 000-53572, (2) The filing date of January 28, 2009, (3) The consistency across 2022, 2023, and 2024 10-K filings, (4) The exhibit reference (Exhibit 4.2). Numeric accuracy is strong - all dates and file numbers are correct. The answer appropriately recognizes this as a multi-hop synthesis question requiring information from multiple years' filings.\n\nWEAKNESSES: (1) The LLM answer is notably more concise than the ground truth, omitting important contextual details. Specifically, it fails to mention the contrast with other governance documents (Certificate of Incorporation revised in 2024), which is a key insight in the original answer about selective updating of governance documents. (2) The answer lacks the explicit statement that Visa 'has not updated or modified its documentation' - while implied, this direct assertion is important for answering the question about consistency. (3) The reasoning about what this stability 'suggests' is less developed - the LLM provides general statements about 'stability and transparency' and 'investor confidence' but doesn't fully explore the implication that Visa found its existing framework adequate despite market/regulatory shifts. (4) The page references (page_109, page_114) are provided but not verified against the ground truth source material.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by correctly connecting information across three years of filings and drawing conclusions about governance approach. However, it misses the comparative analysis dimension (comparing Class C certificate stability to other governance document changes) that strengthens the original answer's reasoning.\n\nSEMANTIC EQUIVALENCE: The core message is preserved - Visa maintained consistency in Class C stock certificate documentation across these years, suggesting a deliberate governance approach. However, the depth of analysis and completeness of supporting evidence is reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 554,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s carrying amount of performance and operating‑cost guarantees fell from **$1,109 million at December 31 2022** to **$1,091 million at December 31 2023** and further to **$993 million at December 31 2024** (2023 table on page 100; 2024 table on page 104).  The decline is driven by fewer guarantees issued in 2024 (216 m vs 305 m in 2023) and a net reduction in settlements, reflecting tighter warranty management and lower exposure to future claim payments under its commercial‑aerospace contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect and appears to reference completely different financial metrics than the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM cites carrying amounts of $1,109M (2022), $1,091M (2023), and $993M (2024) for 'performance and operating-cost guarantees.' The ground truth specifies 'collaboration partners' share of financing guarantees' at $140M (2022), $135M (2023), and $131M (2024). These are entirely different figures - the LLM numbers are approximately 8x larger than the actual values. (2) METRIC CONFUSION: The LLM appears to have pulled data from a different liability category entirely. The ground truth specifically identifies these as 'collaboration partners' share of financing guarantees' - a specific subset of guarantee liabilities. The LLM's figures suggest it may have referenced total guarantee liabilities or a different category. (3) CALCULATION ERRORS: While the LLM correctly identifies a declining trend (which matches the ground truth direction), the magnitude of decline is wrong. The LLM shows a $116M decline from 2022-2024 ($1,109M to $993M), while the actual decline is only $9M ($140M to $131M). (4) MULTI-HOP REASONING: The LLM's interpretation about 'fewer guarantees issued in 2024 (216m vs 305m in 2023)' cannot be verified against the ground truth and appears to reference different data entirely. (5) ENTITY/METRIC IDENTIFICATION: The LLM failed to correctly identify the specific liability category being measured. The ground truth is explicit about 'collaboration partners' share' - a partnership-specific metric, not total company guarantees. This is a fundamental misidentification that invalidates the entire answer. The only correct element is the directional trend (declining), but with completely wrong numbers and wrong underlying metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 500,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease note has not changed materially from FY 2022 through FY 2024.  The company continues to treat free‑rent periods as part of the lease term, recognizing them on a straight‑line basis over the original lease term and any extensions that the company is reasonably certain to exercise, and it records right‑of‑use assets based on the discounted minimum lease payments over that same term.  Consequently, there were no material changes to lease‑term assumptions or the impact on ROU asset valuations during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the key evolution described in the ground truth. While the LLM correctly identifies that Costco uses straight-line basis for free-rent periods and includes extension options, it fails to capture the critical evolution across the three-year period. Specific deficiencies: (1) The LLM states there were 'no material changes' to lease accounting, which directly contradicts the ground truth that shows clear evolution in disclosure emphasis and context. (2) The ground truth explicitly documents that in 2022, Costco emphasized incremental borrowing rate calculations; in 2023, disclosures expanded to clarify variable lease payment treatment; and in 2024, there was heightened focus on impairment evaluation of long-lived assets. The LLM completely omits these disclosure evolution details. (3) The LLM's claim that ROU asset valuations had no material impact changes is contradicted by the ground truth's emphasis on 'growing operational complexity in lease management' and the 2024 focus on impairment evaluation in context of facility relocations/closures. (4) The LLM provides a static description rather than addressing the 'evolution' explicitly requested in the question. (5) While the LLM correctly identifies the core accounting mechanics (straight-line basis, extension options, discounted payments), it fails the multi-hop synthesis requirement by not tracking how disclosure emphasis and operational context changed year-over-year. The answer reads as a generic lease accounting description rather than a temporal analysis of how Costco's treatment evolved from 2022-2024. This represents a significant failure in addressing the nuanced evolution that the ground truth documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 470,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In 2022, Adobe positioned Acrobat as the core of its Document Cloud, embedding Adobe Sensei AI to add intelligent features and expanding its capabilities (page_5). By 2023, the company amplified that focus, adding AI‑driven task actions, improving Acrobat web, and integrating AI across Acrobat, Acrobat Sign, and Adobe Scan while ramping up R&D on AI and machine‑learning (page_7). In 2024, Adobe formalized the Acrobat brand—highlighting distinct products such as Adobe Acrobat Pro, Acrobat Reader, Acrobat web, and Acrobat Sign—and continued heavy investment in AI‑powered document workflows across the Document Cloud (page_94).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year evolution of Adobe's AI strategy. STRENGTHS: (1) Correctly identifies the chronological progression from 2022-2024, with accurate characterization of each year's focus: 2022 (Acrobat as Document Cloud core with Adobe Sensei), 2023 (AI amplification and R&D ramping), 2024 (formalized branding and continued investment). (2) Accurately addresses all three sub-components of the question: Acrobat's role (foundational in 2022, enhanced in 2023, formalized in 2024), R&D investments (explicitly mentioned for 2023 AI/ML ramping), and formal product branding (Acrobat AI Assistant concept implied through 'Acrobat Pro, Acrobat Reader, Acrobat web, Acrobat Sign' formalization in 2024). (3) No quantitative errors detected - no specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is not compromised. (4) Multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and connects strategic emphasis evolution to specific product/investment decisions. (5) Page citations (page_5, page_7, page_94) add credibility though cannot be verified against ground truth. MINOR WEAKNESSES: (1) The LLM answer mentions 'Adobe Sensei AI' in 2022, which is not explicitly mentioned in the ground truth (though not contradicted). (2) The ground truth emphasizes 'trillions of PDFs created annually' as context for Acrobat's market position, which the LLM answer omits - this is a minor contextual detail rather than a factual error. (3) The LLM answer could have been more explicit about the 'Acrobat AI Assistant' branded product name (mentioned in ground truth) versus the more general 'AI-powered document workflows' phrasing used. (4) The ground truth emphasizes 'market opportunity in document intelligence' as strategic motivation, which the LLM answer doesn't explicitly capture. These are semantic/contextual nuances rather than factual errors. OVERALL: The answer correctly captures the evolution trajectory, addresses all question components, maintains chronological accuracy, and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 591,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s fair‑value of client securities available to be pledged rose from roughly $84 billion in 2020 to $120 billion in 2021 (and remained high in 2022) while about $6.3 billion of those securities were pledged for securities‑lending (page 108).  In contrast, the amount of client securities pledged as collateral for CS&Co’s secured uncommitted lines of credit fell from $950 million in 2023 to $500 million in 2024, and the TDAC lines of credit (≈ $700 million) were terminated (page 97).  This evolution shows Schwab tightening collateral use for short‑term borrowing while sustaining robust margin‑lending and securities‑lending activity, indicating a balance‑sheet strategy that reduces short‑term credit exposure yet preserves client leverage through margin and lending programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and temporal errors that undermine its credibility. (1) MAJOR TEMPORAL MISMATCH: The question explicitly asks about evolution from 2022-2024, but the LLM answer leads with 2020-2021 data ($84B to $120B), which is outside the requested timeframe and not mentioned in the ground truth. This is a fundamental misalignment with the question scope. (2) QUANTITATIVE ISSUES: The LLM cites specific numbers ($6.3B for securities lending, $950M declining to $500M for credit lines, $700M TDAC lines) that are not present in the ground truth answer. While these may be accurate filing data, they cannot be verified against the provided ground truth, creating uncertainty about their correctness. The ground truth explicitly states 'specific pledged amounts were not quantified' for 2022, contradicting the LLM's specific figures. (3) MISSING CORE INFORMATION: The LLM fails to address the key progression described in ground truth: the evolution from 2022 (general disclosure) → 2023 (more detailed disclosures) → 2024 (explicit statements about margin requirements and options clearing). This multi-hop temporal synthesis is central to the question but largely absent from the LLM answer. (4) REASONING QUALITY: While the LLM's conclusion about 'tightening collateral use for short-term borrowing while sustaining robust margin-lending' is logically coherent, it's based on data points not validated against ground truth and doesn't capture the 'increasing formalization and expansion' narrative that the ground truth emphasizes. (5) CONTEXTUAL RELEVANCE: The answer addresses balance sheet strategy and client leverage, which are relevant, but the focus on credit line collateral reduction (2023-2024) diverges from the ground truth's emphasis on the formalization of margin lending and securities lending practices across the three-year period. The answer appears to reference specific page numbers (108, 97) suggesting detailed filing analysis, but this specificity cannot be verified and may indicate hallucination of supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 558,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "The 1.375% Senior Notes due June 2027 stayed in the long‑term debt category and its carrying amount remained $1.25 bn in 2022, 2023 and 2024.  Total long‑term debt fell from $6.59 bn in 2022 to $5.92 bn in 2024, as the other long‑term debt component rose from $590 m to $919 m while the current portion fell from $73 m to $103 m, reducing the long‑term debt excluding current portion from $6.48 bn to $5.79 bn.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Major discrepancies in total long-term debt figures. LLM states total long-term debt fell from $6.59 bn in 2022 to $5.92 bn in 2024, but ground truth indicates long-term debt excluding current portion was $6.484 million in 2022 and $5.794 million in 2024. The LLM's figures of $6.59bn and $5.92bn appear to be incorrect or refer to different metrics not specified. (2) The LLM correctly identifies the 1.375% Senior Notes at $1.25bn consistently across 2022-2024, matching ground truth. (3) The LLM correctly identifies the decline from $6.48bn to $5.79bn in long-term debt excluding current portion, matching ground truth exactly. (4) REASONING ISSUE - The LLM's explanation of the decline mechanism is incomplete. Ground truth specifically attributes the decline to reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as maturity approached. The LLM mentions 'other long-term debt component' changes but doesn't identify the specific driver (the 2.750% notes reclassification). (5) The LLM introduces unexplained figures about 'other long-term debt component' rising from $590m to $919m and 'current portion' falling from $73m to $103m - these numbers are not verified against ground truth and appear to contradict the stated decline in total long-term debt. (6) SEMANTIC ISSUE - The LLM's statement that current portion 'fell from $73m to $103m' is contradictory (cannot fall while increasing). This suggests confusion in the data presentation. The answer partially addresses the question but contains significant numerical errors and incomplete causal reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 454,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe has consistently positioned free online self‑service learning as a core element of its Digital Learning Services, which is embedded in the broader learning and enablement portfolio across the 2022, 2023, and 2024 10‑Ks (page_17, page_17, page_18).  Over time the company has increasingly tied this offering to enterprise customer‑success, underscoring custom learning services, skills‑assessment tools, and the role of Customer Success Managers to help large customers adopt and maximize Adobe solutions (page_18).  Thus, while the free‑learning catalog has remained unchanged, its integration with enterprise success strategies has become more explicit in the latest filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's evolution in free online self-service learning positioning from 2022-2024, with generally accurate core facts. STRENGTHS: (1) Correctly identifies free online self-service learning as a core component across all three years (2022, 2023, 2024); (2) Accurately captures the shift toward greater enterprise integration and explicit alignment with customer success strategies; (3) Correctly identifies supporting elements like custom learning services, skills assessments, and Customer Success Managers; (4) Appropriately notes the consistency of the free learning catalog while highlighting the evolution in integration approach; (5) Provides specific page references to support claims. WEAKNESSES: (1) The answer states 'the free-learning catalog has remained unchanged' which is a minor overstatement - the ground truth indicates 'consistent presence' and 'reinforcing importance' but doesn't explicitly confirm the catalog itself was unchanged; (2) The answer could have been more explicit about the 2023 intermediate step and the learning.adobe.com platform's role, which the ground truth emphasizes; (3) Lacks the explicit mention of 'democratizing product knowledge' as a strategic commitment, which the ground truth highlights; (4) The characterization of integration becoming 'more explicit in the latest filing' is accurate but could have been more nuanced about the 'maturing approach' concept from the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects free learning offerings to enterprise customer success strategies, demonstrating appropriate multi-hop reasoning. The logic flow is sound and conclusions are supported. SEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same information as the ground truth, with minor gaps in comprehensiveness rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 518,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 fell from roughly $1.1 billion in 2022 to $1.044 billion in 2023, then rose to $1.250 billion in 2024 (2024: page 72; 2023: page 67; 2022: page 78). This modest fluctuation shows the company is keeping its long‑term debt load stable and aligning maturities with cash flow, a disciplined strategy that supports its rapid AI‑driven revenue growth without overleveraging.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES (Primary Concern): The LLM provides incorrect figures for 2022 and 2023. Ground truth states $1.20 billion (2022) and $1.057 billion (2023), but LLM reports 'roughly $1.1 billion' (2022) and $1.044 billion (2023). The 2022 figure is materially understated by ~$100M, and the 2023 figure is off by ~$13M. The 2024 figure of $1.250 billion is correct. These are not minor rounding differences—they represent meaningful deviations from actual carrying amounts. The LLM's use of 'roughly' for 2022 suggests imprecision, which is problematic for financial data requiring exactness. QUALITATIVE REASONING: The LLM correctly identifies the three-year trend (decrease then increase) and provides reasonable interpretation about debt management strategy. However, the interpretation differs slightly from ground truth: LLM emphasizes 'keeping debt load stable' and 'aligning maturities with cash flow,' while ground truth emphasizes 'dynamic debt management' with possible refinancing optimization. Both interpretations are plausible, but the LLM's characterization of 'modest fluctuation' is somewhat understated given the ~$193M swing from 2023 to 2024. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three fiscal years and connects it to NVIDIA's AI-driven growth strategy, demonstrating adequate multi-hop reasoning. COMPLETENESS: The answer addresses the evolution question and provides strategic interpretation, though it could have been more explicit about the specific dollar changes year-over-year. CRITICAL FLAW: The quantitative inaccuracies in 2022 and 2023 figures are the primary weakness, as financial analysis depends on precise numbers. The 2024 figure being correct suggests selective accuracy rather than systematic error, which is concerning for reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 495,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson has continued to implement a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance, expanding its financial shared‑service capabilities and standardizing financial systems (2022 page 117; 2023 page 118; 2024 page 119). The language in each filing shows the initiative remains active and that the company is aligning and streamlining its financial control environment. This steady, ongoing effort underscores J&J’s strategic emphasis on process standardization and a robust, aligned control framework to support efficient, consistent financial reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the multi-year enterprise-wide initiative with accurate scope (finance, HR, IT, procurement, supply chain); (2) Accurately references the three-year progression (2022, 2023, 2024) with specific page citations (117, 118, 119); (3) Properly synthesizes the core narrative of process standardization and financial control environment alignment; (4) Correctly characterizes the initiative as proactive/strategic rather than reactive; (5) Accurately conveys the consistency of messaging across years. MINOR WEAKNESSES: (1) The LLM answer includes HR, IT, procurement, and supply chain in the scope, whereas the ground truth focuses more narrowly on finance and financial systems - while not incorrect per se, this broader framing slightly differs from the ground truth's emphasis on financial shared services specifically; (2) The answer could have been more explicit about the 'non-reactive' nature of the initiative (i.e., not prompted by control deficiencies), though this is implied in the language about 'strategic emphasis'; (3) The answer is somewhat more concise than the ground truth, omitting some contextual detail about the initiative being described as 'proactive' in 2022 and the company's affirmation that enhancements were 'not reactive.' QUANTITATIVE ACCURACY: Page citations appear reasonable and consistent with typical 10-K structure, though cannot be independently verified. No calculations or specific dollar amounts are present, so quantitative precision is high. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression and consistency of the initiative. The logical connection between process standardization and control environment alignment is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential meaning of the ground truth - sustained strategic focus on modernizing financial infrastructure through standardization - though with slightly different emphasis and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 573,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022 through 2024 consistently name BJ’s Wholesale Club as a direct competitor in the warehouse‑club arena (2022 page 7; 2023 page 8; 2024 page 8).  In each year the company repeats the same wording that its private‑label brand, Kirkland Signature, delivers “high‑quality, lower‑priced” products that “help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” underscoring the brand as a key differentiator (2022 page 7; 2023 page 8; 2024 page 8).  Thus, the competitive positioning language and the strategic emphasis on Kirkland Signature have remained essentially unchanged from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution of competitive positioning language from 2022 to 2024. STRENGTHS: (1) Correctly identifies BJ's Wholesale Club as a named competitor across all three years; (2) Accurately cites the consistent Kirkland Signature messaging about 'high-quality, lower-priced' products and margin benefits; (3) Page citations appear reasonable for 10-K filings; (4) Correctly notes the repeated language across years. CRITICAL WEAKNESSES: (1) The LLM concludes that positioning language 'remained essentially unchanged' from 2022 to 2024, which directly contradicts the ground truth that describes an EVOLUTION in tone and emphasis. The ground truth explicitly states: 'the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures' and notes 2024 introduced 'a stronger tone around differentiating our merchandise offerings.' (2) The LLM completely misses the 2023 evolution point about sustainability initiatives tied to brand loyalty, which the ground truth identifies as a notable addition to the narrative. (3) The LLM fails to capture the contextual shift regarding 'increasingly competitive metropolitan markets' mentioned in 2024. (4) The question specifically asks about HOW the language 'evolved' - the LLM's answer that it remained 'essentially unchanged' fundamentally misses the analytical requirement. The LLM provides accurate factual details about what was said but fails to perform the comparative analysis across years that the question demands. This is a multi-hop reasoning failure where the model identified correct facts but drew an incorrect conclusion about their relationship and evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 481,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s U.S. state and municipal securities holdings fell from **$638 million at year‑end 2022** to **$579 million at year‑end 2023** and remained at **$579 million in 2024**. Throughout this period the firm repeatedly stressed that “substantially all securities in the investment portfolios were rated investment‑grade,” underscoring a conservative, credit‑quality‑focused fixed‑income strategy that prioritizes capital preservation and stable income over higher‑yield, riskier assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that Schwab's U.S. State and Municipal Securities holdings were '$638 million at year-end 2022' and then 'fell to $579 million at year-end 2023.' However, the ground truth explicitly states that the $638 million figure was disclosed in 2023 (not 2022), and this represents Schwab's investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio for that year. The LLM has misattributed the $638 million figure to 2022 when it actually pertains to 2023. Additionally, the LLM provides a 2024 figure of $579 million, which cannot be verified against the ground truth provided. The ground truth does not provide specific dollar amounts for 2022 or 2024, only noting that 'substantially all securities were rated investment grade' in those years. The LLM's claim of a decline from $638M to $579M is therefore based on an incorrect year assignment. The qualitative analysis regarding investment-grade emphasis and conservative strategy is accurate and well-articulated, but this cannot compensate for the significant quantitative error in the core factual claim. The multi-hop reasoning about the evolution across three years is undermined by the incorrect temporal attribution of the key financial figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 381,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum potential exposure to commercial‑aerospace customer financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【page 100】【page 104】.  The portion of those guarantees carried by collaboration partners declined from $140 million in 2022 to $135 million in 2023 and to $131 million in 2024【page 100】【page 104】, indicating a gradual shift toward retaining more risk internally and a more conservative risk‑transfer strategy in this domain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: collaboration partners' share declined from $140M (2022) to $135M (2023) to $131M (2024), matching the ground truth exactly. The LLM also provides additional context by including the maximum potential exposure figures ($304M, $288M, $274M), which adds valuable information about the broader exposure trend without contradicting the ground truth. The multi-hop reasoning is sound: the LLM correctly synthesizes that the declining collaboration partners' share indicates a shift toward internal risk retention and a more conservative risk-transfer strategy, which aligns with the ground truth's interpretation. The LLM's characterization of this as a 'gradual shift toward retaining more risk internally' is semantically equivalent to the ground truth's 'strategic shift toward reducing RTX's reliance on third-party risk sharing.' One minor point: the ground truth explicitly mentions that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees,' which the LLM answer does not address. However, this omission is relatively minor as the core question focuses on the trend and what it indicates about risk transfer strategy, both of which the LLM addresses comprehensively and accurately. The answer is well-structured, properly sourced with page references, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 404,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In the 2023 10‑K (page 12), Frame.io is described as a cloud‑native collaboration platform that supports video, still images, design files and PDFs and is tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, enabling frame‑accurate comments and real‑time review within those apps. By the 2024 filing (page 12), Adobe expanded Frame.io’s role, adding integration with Adobe GenStudio, camera‑to‑cloud uploads from both video and still‑image cameras, and positioning it as a scalable, end‑to‑end production hub that supports shooting, review, approval and marketing workflows at scale. Compared to earlier filings, where Frame.io supported fewer file types and fewer app integrations, the platform has evolved into a central, cloud‑native engine that streamlines the entire content‑production lifecycle. (page_12)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the timeline and evolution of Frame.io integrations. CRITICAL ERRORS: (1) The LLM claims that in 2023, Frame.io was 'tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront' - but the ground truth states that in 2023, Frame.io only supported integration with Premiere Pro and After Effects. Photoshop, Lightroom, and Workfront integrations were added by 2024, not present in 2023. This is a major factual error that misrepresents the evolution timeline. (2) The LLM mentions 'Camera-to-Cloud uploads from both video and still-image cameras' as a 2024 addition, but the ground truth indicates Camera-to-Cloud functionality for video production was already present in 2023. (3) The LLM does not mention the 2022 baseline (Frame.io as registered trademark), which is part of the ground truth's evolution narrative. CORRECT ELEMENTS: The LLM correctly identifies that Frame.io expanded its role from post-production into broader workflows (casting, location scouting, marketing) by 2024, and correctly notes the progression toward an end-to-end content creation platform. The supported file types (video, still images, design files, PDFs) are correctly identified. The mention of GenStudio integration in 2024 appears accurate. MULTI-HOP REASONING: The answer attempts to synthesize information across 2023 and 2024 filings but fails to accurately track which integrations existed in which year, which is the core of the question. The comparison structure is sound, but the factual content undermines the analysis. The answer demonstrates understanding of the general evolution concept but executes it with significant timeline errors that would mislead readers about when specific integrations were introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 489,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s VH‑92A production focus rose in 2023, helping lift RMS net sales from $16.1 billion in 2022 to $16.2 billion in 2023, before falling again in 2024 when volume on the VH‑92A was lower than the prior year [page_41]. This ebb and flow shows that the VH‑92A remains a strategically important Marine‑Corps transport platform, but its production emphasis is shifted to balance competing helicopter and IWSS priorities within the Rotary and Mission Systems segment [page_41, page_50].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. CRITICAL ISSUES: (1) The LLM claims VH-92A production 'rose in 2023' and that volume was 'lower than the prior year' in 2024, but provides no evidence from the filings to support this claim. The ground truth indicates consistent mention across all three years without specifying production volume changes. (2) The LLM cites specific RMS net sales figures ($16.1B in 2022, $16.2B in 2023) and attributes the increase to VH-92A production rise, but this causal claim is not substantiated in the ground truth and appears to be an unsupported inference. (3) The LLM introduces 'IWSS priorities' as a competing factor, which is not mentioned in the ground truth answer. (4) The LLM fundamentally mischaracterizes the program's evolution - the ground truth emphasizes CONSISTENT strategic importance and stable long-term commitment, while the LLM describes an 'ebb and flow' pattern with shifting emphasis. (5) The page citations [page_41, page_50] cannot be verified against the ground truth provided. WHAT WAS CORRECT: The LLM correctly identifies the VH-92A as a Marine Corps transport platform and acknowledges it remains strategically important within RMS. The general framing of balancing competing priorities is reasonable, though not supported by the specific evidence presented. MULTI-HOP REASONING: The LLM attempts to connect production volume changes to segment sales changes, but this synthesis is not grounded in the provided ground truth and appears speculative. The answer diverges significantly from the ground truth's emphasis on consistency and stable commitment across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 463,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From 2022 to 2024 MDLZ’s 10‑K disclosures show a clear expansion of geographic scope and tightening of sales‑and‑media marketing restrictions. The 2022 filing (page 17) did not detail such restrictions, whereas the 2023 filing (page 11) noted that limits on promotions of products with specified nutrient profiles were applied in many jurisdictions, including the EU where over 25 member states had adopted extended producer responsibility (EPR) policies and packaging‑waste directives. By 2024 (page 11) the company added that the EU had adopted its Packaging and Packaging Waste Directive and that single‑use plastic bans and plastic taxes were being considered in Europe and Southeast Asia, indicating a further increase in regulatory stringency, particularly in emerging markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the expansion of geographic scope and regulatory stringency from 2022-2024; (2) Accurately cites the 25+ EU member states with EPR policies; (3) Properly references the EU Packaging and Packaging Waste Directive adoption in 2024; (4) Correctly identifies emerging markets (India, Vietnam, Southeast Asia) as areas of expanding restrictions; (5) Appropriately synthesizes information across multiple years showing progression; (6) Correctly notes the inclusion of data privacy as a regulatory concern in 2023. MINOR WEAKNESSES: (1) The LLM answer states the 2022 filing 'did not detail such restrictions' but the ground truth indicates restrictions were present in 2022 (over 25 EU countries with EPR, bans/taxes being considered) - this is a slight mischaracterization of the 2022 baseline, though the overall trajectory of expansion is correct; (2) The answer could have been more explicit about the specific progression of which restrictions were 'being considered' vs. 'implemented' in each year, though this distinction is somewhat present; (3) Page citations (page 17, page 11, page 11) cannot be verified against ground truth but appear reasonable. QUANTITATIVE VERIFICATION: The '25+ EU member states' figure is accurate per ground truth. The years (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple geographic regions (EU, emerging markets, Southeast Asia, India, Vietnam) to show the evolution of restrictions. The logic connecting EPR policies, plastic bans/taxes, and data privacy regulations is sound. SEMANTIC EQUIVALENCE: The answer conveys the same core message as ground truth - expanding geographic scope and increasing regulatory intensity - despite slightly different framing of the 2022 baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 526,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700% Notes due 2046 were disclosed as part of the Eleventh Supplemental Indenture in the 2022 and 2023 10‑Ks (page 105) and the same indenture appears unchanged in the 2024 10‑K (page 105). The notes have not been repurchased, restructured, or otherwise altered across the three filings. This consistency indicates a long‑term debt strategy that favors stable, moderate‑rate financing and a diversified maturity profile rather than frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 3.700% Notes due 2046 and the Eleventh Supplemental Indenture dated August 8, 2016 across all three years; (2) Accurately states that the notes were not repurchased, restructured, or altered; (3) Correctly cites page 105 for the 2022/2023 10-Ks and 2024 10-K; (4) Properly synthesizes the multi-hop information across three years; (5) Draws appropriate conclusions about Microsoft's debt strategy favoring stability and fixed-rate financing. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it mentions 'stable, moderate-rate financing and diversified maturity profile' but doesn't explicitly emphasize 'confidence in long-term cash flow projections' or 'predictable debt servicing costs' as core strategic motivations; (2) The phrase 'rather than frequent refinancing' is somewhat implied but not as explicitly connected to the broader capital structure strategy as the ground truth's framing of these notes as 'a core component of its capital structure'; (3) The answer could have been more explicit about the consistency across ALL THREE years being the key indicator of deliberate strategy. QUANTITATIVE VERIFICATION: All dates (August 8, 2016; 2022, 2023, 2024), the interest rate (3.700%), and the maturity year (2046) are correct. Page citations (105) appear accurate. No calculation errors present. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and draws logical conclusions about strategic intent from the pattern of consistency. The reasoning is sound and well-structured. Overall, this is a strong answer that captures the essential facts and strategic implications with only minor omissions in depth of analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 500,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, Microsoft did not issue a 2.000% note due 2023; the supplemental indentures listed in each filing (pages 104–105) contain 2.375% Notes due 2023 (Sixth Supplemental Indenture) and 3.625% Notes due 2023 (Eighth Supplemental Indenture) but no 2.000% Notes due 2023. Consequently, the debt‑maturity profile for 2023 remained unchanged, with the company continuing to rely on the 2.375% and 3.625% notes while the 2.000% Notes due 2020 stayed on the books, illustrating a stable maturity structure across the three periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the fundamental factual claim. The ground truth explicitly states that the 2.000% Notes due 2023 were consistently referenced across Microsoft's 2022, 2023, and 2024 10-K filings in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. The LLM answer claims these notes did not exist and instead identifies 2.375% Notes due 2023 and 3.625% Notes due 2023 as the relevant instruments. This is a critical factual error. The LLM also incorrectly references 2.000% Notes due 2020 (not mentioned in the ground truth) and claims the debt maturity profile remained unchanged, which contradicts the ground truth's narrative about the progression of these specific notes through their maturity year. The LLM's citation of specific page numbers (104-105) and supplemental indenture numbers (Sixth and Eighth) cannot be verified against the ground truth but appear to be incorrect identifications of the relevant debt instruments. The multi-hop reasoning fails because the LLM did not correctly identify which debt instruments were actually present in the filings across the three-year period. The answer demonstrates a fundamental misunderstanding or misidentification of the specific debt instruments in question, making it substantially incorrect despite attempting to address the structure and evolution of Microsoft's debt maturity profile.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 392,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across Medtronic’s 2022, 2023 and 2024 Form 10‑K filings, the Non‑Employee Restricted Stock Unit Award Agreements all continued to be governed by the **Amended and Restated 2013 Stock Award and Incentive Plan** (see *10.42 in each filing).  The agreements were re‑issued each year but the underlying plan did not change.  In the 2024 filing, Medtronic added new Restricted Stock Unit Award Agreements for employees under the 2021 Medtronic plc Long‑Term Incentive Plan (see *10.81 and *10.82), but the non‑employee RSU agreements remained tied to the 2013 plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative about continuity in the Non-Employee Restricted Stock Unit Award Agreements across 2022-2024, correctly identifying that they remained tied to the Amended and Restated 2013 Stock Award and Incentive Plan throughout the period. However, there are significant issues with exhibit number accuracy and completeness:\n\n1. EXHIBIT NUMBER DISCREPANCY (Critical Error): The LLM states the agreements are in \"*10.42 in each filing,\" but the ground truth specifies Exhibit 10.45 for the 2022 filing. This is a factual error in document citation that undermines credibility, though the underlying plan reference appears correct.\n\n2. INCOMPLETE SYNTHESIS: The ground truth emphasizes that the form agreement itself remained consistent across all three years (2022, 2023, 2024), showing strategic standardization. The LLM mentions agreements were \"re-issued each year\" but doesn't clearly establish that the FORM remained the same across all three years - it focuses more on the plan continuity.\n\n3. ADDITIONAL INFORMATION NOT IN GROUND TRUTH: The LLM introduces information about 2024 additions (2021 Medtronic plc Long-Term Incentive Plan with exhibits 10.81 and 10.82 for employee RSUs). While this may be accurate, it goes beyond the ground truth answer's scope and wasn't part of the original synthesis, making it difficult to verify against the knowledge graph.\n\n4. MISSING CONTEXT: The ground truth notes the plan was \"effective December 8, 2017\" and emphasizes this as context for understanding the long-term stability. The LLM omits this date detail.\n\n5. SEMANTIC ALIGNMENT: The core message about continuity and stability is present in the LLM answer, but the execution is less precise. The ground truth's emphasis on \"form agreement remained consistent\" as a strategic choice is somewhat lost in the LLM's focus on plan references.\n\nThe answer demonstrates understanding of the multi-hop synthesis required (connecting agreements to plans across years) but contains a critical exhibit number error and introduces unverified additional information that creates uncertainty about accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 575,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated **17 %** of plan assets to buy‑in annuity contracts in 2022, **16 %** in 2023, and returned to **17 %** in 2024 (page 104 shows 17 %/16 % for 2024/2023; page 105 shows 17 % for 2022). The allocation has remained essentially flat, with only a modest dip in 2023, indicating that the company consistently uses buy‑in annuity contracts as a core tool to hedge international pension liabilities and keep funded‑status risk predictable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth clearly states that buy-in annuity allocations were 'effectively discontinued by 2024,' but the LLM claims the allocation 'returned to 17% in 2024.' This is a fundamental misrepresentation of the data. While the LLM correctly identifies the 2022 (17%) and 2023 (16%) percentages, the 2024 figure of 17% is incorrect according to the ground truth. The LLM's interpretation that allocations 'remained essentially flat' and represent a 'core tool' for hedging contradicts the ground truth's characterization of a strategic shift away from insurer-backed annuities. The LLM also fails to address the key insight from the ground truth: that MDLZ shifted to fair value estimation methods, indicating a move toward more direct liability management and valuation control. The reasoning in the LLM answer suggests continuity and stability in strategy, when the ground truth indicates a deliberate strategic pivot away from buy-in annuities. The multi-hop synthesis is flawed because it misinterprets the trend (claiming flatness when there was discontinuation) and misses the strategic implications (de-risking/restructuring efforts). The citation references to pages 104-105 cannot be verified but appear to be fabricated or misinterpreted given the contradiction with ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 386,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued 2.000% Notes due 2023 under the Eleventh Supplemental Indenture (4.14) in 2016【page_105】.  The notes were outstanding in FY 2022, matured in FY 2023, and were fully repaid by FY 2024, as reflected in the debt schedule.  This pattern shows Microsoft’s disciplined debt‑maturity strategy—maintaining a mix of short‑ and long‑term debt to keep borrowing costs low while ensuring liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY ON MATURITY: The LLM claims the notes 'matured in FY 2023' and were 'fully repaid by FY 2024.' However, the ground truth explicitly states the notes 'remained in the disclosures under the same exhibit' through 2024, confirming Microsoft 'maintained this liability on its books through the 2024 reporting period, even as the due date approached.' This directly contradicts the LLM's claim of maturity and repayment. The ground truth indicates the notes were STILL OUTSTANDING in 2024, not repaid. (2) MISINTERPRETATION OF EVOLUTION: The ground truth emphasizes that the notes showed 'consistency' and 'no change in the structure or maturity' across all three years, with identical references in Exhibit 4.14. The LLM incorrectly characterizes this as a lifecycle progression (outstanding→matured→repaid) when it actually represents stable, unchanged inclusion. (3) INCOMPLETE ANALYSIS: The ground truth provides specific exhibit references (Exhibit 4.14, Eleventh Supplemental Indenture dated August 8, 2016) and emphasizes that Microsoft 'did not retire or refinance the 2.000% Notes ahead of schedule.' The LLM mentions the indenture but misses the key insight about deliberate non-refinancing. (4) UNSUPPORTED CONCLUSIONS: The LLM's statement about 'disciplined debt-maturity strategy' and 'keeping borrowing costs low' is not supported by the ground truth, which focuses on consistency and deliberate maintenance of the liability. The ground truth reveals a strategy of HOLDING the debt through maturity, not actively managing it through refinancing. (5) QUANTITATIVE VERIFICATION: The interest rate (2.000%) and due year (2023) are correct, but the characterization of what happened to the notes across the three years is fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 488,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "In each of Microsoft’s 2022, 2023, and 2024 10‑K filings the 4.000% Notes due 2021 are disclosed as part of the **Third Supplemental Indenture (Exhibit 4.6)**, and the indenture’s terms and the notes’ classification as long‑term debt remain unchanged.  The 2023 filing added a new Fifteenth Supplemental Indenture (Exhibit 4.18), and the 2024 filing added an additional Indenture for Activision (Exhibit 4.19), but neither of these new indentures affected the 4.000% Notes due 2021, which stayed within the same supplemental indenture series across all three periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the 4.000% Notes due 2021 remained under the Third Supplemental Indenture (Exhibit 4.6) across all three years (2022, 2023, 2024), which matches the ground truth. The numeric/date references (Third Supplemental Indenture, Exhibit 4.6, the 4.000% rate, 2021 maturity date) are accurate. However, there are significant issues with completeness and reasoning: (1) The LLM mentions new indentures (Fifteenth Supplemental Indenture in 2023, Activision Indenture in 2024) but these are not mentioned in the ground truth answer, raising questions about accuracy or relevance. (2) The ground truth specifically notes that the 4.000% Notes were grouped WITH the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture - the LLM fails to mention these companion notes, which is a material omission for understanding the 'broader debt instrument structure' requested in the question. (3) The ground truth mentions Microsoft introduced new debt instruments like 2.375% Notes due 2023 and 2.125% Notes due 2022 across the years - the LLM completely omits this important context about how the debt structure evolved. (4) The LLM's statement about the notes' 'classification as long-term debt' is not verified in the ground truth and may be inaccurate given that notes due 2021 would have become current/short-term debt by 2022. The answer is partially correct on the core fact (Third Supplemental Indenture consistency) but fails to adequately address the 'broader debt instrument structure' evolution and omits key companion notes and new instruments that were introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 448,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes for FY 2022, 2023 and 2024 all state that no Euro Deferred Shares were issued or outstanding (April 29 2022; April 28 2023; April 26 2024).  The consistent absence of activity in this line item shows the company has not yet exercised its 40 000‑share authorization, indicating a capital‑structure strategy that relies on ordinary and preferred shares (and other instruments) rather than on deferred‑currency equity, thereby avoiding the additional complexity and currency exposure that Euro Deferred Shares would introduce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Medtronic's Euro Deferred Shares disclosures. QUANTITATIVE ACCURACY: All numeric values are correct - the 40,000-share authorization is accurately stated, and the fiscal years (2022, 2023, 2024) with their corresponding filing dates (April 29 2022; April 28 2023; April 26 2024) are precise and properly formatted. The consistent zero balances across all three years are correctly identified. ENTITY ACCURACY: Medtronic is correctly identified, fiscal years are accurate, and the specific financial instrument (Euro Deferred Shares) is properly referenced throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to identify a pattern (consistent absence of activity) and draws a logical inference about capital structure strategy. The reasoning that this absence indicates the company has not exercised its authorization is sound. SEMANTIC EQUIVALENCE: The LLM answer goes slightly beyond the ground truth by providing additional strategic context - specifically mentioning that the company's preference for other instruments avoids \"additional complexity and currency exposure that Euro Deferred Shares would introduce.\" This represents a reasonable inference from the consistent non-utilization pattern and adds valuable analytical depth without contradicting the ground truth. The ground truth states the absence \"potentially signals\" preference for other forms of financing; the LLM answer articulates this more definitively based on the evidence. MINOR CONSIDERATIONS: The LLM uses \"deferred-currency equity\" which is a reasonable characterization, though the ground truth uses the simpler term \"Euro Deferred Shares.\" Both are semantically equivalent. The answer fully addresses all parts of the multi-part question regarding how disclosures evolved (they remained consistent) and what this reveals about capital structure strategy (preference for alternatives). No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 549,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft consistently disclosed the 4.000 % Notes due 2021 as part of Exhibit 4.6 (the third supplemental indenture dated February 8, 2011) in each of its 2022, 2023, and 2024 10‑K filings【page 104】. The unchanged disclosure indicates that the company treats the notes as a stable, long‑term liability and has made no material changes to their terms or status over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key factual elements: (1) Microsoft consistently disclosed the 4.000% Notes due 2021 across 2022, 2023, and 2024 filings, (2) the disclosure appears in Exhibit 4.6, (3) the Third Supplemental Indenture is dated February 8, 2011, (4) the date format and percentage are accurate. The quantitative accuracy is high with all numbers and dates correct.\n\nWEAKNESSES: The LLM answer is incomplete in addressing the full scope of the original question. The original answer provides critical context that the Notes 'were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.' This is a significant interpretive insight about what the consistency of disclosure indicates. The LLM states the notes are treated as 'a stable, long-term liability' which is somewhat contradictory to the ground truth's implication that they were matured/fully accounted for. The LLM also fails to explicitly address the 'incorporation by reference from a prior 8-K filing' detail mentioned in the original answer, which is part of the complete disclosure picture. Additionally, the LLM's characterization of the notes as a 'long-term liability' may be inaccurate given that these are notes due 2021, which would have matured by 2022. The reasoning about what the consistency indicates is therefore partially flawed - the LLM suggests ongoing stability as a liability, while the ground truth suggests the notes were already matured/resolved. The page reference [page 104] adds specificity but doesn't compensate for the interpretive gap regarding the maturity status and what the unchanged disclosure truly indicates about the company's treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 471,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin has not disclosed any new pension‑risk‑transfer transactions in 2022, 2023 or 2024, and the cumulative amount of defined‑benefit obligations transferred via group annuity contracts (GACs) remains at roughly $11.6 billion since 2018 【page 60】.  The company’s 2024 filing notes only cash contributions and CAS pension recoveries, with no additional GAC purchases reported 【page 49】, and its 2023 discussion reiterates that it continues to evaluate such transactions but has not increased the size of recent transfers 【page 21】.  This pattern signals a steady, risk‑transfer‑focused long‑term liability strategy that prioritizes volatility reduction over rapid acceleration of pension obligation transfers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the $11.6 billion cumulative pension obligation transfer amount and accurately notes that no new transactions were disclosed in 2022-2024. However, there are significant issues with the interpretation and synthesis of the ground truth information: (1) QUANTITATIVE ACCURACY: The $11.6 billion figure is correct and properly attributed to the 2018-2022 period. The answer correctly states this amount has remained static. However, the answer omits the $69 million annual PBGC premium elimination mentioned in the ground truth, which is a material detail. (2) MULTI-HOP REASONING FLAW: The ground truth explicitly states that by 2024, Lockheed Martin 'reaffirmed its intent to pursue additional pension risk transfer transactions,' indicating forward-looking commitment to future transfers. The LLM answer misinterprets this as merely 'continuing to evaluate' without capturing the affirmative intent to pursue additional transactions disclosed in 2024. This is a critical distinction—the ground truth shows escalating commitment (2022: disclosed past transfers → 2023: ongoing evaluation → 2024: reaffirmed intent to pursue additional), while the LLM presents it as static evaluation. (3) SEMANTIC MISALIGNMENT: The ground truth characterizes the trajectory as 'deliberate, multi-year liability management approach' with sustained strategy to 'reduce defined benefit pension liabilities.' The LLM characterizes it as 'steady, risk-transfer-focused' but emphasizes 'no acceleration,' which contradicts the ground truth's emphasis on 'sustained strategy' and forward momentum. (4) COMPLETENESS: The LLM answer addresses the evolution question but fails to capture the strategic escalation implied by the 2024 reaffirmation of intent. The answer correctly notes no new transactions occurred but misses that the company signaled future intent. (5) CITATION ACCURACY: Page references provided (60, 49, 21) cannot be verified against ground truth but appear plausible. Overall, the answer is partially correct on static facts but misses the dynamic strategic evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 571,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "In the 2022 10‑K (page 136) the 0.125% Notes due 2029 were disclosed as “incorporated by reference to Exhibit 4.4 of the Company’s 8‑K filed on September 18 2020.” The 2023 10‑K (page 132) retained that same reference, while the 2024 10‑K (page 130) updated the reference to the 8‑K filed on March 9 2021, indicating an amendment or re‑issuance. This evolution shows Coca‑Cola consistently uses the same naming convention and referencing approach for its debt instruments, with only minor updates to reflect amendments, underscoring a stable and consistent debt‑instrument structure over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL DATE ERROR: The LLM claims the 2024 10-K 'updated the reference to the 8-K filed on March 9 2021,' but the ground truth explicitly states that across all three years (2022, 2023, and 2024), the note referenced 'the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021' with 'no change in the referenced Exhibit 4.4 filings' in 2024. The LLM incorrectly characterizes this as an update/amendment when it was actually consistent. (2) EXHIBIT REFERENCE INCOMPLETENESS: The ground truth indicates the note appeared in both Exhibit 4.23 AND 4.31 in each year, but the LLM only mentions single exhibit references without noting the dual disclosure pattern. (3) MISCHARACTERIZATION OF CONSISTENCY: The LLM's conclusion that there was an 'amendment or re-issuance' contradicts the ground truth's finding of complete consistency across all three years. The LLM fundamentally misinterprets the data, suggesting change where there was stability. (4) PAGE NUMBERS: While the LLM provides specific page numbers (136, 132, 130), these cannot be verified against the ground truth and may be inaccurate. (5) CORE THESIS ERROR: The ground truth emphasizes 'consistent approach' and 'stable capital market strategy,' while the LLM suggests evolution and updates that did not occur. The answer demonstrates poor multi-hop synthesis and arrives at an incorrect conclusion about the nature of the disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 420,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s carrying amount of liabilities for performance and operating‑cost guarantees fell from **$1,109 million at December 31 2022** to **$1,091 million at December 31 2023** and further to **$993 million at December 31 2024** (Note 16, page 100). The decline—driven by higher settlements than new guarantees issued—shows a net reduction of $116 million over two years, indicating the company is gradually trimming its exposure to long‑term product‑performance risks in its commercial aerospace business, although the liability remains sizable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different numbers than the ground truth, indicating a fundamental factual error. Ground truth shows collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024). The LLM instead reports total carrying amounts of $1,109M (2022), $1,091M (2023), and $993M (2024)—numbers that are approximately 8x larger and appear to reference a different liability category entirely. While the LLM's numbers may be from RTX's actual 10-K filings (Note 16, page 100 is cited), they do not match the specific metric asked about in the question regarding 'liabilities for performance and operating cost guarantees' as defined in the ground truth knowledge graph. The LLM calculates a $116M reduction over two years, which is arithmetically correct for its stated numbers ($1,109M - $993M = $116M), but this calculation is based on incorrect source data relative to the ground truth. The LLM's interpretation that the company is 'gradually trimming its exposure' is directionally consistent with the declining trend, but the magnitude and specific liability category are wrong. The answer demonstrates a multi-hop synthesis failure—the model appears to have pulled data from a different section or definition of guarantees liabilities rather than the specific collaboration partners' share metric that forms the basis of the ground truth answer. This is a major factual error that undermines the entire response despite reasonable analytical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 420,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes assumptions for non‑qualified options have become more conservative: volatility rose from 23.04 % in 2022 to 24.29 % in 2024, the risk‑free rate climbed from 0.90 % to 4.16 %, dividend yield increased from 1.95 % to 3.18 %, and the expected life lengthened from 6.0 to 6.1 years (page 82). Consequently, the weighted‑average fair value of options granted fell from $22.83 million in 2022 to $17.76 million in 2023 and then edged up to $18.49 million in 2024, reflecting a shift toward higher market‑volatility and risk‑free rate assumptions and a more cautious equity‑compensation risk model (page 82).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that diverges significantly from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific numerical values (volatility 23.04% to 24.29%, risk-free rate 0.90% to 4.16%, dividend yield 1.95% to 3.18%, fair values $22.83M to $17.76M to $18.49M) that cannot be verified against the ground truth provided. The ground truth does not cite these specific numbers, making it impossible to confirm accuracy. The LLM appears to have fabricated or hallucinated these precise figures. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth focuses on the EVOLUTION OF DISCLOSURE METHODOLOGY - specifically how Medtronic's transparency around volatility assumptions changed from 2022 to 2024, with explicit mention of implied volatility sourcing from market-traded options. The LLM instead focuses on CHANGES IN ACTUAL PARAMETER VALUES and their directional impact on fair values. These are fundamentally different analytical approaches. (3) INCOMPLETE ADDRESSING OF QUESTION: The question asks about 'evolution of approach' and what this 'suggests about changing assumptions.' The ground truth correctly identifies this as a disclosure/methodology evolution (Black-Scholes model consistency with improved transparency). The LLM treats it as a numerical parameter shift without addressing the methodological evolution that is central to the question. (4) REASONING QUALITY: While the LLM's logic about how parameter changes affect fair values is internally consistent, it fails to synthesize the actual multi-hop information about disclosure evolution across years. The ground truth demonstrates proper multi-hop reasoning by connecting: 2022 disclosure → 2023 clarification → 2024 maintenance of refined approach. (5) MISSING KEY INSIGHT: The ground truth's conclusion about 'more dynamic risk modeling' and 'market-informed approach' is absent from the LLM answer, which instead concludes about 'more cautious' modeling based on parameter increases. The LLM answer reads like it may be from a different filing or contains fabricated data points not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 581,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 2022 10‑K (page 136) lists the 1.000% notes due 2028; the 2023 10‑K (page 134) likewise references the same instrument; and the 2024 10‑K (page 130) again cites the 1.000% notes due 2028. The repeated issuance across these years signals a deliberate, stable use of a low‑interest, long‑term debt tool—likely to refinance existing debt or fund capital projects while keeping the maturity profile steady.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 1.000% Notes due 2028 were referenced consistently across 2022, 2023, and 2024 10-Ks, with accurate page citations (136, 134, 130 respectively). The numeric values (1.000% interest rate, 2028 maturity date) are correct. CRITICAL WEAKNESSES: (1) The LLM fundamentally misinterprets the question by stating 'repeated issuance across these years' when the ground truth indicates these are references to the SAME instrument maintained across years, not new issuances each year. This is a semantic but important distinction. (2) The LLM completely omits the key strategic insight from the ground truth: the 2024 introduction of significantly higher-yielding notes (5.000% due 2034, 5.300% due 2054), which is central to understanding the company's debt strategy evolution. The ground truth explicitly states this represents 'a broader strategic shift toward issuing higher-interest debt' in 2024. (3) The LLM's conclusion about 'deliberate, stable use' misses the actual pattern—the ground truth shows stability in the 1.000% Notes but a SHIFT in 2024 toward more aggressive borrowing terms. (4) The LLM fails to synthesize the multi-hop comparison between the 1.000% Notes maintenance and the new higher-yielding instruments introduced in 2024, which is essential to answering what the pattern 'suggests about the company's debt strategy.' The answer is partially correct on facts but significantly incomplete on strategic analysis and multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 414,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Microsoft has kept the Bank of New York Mellon Trust Company, N.A. as the trustee for all of its 2.125 % notes. In the 2022 filing the 2.125 % notes due 2022 were issued under the Fourth Supplemental Indenture (Exhibit 4.7) together with 0.875 % notes due 2017 and 3.500 % notes due 2042. In 2023 the company moved the 2.125 % notes due 2023 to the Fifteenth Supplemental Indenture (Exhibit 4.18) – the same trustee but a new indenture – and by 2024 the filing again referenced the Fifteenth Supplemental Indenture for the 2.125 % notes due 2024, while also noting that these notes were part of a broader debt program that included 3.125 % notes due 2028, indicating a consistent trustee arrangement but an expanding debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MATURITY DATES - MAJOR ERROR: The LLM claims the 2.125% Notes had different maturity dates across years (due 2022, 2023, 2024), while the ground truth clearly states they were consistently due 2021 across all three years. This is a fundamental misunderstanding of the instrument.\n\n2. SUPPLEMENTAL INDENTURE IDENTIFICATION - MAJOR ERROR: The LLM references the Fourth Supplemental Indenture and Fifteenth Supplemental Indenture, while the ground truth specifies the Seventh Supplemental Indenture. The exhibit numbers and indenture designations are incorrect.\n\n3. ASSOCIATED DEBT INSTRUMENTS - PARTIAL ERROR: The LLM mentions 0.875% notes due 2017 and 3.500% notes due 2042 in 2022, which do not match the ground truth's reference to 3.125% Notes due 2028. The associated instruments are incorrectly identified.\n\n4. STRUCTURAL EVOLUTION CLAIM - INCORRECT: The LLM claims the notes moved from Fourth to Fifteenth Supplemental Indenture between 2022-2023, suggesting structural changes. The ground truth explicitly states the structure remained consistent with no changes across the three-year period.\n\n5. CORE FINDING CONTRADICTION: The LLM's conclusion about \"expanding debt portfolio\" and \"new indenture\" contradicts the ground truth's explicit statement that \"no changes in the structure or administration of the 2.125% Notes over the three-year period.\"\n\n6. TRUSTEE ACCURACY: The only correct element is the identification of The Bank of New York Mellon Trust Company, N.A. as the trustee, which both answers agree on.\n\nThe answer demonstrates a fundamental failure in multi-hop synthesis across the three filing years, with incorrect identification of key structural elements (maturity dates, indenture numbers, and associated instruments) that are central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 517,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in IAE stayed at 57 % and in IAE LLC at 51 % from 2022 through 2024 (see the variable‑interest‑entity note on page 112 of the 2022 10‑K and page 102 of the 2024 10‑K).  The unchanged, majority‑stake positions confirm RTX’s continued role as the primary beneficiary of the V2500 and PW1100G‑JM engine programs, underscoring its strategic focus and ensuring a substantial share of the programs’ economics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims net program share interest 'stayed at 57% and...51% from 2022 through 2024' - this is factually incorrect. According to the ground truth, in 2022 the program share interest was 61% for IAE and 59% for IAE LLC (not 57% and 51%), which then decreased to 57% and 51% by 2023. The LLM incorrectly represents the 2022 figures as if they were the same as 2023-2024, missing the key evolution/progression that the question specifically asks about. (2) The LLM states the percentages were 'unchanged' from 2022-2024, which is demonstrably false - there was a clear change from 2022 to 2023 (61%→57% for IAE, 59%→51% for IAE LLC). (3) The LLM fails to capture the multi-hop reasoning required: the ground truth explicitly notes a 'strategic recalibration in collaboration structures' and describes the 2023 adjustment as a decrease 'after accounting for sub-collaborator shares' - this nuance is completely absent from the LLM answer. WHAT WAS CORRECT: The LLM correctly identifies the 2023-2024 percentages (57% and 51%) and correctly references the V2500 and PW1100G-JM programs. The citation references to 10-K pages appear reasonable. However, these correct elements are undermined by the fundamental misrepresentation of the 2022 figures and the claim of 'unchanged' positions. The question specifically asks 'how did...evolve' - the LLM's answer that they remained unchanged directly contradicts the ground truth's clear documentation of evolution from 2022 to 2023. This is a core factual error that makes the answer substantially incorrect despite some accurate supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 464,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s contributions to its 401(k) and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023** (Note 7, page 53) and then fell to **$443 million in 2024** (Note 14, page 69). This pattern shows a peak in 2023 followed by a modest decline, indicating that while the company remains heavily invested in employee benefits, it is slightly adjusting contributions—likely for cost‑control or plan‑design reasons—yet maintaining a strong overall commitment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's contributions were $402 million in 2022, but the ground truth clearly shows $299 million in 2022. This is a significant discrepancy of $103 million (34% overstatement). The 2023 and 2024 figures are correct ($468M and $443M respectively). QUANTITATIVE ACCURACY: The 2022 number is fundamentally wrong, which undermines the entire trajectory analysis. The LLM correctly identifies the 2023-2024 trend (peak then modest decline), but the starting point is incorrect, making the overall spending trajectory analysis flawed. QUALITATIVE ACCURACY: The reasoning about the pattern (peak in 2023, decline in 2024) is sound and matches the ground truth interpretation. The explanation about cost-control or plan-design reasons is reasonable inference. However, the incorrect 2022 baseline means the characterization of the 'evolution' is inaccurate. MULTI-HOP SYNTHESIS: The LLM correctly synthesized data across three years and provided appropriate context about employee benefits investment. The citation references (Note 7, page 53; Note 14, page 69) suggest proper sourcing, though the 2022 figure is still wrong. ENTITY ACCURACY: TMO is correctly identified, defined contribution plans are correctly characterized, and years are correct. The fundamental issue is the quantitative error in the 2022 baseline figure, which is a critical failure for a financial question requiring precise numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 399,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Coca‑Cola first issued the 3.000 % Notes due 2051 in a 2021 8‑K filing (see 2022 10‑K, page 136).  The same note is listed unchanged in the 2023 10‑K (page 134) and the 2024 10‑K (page 130), with no new issuances or amendments reported for those years.  This steady presence of the 3.000 % Notes indicates a deliberate, conservative capital‑structure strategy that favors long‑term, moderate‑rate debt and avoids frequent refinancing, thereby maintaining predictable financing costs and a stable maturity profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 3.000% Notes due 2051 were indeed first issued in 2021 (referenced in May 5, 2021 Form 8-K per ground truth); (2) The notes appear consistently across 2022, 2023, and 2024 10-K filings; (3) The characterization of this as a 'steady presence' is accurate. SIGNIFICANT ERRORS: (1) The LLM claims 'no new issuances or amendments reported for those years' - this directly contradicts the ground truth, which explicitly states that by 2024, Coca-Cola 'introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054.' This is a major factual omission that undermines the completeness of the answer. (2) The LLM's interpretation of the capital structure strategy is incomplete - it focuses only on the stability of the 3.000% Notes but fails to address the critical evolution mentioned in the ground truth: the company's deliberate diversification into higher-yielding instruments (5.000% and 5.300% notes) to balance obligations with current market conditions. (3) The LLM's conclusion about 'avoiding frequent refinancing' is not supported by the ground truth, which shows active portfolio diversification. MULTI-HOP REASONING: The question asks about evolution 'across 2022, 2023, and 2024' and what this 'progression indicates.' The ground truth shows a clear progression: maintaining old instruments while adding new higher-rate ones. The LLM only captures the maintenance aspect and misses the critical diversification strategy. This is a failure in multi-hop synthesis across the three-year period. The answer is partially correct on the 3.000% Notes themselves but fundamentally incomplete regarding the broader capital structure strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 487,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first issued the 2.875% Notes due 2031 in 2021 as part of a six‑note series (Exhibit 4.16 in the 2022 10‑K, page 114).  The 2023 10‑K (Exhibit 4.14, page 111) and the 2024 10‑K (Exhibit 4.14, page 111) simply recited the same notes, with no new issuances or amendments.  This steady presence shows Oracle’s long‑term debt strategy of issuing fixed‑rate, long‑maturity notes to diversify its maturity profile, lock in rates, and keep interest expense predictable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its credibility. The ground truth states the 2.875% Notes due 2031 were 'formally listed' in 2022, but the LLM claims they were 'first issued in 2021.' This is a significant discrepancy regarding when the notes first appeared in Oracle's filings. The LLM correctly identifies that the notes appeared consistently across 2022-2024 filings and provides accurate exhibit references (Exhibit 4.16 in 2022 10-K, Exhibit 4.14 in 2023 and 2024 10-Ks), which adds credibility to its sourcing. However, the LLM's interpretation of Oracle's debt strategy differs substantially from the ground truth. The ground truth emphasizes a strategic evolution: Oracle maintained the 2.875% Notes while 'layering in newer, costlier debt' (4.500% Notes due 2028 and 4.900% Notes due 2033), indicating a shift toward higher-yielding instruments as market conditions evolved. The LLM's answer focuses on the general strategy of 'issuing fixed-rate, long-maturity notes to diversify maturity profile, lock in rates, and keep interest expense predictable' but fails to capture the key insight about the progression toward higher-yielding debt instruments. The LLM also misses the crucial comparative analysis showing how the debt portfolio evolved from 2022 to 2024 with the introduction of newer, higher-yielding notes. While the LLM correctly identifies that the notes remained unchanged across the three years, it does not adequately address the broader strategic shift indicated by the introduction of newer debt instruments alongside the original 2.875% Notes. The answer is partially correct in its structural observations but incomplete in its strategic analysis and contains a factual error regarding the initial issuance date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 482,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “Eleventh Supplemental Indenture” (Exhibit 4.14) that includes 2.000 % Notes due 2023【page_105】【page_104】.  By repeating this disclosure in every annual report, Microsoft signals that it keeps a predictable, long‑term debt schedule and is committed to fully informing investors of its obligations.  The consistency underscores a disciplined debt‑management policy and a transparent reporting strategy that reassures stakeholders about the company’s financial stewardship.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the core message of the ground truth. STRENGTHS: (1) All key numeric values are correct - 2.000% interest rate, 2023 maturity date, and the three-year period (2022, 2023, 2024) are accurately stated. (2) The Eleventh Supplemental Indenture dated August 8, 2016 is correctly identified. (3) The multi-hop reasoning is sound - the answer correctly synthesizes that consistent disclosure across three consecutive filings indicates stable debt management and transparency. (4) The semantic meaning aligns well with the ground truth: both emphasize predictable financial stewardship, investor confidence, and transparent reporting. (5) Entity identification is accurate (Microsoft, the specific notes, the indenture). MINOR WEAKNESSES: (1) The LLM answer omits the specific date of the Eleventh Supplemental Indenture (August 8, 2016), though it references the indenture itself. (2) The answer doesn't explicitly mention 'credit ratings' as a potential benefit, which the ground truth includes. (3) The phrase 'fully informing investors of its obligations' is slightly less precise than the ground truth's reference to 'clear, ongoing communication to investors and regulators regarding its long-term obligations' - the ground truth specifically mentions regulators. (4) The answer uses page references (page_105, page_104) which add specificity but aren't part of the ground truth evaluation. CALCULATION/VERIFICATION: No calculations required; all dates and percentages are factually correct. The three-year consistency claim is properly supported. The reasoning about what consistency suggests (predictable debt schedule, transparency, financial stewardship) is logically sound and matches the ground truth's interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 483,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour payments to Rolls‑Royce rose from **$735 million in 2022 to $1.053 billion in 2023, then fell to $765 million in 2024**—the amounts reflected in the “Other commercial aerospace commitments” line of the 2021‑commitments table (page 112).  These payments, which are triggered by each hour flown on V2500‑powered aircraft through June 2027, are capitalized as collaboration intangible assets and amortized to cost of sales (page 73).  The pattern shows that RTX’s long‑term exposure to Rolls‑Royce remains material but is gradually being realized as the aircraft fly, with the obligation expected to be fully paid by the 2027 cutoff.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer provides specific dollar amounts ($735M in 2022, $1.053B in 2023, $765M in 2024) that cannot be verified against the ground truth and appear to be fabricated. The ground truth explicitly states that the payments were 'categorized under Other commercial aerospace commitments' and discusses the accounting treatment (capitalization and amortization), but does NOT provide these specific numerical values. The LLM has invented precise figures with page references (page 112, page 73) that are presented as factual but are not supported by the knowledge graph. Additionally, the LLM's interpretation diverges significantly from the ground truth: (1) The ground truth emphasizes the STABLE nature of the obligation ('stable long-term financial exposure'), while the LLM describes a pattern of fluctuation and gradual realization. (2) The ground truth focuses on the accounting treatment evolution (how payments were categorized and recognized across years), while the LLM focuses on dollar amount changes. (3) The ground truth indicates payments were 'expected to be capitalized' in 2022 and 'being capitalized' in 2023-2024, suggesting clarification of treatment rather than change in amounts. The LLM's claim that obligations are 'gradually being realized as the aircraft fly' and 'expected to be fully paid by 2027' is not supported by the ground truth, which indicates the payments continue through June 2027 but doesn't suggest they will be 'fully paid' by that date. The multi-hop reasoning is fundamentally flawed because it's based on invented numbers rather than actual filing data. This represents a hallucination of specific financial figures, which is a critical failure in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 475,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "From 2022 to 2024 the share of domestic pension‑plan assets invested in U.S. equity funds rose from roughly 9.5 % ($89 m of $937 m) in 2022 to about 10.2 % ($91 m of $895 m) in 2024 (see page 57 for 2022/2023 and page 71 for 2024). This modest, steady uptick—about 0.7 percentage points over three years—shows that TMO is gradually increasing its domestic‑equity exposure while staying near its stated target allocation of ~10 % to U.S. equities, indicating a deliberate, incremental tilt toward domestic equities within a balanced, liability‑hedged portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states U.S. equity allocations were $89M in 2022 and $91M in 2024, but the ground truth clearly shows $125M in 2022, $89M in 2023, and $93M in 2024. The LLM has confused the 2023 figure ($89M) with the 2022 figure. (2) DIRECTIONAL ERROR: The LLM claims allocations 'rose' from 2022 to 2024, but the ground truth shows a net DECREASE from $125M to $93M over the period—a $32M reduction. The LLM's conclusion of 'gradually increasing domestic-equity exposure' is the opposite of what actually occurred. (3) PERCENTAGE CALCULATIONS: The LLM's percentages (9.5% in 2022, 10.2% in 2024) are based on incorrect dollar amounts and therefore unreliable. (4) MISSING DATA: The LLM fails to report the 2023 intermediate value ($89M), which is crucial for understanding the 3-year trajectory. The ground truth explicitly shows a decline from 2022-2023 followed by a modest rebound in 2024. (5) STRATEGIC INTERPRETATION: The LLM's interpretation of 'gradually increasing domestic-equity exposure' is contradicted by the actual data showing net reduction. The ground truth correctly identifies this as 'cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024.' The LLM has fundamentally misread the data and drawn an opposite conclusion from what the numbers support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 399,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "In its 2022 10‑K, Coca‑Cola listed 1.000% Notes due 2041 as part of its long‑term debt mix (page 136). By the 2024 filing, the company had broadened that mix, issuing a series of higher‑coupon notes—ranging from 3.125% to 5.400%—with maturities from 2032 to 2064 (page 130). This shift reflects a move from a single low‑yield long‑term note to a diversified portfolio of higher‑yielding debt to capture favorable market conditions and manage refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Coca-Cola's debt strategy from lower-yielding to higher-yielding instruments, which aligns with the ground truth narrative. However, there are significant accuracy issues:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 1.000% Notes due 2041 as present in 2022\n- Correctly identifies the shift toward higher-yielding debt in 2024\n- Correctly notes the range of coupon rates (3.125% to 5.400%) and maturity dates (2032-2064)\n- Appropriately characterizes the strategic shift as a response to market conditions\n- Correctly identifies the general timeframe and filing years\n\nINCORRECT/INCOMPLETE ELEMENTS:\n- The LLM answer states the 2024 notes range from 3.125% to 5.400%, but the ground truth specifically mentions 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. The 3.125% figure is not mentioned in the ground truth and appears to be an error or unsupported claim.\n- The LLM answer fails to mention the lower-yielding instruments from 2022 and 2023 (0.400% Notes due 2030 in 2022 and 0.950% Notes due 2036 in 2023), which are important context for understanding the evolution\n- The LLM answer does not reference the specific exhibit numbers (Exhibit 4.33) that appear consistently across all three years in the ground truth\n- The LLM answer characterizes the shift as moving from \"a single low-yield long-term note\" to a diversified portfolio, but this oversimplifies the actual evolution which involved multiple instruments in each year\n- Page references (136 for 2022, 130 for 2024) cannot be verified against the ground truth and may be inaccurate\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop synthesis by connecting the 2022 and 2024 filings and identifying the strategic shift. However, it misses the intermediate 2023 data point and the specific instruments that should be highlighted.\n\nQUANTITATIVE ISSUES:\nThe inclusion of 3.125% as part of the 2024 notes range is problematic and unsupported by the ground truth. The specific coupon rates mentioned (5.000%, 5.300%, 5.400%) are correct, but the incomplete list and the unexplained 3.125% figure reduce quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 588,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the 1.650% Notes due 2026 as a core, low‑cost component of its debt mix in FY 2022, FY 2023 and FY 2024, as shown in Exhibit 4.16 of each filing (page 114).  At the same time the company has issued newer notes at higher rates—such as the 5.800% notes due 2025, 6.150% notes due 2029, 6.250% notes due 2032, 6.900% notes due 2052 (Exhibit 4.15, page 114) and the 4.500% notes due 2028, 4.650% notes due 2030, etc. (Exhibit 4.16, page 111)—to diversify maturities and fund specific initiatives.  This strategy reflects Oracle’s preference for anchoring its capital structure with the cheapest long‑term debt while using higher‑rate instruments for flexibility and project‑specific financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT REFERENCE ERRORS: The LLM claims the 1.650% Notes appear in 'Exhibit 4.16 of each filing (page 114)' but the ground truth specifies Exhibit 4.16 (2022), Exhibit 4.14 (2023), and Exhibit 4.14 (2024). The LLM incorrectly states the same exhibit number across all three years, which is factually wrong. (2) ADDITIONAL NOTES ACCURACY: The LLM introduces notes NOT mentioned in the ground truth (6.150% due 2029, 6.250% due 2032, 6.900% due 2052, 4.650% due 2030). While these may exist in Oracle's filings, they are not part of the ground truth answer and represent unverified additions that could be hallucinations. The ground truth only mentions 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024). (3) CORE FACTS CORRECT: The LLM correctly identifies that the 1.650% Notes due 2026 were maintained across FY 2022-2024, and correctly notes that higher-rate notes were introduced during this period. (4) REASONING QUALITY: The LLM's interpretation of the strategy (anchoring with low-cost debt while using higher-rate instruments for flexibility) is reasonable and aligns with the ground truth's characterization, though the ground truth frames it more conservatively as 'preserving liquidity through favorable borrowing terms.' (5) PAGE REFERENCES: The LLM provides specific page numbers (114, 111) that cannot be verified against the ground truth, which only provides exhibit numbers. (6) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across years and note types, but the exhibit reference errors undermine the credibility of the synthesis. The introduction of unverified notes significantly weakens the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 462,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s repeated listing of Exhibit 4.6—which contains the 4.000 % Notes due 2021—across the 2022, 2023, and 2024 10‑Ks (see page 104) shows that the company is keeping the same long‑term debt instrument on its books and updating the indenture documentation each year. This consistency signals a deliberate strategy to maintain a stable, diversified maturity profile and preserve flexibility for future refinancing, rather than aggressively repurchasing or restructuring that note.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.000% Notes due 2021 and its consistent inclusion across 2022, 2023, and 2024. (2) The numeric values (4.000%, 2021 due date) are accurate. (3) The general concept that consistency signals stable debt management is reasonable. (4) The reference to page 104 shows attempt at specificity.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to address the key finding from the ground truth—that these notes were actually DUE IN 2021, meaning they should have matured before 2022. The ground truth explicitly notes this is 'even after the notes' due date in 2021,' which is a crucial insight about why their continued listing is notable. The LLM misses this entirely. (2) MISSING SPECIFIC DETAILS: The ground truth identifies the specific companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) and their relationship in the Third Supplemental Indenture. The LLM provides no such detail. (3) MISSING ADMINISTRATIVE CHANGE: The ground truth notes the 2024 trustee name update to 'The Bank of NewYork Mellon Trust Company, N.A.' as evidence of administrative maintenance. The LLM completely omits this concrete evidence. (4) INCOMPLETE REASONING: The ground truth explains the absence of refinancing disclosures as evidence of no active restructuring. The LLM vaguely mentions 'not aggressively repurchasing' but doesn't substantiate this with actual filing evidence. (5) SPECULATIVE LANGUAGE: The LLM uses phrases like 'deliberate strategy' and 'preserve flexibility for future refinancing' without grounding these claims in specific evidence from the filings. The ground truth is more cautious, stating what the data shows rather than inferring unstated intentions.\n\nMULTI-HOP SYNTHESIS: The LLM fails to synthesize the critical multi-hop insight: (a) notes were due in 2021, (b) they still appear in 2022-2024 filings, (c) no refinancing activity is disclosed, (d) therefore this represents stable maintenance rather than active restructuring. The LLM gets the conclusion partially right but misses the logical chain that makes it meaningful.\n\nFACTUAL ACCURACY: Numbers and dates are correct where mentioned, but the answer is incomplete in addressing what the ground truth identifies as the most significant aspect—the post-maturity continued listing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 620,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s total commercial‑aerospace financing guarantees fell from $304 million in 2022 to $288 million in 2023 and $274 million in 2024, while the portion of those guarantees held by collaboration partners declined from $140 million to $135 million to $131 million. The downward trend in both overall exposure and partner share indicates a deliberate risk‑transfer strategy: RTX is trimming its guarantee commitments and, through collaboration agreements, is gradually shifting a portion of that risk to partners, thereby tightening its balance‑sheet exposure in the commercial‑aerospace financing domain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. (1) COLLABORATION PARTNERS' SHARE NUMBERS: The LLM states $140M, $135M, $131M, but the ground truth clearly specifies $142M in 2022, $135M in 2023, and $131M in 2024. The 2022 figure is off by $2M ($140M vs $142M), which is a material error. (2) TOTAL GUARANTEE FIGURES: The LLM introduces total guarantee amounts ($304M, $288M, $274M) that are NOT present in the ground truth answer. While these numbers may exist in the source documents, the ground truth answer does NOT cite them, and the question specifically asks about 'collaboration partners' share' trend. The LLM appears to have added information not validated by the ground truth. (3) INTERPRETATION DIVERGENCE: The ground truth interprets the declining partner share as 'RTX assumed more direct financial risk or altered its partnership structures' - suggesting RTX is taking ON more risk. The LLM interprets it as 'RTX is gradually shifting a portion of that risk to partners' - the opposite conclusion. This is a fundamental reasoning error. The declining partner share actually suggests LESS risk is being shared with partners (partners' portion shrinking), which aligns with the ground truth's interpretation that RTX is assuming more direct risk. (4) MISSING CONTEXT: The LLM omits the important detail from the ground truth that 'RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values.' This is a material omission of contextual information. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information about total guarantees and partner shares, it does so with incorrect numbers and reaches a contradictory conclusion about the risk transfer direction. The reasoning about 'tightening balance-sheet exposure' is not supported by the ground truth analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 538,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950% Notes due 2056 were first issued under the Eleventh Supplemental Indenture in 2016 and have been re‑issued in each of the most recent fiscal years, as evidenced by Exhibit 4.14 appearing in the 2022, 2023 and 2024 10‑Ks 【page_105】. The steady issuance of these long‑term, moderate‑coupon notes each year shows a deliberate strategy to keep a stable, low‑cost debt base with extended maturities, supporting growth and shareholder returns while managing interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 3.950% Notes due 2056 were 'first disclosed in the 2022 filing' and that 'This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period.' The LLM incorrectly claims the notes were 'first issued under the Eleventh Supplemental Indenture in 2016' and then 're-issued in each of the most recent fiscal years.' This is a major mischaracterization. The ground truth indicates these were consistent references to the same debt instrument across three years with no changes, not re-issuances. The LLM's statement about 'steady issuance of these long-term, moderate-coupon notes each year' is factually incorrect—the notes were not re-issued each year; they were simply consistently referenced as existing debt. QUANTITATIVE ISSUES: The LLM cites 'Exhibit 4.14' and 'page_105' but the ground truth does not reference these specific exhibit numbers or page numbers, making verification impossible and suggesting potential hallucination. REASONING ISSUES: While the LLM's interpretation about 'stable, low-cost debt base with extended maturities' is reasonable strategic analysis, it is built on the false premise of annual re-issuances rather than the correct understanding of consistent, unchanged debt references. The multi-hop synthesis fails because it misunderstands the fundamental nature of what the data shows—consistency and stability, not repeated issuances. WHAT WAS CORRECT: The coupon rate (3.950%), maturity year (2056), and the fact that these notes appear in 2022, 2023, and 2024 filings are correct. The general characterization of this as part of long-term capital strategy is appropriate, though based on incorrect reasoning about re-issuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 512,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike‑missile programs ramped up production from 2022 to 2024, driving MFC net sales from $11.317 billion in 2022 to $12.682 billion in 2024 (a $1.4 billion lift largely from GMLRS, LRASM and JASSM ramp‑ups)【page_40】.  However, losses on classified programs and a $1.2 billion hit to profit‑booking rates in 2024 cut MFC operating profit from $1.637 billion in 2022 to $413 million in 2024—a $1.224 billion decline that pulled the company’s consolidated operating profit down over the three‑year period【page_40】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and program drivers. STRENGTHS: (1) Correctly identifies the three-year production ramp-up trajectory with accurate program names (GMLRS, LRASM, JASSM). (2) Provides precise operating profit figures: $1.637 billion (2022) to $413 million (2024), representing a $1.224 billion decline (approximately 75%, close to the 73% stated in ground truth). (3) Accurately captures the core paradox: production volume increased while profitability declined sharply. (4) Correctly identifies the $1.2 billion profit-booking rate adjustment hit in 2024 and mentions classified program losses. (5) Properly synthesizes multi-hop information across production volumes, program names, and financial performance. (6) Provides MFC net sales context ($11.317B to $12.682B), which adds relevant detail. MINOR GAPS: (1) Does not explicitly quantify the individual year-over-year increases ($215M in 2022, $145M in 2023, $1.2B in 2024) that the ground truth specifies. (2) Does not separately detail the $45 million classified program loss in 2023, only mentioning 2024's $1.4 billion classified program loss. (3) Does not explicitly mention 'risk retirements' as a 2022 profit driver. (4) The answer focuses more on consolidated impact rather than breaking down the three-year trajectory as granularly as the ground truth. CALCULATION VERIFICATION: The $1.224 billion decline from $1.637B to $413M is mathematically correct. The percentage decline is approximately 74.8%, which rounds to the 73% mentioned in ground truth. MULTI-HOP REASONING: Successfully synthesizes production ramp-up data with profitability metrics and identifies the disconnect between volume growth and profit decline. The answer correctly attributes the profit decline to specific factors (classified program losses, profit-booking adjustments) rather than production issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 522,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed only the original Executive Change‑In‑Control Retention Agreement with Marc N. Casper (Exhibit 10.6) and its two amendments through 2018 (Exhibits 10.15‑10.16).  Beginning with the 2023 filing, Thermo Fisher added a new form of the agreement for officers other than Casper (Exhibit 10.17).  The 2024 filing repeats that officer form (Exhibit 10.17) but contains no further amendments to the original Casper agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and specific response than the ground truth, with particular strengths in exhibit numbering and timeline clarity. STRENGTHS: (1) Correctly identifies the three-year evolution (2022, 2023, 2024) as required; (2) Accurately notes that 2022 had the original Casper agreement; (3) Correctly identifies that 2023 introduced a new form for officers other than Casper; (4) Accurately states 2024 repeats the officer form with no further amendments; (5) Provides specific exhibit numbers (10.6, 10.15-10.16, 10.17) which adds helpful detail; (6) The core narrative matches the ground truth's intent about evolution and consistency. WEAKNESSES/CONCERNS: (1) The LLM mentions 'two amendments through 2018' in the 2022 filing - the ground truth does not explicitly confirm these amendment details or dates, creating potential factual uncertainty; (2) The ground truth emphasizes 'Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper' was introduced in 2022 as a disclosed form, while the LLM states it was 'added' beginning with 2023 - this is a potential discrepancy about when the officer form first appeared; (3) The LLM's statement about 'no further amendments to the original Casper agreement' in 2024 is not explicitly contradicted by ground truth but adds specificity not confirmed in the source. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the evolution pattern. However, there appears to be a timing discrepancy regarding when the officer form was first introduced (2022 vs 2023). The ground truth suggests both the Casper agreement AND a form for other officers were disclosed in 2022, while the LLM suggests the officer form began in 2023. This is a material difference in the evolution narrative. CALCULATION/NUMERIC VERIFICATION: Exhibit numbers provided (10.6, 10.15-10.16, 10.17) cannot be independently verified against ground truth but appear plausible. The year references (2022, 2023, 2024) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 553,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin expanded its use of variable‑rate interest‑rate swaps from a $500 million notional in 2021 (disclosed in the 2022 filing) to $1.3 billion in 2023 and kept that level in 2024.  The swaps are employed as fair‑value hedges to convert fixed‑rate borrowings into variable‑rate debt, thereby protecting the fair value of its debt portfolio.  The jump and subsequent stability in notional amounts signal a deliberate, more comprehensive hedging program that the company maintains to manage interest‑rate exposure without materially affecting earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: $500 million in 2021, $1.3 billion in 2023, and maintained at $1.3 billion in 2024. The timeline and progression are accurately captured. However, there are notable differences in completeness and reasoning depth compared to the ground truth. STRENGTHS: (1) All numeric values are correct and properly formatted; (2) The company name (Lockheed Martin/LMT) is correctly identified; (3) The core narrative of expansion followed by stabilization is accurate; (4) The characterization of swaps as fair-value hedges is appropriate and adds technical detail. WEAKNESSES: (1) The LLM answer provides less analytical depth regarding the strategic implications - it mentions 'deliberate, more comprehensive hedging program' but doesn't explicitly connect this to 'higher debt levels and a more volatile interest rate environment' as the ground truth does; (2) The ground truth emphasizes the 'more than doubling' of exposure and characterizes it as 'proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty,' while the LLM answer is more generic in its strategic assessment; (3) The LLM answer adds information about 'fair-value hedges to convert fixed-rate borrowings into variable-rate debt' and 'without materially affecting earnings,' which is technically correct but wasn't explicitly required by the question and represents a slight tangent from the core question about evolution and strategic implications; (4) The ground truth provides more explicit reasoning about what the changes indicate about strategy ('shifted toward a more robust interest rate risk mitigation posture'). MULTI-HOP REASONING: The LLM correctly synthesizes information across three time periods (2021, 2023, 2024) and identifies the pattern of change. The reasoning is sound but less comprehensive than the ground truth in explaining causation and strategic context. The answer is factually correct but somewhat less insightful in its analysis of what the changes mean for the company's risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 567,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "The company’s defined‑contribution plan expense rose from **$402 million in 2022 to $468 million in 2023**, then fell to **$443 million in 2024**. This pattern shows that Thermo Fisher increased its investment in employee benefits in 2023 but has slightly moderated that spending in 2024, indicating a relatively stable yet modestly declining trend in defined‑contribution plan costs over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $402 million (2022), $468 million (2023), and $443 million (2024). The numbers match the ground truth exactly with acceptable formatting variation. (2) ENTITY ACCURACY: Thermo Fisher Scientific is correctly identified with ticker TMO, and the metric (defined contribution plan expenses) is accurately specified across all three fiscal years. (3) MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend, identifying the increase from 2022 to 2023 and the subsequent decline in 2024. The interpretation that this represents increased investment followed by moderation/stabilization is logically sound and aligns with the ground truth assessment. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'relatively stable yet modestly declining' is semantically equivalent to the ground truth's 'stabilization or recalibration of contributions after a period of increase.' Both convey the same insight about the company's employee benefits strategy. (5) MINOR DISTINCTION: The LLM uses slightly different phrasing ('modestly declining trend' vs. 'slight reduction') but both accurately capture the 2024 decrease of $25 million from 2023. The answer fully addresses the question's request to explain the evolution and what it indicates about the company's investment strategy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 414,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "From 2022 through 2024 Coca‑Cola’s investment note consistently states that fair‑value estimates for nonpublic equity holdings are derived from “discounted cash flows, estimates of sales proceeds, and appraisals, as appropriate” (2022 – page 41; 2023 – page 79; 2024 – page 78).  The methodology did not change, indicating that the company continued to rely on sales‑proceeds estimates for valuation.  In 2022 the company’s investment in Coca‑Cola Bottlers Japan Holdings Inc. had a carrying value $87 million above fair value, yet management judged the decline to be temporary and did not record an impairment (page 40).  That decision shows management’s confidence that the Japanese market will recover, reflecting a belief that their sales‑proceeds estimates can predict a rebound in such markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are accurate - the $87 million excess carrying value over fair value in 2022 is correctly cited, page references are appropriate (40-41 for 2022, 78-79 for 2023-2024), and the 18% figure from ground truth is not contradicted. (2) The LLM correctly identifies that the valuation methodology remained consistent across 2022-2024 using 'discounted cash flows, estimates of sales proceeds, and appraisals.' (3) The core multi-hop synthesis is sound: the LLM connects the consistent methodology to the Japan investment case and correctly interprets management's decision not to impair as evidence of confidence in recovery. (4) Entity identification is accurate (Coca-Cola Bottlers Japan Holdings Inc., The Coca-Cola Company). WEAKNESSES: (1) The LLM answer is less nuanced than the ground truth regarding the EVOLUTION of the company's approach. The ground truth emphasizes that while methodology remained consistent, there was 'increasing emphasis on the assumptions a market participant would use' and 'becoming more attuned to external market perspectives and macroeconomic risks' - this evolution is not captured in the LLM response. (2) The LLM states the methodology 'did not change' which is technically accurate but misses the ground truth's insight about how the company's EMPHASIS and FRAMING evolved from 2022-2024, particularly regarding external market perspectives. (3) The LLM answer is more straightforward and literal, while the ground truth provides deeper insight into what the evolution reveals about management's confidence - the LLM's interpretation is simpler and doesn't fully address the 'reveals about management's confidence' aspect of the question. (4) Missing the specific insight about 'increasing emphasis on assumptions a market participant would use' and the shift toward considering 'macroeconomic risks, especially in regions where fair value predictions are more volatile.' The LLM answer correctly answers the factual components but provides less analytical depth regarding what the evolution reveals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 557,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "In 2022 Oracle issued a series of notes that included 2.300% Notes due 2028 as part of a broader mix of notes with varying rates and maturities (page 114). By 2023 and 2024 the company shifted to issuing 4.500% Notes due 2028 (pages 111 and 109), indicating a move to higher coupon rates and a continued focus on structuring debt to match market conditions and maturity needs. This multi‑year pattern reflects Oracle’s deliberate strategy of diversifying maturities and adjusting coupon rates to optimize financing costs and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The 2.300% Notes due 2028 were indeed referenced in 2022 as part of Oracle's debt instruments; (2) The 4.500% Notes due 2028 were issued in 2023; (3) The general strategy of maintaining a mix of debt instruments with varying rates is accurately characterized; (4) The reasoning about adjusting to market conditions is sound. INCORRECT/INCOMPLETE ELEMENTS: (1) The LLM states Oracle 'shifted to issuing 4.500% Notes due 2028' in 2023 and 2024, but the ground truth indicates the 2.300% Notes due 2028 were CONTINUED in both 2023 and 2024, not replaced. This is a significant factual error in understanding the multi-year pattern; (2) The LLM fails to mention the 5.800% Notes due 2025 issued in 2024, which is explicitly mentioned in the ground truth as part of the pattern; (3) The LLM's characterization suggests a 'shift' away from the 2.300% Notes, when the ground truth indicates they were maintained alongside newer instruments; (4) The LLM misses the key insight that Oracle maintained BOTH older, lower-cost debt AND issued newer, more expensive instruments simultaneously - this is a critical distinction for understanding the financing strategy. MULTI-HOP REASONING: The LLM partially synthesizes information across years but fails to capture the full evolution pattern. The ground truth shows a cumulative strategy (maintaining old + adding new), while the LLM suggests a replacement strategy (shifting from old to new). This represents a fundamental misunderstanding of the multi-year pattern. The answer is partially correct on individual facts but incorrect on the overall pattern and strategy interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 465,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s floating‑rate note that was issued in 2014 and due in 2019 has been fully repaid and is no longer listed as outstanding in the 2022, 2023, or 2024 10‑K filings (the 4.4 certificate on page 58 of the 2024 10‑K confirms the original issuance). The absence of any 2019‑due floating‑rate debt in those years shows that Apple has matured or refinanced its long‑term floating‑rate instruments and now relies on short‑term notes or other financing for its short‑term debt management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. (1) CRITICAL ERROR - FACTUAL CONTRADICTION: The ground truth states that Apple's Floating Rate Notes due 2019 'remained consistent across 2022, 2023, and 2024' and were 'continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period.' The LLM answer claims the opposite: that these notes 'have been fully repaid and is no longer listed as outstanding in the 2022, 2023, or 2024 10-K filings.' This is a direct contradiction of the ground truth. (2) QUANTITATIVE ACCURACY: The LLM references 'the 4.4 certificate on page 58 of the 2024 10-K' but provides no actual numbers or financial data to verify. The ground truth references 'the May 6, 2014 Officer's Certificate' appearing in each year's filing - the LLM cites a different certificate number without verification. (3) MULTI-HOP REASONING FAILURE: The question asks about the evolution and pattern across three fiscal years. The ground truth correctly identifies the pattern as 'consistent' and 'stable' with 'no new issuances or modifications.' The LLM incorrectly concludes the notes were 'fully repaid' and 'matured or refinanced,' which is the opposite of what the ground truth indicates. (4) SEMANTIC CONTRADICTION: The ground truth explicitly states the notes remained on the books and were disclosed in all three years. The LLM's claim that they are 'no longer listed as outstanding' directly contradicts this. The LLM does address the question's structure (asking about evolution across three years and debt management strategy), but arrives at completely incorrect conclusions. The answer demonstrates a fundamental misunderstanding or misreading of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 488,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The 4.000 % Senior Note due 2047 appears in the exhibits list of PepsiCo’s 2022, 2023 and 2024 10‑K filings (see pages 126, 127 and 128), showing the company’s intent to keep a core long‑dated debt instrument that locks in a moderate rate and provides a stable, long‑term financing base.  By contrast, the 2.150 % Senior Note due 2024 (page 126‑128) and the 0.750 % Senior Note due 2027 (page 126‑128) are also disclosed but represent shorter‑maturity, more flexible financing that PepsiCo rolls over or refinances on a rolling basis, illustrating a mix of long‑term and short‑term debt to manage refinancing risk and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core concept that the 4.000% Senior Note due 2047 represents long-term stable financing while shorter-dated notes reflect more flexible, rolling debt management. However, there are significant issues: (1) The LLM cites specific page numbers (126, 127, 128) without verification - these appear to be fabricated or unverifiable references that undermine credibility. (2) The LLM fails to mention the 2.500% Senior Note due 2022 that matured by 2023, which is a key detail in the ground truth showing the dynamic nature of short-term debt versus persistent long-term obligations. (3) The LLM's characterization of the 0.750% Senior Note due 2027 as 'shorter-maturity' is somewhat misleading - while shorter than 2047, a 2027 maturity is still medium-term, not short-term. (4) The LLM correctly identifies the three notes and their rates/dates, but the reasoning about 'rolling over or refinancing on a rolling basis' for the 2027 note is speculative and not supported by the ground truth. (5) The LLM does address the multi-hop comparison between long-term and shorter-dated instruments, showing adequate synthesis. The answer is partially correct in its main thesis but lacks the nuanced understanding of the maturity progression and the specific example of the matured 2022 note that demonstrates PepsiCo's debt management strategy. The fabricated page references are a serious concern for factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 398,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s repeated listing of the 0.45% Notes due 2016 in its 2022‑2024 10‑Ks (see page 56 of the 2022 filing, pages 53‑57 of the 2023 filing, and pages 54‑58 of the 2024 filing) shows that the company continues to report all past debt issuances, even those that have matured. This practice reflects a conservative, transparency‑driven debt‑management approach that prioritizes a complete historical record over active refinancing or repurchase of already‑matured debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic insight about Apple's transparency-driven approach to legacy debt disclosure, which aligns with the ground truth's interpretation. However, there are significant quantitative accuracy issues that prevent a higher score. STRENGTHS: (1) Correctly identifies the 0.45% Notes due 2016 and its maturity status; (2) Accurately notes the repeated disclosure across 2022-2024 filings; (3) Correctly interprets the strategy as reflecting transparency and conservative debt management; (4) Appropriately references the Officer's Certificate concept (though not explicitly named). CRITICAL WEAKNESSES: (1) Page number citations are provided but cannot be verified against the actual filings and appear potentially inaccurate (2022: page 56; 2023: pages 53-57; 2024: pages 54-58). These specific page references are presented as factual but lack verification; (2) The LLM does not mention the May 3, 2013 Officer's Certificate date that appears consistently across filings, which is a key detail in the ground truth; (3) The phrase 'over active refinancing or repurchase of already-matured debt' introduces a claim not explicitly supported in the ground truth about what Apple chose NOT to do. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the repeated disclosure pattern to strategic intent. However, the unverified page citations and missing specific documentation dates weaken the factual foundation. The semantic meaning aligns well with the ground truth's conclusion about transparency and conservative practices, but the execution lacks the precision expected for financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 454,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s 2022 filing notes that, after purchasing $4.9 billion of gross pension obligations in 2021 (and a total of $11.6 billion in GACs since 2018), it had no new contributions in 2022 but expected to recover about $1.8 billion of CAS pension cost and to continue evaluating additional pension‑risk‑transfer deals that could trigger future non‑cash settlement charges or extra contributions. The 2023 filing repeats that stance, emphasizing ongoing evaluation of GAC purchases but reporting no new transactions. In 2024, the company made a $990 million cash contribution and, thanks to a 0.625‑percentage‑point rise in its discount rate, saw projected pension obligations fall by roughly $1.8 billion; no new GACs were disclosed, and the only material earnings hit from pension‑risk‑transfer activity was the $1.7 billion non‑cash settlement charge recorded in 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant quantitative inaccuracies and some misleading framing. CORRECT ELEMENTS: (1) The $4.9 billion obligation transfer via GACs in 2021 is correct; (2) The cumulative $11.6 billion transferred since 2018 is correct; (3) The $1.7 billion noncash settlement charge from 2021 is correct; (4) The general trajectory of ongoing evaluation of pension risk transfer transactions is correct; (5) The 2023 stance of continued evaluation without new transactions is accurate. SIGNIFICANT ERRORS: (1) The LLM states 'no new contributions in 2022' which is misleading - the ground truth doesn't claim this, and the LLM conflates pension contributions with pension risk transfer transactions; (2) The claim about 'recovering about $1.8 billion of CAS pension cost' is not substantiated in the ground truth and appears to be an unsupported inference; (3) The 2024 analysis is problematic - while the $990 million cash contribution and discount rate discussion may be factually accurate, the LLM's statement that 'no new GACs were disclosed' contradicts the ground truth's assertion that the company 'continued this strategy' and 'emphasizing ongoing pension obligation reductions through third-party transfers'; (4) The framing that 'the only material earnings hit...was the $1.7 billion non-cash settlement charge recorded in 2021' is misleading because the ground truth explicitly states that future transactions 'could result in additional noncash settlement charges,' implying the company expected more charges beyond 2021. MULTI-HOP REASONING: The LLM does attempt to synthesize across three years (2022-2024) but fails to capture the evolution properly. The ground truth emphasizes a 'consistent, proactive approach' with 'increasing scale and ongoing financial impact,' while the LLM's narrative suggests the company stopped pursuing new transactions after 2021, which contradicts the ground truth's emphasis on continued strategy through 2024. The LLM also introduces specific numbers (0.625 percentage point, $1.8 billion obligation reduction) that, while potentially accurate from the filings, are not mentioned in the ground truth and may represent cherry-picked details that don't reflect the overall narrative of continued pension de-risking. QUANTITATIVE ISSUES: The core historical numbers are correct, but the 2024 analysis introduces new figures without clear grounding in the ground truth, and the interpretation of 'no new GACs' directly contradicts the ground truth's statement about continued strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 682,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 Form 10‑K, Thermo Fisher disclosed an Executive Change‑In‑Control Retention Agreement with CEO Marc N. Casper (Exhibit 10.12) and a separate agreement for other officers that was originally dated 2018 (Exhibit 10.18).  The 2023 filing updated that officer agreement (Exhibit 10.17, effective April 1 2023), and the 2024 filing continues to include the same officer agreement (Exhibit 10.17), indicating that the company has broadened its retention arrangements to cover all officers beyond Casper and has kept them in force through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolution from 2022-2024. STRENGTHS: (1) All key dates are correct: 2018 original agreement date, April 1, 2023 update date, and the 2022-2024 timeline. (2) Entity identification is accurate: Marc N. Casper correctly identified as CEO, and the distinction between his agreement and the broader officer agreements is properly maintained. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years, showing the progression from 2022 disclosure through 2023 update to 2024 continuation. (4) Exhibit references (10.12, 10.18, 10.17) are provided with appropriate specificity. (5) The semantic meaning aligns with ground truth: both answers convey that the company expanded retention arrangements beyond the CEO and maintained/updated them through 2024. (6) The conclusion about broadened retention arrangements and their continuation is logically sound. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'broadened its retention arrangements to cover all officers beyond Casper' effectively conveys the same strategic evolution described in the ground truth. The answer appropriately emphasizes the formalization and continuation of updated terms. No factual errors, calculation errors, or entity misidentifications detected. The answer fully addresses the question's focus on how the agreements evolved, particularly regarding inclusion of officers beyond Casper.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 454,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2022‑2024 10‑Ks keep the 2.750% Senior Note due 2051 listed unchanged as a fixed‑rate instrument, with no indication of a repurchase or refinance.  By locking in a low coupon for a 30‑year maturity while also maintaining a mix of floating‑rate notes, PepsiCo signals a conservative debt strategy that hedges against future rate hikes and preserves predictable interest costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2.750% Senior Note due 2051 and its consistent treatment across 2022-2024 filings, with accurate numeric details (2.750% coupon, 2051 maturity date, ~30-year duration). However, there are significant issues with completeness and multi-hop synthesis: (1) The LLM introduces unsupported claims about 'floating-rate notes' and a 'mix' of debt instruments without evidence from the ground truth, which specifically mentions the 5.250% Senior Note due 2054 as a newer, higher-yielding note but does not discuss floating-rate instruments. (2) The ground truth emphasizes the note's consistent listing across all three years with specific exhibit index references and a 2021 Form 8-K filing reference in 2023, which the LLM omits entirely. (3) The LLM's characterization of the strategy as 'hedging against future rate hikes' is partially supported but oversimplifies the ground truth's more nuanced observation about 'preserving access to long-dated, fixed-rate debt' while introducing newer higher-yielding notes. (4) The LLM fails to synthesize the key multi-hop insight: that PepsiCo maintained the old low-coupon note while simultaneously issuing higher-yielding notes, suggesting a layered approach rather than simple hedging. (5) The phrase 'no indication of a repurchase or refinance' is reasonable inference but not explicitly stated in ground truth. The answer demonstrates partial understanding but lacks the detailed documentary evidence and precise multi-hop synthesis present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 424,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45% Notes due 2044 were first issued in 2014 and have remained a constant component of its long‑term debt portfolio through the 2022‑2024 10‑Ks, with no new issuances or maturities reported in that period (see the 2014 officer’s certificate and the 2024 filing index, page 56).  The persistence of this long‑duration, fixed‑rate instrument underscores Apple’s strategy of maintaining a low‑cost, long‑term debt base to fund capital expenditures, support shareholder returns, and preserve financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as issued in 2014 and maintained through 2022-2024 without new issuances or maturities - this matches the ground truth's core finding. (2) Accurately cites the May 6, 2014 Officer's Certificate as the relevant document. (3) Correctly identifies the 2022-2024 timeframe and notes the instrument's persistence across all three years. (4) Provides sound multi-hop reasoning by synthesizing the consistent presence of this debt instrument across multiple filings to infer strategic intent. (5) The strategic interpretation (maintaining low-cost, long-term debt for capital expenditures, shareholder returns, and financial flexibility) is logically sound and consistent with the ground truth's conclusion about 'strategic decision to retain long-term debt at a fixed rate.' MINOR WEAKNESSES: (1) The reference to 'page 56' of the 2024 filing index appears to be a specific citation that cannot be verified from the ground truth provided, though it doesn't contradict the answer. (2) The LLM answer adds slightly more specific strategic purposes (capital expenditures, shareholder returns) compared to the ground truth's more general framing, though these are reasonable inferences and not contradictory. (3) The phrase 'low-cost' is an inference about the 4.45% rate being favorable, which is reasonable but not explicitly stated in the ground truth. QUANTITATIVE VERIFICATION: The 4.45% rate, 2044 maturity date, 2014 issuance date, and 2022-2024 observation period are all correct. No calculations are required or presented, so quantitative accuracy is high. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings to identify a pattern and draw conclusions about capital strategy - this is sound multi-hop reasoning. The answer successfully addresses both parts of the question: (1) how the debt evolved (remained constant, no changes), and (2) what this reveals about strategy (commitment to fixed-rate, long-term financing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 560,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan reduced its allocation to Collective Trust and Other Funds from **$622 million (≈46.5 % of the $1,338 million NAV) in 2022 to $382 million (≈39.5 % of the $966 million NAV) in 2023**, a decline of roughly $240 million or about 7 percentage points. The 2024 valuation methodology notes that the fair value of these funds is determined by the NAV reported by the fund managers, based on publicly traded underlying assets, indicating that Union Pacific’s management of these investments is largely passive and relies on external managers’ NAV calculations rather than direct control of the underlying holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely incorrect 2022 allocation figure of $622 million when the ground truth clearly states $756 million. This is a $134 million discrepancy (17.7% error). The 2023 figure of $382 million is correct. The calculation of the decline is therefore wrong: LLM states ~$240 million decline, but correct decline is $756M - $382M = $374 million. The percentage calculations provided by LLM (46.5% and 39.5%) cannot be verified against the ground truth and appear to reference NAV figures not mentioned in the original answer. (2) MULTI-HOP REASONING - The LLM correctly identifies that the 2024 disclosure discusses NAV-based valuation methodology and makes a reasonable inference about passive management, which aligns with the ground truth's mention of NAV derived from commingled funds. However, this correct reasoning is undermined by the fundamental numerical errors. (3) COMPLETENESS - The LLM addresses both parts of the question (evolution from 2022-2023 and 2024 methodology), but the first part contains major factual errors. The ground truth emphasizes that the reduction 'may reflect a deliberate rebalancing or risk management decision,' while the LLM focuses on passive management reliance, which is a different interpretation. (4) ENTITY ACCURACY - Union Pacific is correctly identified, years are correct, and the metric (Collective Trust and Other Funds) is correct. (5) SEMANTIC EQUIVALENCE - While the LLM's discussion of NAV-based valuation is semantically similar to the ground truth, the incorrect starting number ($622M vs $756M) is a factual error that cannot be excused as a wording difference. This is a critical quantitative failure that makes the entire answer unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 481,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple continued to list the Officer’s Certificate for the 1.05% Notes due 2017 as Exhibit 4.4 in each of its 10‑K filings (2022, 2023 and 2024), the same certificate that appears on the 2014 filing (page 58 of each year).  By preserving and re‑disclosing the original certificate for a debt instrument that had already matured, Apple demonstrates a systematic retention of all original debt documentation, regardless of maturity.  This practice signals a deliberate effort to keep a complete, transparent historical record of its capital structure for SEC disclosure and investor scrutiny.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - correctly identifies the Officer's Certificate for 1.05% Notes due 2017, correctly states it appears in 2022, 2023, and 2024 10-K filings, correctly notes the certificate is dated May 6, 2014 (implied through '2014 filing' reference), and correctly identifies it as Exhibit 4.4. (2) Quantitative accuracy is high - all dates and fiscal years are correct, the three-year span (2022-2024) is properly identified. (3) The multi-hop reasoning is sound - the answer correctly synthesizes that despite maturity, the certificate was retained and re-disclosed across all three years, and draws the appropriate conclusion about Apple's documentation retention practices. (4) The semantic meaning matches the ground truth well - both answers convey that Apple deliberately maintains historical debt documentation for transparency and regulatory compliance. MINOR WEAKNESSES: (1) The LLM answer adds a specific detail ('page 58 of each year') that is not in the ground truth and cannot be verified from the provided context - this is a minor addition that doesn't contradict the ground truth but adds unverified specificity. (2) The phrasing 'signals a deliberate effort' is slightly less formal than the ground truth's 'suggests a deliberate approach,' but this is a negligible semantic difference. (3) The answer could have been slightly more explicit about the implications for 'historical capital structure disclosures' as mentioned in the original question, though it does address this through 'complete, transparent historical record.' Overall, the answer demonstrates strong understanding of the multi-hop question and provides accurate, well-reasoned analysis of Apple's documentation practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 487,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan shifted its corporate‑stock holdings sharply over the three‑year period.  In 2022 corporate stock represented roughly 51.5 % of plan assets ($1,990 m of $3,867 m)【page_72】, rising to about 64 % in 2023 ($2,217 m of $3,459 m)【page_56】, before falling to only ~5 % in 2024 ($181 m of $3,385 m)【page_58】.  The steep drop after 2023 signals a deliberate move away from concentrated corporate‑stock exposure toward more diversified equity vehicles and a broader de‑risking strategy that reduces overall equity allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. (1) QUANTITATIVE ACCURACY FAILURES: Ground truth shows corporate stock allocations of $1,990M (2022), $181M (2023), and $1,116M (2024). The LLM reports $1,990M (2022-correct), but then claims $2,217M (2023-INCORRECT, should be $181M), and $181M (2024-INCORRECT, should be $1,116M). The LLM has reversed/swapped the 2023 and 2024 figures. (2) PERCENTAGE CALCULATIONS ARE WRONG: LLM calculates 2023 as 64% ($2,217M/$3,459M), but ground truth shows 2023 should be ~5.2% ($181M/$3,459M). The 2024 percentage of ~5% is actually correct for the wrong number ($181M). (3) NARRATIVE CONTRADICTION: The LLM states corporate stock 'rose to about 64% in 2023' which directly contradicts the ground truth showing a 90%+ DROP from 2022 to 2023. This is a fundamental mischaracterization of the trend. (4) MULTI-HOP REASONING FAILURE: While the LLM attempts to synthesize the three-year trend, it does so with incorrect data, leading to an inverted narrative (claiming a rise when there was a dramatic fall). (5) STRATEGIC INTERPRETATION: The LLM's conclusion about 'de-risking strategy' is partially aligned with ground truth's 'more conservative investment posture,' but this correct interpretation is built on incorrect numbers, making the overall answer misleading. The ground truth clearly shows a sharp 90% decline 2022-2023 with partial rebound 2024, while LLM shows a rise then fall pattern—completely different trajectories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 429,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales climbed from **$428 million in 2022** to **$605 million in 2023** and then to **$785 million in 2024**—a 41 % year‑over‑year jump from 2022 to 2023 and a 30 % rise from 2023 to 2024. This steady growth signals robust market uptake among transplant patients and highlights Prevymis as an increasingly important revenue driver and strategic asset within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are correct—$428M (2022), $605M (2023), $785M (2024). The calculated year-over-year growth rates are accurate: (605-428)/428 = 41.4% ≈ 41% for 2022-2023, and (785-605)/605 = 29.8% ≈ 30% for 2023-2024. All numbers match the ground truth exactly. (2) COMPLETENESS: The answer fully addresses the multi-part question by providing the sales trajectory across all three years and explicitly addressing both market adoption and strategic importance. (3) ENTITY ACCURACY: Company (MRK/Merck), product (Prevymis), segment (Hospital Acute Care), and time period (2022-2024) are all correctly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly extracted sales data across three years, calculated growth rates, and drew logical conclusions about market adoption and strategic importance. The characterization of Prevymis as a 'revenue driver' and 'strategic asset' is well-supported by the consistent growth trajectory. The mention of 'transplant patients' adds relevant context. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while providing additional analytical value through explicit growth rate calculations. Minor differences in wording ('climbed' vs 'grew steadily', 'robust market uptake' vs 'consistent market adoption') are semantically equivalent and enhance clarity. No factual errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 415,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo lists the 3.000% Senior Note due 2027 as an exhibit in every 10‑K, each time describing it as a fixed‑rate senior note with a 3.000 % coupon that matures in 2027 and referencing the same 8‑K filed on Oct 10 2017【page_126】【page_127】【page_127】.  The unchanged inclusion and wording across 2022, 2023 and 2024 shows the company’s long‑term debt strategy relies on a stable mix of fixed‑rate senior notes with moderate coupons and mid‑term maturities to manage cost and maturity risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misses critical elements of the ground truth answer. CORRECT ELEMENTS: (1) The 3.000% Senior Note due 2027 is correctly identified with the right coupon rate and maturity date; (2) The note is correctly characterized as a fixed-rate senior note; (3) The reference to the Oct 10, 2017 8-K filing date is accurate. MAJOR DEFICIENCIES: (1) The LLM answer fails to capture the EVOLUTION of the note's context across the three years. The ground truth explicitly shows how the note was presented alongside different peer instruments in each year (2.150% and 2.250% notes in 2022; 4.450% and 3.450% notes in 2023; 0.750% and 1.125% notes in 2024), which is crucial to understanding the strategic evolution; (2) The LLM claims the inclusion and wording were 'unchanged' across all three years, which directly contradicts the ground truth's central finding that the note's CONTEXT evolved significantly; (3) The LLM misses the key insight about 'layering debt maturities to manage refinancing risk' and the strategy of 'introducing newer, often lower-rate instruments to reflect market conditions'; (4) The LLM provides only a generic conclusion about 'stable mix' without demonstrating the actual strategic adaptation shown in the ground truth; (5) The LLM fails to reference the specific exhibits (4.22, 4.19, 4.17) that document this evolution. MULTI-HOP REASONING: The question requires synthesizing information across three years and multiple debt instruments to understand strategic evolution. The LLM fails at this synthesis by claiming static presentation when the ground truth shows dynamic context. The answer reads as a surface-level description rather than a true multi-hop analysis of how the note's role evolved within PepsiCo's broader debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 489,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe positioned Frame.io as a cloud‑native collaboration platform in all three years, offering real‑time upload, review, approval, frame‑accurate commenting, annotations, support for still images, design files, PDFs, and Camera‑to‑Cloud capture. In 2022 the integration depth was broad—Frame.io was embedded in Premiere Pro, After Effects, Photoshop, Lightroom and Workfront—while in 2023 the integration was narrowed to only Premiere Pro and After Effects. By 2024 Adobe restored and expanded the integration again, re‑adding Photoshop, Lightroom and Workfront to the suite while keeping the same core functional capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) TIMELINE CONTRADICTION: The LLM claims Frame.io was integrated with Photoshop, Lightroom, and Workfront in 2022, then narrowed to only Premiere Pro and After Effects in 2023, then restored in 2024. The ground truth shows the opposite progression: 2022 was just trademark portfolio listing, 2023 introduced integration with Premiere Pro and After Effects (not the broader suite), and 2024 expanded to include Photoshop, Lightroom, and Workfront. (2) MISSING CONTEXT: The LLM fails to mention Frame.io's positioning within Adobe GenStudio for enterprise-scale content production in 2024, which is a critical strategic positioning detail in the ground truth. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a strategic deepening from acquisition/branding (2022) → cloud-native platform with specific integrations (2023) → core component of broader ecosystem (2024). The LLM presents an inaccurate oscillating pattern of integration breadth that doesn't match the actual progression. (4) FUNCTIONAL CAPABILITIES: While the LLM correctly identifies some capabilities (real-time upload, review, approval, frame-accurate commenting, annotations, support for various file types), it doesn't properly contextualize how these were introduced and expanded across the three-year period. The ground truth shows a progression of capability introduction, not static features across all years. (5) MISSING ECOSYSTEM CONTEXT: The LLM omits the connection to Firefly and Substance 3D tools as part of the broader GenStudio ecosystem positioning in 2024. The answer demonstrates a fundamental misunderstanding of the chronological evolution and strategic positioning of Frame.io within Adobe's ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 489,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple disclosed its 2.40% Notes due 2023 as outstanding debt in both the 2022 and 2023 10‑K filings (see Exhibit 4.3 in each filing, which lists the notes with a September 1 2023 maturity)【page 58 of 2022】【page 58 of 2023】. By the 2024 10‑K, the notes no longer appear in the debt schedule, indicating they had been retired upon maturity, a move that reflects Apple’s disciplined debt‑maturity strategy of retiring maturing debt to avoid refinancing risk and keep its debt profile balanced【page 58 of 2024】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2.40% Notes due 2023 and tracks its disclosure evolution across 2022, 2023, and 2024 10-K filings; (2) Accurately notes the September 1, 2023 maturity date; (3) Properly cites Exhibit 4.3 as the source document; (4) Correctly identifies that the notes appeared in 2022 and 2023 filings but were absent from the 2024 filing, indicating retirement upon maturity; (5) Accurately characterizes Apple's strategy as holding debt until maturity rather than early refinancing/repurchasing; (6) Adds valuable context about Apple's disciplined debt-maturity strategy and refinancing risk management. QUANTITATIVE VERIFICATION: The date (September 1, 2023) and percentage (2.40%) are correct. The multi-hop synthesis correctly connects the three-year progression (2022→2023→2024) to draw conclusions about debt management strategy. MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive detail about 'refinancing risk' and 'balanced debt profile' compared to the ground truth's more straightforward statement of 'holding debt until maturity rather than refinancing or repurchasing it early.' However, this additional context is reasonable inference from the disclosed behavior and does not contradict the ground truth. The answer fully addresses the question's request to explain how disclosure evolved and what it reveals about debt maturity management strategy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 422,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s Multiple Purpose locomotive fleet was 5,971 owned and 1,037 leased in 2022 (average age 24.3 yrs) and stayed essentially the same in 2023 (5,971 owned, 1,037 leased, 24.3 yrs)【page_22】【page_19】. In 2024 the company added two owned units (5,973) while cutting leased units to 920, bringing the total to 6,893 and raising the average age to 25.2 yrs【page_19】. This gradual shift from leasing to ownership and the aging fleet signals a deliberate asset‑management strategy aimed at reducing leasing costs, consolidating long‑term ownership, and extending locomotive life while preserving operational flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that contradict the ground truth across all three years:\n\n2022 DATA: LLM states 5,971 owned + 1,037 leased = 7,008 total with 24.3 yr average age. Ground truth shows 6,204 owned + 1,038 leased = 7,242 total with 22.5 yr average age. The LLM's 2022 numbers are completely wrong (off by 233 units for owned, 1 unit for leased, and 1.8 years for age).\n\n2023 DATA: LLM claims no change from 2022 (5,971 owned, 1,037 leased, 24.3 yrs). Ground truth shows the average age increased to 24.3 years in 2023 (which matches LLM's stated age), but the LLM incorrectly uses 2022's wrong baseline numbers and claims stasis when there should have been changes.\n\n2024 DATA: LLM states 5,973 owned + 920 leased = 6,893 total with 25.2 yr average age. Ground truth confirms 5,973 owned and 920 leased = 6,893 total with 25.2 yr average age. Only the 2024 numbers are correct.\n\nMULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly track the three-year progression. The ground truth shows a clear declining trend (7,242 → 6,893 units), but the LLM's incorrect 2022-2023 baseline obscures this pattern. The LLM only gets the 2024 endpoint correct.\n\nAGE PROFILE ERROR: The LLM states 2022 average age was 24.3 years, but ground truth shows 22.5 years. This is a 1.8-year discrepancy that undermines the entire narrative about aging assets.\n\nREASONING QUALITY: While the LLM's interpretation about shifting from leasing to ownership and asset management strategy is plausible, it's built on incorrect foundational data. The reasoning itself is sound, but applied to wrong numbers.\n\nONLY 2024 DATA CORRECT: The LLM correctly identifies the 2024 composition (5,973 owned, 920 leased, 6,893 total, 25.2 yr age), but this represents only 1 of 3 years requested, and the multi-year progression narrative is fundamentally broken by the 2022-2023 errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 521,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "From 2022 Merck’s once‑daily doravirine/islatravir (MK‑8591A) was in Phase 2 development and the FDA had placed a clinical hold on the program. The hold remained in place through 2023. In 2024 the FDA lifted the clinical hold on December 4, 2024, and the program advanced to a Phase 2/3 study that began in August 2024, although a partial hold still applies to higher‑dose islatravir regimens.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) PHASE CLASSIFICATION ERROR: The LLM states MK-8591A was in 'Phase 2 development' in 2022, but ground truth clearly indicates it was in Phase 3 since February 2020. This is a major mischaracterization of the clinical development stage. (2) CLINICAL HOLD TIMING ERROR: The LLM claims the FDA placed a clinical hold in 2022 and it 'remained in place through 2023,' but ground truth indicates the clinical hold was lifted in 2024, not that it existed in 2022-2023. The LLM provides no evidence the hold existed in those years. (3) DATE DISCREPANCY: The LLM states the clinical hold was lifted on 'December 4, 2024,' but ground truth only mentions the hold was lifted in 2024 without specifying this exact date. More critically, the LLM's narrative about when the hold existed is contradicted by ground truth. (4) PHASE PROGRESSION ERROR: The LLM claims the program 'advanced to a Phase 2/3 study that began in August 2024,' but ground truth indicates MK-8591A remained in Phase 3 (not Phase 2/3) and that a NEW formulation (MK-8591D) entered Phase 3 in October 2024. The LLM conflates or misidentifies the formulations. (5) MISSING KEY INFORMATION: The LLM completely omits the strategic pivot to MK-8591D (islatravir+lenacapavir), which is a significant development mentioned in ground truth. (6) INCOMPLETE SYNTHESIS: The answer fails to properly synthesize the multi-year trajectory showing Phase 3 status in 2022-2023, the regulatory hold dynamics, and the new formulation entry in 2024. The core narrative is inverted—the LLM suggests the program was held back in 2022-2023 and then advanced, when ground truth shows it was already in Phase 3 and remained there with regulatory complications being resolved in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 495,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck’s 2022 10‑K lists MK‑1308A—an anti‑CTLA‑4 antibody (quavonlimab) co‑formulated with pembrolizumab—as a candidate for renal cell carcinoma (entry date April 2021) [page_25]. The 2023 filing continues to describe MK‑1308A as a key immuno‑oncology asset for RCC, with no regulatory milestone reported [page_21]. In 2024, the company still positions MK‑1308A in its pipeline for RCC, underscoring a sustained commitment to advancing combination checkpoint blockade and expanding its RCC portfolio [page_48].",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All key dates and entities are correct - MK-1308A, quavonlimab, pembrolizumab, RCC, April 2021 entry date, and the 2022-2024 timeline are all accurate. (2) Numeric/date accuracy is strong - the April 2021 entry date and the three-year progression (2022, 2023, 2024) are correctly identified. (3) The LLM correctly identifies MK-1308A as a Phase 3 candidate and accurately describes it as a coformulation of quavonlimab (anti-CTLA-4) with pembrolizumab. (4) Multi-hop synthesis is sound - the answer successfully traces the evolution across three fiscal years and connects the strategic positioning to Merck's immuno-oncology portfolio. (5) Page references are provided, adding credibility.\n\nWEAKNESSES: (1) The LLM answer is more concise and less detailed than the ground truth in characterizing the 'evolution' and 'progression.' The ground truth explicitly describes 2022 as 'early-stage strategic commitment,' 2023 as showing 'deeper investment in combination immunotherapies,' and 2024 as showing 'sustained strategic prioritization.' The LLM answer mentions these concepts more implicitly. (2) The ground truth emphasizes the 'consistent and evolving focus' on leveraging the Keytruda platform in combination with novel agents - this strategic insight about platform leverage is present but less explicitly articulated in the LLM answer. (3) The LLM notes 'no regulatory milestone reported' in 2023, which is accurate but the ground truth doesn't explicitly mention this absence, so this is additional detail rather than an error. (4) The phrase 'combination checkpoint blockade' in the LLM answer is accurate but slightly different terminology than the ground truth's 'combination immunotherapies.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the consistent positioning of MK-1308A across years, demonstrating sound multi-hop reasoning. The connection between the drug's development stage and Merck's strategic focus is appropriately made.\n\nOVERALL ASSESSMENT: The answer is factually correct on all key points and demonstrates proper multi-hop synthesis. The main limitation is that it provides a more surface-level characterization of the 'evolution' compared to the ground truth's more nuanced description of how the strategic commitment deepened over time. The answer is accurate but somewhat less comprehensive in capturing the full narrative arc of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 665,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft continues to list the 4.000 % Notes due 2021 in the Third Supplemental Indenture (Exhibit 4.6) in every 10‑K filing – the same wording and terms appear on page 104 of the 2022, 2023 and 2024 reports.  The unchanged disclosure shows that the note has already matured and been repaid, and that Microsoft’s long‑term debt profile remains stable, with the company focusing its refinancing activity on newer maturities rather than altering older debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states 'The unchanged disclosure shows that the note has already matured and been repaid,' which is INCORRECT. The ground truth explicitly states the notes are described as 'due 2021' and appear consistently in 2022, 2023, and 2024 filings - meaning they would have matured in 2021 (before the 2022 filing period). However, the LLM's interpretation that this represents a note that 'has already matured and been repaid' is a logical inference error. The ground truth does not make this claim; it only states the disclosure remained consistent. CORRECT ELEMENTS: (1) The LLM correctly identifies the notes as 4.000% Notes due 2021, (2) Correctly identifies Exhibit 4.6 and Third Supplemental Indenture, (3) Correctly notes the disclosure appears in 2022, 2023, and 2024 filings, (4) Correctly identifies the original Indenture date as May 18, 2009 (implied by 'Third Supplemental Indenture'). INCORRECT/UNSUPPORTED ELEMENTS: (1) The claim about page 104 is unverified against ground truth, (2) The interpretation that the note 'has already matured and been repaid' is not supported by the ground truth, which only confirms consistent disclosure, (3) The statement about 'focusing refinancing activity on newer maturities' is an inference not present in the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the information. The ground truth indicates consistency in disclosure across three years suggests 'no material changes' and 'no refinancing or restructuring.' The LLM instead made an unsupported leap to conclude the notes were repaid. SEMANTIC ISSUES: While the LLM captures the consistency theme, it introduces an incorrect interpretation about the maturity status that goes beyond what the ground truth supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 502,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s QCT segment has long positioned itself as a key supplier of automotive connectivity, digital‑cockpit and ADAS/AD solutions【page 7】.  Automotive revenue—which includes digital‑cockpit sales—rose from $1.509 B in 2022 to $1.872 B in 2023 and $2.910 B in 2024, a 93 % increase over two years【page 73】.  This trend shows Qualcomm’s shift from a mobile‑centric focus to a diversified technology platform, with digital‑cockpit becoming a growing revenue driver in its automotive transformation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Qualcomm's QCT segment and its three core automotive product lines (digital cockpit, connectivity, ADAS/AD). (2) Revenue figures appear accurate: $1.509B (2022), $1.872B (2023), $2.910B (2024), with the 93% two-year increase calculation being correct ($2.910B/$1.509B = 1.93 or 93% growth). (3) The answer correctly notes the shift toward diversified technology platforms. WEAKNESSES: (1) The LLM answer provides revenue data but fails to address the core multi-hop question about how digital cockpit's STRATEGIC POSITIONING evolved from 2022-2024. The ground truth emphasizes the progression from 2022 (identified as key driver with projections), to 2023 (explicitly categorized as distinct revenue stream), to 2024 (listed as core product line). The LLM does not capture this strategic evolution or the formal integration into financial reporting. (2) Missing key strategic context: the ground truth mentions specific projections (70% of vehicles with embedded cellular by 2028, 60% with 5G) and the conceptual shift toward software-defined vehicles. (3) The LLM conflates total automotive revenue with digital cockpit revenue contribution—it states automotive revenue rose from $1.509B to $2.910B, but does not isolate or discuss digital cockpit's specific revenue contribution or growth trajectory separately. (4) The answer lacks the temporal progression narrative that demonstrates maturation from strategic identification → formal categorization → operationalization. (5) The conclusion about 'shift from mobile-centric focus' is somewhat generic and doesn't capture the specific automotive transformation narrative. CALCULATION VERIFICATION: 2022-2024 growth = ($2.910B - $1.509B)/$1.509B = $1.401B/$1.509B = 0.929 or 92.9% ≈ 93% ✓ MULTI-HOP SYNTHESIS: The answer provides financial data but fails to synthesize the strategic positioning evolution across the three-year period as required by the question. It answers 'what were the revenues' but not 'how did strategic positioning evolve' or 'what does this indicate about transformation.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 561,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin began using variable‑rate interest‑rate swaps to convert fixed‑rate borrowings into variable‑rate borrowings as a fair‑value hedge (page 66).  The aggregate notional of these swaps rose to **$1.3 billion in 2022** and remained at that level through 2023 and 2024 (page 96 for 2022‑23; page 52 for 2024‑23).  The steady notional amount after the 2022 increase indicates a deliberate, consistent hedging strategy to manage the fair‑value risk of its fixed‑rate debt while maintaining a stable exposure level.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental factual error regarding the 2022 notional amount. According to the ground truth, LMT had $500 million in notional swaps in 2022, which increased to $1.3 billion in 2023. The LLM incorrectly states that the notional amount 'rose to $1.3 billion in 2022,' which is factually wrong. This is a major quantitative error that undermines the entire answer. The LLM also fails to capture the key insight from the ground truth: the fourfold increase from 2022 ($500M) to 2023 ($1.3B), which is central to understanding the evolution and strategic shift in LMT's interest rate risk management. The LLM's characterization of a '2022 increase' is misleading since the significant increase actually occurred between 2022 and 2023. While the LLM correctly identifies that the amount remained at $1.3 billion through 2024 and correctly describes the purpose (fair-value hedge of fixed-rate debt), these correct elements cannot offset the fundamental error in the 2022 figure. The reasoning about 'steady notional amount after the 2022 increase' is logically flawed because the major increase happened in 2023, not 2022. The answer demonstrates partial understanding of the hedging strategy but fails on the core quantitative facts that are essential to answering a question specifically about how the use 'evolved from 2022 through 2024.' The multi-hop synthesis is incomplete and inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 402,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently disclosed the 3.950% Notes due 2056 in each filing as part of the Eleventh Supplemental Indenture (Exhibit 4.14, page 105).  The notes appear unchanged in the 2022, 2023, and 2024 10‑Ks, with no indication of refinancing or repayment, showing that Microsoft has kept the long‑term debt in place.  This reflects a conservative maturity‑management strategy that favors stable, low‑rate, long‑dated debt to spread refinancing risk and preserve capital‑structure flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key elements of Microsoft's debt management strategy. STRENGTHS: (1) Correctly identifies the 3.950% Notes due 2056 and the Eleventh Supplemental Indenture dated August 8, 2016 - all numeric and date details are accurate; (2) Accurately states the notes appeared unchanged across 2022, 2023, and 2024 10-Ks with no refinancing or repayment; (3) Correctly synthesizes the multi-hop information showing consistency across three filing years; (4) Appropriately characterizes the strategy as favoring stable, low-rate, long-dated debt; (5) Mentions Exhibit 4.14 and page 105 reference, showing specific filing knowledge. MINOR GAPS: (1) The LLM answer is somewhat more concise than the ground truth and doesn't explicitly mention the contrast with shorter-term instruments maturing (e.g., 2.000% Notes due 2023 in 2022 filings, 2.400% Notes due 2026 in 2024), which provided important context about the broader refinancing strategy; (2) Doesn't explicitly discuss 'capital stability' or 'long-term investment horizons' as strategic drivers, though the answer does mention 'preserve capital-structure flexibility' which is semantically related; (3) The phrase 'conservative maturity-management strategy' is accurate but slightly different framing than the ground truth's 'deliberate strategy of preserving long-term capital stability.' QUANTITATIVE VERIFICATION: All numbers and dates are correct (3.950%, 2056, August 8 2016, 2022/2023/2024). No calculation errors. MULTI-HOP REASONING: The answer correctly synthesizes information across three filing years and connects the consistent disclosure pattern to strategic intent. The logic is sound and well-reasoned. SEMANTIC EQUIVALENCE: The core message matches - Microsoft maintained this debt without modification as part of a deliberate long-term strategy. The answer conveys the essential information accurately, though with slightly less contextual richness than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 541,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 2022‑, 2023‑ and 2024 10‑K filings all list Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – which governs the 3.700 % Notes due 2046 (and related notes through 2056).  By continually incorporating this indenture, Microsoft signals that the covenant framework established in 2016 remains in force and that the 2046‑maturity notes are still subject to the same covenants, covenants that tie the debt to the base indenture and other supplemental indentures.  This consistency demonstrates a stable long‑term debt structure and a deliberate effort to keep its financial obligations and covenant obligations unchanged across filing periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All key dates are accurate - August 8, 2016 for the Eleventh Supplemental Indenture, and the three filing years (2022, 2023, 2024) are correctly identified. (2) The 3.700% Notes due 2046 are correctly cited. (3) The multi-hop reasoning is sound - the answer correctly synthesizes that the consistent reference across three years indicates ongoing relevance and stability. (4) The answer appropriately identifies the covenant framework and its connection to the base indenture structure. (5) The conclusion about stable long-term debt management strategy aligns with the ground truth. MINOR WEAKNESSES: (1) The LLM mentions 'related notes through 2056' which is not mentioned in the ground truth answer and adds information not verified against the original source. While this may be factually correct from the filings, it goes slightly beyond what was confirmed in the ground truth. (2) The ground truth explicitly mentions the base Indenture dated May 18, 2009, which the LLM answer references only generically as 'the base indenture' without the specific date. (3) The LLM answer emphasizes 'covenant framework' more heavily than the ground truth, which focuses more on the structural consistency and ongoing obligations. (4) The ground truth explicitly states 'no material amendments or retirements during this time,' which the LLM answer implies but does not state as directly. QUANTITATIVE VERIFICATION: All dates and percentages are accurate (August 8, 2016; 3.700%; 2046 maturity). The three-year span (2022-2024) is correctly identified. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential meaning as the ground truth - that Microsoft's repeated reference to this indenture across three years demonstrates stability and consistency in its long-term debt structure. The reasoning about covenant obligations and financial planning alignment is sound and semantically equivalent to the ground truth's discussion of 'deliberate and stable long-term debt management strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 561,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft continued to list the Seventh Supplemental Indenture (Exhibit 4.1) that created the 2.125 % Notes due 2021 in each 10‑K (FY 2022, FY 2023, FY 2024) (page 104 of each filing). The notes, which matured on December 6 2021, were fully repaid and therefore no longer appear as a liability after FY 2022 (page 104). This consistent treatment shows that Microsoft has chosen to retire rather than refinance the instrument, reflecting a conservative debt‑management strategy focused on reducing leverage instead of rolling debt into new issues.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The notes matured on December 6, 2021 - this is accurate. (2) The consistent listing in Exhibits across FY 2022, 2023, and 2024 is correctly identified. (3) The page reference (104) is accurate. (4) The indenture reference (Seventh Supplemental Indenture) is correct. PROBLEMATIC ELEMENTS: (1) The claim that notes 'no longer appear as a liability after FY 2022' is stated as fact but the ground truth indicates uncertainty about this - the ground truth explicitly notes 'raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag.' The LLM presents a definitive conclusion ('fully repaid and therefore no longer appear as a liability') without acknowledging the ambiguity present in the actual filings. (2) The interpretation that this reflects 'a conservative debt-management strategy focused on reducing leverage instead of rolling debt into new issues' is speculative and goes beyond what the ground truth supports. The ground truth presents multiple possible explanations (extension, rollover, continued disclosure requirements, reporting lag) without settling on one. (3) The LLM's characterization of 'retiring rather than refinancing' is presented as established fact when the ground truth explicitly states this remains unclear. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and identifies the consistent pattern of disclosure. However, it fails to acknowledge the interpretive uncertainty that the ground truth emphasizes. The question asks what the evolution 'implies' about debt management strategy, but the LLM treats implications as confirmed facts. SEMANTIC ISSUES: The ground truth's careful hedging ('may suggest,' 'raises questions') is replaced with definitive statements in the LLM answer, which represents a meaningful shift in meaning and confidence level. The LLM provides a cleaner narrative but at the cost of accuracy regarding what can actually be concluded from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 556,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued the 2.000% notes due 2023 as part of the Eleventh Supplemental Indenture in 2016 (page 105). The indenture is still listed in FY 2022 and FY 2023 10‑Ks, indicating the notes were outstanding through those years, but they matured in 2023 and are no longer present in FY 2024 (page 104). This multi‑year pattern shows Microsoft’s disciplined debt strategy of issuing long‑term, moderate‑coupon debt and systematically retiring it as maturities approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. Key strengths: (1) Correctly identifies the 2.000% Notes due 2023 as part of the Eleventh Supplemental Indenture dated August 8, 2016; (2) Accurately tracks the presence of these notes across FY 2022 and FY 2023; (3) Correctly notes that the notes matured in 2023 and are no longer present in FY 2024; (4) Provides specific page references (105, 104) showing attention to source documentation. Quantitative accuracy is high—all dates (2016, 2023, 2024) and the coupon rate (2.000%) are correct. Multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and correctly interprets the pattern. Minor differences from ground truth: (1) The LLM characterizes the pattern as showing 'systematic retiring' of debt as maturities approach, which is a reasonable inference but slightly more interpretive than the ground truth's emphasis on 'consistency' and 'stable, long-term approach.' The ground truth emphasizes that Microsoft 'did not retire or refinance it before its maturity,' while the LLM's phrasing about 'systematically retiring it as maturities approach' could imply active management, though the facts support both interpretations. (2) The ground truth emphasizes reliance on 'established structures rather than frequent refinancing,' while the LLM focuses on 'disciplined debt strategy' and 'long-term, moderate-coupon debt'—semantically similar but with slightly different emphasis. The LLM answer is more action-oriented in its interpretation, while ground truth is more structural. Both are defensible interpretations of the same underlying facts. Overall, the answer demonstrates strong comprehension of the multi-year pattern and correctly synthesizes information across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 490,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s 2022 filing disclosed that it had transferred $11.6 billion of pension obligations via group annuity contracts (GACs) since 2018, including a $4.9 billion transfer in 2021 that generated a $1.7 billion non‑cash settlement charge. The 2023 filing reiterated the strategy of evaluating further GAC purchases but reported no new large transfers, noting that future deals could trigger additional contributions or settlement charges. By 2024, the company had made $990 million in cash contributions and still had no new GAC transactions reported, underscoring its continued focus on risk‑transfer to manage pension volatility while remaining open to future transactions that could affect cash flows or earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general trajectory of Lockheed Martin's pension risk transfer strategy but contains significant quantitative errors and omissions that undermine its accuracy. STRENGTHS: (1) Correctly identifies the $11.6 billion cumulative transfer since 2018 and the $4.9 billion 2021 transaction; (2) Correctly notes the $1.7 billion noncash settlement charge; (3) Properly characterizes the strategic intent to pursue further transactions; (4) Accurately reflects that 2023 and 2024 saw no major new GAC transactions reported. CRITICAL ERRORS: (1) The LLM introduces '$990 million in cash contributions' in 2024 without any mention in the ground truth, which appears to be unsupported or misattributed information; (2) Omits the $69 million annual PBGC premium reduction benefit, which is a key financial impact metric mentioned in the original answer; (3) Fails to adequately convey the 'increasing scale and financial clarity over time' trend emphasized in the ground truth; (4) The statement about '2024 had made $990 million in cash contributions' is vague and potentially inaccurate - it's unclear if this is cumulative, annual, or specific to pension funding vs. GAC transactions. MULTI-HOP REASONING: The answer demonstrates adequate synthesis across the three-year period (2022-2024) but misses important connective details about the strategic evolution and financial benefits. The ground truth emphasizes a 'consistent, strategic reduction' with 'increasing scale and financial clarity,' while the LLM presents a more static picture. SEMANTIC ISSUES: The phrase 'still had no new GAC transactions reported' in 2024 is awkwardly phrased and could be misinterpreted. The answer would benefit from clearer articulation of why the company paused major transactions while maintaining strategic intent. The omission of the PBGC premium savings is a material oversight given the question's focus on 'financial impact.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 522,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 2022‑24 10‑Ks all list the same “Floating Rate Notes due 2019” in the “Description of Securities” tables on page 56 (see 2022 p. 56, 2023 p. 56, and 2024 p. 56).  The repeated reference shows that Apple still carries those notes and is monitoring them as part of a diversified debt mix that blends fixed‑rate and floating‑rate instruments.  This indicates a deliberate long‑term debt strategy that balances interest‑rate risk and plans to refinance or roll the 2019 notes when market conditions or maturity dates warrant, rather than extinguishing them abruptly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental factual error that undermines the entire response. The LLM claims that Apple's 2022-24 10-Ks list 'Floating Rate Notes due 2019' on page 56 of each filing. However, this is factually impossible and contradicts basic accounting principles: Notes that matured in 2019 would NOT appear in 2022-2024 filings as current debt instruments. The ground truth answer correctly identifies this as a paradox - the notes are referenced despite their 2019 maturity date, which suggests they may have been rolled over, refinanced, or represent historical disclosure artifacts. The LLM's interpretation that 'Apple still carries those notes' is incorrect. The LLM also provides specific page citations (p. 56) without verification, which is problematic. The LLM's reasoning about 'diversified debt mix' and 'rolling over' the notes is speculative and not grounded in the actual financial data. The ground truth answer appropriately acknowledges the unusual nature of this disclosure pattern and suggests possible explanations (rollover, repricing, transparency around historical instruments), while the LLM treats it as normal ongoing debt. The LLM fails to recognize the temporal inconsistency that is central to understanding what this disclosure pattern actually reveals about Apple's debt management. The answer demonstrates weak multi-hop reasoning by not synthesizing the contradiction between the 2019 maturity date and the 2022-2024 filing references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 415,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 4.000 % Notes due 2021 in Exhibit 4.6 – the Third Supplemental Indenture that includes the 4.000 % Notes (see the identical line “Third Supplemental Indenture for 2.500% Notes due 2016, **4.000% Notes due 2021**, and 5.300% Notes due 2041” on page 104 of each filing). The unchanged reference across the three years shows that the instrument remains an active part of Microsoft’s debt portfolio and continues to be considered in its capital‑structure management.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but differs meaningfully from the ground truth in interpretation and depth. STRENGTHS: (1) Correctly identifies the 4.000% Notes due 2021 appearing in Exhibit 4.6 across 2022, 2023, and 2024 filings; (2) Accurately cites the Third Supplemental Indenture reference; (3) Correctly notes the unchanged/consistent reference across three years; (4) All numeric values (4.000%, 2.500%, 5.300%, years 2021/2016/2041) are accurate; (5) Properly identifies the exhibit location (page 104). WEAKNESSES: (1) The LLM characterizes the Notes as 'an active part of Microsoft's debt portfolio' and 'continues to be considered in its capital-structure management,' which is a stronger claim than the ground truth supports. The ground truth explicitly states the Notes 'remained a part of its structured debt disclosures despite their maturity date having passed' and suggests they were 'likely still outstanding or held ongoing legal or structural relevance' - notably using cautious language ('likely,' 'suggests'). The LLM presents this as definitive fact rather than inference. (2) The ground truth emphasizes the post-maturity aspect ('despite their maturity date having passed') and explores why they might still be referenced (covenants, indentures, transparency, investor understanding), while the LLM simply states they remain 'active' without addressing the temporal anomaly or exploring the underlying reasons. (3) The LLM's interpretation that the Notes are 'active' in the debt portfolio contradicts the logical issue that notes due 2021 should have matured by 2022, which the ground truth acknowledges. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings but does not fully engage with the interpretive complexity that the ground truth addresses - namely, why a matured debt instrument would continue to appear in filings. The answer is factually accurate but interpretively incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 534,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS continued to describe its $276 million 7.620 % debentures as redeemable at any time at the greater of principal plus accrued interest or the present value of remaining payments discounted at a Treasury yield plus 5 bps, with semi‑annual interest payments—terms unchanged in the 2023 and 2024 10‑Ks (see 2022 p.120, 2023 p.103, 2024 p.108). The debentures’ carrying value stayed around $280 million each year, while total long‑term debt rose modestly from $22.1 billion in 2022 to $22.5 billion in 2024, keeping the debentures as a small, stable component of UPS’s debt portfolio (see 2022 p.118, 2023 p.103, 2024 p.108). Thus, UPS’s treatment and disclosure of the 7.620 % debentures remained essentially unchanged in redemption terms and interest structure, with only a slight increase in overall debt positioning over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core financial facts about UPS's 7.620% debentures ($276 million principal, unchanged redemption terms, semi-annual interest payments, ~$280 million carrying value). The quantitative data points are accurate: the debenture amount, interest rate, redemption mechanics, and the general debt portfolio figures ($22.1B in 2022 to $22.5B in 2024) are correct. However, the answer has significant weaknesses in addressing the evolution and progression aspect of the question. The original answer emphasizes a meaningful 3-year evolution: (1) 2022 focused on historical interest rate context (8.375% until April 2020, then 7.620%), (2) 2023 presented debentures in a broader debt table context, and (3) 2024 showed sharper focus on redemption mechanics and positioning within international debt instruments (Pound Sterling, Euro notes). The LLM answer largely dismisses this evolution by stating the treatment 'remained essentially unchanged,' which contradicts the ground truth's explicit finding of a 'shift from historical interest rate context to a more structural and comparative treatment.' The LLM does acknowledge the debentures were 'a small, stable component' but fails to capture the qualitative shift in disclosure emphasis and contextual positioning across the three years. The answer also provides page references (which adds credibility) but doesn't substantively address how the disclosure framing evolved. The multi-hop reasoning is incomplete—while the LLM synthesizes the financial data correctly, it misses the disclosure evolution narrative that is central to the question. The answer is partially correct on facts but significantly underdeveloped on the evolution aspect, which is the primary focus of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 481,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie’s development of Vraylar was completed in 2021 when it announced positive Phase‑3 data for adjunctive treatment of major depressive disorder (page 60).  Commercialization has accelerated, with net revenues climbing from $1.73 B in 2021 to $2.04 B in 2022 (18 % growth) and $2.76 B in 2023 (35 % growth) driven by market‑share gains and overall neuroscience market expansion (pages 42‑44).  The 2024 filing (pages 4‑8) still lists Vraylar as a core neuroscience asset, underscoring its growing revenue contribution and strategic importance as a high‑margin, growth‑oriented product within AbbVie’s portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Vraylar's strategic importance and provides relevant context about its evolution, but contains significant quantitative discrepancies that warrant careful scrutiny. STRENGTHS: (1) Correctly identifies Vraylar as a core neuroscience asset by 2024; (2) Accurately captures the 35% growth rate for 2023 and the $2.76B revenue figure; (3) Properly synthesizes multi-hop information about development, commercialization, and financial performance; (4) Appropriately characterizes Vraylar's transition from clinical asset to revenue driver. CRITICAL ISSUES: (1) The 2021 revenue figure of $1.73B appears problematic - the ground truth indicates 2022 was when Phase 3 results were announced, suggesting Vraylar was still in late-stage development then, not generating $1.73B in revenue; (2) The 2022 revenue of $2.04B cannot be verified against ground truth, which only confirms 2023 revenue of $2.759B (approximately $2.76B); (3) The claim about 'positive Phase-3 data for adjunctive treatment of MDD' being announced in 2021 contradicts the ground truth stating this occurred in 2022; (4) The LLM conflates development completion with clinical trial announcement timing. CALCULATION VERIFICATION: The 18% growth from $1.73B to $2.04B is mathematically correct (1.73 × 1.18 ≈ 2.04), and the 35% growth to $2.76B is accurate (2.04 × 1.35 ≈ 2.75), but the underlying 2021-2022 figures appear unsupported by the ground truth. The answer correctly identifies the 2023 revenue and growth rate but introduces unverified historical data. MULTI-HOP REASONING: The synthesis across development, commercialization, and financial performance is logically sound, but the temporal sequencing contains errors that undermine the narrative's accuracy. The conclusion about strategic importance is well-supported but built partially on questionable premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 510,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s 10‑Ks for 2022, 2023 and 2024 all list the 0.45% Notes due 2016 in Exhibit 4.3 (the officer’s certificate of global notes).  The repeated disclosure shows that Apple treats legacy debt as part of its long‑term capital structure and follows a disclosure policy that requires all securities—past and present—to be presented for full transparency, even when the notes have long since matured or been restructured.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: (1) the 0.45% Notes due 2016 appear in Apple's 10-Ks for 2022, 2023, and 2024; (2) they are found in Exhibit 4.3; (3) the exhibit contains an officer's certificate of global notes; (4) the notes have matured/are legacy instruments. All numeric values (0.45%, 2016, years 2022-2024) are accurate. The multi-hop synthesis across three fiscal years is sound. However, there are minor differences from the ground truth: (1) The LLM states the exhibit is 'the officer's certificate of global notes' while the ground truth specifies it is 'the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments' - the specific date is omitted; (2) The LLM's interpretation that Apple 'treats legacy debt as part of its long-term capital structure' is slightly broader than the ground truth's more specific explanation that Apple 'maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities'; (3) The phrase 'or been restructured' in the LLM answer is not explicitly supported by the ground truth, which focuses on maturity rather than restructuring. The LLM answer is semantically close and captures the core insight about disclosure strategy and legacy instruments, but lacks the specific detail about the May 3, 2013 date and is slightly less precise in characterizing Apple's disclosure rationale. The reasoning is sound and the answer appropriately addresses the question about long-term debt structure and disclosure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 434,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "UPS SurePost began in 2022 as a residential‑ground service that used UPS’s ground network for pickup and sorting but relied on the U.S. Postal Service (USPS) for final delivery (2022 10‑K, page 6). In 2023 UPS maintained that same delivery methodology but announced that it would insource the service in 2025 to gain greater control over the end‑to‑end process (2023 10‑K, page 5). By 2024 the service remained a low‑cost, high‑volume residential option within the U.S. Domestic Package segment, still using USPS for final delivery and positioned as a strategic tool to capture volume and reduce costs (2024 10‑K, page 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - TIMELINE CONTRADICTION: The LLM answer contains a significant factual error regarding when the insourcing announcement was made. The LLM states 'In 2023 UPS maintained that same delivery methodology but announced that it would insource the service in 2025' - however, the ground truth clearly indicates the announcement occurred in 2024 ('In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component'). This is a material error in multi-hop reasoning about the evolution timeline. CORRECT ELEMENTS: (1) 2022 description as residential ground service using UPS network with USPS final delivery is accurate; (2) The January 1, 2025 insourcing date is correct; (3) The characterization of SurePost as low-cost, high-volume residential option is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM incorrectly places the insourcing announcement in 2023 rather than 2024, disrupting the chronological evolution narrative; (2) The LLM states that in 2024 'still using USPS for final delivery' which is technically accurate for 2024 operations but misses the strategic significance that the 2024 announcement represented a turning point - the ground truth emphasizes this as 'a strategic transformation' announced in 2024; (3) The LLM's framing suggests continuity through 2024 without adequately highlighting the 2024 announcement as the key inflection point in the evolution. MULTI-HOP REASONING: The answer attempts to synthesize information across three years but fails to correctly sequence the announcement timing, which is crucial for understanding the evolution narrative. The ground truth emphasizes 2024 as the year of strategic transformation announcement, while the LLM misplaces this to 2023. MISSING CONTEXT: The LLM does not adequately convey that the 2024 announcement represents a strategic shift toward 'enhancing service quality' and 'service differentiation' - instead focusing on cost reduction, which is a different strategic rationale than what the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 549,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45% Notes due 2044, first issued in 2014, have remained a constant part of its debt portfolio through 2024, as shown in the “Description of Securities” tables in the 2022, 2023 and 2024 10‑Ks【page_56 of 2024】【page_56 of 2023】【page_56 of 2022】. No new issuances, maturities or coupon changes for this instrument were reported during that period, underscoring a long‑term capital strategy that relies on stable, low‑coupon, long‑dated debt to secure predictable financing and maintain flexibility for capital allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. Strengths: (1) All numeric values are correct - the 4.45% coupon rate and 2044 maturity date are accurate; the 2014 issuance date is correct; the 2022-2024 time period is properly addressed. (2) The answer correctly identifies that the notes appeared consistently across all three years' 10-K filings without new issuances, maturities, or coupon changes - this is accurate multi-hop synthesis across three separate documents. (3) The reasoning about Apple's capital strategy is sound: the sustained presence of long-duration debt without restructuring does indicate a strategic choice to maintain financial flexibility and manage interest rate risk. (4) The answer properly cites the source documents (Description of Securities tables, page 56 across all three years), demonstrating document-level accuracy. (5) The characterization of the debt as 'stable, low-coupon, long-dated' is semantically equivalent to the ground truth's description of 'sustained reliance on long-term debt instruments.' Minor considerations: The LLM answer is slightly more specific and detailed than the ground truth (mentioning 'no new issuances, maturities or coupon changes'), which adds value rather than detracting. The answer fully addresses the multi-year pattern question and provides appropriate strategic interpretation. No calculation errors, no date errors, no entity misidentifications. The semantic meaning aligns well with the ground truth while providing additional supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 428,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle lists the 2.875 % Notes due 2031 in Exhibit 4.14 in every filing – the same series of notes issued on March 24 2021 with identical terms (see 2022 p. 114, 2023 p. 111, 2024 p. 110). The unchanged presentation shows Oracle’s deliberate use of a fixed‑rate debt ladder to keep interest expense and maturity risk predictable, underscoring a conservative, long‑term capital‑structure strategy that values stability over frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 2.875% Notes due 2031 as Exhibit 4.14 across all three years (2022, 2023, 2024), the March 24, 2021 issuance date, and the consistent treatment across filings. The page number references (2022 p. 114, 2023 p. 111, 2024 p. 110) add specificity and support the multi-hop synthesis across three years of filings. The quantitative elements are accurate: the interest rate (2.875%), the maturity year (2031), and the exhibit designation (4.14) are all correct. The answer correctly synthesizes the key insight that consistent positioning reveals a stable capital structure strategy. However, the LLM answer goes slightly beyond the ground truth by adding interpretive language about 'fixed-rate debt ladder,' 'interest expense and maturity risk predictability,' and 'conservative, long-term capital-structure strategy' that, while logically sound and reasonable inferences, are not explicitly stated in the ground truth. The ground truth focuses on 'no modifications' and 'unchanged structure,' while the LLM adds strategic interpretation about deliberate use and conservative positioning. This represents a minor enhancement rather than an error, as the reasoning is sound and consistent with the facts presented. The answer fully addresses the multi-part question about evolution, consistent positioning, and what this reveals about capital structure management. The semantic equivalence is strong - both answers convey that the Notes remained unchanged and this reflects a stable strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 432,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters agreement raised benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, increasing its service cost and overall pension accruals (page_82).  In 2024 the company’s net periodic benefit cost for U.S. pension benefits rose to $1.212 billion, reflecting those higher accruals and underscoring a sizable, growing long‑term pension obligation that is sensitive to discount‑rate assumptions (page_88 and page_84).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 2023 Teamsters agreement raised benefit rates and increased pension accruals, which aligns with the ground truth. It also correctly notes that 2024 disclosures show increased net periodic benefit costs ($1.212 billion) and sensitivity to discount-rate assumptions. However, there are significant issues: (1) The LLM provides a specific dollar figure ($1.212 billion for 2024 net periodic benefit cost) without verification against ground truth - this number cannot be confirmed from the provided context and may be inaccurate or hallucinated. (2) The LLM cites specific page numbers (page_82, page_88, page_84) that cannot be verified and appear to be fabricated references. (3) The answer is narrower in scope than the ground truth - it focuses primarily on cost impacts but omits important context about the plan's structure (noncontributory status, Central States Pension Fund history, collective bargaining framework) that the ground truth emphasizes. (4) The LLM does not adequately address the 'long-term pension obligations' aspect beyond mentioning they are 'sizable and growing' - the ground truth provides more nuanced discussion of funded status and future obligations. (5) The multi-hop reasoning is partially sound (connecting 2023 agreement → increased accruals → 2024 cost impacts) but incomplete compared to ground truth's fuller synthesis. The answer demonstrates understanding of the general relationship between the agreement and pension costs but lacks the comprehensive framing and contains unverifiable specific claims that undermine confidence in accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 445,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the 1.05 % Notes due 2017 in the “Description of Securities” section as part of the Officer’s Certificate dated May 6 2014. The disclosure has not changed across the three years, indicating that Apple consistently reports its short‑term debt instruments issued under the 2014 Officer’s Certificate and maintains a stable, transparent debt‑management approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but has notable omissions in depth and interpretation. STRENGTHS: (1) All numeric values are accurate - the 1.05% interest rate, 2017 maturity date, and May 6, 2014 Officer's Certificate date are all correct. (2) The key finding that disclosure remained unchanged across 2022, 2023, and 2024 is accurate. (3) Entity identification is correct (Apple, the specific debt instrument, the three fiscal years). (4) The basic reasoning about consistency is sound. WEAKNESSES: (1) The LLM answer lacks the interpretive depth of the ground truth. The ground truth explicitly states this indicates 'a passive management approach' and that Apple 'prioritized stability in its capital structure' and 'chose not to adjust its terms or maturity despite evolving market conditions.' The LLM answer merely notes 'stable, transparent debt-management approach' without the same analytical depth. (2) The ground truth emphasizes what the static disclosure 'reveals' about Apple's strategic approach - that it did not modify or refinance this instrument. The LLM answer states the facts but doesn't fully explore the implications. (3) The LLM answer mentions the disclosure appears in the 'Description of Securities' section, which is a reasonable inference but not explicitly confirmed in the ground truth. (4) The ground truth's framing about 'short-term debt obligation' and the significance of not refinancing despite market conditions is more analytically complete. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the consistency pattern, which is the core multi-hop requirement. However, it doesn't fully synthesize the implications of this consistency for understanding Apple's debt management strategy. The answer is factually sound but interpretively incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 503,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 have been disclosed in the same way every year: each 10‑K (2022, 2023 and 2024) lists the notes in Exhibit 4.3 – the Officer’s Certificate dated May 3 2013 that enumerates the global notes, including the 2.40 % Notes due 2023 (see pages 56 of each filing). The unchanged description and lack of new issuance or amendment over three years signals a deliberate, stable debt‑management approach that prioritizes predictable maturities and low refinancing risk, keeping the debt portfolio diversified and cost‑effective.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) All key numeric values are accurate: 2.40% interest rate, 2023 maturity date, May 3, 2013 Officer's Certificate date are all correct. (2) The multi-hop synthesis is sound - correctly identifies that the same disclosure appears in 2022, 2023, and 2024 10-K filings with no changes. (3) The reasoning about Apple's debt management strategy is logically sound and semantically equivalent to the ground truth - both conclude the static disclosure indicates a stable, consistent approach with no early repayments, modifications, or extensions. (4) The answer appropriately references Exhibit 4.3 as the location of the disclosure, adding helpful specificity. MINOR WEAKNESSES: (1) The LLM adds interpretive language about 'predictable maturities,' 'low refinancing risk,' and 'cost-effective' portfolio management that goes slightly beyond what the ground truth explicitly states. While these inferences are reasonable and not contradicted by the facts, they represent modest extrapolation beyond the documented evidence. (2) The reference to 'page 56' is specific but cannot be verified against the ground truth provided. (3) The phrase 'deliberate, stable debt-management approach' is slightly more interpretive than the ground truth's more measured 'maintained a consistent approach.' These are minor semantic differences that don't materially affect correctness. The core factual content - the disclosure pattern, dates, terms, and the conclusion about stable debt management - is accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 438,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "AbbVie’s Vraylar grew from $2.04 billion in 2022 to $2.76 billion in 2023, a 35 % rise driven by market‑share gains and the FDA approval of Vraylar as an adjunctive therapy for major depressive disorder (2023 10‑K, page 44). Clinically, the drug moved from Phase‑3 top‑line results in 2021 (page 60) to a new MDD indication in 2023, cementing its multi‑indication role in schizophrenia, bipolar disorder and depression within AbbVie’s neuroscience portfolio (pages 4–7). The 2024 10‑K (pages 4–8) continues to list Vraylar as a core neuroscience product, but updated revenue figures are not disclosed in these pages.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy with some notable strengths and minor weaknesses: (1) QUANTITATIVE ACCURACY: The revenue figures are largely correct - $2.04B (2022) vs. ground truth $2.037B (minor rounding), $2.76B (2023) vs. ground truth $2.759B (acceptable rounding), and the 35% growth rate is accurate. However, the LLM states U.S. sales grew from $2.037B in 2022 to $2.755B in 2023, which matches the ground truth's U.S. sales figures, but the LLM conflates total sales ($2.759B) with U.S. sales in its narrative, creating slight ambiguity. (2) CLINICAL DEVELOPMENT: The LLM correctly identifies Phase 3 trial progress and FDA approval for MDD indication in 2023. However, it references 'Phase-3 top-line results in 2021' which is not mentioned in the ground truth and may be inaccurate timing. The ground truth specifies 'one successful Phase 3 trial and a numerically positive but non-significant result in another' in 2022, which the LLM does not capture with this precision. (3) THERAPEUTIC POSITIONING: The LLM correctly identifies the multi-indication positioning (schizophrenia, bipolar disorder, MDD) and its role as a core neuroscience product. (4) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across 2022-2024, connecting clinical progress to revenue growth to portfolio positioning. (5) COMPLETENESS: The LLM appropriately notes that 2024 revenue figures are not disclosed in the pages referenced, which is honest but represents incomplete coverage of the 2024 trajectory requested in the question. The ground truth indicates Vraylar was 'formally positioned' in 2024 with expanded indications, but the LLM doesn't provide specific 2024 revenue or clinical details. (6) MINOR ISSUES: The reference to 'Phase-3 top-line results in 2021' appears to be an error or misinterpretation of the timeline. The answer would benefit from more explicit distinction between total sales and U.S. sales figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 527,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM has consistently highlighted client relationships and trust as a core competitive differentiator across its 2022‑, 2023‑, and 2024‑10 K filings. In 2023, the company explicitly listed “client relationships and trust” among its principal methods of competition (pages 3–4), and the 2024 filing continues this emphasis, underscoring the importance of trust as it deepens its hybrid‑cloud and AI strategy. This sustained focus signals IBM’s positioning as a trusted partner in the hybrid‑cloud and AI market, using long‑term client relationships to differentiate itself from competitors and drive adoption of its integrated solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized client relationships and trust across 2022-2024 and accurately notes the 2023 and 2024 filings' explicit mentions of this competitive differentiator. However, the answer has significant gaps in multi-hop synthesis and evolution analysis. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024); (2) Accurately references specific page numbers (3-4) for 2023 filing; (3) Correctly notes the sustained focus on trust and client relationships; (4) Appropriately connects this to hybrid cloud and AI strategy. WEAKNESSES: (1) INCOMPLETE EVOLUTION ANALYSIS: The LLM answer fails to adequately capture the progression of how IBM's framing evolved. The ground truth shows a clear evolution from 2022 (trust as part of platform), to 2023 (trust linked to strategic partnerships), to 2024 (trust as foundational in go-to-market strategy). The LLM answer mentions 2023 and 2024 but provides minimal detail on 2022 positioning and doesn't articulate the strategic deepening across the three years; (2) MISSING STRATEGIC CONTEXT: The ground truth emphasizes that trust evolved from a 'value proposition' to an 'enabler of integrated, client-centric innovation' - a key insight about strategic positioning that the LLM answer doesn't capture; (3) INCOMPLETE SYNTHESIS: The answer doesn't adequately synthesize how partnerships and ecosystem integration became increasingly central to IBM's trust narrative, which is a critical multi-hop insight; (4) VAGUE ON 2022: While the ground truth provides specific context for 2022 (integration of data, AI, industry expertise), the LLM answer largely omits 2022 analysis. The answer states 'across its 2022-, 2023-, and 2024-10 K filings' but then only substantively discusses 2023 and 2024. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension is less critical. The page references (3-4) appear reasonable but cannot be fully verified. MULTI-HOP REASONING: The answer demonstrates basic multi-hop reasoning by connecting trust emphasis to hybrid cloud/AI positioning, but fails to fully synthesize the evolution across the three-year period as required by the question. The ground truth's insight about strategic deepening (from value proposition to innovation enabler) represents a more sophisticated multi-hop analysis that the LLM answer doesn't achieve.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 645,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM has continued to disclose the 1.250 % Notes due 2027 in the same way each year: the 2019 Form 8‑K instrument is incorporated by reference and the notes are listed as a registered security (IBM27B).  The 2024 filing (p. 1) repeats the 2019 reference and the 2023 filing (p. 20) does likewise, and the 2022 filing (p. 28) also incorporates the same reference.  Thus, the disclosure practice has remained essentially unchanged, and the notes remain a small, low‑yield component of IBM’s long‑term debt without becoming a material portion of the overall debt portfolio between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in fundamental ways: (1) MAJOR CONTRADICTION ON EVOLUTION: The ground truth explicitly states the treatment 'evolved' from 2022 to 2024, showing progression from exhibit list references to explicit listing with trading symbol IBM27B in 2024, indicating 'increasing transparency and emphasis.' The LLM claims disclosure practice 'remained essentially unchanged,' which directly contradicts the ground truth's core finding. (2) INCORRECT CHARACTERIZATION: The LLM describes the notes as 'a small, low-yield component' and 'without becoming a material portion,' which is not supported by the ground truth and appears to be the LLM's own inference rather than information from the filings. The ground truth makes no such materiality assessment. (3) PARTIAL ACCURACY ON DATES/REFERENCES: The LLM correctly identifies the 2019 Form 8-K reference and the IBM27B trading symbol, which are accurate details. However, it misuses these facts to support an incorrect conclusion about unchanged disclosure. (4) MISSING KEY EVOLUTION: The LLM fails to capture the progression described in the ground truth: 2022 (exhibit list with 2019 reference) → 2023 (growing debt instruments list with 2022 references) → 2024 (explicit listing with trading symbol). This represents a clear evolution in disclosure prominence and formalization. (5) REASONING FAILURE: The LLM's logic that 'same reference incorporated = unchanged disclosure' misses the point that the context and prominence of the disclosure changed across years. The quantitative accuracy score reflects correct identification of dates and the trading symbol, but the qualitative accuracy is very low due to the fundamental misinterpretation of the evolution question and the contradictory conclusion about unchanged practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 502,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 10‑K filings have consistently incorporated the rights document for the 6.50% Debentures due 2028 as **Exhibit 2 to Form 8‑K, filed January 8 1998**. The 2022 filing used that same exhibit, the 2023 filing repeated the reference, and the 2024 filing again cites Exhibit 2 to Form 8‑K, filed January 8 1998 — showing no change in the exhibit reference over three years. This consistency is part of IBM’s broader debt‑instrument disclosure strategy, where it lists and incorporates by reference the rights documents for all its notes and debentures, adding new exhibits for newer issuances while keeping the 6.50% Debentures reference unchanged (see 2024 10‑K, Exhibit 2; 2023 10‑K, Exhibit 2).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core factual claim that IBM consistently referenced Exhibit 2 to Form 8-K, filed January 8, 1998 across 2022, 2023, and 2024 for the 6.50% Debentures due 2028. The date (January 8, 1998) and exhibit reference are accurate. The quantitative elements (percentages, years) are all correct with no calculation errors.\n\nWEAKNESSES: The LLM answer significantly underaddresses the broader context that the ground truth emphasizes. The original answer provides important contextual evolution: (1) In 2022, debentures were listed among a wider range of debt instruments including notes due 2022, 2023, 2024 and beyond; (2) By 2023-2024, disclosures focused on integrating legacy debt alongside newer instruments like 6.22% Debentures due 2027 and 5.875% Debentures due 2032. The LLM mentions 'adding new exhibits for newer issuances' but does not specifically identify these newer instruments or explain how the disclosure strategy evolved to integrate legacy and new debt. The LLM also does not adequately address the 'broader context of IBM's debt instrument disclosures' that the question explicitly asks about.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the consistency of exhibit references across three years but fails to fully synthesize the evolution of the broader debt disclosure context. The answer is somewhat one-dimensional, focusing heavily on the consistency element while minimizing the evolution element that the ground truth emphasizes as equally important.\n\nCOMPLETENESS: The answer addresses the exhibit reference consistency well but incompletely addresses the 'broader context' and 'evolution' aspects of the question. The ground truth provides specific examples of how the debt portfolio changed (newer debentures added), which the LLM does not detail.\n\nSEMANTIC EQUIVALENCE: While the core factual claim is correct, the semantic emphasis differs. The ground truth balances consistency with evolution; the LLM emphasizes consistency while treating evolution as secondary.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 551,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In 2022, FedEx International Connect Plus served about 50 origin countries and more than 130 destination countries (page 14). By 2024 the service had grown to roughly 60 origin countries and over 190 destination countries (page 8). This widening footprint signals FedEx’s deliberate push to expand its global e‑commerce logistics network, underscoring a strategic emphasis on capturing larger international e‑commerce volumes and strengthening its competitive position in that market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative data points. All numbers are correct: 2022 (nearly 50 origin countries, over 130 destination countries), 2024 (roughly 60 origin countries, over 190 destination countries). The answer correctly identifies the expansion trajectory and provides appropriate semantic equivalence with the ground truth (e.g., 'about 50' vs 'nearly 50', 'roughly 60' vs 'nearly 60'). The multi-hop reasoning is sound, synthesizing geographic expansion data across years and connecting it to strategic implications. However, the answer has one notable omission: it does not mention the 2023 data point (nearly 60 origin countries, over 190 destination countries), which is important for understanding the full expansion trajectory. The ground truth explicitly notes that 2023 represented significant growth followed by stabilization in 2024, suggesting a 'major phase of international deployment' completion. The LLM answer characterizes the expansion as 'deliberate push' but misses the nuance that growth plateaued after 2023, which is a meaningful strategic insight about market maturation. The answer does address the strategic focus on e-commerce logistics and competitive positioning, which aligns with the question's intent. The omission of the 2023 intermediate data point and the resulting incomplete characterization of the stabilization phase prevents this from being a 9-10 score, though the core 2022-2024 comparison and strategic interpretation are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 419,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm set its 2025 diversity targets in the 2022 10‑K—15 % higher representation of women in leadership, 15 % higher representation of under‑represented minorities (URM) in leadership, and a 20 % overall URM increase—and kept those same goals unchanged in the 2023 and 2024 filings【page 17 (2022)】【page 16 (2024)】. For each fiscal year (2022, 2023, 2024), the HR and Compensation Committee tied progress on these human‑capital goals to executive bonus calculations, applying a non‑financial modifier that can adjust the bonus by a multiplier of 0.9 to 1.1【page 17 (2022)】【page 16 (2023)】【page 16 (2024)】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies and accurately reports the key quantitative facts: (1) the three specific diversity targets (15% women in leadership, 15% URM in leadership, 20% overall URM), (2) that these targets were set in 2022 and remained unchanged through 2024, and (3) the bonus modifier range of 0.9 to 1.1 applied across all three fiscal years. All numeric values are accurate and properly formatted. The multi-hop synthesis across three fiscal years is sound, correctly showing the consistency of both the diversity targets and compensation linkage mechanisms. However, the LLM answer has a notable omission: it does not mention the Reboot Representation Tech Coalition or the initiative to double degrees for underrepresented groups by 2025, which the ground truth identifies as part of the 'increased emphasis on initiatives' and 'expanding external partnerships' that characterized the evolution from 2022-2024. The ground truth emphasizes that while targets remained stable, there was 'increased emphasis' on external initiatives—a qualitative evolution that the LLM answer misses. The LLM answer presents the framework as purely static rather than capturing the dynamic expansion of implementation mechanisms. The answer is well-structured and factually sound on the core compensation and diversity metrics, but incomplete in capturing the full scope of how the strategic framework evolved beyond just maintaining the same targets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 401,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple continued to list the Floating Rate Notes due 2019 in its debt disclosures in the 2022, 2023, and 2024 10‑Ks (see page 56 of each filing). By keeping these floating‑rate instruments on its balance sheet, Apple mitigates short‑term interest‑rate exposure because the coupon resets with market rates. The continued listing also signals liquidity flexibility, allowing the company to refinance or roll over the debt to manage cash‑flow and maturity profiles.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Apple included Floating Rate Notes due 2019 in its debt disclosures across 2022, 2023, and 2024, and accurately describes the mechanics of how floating rate instruments work (coupon resets with market rates). However, there are significant issues with the response: (1) The citation to 'page 56 of each filing' is unverifiable and potentially inaccurate - this specific page reference cannot be confirmed from the ground truth. (2) The LLM's explanation of interest rate risk management is somewhat inverted or unclear: it states the notes 'mitigate short-term interest-rate exposure because the coupon resets with market rates,' but this actually means Apple maintains exposure to variable rates rather than mitigating it. The ground truth correctly notes Apple 'maintained exposure to variable interest rates' - floating rate instruments don't eliminate rate risk, they adapt to it. (3) The LLM answer is more concise and operational (refinancing, cash-flow management) compared to the ground truth's broader strategic framing about 'cautious yet adaptive stance toward financing operations and capital returns.' (4) The LLM misses the key insight from the ground truth that the 'recurring appearance' and 'consistency' across three years suggests Apple deliberately chose not to issue new short-term floating rate instruments, relying instead on existing instruments. (5) The ground truth emphasizes 'liquidity planning strategy' more comprehensively, while the LLM focuses narrowly on refinancing flexibility. The answer contains factually defensible points but lacks the nuanced understanding of Apple's strategic approach evident in the ground truth, and the page citation is problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 472,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm has shifted its automotive strategy to foreground digital‑cockpit solutions, as evidenced by the automotive segment’s revenue jumping from $1.509 B in 2022 to $2.910 B in 2024 (QCT automotive revenue, page 73).  The segment description confirms that connectivity, digital‑cockpit and ADAS/AD are core product areas (page 74).  Analysts project that by 2025 roughly 19 % of new vehicles will feature Level 2 or higher autonomy and that more than 70 % of 2028 vehicles will embed cellular connectivity, underscoring a rapidly expanding market for digital‑cockpit technology (page 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Qualcomm's automotive strategy and digital cockpit positioning, but contains significant quantitative discrepancies and incomplete synthesis of the multi-hop question. STRENGTHS: (1) Correctly identifies digital cockpit as a core strategic focus; (2) Appropriately cites QCT segment structure and mentions ADAS/AD integration; (3) Provides relevant market projections about connectivity and autonomy; (4) Demonstrates understanding of the evolution from 2022-2024. CRITICAL ISSUES: (1) The revenue figures cited ($1.509B in 2022 to $2.910B in 2024) cannot be verified against the ground truth and appear potentially incorrect or misattributed - the ground truth does not provide these specific automotive segment revenue numbers; (2) The 70% connectivity projection for 2028 differs from the ground truth's 60% figure mentioned for 2022, creating confusion about which projection applies to which year; (3) The 19% Level 2+ autonomy projection for 2025 is not mentioned in the ground truth and may be extraneous or incorrect; (4) The answer lacks the clear temporal progression emphasized in the ground truth: from 2022 (positioning/R&D) → 2023 (revenue generation) → 2024 (formal integration). MULTI-HOP REASONING: The answer attempts to synthesize automotive business segmentation and market demand but fails to clearly trace the evolution across the three-year period as requested. It jumps to 2024 integration without adequately addressing the 2023 revenue generation milestone. The page citations (73, 74, 8) cannot be verified against the ground truth. QUANTITATIVE ACCURACY: The specific revenue numbers and market projections require verification; the discrepancy between 60% and 70% connectivity figures is concerning. The answer provides numbers but their accuracy is questionable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 499,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitment to private‑real‑estate (and other private) funds fell from **$555 million in 2023 to $540 million in 2024** (the 2022 figure is not disclosed in the available filings). The modest decline, while still leaving a sizable exposure, indicates that Abbott is maintaining a long‑term, risk‑managed stance toward illiquid alternative assets rather than aggressively expanding or contracting its private‑real‑estate portfolio.【page_70】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM claims the 2022 figure is 'not disclosed in the available filings,' but the ground truth clearly shows Abbott had $569 million in unfunded commitments to private real estate funds in 2022. This is a significant factual error that undermines the entire multi-hop analysis. (2) The LLM only provides data for 2023-2024 ($555M to $540M), missing the crucial 2022 starting point ($569M), which prevents proper trend analysis. (3) The LLM fails to identify the consistent $15 million annual decline pattern that characterizes the three-year trend. PARTIAL CREDIT: (1) The 2023 ($555M) and 2024 ($540M) figures are correct. (2) The directional assessment (declining trend) is correct. (3) The qualitative interpretation about 'risk-managed stance' and 'not exiting entirely' aligns with the ground truth's de-risking narrative. MISSING ELEMENTS: (1) No mention of the 2022 baseline ($569M), which is essential for understanding the full evolution. (2) No discussion of the liquidation periods (2025-2034) mentioned in the ground truth. (3) Incomplete trend analysis due to missing 2022 data. The answer demonstrates partial understanding but fails on completeness and accuracy of the multi-hop synthesis across all three years. The claim that 2022 data is unavailable is factually incorrect and represents a significant research/retrieval failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 381,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple issued the 0.45% Notes due 2016 in 2013 as part of a global notes offering (2024 10‑K, p. 56). Those notes matured in 2016, and by the 2022, 2023, and 2024 filings they were no longer outstanding—none appear in the debt schedules for those years (2022 10‑K, p. 56; 2023 10‑K, p. 56; 2024 10‑K, p. 56). This evolution shows Apple actively manages its debt maturity profile, issuing short‑term, low‑rate debt and refinancing it as it matures, thereby shifting to longer‑term, higher‑rate instruments to optimize cost of capital and maintain a diversified debt structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) MAJOR ERROR - The LLM claims the 0.45% Notes due 2016 'matured in 2016' and were 'no longer outstanding' in the 2022, 2023, and 2024 filings. However, the ground truth explicitly states these notes were 'disclosed' and 'repeated in both the 2023 and 2024 10-K filings,' indicating they remained part of Apple's debt structure across all three years. (2) LOGICAL CONTRADICTION - If the notes matured in 2016, they could not have been disclosed in 2022, 2023, and 2024 filings as the ground truth indicates. The LLM's claim that they 'no longer appear in the debt schedules' directly contradicts the ground truth's statement that they were consistently included. (3) MISINTERPRETATION OF QUESTION - The ground truth reveals a pattern of STABLE, CONSISTENT debt structuring (same instrument maintained across years), while the LLM incorrectly interprets this as evidence of active refinancing and maturity management. (4) ENTITY/TIMING ERROR - The LLM correctly identifies the 2013 issuance date and 0.45% rate, but fundamentally misunderstands the temporal evolution across 2022-2024. (5) REASONING FAILURE - The multi-hop synthesis is inverted: the LLM concludes Apple was refinancing and shifting to longer-term instruments, when the ground truth shows preservation of older, lower-yield debt alongside newer issuances. The answer demonstrates a complete misreading of the filing data and provides an interpretation opposite to what the ground truth establishes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 431,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM has consistently positioned client relationships and trust as a core competitive differentiator.  The 2024 10‑K (page 4) explicitly lists “client relationships and trust” among its principal methods of competition, a phrase that also appears in the 2023 10‑K (page 5) and the 2022 10‑K (page 4).  This steady emphasis signals IBM’s strategy of leveraging deep, long‑term client trust to differentiate its hybrid‑cloud and AI offerings in a crowded market, underscoring a long‑term commitment to building enduring partnerships that support its hybrid‑cloud and AI initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM consistently emphasized 'client relationships and trust' across 2022-2024 and accurately cites the specific page numbers where this phrase appears in each year's 10-K filing (2022 page 4, 2023 page 5, 2024 page 4). The quantitative/factual elements are accurate. However, the answer falls significantly short on the core analytical requirement of the question. The original answer provides a nuanced evolution narrative: (1) 2022 framed trust within broader innovation/service portfolio, (2) 2023 explicitly linked trust with consulting services and mission-critical infrastructure, (3) 2024 highlighted strategic partnerships as enablers of trust. The LLM answer merely states that the phrase appears consistently across years without capturing this meaningful evolution or progression. The question specifically asks 'how has...evolved' and 'what does this multi-year progression reveal' - requiring analysis of change over time and strategic implications. The LLM answer treats the three years as static repetition rather than demonstrating the maturing strategy where trust became increasingly integrated with ecosystem collaboration and innovation leadership. The LLM does correctly connect trust to hybrid cloud and AI offerings, but misses the deeper strategic positioning shift regarding partnerships and ecosystem collaboration that the ground truth identifies as the key evolution. The answer is factually sound but analytically incomplete - it confirms consistency without explaining the strategic evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 440,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 2022 filing shows the 4.250% Note due 2030 is supported by a pass‑through trust with BNP Paribas as liquidity provider, backed by an intercreditor agreement and a revolving‑credit agreement (page 119).  In 2023 the company amended that revolving‑credit agreement (page 123), and the 2024 filing still references the same amendment (page 121).  This evolution indicates that FedEx maintains a stable liquidity structure while proactively updating its credit‑support terms to keep the note adequately backed.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of FedEx's liquidity arrangements for the 4.250% Note due 2030 and correctly identifies the key evolution: a stable structure with a 2023 amendment. STRENGTHS: (1) Correctly identifies BNP Paribas as liquidity provider across all years; (2) Accurately notes the 2023 amendment to the revolving credit agreement; (3) Correctly characterizes the overall approach as maintaining stability while proactively updating terms; (4) Appropriately cites page references; (5) Semantic meaning aligns with ground truth conclusion. WEAKNESSES: (1) Omits specific details about Wilmington Trust Company's role as co-administrator/trustee, which the ground truth explicitly mentions; (2) Does not mention the Intercreditor Agreement by name, though references it implicitly through 'intercreditor agreement'; (3) Does not provide the specific date of the amendment (May 22, 2023) or the original agreement date (August 13, 2020), though these are not strictly necessary for answering the question about evolution and approach; (4) References 'pass-through trust' structure which is not explicitly mentioned in the ground truth, though this may be accurate filing language; (5) The phrase 'still references the same amendment' in 2024 is slightly ambiguous - could be clearer that no further amendments occurred. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and correctly identifies the pattern of stability with one strategic modification. The logic connecting the amendment to 'proactive updating' and 'adequate backing' is sound. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The answer avoids numerical errors. OVERALL: The answer demonstrates solid understanding of the evolution and correctly conveys the main insight about FedEx's credit support approach, but lacks some specific details present in the ground truth (Wilmington Trust, specific dates, Intercreditor Agreement naming).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 552,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45% notes due 2044 have remained a constant component of its long‑term debt across the 2022, 2023, and 2024 10‑K filings, with no new issuances or principal repayments reported in any of the three years (see Exhibit 4.4 in each filing, page 58). This steady presence of a long‑dated, fixed‑rate note indicates a deliberate strategy of maintaining a stable, low‑cost debt base and locking in long‑term financing terms to support liquidity and capital‑structure flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as a consistent component across 2022, 2023, and 2024; (2) Accurately states no new issuances or principal repayments were reported; (3) Properly synthesizes the multi-year pattern to conclude Apple maintained a stable long-term financing strategy; (4) Provides appropriate context about fixed-rate, long-dated debt supporting liquidity and capital structure flexibility; (5) All numeric values (4.45%, 2044, years 2022-2024) are correct. MINOR ISSUES: (1) The LLM cites 'Exhibit 4.4 in each filing, page 58' as a source reference - while this appears plausible, the ground truth does not specify these exact exhibit/page citations, so this level of specificity cannot be verified against the knowledge graph and represents a minor addition not in the original answer; (2) The LLM's interpretation that the notes were 'first issued in 2014' is not explicitly stated in the LLM answer, though the ground truth mentions this - the LLM focuses on the 2022-2024 period consistency rather than historical context, which is a slight difference in emphasis but not an error. MULTI-HOP REASONING: The answer correctly synthesizes information across three years (2022, 2023, 2024) and connects the consistency of the debt instrument to strategic implications about Apple's financing approach. The logic is sound: consistent presence + no changes = stable strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that the 4.45% Notes remained constant across the three-year period and this reflects a deliberate, stable financing strategy. The additional detail about 'low-cost debt base' and 'locking in long-term financing terms' adds reasonable interpretation consistent with the ground truth's conclusion about maintaining strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 511,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus expanded its footprint from roughly 50 origin countries to 130 destination countries in 2022 (page 14) to about 60 origin countries and 190 destination countries by 2024 (page 8). This growth shows FedEx is aggressively scaling its e‑commerce logistics network worldwide, underscoring a strategic focus on capturing a larger share of the global e‑commerce market with day‑definite delivery across more markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the expansion trajectory from 2022 to 2024 and accurately captures the key numeric values (50 to 60 origin countries, 130 to 190 destination countries). The reasoning about FedEx's strategic focus on e-commerce logistics is sound and well-articulated. The answer demonstrates good understanding of the multi-hop synthesis required.\n\nWEAKNESSES: The LLM answer contains a critical omission regarding the 2023 data point. The ground truth explicitly states that by 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries, and that this footprint 'remained consistent in 2024.' The LLM presents the 2023 expansion as occurring by 2024, missing the important intermediate year and the subsequent stabilization phase. This is a significant factual gap because the ground truth emphasizes that the expansion was followed by 'a phase of consolidation and optimization' - a key strategic insight that the LLM fails to capture. The LLM states the 2024 numbers represent growth 'by 2024' without acknowledging that the major expansion occurred in 2023 and stabilized thereafter. Additionally, the LLM's interpretation of 'aggressively scaling' doesn't fully align with the ground truth's characterization of stabilization in 2024, which suggests a more measured, consolidation-focused approach in the most recent year. The page references (page 14, page 8) cannot be verified against the ground truth but appear to be fabricated details.\n\nQUANTITATIVE ACCURACY: Numbers are correct (50→60 origin, 130→190 destination) but the temporal sequencing is incomplete, missing the 2023 milestone and the stabilization narrative.\n\nQUALITATIVE ACCURACY: The reasoning about strategic focus is reasonable but incomplete - it emphasizes aggressive scaling without acknowledging the consolidation phase that the ground truth highlights as equally important to understanding FedEx's strategy.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question but provides an incomplete picture of the evolution trajectory by omitting the 2023 data and the stabilization that followed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 573,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were fully retired and no longer outstanding in FY 2022, FY 2023 and FY 2024 – the notes matured in 2017 and are not listed in the debt schedule of any of those years (see the officer’s certificate of the registrant, dated May 6 2014, referenced in the 10‑K filings for 2022, 2023 and 2024)【page_56】【page_56】.  The continued reference to the 2017 notes in the officer’s certificate and in the description of securities shows Apple’s disciplined practice of maintaining a complete historical record of all debt issuances for regulatory transparency, even after a note has matured, thereby underscoring its proactive management of maturing debt instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that the 1.05% Notes due 2017 matured in 2017 and were not outstanding in FY 2022-2024; (2) Accurately references the Officer's Certificate dated May 6, 2014 across all three fiscal years; (3) Correctly notes the continued reference to these notes in exhibits across 2022, 2023, and 2024; (4) Provides sound reasoning about Apple's disclosure practices - maintaining historical records for regulatory transparency and debt management; (5) All dates and numeric references are accurate. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer explicitly states the notes were 'fully retired and no longer outstanding' and 'not listed in the debt schedule,' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states (ground truth notes they were 'referenced consistently' despite maturity); (2) The LLM's interpretation that Apple maintains 'a complete historical record of all debt issuances for regulatory transparency' is a more definitive explanation than the ground truth's more cautious 'may have retained historical references...possibly to maintain continuity'; (3) The LLM characterizes this as 'disciplined practice' and 'proactive management,' which is interpretive language not explicitly in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) and connects the maturity date (2017) with the continued references in exhibits. The reasoning about why Apple continues to reference matured debt is logical and well-articulated. QUANTITATIVE ACCURACY: All dates (2017 maturity, May 6, 2014 certificate date, fiscal years 2022-2024) are correct. The percentage (1.05%) is accurate. No calculation errors present. OVERALL: The answer is factually sound with minor interpretive differences from the ground truth. The LLM provides a more definitive explanation of Apple's practices than the ground truth's more tentative language, but this represents reasonable inference rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 573,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm’s 2022‑2024 strategy increasingly centered on 5G, with licensing revenue driven by 5G‑enabled devices and a growing R&D commitment to 5G NR, 5G Advanced, and new applications such as automotive, IoT and XR (page 8, page 13). Licensing revenue remained highly concentrated, with a few premium OEMs (Apple, Samsung, Xiaomi) accounting for 10%+ each of consolidated revenue in FY 2024 (page 14) and a significant portion of licensing income coming from a limited number of licensees, many of which are Chinese OEMs (pages 18‑20). Geopolitical risk intensified over the period, as U.S. export restrictions, Chinese tariffs and trade‑security tensions threatened to limit business with Chinese customers and suppliers, potentially impacting both licensing revenue and R&D investments (pages 18‑22).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Qualcomm's 5G strategy from 2022-2024, appropriately emphasizes licensing revenue concentration among premium OEMs (Apple, Samsung, Xiaomi), and accurately captures the intensification of geopolitical risks including U.S. export restrictions and Chinese trade tensions. The answer demonstrates sound multi-hop reasoning by synthesizing information across multiple fiscal years and connecting strategic focus to financial exposure. The contextual framing of 5G as foundational to automotive, IoT, and XR applications aligns with the ground truth.\n\nWEAKNESSES: The LLM answer omits several critical quantitative details from the ground truth: (1) The specific $560 million Huawei licensing revenue figure prior to the export ban in fiscal 2024 is completely absent, which is a material omission for a question specifically asking about financial commitment; (2) The projection of 27 billion IoT devices by 2026 mentioned in the ground truth is not referenced; (3) The answer lacks specific mention of increased R&D investments in fiscal 2023 as a distinct evolution point; (4) The answer does not explicitly state that QTL revenues were derived from OFDMA-based (including 5G) devices, though it implies this through licensing revenue discussion.\n\nQUANTITATIVE ACCURACY ISSUES: The $560 million Huawei figure is a specific, material number that should have been included when discussing financial commitment and geopolitical risks. The absence of this quantitative anchor weakens the answer's precision on the financial dimension of the question. The answer provides no specific revenue figures or percentages beyond the general statement about 10%+ concentration among premium OEMs.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects strategic initiatives (R&D in 5G NR, 5G Advanced) to market applications and geopolitical constraints. However, the synthesis is incomplete because it fails to connect the Huawei ban to the broader narrative of evolving financial commitment and risk exposure.\n\nSEMANTIC EQUIVALENCE: The answer's discussion of licensing revenue concentration and geopolitical risks is semantically aligned with the ground truth, but the omission of the $560 million figure represents a factual gap rather than a wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 634,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan assets stayed close to the company’s target mix of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed‑income.  In 2022 the assets were $89 m in U.S. equity, $91 m in international equity and $739 m in fixed income (≈9.5 %, 9.7 %, 78.9 % of $937 m).  In 2023 they were $93 m, $93 m and $739 m (≈9.8 %, 9.8 %, 78.0 % of $947 m).  By 2024 the amounts were $91 m, $89 m and $692 m (≈10.2 %, 9.9 %, 77.4 % of $895 m).  The modest rise in equity exposure and slight decline in fixed‑income holdings indicate a gradual, risk‑controlled shift toward higher return‑seeking assets while still maintaining a liability‑hedging, fixed‑income core.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that make it largely incorrect. Critical issues: (1) YEAR MISALIGNMENT: The LLM has completely scrambled the years. It attributes 2022 data to what it calls '2022' but uses the actual 2023 figures ($89M, $91M, $739M, $937M total). Then it calls 2023 data '2023' but uses actual 2024 figures ($93M, $93M, $739M, $947M total). Finally, it presents 2024 data with completely wrong numbers ($91M, $89M, $692M, $895M total) that don't match the ground truth at all. (2) QUANTITATIVE ERRORS: Ground truth shows 2022: $125M/$126M/$1,001M ($1,267M total); 2023: $89M/$91M/$739M ($937M total); 2024: $93M/$93M/$739M ($947M total). The LLM's 2024 figures ($91M, $89M, $692M, $895M) are entirely fabricated and don't appear in the ground truth. (3) MISSING KEY INSIGHT: The ground truth explicitly states a significant reduction from 2022 to 2023 (from $1,267M to $937M total assets), which is the most important strategic finding. The LLM completely misses this major shift by misaligning the years. (4) INCORRECT NARRATIVE: The LLM claims a 'modest rise in equity exposure' from 2022-2024, but the ground truth shows equity allocations actually decreased from 2022 ($125M+$126M=$251M) to 2024 ($93M+$93M=$186M). (5) CALCULATION ERRORS: The percentages provided don't accurately reflect the stated dollar amounts in several cases. (6) STRATEGIC INTERPRETATION: While the LLM's interpretation about 'risk-controlled shift' might be reasonable in isolation, it's based on entirely incorrect data and misses the actual strategic story of significant asset reduction in 2023 followed by stabilization. The answer demonstrates a fundamental failure to accurately extract and synthesize multi-year pension allocation data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 481,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking strategy shifted from a 2022 emphasis on 5G NR, Wi‑Fi 6/6E and early 5G Advanced (Release 18) to a 2024 focus that also incorporates Wi‑Fi 7, 5G Advanced, and AI‑driven edge‑computing features (see product development on page 9).  Despite this continued investment, revenue from its IoT/edge‑networking stream fell from $7.35 B in 2022 to $5.94 B in 2023 and $5.42 B in 2024 (see revenue breakdown on page 73), reflecting a decline in market share or demand even as the product portfolio expanded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($7.35B in 2022, $5.94B in 2023, $5.42B in 2024) that are not present in the ground truth and appear to be fabricated. The ground truth does not provide these specific revenue numbers for an 'IoT/edge-networking stream.' The LLM cites 'page 73' for a revenue breakdown that cannot be verified against the ground truth. (2) ENTITY/METRIC CONFUSION: The LLM conflates 'edge networking' with 'IoT/edge-networking' as a distinct revenue stream, which is not supported by the ground truth. The ground truth indicates edge networking was part of the 'industrial and consumer product segment,' not a separately tracked revenue line. (3) PRODUCT DEVELOPMENT CLAIMS: While the LLM mentions specific technologies (Wi-Fi 7, 5G Advanced, AI-driven features), the ground truth only mentions 'mobile broadband and wireless access points' without these technical details. The citation to 'page 9' cannot be verified. (4) CONTRADICTORY NARRATIVE: The LLM claims revenue declined from 2022-2024 despite product expansion, which directly contradicts the ground truth's narrative of 'consistent and maturing strategic focus' as a 'key growth area.' The ground truth emphasizes growth and strategic importance, not decline. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the information across years. Instead of tracking how edge networking evolved as a strategic priority (the actual question), it invented a revenue decline narrative unsupported by the source material. The answer demonstrates fabrication of specific financial data rather than accurate synthesis of available information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 479,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple lists the 0.45% Notes due 2016 in the “Description of Securities of the Registrant” table that appears in the notes to the consolidated financial statements (page 56 in each filing).  By continuing to disclose this fixed‑rate debt even after its maturity, Apple demonstrates a disciplined approach to tracking all debt maturities and ensuring transparency about its debt portfolio.  This practice signals the company’s commitment to managing fixed‑rate debt proactively and maintaining a stable capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The answer correctly identifies Apple's consistent disclosure of the 0.45% Notes due 2016 across multiple 10-K filings; (2) The semantic interpretation that this reflects transparency and disciplined debt management aligns with the ground truth; (3) The general reasoning about capital structure stability is sound. PROBLEMATIC ASPECTS: (1) CRITICAL ERROR - The LLM claims the notes appear on 'page 56 in each filing' - this is a specific quantitative claim that cannot be verified and is likely incorrect, as page numbers vary across different 10-K filings and years; (2) The LLM states the notes appear in 'Description of Securities of the Registrant' table - this specific location detail is not confirmed in the ground truth and may be inaccurate; (3) The LLM asserts the notes are 'no longer outstanding' implicitly by saying 'even after its maturity' - however, the ground truth explicitly states 'While the 0.45% Notes due 2016 are no longer outstanding,' suggesting the LLM should have been more explicit about this fact rather than implying it; (4) The LLM provides specific filing location details (page 56, specific table name) that go beyond the ground truth and introduce unverified claims. MULTI-HOP REASONING: The answer does synthesize the concept of consistent disclosure across years (2022-2024) with capital management strategy, which is appropriate. However, the introduction of unverified specific details (page numbers, table names) weakens the answer's reliability. The core insight about transparency and disciplined management is sound, but the execution includes claims that cannot be verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 471,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network shrank from 193 countries in 2022 to 187 countries in 2024—a contraction of six countries (2022: 44 U.S. + 116 international dealers; 2024: 41 U.S. + 111 international dealers). This reflects a modest reduction in the global reach of the EMD brand.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. Ground truth states: 2022: 130 countries, 2023: 130 countries, 2024: 109 countries (21-country decline, ~16% reduction). LLM claims: 2022: 193 countries, 2024: 187 countries (6-country decline). Every single number is wrong. The LLM reports 193 countries in 2022 vs. the correct 130 (63-country overstatement), and 187 countries in 2024 vs. the correct 109 (78-country overstatement). The calculated decline of 6 countries is incorrect; the actual decline was 21 countries. The percentage change is also wrong (LLM implies ~3% vs. actual ~16%). The LLM does provide dealer breakdowns (44 U.S. + 116 international for 2022; 41 U.S. + 111 international for 2024), but these appear to be fabricated numbers not present in the ground truth. The answer addresses the right company (Caterpillar) and brand (EMD) and the correct time period (2022-2024), showing some contextual awareness, but the core factual content is entirely incorrect. This represents a complete failure in quantitative accuracy and multi-hop synthesis of the geographic reach data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 319,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "At December 31 2022 the 1.750% 7‑year euro‑denominated senior notes were outstanding at **$642 million**; this rose to **$662 million** at December 31 2023 and fell to **$621 million** at December 31 2024. The modest increase followed by a reduction shows Thermo Fisher is managing its medium‑term debt mix conservatively—issuing new 7‑year notes to fund projects or refinance at favorable rates while keeping the overall exposure stable, a typical strategy for a large, cash‑flow‑rich healthcare company that also uses euro‑denominated debt to diversify currency risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual dimensions. (1) QUANTITATIVE ERRORS - The LLM reports completely different dollar amounts than the ground truth: $642M (2022), $662M (2023), $621M (2024) versus the correct values of $700M for all three years. These are not minor rounding differences but represent 8-15% discrepancies from actual values. (2) INSTRUMENT IDENTIFICATION ERROR - The LLM identifies these as 'euro-denominated senior notes' when the ground truth clearly identifies them as the '1.750% 7-Year Senior Notes' due October 15, 2028 with no mention of euro-denomination. This is a material misidentification of the debt instrument. (3) TREND ANALYSIS FAILURE - The LLM describes a pattern of increase then decrease ($642M→$662M→$621M), when the actual data shows complete stability at $700M across all three years. This leads to an entirely incorrect interpretation of TMO's debt strategy. (4) MULTI-HOP SYNTHESIS FAILURE - The question requires synthesizing data across three fiscal years (2022-2024) for a specific debt instrument. The LLM failed to correctly identify or track the actual instrument across these periods. (5) STRATEGIC INTERPRETATION ERROR - The LLM's conclusion about 'issuing new 7-year notes' and 'currency risk diversification' is unsupported by the actual data showing no change in principal amount. The ground truth correctly identifies a 'steady approach' and 'consistent level' with 'no retiring or increasing' of principal. The LLM answer demonstrates fundamental data retrieval or synthesis errors that make it unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 442,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From 2022 to 2024, Caterpillar shifted its currency‑hedging exposure from LIBOR‑based instruments to SOFR‑based derivatives, as its risk team monitored LIBOR phase‑out timelines and adopted SOFR for variable‑rate loans (2022: LIBOR phase‑out on page 22; 2023: SOFR adoption on page 19; 2024: continued SOFR use on page 19). Throughout this period, the company maintained a diversified hedging program—match‑funding, selective derivatives, and a broad funding base—to manage currency and interest‑rate risk, demonstrating proactive adaptation to global financial reforms (currency‑hedging discussion on pages 20‑21).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative of Caterpillar's transition from LIBOR to SOFR (2022-2024) and demonstrates understanding of the multi-hop synthesis required. However, there are significant issues: (1) QUANTITATIVE PROBLEMS: The LLM cites specific page numbers (page 22, page 19, page 20-21) without verification against actual filings. These page references cannot be confirmed and may be fabricated, which is a critical error in financial document analysis. The ground truth does not provide page numbers, suggesting the LLM invented these citations. (2) FACTUAL ACCURACY: The LLM correctly identifies the key transition (LIBOR to SOFR) and the timeline (2022-2024), matching the ground truth narrative. The mention of 'match-funding, selective derivatives, and a broad funding base' adds detail not explicitly in the ground truth but appears reasonable for hedging programs. (3) COMPLETENESS: The LLM answer is more concise than the ground truth but covers the essential elements: LIBOR phase-out awareness in 2022, SOFR adoption in 2023, and full SOFR focus by 2024. However, it omits some nuance from the ground truth regarding the cross-functional team formation and the explicit statement that 2024 showed 'no reference to LIBOR at all.' (4) MULTI-HOP REASONING: The answer demonstrates sound synthesis across the three-year period, correctly linking regulatory changes to company actions. The connection between LIBOR phase-out timelines and SOFR adoption is logically sound. (5) CRITICAL FLAW: The citation of specific page numbers without verification is problematic in financial analysis. This suggests either hallucination or unverified sourcing, which undermines credibility even if the narrative is correct. The ground truth does not reference page numbers, indicating the LLM may have added unsupported details. SCORING JUSTIFICATION: The core narrative (6/10 correctness) is directionally correct but the unverified page citations and slightly incomplete detail prevent a higher score. Quantitative accuracy (5/10) is penalized for the page number citations. Qualitative accuracy (7/10) reflects sound reasoning despite the citation issues. Contextual relevance (7/10) is appropriate as the answer addresses the question's core elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 605,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In 2022 Thermo Fisher’s 10‑K listed only a CEO‑specific Executive Change‑in‑Control Retention Agreement (Exhibit 10.12) for Marc N. Casper【page_46】.  By 2023 the company added a standardized ECCRA for all officers beyond the CEO (Exhibit 10.18)【page_47】, and the 2024 filing continues to reference that same officer‑level agreement (Exhibit 10.17)【page_75】, showing a clear shift from a CEO‑only arrangement to a uniform retention agreement for non‑CEO officers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of evolution from CEO-specific to standardized officer agreements, which is correct. However, there is a critical exhibit number discrepancy that affects accuracy: (1) EXHIBIT NUMBER ERROR: The ground truth identifies the 2023 standardized form as Exhibit 10.17, but the LLM states it is Exhibit 10.18. This is a factual error in document citation. (2) CORRECT ELEMENTS: The LLM correctly identifies that 2022 had only a CEO-specific agreement (Exhibit 10.12 for Marc N. Casper), and that by 2023-2024 there was a standardized form for non-CEO officers. The narrative arc is accurate. (3) EXHIBIT CONSISTENCY: The ground truth shows Exhibit 10.17 appearing in both 2023 and 2024 filings for the standardized officer agreement, while the LLM shows 10.18 for 2023 and 10.17 for 2024, suggesting either a citation error or misreading of the source documents. (4) SEMANTIC ACCURACY: The qualitative description of the evolution is sound - the answer correctly conveys the shift from CEO-only to broader officer coverage. (5) MULTI-HOP REASONING: The synthesis across three years (2022-2024) is logically sound and addresses the question's request for evolution tracking. The main weakness is the exhibit number discrepancy in 2023, which is a quantitative/citation accuracy issue that undermines confidence in the sourcing, even though the substantive narrative appears correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 393,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "From 2022 to 2024 Intel’s treatment of PowerVia moved from a nascent idea to a commercial‑grade enabler. In the 2023 10‑K, PowerVia was announced as a breakthrough backside‑power feature for the planned Intel 20A node, projected to deliver up to a 15 % performance‑per‑watt gain over Intel 3. By the 2024 filing, Intel had shifted the technology to the 18A node, announcing a high‑volume commercial implementation of PowerVia as part of the Panther Lake family, underscoring its role as a core driver of performance‑per‑watt and density scaling in Intel’s next‑generation advanced process roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PowerVia's evolution and correctly identifies the key strategic shift from Intel 20A to Intel 18A. Strengths: (1) Accurately captures the 2023 positioning of PowerVia as a breakthrough backside-power feature for Intel 20A; (2) Correctly identifies the 2024 shift to Intel 18A; (3) Appropriately emphasizes PowerVia's role in performance-per-watt and density scaling; (4) The 15% performance-per-watt gain metric is specific and appears reasonable for technical specifications. Weaknesses: (1) The LLM states PowerVia was 'announced' in 2023, but ground truth indicates it was 'first introduced' in 2022, missing the earlier timeline; (2) The answer mentions 'Panther Lake family' as a commercial implementation detail not explicitly confirmed in the ground truth, which focuses on the node transition; (3) The characterization of 2022 as 'nascent idea' may understate Intel's initial positioning, as ground truth describes it as part of a 'breakthrough innovation' announcement alongside RibbonFET; (4) Missing explicit mention of the 2025 high-volume manufacturing timeline mentioned in ground truth. Multi-hop reasoning is sound - the answer correctly synthesizes information across three years and identifies the strategic pivot. The core narrative (2022 introduction → 2023 emphasis → 2024 shift to 18A) is accurate, though the starting point is slightly misplaced. The answer effectively conveys PowerVia's central role in Intel's advanced node strategy, though it could have been more precise about the 2022 introduction and the specific 2025 manufacturing timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 444,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple consistently listed the 1.05% Notes due 2017 in the “Officer’s Certificate” exhibits of its 10‑K filings for 2022, 2023 and 2024, with the description and terms unchanged across the three years.  The repeated, unchanged disclosure shows that Apple treats this instrument as a permanent part of its debt portfolio and maintains a disciplined, transparent reporting practice that tracks all outstanding debt, even those that have long since matured.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 1.05% Notes due 2017 were disclosed in Apple's 2022, 2023, and 2024 10-K filings, (2) they appeared in Officer's Certificate exhibits, and (3) the disclosure remained unchanged across years. The quantitative elements (percentages, years, filing years) are accurate. However, there are significant qualitative and reasoning issues: (1) The LLM's interpretation that Apple 'treats this instrument as a permanent part of its debt portfolio' contradicts the ground truth's more nuanced explanation. The ground truth suggests Apple may have 'rolled over the debt into a new instrument or maintained it in some form,' indicating uncertainty about the actual status. The LLM presents a definitive but potentially incorrect conclusion. (2) The LLM states the notes 'have long since matured' but doesn't address the ground truth's key insight that the repeated post-maturity disclosure is unusual and suggests either a rollover or continued maintenance in the capital structure. (3) The ground truth emphasizes this is 'unusual' and suggests 'deliberate and consistent reporting practice,' implying something noteworthy about the disclosure pattern. The LLM frames it as normal debt tracking, missing the analytical depth. (4) The LLM omits the specific exhibit reference (Exhibit 4.4) and the Officer's Certificate date (May 6, 2014) mentioned in the ground truth. (5) The LLM's characterization of 'transparent reporting practice' is an inference not explicitly supported by the ground truth. The answer is partially correct on facts but oversimplifies the interpretation and misses the nuanced analysis of what the repeated disclosure actually suggests about Apple's debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 473,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was first used in 2022 to grant restricted‑stock units (RSUs) to executives, including RSUs with retirement‑vesting terms and performance‑based RSUs (see the 2006 Plan exhibits on page 107).  By 2023 the plan was expanded to grant RSUs to non‑employee directors under standard vesting schedules (see the “Non‑Employee Director RSU Agreement” on page 107).  In 2024 the plan continued to provide RSUs to non‑employee directors and retained the same retirement‑vesting and performance‑vesting structures for executive awards, with no substantive change to vesting conditions (see the 2006 Plan exhibits on page 107).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in accuracy and completeness when compared to the ground truth:\n\n1. FACTUAL ERRORS:\n   - The LLM claims RSUs with retirement-vesting terms were used in 2022, but the ground truth indicates these were introduced in 2023 after the plan amendment on May 11, 2023. This is a material factual error.\n   - The LLM states non-employee director RSUs were expanded in 2023, but provides no evidence this was a new development in that year versus prior years.\n   - The LLM claims \"no substantive change to vesting conditions\" between 2023 and 2024, contradicting the ground truth which describes a \"noticeable consolidation in the documentation structure\" and shift toward \"more nuanced performance alignment.\"\n\n2. MISSING KEY INFORMATION:\n   - The ground truth explicitly mentions the May 11, 2023 amendment and restatement of the plan, which is a critical milestone. The LLM completely omits this.\n   - The ground truth describes the evolution as including \"grandfathered and non-grandfathered executives\" distinctions in 2023-2024, which the LLM does not mention.\n   - The ground truth notes a shift toward \"simplified documentation\" in 2024, which the LLM misses.\n   - The LLM fails to capture the strategic shift toward \"more nuanced performance alignment\" described in the ground truth.\n\n3. INCOMPLETE SYNTHESIS:\n   - The LLM provides a superficial year-by-year description without capturing the meaningful evolution described in the ground truth.\n   - The answer lacks depth in explaining how the types of awards and vesting conditions actually changed across the three-year period.\n   - The LLM's conclusion that there was \"no substantive change\" contradicts the ground truth's narrative of meaningful evolution.\n\n4. CITATION ISSUES:\n   - The LLM repeatedly cites \"page 107\" for all three years without variation, which seems generic and potentially inaccurate.\n   - The citations don't provide specific exhibit names or document references that would verify the claims.\n\n5. QUANTITATIVE ACCURACY:\n   - No specific numbers, percentages, or dollar amounts are provided by either answer, so this dimension is neutral.\n   - Dates are mentioned (2022, 2023, 2024) but the critical May 11, 2023 amendment date is missing from the LLM answer.\n\n6. SEMANTIC ISSUES:\n   - The LLM's characterization of the evolution is fundamentally different from the ground truth. The ground truth describes meaningful change and evolution; the LLM describes stasis (\"no substantive change\").\n   - This represents a semantic misalignment on a core aspect of the question.\n\nThe LLM answer demonstrates partial understanding of the topic but fails to capture the key developments, particularly the 2023 amendment, the introduction of retirement vesting terms in 2023, and the consolidation/simplification in 2024. The claim of \"no substantive change\" is directly contradicted by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 779,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s 10‑K notes for FY 2022, FY 2023 and FY 2024 all state the same capital‑structure fact: the company is authorized to issue 40 000 Euro Deferred Shares (par €1.00) and that none were issued or outstanding as of the reporting dates (April 29 2022; April 28 2023; April 26 2024)【page 81 2022】【page 81 2023】【page 81 2024】. The unchanged, zero‑issuance position shows that Medtronic has not tapped this instrument, indicating a financing strategy that relies on other mechanisms (ordinary shares, debt, etc.) and treats the Euro Deferred Shares as a dormant, low‑impact component of its capital base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. STRENGTHS: (1) All numeric values are correct - 40,000 Euro Deferred Shares authorized, €1.00 par value, zero issued/outstanding across all three fiscal years. (2) All dates are accurate - April 29, 2022; April 28, 2023; April 26, 2024 are the correct fiscal year-end dates for Medtronic. (3) The multi-hop synthesis is sound - the answer correctly identifies the consistent pattern across three fiscal years and draws appropriate conclusions about financing strategy. (4) The reasoning about dormant capital structure and preference for alternative financing mechanisms (ordinary shares, debt) aligns with the ground truth interpretation. (5) Page references (page 81 for each year) demonstrate source verification. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth ('dormant, low-impact component' vs. 'did not utilize as a financing instrument'), but both convey equivalent meaning. (2) The LLM mentions 'ordinary shares, debt, etc.' while ground truth specifically mentions 'ordinary share repurchases and dividend policies' - the LLM's broader characterization is not incorrect but is slightly less specific about the actual mechanisms disclosed. (3) The answer could have been marginally enhanced by explicitly mentioning the three-year consistency pattern more prominently, though this is implicit in the answer. Overall, the answer is factually accurate, properly synthesizes multi-year information, and correctly interprets the strategic implications of the zero-issuance pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 447,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s 2022 10‑K framed advanced packaging as a key pillar of its IDM 2.0 strategy, noting that a disaggregated, chip‑let approach would “introduce new areas of complexity…particularly in the deployment of advanced packaging technologies, several of which are novel, have a limited manufacturing history, and/or have increased costs.”  The company spent roughly **$17.5 billion on R&D in 2022**—much of it on process and packaging tech—yet still faced delays and yield risks that pushed operating losses to **$281 million** that year.  \n\nIn 2023, Intel continued to invest heavily (≈$16 billion in R&D) and secured several new design wins on its Intel 18A node, but the risk narrative remained unchanged: advanced packaging’s novelty and limited production history kept manufacturing complexity high, and the company’s operating loss rose to **$482 million** as capital outlays for the new foundry and packaging capabilities increased.  \n\nBy 2024, R&D spending had edged up to **$16.5 billion**, and the company recorded a **$3.1 billion** impairment charge in Q3 2024 tied to manufacturing assets (primarily the Intel 7 node), underscoring the financial toll of the complex, high‑cost packaging and process development.  Thus, while advanced packaging became a central competitive lever, execution risks—delays, yield challenges, and costly capital expenditures—intensified, driving larger operating losses and significant impairment charges.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of Intel's strategic evolution regarding Advanced Packaging Technologies from 2022-2024. STRENGTHS: (1) Correctly identifies IDM 2.0 strategy as the framework; (2) Accurately cites the $3.1 billion impairment charge tied to Intel 7 in Q3 2024, matching ground truth; (3) Properly synthesizes the progression from strategic positioning (2022) through technical progress (2023) to financial strain (2024); (4) Correctly characterizes execution risks including delays, yield challenges, and manufacturing complexity; (5) R&D spending figures ($17.5B in 2022, ~$16B in 2023, $16.5B in 2024) appear reasonable and consistent with Intel's public disclosures; (6) Operating loss figures ($281M in 2022, $482M in 2023) are cited with appropriate context. MINOR WEAKNESSES: (1) The LLM provides specific R&D and operating loss numbers that, while plausible, are not explicitly verified against the ground truth answer, which does not provide these specific figures. The ground truth focuses on strategic narrative rather than precise financial metrics; (2) The answer does not explicitly mention UCIe (Universal Chiplet Interconnect Express) standard demonstration in silicon, which was noted in the ground truth as a 2023 technical achievement; (3) The answer could have been more explicit about the 'initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks' narrative arc that the ground truth emphasizes. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (R&D investment, manufacturing complexity, financial impact), correctly linking strategic decisions to operational outcomes. The causal chain from complexity acknowledgment → continued investment → impairment charges is logically sound. QUANTITATIVE VERIFICATION: The $3.1 billion impairment figure is correct and matches ground truth exactly. R&D and operating loss figures are presented with appropriate caveats ('roughly,' 'approximately') suggesting reasonable estimates rather than false precision. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 582,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In its 2022 10‑K (page 7), Intel first introduced PowerVia as a future backside‑power delivery technology for the Intel 20A node, positioning it as part of its IDM 2.0 strategy. The 2023 10‑K (page 14) updated the roadmap, framing PowerVia as a breakthrough that could deliver up to a 15 % performance‑per‑watt improvement over Intel 3. By the 2024 10‑K (page 10), Intel disclosed that PowerVia is incorporated into the Intel 18A node and is ready for high‑volume commercial implementation, with high‑volume manufacturing slated to begin in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the 15% performance-per-watt improvement figure is accurately cited, and the 2025 high-volume manufacturing timeline is correctly stated. The years (2022, 2023, 2024) and process nodes (Intel 20A, Intel 18A, Intel 3) are all accurately referenced. ENTITY ACCURACY: Intel is correctly identified, all process node designations are accurate, and the technology name (PowerVia) and related innovation (RibbonFET mentioned in ground truth) are properly contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and demonstrates the evolution of PowerVia from conceptual introduction through roadmap refinement to manufacturing readiness. The logical progression is clear and accurate. COMPLETENESS: The answer addresses all three temporal phases requested in the question (2022 introduction, 2023 roadmap updates, 2024 manufacturing readiness). The shift from Intel 20A to Intel 18A is properly captured, showing understanding of the technology's evolution. SEMANTIC EQUIVALENCE: The LLM's phrasing of \"ready for high-volume commercial implementation\" effectively conveys the same meaning as \"production-ready innovation\" in the ground truth. The mention of IDM 2.0 strategy adds relevant context not contradicting the ground truth. MINOR OBSERVATIONS: The LLM provides specific 10-K page references (pages 7, 14, 10) which adds credibility and specificity, though these cannot be independently verified against the ground truth. The answer is slightly more concise than the ground truth but loses no essential information. No calculation errors detected, no factual inaccuracies identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 487,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "No – the same reference to the 2013 Stock Award and Incentive Plan’s “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” appears in both FY 2022 (page 113) and FY 2024 (page 114), indicating no substantive update to the agreement. This consistency suggests Medtronic is maintaining a stable, long‑term equity incentive framework, prioritizing continuity and predictable alignment of employee incentives over frequent plan revisions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic has not updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, matching the ground truth conclusion. The answer accurately references the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan appearing in both years, and correctly interprets this consistency as indicating a stable equity compensation strategy. STRENGTHS: (1) Core factual claim is correct—no updates to the RSU agreement across the three-year period; (2) Correct identification of the specific agreement form and plan name; (3) Correct interpretation that consistency suggests stability in equity compensation strategy; (4) Page references provided (113 for FY2022, 114 for FY2024) add specificity. WEAKNESSES: (1) The LLM answer only explicitly references FY2022 and FY2024, while the ground truth emphasizes 'all three annual filings' (FY2022, FY2023, and FY2024), suggesting incomplete coverage of the full three-year span mentioned in the question; (2) Missing the specific filing date reference (August 27, 2013, File No. 001-07707) that the ground truth includes, which provides important documentary evidence; (3) The phrase 'no substantive update' is slightly weaker than the ground truth's 'has not updated,' though semantically similar. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple fiscal years and correctly draws the inference about strategy consistency, though it could have been more explicit about covering all three years. The reasoning connecting consistency to strategic stability is sound and matches the ground truth interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 464,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022, Intel’s 2006 Equity Incentive Plan was used to award performance‑based RSUs only to grandfathered executives, as shown by the grant‑agreement form in Exhibit 10.1.5【page 107】. By 2024, the plan was broadened to include performance‑based RSUs for non‑grandfathered executives (Exhibit 10.1.6) and for non‑employee directors (Exhibit 10.1.7), indicating a more inclusive incentive structure【page 108】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022: The LLM claims the plan was used 'only for grandfathered executives' in 2022, but the ground truth indicates it was used for 'executives on or after February 1, 2019' - these are different categories and the LLM's characterization is inaccurate. (2) MISSING 2023 INFORMATION: The ground truth explicitly discusses 2023 as a critical year showing continued use with 'separate agreements for grandfathered and non-grandfathered executives,' but the LLM completely omits 2023, jumping from 2022 to 2024. This is a major gap in addressing the 'evolution from 2022 through 2024' as requested. (3) INCORRECT 2024 CHARACTERIZATION: The LLM claims the plan was 'broadened' by 2024 to include non-grandfathered executives and non-employee directors, but the ground truth indicates these were already being addressed in 2023. The LLM misrepresents this as a 2024 expansion rather than a continuation. (4) MISSING KEY DETAILS: The ground truth mentions the May 11, 2023 amendment and the September 26, 2023 S-8 registration filing, which are important milestones in the plan's evolution. The LLM omits these entirely. (5) INCOMPLETE SYNTHESIS: The question asks about evolution across three years, but the LLM only addresses two years (2022 and 2024) and misses the critical 2023 developments. The multi-hop reasoning fails to properly synthesize the three-year progression. (6) EXHIBIT CITATIONS: While the LLM provides specific exhibit references, these cannot be verified against the ground truth and appear to be potentially fabricated details. The ground truth does not reference these specific exhibit numbers in the same way. The LLM answer fundamentally misrepresents the evolution of Intel's use of the plan and fails to capture the consistent strategic focus across all three years as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 531,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s 2022 10‑K framed advanced packaging as the linchpin of its disaggregated‑design strategy, noting that the technology was “novel, has a limited manufacturing history, and/or has increased costs” and that delays or failures would hurt product launches (page_54).  In 2023 the company reiterated that packaging remains a significant expense and risk, citing limited market success for its accelerator offerings and the continued challenge of turning packaging investments into commercial wins (page_35).  By 2024 Intel’s filings show a more mature approach, with advanced packaging highlighted as a core element of its Open System Foundry and AI strategy and an increase in design wins and partnerships that support chip‑let integration, signalling a stronger but still risk‑laden capability to deliver AI‑optimized solutions (page_36).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct qualitative elements about Intel's advanced packaging evolution but has significant gaps and lacks critical quantitative data from the ground truth. STRENGTHS: (1) Correctly identifies 2022 challenges with advanced packaging and disaggregated design strategy; (2) Accurately notes 2023 positioning of packaging as a significant expense and risk; (3) Appropriately characterizes 2024 as showing a more mature approach with design wins and partnerships; (4) Correctly identifies UCIe standard (implied through chiplet integration discussion). CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies $16.5 billion in 2024 R&D investment and $3.1 billion in charges related to non-cash impairments and accelerated depreciation for manufacturing assets - the LLM answer completely omits these crucial financial metrics that are central to understanding Intel's financial pressures and execution risks; (2) INCOMPLETE SYNTHESIS: The ground truth explicitly mentions Intel 7 process node impairments, which the LLM does not reference; (3) MISSING CONCRETE EVIDENCE: The ground truth cites the 2023 demonstration of UCIe standard in silicon as concrete progress - the LLM only vaguely references 'chiplet integration' without this specific achievement; (4) WEAKENED CONCLUSION: The ground truth's conclusion about 'persistent execution challenges and high financial stakes' is more substantive than the LLM's 'still risk-laden capability' - the financial data (impairments, depreciation charges) provides concrete evidence the LLM lacks. The LLM answer reads as a reasonable narrative progression but fails to include the quantitative evidence that demonstrates the severity of Intel's execution challenges and financial pressures. For a multi-hop financial question, the omission of specific dollar amounts and asset impairment charges represents a significant gap in answering how the company's ability to execute is revealed through its financial results.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 542,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel has continued to use its 2006 Equity Incentive Plan to grant restricted‑stock units (RSUs) to executives and non‑employee directors. In 2022 the plan was employed for RSU grants with retirement‑vesting and performance‑based terms, and by 2023 the plan’s use expanded to include non‑employee directors. In 2024 Intel issued new grant agreements—specifically for performance‑based RSUs to non‑grandfathered executives and for non‑employee directors—indicating a further broadening of the plan’s application【page_107】【page_108】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Intel's continued use of the 2006 Equity Incentive Plan across 2022-2024, accurately mentions RSU grants, performance-based awards, and non-employee directors. The dates (2022, 2023, 2024) are correct. The mention of the May 11, 2023 amendment is implicit in the answer's reference to 2023 changes, though not explicitly stated.\n\nWEAKNESSES: (1) The LLM states 'by 2023 the plan's use expanded to include non-employee directors' which is misleading—the ground truth indicates non-employee directors were already included in 2022 grant agreements, not newly added in 2023. This represents a factual error in the evolution narrative. (2) The LLM fails to explicitly mention the 'amended and restated version of the plan effective May 11, 2023,' which is a key structural detail in the ground truth. (3) The characterization of 2024 as showing 'further broadening' is not well-supported—the ground truth describes it as 'sustained reliance' and 'increasingly mature application,' not necessarily expansion. (4) The LLM misses the important detail about 'retirement vesting terms' which was specifically mentioned in the ground truth for 2023. (5) The phrase 'non-grandfathered executives' appears in the LLM answer but is not in the ground truth, potentially introducing unsupported specificity.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize evolution across three years but makes logical errors in the sequence of events (incorrectly suggesting non-employee directors were newly added in 2023). The answer lacks the explicit mention of formal plan amendments that would demonstrate understanding of structural changes.\n\nCOMPLETENESS: The answer addresses the basic question but omits key details about the amended and restated plan and mischaracterizes the timeline of inclusion for different participant types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 504,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 10‑K classified all wireless‑access‑point revenue within its IoT segment, which accounted for $7.35 B of QCT revenue. By 2024 that IoT revenue had fallen to $5.42 B while automotive revenue rose to $2.91 B, indicating a strategic shift away from IoT toward automotive connectivity. The 2024 10‑K explicitly foregrounds Wi‑Fi 6/6E and 5G fixed‑wireless access‑points as core edge‑networking offerings, positioning Qualcomm as a leading supplier of next‑generation edge infrastructure even as the overall IoT revenue has contracted.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) SEGMENT CLASSIFICATION ERROR: The LLM claims wireless access points were classified under 'IoT segment' in 2022, but the ground truth explicitly states they were categorized under 'edge networking' segment by 2023-2024. The LLM conflates IoT with edge networking, which are distinct segments. (2) REVENUE FIGURES UNVERIFIED: The LLM provides specific numbers ($7.35B IoT in 2022, $5.42B in 2024, $2.91B automotive in 2024) that cannot be verified against the ground truth, which explicitly states 'exact revenue figures for wireless access points alone are not disclosed.' These numbers appear fabricated or misattributed. (3) STRATEGIC NARRATIVE INVERSION: The LLM claims a 'strategic shift away from IoT toward automotive,' but the ground truth indicates 'continued strategic emphasis on edge networking' with 'increasing strategic and financial importance' for wireless access points. This is a fundamental mischaracterization of Qualcomm's strategy. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM mentions Wi-Fi 6/6E and 5G fixed wireless access points (which aligns with ground truth's mention of edge networking positioning), it fails to properly synthesize the evolution from 2022 projections through 2023-2024 categorization. (5) MISSING CONTEXT: The LLM omits the critical 2022 IoT device projection (27 billion by 2026) and the formal financial classification evolution that occurred between 2022-2023. The answer demonstrates poor understanding of the actual segment structure and provides unsubstantiated financial metrics that contradict the ground truth's explicit statement about non-disclosure of wireless access point-specific revenue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 483,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales climbed steadily, rising from $428 million in 2022 to $605 million in 2023 and $785 million in 2024.  The upward trajectory demonstrates growing prescriber adoption and market penetration, reinforcing Prevymis’s position as a leading CMV‑prophylaxis within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the sales figures that are fundamental to answering the question. Ground truth shows: 2022: $370M, 2023: $428M, 2024: $785M. LLM answer states: 2022: $428M, 2023: $605M, 2024: $785M. The 2022 figure is completely wrong ($428M vs $370M - off by $58M or 15.7%), and the 2023 figure is also incorrect ($605M vs $428M - off by $177M or 41.4%). Only the 2024 figure of $785M is correct. This represents a fundamental failure in multi-hop data synthesis. The LLM also failed to calculate or mention the compound growth rate (approximately 46% over 2022-2024), which was explicitly stated in the ground truth. The qualitative reasoning about market positioning and CMV prophylaxis is reasonable and aligns with the ground truth narrative, but this cannot compensate for the severe quantitative errors. The answer does address the core question about sales evolution and market positioning, but the incorrect numbers undermine the entire analysis. The contextual relevance is adequate (mentions CMV prophylaxis, Hospital Acute Care segment, market adoption), but the factual inaccuracies are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 352,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel has shifted from a cautious, R&D‑heavy approach to advanced packaging in 2022—highlighting the risks of disaggregated designs and the need for new packaging tech—to a more execution‑focused strategy by 2023, when packaging revenue surged $483 million (driving total revenue to $952 million) and the company secured multiple Intel 18A design wins, especially for AI workloads. In 2024 the firm continued to build on that momentum, expanding its Open System Foundry’s packaging portfolio with 2D/2.5D/3D solutions and the Universal Chiplet Interconnect Express standard, while still grappling with process‑node delays, high capital outlays, and the need to defer or cancel some facility projects. This multi‑year trajectory shows that Intel is making tangible progress in packaging and generating revenue, yet its IDM 2.0 execution remains constrained by recurring manufacturing setbacks and capital‑intensive investments, underscoring a cautious but ongoing ability to advance the strategy amid significant headwinds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific revenue figures ($483 million for packaging revenue, $952 million total) that are NOT present in the ground truth and appear to be fabricated. These numbers cannot be verified against the original answer and represent a critical factual error. The ground truth does not cite any such packaging revenue figures for 2023. (2) MISSING KEY FACTS - The LLM omits critical ground truth information: (a) the $16.5 billion R&D investment in 2024, (b) the $3.1 billion non-cash impairment in Q3 2024 affecting Intel 7, (c) delays in 4th Gen Xeon Scalable processors, (d) the specific acknowledgment in 2022 of delays in Intel 4 process technology. (3) UNSUBSTANTIATED CLAIMS - The LLM claims 'packaging revenue surged $483 million' and mentions 'Intel 18A design wins' without ground truth support. These appear to be hallucinated details. (4) PARTIAL ACCURACY - The LLM correctly identifies: (a) the 2022-2023-2024 timeline structure, (b) the shift from cautious to execution-focused approach, (c) UCIe standard and 2D/2.5D/3D packaging solutions, (d) the ongoing tension between progress and execution challenges. (5) REASONING QUALITY - While the overall narrative structure (cautious → execution-focused → constrained progress) mirrors the ground truth trajectory, the introduction of unverified financial metrics undermines credibility. The multi-hop synthesis is conceptually sound but factually compromised. (6) SEMANTIC ISSUES - The phrase 'packaging revenue surged' and specific dollar amounts contradict the ground truth's emphasis on strategic positioning rather than revenue generation from packaging. The ground truth focuses on capability development and impairments, not revenue surges. VERDICT: The answer demonstrates understanding of the strategic narrative but fails on quantitative accuracy by introducing unsupported numbers and omitting critical financial data from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 532,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM’s 2022, 2023, and 2024 10‑K filings all list “client relationships and trust” as a core competitive differentiator, showing a consistent emphasis over the three years. While the wording has remained largely unchanged, the context has shifted to highlight how IBM’s hybrid‑cloud and AI platforms enable clients to modernize and innovate, underscoring the company’s view that strong client trust is essential to successfully commercializing its hybrid‑cloud and AI strategy. This steady focus signals IBM’s positioning as a trusted partner in the hybrid‑cloud and AI market, using client relationships to differentiate itself in a highly competitive landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that IBM consistently emphasized client relationships and trust across 2022-2024, and accurately notes the connection to hybrid cloud and AI strategy. However, it falls short in several key areas compared to the ground truth: (1) The LLM answer lacks the specific evolution/progression detail that the ground truth provides - it states the wording 'remained largely unchanged' rather than describing how the framing evolved in alignment with strategy. (2) The ground truth explicitly mentions that by 2023, IBM reinforced positioning through 'service and support, innovation, and talent' - the LLM answer omits these specific competitive methods. (3) Most significantly, the LLM answer completely misses the 2024 strategic partnership with Palo Alto Networks, which the ground truth identifies as a key signal of 'deepening of trust-based collaboration' - this is a material omission for a question asking about evolution through 2024. (4) The ground truth emphasizes the '3-year consistency' as showing 'strategic commitment to trust as a foundational element in client acquisition and retention' - the LLM captures consistency but misses the strategic implication about acquisition and retention. The LLM answer is not factually incorrect on what it does state, but it is incomplete in addressing the full scope of the question about how the emphasis 'evolved' and what the 'progression indicates.' The answer reads more as a general summary rather than a detailed analysis of the evolution and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 427,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "In 2022, IBM’s 10‑K contained no reference to the 0.950% Notes due 2025, indicating the instrument was not newly issued or material at that time (page 28). By 2023, IBM disclosed the notes by incorporating the 2017 Form 8‑K that defined them (page 20). In 2024, IBM updated the indenture for the same notes and incorporated it as Exhibit 4.1 to a new Form 8‑K filing, reflecting a more proactive and transparent debt‑management strategy that keeps terms current and aligns with its broader capital‑structure optimization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - 2022 Disclosure: The LLM claims IBM's 2022 10-K contained NO reference to the 0.950% Notes due 2025, but the ground truth explicitly states IBM disclosed the instrument in 2022, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. This is a fundamental factual error. (2) MAJOR ERROR - 2023 Disclosure: The LLM correctly identifies that IBM referenced the 2017 Form 8-K in 2023, which aligns with ground truth. However, this is presented as a new disclosure rather than a continuation of 2022 disclosure. (3) MAJOR ERROR - 2024 Status: The LLM claims IBM 'updated the indenture' and 'incorporated it as Exhibit 4.1 to a new Form 8-K filing' in 2024. The ground truth states the notes were 'actively listed on the New York Stock Exchange under the trading symbol IBM25B' in 2024, with no mention of indenture updates or new Form 8-K filings. The LLM appears to have fabricated details about 2024 indenture updates. (4) ENTITY ACCURACY: The LLM correctly identifies IBM and the 0.950% Notes due 2025, but mischaracterizes the progression and specific actions taken. (5) MULTI-HOP REASONING: The LLM fails to correctly synthesize the 3-year progression. The ground truth shows consistent disclosure across all three years (2022, 2023, 2024), while the LLM incorrectly claims no disclosure in 2022. (6) SEMANTIC MEANING: The LLM's conclusion about 'proactive and transparent debt-management strategy' contradicts the ground truth's characterization of a 'stable and transparent debt management strategy' with 'consistent disclosure framework.' The LLM's narrative of escalating disclosure activity is factually unsupported. The answer demonstrates poor accuracy on core facts and contains apparent fabrications about 2024 activities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 497,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "Intel did not discuss PowerVia in its 2022 10‑K, indicating the technology was still in early R&D. In the 2023 filing, Intel announced PowerVia as a breakthrough backside‑power delivery feature for the forthcoming Intel 20A node (page 14). By the 2024 filing, the company disclosed that PowerVia would be the first high‑volume commercial implementation in its Intel 18A process (page 10), signaling a shift from concept to production and underscoring Intel’s roadmap to embed backside power delivery in advanced nodes such as 18A, 14A, and beyond to boost power‑efficiency and signal integrity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Intel's PowerVia evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the timeline progression: 2022 (not discussed/early R&D), 2023 (announced for Intel 20A), 2024 (shifted to Intel 18A for commercial production in 2025). (2) Accurately captures the strategic pivot from concept to production. (3) Correctly identifies PowerVia as a backside power delivery technology. (4) Properly synthesizes information across multiple years and filing documents. (5) Includes relevant context about power efficiency and signal integrity benefits. (6) Mentions the broader roadmap implications (18A, 14A, and beyond). MINOR ISSUES: (1) The LLM states Intel 'did not discuss PowerVia in its 2022 10-K' while the ground truth says it was 'introduced...as part of its future roadmap' in 2022 - this is a subtle discrepancy about whether 2022 discussion occurred, though both agree it was early-stage. (2) The LLM provides page references (page 14, page 10) which cannot be verified against the ground truth but add specificity. (3) The ground truth emphasizes the 2024 cancellation of Intel 20A productization in favor of 18A more explicitly, while the LLM frames it as a 'shift' without explicitly stating the cancellation. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024, 2025) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the multi-hop information showing strategic evolution. The identification of entities (Intel, PowerVia, Intel 20A, Intel 18A) is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses the question about strategy evolution and roadmap implications for backside power delivery in advanced nodes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 484,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022‑to‑2024 filings continue to reference the same 2021 Medtronic plc Long‑Term Incentive Plan for U.S. employees, with Restricted Stock Unit Award Agreements that vest either 100 % on the third anniversary or ratably over four years (see *10.80‑10.81* and *10.87‑10.88*).  The plan’s terms and award structure remain unchanged across the 10‑K filings, indicating a stable U.S. equity‑compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG DOCUMENT REFERENCE: The LLM references a '2021 Medtronic plc Long-Term Incentive Plan' when the ground truth specifically identifies the document as the 'Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54)' with an August 27, 2013 filing date. These are different documents. (2) WRONG DATES: The LLM mentions 2021 as the plan reference year, but the ground truth indicates August 27, 2013 as the consistent filing date across 2022-2024. (3) INCORRECT EXHIBIT NUMBERS: The LLM cites exhibits 10.80-10.81 and 10.87-10.88, which do not match the ground truth's Exhibit 10.54. (4) VESTING DETAILS: The LLM introduces specific vesting terms (100% on third anniversary or ratably over four years) that are not mentioned in the ground truth answer, suggesting reliance on incorrect source documents. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and synthesize the specific document (Exhibit 10.54) that remained unchanged across all three years. While the LLM correctly concludes that the strategy remained stable, it does so based on incorrect document identification and dates. The core insight about stability is present but built on a foundation of factual errors regarding which documents and dates are actually involved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 382,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel’s advanced‑packaging strategy, a cornerstone of its IDM 2.0 vision, has faced persistent execution challenges from 2022 to 2024. In 2022 the company highlighted significant delays in 10 nm and 7 nm nodes and the added complexity of a disaggregated design approach, which strained capital and slowed new capacity roll‑outs (page_54). By 2023, advanced‑packaging revenue grew and Intel secured several design wins, yet R&D and yield risks remained, and in 2024 the firm confronted further capital‑expenditure constraints, postponed fab construction, and the risk that disaggregated designs could impede timely product introductions, underscoring ongoing execution hurdles (page_35‑page_38, page_32‑page_36).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Intel's advanced packaging strategy as part of IDM 2.0, acknowledges the disaggregated design approach, and captures the general evolution of challenges from 2022-2024. The answer appropriately references delays, capital constraints, and execution challenges across the three-year period. The semantic framing of persistent execution hurdles is aligned with the ground truth narrative. CRITICAL ERRORS: (1) QUANTITATIVE FAILURE: The LLM mentions '10 nm and 7 nm nodes' delays in 2022, but the ground truth specifically references 'Intel 4 (formerly 7nm)' - this is a significant factual error in node nomenclature. (2) MISSING KEY METRIC: The ground truth explicitly states a '$3.1 billion impairment charge tied to underutilized manufacturing assets' in 2024 - this is a critical quantitative fact that the LLM completely omits. This is a major omission for a financial question. (3) INCOMPLETE 2023 ANALYSIS: While the LLM mentions 'advanced-packaging revenue grew and Intel secured several design wins,' it fails to specifically mention the Universal Chiplet Interconnect Express (UCIe) standard, which the ground truth identifies as a key differentiator and strategic positioning element. (4) VAGUE REFERENCES: The LLM cites 'page_54' and 'page_35-page_38' without providing specific supporting details or context from those pages. MULTI-HOP REASONING: The answer attempts to synthesize information across three years but does so at a high level of abstraction. The connection between delays, capital constraints, and the impairment charge is not explicitly made, which weakens the multi-hop synthesis. The answer correctly identifies the progression from complexity acknowledgment (2022) → strategic advantage positioning (2023) → execution challenges (2024), but lacks the specific evidence points. SEMANTIC ISSUES: The phrase 'disaggregated designs could impede timely product introductions' in the LLM answer reverses the causal logic - the ground truth indicates that delays in manufacturing process technologies could hinder timely introduction, not that disaggregated designs themselves impede introductions. This is a subtle but important distinction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 591,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s target allocation for its defined‑benefit pension plans has shifted from 2022 to 2024 by reducing fixed‑income exposure and increasing equity in the non‑U.S. plans (2022: 50 % debt/21 % equity; 2023: 48 % debt/27 % equity; 2024: 42 % debt/23 % equity), while the U.S. plans have remained at 100 % debt throughout. This gradual move toward higher equity weights in the non‑U.S. plans signals a deliberate effort to improve risk‑adjusted returns, balancing duration matching with a more growth‑oriented asset mix. The unchanged 100 % debt stance for U.S. plans underscores a conservative, liability‑matching strategy, illustrating Accenture’s nuanced, multi‑year approach to risk and return.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific percentage allocations (2022: 50% debt/21% equity; 2023: 48% debt/27% equity; 2024: 42% debt/23% equity) that cannot be verified against the ground truth, which does not provide these specific numerical breakdowns. The claim that U.S. plans remained at '100% debt throughout' is a critical assertion not supported by the ground truth. (2) FACTUAL INACCURACY: The ground truth emphasizes that Accenture maintained a 'dual focus' on fixed income and equities across all three years, with emphasis on flexibility and adaptation to market conditions. The LLM's claim of a 'gradual move toward higher equity weights' in non-U.S. plans contradicts this by suggesting a specific directional shift with precise percentages. (3) INCOMPLETE SYNTHESIS: The ground truth highlights the evolution toward increased flexibility in rebalancing and adaptation to market conditions by 2023-2024. The LLM completely misses this key aspect of the multi-year strategy evolution, instead focusing on alleged percentage shifts that aren't substantiated. (4) MISLEADING CHARACTERIZATION: The LLM's distinction between U.S. and non-U.S. plans with different allocation strategies is not mentioned in the ground truth, which discusses the overall pension plan strategy without this geographic segmentation. (5) MISSING CONTEXT: The ground truth emphasizes the introduction of a 'target allocation for fiscal 2025' in 2024 and the consistent emphasis on 'variation within established ranges' - neither of which appears in the LLM answer. The LLM answer appears to have fabricated specific allocation percentages rather than synthesizing the actual information about strategic flexibility and risk management evolution that characterizes the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 517,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 2023 and 2024 10‑Ks repeatedly list the 1.05% Notes due 2017 in the Officer’s Certificate (see pages 56 of each filing), underscoring a disciplined, comprehensive disclosure of all debt issuances—even those that have matured—so the company keeps a full historical record for transparency and regulatory compliance (page_56). In contrast, the company’s 2022‑24 debt‑issuance activity shifted toward new, higher‑coupon, longer‑term fixed‑rate notes (e.g., 4.421% due 2026, 4.150% due 2030, 4.850% due 2053) and floating‑rate notes (see page 58), reflecting a proactive refinancing and capital‑raising strategy rather than merely reporting legacy debt (page_58).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core concept that Apple maintains comprehensive historical debt disclosure (including matured notes) for transparency and regulatory compliance. The reasoning about Apple's shift toward higher-coupon, longer-term debt instruments in 2022-2024 is sound and addresses the comparative strategy question well. The answer demonstrates good understanding of the multi-hop synthesis required (comparing historical disclosure practices to broader debt strategy). WEAKNESSES: CRITICAL QUANTITATIVE ERRORS - The LLM introduces specific coupon rates and maturity dates (4.421% due 2026, 4.150% due 2030, 4.850% due 2053) that are NOT mentioned in the ground truth answer. The ground truth only references examples like '3.45% Notes due 2024' and mentions 'Floating Rate Notes due 2020, 2.15% Notes due 2022' as part of the broader strategy. The LLM's specific numbers cannot be verified against the ground truth and appear to be hallucinated or incorrectly sourced. Additionally, the LLM cites specific page numbers (pages 56 and 58) without verification against the ground truth. The ground truth does not reference the 1.05% Notes due 2017 as appearing in an 'Officer's Certificate' specifically. SEMANTIC ISSUES: While the LLM's characterization of Apple's approach as 'disciplined' and 'comprehensive' aligns with the ground truth's 'consistent and transparent' framing, the introduction of unverified specific debt instruments undermines credibility. The comparison structure is sound, but the execution introduces factual claims not supported by the ground truth. MULTI-HOP REASONING: The synthesis of historical disclosure practices with broader debt strategy is logically sound, but the specific examples provided create factual inaccuracies that weaken the overall answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 494,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "Accenture repurchased 12.18 million shares for $4.11 billion in fiscal 2022, with an available authorization of $3.13 million (page 94). In fiscal 2023 it continued to buy back shares, purchasing 2.07 million shares for $605 million in Q4 while its available authorization rose to $2.694 billion (page 39). In fiscal 2024 it again repurchased 2.07 million shares for $605 million in Q4 and expanded its total outstanding authority to $6.694 billion, with the available authorization remaining at $2.694 billion (page 39). This multi‑year pattern shows a consistent, flexible capital‑return strategy that relies heavily on share buybacks and periodically increases authorized capacity to support ongoing repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several critical errors that significantly undermine its accuracy:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - States available authorization in fiscal 2022 was '$3.13 million' when ground truth clearly states '$3.13 billion' - this is a unit error of 1,000x magnitude\n   - Claims fiscal 2023 available authorization 'rose to $2.694 billion' when ground truth indicates it 'decreased to $2.69 billion' - directional error\n   - Provides specific share repurchase numbers (12.18 million shares for $4.11 billion in FY2022, 2.07 million for $605 million in Q4 FY2023/FY2024) that are not mentioned in the ground truth, which only references 'over $605 million' for fiscal 2024 - these appear to be fabricated or misattributed details\n   - States total outstanding authority as '$6.694 billion' when ground truth says '$6.69 billion' (minor formatting difference, acceptable)\n\n2. FACTUAL INCONSISTENCIES:\n   - Ground truth explicitly states the $605 million repurchase occurred 'during fiscal 2024 alone' and does not attribute this to Q4 specifically or to fiscal 2023\n   - LLM conflates fiscal 2023 and fiscal 2024 Q4 activity, suggesting the same $605 million purchase occurred in both periods\n   - Ground truth notes the $4.0 billion new authorization was 'approved in September 2024' - LLM does not mention this timing detail\n\n3. MULTI-HOP REASONING:\n   - The LLM correctly identifies the pattern of decreasing available authorization offset by new authorizations\n   - However, the reasoning is built on incorrect numbers, undermining the validity of the conclusion\n   - The conclusion about 'consistent, flexible capital-return strategy' is reasonable but based on flawed data\n\n4. COMPLETENESS:\n   - LLM addresses the three-year evolution (FY2022-FY2024) as requested\n   - Attempts to synthesize the pattern and strategy implications\n   - However, missing the important context that the 2023 filing 'mirrors the 2024 disclosures' regarding consistency\n\n5. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies Accenture and Class A ordinary shares\n   - Correctly references fiscal years 2022-2024\n   - Metric terminology is appropriate\n\nThe most damaging error is the '$3.13 million' vs '$3.13 billion' mistake, which represents a fundamental misreading of the source material. The fabrication or misattribution of specific share counts and Q4-specific repurchase amounts further erodes credibility. While the overall narrative structure and strategic conclusion are reasonable, the quantitative foundation is too flawed to support a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 687,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMS continued to hold a $1 billion 4.350 % senior note due 2047 in each of its 2022, 2023 and 2024 10‑K filings (page 138 for 2022, page 136 for 2023, page 134 for 2024).  The note’s principal, coupon and maturity remained unchanged and it was incorporated by reference to the same 2019 8‑K exhibit each year.  This consistency shows BMS’s long‑term financing strategy of maintaining a stable, low‑cost, fixed‑rate debt mix with long maturities to manage interest‑rate risk and support its capital needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that BMY (Bristol Myers Squibb) held the 4.350% Senior Notes due 2047 across 2022, 2023, and 2024, and accurately notes the consistency of principal, coupon, and maturity. However, there are significant issues: (1) QUANTITATIVE ERROR: The LLM specifies '$1 billion' as the principal amount, but the ground truth does not mention a specific dollar amount for these notes. This is a factual claim that cannot be verified against the provided ground truth and may be incorrect. (2) INCOMPLETENESS: The LLM answer fails to address the multi-year evolution pattern that is central to the question. The ground truth emphasizes that the 2047 notes were issued under the Eleventh Supplemental Indenture dated November 22, 2019, and that their persistence occurred alongside NEW issuances in 2023 ($1.75B 2.950% Notes due 2032, $2B 3.700% Notes due 2052) and 2024 ($3.75B 4.250% Notes due 2049). The LLM answer completely omits these other debt issuances, which are critical to understanding the 'multi-year pattern' and 'diversified long-term liabilities with staggered maturities' strategy. (3) REASONING QUALITY: While the LLM correctly concludes that the strategy involves maintaining stable, fixed-rate debt, it mischaracterizes the strategy as 'low-cost' when the 4.350% coupon is actually relatively high compared to the 2.950% and 3.700% notes issued in subsequent years. The ground truth emphasizes the 4.350% notes as a 'high-yield component,' which the LLM misses. (4) MULTI-HOP SYNTHESIS: The question explicitly asks about evolution 'across 2022, 2023, and 2024' and what the 'multi-year pattern' indicates. The LLM treats this as a static fact rather than analyzing the dynamic pattern of new issuances alongside the persistent 2047 notes. The ground truth demonstrates sophisticated multi-hop reasoning by connecting the persistence of the 2047 notes to concurrent new issuances, showing a deliberate diversification strategy. The LLM fails this synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 538,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 via an officer’s certificate (Exhibit 4.3) in its 2022 10‑K (page 56). The 2023 filing omitted that certificate, suggesting a brief shift to consolidating the disclosure within the “Description of Securities” exhibit (pages 53‑57). By 2024 Apple re‑introduced the officer’s certificate while still maintaining the “Description of Securities” exhibit, returning to its original disclosure format (page 56).",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth and contains major factual errors: (1) CORE CONTRADICTION: Ground truth states Apple disclosed the notes identically across all three periods (2022, 2023, 2024) with no changes. LLM claims significant shifts occurred—omission in 2023, reintroduction in 2024—which directly contradicts the established fact of consistent disclosure. (2) EXHIBIT LOCATION ERRORS: LLM cites specific page numbers (56, 53-57) without verification against actual filings. Ground truth indicates consistent Exhibit 4.3 placement across all years. LLM's claim of 2023 omission followed by 2024 reintroduction is factually incorrect. (3) DISCLOSURE FORMAT CLAIMS: LLM asserts a shift to 'Description of Securities' exhibit in 2023 then back to officer's certificate in 2024. Ground truth explicitly states the disclosure approach was 'stable and unchanging' with 'identical descriptions' across all periods. (4) MULTI-HOP REASONING FAILURE: The question asks how disclosure 'evolved'—implying potential changes. Ground truth correctly identifies that NO evolution occurred (stable approach). LLM incorrectly synthesizes a narrative of change where none existed. (5) SEMANTIC MISALIGNMENT: LLM's entire narrative structure (change-omission-reintroduction) is incompatible with ground truth's finding of consistency. This is not a wording difference but a fundamental factual error about the nature of Apple's disclosure practices. The LLM appears to have fabricated specific filing details and page numbers rather than accurately representing the consistent disclosure pattern documented in the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 451,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A shares in FY 2022 (page 91) and the number remained unchanged in FY 2023 (no change was reported in the 2023 filing).  By FY 2024 the authorized pool had grown to 141 million shares (page 98).  This incremental expansion shows Accenture is deliberately enlarging its share‑based compensation pool to support long‑term incentive plans and keep pace with growth while aligning employee incentives with shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the year-over-year progression. According to the ground truth, the shares authorized were: FY 2022: 127 million → FY 2023: 141 million → FY 2024: 141 million (remained stable). However, the LLM states that FY 2023 'remained unchanged' from FY 2022 and that 'by FY 2024 the authorized pool had grown to 141 million shares.' This reverses the actual timing of the increase - the increase occurred between FY 2022 and FY 2023, not between FY 2023 and FY 2024. The LLM incorrectly implies the increase happened in FY 2024 when it actually happened in FY 2023. This is a fundamental error in the multi-hop synthesis of year-over-year data. CORRECT NUMBERS: The individual share counts (127M and 141M) are accurate, but their assignment to fiscal years is wrong. REASONING QUALITY: The qualitative interpretation about strategic expansion and stabilization is reasonable and aligns with the ground truth narrative, but this cannot compensate for the incorrect temporal sequencing of events. The LLM demonstrates understanding of the strategic implications but fails on the core factual requirement of correctly tracking the progression across the three fiscal years. COMPLETENESS: The answer addresses the question's components but with inverted chronology, which fundamentally undermines the answer's accuracy regarding 'how the total evolved from fiscal year 2022 through 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 407,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "In the 2022 10‑K, PowerVia is not referenced, indicating it was still in early concept stages. By the 2023 filing (page 14), Intel announced PowerVia as a breakthrough backside‑power delivery technology for the upcoming Intel 20A node, underscoring its strategic importance. In the 2024 filing (page 10), PowerVia is highlighted as a core feature of the Intel 18A node—its first high‑volume commercial implementation—showing that the technology has moved from a future innovation to a commercial cornerstone of Intel’s advanced process roadmap for performance‑per‑watt and density scaling.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PowerVia's evolution and correctly identifies the key progression from 2022-2024. Strengths: (1) Correctly notes PowerVia was not mentioned in 2022 10-K, (2) Accurately identifies 2023 as when PowerVia was announced as backside-power delivery technology for Intel 20A, (3) Correctly states 2024 shows PowerVia as core feature of Intel 18A, (4) Properly synthesizes the transition from concept to commercial implementation, (5) Appropriately emphasizes performance-per-watt and density scaling benefits. Weaknesses: (1) The LLM states PowerVia's 'first high-volume commercial implementation' is Intel 18A, but the ground truth indicates Intel 18A was 'slated for high-volume manufacturing in 2025' - this is a subtle but important distinction suggesting future implementation rather than current/completed implementation, (2) Missing the specific detail that Intel 20A was canceled in favor of Intel 18A, which is a significant strategic decision that contextualizes the evolution, (3) Does not mention Panther Lake client processor family as the vehicle for Intel 18A deployment, which provides concrete product context. The multi-hop reasoning is sound - the answer correctly traces PowerVia across three years and synthesizes its strategic importance. The core narrative is accurate: concept → announcement → core feature. However, the temporal framing around 'first high-volume commercial implementation' could be interpreted as slightly misleading regarding timing. Overall, the answer captures the essential evolution and strategic importance but omits some contextual details about the 20A cancellation and the forward-looking nature of 18A's HVM timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 467,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s defined‑benefit pension plan invested **$239,293** in mutual‑fund equity securities in FY 2022, **$196,226** in FY 2023, and **$273,699** in FY 2024 (fair‑value data for pension assets, pages 89 and 96). The dip in 2023 followed by a rebound that surpassed the 2022 level signals a shift from a more cautious stance to a renewed emphasis on equity exposure, reflecting confidence in market growth and a willingness to take on higher risk for potential returns. This 3‑year trajectory indicates a dynamic asset‑allocation strategy that adjusts to market conditions and risk appetite.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the FY 2024 figure. Ground truth states the allocation remained unchanged at $196,226 million in FY 2024, but the LLM claims it was $273,699 million. This is a significant discrepancy ($77.5 billion difference) that fundamentally undermines the entire analysis. QUANTITATIVE ACCURACY ASSESSMENT: FY 2022: $239,293M ✓ CORRECT; FY 2023: $196,226M ✓ CORRECT; FY 2024: $273,699M ✗ INCORRECT (should be $196,226M). The LLM's calculation of the 2023-to-2024 change is therefore wrong - there was no 'rebound that surpassed the 2022 level.' The actual trajectory shows a decline from 2022 to 2023 with stability in 2024, not a V-shaped recovery. REASONING QUALITY: The LLM's interpretation of the data trajectory is fundamentally flawed due to the incorrect FY 2024 number. The conclusion about 'renewed emphasis on equity exposure' and 'confidence in market growth' is based on false data. The ground truth indicates a 'consistent reduction in exposure' and 'strategic rebalancing away from mutual fund equity securities,' which is the opposite of what the LLM concluded. MULTI-HOP SYNTHESIS: While the LLM correctly identified the source (pension assets, pages 89 and 96), it failed to accurately extract or report the FY 2024 data point, breaking the multi-hop synthesis chain. CONTEXTUAL RELEVANCE: The question asks about strategic positioning indicated by the 3-year trajectory. The LLM addresses this but with incorrect data, leading to an inverted strategic interpretation. The ground truth suggests a deliberate reduction strategy, while the LLM suggests opportunistic equity increases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 455,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck has kept Dificid (fidaxomicin) in the same niche hospital‑acute‑care portfolio as a treatment for C. difficile‑associated diarrhea, with no new indications or repositioning announced from 2022 through 2024 (see 2023 page 4 and 2024 page 130).  The intangible asset tied to Dificid remained valued at $145 million (net) in 2021 and was not impaired in the subsequent years, indicating stable confidence in its future cash flows (see 2021 page 115 and no impairment notes in 2024).  Global sales grew modestly from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, representing a small but slightly expanding share of the pharmaceutical segment (≈0.5–0.6 % of total sales).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on most key metrics but contains one significant discrepancy and some minor issues. CORRECT ELEMENTS: (1) Dificid's therapeutic positioning as a C. difficile treatment in hospital acute care is accurate; (2) The $145 million intangible asset valuation is correct; (3) The 2024 global sales figure of $340 million matches ground truth; (4) The U.S./international split ($303M U.S., $37M international) is accurate; (5) No impairment treatment is correct; (6) The strategic positioning narrative is sound. QUANTITATIVE DISCREPANCIES: The LLM reports 2022 sales as $263 million and 2023 sales as $302 million, but the ground truth does not provide these specific year-over-year figures in the original answer. The original answer only confirms 2024 sales of $340 million ($303M U.S., $37M international). The LLM's intermediate year figures cannot be verified against the provided ground truth and appear to be inferred or from additional sources not cited in the original answer. This represents a potential factual error if these numbers are incorrect. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and dimensions (asset valuation, therapeutic positioning, revenue contribution), which addresses the multi-part nature of the question. The progression narrative is logical and well-structured. COMPLETENESS: The answer addresses all three sub-questions (asset valuation evolution, therapeutic positioning, global revenue contribution) and provides temporal context from 2022-2024. MINOR ISSUES: (1) The percentage calculation (0.5-0.6% of total sales) is not verified against ground truth and appears to be an inference; (2) The citation format (page numbers) suggests specific filing references but cannot be independently verified. SEMANTIC EQUIVALENCE: The core narrative matches the ground truth's characterization of Dificid's evolution from a modest asset to a recognized revenue contributor, though the LLM emphasizes stability more than the original answer's emphasis on growth/progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 561,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022‑24 Intel positioned advanced‑packaging as a core pillar of its IDM 2.0 and Intel Foundry strategy, investing roughly $17.5 B in R&D in 2022, $16.0 B in 2023 and $16.5 B in 2024, with a focus on process‑and‑packaging technology and a disaggregated, chip‑let design approach.  Yet the company continued to hit implementation delays—10 nm and 7 nm process setbacks, a 4th‑Gen Xeon Scalable launch delay, and a $922 M inventory charge for Gaudi AI accelerators—highlighting the complexity of its advanced‑packaging roadmap.  These delays, coupled with a $3.1 B impairment of Intel 7 assets in Q3 2024 and a $755 M penalty for construction delays, amplified financial‑risk exposure, raising concerns about write‑downs, penalties, and the ability to recoup long‑term R&D and capital‑intensive manufacturing investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Intel's advanced packaging evolution from 2022-2024 and correctly identifies key themes: strategic positioning, R&D investment, implementation delays, and financial risk exposure. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies advanced packaging as core to IDM 2.0 and foundry strategy\n- Accurately cites the $3.1B impairment charge in Q3 2024\n- Correctly mentions implementation delays (10nm, 7nm process setbacks, 4th-Gen Xeon delays)\n- Appropriately characterizes the trajectory from strategic optimism to operational strain\n- Correctly references UCIe standard and chiplet design approach (implicit in disaggregated approach)\n- Properly synthesizes multi-hop information across 2022-2024 period\n\nPROBLEMATIC ELEMENTS:\n1. R&D INVESTMENT FIGURES: The LLM provides specific R&D numbers ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024). While these may be approximately correct for total R&D, the ground truth does not provide these specific figures, and they cannot be verified against the provided context. This represents unverified quantitative claims.\n\n2. $922M INVENTORY CHARGE: The LLM cites a \"$922M inventory charge for Gaudi AI accelerators.\" This specific figure and attribution are not mentioned in the ground truth and cannot be verified.\n\n3. $755M PENALTY: The LLM mentions a \"$755M penalty for construction delays.\" This specific figure is not in the ground truth and appears to be either fabricated or from unverified sources.\n\n4. MISSING GROUND TRUTH DETAILS: The LLM does not explicitly mention Intel's 2023 progress with 2D and 2.5D/3D packaging solutions or the demonstration of UCIe standard in silicon, which were highlighted in the ground truth as important 2023 developments.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects R&D investment, delays, and financial impacts. The logical flow from strategic positioning through execution challenges to financial strain is sound.\n\nSEMANTIC EQUIVALENCE: The answer conveys similar overall meaning to the ground truth regarding the evolution from optimism to strain, though with different emphasis and some unverified details.\n\nJUSTIFICATION: The answer demonstrates good understanding of the question and reasonable synthesis, but the introduction of specific financial figures ($922M, $755M) that cannot be verified against the ground truth, combined with omission of verified 2023 technical achievements, reduces confidence in accuracy. The $3.1B impairment is correctly cited, but other numbers lack verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 714,
        "total_tokens": 2193
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "In the 2022 and 2023 10‑K filings (page 23 of each), MK‑8591A is listed as a Phase 2 HIV‑1 candidate with footnote (4) indicating an FDA clinical hold. By the 2024 filing (page 24), footnote (4) notes that the hold was lifted on December 4 2024 (with a partial hold for higher‑dose regimens) and the program had entered a Phase 2/3 study that began in August 2024. This evolution shows Merck’s commitment to advancing a novel oral HIV therapy through late‑stage development, underscoring a long‑term strategy to expand its HIV portfolio despite earlier regulatory setbacks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) PHASE CLASSIFICATION ERROR: The LLM states MK-8591A was in 'Phase 2' in 2022-2023, but the ground truth clearly indicates it was in 'Phase 3' with a Phase 3 entry date of February 2020. This is a major mischaracterization of the development stage. (2) TIMELINE DISCREPANCY: The LLM claims the program 'entered a Phase 2/3 study that began in August 2024,' but the ground truth indicates it remained in Phase 3 throughout 2022-2024 with no mention of entering Phase 2/3 in 2024. The ground truth shows continuous Phase 3 status, not a transition to Phase 2/3. (3) CLINICAL HOLD DETAILS: While the LLM correctly identifies the December 4, 2024 lifting of the clinical hold and the partial hold for higher doses, it misses the critical context that the compound was already in Phase 3 when the hold was in place, indicating more advanced development than Phase 2. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the progression across years. The ground truth shows: 2022 (Phase 3, ongoing), 2023 (Phase 3, ongoing), 2024 (Phase 3, hold lifted). The LLM incorrectly downgraded the phase classification and introduced a non-existent Phase 2/3 transition. (5) STRATEGIC INTERPRETATION: While both answers correctly identify Merck's commitment to HIV despite regulatory challenges, the LLM's incorrect phase classification undermines the credibility of this assessment. The ground truth's narrative of persistent Phase 3 development despite holds is more compelling evidence of commitment than the LLM's confused Phase 2/3 narrative. The answer demonstrates a fundamental misreading of the source documents regarding development stage classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 486,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "In 2022, Merck positioned MK‑1308A (quavonlimab + pembrolizumab) as a broad‑based advanced‑solid‑tumor therapy, with activity planned in colorectal, hepatocellular, melanoma and small‑cell lung cancers (page 25). By 2023 the program had narrowed its clinical focus to renal cell carcinoma (RCC), retaining the same combination (page 18). In 2024 the RCC focus continues, with MK‑1308A still described as a quavonlimab‑pembrolizumab co‑formulation for RCC (page 48). Across all filings, no regulatory submissions, approvals or CRLs for MK‑1308A are reported, indicating the program remains in early clinical development.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) CLINICAL FOCUS ERROR: The LLM claims that in 2022, MK-1308A was positioned for 'broad-based advanced-solid-tumor therapy' with activity in colorectal, hepatocellular, melanoma, and small-cell lung cancers. The ground truth explicitly states that in 2022, MK-1308A was specifically for renal cell carcinoma (RCC) in Phase 3 development. This is a fundamental mischaracterization of the 2022 strategy. (2) FORMULATION TIMING ERROR: The LLM states that in 2022, MK-1308A was already described as 'quavonlimab + pembrolizumab,' but the ground truth indicates this explicit coformulation description only appeared in 2023. In 2022, it was simply listed as part of the oncology pipeline without the detailed formulation specification. (3) PROGRESSION NARRATIVE INVERTED: The LLM describes a narrowing from broad indications to RCC, but the ground truth shows consistent RCC focus from 2022 onward with increasing specificity in formulation definition. The LLM's narrative of 'narrowing' suggests a strategic pivot that did not occur. (4) REGULATORY STATUS: While the LLM correctly notes no regulatory submissions/approvals, this is a minor point of agreement. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution across years - it appears to have confused or misread the clinical indication data across the three-year period. The page citations provided (25, 18, 48) cannot be verified but the factual claims contradict the ground truth substantially. The answer demonstrates poor accuracy on the core question about how the development strategy evolved, particularly regarding clinical focus and combination therapy details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 477,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.18 million shares for $4.11 million, with an available authorization of $3.13 million and total outstanding authority of $6.13 million after a $3.00 million increase. In fiscal 2023 the company continued to use its share‑repurchase program, and in fiscal 2024 it bought 2.07 million shares in Q4 for $605 million while the Board added $4.00 billion in new authority, raising total outstanding authority to $6.694 billion and leaving $2.694 million available for the open‑market program. This steady repurchase activity, coupled with incremental increases in authorized capacity over three years, demonstrates Accenture’s disciplined, long‑term capital‑return strategy that balances shareholder payouts with flexibility for future investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - Multiple severe quantitative inaccuracies undermine the entire answer: (1) FISCAL 2022 NUMBERS: LLM states '12.18 million shares for $4.11 million' - this is completely wrong. Ground truth shows available authorization of $3,129,296 thousand ($3.13 billion), not $4.11 million. The LLM appears to have confused share count with dollar amounts and used wrong units entirely. (2) FISCAL 2024 SHARE REPURCHASE: LLM correctly identifies 2.07 million shares (ground truth: 2,000,308 shares ≈ 2.0 million) for $605 million - this is approximately correct. (3) NEW AUTHORITY: LLM correctly states $4.00 billion new authority approved in September 2024 - correct. (4) TOTAL OUTSTANDING AUTHORITY: LLM states $6.694 billion - correct. (5) AVAILABLE AUTHORIZATION: LLM states '$2.694 million available' - this is a UNIT ERROR. Ground truth shows $2,694 million ($2.694 billion), not $2.694 million. This is a 1,000x error. (6) FISCAL 2022 BASELINE: LLM states '$3.13 million' available authorization - should be $3.13 billion. Another 1,000x unit error. (7) MISSING CONTEXT: LLM fails to clearly explain the evolution from fiscal 2022 ($3.13B available) to fiscal 2024 ($2.694B available) despite new $4B authorization, which is a key insight about how repurchases consumed authorization. The reasoning about 'disciplined, long-term capital-return strategy' is qualitatively sound but is undermined by the fundamental numerical errors. The multi-hop synthesis is attempted but corrupted by unit conversion failures throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 422,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb has kept the $750 million 2.350 % notes due 2040 on its balance sheet in both the 2023 and 2024 10‑Ks (see the debt schedule on pages 134–136 of each filing), and the same instrument was also disclosed in the 2022 filing, indicating a deliberate decision to retain a long‑term fixed‑rate debt. This persistence reflects the company’s strategy of locking in a relatively low interest rate and maintaining a stable maturity profile to reduce refinancing risk and manage its long‑term debt obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All quantitative data is accurate - correctly identifies the $750 million principal amount, 2.350% interest rate, and 2040 maturity date; (2) Correctly identifies the persistence of this debt instrument across 2022, 2023, and 2024 filings; (3) Provides specific citation references (pages 134-136) showing familiarity with actual filing structure; (4) Accurately characterizes the strategic rationale - locking in a relatively low fixed rate, maintaining stable maturity profile, reducing refinancing risk; (5) Multi-hop synthesis is sound, connecting the persistence of the debt across three years to strategic intent. MINOR WEAKNESSES: (1) The LLM answer explicitly references only 2023 and 2024 10-Ks with page citations, then mentions 2022 'was also disclosed' without the same level of detail - while factually correct, this creates slightly less balanced coverage compared to the ground truth which gives equal weight to all three years; (2) The ground truth emphasizes 'despite market fluctuations' and 'deliberate approach to long-term interest rate risk management' with slightly more nuanced language about the strategic decision-making process; (3) The LLM answer could have been more explicit about the consistency across all three years being equally important to the narrative. CALCULATION/VERIFICATION: No calculations required; all numbers verified as correct. The reasoning about fixed-rate debt strategy, interest rate risk management, and refinancing risk reduction is logically sound and semantically equivalent to the ground truth. The answer demonstrates understanding of the multi-hop requirement (synthesizing information across three years of filings) and correctly interprets what the persistence of this specific debt instrument signifies about corporate strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 511,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb has kept the same fixed‑rate commitment on its $1 billion senior notes due 2047 across the 2022, 2023 and 2024 10‑K filings (see the 4.350% Senior Notes listed on pages 134, 136, 138 and 137).  The unchanged 4.350% rate shows the company’s preference for stable, predictable long‑term debt, avoiding refinancing risk and maintaining a conservative interest‑expense profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.350% interest rate and confirms it remained consistent across 2022, 2023, and 2024 filings. The company name (Bristol-Myers Squibb) is correct. The interpretation about stable, predictable long-term debt strategy aligns with the ground truth's conclusion. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a '$1 billion senior notes' figure that is NOT present in the ground truth answer. This is a significant factual addition without verification. (2) PAGE NUMBER ERRORS - The LLM cites specific page numbers (134, 136, 138, 137) that cannot be verified against the ground truth and appear to be hallucinated. (3) MISSING KEY DETAILS - The ground truth provides specific exhibit references (Exhibit 4bbb in 2022, Exhibit 4ff in 2023 and 2024) and supplemental indenture dates (Twelfth Supplemental Indenture dated November 13, 2020; Fourteenth Supplemental Indenture dated November 13, 2023; Form 8-K from November 22, 2019). The LLM completely omits these important documentary references that demonstrate the multi-hop synthesis across filings. (4) INCOMPLETE MULTI-HOP REASONING - While the LLM correctly identifies the consistency pattern, it fails to cite the specific indenture documents and exhibit references that form the basis of the ground truth's analysis. This represents incomplete synthesis of the multi-document evidence. (5) UNVERIFIED CLAIM - The '$1 billion' amount is introduced without source attribution and contradicts the principle of strict accuracy on financial figures. The reasoning about debt strategy is sound but lacks the documentary evidence that supports it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 452,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike’s 2022 filing simply listed FlyEase among its suite of technologies (source: page_7). In the 2024 filing, FlyEase is still mentioned in that same list, but the company adds detailed manufacturing metrics—96 finished‑goods footwear factories in 11 countries, 15 contract manufacturers producing Nike Brand footwear, and 50 % of production in Vietnam, 27 % in Indonesia and 18 % in China—demonstrating the scale and global integration of FlyEase technology (source: page_6).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the manufacturing percentages (Vietnam 50%, Indonesia 27%, China 18%) which match the ground truth exactly. The numeric data about factory counts (96 finished-goods footwear factories in 11 countries, 15 contract manufacturers) appears accurate and adds relevant detail. The LLM correctly notes FlyEase's presence in both 2022 and 2024 filings.\n\nWEAKNESSES: (1) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to address fiscal 2023 entirely, missing a critical part of the three-year evolution requested. The ground truth explicitly notes that fiscal 2023 showed FlyEase being 'consistently mentioned alongside established technologies like Nike Air and Dri-FIT,' indicating growing integration. The LLM jumps from 2022 to 2024, breaking the multi-hop synthesis across three fiscal years. (2) MISSING CONTEXTUAL ANALYSIS: The ground truth emphasizes the EVOLUTION and PROGRESSION of FlyEase's importance (early-stage → growing integration → full-scale integration). The LLM treats 2022 and 2024 as static mentions without capturing this strategic progression. (3) INCOMPLETE REASONING: While the LLM correctly states the manufacturing data 'demonstrates the scale and global integration,' it doesn't explain WHY this geographic distribution proves 'full-scale integration into Nike's global supply chain' as the ground truth does. (4) MISSING SYNTHESIS: The ground truth connects the manufacturing data to 'scalability and strategic embedding into core footwear production'—the LLM mentions integration but doesn't fully synthesize how the specific percentages prove this.\n\nQUANTITATIVE VERIFICATION: All percentages and factory numbers appear correct (50%, 27%, 18%, 96 factories, 15 contract manufacturers, 11 countries). No calculation errors detected.\n\nMULTI-HOP REASONING: Partially successful. The LLM correctly synthesizes manufacturing data with FlyEase integration but fails to complete the three-year evolution analysis required by the question. This is a significant gap in multi-hop reasoning across the temporal dimension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 559,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s debit‑card/RedCard suite has seen a steady decline in penetration: 20.5 % of purchases were paid with a RedCard in 2022, falling to 19.8 % in 2023 and 18.6 % in 2024 (Target Circle Card penetration)【page_27】【page_29】. The downward trend suggests that the loyalty‑driven payment strategy is losing momentum—while still capturing a sizable share of sales, its growth is slowing, indicating that the program may need to be refreshed to sustain or increase adoption.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL ERROR: The LLM provides 18.6% for 2024, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The error in the 2024 figure is a significant factual mistake that undermines the accuracy of the answer. QUALITATIVE ASSESSMENT: The LLM correctly identifies the overall trend (declining penetration), correctly names the product (RedCard/Target Circle Card), and provides sound reasoning about what the decline suggests (weakening effectiveness, need for program refresh). The multi-hop synthesis is appropriate - the model connects the penetration rate data to strategic implications. COMPLETENESS: The answer addresses both parts of the question: (1) how the penetration rate evolved (though with an error in the final year), and (2) what the trend suggests about strategy effectiveness. The interpretation that the program 'may need to be refreshed' is reasonable and aligns with the ground truth's assessment of 'reduced customer engagement.' SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'losing momentum' and 'slowing growth' is semantically equivalent to the ground truth's 'weakening effectiveness.' However, the specific numeric error in 2024 (18.6% vs. 17.8%) is a factual mistake that cannot be overlooked in financial analysis. This is not a formatting difference but an actual data error. The reasoning quality is sound, but the quantitative foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 421,
        "total_tokens": 1659
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 798,
    "successful_evaluations": 797,
    "failed_evaluations": 1,
    "average_correctness_score": 5.34,
    "average_quantitative_accuracy": 5.62,
    "average_qualitative_accuracy": 5.59,
    "average_contextual_relevance": 6.51,
    "score_distribution": {
      "excellent": 96,
      "good": 181,
      "fair": 269,
      "poor": 251
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 798,
    "failed": 2,
    "elapsed_seconds": 44518.91,
    "timestamp": "2026-02-03T13:25:53.191415"
  }
}